1	From	IN	O	from	_	0	SENT_1	[p1l95t1203r159b1224],
2	Royal	NNP	ORGANIZATION	Royal	nn	4	SENT_1	[p1l173t1201r238b1232],
3	Perth	NNP	ORGANIZATION	Perth	nn	4	SENT_1	[p1l252t1201r318b1224],
4	Hospital	NNP	ORGANIZATION	Hospital	pobj	1	SENT_1	[p1l332t1201r440b1232],
5	and	CC	O	and	_	0	SENT_1	[p1l452t1201r498b1224],
6	Murdoch	NNP	ORGANIZATION	Murdoch	nn	8	SENT_1	[p1l511t1201r627b1224],
7	University	NNP	ORGANIZATION	University	nn	8	SENT_1	[p1l94t1240r225b1269],
8	—	NN	O	—	conj_and	4	SENT_1	[p1l243t1252r275b1255],
9	both	CC	O	both	dep	13	SENT_1	[p1l294t1238r351b1262],
10	in	IN	O	in	_	0	SENT_1	[p1l373t1240r393b1261],
11	Perth	NNP	LOCATION	Perth	prep_in	13	SENT_1	[p1l417t1238r492b1266],
12	,	,	O	,	_	0	SENT_1	[p1l417t1238r492b1266],
13	Australia	NNP	LOCATION	Australia	dep	4	SENT_1	[p1l512t1238r628b1262],
14	(	CD	NUMBER	(	num	13	SENT_1	[p1l95t1277r170b1307],
15	S.M.	NNP	LOCATION	S.M.	nn	20	SENT_1	[p1l95t1277r170b1307],
16	,	,	O	,	_	0	SENT_1	[p1l95t1277r170b1307],
17	E.P.	NNP	LOCATION	E.P.	appos	20	SENT_1	[p1l186t1278r237b1303],
18	,	,	O	,	_	0	SENT_1	[p1l186t1278r237b1303],
19	D.N.	NNP	O	D.N.	appos	20	SENT_1	[p1l253t1277r328b1307],
20	)	NNP	O	)	dep	13	SENT_1	[p1l253t1277r328b1307],
21	;	:	O	;	_	0	SENT_1	[p1l253t1277r328b1307],
22	Universita	NNP	ORGANIZATION	Universita	nn	26	SENT_1	[p1l343t1278r474b1299],
23	degli	NNP	O	degli	nn	26	SENT_1	[p1l487t1275r548b1307],
24	Studi	NNP	PERSON	Studi	nn	26	SENT_1	[p1l562t1275r627b1299],
25	di	NNP	O	di	nn	26	SENT_1	[p1l93t1313r114b1337],
26	Brescia	NNP	ORGANIZATION	Brescia	dep	13	SENT_1	[p1l132t1315r231b1341],
27	,	,	O	,	_	0	SENT_1	[p1l132t1315r231b1341],
28	Brescia	NNP	LOCATION	Brescia	nn	33	SENT_1	[p1l248t1315r348b1341],
29	,	,	O	,	_	0	SENT_1	[p1l248t1315r348b1341],
30	Italy	NNP	LOCATION	Italy	appos	33	SENT_1	[p1l365t1313r417b1344],
31	(	NNP	O	(	nn	33	SENT_1	[p1l434t1315r515b1344],
32	G.C.	NNP	LOCATION	G.C.	nn	33	SENT_1	[p1l434t1315r515b1344],
33	)	NNP	O	)	appos	26	SENT_1	[p1l434t1315r515b1344],
34	;	:	O	;	_	0	SENT_1	[p1l434t1315r515b1344],
35	Hopital	NNP	ORGANIZATION	Hopital	nn	41	SENT_1	[p1l532t1313r627b1344],
36	Saint	NNP	ORGANIZATION	Saint	nn	41	SENT_1	[p1l93t1352r158b1374],
37	Louis	NNP	ORGANIZATION	Louis	nn	41	SENT_1	[p1l178t1352r253b1378],
38	,	,	O	,	_	0	SENT_1	[p1l178t1352r253b1378],
39	Paris	NNP	LOCATION	Paris	appos	41	SENT_1	[p1l275t1352r336b1374],
40	(	CD	NUMBER	(	num	41	SENT_1	[p1l358t1352r484b1381],
41	J.-M.M.	NNP	O	J.-M.M.	dep	13	SENT_1	[p1l358t1352r484b1381],
42	)	NN	O	)	dep	41	SENT_1	[p1l358t1352r484b1381],
43	;	:	O	;	_	0	SENT_1	[p1l358t1352r484b1381],
44	AIDS	NNP	MISC	AIDS	nn	50	SENT_1	[p1l502t1352r568b1374],
45	Research	NNP	MISC	Research	nn	50	SENT_1	[p1l589t1352r628b1374, p1l93t1383r176b1407],
46	Initiative	NNP	MISC	Initiative	nn	50	SENT_1	[p1l193t1385r310b1411],
47	,	,	O	,	_	0	SENT_1	[p1l193t1385r310b1411],
48	Darlinghurst	NNP	LOCATION	Darlinghurst	appos	50	SENT_1	[p1l327t1383r498b1414],
49	,	,	O	,	_	0	SENT_1	[p1l327t1383r498b1414],
50	Australia	NNP	LOCATION	Australia	dep	13	SENT_1	[p1l512t1383r627b1407],
51	(	CD	NUMBER	(	num	50	SENT_1	[p1l95t1423r180b1452],
52	C.W.	NNP	O	C.W.	nn	53	SENT_1	[p1l95t1423r180b1452],
53	)	NNP	O	)	dep	50	SENT_1	[p1l95t1423r180b1452],
54	;	:	O	;	_	0	SENT_1	[p1l95t1423r180b1452],
55	University	NNP	ORGANIZATION	University	nn	58	SENT_1	[p1l202t1423r332b1452],
56	Medical	NNP	ORGANIZATION	Medical	nn	58	SENT_1	[p1l354t1421r454b1444],
57	Center	NNP	ORGANIZATION	Center	nn	58	SENT_1	[p1l475t1423r561b1444],
58	Ljubljana	NNP	ORGANIZATION	Ljubljana	dep	13	SENT_1	[p1l582t1423r628b1452, p1l94t1458r178b1489],
59	,	,	O	,	_	0	SENT_1	[p1l582t1423r628b1452, p1l94t1458r178b1489],
60	Ljubljana	NNP	LOCATION	Ljubljana	nn	65	SENT_1	[p1l191t1458r315b1489],
61	,	,	O	,	_	0	SENT_1	[p1l191t1458r315b1489],
62	Slovenia	NNP	LOCATION	Slovenia	appos	65	SENT_1	[p1l328t1458r435b1482],
63	(	NNP	O	(	nn	65	SENT_1	[p1l449t1460r515b1489],
64	J.T.	NNP	PERSON	J.T.	nn	65	SENT_1	[p1l449t1460r515b1489],
65	)	NNP	O	)	appos	58	SENT_1	[p1l449t1460r515b1489],
66	;	:	O	;	_	0	SENT_1	[p1l449t1460r515b1489],
67	HIV	NN	O	hiv	nn	68	SENT_1	[p1l529t1460r577b1482],
68	Research	NN	O	research	dep	13	SENT_1	[p1l589t1460r628b1482, p1l93t1496r176b1519],
69	and	CC	O	and	_	0	SENT_1	[p1l189t1496r235b1519],
70	Clinical	JJ	ORGANIZATION	clinical	amod	73	SENT_1	[p1l248t1496r341b1519],
71	Care	NNP	ORGANIZATION	Care	nn	73	SENT_1	[p1l355t1498r412b1519],
72	Center	NNP	ORGANIZATION	Center	nn	73	SENT_1	[p1l424t1498r510b1519],
73	Munich	NNP	ORGANIZATION	Munich	conj_and	68	SENT_1	[p1l523t1496r627b1524],
74	,	,	O	,	_	0	SENT_1	[p1l523t1496r627b1524],
75	Munich	NNP	LOCATION	Munich	appos	73	SENT_1	[p1l95t1533r199b1561],
76	,	,	O	,	_	0	SENT_1	[p1l95t1533r199b1561],
77	Germany	NNP	LOCATION	Germany	nn	79	SENT_1	[p1l219t1535r337b1564],
78	(	CD	NUMBER	(	num	79	SENT_1	[p1l358t1535r465b1564],
79	E.J.-G	NN	O	e.j.-g	appos	73	SENT_1	[p1l358t1535r465b1564],
80	.	.	O	.	_	0	SENT_1	[p1l358t1535r465b1564],
81	)	SYM	O	)	dep	13	SENT_1	[p1l358t1535r465b1564],

1	;	:	O	;	_	0	SENT_2	[p1l358t1535r465b1564],
2	Infectioase	NNP	LOCATION	Infectioase	nn	9	SENT_2	[p1l487t1533r628b1557],
3	Constanta	NNP	LOCATION	Constanta	nn	9	SENT_2	[p1l93t1573r234b1599],
4	,	,	O	,	_	0	SENT_2	[p1l93t1573r234b1599],
5	Bucharest	NNP	LOCATION	Bucharest	appos	9	SENT_2	[p1l256t1571r393b1599],
6	,	,	O	,	_	0	SENT_2	[p1l256t1571r393b1599],
7	Romania	NNP	LOCATION	Romania	appos	9	SENT_2	[p1l416t1573r528b1594],
8	(	CD	NUMBER	(	num	9	SENT_2	[p1l551t1573r627b1602],
9	S.R.	NNP	LOCATION	S.R.	_	0	SENT_2	[p1l551t1573r627b1602],
10	)	CD	NUMBER	)	dep	9	SENT_2	[p1l551t1573r627b1602],
11	;	:	O	;	_	0	SENT_2	[p1l551t1573r627b1602],
12	Volgograd	NNP	ORGANIZATION	Volgograd	nn	14	SENT_2	[p1l92t1608r224b1639],
13	Regional	NNP	ORGANIZATION	Regional	nn	14	SENT_2	[p1l237t1608r346b1639],
14	Center	NNP	ORGANIZATION	Center	dep	9	SENT_2	[p1l357t1610r443b1632],
15	for	IN	O	for	_	0	SENT_2	[p1l451t1608r487b1632],
16	AIDS	NNP	MISC	AIDS	nn	22	SENT_2	[p1l495t1610r568b1636],
17	,	,	O	,	_	0	SENT_2	[p1l495t1610r568b1636],
18	Volgograd	NNP	LOCATION	Volgograd	appos	22	SENT_2	[p1l578t1608r628b1632, p1l93t1646r190b1677],
19	,	,	O	,	_	0	SENT_2	[p1l578t1608r628b1632, p1l93t1646r190b1677],
20	Russia	NNP	LOCATION	Russia	appos	22	SENT_2	[p1l213t1648r294b1669],
21	(	CD	NUMBER	(	num	22	SENT_2	[p1l317t1648r399b1677],
22	O.K.	NNP	O	O.K.	prep_for	14	SENT_2	[p1l317t1648r399b1677],
23	)	CD	NUMBER	)	dep	22	SENT_2	[p1l317t1648r399b1677],
24	;	:	O	;	_	0	SENT_2	[p1l317t1648r399b1677],
25	Hospital	NNP	PERSON	Hospital	nn	28	SENT_2	[p1l422t1646r530b1677],
26	Arnau	NNP	PERSON	Arnau	nn	28	SENT_2	[p1l550t1647r627b1669],
27	de	IN	PERSON	de	amod	28	SENT_2	[p1l93t1753r123b1776],
28	Vilanova	NNP	PERSON	Vilanova	dep	9	SENT_2	[p1l135t1753r254b1781],
29	,	,	O	,	_	0	SENT_2	[p1l135t1753r254b1781],
30	Valencia	NNP	LOCATION	Valencia	nn	34	SENT_2	[p1l267t1753r384b1781],
31	,	,	O	,	_	0	SENT_2	[p1l267t1753r384b1781],
32	Spain	NNP	LOCATION	Spain	appos	34	SENT_2	[p1l399t1755r469b1784],
33	(	CD	NUMBER	(	num	34	SENT_2	[p1l486t1755r581b1784],
34	j.F.C.	NNP	O	j.F.C.	appos	28	SENT_2	[p1l486t1755r581b1784],
35	)	NN	O	)	dep	34	SENT_2	[p1l486t1755r581b1784],
36	;	:	O	;	_	0	SENT_2	[p1l486t1755r581b1784],
37	St.	NNP	LOCATION	St.	nn	38	SENT_2	[p1l595t1755r627b1776],
38	George	NNP	LOCATION	George	poss	43	SENT_2	[p1l93t1792r208b1822],
39	's	POS	LOCATION	's	_	0	SENT_2	[p1l93t1792r208b1822],
40	Hospital	NNP	LOCATION	Hospital	nn	43	SENT_2	[p1l225t1790r333b1821],
41	(	NNP	O	(	nn	43	SENT_2	[p1l351t1792r422b1821],
42	P.H.	NNP	LOCATION	P.H.	nn	43	SENT_2	[p1l351t1792r422b1821],
43	)	NNP	O	)	dep	9	SENT_2	[p1l351t1792r422b1821],
44	and	CC	O	and	_	0	SENT_2	[p1l439t1790r485b1814],
45	MediTech	NNP	O	MediTech	nn	48	SENT_2	[p1l502t1790r627b1814],
46	Media	NNP	O	Media	nn	48	SENT_2	[p1l95t1828r173b1852],
47	(	CD	NUMBER	(	num	48	SENT_2	[p1l190t1830r257b1859],
48	S.R.	NNP	LOCATION	S.R.	conj_and	43	SENT_2	[p1l190t1830r257b1859],
49	)	CD	NUMBER	)	number	50	SENT_2	[p1l190t1830r257b1859],
50	—	CD	NUMBER	—	dep	48	SENT_2	[p1l271t1843r303b1845],
51	both	DT	O	both	dep	9	SENT_2	[p1l317t1828r373b1852],
52	in	IN	O	in	_	0	SENT_2	[p1l389t1830r409b1851],
53	London	NNP	LOCATION	London	prep_in	9	SENT_2	[p1l426t1828r530b1856],
54	;	:	O	;	_	0	SENT_2	[p1l426t1828r530b1856],
55	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	63	SENT_2	[p1l545t1828r628b1852, p1l93t1866r243b1894],
56	,	,	O	,	_	0	SENT_2	[p1l545t1828r628b1852, p1l93t1866r243b1894],
57	Greenford	NNP	LOCATION	Greenford	appos	63	SENT_2	[p1l257t1865r397b1894],
58	,	,	O	,	_	0	SENT_2	[p1l257t1865r397b1894],
59	United	NNP	LOCATION	United	appos	63	SENT_2	[p1l412t1866r497b1890],
60	Kingdom	NNP	LOCATION	Kingdom	nn	63	SENT_2	[p1l512t1866r627b1897],
61	(	NNP	O	(	nn	63	SENT_2	[p1l95t1905r173b1934],
62	S.H.	NNP	LOCATION	S.H.	nn	63	SENT_2	[p1l95t1905r173b1934],
63	)	NNP	O	)	conj_and	53	SENT_2	[p1l95t1905r173b1934],
64	;	:	O	;	_	0	SENT_2	[p1l95t1905r173b1934],
65	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_in	9	SENT_2	[p1l182t1903r398b1931],
66	,	,	O	,	_	0	SENT_2	[p1l182t1903r398b1931],
67	Research	NNP	O	Research	nn	69	SENT_2	[p1l409t1903r519b1926],
68	Triangle	NNP	O	Triangle	nn	69	SENT_2	[p1l527t1903r628b1934],
69	Park	NNP	O	Park	prep_in	9	SENT_2	[p1l95t1940r156b1968],
70	,	,	O	,	_	0	SENT_2	[p1l95t1940r156b1968],
71	NC	NNP	O	NC	nn	73	SENT_2	[p1l176t1942r216b1964],
72	(	NNP	O	(	nn	73	SENT_2	[p1l235t1942r319b1971],
73	A.H.	NNP	LOCATION	A.H.	prep_in	9	SENT_2	[p1l235t1942r319b1971],
74	)	NN	O	)	dep	73	SENT_2	[p1l235t1942r319b1971],
75	;	:	O	;	_	0	SENT_2	[p1l235t1942r319b1971],
76	and	CC	O	and	_	0	SENT_2	[p1l338t1940r383b1964],
77	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	89	SENT_2	[p1l402t1940r627b1968],
78	,	,	O	,	_	0	SENT_2	[p1l402t1940r627b1968],
79	Brentford	NNP	ORGANIZATION	Brentford	appos	89	SENT_2	[p1l95t1977r225b2006],
80	,	,	O	,	_	0	SENT_2	[p1l95t1977r225b2006],
81	United	NNP	LOCATION	United	appos	89	SENT_2	[p1l244t1977r329b2001],
82	Kingdom	NNP	LOCATION	Kingdom	nn	89	SENT_2	[p1l349t1977r464b2009],
83	(	NNP	O	(	nn	89	SENT_2	[p1l485t1979r553b2009],
84	N.F.	NNP	LOCATION	N.F.	nn	89	SENT_2	[p1l485t1979r553b2009],
85	,	,	O	,	_	0	SENT_2	[p1l485t1979r553b2009],
86	D.T.	NNP	LOCATION	D.T.	appos	89	SENT_2	[p1l573t1979r627b2005],
87	,	,	O	,	_	0	SENT_2	[p1l573t1979r627b2005],
88	A.B.	NNP	O	A.B.	appos	89	SENT_2	[p1l92t2012r161b2042],
89	)	NNP	O	)	prep_in	9	SENT_2	[p1l92t2012r161b2042],
90	.	.	O	.	_	0	SENT_2	[p1l92t2012r161b2042],

1	Address	NN	O	address	nsubj	2	SENT_3	[p1l170t2011r273b2035],
2	reprint	VB	O	reprint	conj_or	2	SENT_3	[p1l283t2013r368b2042],
3	requests	NNS	O	request	dobj	2	SENT_3	[p1l377t2015r484b2042],
4	to	TO	O	to	_	0	SENT_3	[p1l492t2015r517b2035],
5	Dr.	NNP	O	Dr.	nn	6	SENT_3	[p1l527t2013r562b2035],
6	Mallal	NNP	PERSON	Mallal	prep_to	2	SENT_3	[p1l573t2011r628b2035, p1l94t2048r120b2072],
7	at	IN	O	at	_	0	SENT_3	[p1l136t2053r159b2072],
8	the	DT	O	the	det	9	SENT_3	[p1l172t2048r212b2072],
9	Institute	NNP	ORGANIZATION	Institute	prep_at	6	SENT_3	[p1l229t2050r336b2072],
10	for	IN	ORGANIZATION	for	_	0	SENT_3	[p1l350t2048r386b2072],
11	Immunology	NNP	ORGANIZATION	Immunology	prep_for	9	SENT_3	[p1l401t2048r567b2079],
12	and	CC	O	and	_	0	SENT_3	[p1l581t2048r627b2072],
13	Infectious	JJ	O	infectious	amod	14	SENT_3	[p1l95t2086r223b2109],
14	Diseases	NNS	O	disease	prep_at	6	SENT_3	[p1l233t2088r354b2114],
15	,	,	O	,	_	0	SENT_3	[p1l233t2088r354b2114],
16	Murdoch	NNP	ORGANIZATION	Murdoch	nn	17	SENT_3	[p1l365t2086r481b2109],
17	University	NNP	ORGANIZATION	University	appos	14	SENT_3	[p1l491t2088r627b2117],
18	,	,	O	,	_	0	SENT_3	[p1l491t2088r627b2117],
19	South	NNP	LOCATION	South	nn	20	SENT_3	[p1l93t2123r168b2147],
20	St.	NNP	LOCATION	St.	appos	14	SENT_3	[p1l180t2125r220b2151],
21	,	,	O	,	_	0	SENT_3	[p1l180t2125r220b2151],
22	Murdoch	NNP	PERSON	Murdoch	appos	14	SENT_3	[p1l234t2123r358b2151],
23	,	,	O	,	_	0	SENT_3	[p1l234t2123r358b2151],
24	WA	NNP	LOCATION	WA	appos	14	SENT_3	[p1l370t2125r414b2147],
25	6150	CD	NUMBER	6150	num	24	SENT_3	[p1l425t2125r492b2151],
26	,	,	O	,	_	0	SENT_3	[p1l425t2125r492b2151],
27	Australia	NNP	LOCATION	Australia	appos	14	SENT_3	[p1l504t2123r627b2151],
28	,	,	O	,	_	0	SENT_3	[p1l504t2123r627b2151],
29	or	CC	O	or	_	0	SENT_3	[p1l93t2169r119b2184],
30	at	IN	O	at	_	0	SENT_3	[p1l128t2165r151b2184],
31	s.mallal@murdoch.edu.au	NN	O	s.mallal@murdoch.edu.au	prep_at	2	SENT_3	[p1l160t2161r517b2189],
32	.	.	O	.	_	0	SENT_3	[p1l160t2161r517b2189],

1	*	NN	O	*	nn	2	SENT_4	[p1l92t2236r233b2259],
2	Members	NNS	O	member	_	0	SENT_4	[p1l92t2236r233b2259],
3	of	IN	O	of	_	0	SENT_4	[p1l248t2236r276b2259],
4	the	DT	O	the	det	7	SENT_4	[p1l286t2236r327b2259],
5	Prospective	JJ	O	prospective	amod	7	SENT_4	[p1l344t2238r494b2267],
6	Randomized	NNP	O	Randomized	nn	7	SENT_4	[p1l511t2236r628b2259, p1l110t2273r161b2297],
7	Evaluation	NN	O	evaluation	prep_of	2	SENT_4	[p1l177t2273r310b2297],
8	of	IN	O	of	_	0	SENT_4	[p1l324t2273r352b2297],
9	DNA	NN	O	dna	nn	10	SENT_4	[p1l363t2275r425b2297],
10	Screening	NN	O	screening	prep_of	7	SENT_4	[p1l438t2275r567b2304],
11	in	IN	O	in	mark	24	SENT_4	[p1l580t2276r601b2297],
12	a	DT	O	a	det	22	SENT_4	[p1l616t2282r628b2297],
13	ClinicalTrial	JJ	O	clinicaltrial	amod	22	SENT_4	[p1l110t2311r263b2334],
14	(	CD	NUMBER	(	num	22	SENT_4	[p1l275t2313r430b2342],
15	PRED	NNP	O	PRED	nn	22	SENT_4	[p1l275t2313r430b2342],
16	|	CD	NUMBER	|	num	22	SENT_4	[p1l275t2313r430b2342],
17	CT	NNP	O	CT	nn	22	SENT_4	[p1l275t2313r430b2342],
18	—	CD	NUMBER	—	num	22	SENT_4	[p1l275t2313r430b2342],
19	1	CD	NUMBER	1	num	22	SENT_4	[p1l275t2313r430b2342],
20	)	NN	O	)	nn	22	SENT_4	[p1l275t2313r430b2342],
21	study	NN	O	study	nn	22	SENT_4	[p1l442t2311r510b2342],
22	team	NN	O	team	nsubjpass	24	SENT_4	[p1l517t2315r580b2334],
23	are	VBP	O	be	auxpass	24	SENT_4	[p1l590t2319r628b2334],
24	listed	VBN	O	list	dep	7	SENT_4	[p1l111t2348r178b2372],
25	in	IN	O	in	_	0	SENT_4	[p1l191t2350r212b2371],
26	the	DT	O	the	det	27	SENT_4	[p1l223t2348r264b2372],
27	Appendix	NNP	O	Appendix	prep_in	24	SENT_4	[p1l273t2348r405b2379],
28	.	.	O	.	_	0	SENT_4	[p1l273t2348r405b2379],

1	N	NN	MISC	n	nn	3	SENT_5	[p1l95t2425r112b2446],
2	Englj	NNP	MISC	Englj	nn	3	SENT_5	[p1l126t2423r194b2454],
3	Med	NNP	O	Med	_	0	SENT_5	[p1l207t2423r262b2446],
4	2008	CD	DATE	2008	num	3	SENT_5	[p1l273t2424r494b2451],
5	;	:	O	;	_	0	SENT_5	[p1l273t2424r494b2451],
6	358:568	CD	NUMBER	358:568	number	7	SENT_5	[p1l273t2424r494b2451],
7	-79	CD	NUMBER	-79	dep	3	SENT_5	[p1l273t2424r494b2451],
8	.	.	O	.	_	0	SENT_5	[p1l273t2424r494b2451],

1	Copyright	NN	O	copyright	_	0	SENT_6	[p1l93t2465r187b2490],
2	©	CD	NUMBER	©	num	6	SENT_6	[p1l196t2467r217b2488],
3	2008	CD	DATE	2008	num	6	SENT_6	[p1l227t2466r276b2484],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_6	[p1l285t2465r425b2484],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_6	[p1l434t2465r511b2484],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_6	[p1l519t2466r591b2490],
7	.	.	O	.	_	0	SENT_6	[p1l519t2466r591b2490],

1	The	DT	O	the	det	4	SENT_7	[p1l959t81r1004b102],
2	NEW	NNP	O	NEW	nn	4	SENT_7	[p1l1023t83r1108b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_7	[p1l1127t83r1316b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_7	[p1l1335t83r1515b109],
5	of	IN	O	of	_	0	SENT_7	[p1l1534t81r1562b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_7	[p1l1574t83r1774b102],

1	l	NN	O	l	_	0	SENT_8	[p1l666t184r669b303],
2	ORIGINAL	NNP	O	ORIGINAL	nn	3	SENT_8	[p1l1155t234r1379b260],
3	ARTICLE	NN	O	article	dep	1	SENT_8	[p1l1391t234r1578b260],
4	l	NN	O	l	tmod	3	SENT_8	[p1l2064t184r2067b303],

1	HLA-B	NN	O	hla-b	_	0	SENT_9	[p1l695t379r1084b433],
2	*	CD	NUMBER	*	number	3	SENT_9	[p1l695t379r1084b433],
3	5701	CD	NUMBER	5701	num	4	SENT_9	[p1l695t379r1084b433],
4	Screening	NNP	O	Screening	dep	1	SENT_9	[p1l1115t380r1414b449],
5	for	IN	O	for	_	0	SENT_9	[p1l1441t378r1528b433],
6	Hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_9	[p1l1555t379r2041b448],
7	to	TO	O	to	_	0	SENT_9	[p1l1195t473r1251b516],
8	Abacavir	NNP	O	Abacavir	prep_to	6	SENT_9	[p1l1279t461r1541b516],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_10	[p1l727t587r834b615],
2	Mallal	NNP	PERSON	Mallal	_	0	SENT_10	[p1l852t584r961b621],
3	,	,	O	,	_	0	SENT_10	[p1l852t584r961b621],
4	M.B.	NNP	LOCATION	M.B.	appos	2	SENT_10	[p1l978t587r1063b621],
5	,	,	O	,	_	0	SENT_10	[p1l978t587r1063b621],
6	B.S.	NNP	O	B.S.	appos	2	SENT_10	[p1l1080t587r1151b621],
7	,	,	O	,	_	0	SENT_10	[p1l1080t587r1151b621],
8	Elizabeth	NNP	PERSON	Elizabeth	nn	9	SENT_10	[p1l1168t584r1319b615],
9	Phillips	NNP	PERSON	Phillips	appos	2	SENT_10	[p1l1336t584r1467b625],
10	,	,	O	,	_	0	SENT_10	[p1l1336t584r1467b625],
11	M.D.	NNP	O	M.D.	appos	2	SENT_10	[p1l1484t587r1574b621],
12	,	,	O	,	_	0	SENT_10	[p1l1484t587r1574b621],
13	Giampiero	NNP	PERSON	Giampiero	nn	14	SENT_10	[p1l1589t586r1769b625],
14	Carosi	NNP	PERSON	Carosi	appos	2	SENT_10	[p1l1782t586r1898b621],
15	,	,	O	,	_	0	SENT_10	[p1l1782t586r1898b621],
16	M.D.	NNP	O	M.D.	appos	2	SENT_10	[p1l1915t587r2005b621],
17	,	,	O	,	_	0	SENT_10	[p1l1915t587r2005b621],
18	Jean-Michel	NNP	PERSON	Jean-Michel	nn	19	SENT_10	[p1l703t634r907b674],
19	Molina	NNP	PERSON	Molina	appos	2	SENT_10	[p1l925t634r1049b671],
20	,	,	O	,	_	0	SENT_10	[p1l925t634r1049b671],
21	M.D.	NNP	O	M.D.	appos	2	SENT_10	[p1l1066t637r1156b671],
22	,	,	O	,	_	0	SENT_10	[p1l1066t637r1156b671],
23	Cassy	NNP	PERSON	Cassy	nn	24	SENT_10	[p1l1171t636r1268b675],
24	Workman	NNP	PERSON	Workman	appos	2	SENT_10	[p1l1278t634r1454b671],
25	,	,	O	,	_	0	SENT_10	[p1l1278t634r1454b671],
26	M.B.	NNP	LOCATION	M.B.	appos	2	SENT_10	[p1l1472t637r1557b671],
27	,	,	O	,	_	0	SENT_10	[p1l1472t637r1557b671],
28	B.S.	NNP	O	B.S.	appos	2	SENT_10	[p1l1574t636r1750b674],
29	,	,	O	,	_	0	SENT_10	[p1l1574t636r1750b674],
30	Janez	NNP	PERSON	Janez	nn	33	SENT_10	[p1l1574t636r1750b674],
31	Tomaiic	NNP	PERSON	Tomaiic	nn	33	SENT_10	[p1l1761t634r1916b671],
32	,	,	O	,	_	0	SENT_10	[p1l1761t634r1916b671],
33	M.D.	NNP	O	M.D.	appos	2	SENT_10	[p1l1933t637r2023b671],
34	,	,	O	,	_	0	SENT_10	[p1l1933t637r2023b671],

1	Evajagel-Guedes	NNP	O	Evajagel-Guedes	_	0	SENT_11	[p1l812t683r1112b724],
2	,	,	O	,	_	0	SENT_11	[p1l812t683r1112b724],
3	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1129t686r1219b720],
4	,	,	O	,	_	0	SENT_11	[p1l1129t686r1219b720],
5	Sorin	NNP	PERSON	Sorin	nn	6	SENT_11	[p1l1234t685r1320b714],
6	Rugina	NNP	PERSON	Rugina	appos	1	SENT_11	[p1l1338t686r1461b724],
7	,	,	O	,	_	0	SENT_11	[p1l1338t686r1461b724],
8	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1479t686r1569b720],
9	,	,	O	,	_	0	SENT_11	[p1l1479t686r1569b720],
10	Oleg	NNP	PERSON	Oleg	nn	11	SENT_11	[p1l1584t683r1663b724],
11	Kozyrev	NNP	PERSON	Kozyrev	appos	1	SENT_11	[p1l1678t686r1815b724],
12	,	,	O	,	_	0	SENT_11	[p1l1678t686r1815b724],
13	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1832t686r1923b720],
14	,	,	O	,	_	0	SENT_11	[p1l1832t686r1923b720],
15	Juan	NNP	PERSON	Juan	nn	17	SENT_11	[p1l761t735r839b772],
16	Flores	NNP	PERSON	Flores	nn	17	SENT_11	[p1l856t732r956b763],
17	Cid	NNP	PERSON	Cid	appos	1	SENT_11	[p1l970t732r1033b769],
18	,	,	O	,	_	0	SENT_11	[p1l970t732r1033b769],
19	M.D.	NNP	O	M.D.	appos	1	SENT_11	[p1l1050t735r1140b769],
20	,	,	O	,	_	0	SENT_11	[p1l1050t735r1140b769],
21	Phillip	NNP	PERSON	Phillip	nn	22	SENT_11	[p1l1158t732r1260b773],
22	Hay	NNP	PERSON	Hay	appos	1	SENT_11	[p1l1276t735r1348b773],
23	,	,	O	,	_	0	SENT_11	[p1l1276t735r1348b773],
24	M.B.	NNP	LOCATION	M.B.	appos	1	SENT_11	[p1l1365t735r1450b769],
25	,	,	O	,	_	0	SENT_11	[p1l1365t735r1450b769],
26	B.S.	NNP	O	B.S.	appos	1	SENT_11	[p1l1467t734r1538b769],
27	,	,	O	,	_	0	SENT_11	[p1l1467t734r1538b769],
28	David	NNP	PERSON	David	nn	29	SENT_11	[p1l1555t732r1648b763],
29	Nolan	NNP	PERSON	Nolan	appos	1	SENT_11	[p1l1666t732r1775b769],
30	,	,	O	,	_	0	SENT_11	[p1l1666t732r1775b769],
31	M.B.	NNP	LOCATION	M.B.	appos	1	SENT_11	[p1l1792t735r1877b769],
32	,	,	O	,	_	0	SENT_11	[p1l1792t735r1877b769],
33	B.S.	NNP	O	B.S.	appos	1	SENT_11	[p1l1894t734r1965b769],
34	,	,	O	,	_	0	SENT_11	[p1l1894t734r1965b769],
35	Sara	NNP	PERSON	Sara	nn	36	SENT_11	[p1l808t783r879b812],
36	Hughes	NNP	PERSON	Hughes	appos	1	SENT_11	[p1l896t781r1035b822],
37	,	,	O	,	_	0	SENT_11	[p1l896t781r1035b822],
38	M.	NNP	PERSON	M.	nn	39	SENT_11	[p1l1052t783r1153b818],
39	Sc.	NNP	PERSON	Sc.	appos	1	SENT_11	[p1l1052t783r1153b818],
40	,	,	O	,	_	0	SENT_11	[p1l1052t783r1153b818],
41	Arlene	NNP	PERSON	Arlene	nn	42	SENT_11	[p1l1167t781r1275b812],
42	Hughes	NNP	PERSON	Hughes	appos	1	SENT_11	[p1l1291t781r1430b822],
43	,	,	O	,	_	0	SENT_11	[p1l1291t781r1430b822],
44	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_11	[p1l1447t781r1546b818],
45	,	,	O	,	_	0	SENT_11	[p1l1447t781r1546b818],
46	Susanna	NNP	PERSON	Susanna	nn	49	SENT_11	[p1l1561t783r1705b812],
47	Ryan	NNP	PERSON	Ryan	nn	49	SENT_11	[p1l1721t784r1808b822],
48	,	,	O	,	_	0	SENT_11	[p1l1721t784r1808b822],
49	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_11	[p1l1825t781r1924b818],
50	,	,	O	,	_	0	SENT_11	[p1l1825t781r1924b818],

1	Nicholas	NNP	PERSON	Nicholas	nn	2	SENT_12	[p1l694t830r841b862],
2	Fitch	NNP	PERSON	Fitch	_	0	SENT_12	[p1l857t830r946b867],
3	,	,	O	,	_	0	SENT_12	[p1l857t830r946b867],
4	Ph.D.	NNP	O	Ph.D.	conj_and	2	SENT_12	[p1l963t830r1062b867],
5	,	,	O	,	_	0	SENT_12	[p1l963t830r1062b867],
6	Daren	NNP	PERSON	Daren	nn	7	SENT_12	[p1l1079t833r1178b862],
7	Thorborn	NNP	PERSON	Thorborn	conj_and	2	SENT_12	[p1l1191t830r1360b867],
8	,	,	O	,	_	0	SENT_12	[p1l1191t830r1360b867],
9	Ph.D.	NNP	O	Ph.D.	conj_and	2	SENT_12	[p1l1377t830r1476b867],
10	,	,	O	,	_	0	SENT_12	[p1l1377t830r1476b867],
11	and	CC	O	and	_	0	SENT_12	[p1l1491t830r1551b862],
12	Alastair	NNP	PERSON	Alastair	nn	17	SENT_12	[p1l1564t830r1694b862],
13	Benbow	NNP	PERSON	Benbow	nn	17	SENT_12	[p1l1708t830r1850b867],
14	,	,	O	,	_	0	SENT_12	[p1l1708t830r1850b867],
15	M.B.	NNP	LOCATION	M.B.	appos	17	SENT_12	[p1l1867t833r1952b867],
16	,	,	O	,	_	0	SENT_12	[p1l1867t833r1952b867],
17	B.S.	NNP	O	B.S.	conj_and	2	SENT_12	[p1l1969t833r2040b867],
18	,	,	O	,	_	0	SENT_12	[p1l1969t833r2040b867],

1	for	IN	O	for	mark	10	SENT_13	[p1l1093t880r1140b912],
2	the	DT	O	the	det	10	SENT_13	[p1l1151t881r1203b912],
3	PRED	NNP	O	PRED	nn	10	SENT_13	[p1l1219t883r1403b912],
4	|	CD	NUMBER	|	num	10	SENT_13	[p1l1219t883r1403b912],
5	CT	NNP	O	CT	nn	10	SENT_13	[p1l1219t883r1403b912],
6	—	CD	NUMBER	—	num	10	SENT_13	[p1l1219t883r1403b912],
7	1	CD	NUMBER	1	num	10	SENT_13	[p1l1219t883r1403b912],
8	Study	NNP	O	Study	nn	10	SENT_13	[p1l1418t881r1513b922],
9	Team	NNP	O	Team	nn	10	SENT_13	[p1l1523t883r1639b912],
10	*	NN	O	*	_	0	SENT_13	[p1l1523t883r1639b912],

1	ABSTRACT	NN	O	abstract	_	0	SENT_14	[p1l1255t1028r1478b1051],

1	BAC	NN	O	bac	nn	9	SENT_15	[p1l669t1152r725b1171],
2	KG	NN	O	kg	nn	9	SENT_15	[p1l730t1152r766b1171],
3	R	NN	O	r	nn	9	SENT_15	[p1l773t1152r787b1171],
4	o	NN	O	o	nn	9	SENT_15	[p1l792t1152r813b1171],
5	u	NN	O	u	nn	9	SENT_15	[p1l818t1152r835b1171],
6	N	NN	O	n	nn	9	SENT_15	[p1l842t1152r859b1171],
7	D	NN	O	d	nn	9	SENT_15	[p1l867t1152r885b1171],
8	Hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_15	[p1l667t1195r939b1233],
9	reaction	NN	O	reaction	nsubjpass	14	SENT_15	[p1l950t1195r1085b1225],
10	to	TO	O	to	_	0	SENT_15	[p1l1097t1201r1129b1225],
11	abacavir	NN	O	abacavir	prep_to	9	SENT_15	[p1l1141t1194r1280b1225],
12	is	VBZ	O	be	auxpass	14	SENT_15	[p1l1290t1195r1316b1225],
13	strongly	RB	O	strongly	advmod	14	SENT_15	[p1l1330t1194r1467b1233],
14	associated	VBN	O	associate	_	0	SENT_15	[p1l1477t1194r1649b1225],
15	with	IN	O	with	_	0	SENT_15	[p1l1660t1194r1736b1225],
16	the	DT	O	the	det	17	SENT_15	[p1l1748t1194r1800b1225],
17	presence	NN	O	presence	prep_with	14	SENT_15	[p1l1811t1204r1957b1233],
18	of	IN	O	of	_	0	SENT_15	[p1l1970t1194r2008b1225],
19	the	DT	O	the	det	20	SENT_15	[p1l2014t1194r2065b1225],
20	HLA	NN	O	hlum	prep_of	17	SENT_15	[p1l668t1244r872b1274],
21	.	.	O	.	_	0	SENT_15	[p1l668t1244r872b1274],

1	—	NN	O	—	_	0	SENT_16	[p1l668t1244r872b1274],
2	.	.	O	.	_	0	SENT_16	[p1l668t1244r872b1274],

1	B	NN	O	b	_	0	SENT_17	[p1l668t1244r872b1274],
2	*	CD	NUMBER	*	number	3	SENT_17	[p1l668t1244r872b1274],
3	5701	CD	NUMBER	5701	dep	1	SENT_17	[p1l668t1244r872b1274],
4	allele	NN	O	allele	dep	3	SENT_17	[p1l883t1244r977b1274],
5	.	.	O	.	_	0	SENT_17	[p1l883t1244r977b1274],

1	This	DT	O	this	det	2	SENT_18	[p1l989t1244r1061b1274],
2	study	NN	O	study	nsubjpass	4	SENT_18	[p1l1073t1244r1161b1283],
3	was	VBD	O	be	auxpass	4	SENT_18	[p1l1169t1254r1231b1275],
4	designed	VBN	O	design	_	0	SENT_18	[p1l1243t1244r1389b1283],
5	to	TO	O	to	aux	6	SENT_18	[p1l1400t1250r1431b1274],
6	establish	VB	O	establish	xcomp	4	SENT_18	[p1l1443t1244r1588b1274],
7	the	DT	O	the	det	8	SENT_18	[p1l1599t1244r1650b1274],
8	effectiveness	NN	O	effectiveness	dobj	6	SENT_18	[p1l1662t1243r1869b1275],
9	of	IN	O	of	_	0	SENT_18	[p1l1881t1243r1920b1274],
10	prospective	JJ	O	prospective	amod	11	SENT_18	[p1l1923t1254r2065b1283, p1l668t1294r725b1325],
11	HLA-B	NN	O	hla-b	prep_of	8	SENT_18	[p1l738t1294r947b1325],
12	*	CD	NUMBER	*	number	13	SENT_18	[p1l738t1294r947b1325],
13	5701	CD	NUMBER	5701	num	14	SENT_18	[p1l738t1294r947b1325],
14	screening	NN	O	screening	dep	11	SENT_18	[p1l961t1294r1123b1333],
15	to	TO	O	to	aux	16	SENT_18	[p1l1135t1300r1167b1325],
16	prevent	VB	O	prevent	xcomp	6	SENT_18	[p1l1180t1300r1304b1333],
17	the	DT	O	the	det	19	SENT_18	[p1l1316t1294r1367b1324],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_18	[p1l1380t1294r1645b1333],
19	reaction	NN	O	reaction	dobj	16	SENT_18	[p1l1656t1294r1791b1325],
20	to	TO	O	to	_	0	SENT_18	[p1l1805t1300r1837b1325],
21	abacavir	NN	O	abacavir	prep_to	16	SENT_18	[p1l1850t1294r1995b1325],
22	.	.	O	.	_	0	SENT_18	[p1l1850t1294r1995b1325],

1	METHODS	NNS	O	method	nsubj	9	SENT_19	[p1l671t1396r823b1415],
2	This	DT	O	this	det	8	SENT_19	[p1l666t1439r737b1470],
3	double-blind	JJ	O	double-blind	amod	8	SENT_19	[p1l748t1439r959b1476],
4	,	,	O	,	_	0	SENT_19	[p1l748t1439r959b1476],
5	prospective	JJ	O	prospective	amod	8	SENT_19	[p1l971t1440r1160b1478],
6	,	,	O	,	_	0	SENT_19	[p1l971t1440r1160b1478],
7	randomized	JJ	O	randomized	amod	8	SENT_19	[p1l1172t1439r1367b1470],
8	study	NN	O	study	dep	1	SENT_19	[p1l1377t1439r1463b1478],
9	involved	VBD	O	involve	_	0	SENT_19	[p1l1471t1439r1602b1470],
10	1956	CD	DATE	1956	num	11	SENT_19	[p1l1613t1441r1688b1470],
11	patients	NNS	O	patient	dobj	9	SENT_19	[p1l1697t1440r1824b1478],
12	from	IN	O	from	_	0	SENT_19	[p1l1834t1439r1914b1470],
13	19	CD	NUMBER	19	num	14	SENT_19	[p1l1925t1441r1961b1470],
14	countries	NNS	O	country	prep_from	9	SENT_19	[p1l1972t1449r2065b1470, p1l668t1490r750b1526],
15	,	,	O	,	_	0	SENT_19	[p1l1972t1449r2065b1470, p1l668t1490r750b1526],
16	who	WP	O	who	nsubjpass	18	SENT_19	[p1l764t1489r835b1520],
17	were	VBD	O	be	auxpass	18	SENT_19	[p1l847t1499r926b1520],
18	infected	VBN	O	infect	rcmod	14	SENT_19	[p1l939t1489r1074b1520],
19	with	IN	O	with	_	0	SENT_19	[p1l1086t1489r1162b1520],
20	human	JJ	O	human	amod	23	SENT_19	[p1l1176t1489r1294b1520],
21	immunodeficiency	NN	O	immunodeficiency	nn	23	SENT_19	[p1l1307t1489r1622b1528],
22	virus	NN	O	virus	nn	23	SENT_19	[p1l1632t1490r1715b1520],
23	type	NN	O	type	prep_with	18	SENT_19	[p1l1730t1496r1800b1528],
24	1	CD	NUMBER	1	dep	23	SENT_19	[p1l1815t1491r1832b1519],
25	and	CC	O	and	_	0	SENT_19	[p1l1846t1489r1907b1520],
26	who	WP	O	who	nsubj	30	SENT_19	[p1l1919t1489r1990b1520],
27	had	VBD	O	have	aux	30	SENT_19	[p1l2005t1489r2065b1520],
28	not	RB	O	not	neg	30	SENT_19	[p1l668t1546r722b1570],
29	previously	RB	DATE	previously	advmod	30	SENT_19	[p1l732t1539r899b1578],
30	received	VBN	O	receive	prep_with	18	SENT_19	[p1l909t1539r1040b1570],
31	abacavir	NN	O	abacavir	dobj	30	SENT_19	[p1l1052t1539r1194b1570],
32	.	.	O	.	_	0	SENT_19	[p1l1052t1539r1194b1570],

1	We	PRP	O	we	nsubj	3	SENT_20	[p1l1206t1542r1257b1570],
2	randomly	RB	O	randomly	advmod	3	SENT_20	[p1l1269t1539r1427b1578],
3	assigned	VBD	O	assign	_	0	SENT_20	[p1l1437t1539r1580b1578],
4	patients	NNS	O	patient	dobj	3	SENT_20	[p1l1591t1540r1721b1578],
5	to	TO	O	to	aux	6	SENT_20	[p1l1733t1546r1765b1570],
6	undergo	VB	O	undergo	dep	3	SENT_20	[p1l1777t1539r1913b1578],
7	prospective	JJ	O	prospective	amod	8	SENT_20	[p1l1925t1549r2065b1578, p1l668t1590r723b1620],
8	HLA-B	NN	O	hla-b	dobj	6	SENT_20	[p1l734t1589r936b1620],
9	*	CD	NUMBER	*	number	10	SENT_20	[p1l734t1589r936b1620],
10	5701	CD	NUMBER	5701	num	11	SENT_20	[p1l734t1589r936b1620],
11	screening	NN	O	screening	dep	21	SENT_20	[p1l948t1590r1110b1628],
12	,	,	O	,	_	0	SENT_20	[p1l948t1590r1110b1628],
13	with	IN	O	with	_	0	SENT_20	[p1l1123t1589r1196b1620],
14	exclusion	NN	O	exclusion	prep_with	11	SENT_20	[p1l1208t1589r1356b1620],
15	of	IN	O	of	_	0	SENT_20	[p1l1368t1589r1406b1620],
16	HLA-B	NN	O	hla-b	prep_of	11	SENT_20	[p1l1411t1589r1754b1628],
17	*	CD	NUMBER	*	num	16	SENT_20	[p1l1411t1589r1754b1628],
18	5701	CD	NUMBER	5701	num	19	SENT_20	[p1l1411t1589r1754b1628],
19	—	NN	O	—	dep	21	SENT_20	[p1l1411t1589r1754b1628],
20	positive	JJ	O	positive	amod	21	SENT_20	[p1l1411t1589r1754b1628],
21	patients	NNS	O	patient	dep	24	SENT_20	[p1l1765t1590r1892b1628],
22	from	IN	O	from	_	0	SENT_20	[p1l1905t1589r1984b1620],
23	abacavir	NN	O	abacavir	prep_from	21	SENT_20	[p1l1996t1589r2065b1620, p1l668t1640r746b1670],
24	treatment	NN	O	treatment	dep	28	SENT_20	[p1l760t1646r921b1670],
25	(	CD	NUMBER	(	num	24	SENT_20	[p1l936t1640r1306b1678],
26	prospective-screening	JJ	O	prospective-screening	amod	28	SENT_20	[p1l936t1640r1306b1678],
27	group	NN	O	group	nn	28	SENT_20	[p1l1319t1642r1434b1678],
28	)	NN	O	)	dep	6	SENT_20	[p1l1319t1642r1434b1678],
29	,	,	O	,	_	0	SENT_20	[p1l1319t1642r1434b1678],
30	or	CC	O	or	_	0	SENT_20	[p1l1452t1649r1486b1670],
31	to	TO	O	to	aux	32	SENT_20	[p1l1500t1646r1531b1670],
32	undergo	VB	O	undergo	dep	3	SENT_20	[p1l1546t1639r1682b1678],
33	a	DT	O	a	det	35	SENT_20	[p1l1697t1649r1715b1670],
34	standard-of-care	JJ	O	standard-of-care	amod	35	SENT_20	[p1l1730t1639r1999b1670],
35	approach	NN	O	approach	dobj	32	SENT_20	[p1l2014t1649r2065b1678, p1l667t1759r779b1798],

1	of	IN	O	of	_	0	SENT_21	[p1l790t1758r828b1789],
2	abacavir	NN	O	abacavir	nn	3	SENT_21	[p1l831t1759r966b1789],
3	use	NN	O	use	pobj	1	SENT_21	[p1l975t1769r1029b1790],
4	without	IN	O	without	_	0	SENT_21	[p1l1037t1759r1166b1790],
5	prospective	JJ	O	prospective	amod	6	SENT_21	[p1l1174t1759r1360b1798],
6	HLA	NN	O	hlum	prep_without	3	SENT_21	[p1l1370t1759r1574b1789],
7	.	.	O	.	_	0	SENT_21	[p1l1370t1759r1574b1789],

1	—	NN	O	—	_	0	SENT_22	[p1l1370t1759r1574b1789],
2	.	.	O	.	_	0	SENT_22	[p1l1370t1759r1574b1789],

1	B	NN	O	b	_	0	SENT_23	[p1l1370t1759r1574b1789],
2	*	CD	NUMBER	*	number	3	SENT_23	[p1l1370t1759r1574b1789],
3	5701	CD	NUMBER	5701	num	7	SENT_23	[p1l1370t1759r1574b1789],
4	screening	NN	O	screening	nn	7	SENT_23	[p1l1585t1759r1744b1798],
5	(	NN	O	(	nn	7	SENT_23	[p1l1755t1759r1880b1794],
6	control	NN	O	control	nn	7	SENT_23	[p1l1755t1759r1880b1794],
7	group	NN	O	group	dep	1	SENT_23	[p1l1890t1761r2005b1798],
8	)	CD	NUMBER	)	dep	7	SENT_23	[p1l1890t1761r2005b1798],
9	.	.	O	.	_	0	SENT_23	[p1l1890t1761r2005b1798],

1	All	DT	O	all	det	2	SENT_24	[p1l2016t1759r2065b1789],
2	patients	NNS	O	patient	nsubjpass	7	SENT_24	[p1l667t1809r800b1848],
3	who	WP	O	who	nsubj	4	SENT_24	[p1l812t1809r883b1840],
4	started	VBD	O	start	rcmod	2	SENT_24	[p1l898t1809r1013b1839],
5	abacavir	NN	O	abacavir	dobj	4	SENT_24	[p1l1026t1809r1164b1840],
6	were	VBD	O	be	auxpass	7	SENT_24	[p1l1175t1819r1253b1840],
7	observed	VBN	O	observe	_	0	SENT_24	[p1l1267t1809r1414b1840],
8	for	IN	O	for	_	0	SENT_24	[p1l1428t1808r1475b1839],
9	6	CD	DURATION	6	num	10	SENT_24	[p1l1488t1811r1506b1839],
10	weeks	NNS	NUMBER	week	prep_for	7	SENT_24	[p1l1518t1809r1629b1840],
11	.	.	O	.	_	0	SENT_24	[p1l1518t1809r1629b1840],

1	To	TO	O	to	aux	3	SENT_25	[p1l1643t1811r1684b1839],
2	immunologically	RB	O	immunologically	advmod	3	SENT_25	[p1l1697t1809r1983b1848],
3	confirm	VB	O	confirm	purpcl	21	SENT_25	[p1l1995t1819r2065b1839, p1l668t1859r750b1896],
4	,	,	O	,	_	0	SENT_25	[p1l1995t1819r2065b1839, p1l668t1859r750b1896],
5	and	CC	O	and	dep	6	SENT_25	[p1l762t1859r823b1890],
6	enhance	VBP	O	enhance	dep	3	SENT_25	[p1l833t1859r969b1890],
7	the	DT	O	the	det	8	SENT_25	[p1l979t1859r1030b1890],
8	specificity	NN	O	specificity	dobj	6	SENT_25	[p1l1041t1859r1208b1898],
9	of	IN	O	of	prep	8	SENT_25	[p1l1217t1859r1256b1896],
10	,	,	O	,	_	0	SENT_25	[p1l1217t1859r1256b1896],
11	the	DT	O	the	det	13	SENT_25	[p1l1269t1859r1319b1890],
12	clinical	JJ	O	clinical	amod	13	SENT_25	[p1l1330t1859r1448b1889],
13	diagnosis	NN	O	diagnosis	dobj	3	SENT_25	[p1l1459t1859r1615b1898],
14	of	IN	O	of	_	0	SENT_25	[p1l1626t1859r1664b1890],
15	hypersensitivity	NN	O	hypersensitivity	nn	16	SENT_25	[p1l1667t1859r1925b1898],
16	reaction	NN	O	reaction	prep_of	3	SENT_25	[p1l1933t1859r2066b1890],
17	to	TO	O	to	_	0	SENT_25	[p1l668t1915r699b1939],
18	abacavir	NN	O	abacavir	prep_to	16	SENT_25	[p1l712t1909r854b1946],
19	,	,	O	,	_	0	SENT_25	[p1l712t1909r854b1946],
20	we	PRP	O	we	nsubj	21	SENT_25	[p1l867t1919r912b1939],
21	performed	VBD	O	perform	_	0	SENT_25	[p1l924t1908r1100b1948],
22	epicutaneous	JJ	O	epicutaneous	amod	24	SENT_25	[p1l1114t1909r1333b1948],
23	patch	NN	O	patch	nn	24	SENT_25	[p1l1346t1909r1438b1948],
24	testing	NN	O	testing	dobj	21	SENT_25	[p1l1451t1909r1567b1948],
25	with	IN	O	with	_	0	SENT_25	[p1l1577t1909r1653b1939],
26	the	DT	O	the	det	27	SENT_25	[p1l1666t1909r1718b1939],
27	use	NN	O	use	prep_with	21	SENT_25	[p1l1731t1919r1786b1939],
28	of	IN	O	of	_	0	SENT_25	[p1l1800t1908r1838b1939],
29	abacavir	NN	O	abacavir	prep_of	27	SENT_25	[p1l1844t1909r1990b1939],
30	.	.	O	.	_	0	SENT_25	[p1l1844t1909r1990b1939],

1	RESULTS	NNS	O	result	nsubj	10	SENT_26	[p1l670t2011r797b2030],
2	The	DT	O	the	det	3	SENT_26	[p1l666t2054r728b2085],
3	prevalence	NN	O	prevalence	npadvmod	1	SENT_26	[p1l738t2054r910b2093],
4	of	IN	O	of	_	0	SENT_26	[p1l921t2054r959b2085],
5	HLA-B	NN	O	hla-b	prep_of	1	SENT_26	[p1l962t2054r1166b2085],
6	*	CD	NUMBER	*	number	7	SENT_26	[p1l962t2054r1166b2085],
7	5701	CD	NUMBER	5701	num	5	SENT_26	[p1l962t2054r1166b2085],
8	was	VBD	O	be	cop	10	SENT_26	[p1l1175t2064r1237b2085],
9	5.6	CD	PERCENT	5.6	num	10	SENT_26	[p1l1249t2056r1328b2085],
10	%	NN	PERCENT	%	_	0	SENT_26	[p1l1249t2056r1328b2085],
11	(	CD	NUMBER	(	number	12	SENT_26	[p1l1340t2056r1407b2089],
12	109	CD	NUMBER	109	num	10	SENT_26	[p1l1340t2056r1407b2089],
13	of	IN	O	of	_	0	SENT_26	[p1l1418t2054r1456b2085],
14	1956	CD	DATE	1956	num	15	SENT_26	[p1l1461t2056r1537b2085],
15	patients	NNS	O	patient	prep_of	10	SENT_26	[p1l1546t2055r1695b2093],
16	)	CD	NUMBER	)	dep	15	SENT_26	[p1l1546t2055r1695b2093],
17	.	.	O	.	_	0	SENT_26	[p1l1546t2055r1695b2093],

1	Of	IN	O	of	_	0	SENT_27	[p1l1707t2054r1754b2085],
2	the	DT	O	the	det	3	SENT_27	[p1l1757t2054r1808b2085],
3	patients	NNS	O	patient	nsubj	4	SENT_27	[p1l1818t2055r1947b2093],
4	receiving	VBG	O	receive	prepc_of	10	SENT_27	[p1l1958t2055r2065b2085, p1l667t2105r722b2143],
5	abacavir	NN	O	abacavir	dobj	4	SENT_27	[p1l733t2104r878b2141],
6	,	,	O	,	_	0	SENT_27	[p1l733t2104r878b2141],
7	72	CD	PERCENT	72	num	8	SENT_27	[p1l894t2106r965b2135],
8	%	NN	PERCENT	%	nsubj	10	SENT_27	[p1l894t2106r965b2135],
9	were	VBD	O	be	cop	10	SENT_27	[p1l976t2114r1055b2135],
10	men	NNS	O	man	_	0	SENT_27	[p1l1067t2114r1148b2141],
11	,	,	O	,	_	0	SENT_27	[p1l1067t2114r1148b2141],
12	84	CD	PERCENT	84	num	13	SENT_27	[p1l1164t2106r1235b2135],
13	%	NN	PERCENT	%	appos	10	SENT_27	[p1l1164t2106r1235b2135],
14	were	VBD	O	be	cop	15	SENT_27	[p1l1246t2114r1324b2135],
15	white	JJ	O	white	rcmod	13	SENT_27	[p1l1336t2104r1437b2141],
16	,	,	O	,	_	0	SENT_27	[p1l1336t2104r1437b2141],
17	and	CC	O	and	_	0	SENT_27	[p1l1452t2104r1513b2135],
18	18	CD	NUMBER	18	number	19	SENT_27	[p1l1527t2106r1598b2135],
19	°	CD	NUMBER	°	conj_and	13	SENT_27	[p1l1527t2106r1598b2135],
20	/	:	O	/	punct	25	SENT_27	[p1l1527t2106r1598b2135],
21	o	NN	O	o	nsubj	25	SENT_27	[p1l1527t2106r1598b2135],
22	had	VBD	O	have	aux	25	SENT_27	[p1l1611t2104r1671b2135],
23	not	RB	O	not	neg	25	SENT_27	[p1l1684t2111r1740b2135],
24	previously	RB	DATE	previously	advmod	25	SENT_27	[p1l1750t2104r1920b2143],
25	received	VBN	O	receive	dep	10	SENT_27	[p1l1931t2104r2065b2135],
26	antiretroviral	JJ	O	antiretroviral	amod	27	SENT_27	[p1l668t2154r890b2185],
27	therapy	NN	O	therapy	dep	10	SENT_27	[p1l902t2154r1032b2193],
28	.	.	O	.	_	0	SENT_27	[p1l902t2154r1032b2193],

1	Screening	VBG	O	screen	dep	11	SENT_28	[p1l1048t2155r1213b2193],
2	eliminated	VBN	O	eliminate	dep	1	SENT_28	[p1l1225t2154r1404b2185],
3	immunologically	RB	O	immunologically	advmod	2	SENT_28	[p1l1416t2154r1703b2193],
4	confirmed	VBN	O	confirm	dep	2	SENT_28	[p1l1714t2154r1890b2185],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_28	[p1l1902t2154r2065b2193, p1l668t2205r782b2243],
6	reaction	NN	O	reaction	nsubj	8	SENT_28	[p1l797t2205r936b2235],
7	(	CD	NUMBER	(	num	8	SENT_28	[p1l955t2206r1018b2239],
8	O	NN	O	o	xcomp	4	SENT_28	[p1l955t2206r1018b2239],
9	°	CD	NUMBER	°	dep	8	SENT_28	[p1l955t2206r1018b2239],
10	/	:	O	/	punct	11	SENT_28	[p1l955t2206r1018b2239],
11	o	NN	O	o	_	0	SENT_28	[p1l955t2206r1018b2239],
12	in	IN	O	in	_	0	SENT_28	[p1l1035t2205r1068b2234],
13	the	DT	O	the	det	15	SENT_28	[p1l1085t2204r1137b2235],
14	prospective-screening	JJ	O	prospective-screening	amod	15	SENT_28	[p1l1154t2205r1530b2243],
15	group	NN	O	group	prep_in	11	SENT_28	[p1l1546t2214r1646b2243],
16	vs.	CC	O	vs.	prep	15	SENT_28	[p1l1662t2214r1705b2235],
17	2.7	CD	PERCENT	2.7	num	18	SENT_28	[p1l1724t2206r1808b2235],
18	%	NN	PERCENT	%	dep	16	SENT_28	[p1l1724t2206r1808b2235],
19	in	IN	O	in	_	0	SENT_28	[p1l1824t2205r1858b2234],
20	the	DT	O	the	det	22	SENT_28	[p1l1875t2204r1927b2235],
21	control	NN	O	control	nn	22	SENT_28	[p1l1945t2204r2066b2235],
22	group	NN	O	group	prep_in	18	SENT_28	[p1l668t2264r770b2293],
23	,	,	O	,	_	0	SENT_28	[p1l668t2264r770b2293],
24	P	NN	O	p	dep	25	SENT_28	[p1l782t2256r927b2291],
25	<	JJR	O	<	appos	22	SENT_28	[p1l782t2256r927b2291],
26	0.001	CD	NUMBER	0.001	num	27	SENT_28	[p1l782t2256r927b2291],
27	)	NN	O	)	dep	25	SENT_28	[p1l782t2256r927b2291],
28	,	,	O	,	_	0	SENT_28	[p1l782t2256r927b2291],
29	with	IN	O	with	_	0	SENT_28	[p1l938t2254r1011b2285],
30	a	DT	O	a	det	33	SENT_28	[p1l1021t2264r1038b2285],
31	negative	JJ	O	negative	amod	33	SENT_28	[p1l1048t2255r1179b2293],
32	predictive	JJ	O	predictive	amod	33	SENT_28	[p1l1189t2254r1345b2293],
33	value	NN	O	value	prep_with	22	SENT_28	[p1l1353t2254r1435b2285],
34	of	IN	O	of	_	0	SENT_28	[p1l1446t2254r1484b2285],
35	100	CD	PERCENT	100	num	36	SENT_28	[p1l1489t2256r1578b2285],
36	%	NN	PERCENT	%	prep_of	33	SENT_28	[p1l1489t2256r1578b2285],
37	and	CC	O	and	_	0	SENT_28	[p1l1588t2254r1647b2285],
38	a	DT	O	a	det	41	SENT_28	[p1l1657t2264r1675b2285],
39	positive	JJ	O	positive	amod	41	SENT_28	[p1l1684t2255r1806b2293],
40	predictive	JJ	O	predictive	amod	41	SENT_28	[p1l1816t2254r1971b2293],
41	value	NN	O	value	conj_and	22	SENT_28	[p1l1980t2254r2065b2285],
42	of	IN	O	of	_	0	SENT_28	[p1l668t2304r707b2335],
43	47.9	CD	PERCENT	47.9	num	44	SENT_28	[p1l714t2306r822b2335],
44	%	NN	PERCENT	%	prep_of	41	SENT_28	[p1l714t2306r822b2335],
45	.	.	O	.	_	0	SENT_28	[p1l714t2306r822b2335],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_29	[p1l838t2305r1110b2343],
2	reaction	NN	O	reaction	nsubjpass	5	SENT_29	[p1l1123t2305r1258b2335],
3	was	VBD	O	be	auxpass	5	SENT_29	[p1l1271t2314r1334b2335],
4	clinically	RB	O	clinically	advmod	5	SENT_29	[p1l1350t2304r1502b2343],
5	diagnosed	VBN	O	diagnose	_	0	SENT_29	[p1l1515t2304r1687b2343],
6	in	IN	O	in	_	0	SENT_29	[p1l1702t2305r1734b2334],
7	93	CD	NUMBER	93	num	8	SENT_29	[p1l1749t2306r1786b2335],
8	patients	NNS	O	patient	prep_in	5	SENT_29	[p1l1801t2305r1943b2343],
9	,	,	O	,	_	0	SENT_29	[p1l1801t2305r1943b2343],
10	with	IN	O	with	_	0	SENT_29	[p1l1958t2304r2034b2335],
11	a	DT	O	a	det	14	SENT_29	[p1l2049t2314r2066b2335],
12	significantly	RB	O	significantly	advmod	13	SENT_29	[p1l668t2353r879b2393],
13	lower	JJR	O	lower	amod	14	SENT_29	[p1l890t2354r982b2385],
14	incidence	NN	O	incidence	prep_with	5	SENT_29	[p1l993t2354r1151b2385],
15	in	IN	O	in	_	0	SENT_29	[p1l1163t2354r1195b2384],
16	the	DT	O	the	det	18	SENT_29	[p1l1208t2354r1260b2384],
17	prospective-screening	JJ	O	prospective-screening	amod	18	SENT_29	[p1l1272t2354r1640b2393],
18	group	NN	O	group	prep_in	14	SENT_29	[p1l1651t2364r1749b2393],
19	(	CD	PERCENT	(	number	20	SENT_29	[p1l1764t2356r1865b2389],
20	3.4	CD	PERCENT	3.4	dep	21	SENT_29	[p1l1764t2356r1865b2389],
21	%	NN	PERCENT	%	dep	18	SENT_29	[p1l1764t2356r1865b2389],
22	)	CD	NUMBER	)	npadvmod	23	SENT_29	[p1l1764t2356r1865b2389],
23	than	IN	O	than	advmod	18	SENT_29	[p1l1880t2354r1956b2384],
24	in	IN	O	in	_	0	SENT_29	[p1l1969t2354r2001b2384],
25	the	DT	O	the	det	27	SENT_29	[p1l2014t2354r2066b2384],
26	control	NN	O	control	nn	27	SENT_29	[p1l668t2404r787b2434],
27	group	NN	O	group	prep_in	18	SENT_29	[p1l800t2414r898b2443],
28	(	CD	PERCENT	(	number	29	SENT_29	[p1l913t2406r1014b2439],
29	7.8	CD	PERCENT	7.8	dep	30	SENT_29	[p1l913t2406r1014b2439],
30	%	NN	PERCENT	%	dep	27	SENT_29	[p1l913t2406r1014b2439],
31	)	CD	NUMBER	)	number	32	SENT_29	[p1l913t2406r1014b2439],
32	(	CD	NUMBER	(	num	33	SENT_29	[p1l1031t2406r1194b2439],
33	P	NN	O	p	npadvmod	34	SENT_29	[p1l1031t2406r1194b2439],
34	<	JJR	O	<	amod	27	SENT_29	[p1l1031t2406r1194b2439],
35	0.001	CD	NUMBER	0.001	num	36	SENT_29	[p1l1031t2406r1194b2439],
36	)	NN	O	)	dep	18	SENT_29	[p1l1031t2406r1194b2439],
37	.	.	O	.	_	0	SENT_29	[p1l1031t2406r1194b2439],

1	CONCLUSIONS	NNS	O	conclusion	nsubj	6	SENT_30	[p1l668t2499r895b2518],
2	HLA-B	JJ	O	hla-b	amod	1	SENT_30	[p1l667t2541r876b2572],
3	*	CD	NUMBER	*	tmod	2	SENT_30	[p1l667t2541r876b2572],
4	5701	CD	NUMBER	5701	num	5	SENT_30	[p1l667t2541r876b2572],
5	screening	NN	O	screening	dep	1	SENT_30	[p1l891t2542r1053b2580],
6	reduced	VBD	O	reduce	_	0	SENT_30	[p1l1066t2541r1196b2572],
7	the	DT	O	the	det	8	SENT_30	[p1l1210t2541r1262b2572],
8	risk	NN	O	risk	dobj	6	SENT_30	[p1l1276t2541r1340b2572],
9	of	IN	O	of	_	0	SENT_30	[p1l1352t2541r1391b2572],
10	hypersensitivity	NN	O	hypersensitivity	nn	11	SENT_30	[p1l1398t2541r1662b2580],
11	reaction	NN	O	reaction	prep_of	8	SENT_30	[p1l1674t2542r1810b2572],
12	to	TO	O	to	_	0	SENT_30	[p1l1824t2548r1856b2572],
13	abacavir	NN	O	abacavir	prep_to	6	SENT_30	[p1l1870t2541r2015b2572],
14	.	.	O	.	_	0	SENT_30	[p1l1870t2541r2015b2572],

1	In	IN	O	in	_	0	SENT_31	[p1l2031t2544r2065b2571],
2	predominantly	RB	O	predominantly	advmod	3	SENT_31	[p1l667t2590r916b2629],
3	white	JJ	O	white	amod	4	SENT_31	[p1l926t2590r1019b2621],
4	populations	NNS	O	population	prep_in	20	SENT_31	[p1l1032t2590r1240b2629],
5	,	,	O	,	_	0	SENT_31	[p1l1032t2590r1240b2629],
6	similar	JJ	O	similar	amod	4	SENT_31	[p1l1256t2590r1375b2621],
7	to	TO	O	to	_	0	SENT_31	[p1l1387t2597r1419b2621],
8	the	DT	O	the	det	9	SENT_31	[p1l1433t2590r1485b2621],
9	one	CD	NUMBER	one	prep_to	6	SENT_31	[p1l1498t2600r1557b2621],
10	in	IN	O	in	_	0	SENT_31	[p1l1570t2591r1603b2620],
11	this	DT	O	this	det	12	SENT_31	[p1l1616t2590r1678b2621],
12	study	NN	O	study	prep_in	9	SENT_31	[p1l1693t2590r1787b2629],
13	,	,	O	,	_	0	SENT_31	[p1l1693t2590r1787b2629],
14	94	CD	PERCENT	94	num	15	SENT_31	[p1l1802t2592r1874b2621],
15	%	NN	PERCENT	%	nsubj	27	SENT_31	[p1l1802t2592r1874b2621],
16	of	IN	O	of	_	0	SENT_31	[p1l1888t2590r1926b2621],
17	patients	NNS	O	patient	prep_of	15	SENT_31	[p1l1932t2591r2065b2629],
18	do	VBP	O	do	aux	20	SENT_31	[p1l668t2639r708b2670],
19	not	RB	O	not	neg	20	SENT_31	[p1l721t2646r777b2670],
20	carry	VB	O	carry	_	0	SENT_31	[p1l788t2649r874b2678],
21	the	DT	O	the	det	25	SENT_31	[p1l885t2639r937b2670],
22	HLA-B	NN	O	hla-b	nn	25	SENT_31	[p1l950t2639r1158b2670],
23	*	CD	NUMBER	*	number	24	SENT_31	[p1l950t2639r1158b2670],
24	5701	CD	DATE	5701	num	25	SENT_31	[p1l950t2639r1158b2670],
25	allele	NN	O	allele	dobj	20	SENT_31	[p1l1171t2639r1258b2670],
26	and	CC	O	and	_	0	SENT_31	[p1l1271t2639r1332b2670],
27	are	VBP	O	be	conj_and	20	SENT_31	[p1l1344t2649r1395b2670],
28	at	IN	O	at	_	0	SENT_31	[p1l1407t2646r1438b2670],
29	low	JJ	O	low	amod	30	SENT_31	[p1l1449t2639r1509b2670],
30	risk	NN	O	risk	prep_at	27	SENT_31	[p1l1520t2639r1584b2670],
31	for	IN	O	for	_	0	SENT_31	[p1l1595t2639r1643b2670],
32	hypersensitivity	NN	O	hypersensitivity	nn	33	SENT_31	[p1l1655t2639r1919b2678],
33	reaction	NN	O	reaction	prep_for	27	SENT_31	[p1l1930t2640r2066b2670],
34	to	TO	O	to	_	0	SENT_31	[p1l668t2695r699b2719],
35	abacavir	NN	O	abacavir	prep_to	27	SENT_31	[p1l714t2688r856b2719],
36	.	.	O	.	_	0	SENT_31	[p1l714t2688r856b2719],

1	Our	PRP$	O	we	poss	2	SENT_32	[p1l873t2690r937b2719],
2	results	NNS	O	result	nsubj	3	SENT_32	[p1l951t2688r1058b2719],
3	show	VBP	O	show	_	0	SENT_32	[p1l1075t2688r1161b2719],
4	that	IN	O	that	complm	10	SENT_32	[p1l1174t2688r1240b2719],
5	a	DT	O	a	det	7	SENT_32	[p1l1252t2698r1270b2719],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_32	[p1l1283t2688r1568b2727],
7	test	NN	O	test	nsubjpass	10	SENT_32	[p1l1583t2695r1642b2719],
8	can	MD	O	can	aux	10	SENT_32	[p1l1655t2698r1712b2718],
9	be	VB	O	be	auxpass	10	SENT_32	[p1l1727t2688r1764b2719],
10	used	VBN	O	use	ccomp	3	SENT_32	[p1l1779t2688r1854b2719],
11	to	TO	O	to	aux	12	SENT_32	[p1l1869t2695r1900b2719],
12	prevent	VB	O	prevent	xcomp	10	SENT_32	[p1l1915t2695r2036b2727],
13	a	DT	O	a	det	16	SENT_32	[p1l2049t2698r2066b2719],
14	specific	JJ	O	specific	amod	16	SENT_32	[p1l668t2737r796b2776],
15	toxic	JJ	O	toxic	amod	16	SENT_32	[p1l809t2738r889b2768],
16	effect	NN	O	effect	dobj	12	SENT_32	[p1l903t2737r996b2768],
17	of	IN	O	of	_	0	SENT_32	[p1l1008t2737r1047b2768],
18	a	DT	O	a	det	19	SENT_32	[p1l1053t2747r1070b2768],
19	drug	NN	O	drug	prep_of	16	SENT_32	[p1l1083t2737r1170b2776],
20	.	.	O	.	_	0	SENT_32	[p1l1083t2737r1170b2776],

1	(	NN	O	(	nn	2	SENT_33	[p1l1187t2737r1493b2776],
2	ClinicalTrials	NNS	O	clinicaltrial	_	0	SENT_33	[p1l1187t2737r1493b2776],
3	.	.	O	.	_	0	SENT_33	[p1l1187t2737r1493b2776],

1	gov	NN	O	gov	nn	2	SENT_34	[p1l1187t2737r1493b2776],
2	number	NN	O	number	_	0	SENT_34	[p1l1504t2737r1643b2774],
3	,	,	O	,	_	0	SENT_34	[p1l1504t2737r1643b2774],
4	NCT00340080	NN	O	nct00340080	appos	2	SENT_34	[p1l1657t2739r1919b2772],
5	.	.	O	.	_	0	SENT_34	[p1l1657t2739r1919b2772],
6	)	SYM	O	)	dep	2	SENT_34	[p1l1657t2739r1919b2772],

1	N	NN	O	n	nn	2	SENT_35	[p1l853t2862r866b2877],
2	ENGLJ	NN	MISC	englj	_	0	SENT_35	[p1l881t2862r959b2884],
3	Mi	SYM	MISC	mi	dep	2	SENT_35	[p1l974t2856r1099b2884],
4	-	:	O	-	_	0	SENT_35	[p1l974t2856r1099b2884],
5	:	:	O	:	_	0	SENT_35	[p1l974t2856r1099b2884],
6	D358	NN	O	d358	nn	9	SENT_35	[p1l974t2856r1099b2884],
7	;	:	O	;	_	0	SENT_35	[p1l974t2856r1099b2884],
8	6	CD	NUMBER	6	dep	6	SENT_35	[p1l974t2856r1099b2884],
9	WWW.NEjM.ORG	NN	O	www.nejm.org	dep	2	SENT_35	[p1l1133t2862r1334b2884],
10	FEBRUARY7	NN	O	february7	dep	9	SENT_35	[p1l1371t2862r1521b2883],
11	,	,	O	,	_	0	SENT_35	[p1l1371t2862r1521b2883],
12	2008	CD	DATE	2008	appos	10	SENT_35	[p1l1532t2856r1595b2878],

1	The	DT	O	the	det	4	SENT_36	[p1l880t2919r931b2943],
2	New	NNP	O	New	nn	4	SENT_36	[p1l940t2920r1002b2943],
3	England	NNP	O	England	nn	4	SENT_36	[p1l1011t2919r1122b2950],
4	Journal	NNP	O	Journal	_	0	SENT_36	[p1l1131t2919r1228b2943],
5	of	IN	O	of	_	0	SENT_36	[p1l1238t2919r1267b2943],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_36	[p1l1274t2919r1399b2943],

1	HLA-B	NN	O	hla-b	_	0	SENT_37	[p1l584t3107r779b3130],
2	*	CD	NUMBER	*	number	3	SENT_37	[p1l584t3107r779b3130],
3	5701	CD	NUMBER	5701	num	4	SENT_37	[p1l584t3107r779b3130],
4	SCREENING	NNP	O	SCREENING	dep	1	SENT_37	[p1l793t3110r989b3129],
5	FOR	IN	O	for	_	0	SENT_37	[p1l1004t3110r1068b3129],
6	ABACAVIR	NNP	O	ABACAVIR	nn	7	SENT_37	[p1l1079t3110r1244b3129],
7	HYPERSENSITIVITY	NN	O	hypersensitivity	prep_for	4	SENT_37	[p1l1257t3110r1576b3129],

1	HARMACOGENETIC	JJ	O	harmacogenetic	amod	2	SENT_38	[p1l286t3341r1181b3398],
2	TESTING	NN	O	testing	nsubj	4	SENT_38	[p1l1268t3341r1675b3398],
3	IS	VBZ	O	be	cop	4	SENT_38	[p1l1766t3341r1844b3397],
4	NOT	NN	O	not	_	0	SENT_38	[p1l1939t3341r2136b3398],

1	widely	RB	O	widely	advmod	2	SENT_39	[p1l278t3448r562b3548],
2	used	VBN	O	use	_	0	SENT_39	[p1l600t3448r797b3527],
3	in	IN	O	in	_	0	SENT_39	[p1l838t3449r921b3525],
4	routine	JJ	O	routine	amod	6	SENT_39	[p1l963t3449r1273b3527],
5	clinical	JJ	O	clinical	amod	6	SENT_39	[p1l1316t3448r1629b3526],
6	practice	NN	O	practice	prep_in	2	SENT_39	[p1l1669t3449r2008b3548],
7	to	TO	O	to	aux	8	SENT_39	[p1l2050t3464r2132b3526],
8	optimize	VB	O	optimize	infmod	6	SENT_39	[p1l283t3578r667b3677],
9	drug	NN	O	drug	nn	10	SENT_39	[p1l712t3577r916b3677],
10	choice	NN	O	choice	dobj	8	SENT_39	[p1l957t3577r1226b3655],
11	or	CC	O	or	_	0	SENT_39	[p1l1271t3602r1359b3655],
12	clinical	JJ	O	clinical	amod	14	SENT_39	[p1l1401t3577r1714b3655],
13	management	NN	O	management	nn	14	SENT_39	[p1l1757t3602r2132b3677, p1l11t3710r293b3784],
14	.1	NN	NUMBER	.1	dobj	8	SENT_39	[p1l1757t3602r2132b3677, p1l11t3710r293b3784],
15	This	DT	O	this	det	16	SENT_39	[p1l346t3705r533b3784],
16	gap	NN	O	gap	nsubjpass	25	SENT_39	[p1l592t3731r744b3806],
17	between	IN	O	between	_	0	SENT_39	[p1l803t3705r1160b3784],
18	scientific	JJ	O	scientific	amod	19	SENT_39	[p1l1218t3705r1611b3784],
19	knowledge	NN	O	knowledge	prep_between	16	SENT_39	[p1l1667t3705r2133b3806],
20	and	CC	O	and	_	0	SENT_39	[p2l11t20r168b99],
21	clinical	JJ	O	clinical	amod	22	SENT_39	[p2l205t20r519b99],
22	application	NN	O	application	conj_and	19	SENT_39	[p2l555t20r1034b121],
23	may	MD	O	may	aux	25	SENT_39	[p2l1071t46r1250b121],
24	be	VB	O	be	auxpass	25	SENT_39	[p2l1283t20r1380b99],
25	explained	VBN	O	explain	rcmod	10	SENT_39	[p2l1417t20r1832b121],
26	by	IN	O	by	_	0	SENT_39	[p2l1870t20r1967b121],
27	the	DT	O	the	det	28	SENT_39	[p2l2000t20r2133b99],
28	fact	NN	O	fact	agent	25	SENT_39	[p2l11t148r170b227],
29	that	IN	O	that	complm	40	SENT_39	[p2l205t148r377b227],
30	the	DT	O	the	det	32	SENT_39	[p2l413t148r546b227],
31	successful	JJ	O	successful	amod	32	SENT_39	[p2l587t148r1026b227],
32	incorporation	NN	O	incorporation	nsubj	40	SENT_39	[p2l1066t149r1660b249],
33	of	IN	O	of	_	0	SENT_39	[p2l1700t148r1800b227],
34	a	DT	O	a	det	36	SENT_39	[p2l1822t175r1866b227],
35	pharmacogenetic	JJ	O	pharmacogenetic	amod	36	SENT_39	[p2l1903t148r2132b249, p2l11t279r555b378],
36	test	NN	O	test	prep_of	32	SENT_39	[p2l591t294r746b356],
37	into	IN	O	into	_	0	SENT_39	[p2l777t279r946b356],
38	routine	JJ	O	routine	amod	39	SENT_39	[p2l984t279r1293b356],
39	practice	NN	O	practice	prep_into	36	SENT_39	[p2l1329t279r1667b378],
40	requires	VBZ	O	require	ccomp	25	SENT_39	[p2l1704t279r2052b378],
41	a	DT	O	a	det	42	SENT_39	[p2l2090t304r2134b356],
42	combination	NN	O	combination	dobj	40	SENT_39	[p2l12t406r558b485],
43	of	IN	O	of	_	0	SENT_39	[p2l608t406r708b485],
44	high	JJ	O	high	amod	47	SENT_39	[p2l738t406r1157b507],
45	—	NN	O	—	nn	47	SENT_39	[p2l738t406r1157b507],
46	level	NN	O	level	nn	47	SENT_39	[p2l738t406r1157b507],
47	evidence	NN	O	evidence	prep_of	42	SENT_39	[p2l1206t406r1572b485],
48	that	IN	O	that	nsubjpass	51	SENT_39	[p2l1621t406r1794b485],
49	can	MD	O	can	aux	51	SENT_39	[p2l1838t432r1987b485],
50	be	VB	O	be	auxpass	51	SENT_39	[p2l2037t406r2133b485],
51	generalized	VBN	O	generalize	rcmod	42	SENT_39	[p2l11t534r512b635],
52	to	TO	O	to	_	0	SENT_39	[p2l576t551r657b613],
53	diverse	JJ	O	diverse	amod	55	SENT_39	[p2l724t534r1021b613],
54	clinical	JJ	O	clinical	amod	55	SENT_39	[p2l1086t534r1400b613],
55	settings	NNS	O	setting	prep_to	51	SENT_39	[p2l1466t535r1828b635],
56	,	,	O	,	_	0	SENT_39	[p2l1466t535r1828b635],
57	Widespread	JJ	O	widespread	amod	58	SENT_39	[p2l1894t534r2132b613, p2l13t662r292b763],
58	availability	NN	O	availability	prep_in	2	SENT_39	[p2l342t662r814b763],
59	of	IN	O	of	_	0	SENT_39	[p2l861t662r961b741],
60	cost	NN	O	cost	npadvmod	62	SENT_39	[p2l994t662r1559b741],
61	—	CD	NUMBER	—	num	60	SENT_39	[p2l994t662r1559b741],
62	effective	JJ	O	effective	amod	66	SENT_39	[p2l994t662r1559b741],
63	and	CC	O	and	_	0	SENT_39	[p2l1609t662r1767b741],
64	reliable	JJ	O	reliable	conj_and	62	SENT_39	[p2l1818t662r2133b741],
65	laboratory	NN	O	laboratory	nn	66	SENT_39	[p2l10t790r457b891],
66	tests	NNS	O	test	prep_of	58	SENT_39	[p2l484t807r703b886],
67	,	,	O	,	_	0	SENT_39	[p2l484t807r703b886],
68	and	CC	O	and	_	0	SENT_39	[p2l740t790r897b869],
69	effective	JJ	O	effective	amod	70	SENT_39	[p2l930t790r1288b869],
70	strategies	NNS	O	strategy	prep_in	2	SENT_39	[p2l1322t791r1732b891],
71	to	TO	O	to	aux	72	SENT_39	[p2l1766t807r1848b869],
72	incorporate	VB	O	incorporate	infmod	70	SENT_39	[p2l1880t791r2132b869, p2l10t935r282b1019],
73	testing	NN	O	testing	dobj	72	SENT_39	[p2l317t919r615b1019],
74	into	IN	O	into	_	0	SENT_39	[p2l646t919r815b997],
75	routine	JJ	O	routine	amod	77	SENT_39	[p2l851t919r1160b997],
76	clinical	JJ	O	clinical	amod	77	SENT_39	[p2l1196t918r1510b997],
77	practice	NN	O	practice	prep_into	72	SENT_39	[p2l1542t919r1903b1019],
78	.	.	O	.	_	0	SENT_39	[p2l1542t919r1903b1019],

1	Abacavir	NNP	O	Abacavir	nsubj	8	SENT_40	[p2l136t1046r513b1125],
2	is	VBZ	O	be	cop	8	SENT_40	[p2l550t1047r616b1125],
3	a	DT	O	a	det	8	SENT_40	[p2l658t1073r702b1125],
4	nucleoside	JJ	O	nucleoside	amod	8	SENT_40	[p2l741t1046r1193b1125],
5	reverse	JJ	O	reverse	amod	8	SENT_40	[p2l1233t1047r2133b1147],
6	—	NN	O	—	nn	8	SENT_40	[p2l1233t1047r2133b1147],
7	transcriptase	NN	O	transcriptase	nn	8	SENT_40	[p2l1233t1047r2133b1147],
8	inhibitor	NN	O	inhibitor	_	0	SENT_40	[p2l11t1174r393b1253],
9	with	IN	O	with	_	0	SENT_40	[p2l445t1174r640b1253],
10	activity	NN	O	activity	prep_with	8	SENT_40	[p2l698t1175r1008b1275],
11	against	IN	O	against	_	0	SENT_40	[p2l1063t1175r1378b1275],
12	the	DT	O	the	det	20	SENT_40	[p2l1433t1174r1565b1253],
13	human	JJ	O	human	amod	20	SENT_40	[p2l1625t1174r1929b1253],
14	im	NN	O	im	nn	20	SENT_40	[p2l1988t1175r2132b1252],
15	—	NN	O	—	nn	20	SENT_40	[p2l1988t1175r2132b1252],
16	munodeficiency	NN	O	munodeficiency	nn	20	SENT_40	[p2l11t1302r702b1403],
17	virus	NN	O	virus	nn	20	SENT_40	[p2l740t1303r953b1381],
18	(	CD	NUMBER	(	num	20	SENT_40	[p2l1005t1309r1264b1398],
19	HIV	NN	MISC	hiv	nn	20	SENT_40	[p2l1005t1309r1264b1398],
20	)	NN	O	)	prep_against	10	SENT_40	[p2l1005t1309r1264b1398],
21	,	,	O	,	_	0	SENT_40	[p2l1005t1309r1264b1398],
22	available	JJ	O	available	amod	20	SENT_40	[p2l1315t1302r1687b1381],
23	for	IN	O	for	_	0	SENT_40	[p2l1733t1302r1857b1381],
24	oncedaily	JJ	O	oncedaily	amod	25	SENT_40	[p2l1900t1328r2131b1381, p2l12t1430r215b1531],
25	use	NN	O	use	prep_for	22	SENT_40	[p2l244t1457r382b1509],
26	in	IN	O	in	_	0	SENT_40	[p2l414t1431r497b1508],
27	combination	NN	O	combination	prep_in	25	SENT_40	[p2l531t1430r1067b1509],
28	with	IN	O	with	_	0	SENT_40	[p2l1095t1430r1288b1510],
29	other	JJ	O	other	amod	31	SENT_40	[p2l1321t1430r1545b1509],
30	antiretroviral	JJ	O	antiretroviral	amod	31	SENT_40	[p2l1574t1430r2133b1509],
31	agents	NNS	O	agent	prep_with	27	SENT_40	[p2l11t1575r311b1659],
32	,	,	O	,	_	0	SENT_40	[p2l11t1575r311b1659],
33	that	WDT	O	that	nsubj	35	SENT_40	[p2l357t1558r530b1637],
34	has	VBZ	O	have	aux	35	SENT_40	[p2l564t1558r709b1637],
35	shown	VBN	O	show	rcmod	20	SENT_40	[p2l752t1558r1034b1638],
36	efficacy	NN	O	efficacy	dobj	35	SENT_40	[p2l1075t1558r1424b1659],
37	,	,	O	,	_	0	SENT_40	[p2l1075t1558r1424b1659],
38	few	JJ	O	few	amod	40	SENT_40	[p2l1470t1558r1624b1637],
39	drug	NN	O	drug	nn	40	SENT_40	[p2l1661t1558r1865b1659],
40	inter	NN	O	inter	conj_and	36	SENT_40	[p2l1901t1559r2132b1637],
41	—	CD	NUMBER	—	num	42	SENT_40	[p2l1901t1559r2132b1637],
42	actions	NNS	O	action	dep	40	SENT_40	[p2l11t1687r340b1782],
43	,	,	O	,	_	0	SENT_40	[p2l11t1687r340b1782],
44	and	CC	O	and	_	0	SENT_40	[p2l392t1686r550b1765],
45	a	DT	O	a	det	51	SENT_40	[p2l596t1713r641b1765],
46	favorable	JJ	O	favorable	amod	51	SENT_40	[p2l686t1686r1074b1765],
47	long	JJ	O	long	amod	51	SENT_40	[p2l1120t1686r1547b1787],
48	—	NN	O	—	nn	51	SENT_40	[p2l1120t1686r1547b1787],
49	term	NN	O	term	nn	51	SENT_40	[p2l1120t1686r1547b1787],
50	toxicity	NN	O	toxicity	nn	51	SENT_40	[p2l1595t1687r1912b1787],
51	profile	NN	O	profile	conj_and	36	SENT_40	[p2l1953t1712r2132b1787, p2l11t1814r174b1893],
52	.	.	O	.	_	0	SENT_40	[p2l1953t1712r2132b1787, p2l11t1814r174b1893],

1	The	DT	O	the	det	5	SENT_41	[p2l211t1814r372b1893],
2	most	RBS	O	most	advmod	3	SENT_41	[p2l407t1831r623b1893],
3	important	JJ	O	important	amod	5	SENT_41	[p2l652t1815r1093b1915],
4	adverse	JJ	O	adverse	amod	5	SENT_41	[p2l1122t1814r1437b1893],
5	effect	NN	O	effect	nsubj	27	SENT_41	[p2l1473t1814r1715b1893],
6	of	IN	O	of	_	0	SENT_41	[p2l1745t1814r1845b1893],
7	abaca	NN	O	abaca	nn	9	SENT_41	[p2l1860t1814r2132b1893],
8	—	NN	O	—	nn	9	SENT_41	[p2l1860t1814r2132b1893],
9	vir	NN	O	vir	prep_of	5	SENT_41	[p2l7t1943r122b2021],
10	that	WDT	O	that	nsubj	17	SENT_41	[p2l157t1942r329b2021],
11	limits	VBZ	O	limit	rcmod	9	SENT_41	[p2l360t1942r609b2021],
12	its	PRP$	O	its	poss	13	SENT_41	[p2l648t1943r747b2021],
13	use	NN	O	use	dobj	11	SENT_41	[p2l786t1969r927b2021],
14	in	IN	O	in	_	0	SENT_41	[p2l964t1943r1048b2020],
15	therapy	NN	O	therapy	prep_in	11	SENT_41	[p2l1085t1942r1408b2043],
16	and	CC	O	and	_	0	SENT_41	[p2l1440t1942r1598b2021],
17	mandates	VBZ	O	mandate	conj_and	11	SENT_41	[p2l1635t1942r2051b2021],
18	a	DT	O	a	det	20	SENT_41	[p2l2090t1969r2135b2021],
19	high	JJ	O	high	amod	20	SENT_41	[p2l11t2070r206b2171],
20	degree	NN	O	degree	dobj	17	SENT_41	[p2l248t2070r532b2171],
21	of	IN	O	of	_	0	SENT_41	[p2l574t2070r674b2149],
22	clinical	JJ	O	clinical	amod	23	SENT_41	[p2l698t2070r1012b2149],
23	vigilance	NN	O	vigilance	prep_of	20	SENT_41	[p2l1048t2070r1435b2171],
24	is	VBZ	O	be	cop	27	SENT_41	[p2l1476t2071r1542b2149],
25	an	DT	O	a	det	27	SENT_41	[p2l1585t2096r1688b2149],
26	immuno	NN	O	immuno	nn	27	SENT_41	[p2l1729t2071r2132b2149],
27	—	NN	O	—	_	0	SENT_41	[p2l1729t2071r2132b2149],
28	logically	RB	O	logically	advmod	29	SENT_41	[p2l10t2198r358b2299],
29	mediated	VBD	O	mediate	partmod	27	SENT_41	[p2l394t2198r777b2277],
30	hypersensitivity	NN	O	hypersensitivity	nn	31	SENT_41	[p2l817t2198r1466b2299],
31	reaction	NN	O	reaction	dobj	29	SENT_41	[p2l1502t2199r1835b2277],
32	affecting	VBG	O	affect	xcomp	29	SENT_41	[p2l1874t2198r2132b2277, p2l11t2327r146b2427],
33	5	CD	NUMBER	5	number	35	SENT_41	[p2l182t2334r225b2405],
34	to	TO	O	to	dep	35	SENT_41	[p2l269t2343r350b2405],
35	8	CD	PERCENT	8	num	36	SENT_41	[p2l391t2331r525b2405],
36	%	NN	PERCENT	%	dobj	32	SENT_41	[p2l391t2331r525b2405],
37	of	IN	O	of	_	0	SENT_41	[p2l565t2326r665b2405],
38	patients	NNS	O	patient	prep_of	36	SENT_41	[p2l685t2327r1026b2427],
39	during	IN	O	during	_	0	SENT_41	[p2l1069t2326r1358b2427],
40	the	DT	DURATION	the	det	43	SENT_41	[p2l1395t2326r1528b2405],
41	first	JJ	DURATION	first	amod	43	SENT_41	[p2l1568t2326r1752b2405],
42	6	CD	DURATION	6	num	43	SENT_41	[p2l1787t2332r1834b2405],
43	Weeks	NNS	DURATION	week	prep_during	32	SENT_41	[p2l1870t2326r2131b2406],
44	of	IN	O	of	_	0	SENT_41	[p2l12t2454r112b2533],
45	treatment	NN	O	treatment	prep_of	43	SENT_41	[p2l141t2460r685b2533],
46	.23	CD	NUMBER	.23	num	47	SENT_41	[p2l141t2460r685b2533],
47	Symptoms	NNS	O	symptom	nsubj	54	SENT_41	[p2l737t2460r1186b2555],
48	of	IN	O	of	_	0	SENT_41	[p2l1237t2454r1337b2533],
49	a	DT	O	a	det	51	SENT_41	[p2l1366t2481r1410b2533],
50	hypersensitivity	NN	O	hypersensitivity	nn	51	SENT_41	[p2l1457t2454r2138b2555],
51	reaction	NN	O	reaction	prep_of	47	SENT_41	[p2l11t2582r344b2659],
52	to	TO	O	to	_	0	SENT_41	[p2l379t2598r458b2659],
53	abacavir	NN	O	abacavir	prep_to	51	SENT_41	[p2l493t2581r835b2660],
54	include	VBP	O	include	rcmod	27	SENT_41	[p2l866t2581r1163b2660],
55	combinations	NNS	O	combination	dobj	54	SENT_41	[p2l1199t2581r1764b2659],
56	of	IN	O	of	_	0	SENT_41	[p2l1801t2581r1898b2659],
57	fever	NN	O	fever	prep_of	55	SENT_41	[p2l1914t2581r2128b2676],
58	,	,	O	,	_	0	SENT_41	[p2l1914t2581r2128b2676],
59	rash	NN	O	rash	prep_of	55	SENT_41	[p2l11t2709r216b2805],
60	,	,	O	,	_	0	SENT_41	[p2l11t2709r216b2805],
61	constitutional	JJ	O	constitutional	amod	62	SENT_41	[p2l274t2709r876b2788],
62	symptoms	NNS	O	symptom	prep_of	55	SENT_41	[p2l928t2726r1395b2810],
63	,	,	O	,	_	0	SENT_41	[p2l928t2726r1395b2810],
64	gastrointestinal	JJ	O	gastrointestinal	amod	66	SENT_41	[p2l1451t2709r2134b2810],
65	tract	NN	O	tract	nn	66	SENT_41	[p2l12t2854r209b2916],
66	symptoms	NNS	O	symptom	prep_of	55	SENT_41	[p2l249t2854r716b2938],
67	,	,	O	,	_	0	SENT_41	[p2l249t2854r716b2938],
68	and	CC	O	and	_	0	SENT_41	[p2l765t2837r923b2916],
69	respiratory	JJ	O	respiratory	amod	70	SENT_41	[p2l966t2838r1437b2938],
70	symptoms	NNS	O	symptom	prep_of	55	SENT_41	[p2l1477t2854r1920b2938],
71	that	WDT	O	that	nsubj	74	SENT_41	[p2l1966t2837r2138b2916],
72	become	VBP	O	become	cop	74	SENT_41	[p2l12t2965r341b3044],
73	more	RBR	O	more	advmod	74	SENT_41	[p2l379t2991r599b3044],
74	severe	JJ	O	severe	rcmod	55	SENT_41	[p2l638t2991r895b3044],
75	with	IN	O	with	_	0	SENT_41	[p2l929t2965r1124b3044],
76	continued	JJ	O	continued	amod	77	SENT_41	[p2l1162t2965r1591b3044],
77	dosing	NN	O	dosing	prep_with	74	SENT_41	[p2l1629t2965r1940b3066],
78	.	.	O	.	_	0	SENT_41	[p2l1629t2965r1940b3066],

1	Immediate	NNP	O	Immediate	nsubjpass	8	SENT_42	[p2l1982t2973r2132b3043, p2l11t3093r353b3172],
2	and	CC	O	and	_	0	SENT_42	[p2l386t3093r544b3172],
3	permanent	JJ	O	permanent	amod	4	SENT_42	[p2l577t3110r1051b3194],
4	discontinuation	NN	O	discontinuation	nsubjpass	8	SENT_42	[p2l1080t3093r1761b3172],
5	of	IN	O	of	_	0	SENT_42	[p2l1796t3093r1896b3172],
6	abacavir	NN	O	abacavir	prep_of	4	SENT_42	[p2l1911t3093r2132b3172, p2l11t3222r166b3300],
7	is	VBZ	O	be	auxpass	8	SENT_42	[p2l204t3222r269b3300],
8	mandated	VBN	O	mandate	_	0	SENT_42	[p2l313t3221r758b3317],
9	,	,	O	,	_	0	SENT_42	[p2l313t3221r758b3317],
10	resulting	VBG	O	result	xcomp	8	SENT_42	[p2l805t3221r1184b3322],
11	in	IN	O	in	_	0	SENT_42	[p2l1222t3222r1305b3299],
12	a	DT	O	a	det	14	SENT_42	[p2l1346t3248r1390b3300],
13	rapid	JJ	O	rapid	amod	14	SENT_42	[p2l1430t3221r1644b3322],
14	reversal	NN	O	reversal	prep_in	10	SENT_42	[p2l1686t3221r2010b3300],
15	of	IN	O	of	_	0	SENT_42	[p2l2052t3221r2151b3300],
16	symptoms	NNS	O	symptom	prep_of	14	SENT_42	[p2l13t3366r471b3450],
17	.	.	O	.	_	0	SENT_42	[p2l13t3366r471b3450],

1	Subsequent	JJ	O	subsequent	amod	2	SENT_43	[p2l519t3349r1002b3450],
2	rechallenge	NN	O	rechallenge	nsubjpass	6	SENT_43	[p2l1036t3349r1520b3450],
3	with	IN	O	with	_	0	SENT_43	[p2l1556t3349r1748b3429],
4	abacavir	NN	O	abacavir	prep_with	2	SENT_43	[p2l1787t3349r2136b3428],
5	is	VBZ	O	be	auxpass	6	SENT_43	[p2l11t3477r76b3554],
6	contraindicated	VBN	O	contraindicate	_	0	SENT_43	[p2l122t3476r822b3571],
7	,	,	O	,	_	0	SENT_43	[p2l122t3476r822b3571],
8	since	IN	O	since	mark	11	SENT_43	[p2l873t3477r1088b3554],
9	it	PRP	O	it	nsubj	11	SENT_43	[p2l1130t3477r1190b3554],
10	can	MD	O	can	aux	11	SENT_43	[p2l1228t3502r1377b3554],
11	result	VB	O	result	advcl	6	SENT_43	[p2l1420t3476r1664b3555],
12	in	IN	O	in	_	0	SENT_43	[p2l1702t3477r1785b3553],
13	a	DT	O	a	det	15	SENT_43	[p2l1827t3503r1872b3554],
14	more	RBR	O	more	advmod	15	SENT_43	[p2l1913t3502r2133b3554],
15	severe	JJ	O	severe	prep_in	11	SENT_43	[p2l13t3630r287b3700],
16	,	,	O	,	_	0	SENT_43	[p2l13t3630r287b3700],
17	rapid	JJ	O	rapid	dep	15	SENT_43	[p2l337t3604r573b3705],
18	,	,	O	,	_	0	SENT_43	[p2l337t3604r573b3705],
19	and	CC	O	and	_	0	SENT_43	[p2l622t3604r778b3683],
20	potentially	RB	O	potentially	advmod	23	SENT_43	[p2l821t3604r1276b3705],
21	life	NN	O	life	npadvmod	23	SENT_43	[p2l1315t3604r1979b3705],
22	—	CD	NUMBER	—	num	21	SENT_43	[p2l1315t3604r1979b3705],
23	threatening	JJ	O	threatening	amod	24	SENT_43	[p2l1315t3604r1979b3705],
24	reaction	NN	O	reaction	prep_in	11	SENT_43	[p2l2020t3630r2132b3683, p2l11t3733r331b3810],
25	?	.	O	?	_	0	SENT_43	[p2l2020t3630r2132b3683, p2l11t3733r331b3810],

1	Symptoms	NNS	O	symptom	nsubj	9	SENT_44	[p3l142t50r592b145],
2	of	IN	O	of	_	0	SENT_44	[p3l638t44r738b123],
3	the	DT	O	the	det	5	SENT_44	[p3l763t44r896b123],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_44	[p3l939t44r1620b145],
5	reaction	NN	O	reaction	prep_of	1	SENT_44	[p3l1658t45r2007b123],
6	to	TO	O	to	_	0	SENT_44	[p3l2050t61r2132b123],
7	abacavir	NN	O	abacavir	prep_to	5	SENT_44	[p3l11t172r367b251],
8	are	VBP	O	be	cop	9	SENT_44	[p3l407t198r535b251],
9	nonspeciﬁc	JJ	O	nonspeciﬁc	_	0	SENT_44	[p3l579t172r1079b273],
10	and	CC	O	and	_	0	SENT_44	[p3l1121t172r1279b251],
11	can	MD	O	can	aux	13	SENT_44	[p3l1323t198r1472b251],
12	be	VB	O	be	cop	13	SENT_44	[p3l1516t172r1612b251],
13	difficult	JJ	O	difficult	conj_and	9	SENT_44	[p3l1657t172r2012b251],
14	to	TO	O	to	aux	15	SENT_44	[p3l2050t189r2132b251],
15	distinguish	VB	O	distinguish	xcomp	13	SENT_44	[p3l12t300r491b401],
16	from	IN	O	from	_	0	SENT_44	[p3l530t300r737b379],
17	concomitant	JJ	O	concomitant	amod	18	SENT_44	[p3l778t301r1313b379],
18	infection	NN	O	infection	prep_from	15	SENT_44	[p3l1347t300r1747b396],
19	,	,	O	,	_	0	SENT_44	[p3l1347t300r1747b396],
20	reaction	NN	O	reaction	prep_from	15	SENT_44	[p3l1792t301r2133b379],
21	to	TO	O	to	_	0	SENT_44	[p3l12t445r93b507],
22	other	JJ	O	other	amod	23	SENT_44	[p3l131t428r359b507],
23	drugs	NNS	O	drug	prep_to	20	SENT_44	[p3l393t428r661b529],
24	,	,	O	,	_	0	SENT_44	[p3l393t428r661b529],
25	or	CC	O	or	_	0	SENT_44	[p3l704t454r792b507],
26	inﬂammatory	JJ	O	inﬂammatory	amod	27	SENT_44	[p3l825t428r1435b529],
27	disease	NN	O	disease	prep_from	15	SENT_44	[p3l1467t428r1801b507],
28	.	.	O	.	_	0	SENT_44	[p3l1467t428r1801b507],

1	This	DT	O	this	nsubj	4	SENT_45	[p3l1840t428r2027b507],
2	is	VBZ	O	be	cop	4	SENT_45	[p3l2065t429r2130b507],
3	a	DT	O	a	det	4	SENT_45	[p3l11t583r55b635],
4	problem	NN	O	problem	_	0	SENT_45	[p3l89t556r447b657],
5	for	IN	O	for	_	0	SENT_45	[p3l484t556r608b635],
6	phenotyping	NN	O	phenotyping	prep_for	4	SENT_45	[p3l640t556r1190b657],
7	and	CC	O	and	_	0	SENT_45	[p3l1223t556r1381b635],
8	can	MD	O	can	aux	9	SENT_45	[p3l1418t582r1568b635],
9	lead	VB	O	lead	conj_and	4	SENT_45	[p3l1604t556r1777b635],
10	to	TO	O	to	_	0	SENT_45	[p3l1814t573r1896b635],
11	false	JJ	O	false	amod	14	SENT_45	[p3l1934t556r2133b635],
12	positive	JJ	O	positive	amod	14	SENT_45	[p3l10t685r340b785],
13	clinical	JJ	O	clinical	amod	14	SENT_45	[p3l373t684r687b763],
14	diagnoses	NNS	O	diagnosis	prep_to	9	SENT_45	[p3l719t684r1174b785],
15	:	:	O	:	_	0	SENT_45	[p3l719t684r1174b785],
16	in	IN	O	in	_	0	SENT_45	[p3l1209t685r1293b762],
17	blind	JJ	O	blind	amod	20	SENT_45	[p3l1325t684r1570b780],
18	,	,	O	,	_	0	SENT_45	[p3l1325t684r1570b780],
19	comparative	JJ	O	comparative	amod	20	SENT_45	[p3l1609t685r2133b785],
20	trials	NNS	O	trial	nsubj	23	SENT_45	[p3l12t812r231b891],
21	of	IN	O	of	_	0	SENT_45	[p3l279t812r379b891],
22	regimens	NNS	O	regimen	prep_of	20	SENT_45	[p3l404t813r803b913],
23	involving	VBG	O	involve	prepc_in	29	SENT_45	[p3l849t812r1247b913],
24	abacavir	NN	O	abacavir	dobj	23	SENT_45	[p3l1288t812r1662b908],
25	,	,	O	,	_	0	SENT_45	[p3l1288t812r1662b908],
26	hypersensitivity	NN	O	hypersensitivity	nn	27	SENT_45	[p3l1712t812r2132b913, p3l13t941r298b1041],
27	reaction	NN	O	reaction	nsubjpass	29	SENT_45	[p3l338t941r687b1019],
28	was	VBD	O	be	auxpass	29	SENT_45	[p3l727t967r889b1019],
29	reported	VBN	O	report	parataxis	4	SENT_45	[p3l937t940r1303b1041],
30	in	IN	O	in	_	0	SENT_45	[p3l1347t941r1430b1018],
31	2	CD	NUMBER	2	number	33	SENT_45	[p3l1475t946r1523b1018],
32	to	TO	O	to	dep	33	SENT_45	[p3l1569t957r1650b1019],
33	7	CD	PERCENT	7	num	34	SENT_45	[p3l1698t946r1830b1019],
34	%	NN	PERCENT	%	prep_in	29	SENT_45	[p3l1698t946r1830b1019],
35	of	IN	O	of	_	0	SENT_45	[p3l1875t940r1975b1019],
36	patients	NNS	O	patient	prep_of	34	SENT_45	[p3l2000t966r2132b1041, p3l12t1069r248b1147],
37	who	WP	O	who	nsubj	40	SENT_45	[p3l285t1068r468b1148],
38	were	VBD	O	be	aux	40	SENT_45	[p3l505t1094r706b1148],
39	not	RB	O	not	neg	40	SENT_45	[p3l746t1085r889b1147],
40	receiving	VBG	O	receive	rcmod	36	SENT_45	[p3l923t1069r1314b1169],
41	abacavir	NN	O	abacavir	nn	42	SENT_45	[p3l1350t1068r1833b1147],
42	.4	NN	NUMBER	.4	dobj	40	SENT_45	[p3l1350t1068r1833b1147],
43	'	''	O	'	_	0	SENT_45	[p3l1350t1068r1833b1147],
44	6	CD	NUMBER	6	dobj	40	SENT_45	[p3l1350t1068r1833b1147],

1	In	IN	O	in	dep	5	SENT_46	[p3l138t1204r226b1274],
2	2002	CD	DATE	2002	pobj	1	SENT_46	[p3l258t1202r482b1292],
3	,	,	O	,	_	0	SENT_46	[p3l258t1202r482b1292],
4	an	DT	O	a	det	5	SENT_46	[p3l519t1222r621b1275],
5	association	NN	O	association	_	0	SENT_46	[p3l652t1197r1125b1275],
6	between	IN	O	between	_	0	SENT_46	[p3l1158t1196r1510b1275],
7	a	DT	O	a	det	8	SENT_46	[p3l1540t1223r1585b1275],
8	diagnosis	NN	O	diagnosis	prep_between	5	SENT_46	[p3l1616t1196r2018b1297],
9	of	IN	O	of	_	0	SENT_46	[p3l2053t1196r2152b1275],
10	hypersensitivity	NN	O	hypersensitivity	nn	11	SENT_46	[p3l11t1324r676b1425],
11	reaction	NN	O	reaction	prep_of	8	SENT_46	[p3l711t1325r1052b1403],
12	to	TO	O	to	_	0	SENT_46	[p3l1092t1341r1172b1403],
13	abacavir	NN	O	abacavir	prep_to	11	SENT_46	[p3l1212t1324r1560b1403],
14	and	CC	O	and	_	0	SENT_46	[p3l1596t1324r1752b1403],
15	carriage	NN	O	carriage	prep_to	11	SENT_46	[p3l1792t1325r2133b1425],
16	of	IN	O	of	_	0	SENT_46	[p3l12t1452r112b1531],
17	the	DT	O	the	det	20	SENT_46	[p3l140t1452r273b1531],
18	major	JJ	O	major	amod	20	SENT_46	[p3l319t1453r569b1553],
19	histocompatibility	NN	O	histocompatibility	nn	20	SENT_46	[p3l612t1452r1408b1553],
20	complex	NN	O	complex	prep_of	5	SENT_46	[p3l1450t1452r1810b1553],
21	class	NN	O	class	nn	24	SENT_46	[p3l1854t1452r2057b1531],
22	1	CD	NUMBER	1	num	24	SENT_46	[p3l2104t1460r2134b1530],
23	allele	NN	O	allele	nn	24	SENT_46	[p3l11t1580r234b1659],
24	HLA	NN	O	hlum	dep	20	SENT_46	[p3l289t1580r827b1659],
25	.	.	O	.	_	0	SENT_46	[p3l289t1580r827b1659],

1	—	NN	O	—	_	0	SENT_47	[p3l289t1580r827b1659],
2	.	.	O	.	_	0	SENT_47	[p3l289t1580r827b1659],

1	B	NN	O	b	nsubj	21	SENT_48	[p3l289t1580r827b1659],
2	*	CD	NUMBER	*	number	3	SENT_48	[p3l289t1580r827b1659],
3	5701	CD	NUMBER	5701	nsubjpass	16	SENT_48	[p3l289t1580r827b1659],
4	was	VBD	O	be	auxpass	5	SENT_48	[p3l880t1607r1043b1659],
5	reported	VBN	O	report	rcmod	1	SENT_48	[p3l1101t1580r1467b1681],
6	independently	RB	O	independently	advmod	5	SENT_48	[p3l1524t1580r2138b1681],
7	by	IN	O	by	_	0	SENT_48	[p3l12t1708r109b1809],
8	two	CD	NUMBER	two	num	10	SENT_48	[p3l145t1725r303b1787],
9	research	NN	O	research	nn	10	SENT_48	[p3l345t1708r707b1787],
10	groups7	NN	O	groups7	agent	5	SENT_48	[p3l747t1714r1134b1809],
11	»	CD	NUMBER	»	number	12	SENT_48	[p3l747t1714r1134b1809],
12	8	CD	NUMBER	8	dep	10	SENT_48	[p3l747t1714r1134b1809],
13	and	CC	O	and	_	0	SENT_48	[p3l1175t1708r1333b1787],
14	was	VBD	O	be	auxpass	16	SENT_48	[p3l1369t1735r1532b1787],
15	subsequently	RB	O	subsequently	advmod	16	SENT_48	[p3l1577t1708r2138b1809],
16	corroborated	VBN	O	corroborate	rcmod	1	SENT_48	[p3l12t1836r568b1915],
17	by	IN	O	by	_	0	SENT_48	[p3l614t1836r711b1937],
18	several	JJ	O	several	amod	20	SENT_48	[p3l753t1836r1044b1915],
19	independent	JJ	O	independent	amod	20	SENT_48	[p3l1088t1836r1627b1937],
20	studies	NNS	O	study	agent	16	SENT_48	[p3l1668t1836r2133b1915],
21	.9	VBP	NUMBER	.9	_	0	SENT_48	[p3l1668t1836r2133b1915],
22	'12	CD	NUMBER	'12	num	23	SENT_48	[p3l1668t1836r2133b1915],
23	Studies	NNS	O	study	nsubj	31	SENT_48	[p3l13t1964r321b2043],
24	of	IN	O	of	_	0	SENT_48	[p3l365t1964r465b2043],
25	cohorts	NNS	O	cohort	prep_of	23	SENT_48	[p3l490t1964r811b2043],
26	with	IN	O	with	_	0	SENT_48	[p3l851t1964r1046b2043],
27	HIV	NN	MISC	hiv	nn	28	SENT_48	[p3l1088t1972r1262b2043],
28	infection	NN	O	infection	prep_with	25	SENT_48	[p3l1300t1964r1687b2043],
29	have	VBP	O	have	aux	31	SENT_48	[p3l1729t1964r1919b2043],
30	also	RB	O	also	advmod	31	SENT_48	[p3l1961t1964r2132b2043],
31	shown	VBN	O	show	ccomp	21	SENT_48	[p3l13t2092r286b2171],
32	that	IN	O	that	complm	33	SENT_48	[p3l320t2092r487b2171],
33	avoiding	VBG	O	avoid	ccomp	31	SENT_48	[p3l515t2092r869b2193],
34	abacavir	NN	O	abacavir	dobj	33	SENT_48	[p3l898t2092r1240b2171],
35	in	IN	O	in	_	0	SENT_48	[p3l1271t2093r1351b2170],
36	HLA	NN	O	hlum	prep_in	33	SENT_48	[p3l1386t2092r2132b2193],
37	.	.	O	.	_	0	SENT_48	[p3l1386t2092r2132b2193],

1	—	NN	O	—	_	0	SENT_49	[p3l1386t2092r2132b2193],
2	.	.	O	.	_	0	SENT_49	[p3l1386t2092r2132b2193],

1	B	NN	O	b	_	0	SENT_50	[p3l1386t2092r2132b2193],
2	*	CD	NUMBER	*	number	3	SENT_50	[p3l1386t2092r2132b2193],
3	5701	CD	NUMBER	5701	num	1	SENT_50	[p3l1386t2092r2132b2193],
4	.	.	O	.	_	0	SENT_50	[p3l1386t2092r2132b2193],

1	—	NN	O	—	_	0	SENT_51	[p3l1386t2092r2132b2193],
2	.	.	O	.	_	0	SENT_51	[p3l1386t2092r2132b2193],

1	pos	NN	O	po	nn	3	SENT_52	[p3l1386t2092r2132b2193],
2	itive	JJ	O	itive	amod	3	SENT_52	[p3l11t2221r177b2299],
3	patients	NNS	O	patient	nsubj	5	SENT_52	[p3l212t2221r553b2321],
4	significantly	RB	O	significantly	advmod	5	SENT_52	[p3l598t2220r1141b2321],
5	reduced	VBD	O	reduce	_	0	SENT_52	[p3l1177t2220r1514b2299],
6	the	DT	O	the	det	7	SENT_52	[p3l1555t2220r1688b2299],
7	incidence	NN	O	incidence	dobj	5	SENT_52	[p3l1727t2220r2133b2299],
8	of	IN	O	of	_	0	SENT_52	[p3l12t2348r109b2427],
9	suspected	VBN	O	suspect	amod	11	SENT_52	[p3l120t2348r523b2449],
10	hypersensitivity	NN	O	hypersensitivity	nn	11	SENT_52	[p3l550t2348r1199b2449],
11	reaction	NN	O	reaction	prep_of	7	SENT_52	[p3l1222t2349r1576b2444],
12	,	,	O	,	_	0	SENT_52	[p3l1222t2349r1576b2444],
13	as	IN	O	as	mark	46	SENT_52	[p3l1609t2375r1692b2427],
14	compared	VBN	O	compare	_	0	SENT_52	[p3l1722t2348r2133b2449],
15	with	IN	O	with	prepc_compared_with	46	SENT_52	[p3l7t2476r202b2555],
16	prescreening	VBG	O	prescreen	pcomp	46	SENT_52	[p3l242t2477r803b2577],
17	rates	NNS	O	rate	dobj	16	SENT_52	[p3l840t2493r1043b2554],
18	in	IN	O	in	_	0	SENT_52	[p3l1085t2477r1168b2554],
19	a	DT	O	a	det	22	SENT_52	[p3l1209t2502r1253b2554],
20	Western	JJ	MISC	western	amod	22	SENT_52	[p3l1289t2484r1643b2554],
21	Australian	JJ	MISC	australian	amod	22	SENT_52	[p3l1680t2476r2133b2555],
22	cohort13	NN	O	cohort13	prep_in	16	SENT_52	[p3l12t2604r364b2683],
23	and	CC	O	and	_	0	SENT_52	[p3l403t2604r561b2683],
24	historical	JJ	O	historical	amod	25	SENT_52	[p3l597t2604r1004b2683],
25	rates	NNS	O	rate	prep_in	16	SENT_52	[p3l1040t2621r1243b2682],
26	in	IN	O	in	_	0	SENT_52	[p3l1281t2605r1365b2682],
27	Brighton	NNP	LOCATION	Brighton	prep_in	16	SENT_52	[p3l1400t2604r1804b2705],
28	,	,	O	,	_	0	SENT_52	[p3l1400t2604r1804b2705],
29	United	NNP	LOCATION	United	nn	30	SENT_52	[p3l1845t2604r2133b2683],
30	Kingdom	NNP	LOCATION	Kingdom	appos	27	SENT_52	[p3l11t2732r514b2833],
31	,	,	O	,	_	0	SENT_52	[p3l11t2732r514b2833],
32	“	NN	O	“	appos	30	SENT_52	[p3l11t2732r514b2833],
33	and	CC	O	and	_	0	SENT_52	[p3l555t2732r714b2811],
34	in	IN	O	in	_	0	SENT_52	[p3l755t2733r839b2810],
35	France	NNP	LOCATION	France	conj_and	27	SENT_52	[p3l880t2737r1264b2811],
36	.15	CD	NUMBER	.15	num	35	SENT_52	[p3l880t2737r1264b2811],
37	Overall	JJ	O	overall	dep	16	SENT_52	[p3l1310t2732r1640b2828],
38	,	,	O	,	_	0	SENT_52	[p3l1310t2732r1640b2828],
39	these	DT	O	these	det	43	SENT_52	[p3l1689t2732r1912b2810],
40	prospective	JJ	O	prospective	amod	43	SENT_52	[p3l1953t2758r2132b2832, p3l12t2861r350b2959],
41	and	CC	O	and	_	0	SENT_52	[p3l394t2860r552b2938],
42	retrospective	JJ	O	retrospective	amod	43	SENT_52	[p3l595t2861r1148b2959],
43	studies	NNS	O	study	nsubj	46	SENT_52	[p3l1194t2860r1493b2939],
44	have	VBP	O	have	aux	46	SENT_52	[p3l1539t2860r1729b2939],
45	not	RB	O	not	neg	46	SENT_52	[p3l1773t2876r1916b2938],
46	provided	VBN	O	provide	dep	11	SENT_52	[p3l1953t2886r2132b2959, p3l7t2987r236b3066],
47	evidence	NN	O	evidence	dobj	46	SENT_52	[p3l288t2987r653b3066],
48	that	DT	O	that	nsubj	50	SENT_52	[p3l705t2987r878b3065],
49	is	VBZ	O	be	cop	50	SENT_52	[p3l924t2988r989b3065],
50	sufficient	JJ	O	sufficient	rcmod	47	SENT_52	[p3l1044t2986r1456b3066],
51	for	IN	O	for	_	0	SENT_52	[p3l1502t2986r1625b3066],
52	the	DT	O	the	det	53	SENT_52	[p3l1674t2987r1807b3065],
53	implementation	NN	O	implementation	prep_for	50	SENT_52	[p3l1858t2987r2132b3087, p3l11t3117r453b3195],
54	of	IN	O	of	_	0	SENT_52	[p3l499t3115r599b3195],
55	HLA	NN	O	hlum	prep_of	53	SENT_52	[p3l625t3116r1162b3195],
56	.	.	O	.	_	0	SENT_52	[p3l625t3116r1162b3195],

1	—	NN	O	—	_	0	SENT_53	[p3l625t3116r1162b3195],
2	.	.	O	.	_	0	SENT_53	[p3l625t3116r1162b3195],

1	B	NN	O	b	_	0	SENT_54	[p3l625t3116r1162b3195],
2	*	CD	NUMBER	*	number	3	SENT_54	[p3l625t3116r1162b3195],
3	5701	CD	NUMBER	5701	num	4	SENT_54	[p3l625t3116r1162b3195],
4	screening	NN	O	screening	dep	1	SENT_54	[p3l1209t3117r1627b3217],
5	because	IN	O	because	dep	1	SENT_54	[p3l1669t3116r2005b3195],
6	of	IN	O	of	_	0	SENT_54	[p3l2051t3115r2151b3195],
7	limitations	NNS	O	limitation	prep_of	12	SENT_54	[p3l10t3243r450b3322],
8	such	JJ	O	such	_	0	SENT_54	[p3l486t3243r670b3323],
9	as	IN	O	as	_	0	SENT_54	[p3l702t3269r784b3321],
10	small	JJ	O	small	amod	11	SENT_54	[p3l821t3243r1042b3321],
11	numbers	NNS	O	number	prep_such_as	7	SENT_54	[p3l1074t3243r1432b3323],
12	of	IN	O	of	pobj	5	SENT_54	[p3l1467t3242r1564b3322],
13	patients	NNS	O	patient	pobj	12	SENT_54	[p3l1577t3244r1895b3343],
14	studied	VBN	O	study	partmod	13	SENT_54	[p3l1932t3243r2132b3323, p3l11t3372r159b3468],
15	,	,	O	,	_	0	SENT_54	[p3l1932t3243r2132b3323, p3l11t3372r159b3468],
16	geographic	JJ	O	geographic	amod	17	SENT_54	[p3l201t3372r682b3473],
17	localization	NN	O	localization	conj_and	12	SENT_54	[p3l717t3372r1248b3468],
18	,	,	O	,	_	0	SENT_54	[p3l717t3372r1248b3468],
19	retrospective	JJ	O	retrospective	amod	20	SENT_54	[p3l1290t3373r1843b3472],
20	methods	NNS	O	method	appos	17	SENT_54	[p3l1879t3372r2132b3450, p3l12t3499r184b3595],
21	,	,	O	,	_	0	SENT_54	[p3l1879t3372r2132b3450, p3l12t3499r184b3595],
22	lack	NN	O	lack	conj_and	12	SENT_54	[p3l229t3499r404b3579],
23	of	IN	O	of	_	0	SENT_54	[p3l441t3498r541b3578],
24	a	DT	O	a	det	27	SENT_54	[p3l563t3525r607b3577],
25	contemporary	JJ	O	contemporary	amod	27	SENT_54	[p3l647t3516r1252b3599],
26	control	NN	O	control	nn	27	SENT_54	[p3l1289t3499r1595b3578],
27	population	NN	O	population	prep_of	22	SENT_54	[p3l1633t3499r2128b3599],
28	,	,	O	,	_	0	SENT_54	[p3l1633t3499r2128b3599],
29	lack	NN	O	lack	conj_and	12	SENT_54	[p3l10t3627r183b3707],
30	of	IN	O	of	_	0	SENT_54	[p3l223t3626r322b3706],
31	racial	JJ	O	racial	amod	32	SENT_54	[p3l347t3627r577b3705],
32	diversity	NN	O	diversity	prep_of	29	SENT_54	[p3l621t3627r987b3727],
33	,	,	O	,	_	0	SENT_54	[p3l621t3627r987b3727],
34	and	CC	O	and	_	0	SENT_54	[p3l1036t3627r1191b3706],
35	nonuniform	JJ	O	nonuniform	amod	37	SENT_54	[p3l1236t3626r1750b3707],
36	case	NN	O	case	nn	37	SENT_54	[p3l1795t3653r1971b3705],
37	ascertainment	NN	O	ascertainment	pobj	5	SENT_54	[p3l2015t3653r2132b3705, p4l12t22r529b99],

1	of	IN	O	of	_	0	SENT_55	[p4l554t20r654b100],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_55	[p4l666t21r1347b121],
3	reactions	NNS	O	reaction	pobj	1	SENT_55	[p4l1373t22r1763b100],
4	to	TO	O	to	_	0	SENT_55	[p4l1796t38r1877b100],
5	abacavir	NN	O	abacavir	prep_to	3	SENT_55	[p4l1909t21r2132b100, p4l11t151r183b229],
6	.	.	O	.	_	0	SENT_55	[p4l1909t21r2132b100, p4l11t151r183b229],

1	Moreover	RB	O	moreover	advmod	6	SENT_56	[p4l221t158r637b246],
2	,	,	O	,	_	0	SENT_56	[p4l221t158r637b246],
3	clinical	JJ	O	clinical	amod	4	SENT_56	[p4l679t150r985b228],
4	overdiagnosis	NN	O	overdiagnosis	nsubj	6	SENT_56	[p4l1020t150r1599b251],
5	has	VBZ	O	have	aux	6	SENT_56	[p4l1636t150r1778b228],
6	led	VBN	O	lead	_	0	SENT_56	[p4l1814t150r1938b229],
7	to	TO	O	to	_	0	SENT_56	[p4l1974t167r2054b229],
8	a	DT	O	a	det	10	SENT_56	[p4l2090t176r2134b228],
9	substantial	JJ	O	substantial	amod	10	SENT_56	[p4l12t277r500b357],
10	overestimation	NN	O	overestimation	prep_to	6	SENT_56	[p4l542t278r1198b356],
11	of	IN	O	of	_	0	SENT_56	[p4l1242t276r1342b356],
12	the	DT	O	the	det	13	SENT_56	[p4l1368t277r1502b355],
13	prevalence	NN	O	prevalence	prep_of	10	SENT_56	[p4l1544t277r2007b377],
14	of	IN	O	of	_	0	SENT_56	[p4l2051t276r2152b356],
15	hypersensitivity	NN	O	hypersensitivity	nn	16	SENT_56	[p4l11t406r692b505],
16	reaction	NN	O	reaction	prep_of	13	SENT_56	[p4l720t407r1069b484],
17	over	IN	O	over	_	0	SENT_56	[p4l1102t432r1280b485],
18	the	DT	O	the	det	20	SENT_56	[p4l1311t406r1443b484],
19	true	JJ	O	true	amod	20	SENT_56	[p4l1477t423r1648b485],
20	prevalence	NN	O	prevalence	prep_over	6	SENT_56	[p4l1680t406r2133b505],
21	of	IN	O	of	prep	20	SENT_56	[p4l12t533r110b613],
22	immunologically	RB	O	immunologically	pcomp	21	SENT_56	[p4l131t534r854b635],
23	mediated	VBN	O	mediate	partmod	20	SENT_56	[p4l889t534r1280b613],
24	hypersensitivity	NN	O	hypersensitivity	nn	25	SENT_56	[p4l1319t534r1984b634],
25	reaction	NN	O	reaction	dobj	23	SENT_56	[p4l2019t560r2132b612, p4l11t663r296b741],
26	.	.	O	.	_	0	SENT_56	[p4l2019t560r2132b612, p4l11t663r296b741],

1	This	DT	O	this	nsubj	4	SENT_57	[p4l341t662r529b740],
2	is	VBZ	O	be	cop	4	SENT_57	[p4l572t663r638b740],
3	particularly	RB	O	particularly	advmod	4	SENT_57	[p4l681t662r1183b762],
4	true	JJ	O	true	_	0	SENT_57	[p4l1221t679r1392b741],
5	in	IN	O	in	_	0	SENT_57	[p4l1434t663r1517b740],
6	racial	JJ	O	racial	amod	7	SENT_57	[p4l1560t662r1794b740],
7	groups	NNS	O	group	prep_in	4	SENT_57	[p4l1836t688r2130b763],
8	with	IN	O	with	_	0	SENT_57	[p4l7t790r202b869],
9	a	DT	O	a	det	12	SENT_57	[p4l235t816r280b868],
10	low	JJ	O	low	amod	12	SENT_57	[p4l311t790r467b869],
11	carriage	NN	O	carriage	nn	12	SENT_57	[p4l498t791r846b891],
12	frequency	NN	O	frequency	prep_with	4	SENT_57	[p4l880t789r1305b890],
13	of	IN	O	of	_	0	SENT_57	[p4l1335t789r1435b869],
14	HLA	NN	O	hlum	prep_of	12	SENT_57	[p4l1450t790r2010b886],
15	.	.	O	.	_	0	SENT_57	[p4l1450t790r2010b886],

1	—	NN	O	—	_	0	SENT_58	[p4l1450t790r2010b886],
2	.	.	O	.	_	0	SENT_58	[p4l1450t790r2010b886],

1	B	NN	O	b	_	0	SENT_59	[p4l1450t790r2010b886],
2	*	CD	NUMBER	*	number	3	SENT_59	[p4l1450t790r2010b886],
3	5701	CD	NUMBER	5701	dobj	1	SENT_59	[p4l1450t790r2010b886],
4	,	,	O	,	_	0	SENT_59	[p4l1450t790r2010b886],
5	in	IN	O	in	_	0	SENT_59	[p4l2050t791r2133b868],
6	which	WDT	O	which	rel	12	SENT_59	[p4l7t918r260b997],
7	false	JJ	O	false	amod	10	SENT_59	[p4l292t917r482b997],
8	positive	JJ	O	positive	amod	10	SENT_59	[p4l513t919r829b1018],
9	clinical	JJ	O	clinical	amod	10	SENT_59	[p4l862t918r1160b996],
10	diagnosis	NN	O	diagnosis	nsubj	12	SENT_59	[p4l1193t918r1586b1019],
11	has	VBZ	O	have	aux	12	SENT_59	[p4l1620t918r1760b996],
12	resulted	VBN	O	result	rcmod	3	SENT_59	[p4l1795t918r2133b997],
13	in	IN	O	in	_	0	SENT_59	[p4l11t1048r95b1125],
14	the	DT	O	the	det	16	SENT_59	[p4l140t1047r275b1125],
15	erroneous	JJ	O	erroneous	amod	16	SENT_59	[p4l321t1073r757b1126],
16	conclusion	NN	O	conclusion	prep_in	12	SENT_59	[p4l804t1047r1275b1126],
17	that	IN	O	that	complm	20	SENT_59	[p4l1320t1047r1496b1125],
18	the	DT	O	the	det	19	SENT_59	[p4l1537t1047r1671b1125],
19	test	NN	O	test	nsubj	20	SENT_59	[p4l1717t1064r1874b1125],
20	lacks	VBZ	O	lack	ccomp	12	SENT_59	[p4l1913t1047r2131b1126],
21	sensitivity	NN	O	sensitivity	dobj	20	SENT_59	[p4l12t1176r536b1274],
22	.	.	O	.	_	0	SENT_59	[p4l12t1176r536b1274],

1	”	NN	O	”	_	0	SENT_60	[p4l12t1176r536b1274],

1	The	DT	O	the	det	2	SENT_61	[p4l136t1303r293b1381],
2	use	NN	O	use	_	0	SENT_61	[p4l322t1329r458b1382],
3	of	IN	O	of	_	0	SENT_61	[p4l488t1302r586b1382],
4	epicutaneous	JJ	O	epicutaneous	amod	7	SENT_61	[p4l597t1304r1137b1403],
5	patch	NN	O	patch	nn	7	SENT_61	[p4l1167t1303r1394b1403],
6	testing	NN	O	testing	nn	7	SENT_61	[p4l1423t1304r1708b1404],
7	addresses	NNS	O	address	prep_of	2	SENT_61	[p4l1733t1303r2131b1382],
8	the	DT	O	the	det	9	SENT_61	[p4l12t1431r142b1509],
9	problem	NN	O	problem	dep	7	SENT_61	[p4l175t1431r527b1531],
10	of	IN	O	of	_	0	SENT_61	[p4l563t1430r661b1510],
11	false	JJ	O	false	amod	14	SENT_61	[p4l677t1430r870b1509],
12	positive	JJ	O	positive	amod	14	SENT_61	[p4l904t1432r1227b1531],
13	clinical	JJ	O	clinical	amod	14	SENT_61	[p4l1262t1431r1568b1509],
14	diagnosis	NN	O	diagnosis	prep_of	2	SENT_61	[p4l1602t1431r2005b1532],
15	by	IN	O	by	_	0	SENT_61	[p4l2042t1431r2138b1531],
16	identifying	VBG	O	identify	prepc_by	2	SENT_61	[p4l11t1558r465b1660],
17	patients	NNS	O	patient	dobj	16	SENT_61	[p4l492t1560r817b1659],
18	who	WP	O	who	nsubj	20	SENT_61	[p4l847t1559r1026b1638],
19	have	VBP	O	have	aux	20	SENT_61	[p4l1058t1559r1241b1638],
20	had	VBD	O	have	rcmod	17	SENT_61	[p4l1273t1559r1425b1638],
21	an	DT	O	a	det	22	SENT_61	[p4l1456t1585r1557b1637],
22	immunologically	RB	O	immunologically	dobj	20	SENT_61	[p4l1587t1559r2132b1660, p4l12t1687r202b1786],
23	mediated	VBN	O	mediate	dep	22	SENT_61	[p4l245t1687r644b1765],
24	hypersensitivity	NN	O	hypersensitivity	nn	25	SENT_61	[p4l694t1687r1376b1786],
25	reaction	NN	O	reaction	dobj	23	SENT_61	[p4l1422t1688r1770b1765],
26	to	TO	O	to	_	0	SENT_61	[p4l1822t1704r1903b1765],
27	abacavir	NN	O	abacavir	prep_to	25	SENT_61	[p4l1954t1687r2132b1765, p4l12t1816r235b1910],
28	,	,	O	,	_	0	SENT_61	[p4l1954t1687r2132b1765, p4l12t1816r235b1910],
29	without	IN	O	without	_	0	SENT_61	[p4l273t1815r612b1894],
30	the	DT	O	the	det	31	SENT_61	[p4l645t1815r777b1893],
31	risks	NNS	O	risk	prep_without	23	SENT_61	[p4l815t1815r1017b1894],
32	associated	VBN	O	associate	partmod	31	SENT_61	[p4l1055t1815r1500b1893],
33	with	IN	O	with	_	0	SENT_61	[p4l1533t1815r1728b1894],
34	systemic	JJ	O	systemic	amod	35	SENT_61	[p4l1766t1816r2133b1914],
35	rechallenge	NN	O	rechallenge	prep_with	32	SENT_61	[p4l11t1943r684b2044],
36	.11	CD	NUMBER	.11	num	22	SENT_61	[p4l11t1943r684b2044],
37	»	CD	NUMBER	»	number	38	SENT_61	[p4l11t1943r684b2044],
38	15	CD	NUMBER	15	nsubj	55	SENT_61	[p4l11t1943r684b2044],
39	A	DT	O	a	det	44	SENT_61	[p4l719t1951r785b2021],
40	positive	JJ	O	positive	amod	44	SENT_61	[p4l818t1944r1141b2043],
41	patch	NN	O	patch	nn	44	SENT_61	[p4l1177t1943r1594b2043],
42	—	CD	NUMBER	—	num	44	SENT_61	[p4l1177t1943r1594b2043],
43	test	NN	O	test	nn	44	SENT_61	[p4l1177t1943r1594b2043],
44	result	NN	O	result	dep	38	SENT_61	[p4l1626t1943r1884b2039],
45	,	,	O	,	_	0	SENT_61	[p4l1626t1943r1884b2039],
46	measured	VBN	O	measure	partmod	38	SENT_61	[p4l1927t1969r2132b2022, p4l12t2071r242b2150],
47	by	IN	O	by	_	0	SENT_61	[p4l272t2071r368b2170],
48	a	DT	O	a	det	53	SENT_61	[p4l393t2097r437b2148],
49	visible	JJ	O	visible	dep	52	SENT_61	[p4l461t2071r727b2150],
50	and	CC	O	and	_	0	SENT_61	[p4l756t2071r911b2149],
51	palpable	JJ	O	palpable	conj_and	52	SENT_61	[p4l939t2071r1293b2170],
52	localized	JJ	O	localized	amod	53	SENT_61	[p4l1322t2071r1702b2149],
53	response	NN	O	response	agent	46	SENT_61	[p4l1732t2097r2128b2170],
54	,	,	O	,	_	0	SENT_61	[p4l1732t2097r2128b2170],
55	denotes	VBZ	O	denote	rcmod	22	SENT_61	[p4l12t2199r340b2277],
56	a	DT	O	a	det	59	SENT_61	[p4l400t2225r444b2277],
57	delayed	VBN	O	delay	amod	59	SENT_61	[p4l501t2199r819b2298],
58	hypersensitivity	NN	O	hypersensitivity	nn	59	SENT_61	[p4l877t2199r1558b2298],
59	response	NN	O	response	dobj	55	SENT_61	[p4l1611t2225r1992b2298],
60	to	TO	O	to	_	0	SENT_61	[p4l2050t2215r2132b2277],
61	abacavir	NN	O	abacavir	prep_to	55	SENT_61	[p4l11t2327r367b2406],
62	in	IN	O	in	_	0	SENT_61	[p4l395t2328r479b2405],
63	patients	NNS	O	patient	prep_in	2	SENT_61	[p4l510t2328r851b2427],
64	for	IN	O	for	_	0	SENT_61	[p4l885t2326r1009b2406],
65	Whom	WP	O	whom	dobj	79	SENT_61	[p4l1034t2327r1305b2406],
66	previous	JJ	O	previous	amod	67	SENT_61	[p4l1335t2328r1698b2427],
67	ingestion	NN	O	ingestion	nsubj	79	SENT_61	[p4l1731t2328r2133b2428],
68	of	IN	O	of	_	0	SENT_61	[p4l12t2454r110b2534],
69	the	DT	O	the	det	71	SENT_61	[p4l129t2455r260b2533],
70	drug	NN	O	drug	nn	71	SENT_61	[p4l297t2455r498b2556],
71	(	NN	O	(	prep_of	67	SENT_61	[p4l536t2455r940b2556],
72	resulting	VBG	O	result	partmod	71	SENT_61	[p4l536t2455r940b2556],
73	in	IN	O	in	_	0	SENT_61	[p4l973t2456r1055b2533],
74	adequate	JJ	O	adequate	amod	77	SENT_61	[p4l1090t2455r1465b2555],
75	systemic	JJ	O	systemic	amod	77	SENT_61	[p4l1503t2456r1863b2555],
76	exposure	NN	O	exposure	nn	77	SENT_61	[p4l1899t2481r2132b2555, p4l12t2590r210b2674],
77	)	NN	O	)	prep_in	72	SENT_61	[p4l1899t2481r2132b2555, p4l12t2590r210b2674],
78	has	VBZ	O	have	aux	79	SENT_61	[p4l255t2583r397b2661],
79	caused	VBN	O	cause	prepc_for	2	SENT_61	[p4l439t2583r724b2662],
80	immunologic	JJ	O	immunologic	amod	81	SENT_61	[p4l763t2583r1332b2684],
81	priming	NN	O	priming	dobj	79	SENT_61	[p4l1369t2584r1718b2684],
82	to	TO	O	to	aux	83	SENT_61	[p4l1754t2600r1835b2662],
83	occur	VB	O	occur	xcomp	79	SENT_61	[p4l1876t2609r2128b2662],
84	.	.	O	.	_	0	SENT_61	[p4l1876t2609r2128b2662],

1	For	IN	O	for	_	0	SENT_62	[p4l9t2718r148b2790],
2	this	DT	O	this	det	3	SENT_62	[p4l178t2711r331b2789],
3	reason	NN	O	reason	prep_for	11	SENT_62	[p4l366t2737r661b2807],
4	,	,	O	,	_	0	SENT_62	[p4l366t2737r661b2807],
5	epicutaneous	JJ	O	epicutaneous	amod	7	SENT_62	[p4l700t2712r1241b2811],
6	patch	NN	O	patch	nn	7	SENT_62	[p4l1274t2711r1501b2811],
7	testing	NN	O	testing	nsubjpass	11	SENT_62	[p4l1534t2712r1819b2812],
8	can	MD	O	can	aux	11	SENT_62	[p4l1850t2728r2138b2790],
9	not	RB	O	not	neg	11	SENT_62	[p4l1850t2728r2138b2790],
10	be	VB	O	be	auxpass	11	SENT_62	[p4l12t2839r108b2918],
11	used	VBN	O	use	_	0	SENT_62	[p4l142t2839r339b2918],
12	as	IN	O	as	_	0	SENT_62	[p4l373t2865r458b2917],
13	a	DT	O	a	det	16	SENT_62	[p4l494t2865r538b2917],
14	predictive	JJ	O	predictive	amod	16	SENT_62	[p4l569t2839r989b2939],
15	screening	NN	O	screening	nn	16	SENT_62	[p4l1025t2840r1443b2940],
16	tool	NN	O	tool	prep_as	11	SENT_62	[p4l1475t2839r1640b2918],
17	in	IN	O	in	_	0	SENT_62	[p4l1673t2840r1756b2917],
18	patients	NNS	O	patient	prep_in	16	SENT_62	[p4l1789t2840r2131b2939],
19	who	WP	O	who	nsubj	23	SENT_62	[p4l7t2967r185b3046],
20	have	VBP	O	have	aux	23	SENT_62	[p4l224t2967r407b3046],
21	not	RB	O	not	neg	23	SENT_62	[p4l444t2984r584b3046],
22	previously	RB	DATE	previously	advmod	23	SENT_62	[p4l614t2967r1035b3067],
23	ingested	VBN	O	ingest	rcmod	18	SENT_62	[p4l1067t2967r1414b3068],
24	abacavir	NN	O	abacavir	dobj	23	SENT_62	[p4l1451t2967r1808b3046],
25	.	.	O	.	_	0	SENT_62	[p4l1451t2967r1808b3046],

1	All	DT	O	all	det	2	SENT_63	[p4l1847t2967r1969b3045],
2	patients	NNS	O	patient	nsubj	27	SENT_63	[p4l2004t2993r2132b3067, p4l12t3096r253b3173],
3	with	IN	O	with	_	0	SENT_63	[p4l286t3095r484b3174],
4	a	DT	O	a	det	6	SENT_63	[p4l519t3121r563b3173],
5	clinical	JJ	O	clinical	amod	6	SENT_63	[p4l597t3095r918b3173],
6	syndrome	NN	O	syndrome	prep_with	2	SENT_63	[p4l954t3095r1384b3194],
7	compatible	JJ	O	compatible	amod	6	SENT_63	[p4l1420t3095r1904b3194],
8	with	IN	O	with	_	0	SENT_63	[p4l1935t3095r2133b3174],
9	hypersensitivity	NN	O	hypersensitivity	prep_with	7	SENT_63	[p4l11t3222r660b3322],
10	to	TO	O	to	_	0	SENT_63	[p4l690t3239r770b3301],
11	abacavir	NN	O	abacavir	prep_to	7	SENT_63	[p4l805t3222r1146b3301],
12	who	WP	O	who	nsubjpass	14	SENT_63	[p4l1173t3222r1352b3302],
13	were	VBD	O	be	auxpass	14	SENT_63	[p4l1383t3248r1579b3302],
14	identified	VBN	O	identify	rcmod	11	SENT_63	[p4l1613t3221r2012b3301],
15	as	IN	O	as	_	0	SENT_63	[p4l2045t3248r2131b3300],
16	having	VBG	O	have	prepc_as	14	SENT_63	[p4l11t3351r292b3452],
17	a	DT	O	a	det	19	SENT_63	[p4l317t3377r362b3429],
18	positive	JJ	O	positive	amod	19	SENT_63	[p4l388t3352r704b3451],
19	result	NN	O	result	dobj	16	SENT_63	[p4l733t3351r966b3430],
20	on	IN	O	on	_	0	SENT_63	[p4l991t3377r1095b3430],
21	epicutaneous	JJ	O	epicutaneous	amod	23	SENT_63	[p4l1125t3352r1666b3451],
22	patch	NN	O	patch	nn	23	SENT_63	[p4l1696t3351r1923b3451],
23	testing	NN	O	testing	prep_on	19	SENT_63	[p4l1953t3368r2132b3429, p4l11t3480r148b3580],
24	to	TO	O	to	_	0	SENT_63	[p4l180t3496r261b3558],
25	date	NN	O	date	prep_to	16	SENT_63	[p4l298t3479r472b3558],
26	have	VBP	O	have	aux	27	SENT_63	[p4l507t3479r694b3558],
27	carried	VBN	O	carry	_	0	SENT_63	[p4l730t3479r1025b3558],
28	HLA	NN	O	hlum	dobj	27	SENT_63	[p4l1059t3479r1914b3575],
29	.	.	O	.	_	0	SENT_63	[p4l1059t3479r1914b3575],

1	—	NN	O	—	_	0	SENT_64	[p4l1059t3479r1914b3575],
2	.	.	O	.	_	0	SENT_64	[p4l1059t3479r1914b3575],

1	B	NN	O	b	dep	5	SENT_65	[p4l1059t3479r1914b3575],
2	*	CD	NUMBER	*	dep	1	SENT_65	[p4l1059t3479r1914b3575],
3	57O1	NN	O	57o1	dep	5	SENT_65	[p4l1059t3479r1914b3575],
4	,9	CD	NUMBER	,9	num	3	SENT_65	[p4l1059t3479r1914b3575],
5	’	CD	NUMBER	’	dep	9	SENT_65	[p4l1059t3479r1914b3575],
6	11	CD	NUMBER	11	num	7	SENT_65	[p4l1059t3479r1914b3575],
7	’	NN	O	’	dep	5	SENT_65	[p4l1059t3479r1914b3575],
8	17	CD	NUMBER	17	num	9	SENT_65	[p4l1059t3479r1914b3575],
9	’18	CD	NUMBER	’18	_	0	SENT_65	[p4l1059t3479r1914b3575],
10	supporting	VBG	O	support	rcmod	9	SENT_65	[p4l1952t3505r2132b3579, p4l10t3608r331b3708],
11	the	DT	O	the	det	12	SENT_65	[p4l357t3607r488b3685],
12	robustness	NN	O	robustness	dobj	10	SENT_65	[p4l518t3607r972b3686],
13	of	IN	O	of	_	0	SENT_65	[p4l1005t3606r1104b3686],
14	the	DT	O	the	det	15	SENT_65	[p4l1115t3607r1245b3685],
15	association	NN	O	association	prep_of	12	SENT_65	[p4l1275t3608r1747b3686],
16	between	IN	O	between	amod	15	SENT_65	[p4l1778t3607r2133b3686],

1	HLA-B	NN	O	hla-b	_	0	SENT_66	[p5l11t20r538b98],
2	*	CD	NUMBER	*	num	3	SENT_66	[p5l11t20r538b98],
3	5701	CD	DATE	5701	dep	1	SENT_66	[p5l11t20r538b98],
4	and	CC	O	and	_	0	SENT_66	[p5l574t20r730b98],
5	hypersensitivity	NN	O	hypersensitivity	dep	1	SENT_66	[p5l765t20r1430b119],
6	reaction	NN	O	reaction	dep	1	SENT_66	[p5l1461t21r1801b98],
7	to	TO	O	to	_	0	SENT_66	[p5l1837t36r1918b98],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_66	[p5l1954t20r2132b98, p5l12t149r295b227],
9	.19	CD	NUMBER	.19	num	8	SENT_66	[p5l1954t20r2132b98, p5l12t149r295b227],
10	However	RB	O	however	advmod	8	SENT_66	[p5l336t155r715b243],
11	,	,	O	,	_	0	SENT_66	[p5l336t155r715b243],
12	not	RB	O	not	neg	14	SENT_66	[p5l762t165r900b226],
13	all	DT	O	all	det	14	SENT_66	[p5l936t148r1036b225],
14	HLA	NN	O	hlum	appos	1	SENT_66	[p5l1076t148r1960b247],
15	.	.	O	.	_	0	SENT_66	[p5l1076t148r1960b247],

1	—	NN	O	—	_	0	SENT_67	[p5l1076t148r1960b247],
2	.	.	O	.	_	0	SENT_67	[p5l1076t148r1960b247],

1	B	NN	O	b	_	0	SENT_68	[p5l1076t148r1960b247],
2	*	CD	NUMBER	*	number	3	SENT_68	[p5l1076t148r1960b247],
3	5701	CD	NUMBER	5701	num	1	SENT_68	[p5l1076t148r1960b247],
4	.	.	O	.	_	0	SENT_68	[p5l1076t148r1960b247],

1	—	NN	O	—	_	0	SENT_69	[p5l1076t148r1960b247],
2	.	.	O	.	_	0	SENT_69	[p5l1076t148r1960b247],

1	positive	JJ	O	positive	amod	2	SENT_70	[p5l1076t148r1960b247],
2	patients	NNS	O	patient	nsubj	4	SENT_70	[p5l2000t174r2132b247, p5l12t277r242b354],
3	will	MD	O	will	aux	4	SENT_70	[p5l275t276r436b355],
4	have	VB	O	have	_	0	SENT_70	[p5l470t276r657b355],
5	a	DT	O	a	det	7	SENT_70	[p5l691t302r736b354],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_70	[p5l768t276r1433b375],
7	reaction	NN	O	reaction	dobj	4	SENT_70	[p5l1463t277r1804b354],
8	to	TO	O	to	_	0	SENT_70	[p5l1839t293r1920b354],
9	abacavir	NN	O	abacavir	prep_to	4	SENT_70	[p5l1955t276r2132b354, p5l12t405r235b482],
10	.	.	O	.	_	0	SENT_70	[p5l1955t276r2132b354, p5l12t405r235b482],

1	The	DT	O	the	det	2	SENT_71	[p5l136t531r293b609],
2	strength	NN	O	strength	_	0	SENT_71	[p5l328t531r676b632],
3	of	IN	O	of	_	0	SENT_71	[p5l710t530r808b610],
4	the	DT	O	the	det	6	SENT_71	[p5l823t531r951b609],
5	existing	VBG	O	exist	amod	6	SENT_71	[p5l986t532r1314b632],
6	evidence	NN	O	evidence	prep_of	2	SENT_71	[p5l1345t531r1716b627],
7	,	,	O	,	_	0	SENT_71	[p5l1345t531r1716b627],
8	the	DT	O	the	det	9	SENT_71	[p5l1756t531r1884b609],
9	availability	NN	O	availability	appos	6	SENT_71	[p5l1916t531r2132b610, p5l11t659r268b759],
10	of	IN	O	of	_	0	SENT_71	[p5l301t658r401b738],
11	patch	NN	O	patch	nn	12	SENT_71	[p5l420t659r656b759],
12	testing	NN	O	testing	prep_of	2	SENT_71	[p5l695t660r993b760],
13	as	IN	O	as	_	0	SENT_71	[p5l1027t685r1113b737],
14	a	DT	O	a	det	16	SENT_71	[p5l1153t685r1198b737],
15	research	NN	O	research	nn	16	SENT_71	[p5l1235t659r1597b737],
16	tool	NN	O	tool	prep_as	2	SENT_71	[p5l1636t659r1802b738],
17	for	IN	O	for	_	0	SENT_71	[p5l1841t658r1964b738],
18	the	DT	O	the	det	19	SENT_71	[p5l2000t659r2133b737],
19	identification	NN	O	identification	prep_for	2	SENT_71	[p5l11t785r608b865],
20	of	IN	O	of	_	0	SENT_71	[p5l649t785r750b865],
21	patients	NNS	O	patient	prep_of	2	SENT_71	[p5l769t787r1118b886],
22	who	WP	O	who	nsubj	25	SENT_71	[p5l1156t786r1341b866],
23	could	MD	O	could	aux	25	SENT_71	[p5l1382t786r1621b866],
24	have	VB	O	have	aux	25	SENT_71	[p5l1660t786r1853b865],
25	had	VBD	O	have	rcmod	21	SENT_71	[p5l1893t786r2051b865],
26	a	DT	O	a	det	28	SENT_71	[p5l2090t812r2134b864],
27	hypersensitivity	NN	O	hypersensitivity	nn	28	SENT_71	[p5l11t915r660b1014],
28	reaction	NN	O	reaction	dobj	25	SENT_71	[p5l684t916r1038b1010],
29	,	,	O	,	_	0	SENT_71	[p5l684t916r1038b1010],
30	and	CC	O	and	_	0	SENT_71	[p5l1071t915r1225b993],
31	widespread	JJ	O	widespread	amod	32	SENT_71	[p5l1248t915r1720b1014],
32	acknowledgment	NN	O	acknowledgment	prep_of	2	SENT_71	[p5l1747t915r2132b994, p5l12t1043r390b1144],
33	that	WDT	O	that	dobj	38	SENT_71	[p5l429t1043r601b1121],
34	definitive	JJ	O	definitive	amod	36	SENT_71	[p5l640t1042r1047b1122],
35	prospective	JJ	O	prospective	amod	36	SENT_71	[p5l1089t1044r1578b1143],
36	data	NNS	O	datum	nsubjpass	38	SENT_71	[p5l1622t1043r1805b1122],
37	are	VBP	O	be	auxpass	38	SENT_71	[p5l1846t1069r1975b1121],
38	required	VBN	O	require	rcmod	32	SENT_71	[p5l2019t1069r2132b1122, p5l12t1171r294b1271],
39	to	TO	O	to	aux	40	SENT_71	[p5l335t1188r417b1250],
40	include	VB	O	include	xcomp	38	SENT_71	[p5l460t1171r777b1250],
41	HLA	NN	O	hlum	dobj	40	SENT_71	[p5l817t1171r1364b1250],
42	.	.	O	.	_	0	SENT_71	[p5l817t1171r1364b1250],

1	—	NN	O	—	_	0	SENT_72	[p5l817t1171r1364b1250],
2	.	.	O	.	_	0	SENT_72	[p5l817t1171r1364b1250],

1	B	NN	O	b	nsubj	10	SENT_73	[p5l817t1171r1364b1250],
2	*	CD	NUMBER	*	number	3	SENT_73	[p5l817t1171r1364b1250],
3	5701	CD	NUMBER	5701	num	4	SENT_73	[p5l817t1171r1364b1250],
4	screening	NN	O	screening	npadvmod	1	SENT_73	[p5l1408t1172r1834b1272],
5	in	IN	O	in	_	0	SENT_73	[p5l1872t1172r1956b1249],
6	the	DT	O	the	det	7	SENT_73	[p5l1997t1171r2133b1249],
7	standard	NN	O	standard	prep_in	1	SENT_73	[p5l12t1298r399b1377],
8	of	IN	O	of	_	0	SENT_73	[p5l450t1297r551b1377],
9	care	NN	O	care	prep_of	7	SENT_73	[p5l585t1324r763b1376],
10	provide	VBP	O	provide	_	0	SENT_73	[p5l812t1298r1137b1398],
11	the	DT	O	the	det	12	SENT_73	[p5l1188t1298r1324b1376],
12	rationale	NN	O	rationale	dobj	10	SENT_73	[p5l1374t1298r1764b1377],
13	for	IN	O	for	_	0	SENT_73	[p5l1814t1297r1940b1377],
14	our	PRP$	O	we	poss	15	SENT_73	[p5l1988t1324r2136b1377],
15	study	NN	O	study	prep_for	12	SENT_73	[p5l12t1427r255b1526],
16	.	.	O	.	_	0	SENT_73	[p5l12t1427r255b1526],

1	The	DT	O	the	det	4	SENT_74	[p5l305t1427r466b1505],
2	Prospective	JJ	O	prospective	amod	4	SENT_74	[p5l512t1428r1013b1526],
3	Randomized	NNP	O	Randomized	nn	4	SENT_74	[p5l1061t1427r1623b1510],
4	Evaluation	NN	O	evaluation	dep	13	SENT_74	[p5l1672t1427r2133b1506],
5	of	IN	O	of	_	0	SENT_74	[p5l12t1554r110b1634],
6	DNA	NN	O	dna	nn	7	SENT_74	[p5l127t1562r333b1634],
7	Screening	NN	O	screening	prep_of	4	SENT_74	[p5l369t1556r785b1656],
8	in	IN	O	in	_	0	SENT_74	[p5l818t1556r900b1633],
9	a	DT	O	a	det	11	SENT_74	[p5l936t1581r980b1633],
10	Clinical	JJ	MISC	clinical	amod	11	SENT_74	[p5l1015t1555r1340b1634],
11	Trial	NN	MISC	trial	prep_in	7	SENT_74	[p5l1372t1555r1571b1633],
12	(	CD	NUMBER	(	dep	13	SENT_74	[p5l1611t1561r2128b1646],
13	PREDICT	NNP	O	PREDICT	dep	20	SENT_74	[p5l1611t1561r2128b1646],
14	—	CD	NUMBER	—	num	13	SENT_74	[p5l1611t1561r2128b1646],
15	1	CD	NUMBER	1	num	17	SENT_74	[p5l1611t1561r2128b1646],
16	)	NN	O	)	nn	17	SENT_74	[p5l1611t1561r2128b1646],
17	study	NN	O	study	dep	13	SENT_74	[p5l12t1683r242b1782],
18	is	VBZ	O	be	cop	20	SENT_74	[p5l277t1684r343b1760],
19	a	DT	O	a	det	20	SENT_74	[p5l384t1709r429b1761],
20	prospective	JJ	O	prospective	_	0	SENT_74	[p5l465t1684r978b1782],
21	,	,	O	,	_	0	SENT_74	[p5l465t1684r978b1782],
22	randomized	VBN	O	randomize	partmod	20	SENT_74	[p5l1023t1683r1568b1778],
23	,	,	O	,	_	0	SENT_74	[p5l1023t1683r1568b1778],
24	multicenter	NN	O	multicenter	dobj	22	SENT_74	[p5l1613t1683r2128b1778],
25	,	,	O	,	_	0	SENT_74	[p5l1613t1683r2128b1778],

1	ENGLJMED	VBN	LOCATION	engljm	_	0	SENT_75	[p5l544t1851r689b1873],
2	;	:	O	;	_	0	SENT_75	[p5l742t1852r745b1871],
3	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	4	SENT_75	[p5l796t1851r997b1873],
4	FEBRUARY7	NNP	O	FEBRUARY7	dep	1	SENT_75	[p5l1034t1845r1258b1872],
5	,2008	CD	NUMBER	,2008	num	6	SENT_75	[p5l1034t1845r1258b1872],
6	569	CD	NUMBER	569	dep	4	SENT_75	[p5l1960t1840r2016b1864],

1	e	LS	O	e	dep	4	SENT_76	[p5l739t1892r753b1908],
2	New	NNP	O	New	nn	4	SENT_76	[p5l762t1885r824b1908],
3	England	NNP	O	England	nn	4	SENT_76	[p5l833t1884r944b1915],
4	Journal	NNP	O	Journal	_	0	SENT_76	[p5l952t1884r1050b1908],
5	of	IN	O	of	prep	4	SENT_76	[p5l1059t1884r1088b1908],
6	Medicine	NNP	O	Medicine	dep	4	SENT_76	[p5l1095t1884r1220b1908],

1	The	DT	O	the	det	3	SENT_77	[p5l672t2072r717b2093],
2	NEW	NNP	O	NEW	nn	3	SENT_77	[p5l736t2074r821b2093],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_77	[p5l840t2074r1029b2093],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_77	[p5l1048t2074r1228b2100],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_77	[p5l1247t2072r1487b2099],

1	double	RB	O	double	advmod	4	SENT_78	[p5l12t2295r577b2374],
2	—	RB	O	—	advmod	3	SENT_78	[p5l12t2295r577b2374],
3	blind	JJ	O	blind	amod	4	SENT_78	[p5l12t2295r577b2374],
4	study	NN	O	study	_	0	SENT_78	[p5l640t2295r877b2395],
5	to	TO	O	to	aux	6	SENT_78	[p5l934t2312r1017b2374],
6	determine	VB	O	determine	infmod	4	SENT_78	[p5l1080t2295r1531b2374],
7	whether	IN	O	whether	complm	12	SENT_78	[p5l1588t2295r1953b2374],
8	the	DT	O	the	det	9	SENT_78	[p5l2011t2295r2148b2373],
9	screening	NN	O	screening	nsubj	12	SENT_78	[p5l13t2425r442b2526],
10	of	IN	O	of	_	0	SENT_78	[p5l497t2423r599b2504],
11	adults	NNS	O	adult	prep_of	9	SENT_78	[p5l636t2424r900b2504],
12	infected	VBN	O	infect	ccomp	6	SENT_78	[p5l958t2423r1316b2504],
13	with	IN	O	with	_	0	SENT_78	[p5l1369t2424r1569b2504],
14	HIV	NN	MISC	hiv	nn	15	SENT_78	[p5l1624t2432r1803b2504],
15	type	NN	O	type	prep_with	12	SENT_78	[p5l1857t2441r2042b2525],
16	1	CD	NUMBER	1	number	17	SENT_78	[p5l2102t2430r2147b2502],
17	(	CD	NUMBER	(	num	19	SENT_78	[p5l17t2559r325b2644],
18	HIV-1	NN	O	hiv-1	nn	19	SENT_78	[p5l17t2559r325b2644],
19	)	NN	O	)	dobj	12	SENT_78	[p5l17t2559r325b2644],
20	for	IN	O	for	_	0	SENT_78	[p5l378t2552r505b2632],
21	HLA	NN	O	hlum	prep_for	19	SENT_78	[p5l549t2553r1100b2632],
22	.	.	O	.	_	0	SENT_78	[p5l549t2553r1100b2632],

1	—	NN	O	—	_	0	SENT_79	[p5l549t2553r1100b2632],
2	.	.	O	.	_	0	SENT_79	[p5l549t2553r1100b2632],

1	B	NN	O	b	_	0	SENT_80	[p5l549t2553r1100b2632],
2	*	CD	NUMBER	*	number	3	SENT_80	[p5l549t2553r1100b2632],
3	5701	CD	NUMBER	5701	npadvmod	1	SENT_80	[p5l549t2553r1100b2632],
4	before	IN	O	before	_	0	SENT_80	[p5l1149t2552r1425b2632],
5	treatment	NN	O	treatment	prep_before	1	SENT_80	[p5l1474t2570r1909b2632],
6	with	IN	O	with	_	0	SENT_80	[p5l1948t2553r2148b2633],
7	antiretroviral	JJ	O	antiretroviral	amod	8	SENT_80	[p5l11t2682r588b2761],
8	therapy	NN	O	therapy	prep_with	5	SENT_80	[p5l639t2682r963b2782],
9	involving	VBG	O	involve	partmod	1	SENT_80	[p5l1008t2682r1408b2783],
10	abacavir	NN	O	abacavir	nn	11	SENT_80	[p5l1454t2682r1813b2761],
11	results	NNS	O	result	dobj	9	SENT_80	[p5l1861t2682r2145b2761],
12	in	IN	O	in	_	0	SENT_80	[p5l11t2811r95b2888],
13	a	DT	O	a	det	16	SENT_80	[p5l130t2837r175b2889],
14	significantly	RB	O	significantly	advmod	16	SENT_80	[p5l210t2809r758b2912],
15	reduced	VBN	O	reduce	amod	16	SENT_80	[p5l788t2810r1127b2890],
16	incidence	NN	O	incidence	prep_in	9	SENT_80	[p5l1162t2810r1570b2890],
17	of	IN	O	of	_	0	SENT_80	[p5l1606t2809r1707b2890],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_80	[p5l1724t2810r2147b2911, p5l13t2940r301b3039],
19	reaction	NN	O	reaction	prep_of	16	SENT_80	[p5l336t2940r686b3018],
20	to	TO	O	to	_	0	SENT_80	[p5l726t2956r808b3018],
21	abacavir	NN	O	abacavir	prep_to	19	SENT_80	[p5l849t2939r1226b3018],
22	.	.	O	.	_	0	SENT_80	[p5l849t2939r1226b3018],

1	METHODS	NNS	O	method	_	0	SENT_81	[p5l806t3236r1352b3297],

1	ROLES	NNS	O	role	nsubj	11	SENT_82	[p5l17t3472r262b3523],
2	AND	CC	O	and	_	0	SENT_82	[p5l294t3473r464b3522],
3	CONTRIBUTIONS	NNS	O	contribution	conj_and	1	SENT_82	[p5l499t3472r1170b3523],
4	The	DT	O	the	det	6	SENT_82	[p5l8t3572r171b3650],
5	industry	NN	O	industry	nn	6	SENT_82	[p5l201t3572r564b3672],
6	authors	NNS	O	author	dep	3	SENT_82	[p5l590t3572r915b3651],
7	and	CC	O	and	_	0	SENT_82	[p5l947t3572r1106b3651],
8	three	CD	NUMBER	three	num	10	SENT_82	[p5l1137t3572r1359b3650],
9	academic	JJ	O	academic	amod	10	SENT_82	[p5l1389t3572r1792b3651],
10	authors	NNS	O	author	conj_and	1	SENT_82	[p5l1822t3572r2146b3651],
11	designed	VBN	O	design	_	0	SENT_82	[p5l12t3701r398b3802],
12	the	DT	O	the	det	13	SENT_82	[p5l439t3701r573b3779],
13	study	NN	O	study	dobj	11	SENT_82	[p5l616t3701r847b3801],
14	and	CC	O	and	_	0	SENT_82	[p5l883t3701r1042b3780],
15	the	DT	O	the	det	16	SENT_82	[p5l1083t3701r1217b3779],
16	analyses	NNS	O	analysis	conj_and	13	SENT_82	[p5l1258t3701r1644b3801],
17	,	,	O	,	_	0	SENT_82	[p5l1258t3701r1644b3801],
18	with	IN	O	with	_	0	SENT_82	[p5l1687t3701r1883b3780],
19	input	NN	O	input	prep_with	11	SENT_82	[p5l1923t3702r2153b3801],
20	from	IN	O	from	_	0	SENT_82	[p6l12t20r224b101],
21	the	DT	O	the	det	23	SENT_82	[p6l261t21r395b100],
22	other	JJ	O	other	amod	23	SENT_82	[p6l433t21r662b101],
23	investigators	NNS	O	investigator	prep_from	19	SENT_82	[p6l695t22r1272b123],
24	.	.	O	.	_	0	SENT_82	[p6l695t22r1272b123],

1	The	DT	O	the	det	2	SENT_83	[p6l1311t21r1473b100],
2	data	NNS	O	datum	nsubjpass	9	SENT_83	[p6l1511t21r1695b101],
3	were	VBD	O	be	auxpass	4	SENT_83	[p6l1726t47r1929b101],
4	held	VBN	O	hold	_	0	SENT_83	[p6l1966t21r2148b101],
5	by	IN	O	by	_	0	SENT_83	[p6l12t149r110b249],
6	the	DT	O	the	det	7	SENT_83	[p6l150t149r283b227],
7	sponsor	NN	O	sponsor	agent	4	SENT_83	[p6l328t175r673b249],
8	and	CC	O	and	_	0	SENT_83	[p6l713t149r872b228],
9	shared	VBN	O	share	conj_and	4	SENT_83	[p6l916t149r1203b228],
10	in	IN	O	in	_	0	SENT_83	[p6l1245t150r1330b227],
11	full	JJ	O	full	prep_in	9	SENT_83	[p6l1373t148r1522b229],
12	with	IN	O	with	_	0	SENT_83	[p6l1561t149r1757b229],
13	the	DT	O	the	det	15	SENT_83	[p6l1801t149r1934b227],
14	academic	JJ	O	academic	amod	15	SENT_83	[p6l1977t175r2147b227, p6l12t277r272b356],
15	authors	NNS	O	author	prep_with	11	SENT_83	[p6l307t277r656b373],
16	,	,	O	,	_	0	SENT_83	[p6l307t277r656b373],
17	and	CC	O	and	_	0	SENT_83	[p6l697t277r856b356],
18	the	DT	O	the	det	19	SENT_83	[p6l892t277r1026b355],
19	analyses	NNS	O	analysis	nsubjpass	21	SENT_83	[p6l1061t277r1422b377],
20	were	VBD	O	be	auxpass	21	SENT_83	[p6l1456t303r1659b357],
21	performed	VBN	O	perform	conj_and	4	SENT_83	[p6l1693t276r2148b377],
22	by	IN	O	by	_	0	SENT_83	[p6l12t406r110b506],
23	an	DT	O	a	det	25	SENT_83	[p6l132t432r234b484],
24	industry	NN	O	industry	nn	25	SENT_83	[p6l261t406r617b506],
25	author	NN	O	author	agent	21	SENT_83	[p6l639t406r919b485],
26	and	CC	O	and	_	0	SENT_83	[p6l943t406r1099b485],
27	three	CD	NUMBER	three	num	29	SENT_83	[p6l1127t406r1344b485],
28	academic	JJ	O	academic	amod	29	SENT_83	[p6l1371t406r1766b485],
29	authors	NNS	O	author	agent	21	SENT_83	[p6l1793t406r2143b485],
30	.	.	O	.	_	0	SENT_83	[p6l1793t406r2143b485],

1	The	DT	O	the	det	2	SENT_84	[p6l8t535r171b613],
2	manuscript	NN	O	manuscript	nsubjpass	4	SENT_84	[p6l203t536r699b635],
3	was	VBD	O	be	auxpass	4	SENT_84	[p6l722t561r886b614],
4	written	VBN	O	write	_	0	SENT_84	[p6l917t536r1233b614],
5	by	IN	O	by	_	0	SENT_84	[p6l1266t535r1364b635],
6	two	CD	NUMBER	two	num	8	SENT_84	[p6l1392t552r1551b614],
7	academic	JJ	O	academic	amod	8	SENT_84	[p6l1584t535r1987b614],
8	authors	NNS	O	author	agent	4	SENT_84	[p6l2018t561r2147b614, p6l12t663r239b742],
9	and	CC	O	and	_	0	SENT_84	[p6l276t663r437b742],
10	four	CD	NUMBER	four	num	12	SENT_84	[p6l471t662r656b743],
11	industry	NN	O	industry	nn	12	SENT_84	[p6l687t663r1059b763],
12	authors	NNS	O	author	agent	4	SENT_84	[p6l1088t663r1445b743],
13	.	.	O	.	_	0	SENT_84	[p6l1088t663r1445b743],

1	All	PDT	O	all	predet	3	SENT_85	[p6l1482t663r1610b741],
2	the	DT	O	the	det	3	SENT_85	[p6l1645t663r1781b741],
3	authors	NNS	O	author	nsubj	4	SENT_85	[p6l1815t663r2146b743],
4	evaluated	VBD	O	evaluate	_	0	SENT_85	[p6l12t792r417b872],
5	the	DT	O	the	det	6	SENT_85	[p6l461t792r595b870],
6	study	NN	O	study	nsubj	7	SENT_85	[p6l639t792r871b892],
7	results	VBZ	O	result	ccomp	4	SENT_85	[p6l910t792r1220b888],
8	,	,	O	,	_	0	SENT_85	[p6l910t792r1220b888],
9	reviewed	VBN	O	review	ccomp	4	SENT_85	[p6l1269t792r1648b871],
10	and	CC	O	and	_	0	SENT_85	[p6l1691t792r1848b871],
11	edited	VBN	O	edit	conj_and	7	SENT_85	[p6l1889t792r2147b871],
12	the	DT	O	the	det	13	SENT_85	[p6l12t920r144b998],
13	manuscript	NN	O	manuscript	dobj	11	SENT_85	[p6l189t921r695b1020],
14	,	,	O	,	_	0	SENT_85	[p6l189t921r695b1020],
15	and	CC	O	and	_	0	SENT_85	[p6l744t920r901b999],
16	vouch	NN	O	vouch	conj_and	13	SENT_85	[p6l941t920r1191b1000],
17	for	IN	O	for	_	0	SENT_85	[p6l1235t919r1357b999],
18	the	DT	O	the	det	19	SENT_85	[p6l1399t920r1530b998],
19	completeness	NN	O	completeness	prep_for	13	SENT_85	[p6l1576t920r2145b1020],
20	and	CC	O	and	_	0	SENT_85	[p6l11t1048r168b1127],
21	accuracy	NN	O	accuracy	conj_and	19	SENT_85	[p6l200t1074r567b1148],
22	of	IN	O	of	_	0	SENT_85	[p6l595t1047r695b1127],
23	the	DT	O	the	det	24	SENT_85	[p6l709t1048r841b1126],
24	data	NNS	O	datum	prep_of	19	SENT_85	[p6l875t1048r1056b1127],
25	presented	VBN	O	present	partmod	24	SENT_85	[p6l1086t1048r1521b1148],
26	.	.	O	.	_	0	SENT_85	[p6l1086t1048r1521b1148],

1	PARTICIPANTS	NNS	O	participant	nn	2	SENT_86	[p6l17t1324r580b1375],
2	Patients	NNS	O	patient	nsubjpass	10	SENT_86	[p6l11t1425r345b1503],
3	were	VBD	O	be	auxpass	4	SENT_86	[p6l372t1450r572b1504],
4	assessed	VBN	O	assess	_	0	SENT_86	[p6l600t1424r963b1504],
5	for	IN	O	for	_	0	SENT_86	[p6l992t1423r1113b1504],
6	eligibility	NN	O	eligibility	prep_for	4	SENT_86	[p6l1140t1424r1543b1526],
7	and	CC	O	and	_	0	SENT_86	[p6l1566t1424r1723b1504],
8	were	VBD	O	be	auxpass	10	SENT_86	[p6l1748t1450r1947b1504],
9	randomly	RB	O	randomly	advmod	10	SENT_86	[p6l1976t1450r2147b1503, p6l12t1553r279b1653],
10	assigned	VBN	O	assign	conj_and	4	SENT_86	[p6l311t1553r687b1654],
11	to	TO	O	to	aux	12	SENT_86	[p6l726t1570r808b1632],
12	undergo	VB	O	undergo	xcomp	10	SENT_86	[p6l848t1553r1206b1654],
13	either	CC	O	either	preconj	14	SENT_86	[p6l1247t1553r1496b1631],
14	prospective	JJ	O	prospective	amod	17	SENT_86	[p6l1530t1554r2022b1653],
15	or	CC	O	or	_	0	SENT_86	[p6l2062t1579r2151b1632],
16	retrospective	JJ	O	retrospective	conj_or	14	SENT_86	[p6l12t1682r568b1781],
17	HLA	NN	O	hlum	dobj	12	SENT_86	[p6l614t1681r1146b1760],
18	.	.	O	.	_	0	SENT_86	[p6l614t1681r1146b1760],

1	—	NN	O	—	_	0	SENT_87	[p6l614t1681r1146b1760],
2	.	.	O	.	_	0	SENT_87	[p6l614t1681r1146b1760],

1	B	NN	O	b	nn	4	SENT_88	[p6l614t1681r1146b1760],
2	*	CD	NUMBER	*	num	4	SENT_88	[p6l614t1681r1146b1760],
3	S701	NN	O	s701	nn	4	SENT_88	[p6l614t1681r1146b1760],
4	testing	NN	O	testing	_	0	SENT_88	[p6l1191t1682r1484b1782],
5	between	IN	O	between	_	0	SENT_88	[p6l1527t1681r1887b1760],
6	April	NNP	DATE	April	nn	12	SENT_88	[p6l1931t1681r2148b1781],
7	and	CC	DATE	and	_	0	SENT_88	[p6l11t1809r166b1888],
8	September	NNP	DATE	September	nn	12	SENT_88	[p6l197t1809r639b1909],
9	2006	CD	DATE	2006	num	12	SENT_88	[p6l665t1815r868b1888],
10	at	IN	O	at	amod	12	SENT_88	[p6l897t1826r975b1887],
11	265	CD	NUMBER	265	num	12	SENT_88	[p6l999t1815r1142b1888],
12	centers	NNS	O	center	prep_between	4	SENT_88	[p6l1174t1826r1466b1887],
13	in	IN	O	in	_	0	SENT_88	[p6l1497t1810r1578b1887],
14	19	CD	NUMBER	19	num	15	SENT_88	[p6l1611t1815r1705b1888],
15	countries	NNS	O	country	prep_in	4	SENT_88	[p6l1736t1810r2142b1888],
16	.	.	O	.	_	0	SENT_88	[p6l1736t1810r2142b1888],

1	Eligible	JJ	O	eligible	amod	2	SENT_89	[p6l11t1938r336b2040],
2	patients	NNS	O	patient	nsubj	4	SENT_89	[p6l365t1939r709b2039],
3	were	VBD	O	be	cop	4	SENT_89	[p6l737t1964r940b2018],
4	adults	NNS	O	adult	_	0	SENT_89	[p6l970t1938r1229b2018],
5	with	IN	O	with	_	0	SENT_89	[p6l1256t1938r1453b2018],
6	HIV-1	NN	MISC	hiv-1	nn	7	SENT_89	[p6l1483t1944r1729b2018],
7	infection	NN	O	infection	prep_with	4	SENT_89	[p6l1758t1937r2148b2018],
8	and	CC	O	and	_	0	SENT_89	[p6l11t2066r170b2145],
9	a	DT	O	a	det	12	SENT_89	[p6l210t2092r255b2144],
10	preestablished	JJ	O	preestablished	amod	12	SENT_89	[p6l293t2066r922b2166],
11	clinical	JJ	O	clinical	amod	12	SENT_89	[p6l964t2066r1279b2144],
12	need	NN	O	need	conj_and	4	SENT_89	[p6l1320t2066r1522b2145],
13	for	IN	O	for	_	0	SENT_89	[p6l1563t2065r1687b2145],
14	treatment	NN	O	treatment	prep_for	12	SENT_89	[p6l1726t2083r2152b2144],
15	with	IN	O	with	_	0	SENT_89	[p6l7t2195r204b2274],
16	an	DT	O	a	det	20	SENT_89	[p6l252t2221r355b2273],
17	antiretroviral	JJ	O	antiretroviral	amod	20	SENT_89	[p6l403t2195r1224b2296],
18	—	NN	O	—	nn	20	SENT_89	[p6l403t2195r1224b2296],
19	drug	NN	O	drug	nn	20	SENT_89	[p6l403t2195r1224b2296],
20	regimen	NNS	O	regimen	prep_with	4	SENT_89	[p6l1269t2196r1628b2296],
21	containing	VBG	O	contain	partmod	20	SENT_89	[p6l1678t2196r2151b2296],
22	abacavir	NN	O	abacavir	dobj	21	SENT_89	[p6l11t2324r370b2403],
23	but	CC	O	but	cc	21	SENT_89	[p6l407t2324r547b2403],
24	with	IN	O	with	_	0	SENT_89	[p6l578t2324r774b2403],
25	an	DT	O	a	det	27	SENT_89	[p6l813t2350r917b2402],
26	unknown	JJ	O	unknown	amod	27	SENT_89	[p6l956t2324r1373b2403],
27	HLA	NN	O	hlum	prep_with	21	SENT_89	[p6l1412t2324r1953b2403],
28	.	.	O	.	_	0	SENT_89	[p6l1412t2324r1953b2403],

1	—	NN	O	—	_	0	SENT_90	[p6l1412t2324r1953b2403],
2	.	.	O	.	_	0	SENT_90	[p6l1412t2324r1953b2403],

1	B	NN	O	b	_	0	SENT_91	[p6l1412t2324r1953b2403],
2	*	CD	NUMBER	*	number	3	SENT_91	[p6l1412t2324r1953b2403],
3	5701	CD	NUMBER	5701	dep	1	SENT_91	[p6l1412t2324r1953b2403],
4	status	NN	O	status	dep	3	SENT_91	[p6l1994t2341r2147b2402, p6l12t2469r165b2531],
5	.	.	O	.	_	0	SENT_91	[p6l1994t2341r2147b2402, p6l12t2469r165b2531],

1	Patients	NNS	O	patient	nsubj	6	SENT_92	[p6l216t2453r559b2530],
2	could	MD	O	could	aux	6	SENT_92	[p6l609t2452r845b2531],
3	not	RB	O	not	neg	6	SENT_92	[p6l891t2469r1035b2531],
4	have	VB	O	have	aux	6	SENT_92	[p6l1078t2452r1268b2531],
5	previously	RB	DATE	previously	advmod	6	SENT_92	[p6l1314t2452r1757b2552],
6	received	VBN	O	receive	_	0	SENT_92	[p6l1800t2452r2147b2532],
7	abacavir	NN	O	abacavir	dobj	6	SENT_92	[p6l11t2581r388b2677],
8	,	,	O	,	_	0	SENT_92	[p6l11t2581r388b2677],
9	but	CC	O	but	_	0	SENT_92	[p6l429t2581r569b2660],
10	they	PRP	O	they	nsubj	13	SENT_92	[p6l598t2581r782b2681],
11	could	MD	O	could	aux	13	SENT_92	[p6l812t2581r1048b2660],
12	have	VB	O	have	aux	13	SENT_92	[p6l1082t2581r1273b2661],
13	received	VBN	O	receive	conj_but	6	SENT_92	[p6l1307t2581r1655b2660],
14	other	JJ	O	other	amod	16	SENT_92	[p6l1689t2581r1918b2660],
15	antiretroviral	JJ	O	antiretroviral	amod	16	SENT_92	[p6l1949t2582r2147b2659, p6l12t2710r415b2789],
16	drugs	NNS	O	drug	dobj	13	SENT_92	[p6l443t2710r713b2811],
17	.	.	O	.	_	0	SENT_92	[p6l443t2710r713b2811],

1	All	DT	O	all	det	3	SENT_93	[p6l743t2710r869b2788],
2	abacavir	NN	O	abacavir	nn	3	SENT_93	[p6l896t2710r1255b2789],
3	treatment	NN	O	treatment	nsubjpass	5	SENT_93	[p6l1281t2727r1708b2788],
4	was	VBD	O	be	auxpass	5	SENT_93	[p6l1726t2736r1890b2789],
5	given	VBN	O	give	_	0	SENT_93	[p6l1919t2711r2148b2811],
6	in	IN	O	in	_	0	SENT_93	[p6l11t2840r95b2917],
7	accordance	NN	O	accordance	prep_in	5	SENT_93	[p6l130t2839r615b2918],
8	with	IN	O	with	_	0	SENT_93	[p6l646t2839r842b2918],
9	the	DT	O	the	det	10	SENT_93	[p6l879t2839r1012b2918],
10	recommendations	NNS	O	recommendation	prep_with	5	SENT_93	[p6l1048t2839r1833b2918],
11	on	IN	O	on	_	0	SENT_93	[p6l1871t2865r1978b2918],
12	the	DT	O	the	det	14	SENT_93	[p6l2014t2839r2148b2917],
13	product	NN	O	product	nn	14	SENT_93	[p6l11t2966r342b3066],
14	label	NN	O	label	prep_on	10	SENT_93	[p6l373t2966r597b3045],
15	.	.	O	.	_	0	SENT_93	[p6l373t2966r597b3045],

1	The	DT	O	the	det	2	SENT_94	[p6l635t2966r795b3044],
2	study	NN	O	study	nsubjpass	4	SENT_94	[p6l834t2966r1061b3066],
3	was	VBD	O	be	auxpass	4	SENT_94	[p6l1089t2992r1250b3046],
4	performed	VBN	O	perform	_	0	SENT_94	[p6l1288t2965r1739b3066],
5	in	IN	O	in	_	0	SENT_94	[p6l1775t2967r1857b3044],
6	accordance	NN	O	accordance	prep_in	4	SENT_94	[p6l1893t2992r2147b3045, p6l12t3095r259b3174],
7	with	IN	O	with	_	0	SENT_94	[p6l287t3095r485b3174],
8	the	DT	O	the	det	10	SENT_94	[p6l518t3095r651b3174],
9	International	NNP	ORGANIZATION	International	nn	10	SENT_94	[p6l684t3095r1256b3174],
10	Conference	NNP	ORGANIZATION	Conference	prep_with	4	SENT_94	[p6l1289t3094r1779b3174],
11	on	IN	O	on	_	0	SENT_94	[p6l1814t3121r1920b3174],
12	Harmonisation	NNP	O	Harmonisation	prep_on	10	SENT_94	[p6l1953t3103r2147b3173, p6l12t3224r495b3302],
13	and	CC	O	and	_	0	SENT_94	[p6l525t3223r681b3302],
14	Good	JJ	O	good	amod	16	SENT_94	[p6l711t3223r947b3302],
15	Clinical	JJ	O	clinical	amod	16	SENT_94	[p6l976t3223r1303b3302],
16	Practice	NN	O	practice	conj_and	10	SENT_94	[p6l1331t3224r1664b3301],
17	Standards	NNPS	O	Standards	dep	16	SENT_94	[p6l1696t3223r2142b3319],
18	,	,	O	,	_	0	SENT_94	[p6l1696t3223r2142b3319],
19	including	VBG	O	include	_	0	SENT_94	[p6l11t3352r425b3453],
20	approval	NN	O	approval	conj_and	20	SENT_94	[p6l456t3352r825b3452],
21	by	IN	O	by	_	0	SENT_94	[p6l860t3352r957b3452],
22	the	DT	O	the	det	25	SENT_94	[p6l987t3352r1121b3431],
23	local	JJ	O	local	amod	25	SENT_94	[p6l1154t3352r1360b3431],
24	ethics	NNS	O	ethic	nn	25	SENT_94	[p6l1395t3352r1647b3431],
25	committee	NN	O	committee	prep_by	20	SENT_94	[p6l1684t3353r2148b3431],
26	at	IN	O	at	_	0	SENT_94	[p6l11t3497r90b3558],
27	each	DT	O	each	det	29	SENT_94	[p6l118t3480r311b3559],
28	participating	VBG	O	participate	amod	29	SENT_94	[p6l341t3481r906b3581],
29	institution	NN	O	institution	prep_at	25	SENT_94	[p6l934t3481r1391b3559],
30	and	CC	O	and	_	0	SENT_94	[p6l1422t3480r1581b3559],
31	with	IN	O	with	_	0	SENT_94	[p6l1608t3480r1804b3559],
32	written	VBN	O	write	amod	34	SENT_94	[p6l1831t3481r2148b3559],
33	informed	JJ	O	informed	amod	34	SENT_94	[p6l11t3606r416b3686],
34	consent	NN	O	consent	prep_with	20	SENT_94	[p6l451t3624r789b3686],
35	from	IN	O	from	_	0	SENT_94	[p6l818t3606r1030b3686],
36	all	DT	O	all	det	37	SENT_94	[p6l1065t3607r1169b3685],
37	patients	NNS	O	patient	prep_from	34	SENT_94	[p6l1203t3608r1572b3707],
38	.	.	O	.	_	0	SENT_94	[p6l1203t3608r1572b3707],

1	PROCEDURES	NNS	O	procedure	_	0	SENT_95	[p7l17t119r545b170],

1	The	DT	O	the	det	3	SENT_96	[p7l8t219r171b298],
2	study	NN	O	study	nn	3	SENT_96	[p7l207t219r438b320],
3	design	NN	O	design	nsubj	4	SENT_96	[p7l469t219r752b321],
4	consisted	VBD	O	consist	_	0	SENT_96	[p7l787t219r1192b299],
5	of	IN	O	of	_	0	SENT_96	[p7l1228t218r1328b299],
6	a	DT	O	a	det	11	SENT_96	[p7l1344t246r1389b298],
7	28-day	JJ	DURATION	28-day	amod	9	SENT_96	[p7l1422t219r1711b320],
8	to	TO	O	to	dep	9	SENT_96	[p7l1741t236r1823b299],
9	60-day	JJ	DURATION	60-day	amod	11	SENT_96	[p7l1860t219r2152b320],
10	evaluation	NN	O	evaluation	nn	11	SENT_96	[p7l12t348r447b427],
11	period	NN	O	period	prep_of	4	SENT_96	[p7l478t348r751b448],
12	to	TO	O	to	aux	13	SENT_96	[p7l784t365r865b427],
13	determine	VB	O	determine	xcomp	4	SENT_96	[p7l899t348r1330b427],
14	eligibility	NN	O	eligibility	dobj	13	SENT_96	[p7l1364t348r1766b449],
15	and	CC	O	and	_	0	SENT_96	[p7l1793t348r1950b427],
16	perform	VB	O	perform	xcomp	4	SENT_96	[p7l1980t374r2147b448, p7l12t475r220b555],
17	randomization	NN	O	randomization	dobj	16	SENT_96	[p7l273t476r942b555],
18	.	.	O	.	_	0	SENT_96	[p7l273t476r942b555],

1	Abacavir	NNP	O	Abacavir	nsubjpass	3	SENT_97	[p7l999t476r1378b555],
2	was	VBD	O	be	auxpass	3	SENT_97	[p7l1426t502r1590b555],
3	initiated	VBN	O	initiate	_	0	SENT_97	[p7l1646t476r2009b555],
4	in	IN	O	in	_	0	SENT_97	[p7l2063t477r2148b554],
5	eligible	JJ	O	eligible	amod	6	SENT_97	[p7l12t604r318b706],
6	patients	NNS	O	patient	prep_in	3	SENT_97	[p7l348t605r684b705],
7	on	IN	O	on	_	0	SENT_97	[p7l718t630r824b684],
8	day	NN	DURATION	day	prep_on	3	SENT_97	[p7l855t604r1000b705],
9	1	CD	NUMBER	1	num	8	SENT_97	[p7l1030t610r1074b682],
10	of	IN	O	of	_	0	SENT_97	[p7l1107t603r1206b684],
11	the	DT	O	the	det	12	SENT_97	[p7l1219t604r1351b683],
12	study	NN	O	study	prep_of	8	SENT_97	[p7l1383t604r1622b705],
13	,	,	O	,	_	0	SENT_97	[p7l1383t604r1622b705],
14	followed	VBN	O	follow	_	0	SENT_97	[p7l1659t603r2024b684],
15	by	IN	O	by	prepc_followed_by	3	SENT_97	[p7l2055t604r2152b705],
16	an	DT	O	a	det	18	SENT_97	[p7l11t759r115b812],
17	observation	NN	O	observation	nn	18	SENT_97	[p7l146t733r650b813],
18	period	NN	O	period	pobj	3	SENT_97	[p7l678t733r958b834],
19	of	IN	O	of	_	0	SENT_97	[p7l988t732r1089b813],
20	6	CD	DURATION	6	num	21	SENT_97	[p7l1100t739r1147b813],
21	weeks	NNS	NUMBER	week	prep_of	18	SENT_97	[p7l1173t733r1436b813],
22	(	CD	NUMBER	(	num	23	SENT_97	[p7l1473t734r1654b835],
23	Fig	NN	O	fig	dep	21	SENT_97	[p7l1473t734r1654b835],
24	.	.	O	.	_	0	SENT_97	[p7l1473t734r1654b835],

1	1	CD	NUMBER	1	_	0	SENT_98	[p7l1692t739r1788b825],
2	)	NN	O	)	dep	1	SENT_98	[p7l1692t739r1788b825],
3	.	.	O	.	_	0	SENT_98	[p7l1692t739r1788b825],

1	Eligible	JJ	O	eligible	amod	2	SENT_99	[p7l1822t733r2148b835],
2	patients	NNS	O	patient	nsubjpass	5	SENT_99	[p7l11t863r346b962],
3	were	VBD	O	be	auxpass	5	SENT_99	[p7l381t888r580b941],
4	randomly	RB	O	randomly	advmod	5	SENT_99	[p7l617t862r1026b962],
5	assigned	VBN	O	assign	_	0	SENT_99	[p7l1057t862r1449b963],
6	,	,	O	,	_	0	SENT_99	[p7l1057t862r1449b963],
7	in	IN	O	in	_	0	SENT_99	[p7l1490t863r1573b940],
8	a	DT	O	a	quantmod	13	SENT_99	[p7l1608t888r1653b940],
9	one	CD	NUMBER	one	number	13	SENT_99	[p7l1688t879r2148b941],
10	—	CD	NUMBER	—	number	13	SENT_99	[p7l1688t879r2148b941],
11	to	TO	O	to	dep	13	SENT_99	[p7l1688t879r2148b941],
12	—	CD	NUMBER	—	number	13	SENT_99	[p7l1688t879r2148b941],
13	one	CD	NUMBER	one	num	14	SENT_99	[p7l1688t879r2148b941],
14	ratio	NN	O	ratio	prep_in	5	SENT_99	[p7l12t991r233b1087],
15	,	,	O	,	_	0	SENT_99	[p7l12t991r233b1087],
16	to	TO	O	to	aux	17	SENT_99	[p7l286t1007r368b1070],
17	undergo	VB	O	undergo	xcomp	5	SENT_99	[p7l416t990r774b1092],
18	one	CD	TIME	one	dobj	17	SENT_99	[p7l823t1016r976b1070],
19	of	IN	TIME	of	_	0	SENT_99	[p7l1023t989r1124b1070],
20	two	CD	TIME	two	num	22	SENT_99	[p7l1153t1007r1311b1070],
21	study	NN	O	study	nn	22	SENT_99	[p7l1361t990r1592b1091],
22	approaches	NNS	O	approach	prep_of	18	SENT_99	[p7l1634t990r2144b1091],
23	:	:	O	:	_	0	SENT_99	[p7l1634t990r2144b1091],
24	prospective	JJ	O	prospective	amod	25	SENT_99	[p7l11t1120r492b1219],
25	HLA	NN	O	hlum	dep	18	SENT_99	[p7l521t1119r1052b1198],
26	.	.	O	.	_	0	SENT_99	[p7l521t1119r1052b1198],

1	—	NN	O	—	_	0	SENT_100	[p7l521t1119r1052b1198],
2	.	.	O	.	_	0	SENT_100	[p7l521t1119r1052b1198],

1	B	NN	O	b	nsubj	5	SENT_101	[p7l521t1119r1052b1198],
2	*	CD	NUMBER	*	number	3	SENT_101	[p7l521t1119r1052b1198],
3	5701	CD	NUMBER	5701	dep	4	SENT_101	[p7l521t1119r1052b1198],
4	pharmacogenetic	JJ	O	pharmacogenetic	dep	1	SENT_101	[p7l1079t1119r1818b1220],
5	screen	NN	O	screen	_	0	SENT_101	[p7l1848t1145r2147b1198],
6	—	NN	O	—	nn	7	SENT_101	[p7l1848t1145r2147b1198],
7	ing	NN	O	ing	dobj	5	SENT_101	[p7l11t1248r150b1349],
8	followed	VBN	O	follow	partmod	7	SENT_101	[p7l178t1246r551b1327],
9	by	IN	O	by	_	0	SENT_101	[p7l586t1247r683b1348],
10	combination	NN	O	combination	agent	8	SENT_101	[p7l713t1247r1263b1327],
11	active	JJ	O	active	amod	13	SENT_101	[p7l1296t1248r1538b1327],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_101	[p7l1571t1247r2148b1327],
13	therapy	NN	O	therapy	tmod	8	SENT_101	[p7l12t1376r337b1476],
14	that	WDT	O	that	nsubj	15	SENT_101	[p7l379t1376r552b1454],
15	included	VBD	O	include	rcmod	13	SENT_101	[p7l594t1376r963b1455],
16	abacavir	NN	O	abacavir	dobj	15	SENT_101	[p7l1009t1376r1368b1455],
17	(	IN	O	(	_	0	SENT_101	[p7l1416t1376r1574b1467],
18	the	DT	O	the	det	20	SENT_101	[p7l1416t1376r1574b1467],
19	prospectivescreening	VBG	O	prospectivescreen	amod	20	SENT_101	[p7l1619t1377r2147b1476, p7l13t1506r423b1606],
20	group	NN	O	group	prep_(	15	SENT_101	[p7l449t1512r745b1606],
21	)	CD	NUMBER	)	dep	13	SENT_101	[p7l449t1512r745b1606],
22	,	,	O	,	_	0	SENT_101	[p7l449t1512r745b1606],
23	or	CC	O	or	_	0	SENT_101	[p7l782t1531r870b1584],
24	combination	NN	O	combination	nn	27	SENT_101	[p7l898t1505r1434b1584],
25	active	JJ	O	active	amod	27	SENT_101	[p7l1463t1506r1698b1584],
26	antiretroviral	JJ	O	antiretroviral	amod	27	SENT_101	[p7l1729t1506r2133b1584, p7l7t1632r195b1711],
27	therapy	NN	O	therapy	dobj	5	SENT_101	[p7l235t1632r558b1732],
28	that	WDT	O	that	nsubj	29	SENT_101	[p7l594t1632r767b1710],
29	included	VBD	O	include	rcmod	27	SENT_101	[p7l801t1632r1169b1712],
30	abacavir	NN	O	abacavir	dobj	29	SENT_101	[p7l1209t1632r1583b1728],
31	,	,	O	,	_	0	SENT_101	[p7l1209t1632r1583b1728],
32	followed	VBN	O	follow	_	0	SENT_101	[p7l1630t1631r2000b1712],
33	by	IN	O	by	prepc_followed_by	29	SENT_101	[p7l2041t1632r2138b1732],
34	retrospective	JJ	O	retrospective	amod	35	SENT_101	[p7l12t1762r539b1861],
35	HLA	NN	O	hlum	pobj	29	SENT_101	[p7l560t1761r1079b1840],
36	.	.	O	.	_	0	SENT_101	[p7l560t1761r1079b1840],

1	—	NN	O	—	_	0	SENT_102	[p7l560t1761r1079b1840],
2	.	.	O	.	_	0	SENT_102	[p7l560t1761r1079b1840],

1	B	NN	O	b	_	0	SENT_103	[p7l560t1761r1079b1840],
2	*	CD	NUMBER	*	number	3	SENT_103	[p7l560t1761r1079b1840],
3	5701	CD	NUMBER	5701	dep	1	SENT_103	[p7l560t1761r1079b1840],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_103	[p7l1101t1761r1819b1862],
5	screen	NN	O	screen	dep	3	SENT_103	[p7l1842t1787r2133b1840],
6	—	CD	NUMBER	—	num	7	SENT_103	[p7l1842t1787r2133b1840],
7	ing	NN	O	ing	dep	1	SENT_103	[p7l11t1890r147b1990],
8	(	CD	NUMBER	(	dep	7	SENT_103	[p7l178t1889r336b1980],
9	the	DT	O	the	det	11	SENT_103	[p7l178t1889r336b1980],
10	control	NN	O	control	nn	11	SENT_103	[p7l372t1889r678b1968],
11	group	NN	O	group	dep	1	SENT_103	[p7l712t1895r1015b1990],
12	)	CD	NUMBER	)	dep	11	SENT_103	[p7l712t1895r1015b1990],
13	.	.	O	.	_	0	SENT_103	[p7l712t1895r1015b1990],

1	Randomization	NN	O	randomization	nsubjpass	27	SENT_104	[p7l140t2017r799b2100],
2	was	VBD	O	be	auxpass	27	SENT_104	[p7l829t2043r989b2096],
3	based	VBN	O	base	_	0	SENT_104	[p7l1026t2017r1266b2096],
4	on	IN	O	on	_	0	SENT_104	[p7l1301t2043r1406b2096],
5	a	DT	O	a	det	7	SENT_104	[p7l1440t2043r1484b2095],
6	computer	NN	O	computer	nn	7	SENT_104	[p7l1517t2034r2133b2118],
7	—	NN	O	—	prep_based_on	27	SENT_104	[p7l1517t2034r2133b2118],
8	gen	NN	O	gen	npadvmod	10	SENT_104	[p7l1517t2034r2133b2118],
9	—	CD	NUMBER	—	num	8	SENT_104	[p7l1517t2034r2133b2118],
10	erated	JJ	O	erated	amod	7	SENT_104	[p7l12t2144r291b2240],
11	,	,	O	,	_	0	SENT_104	[p7l12t2144r291b2240],
12	centralized	JJ	O	centralized	amod	13	SENT_104	[p7l337t2144r806b2223],
13	schedule	NN	O	schedule	appos	7	SENT_104	[p7l847t2144r1233b2240],
14	,	,	O	,	_	0	SENT_104	[p7l847t2144r1233b2240],
15	with	IN	O	with	_	0	SENT_104	[p7l1272t2144r1465b2223],
16	a	DT	O	a	det	18	SENT_104	[p7l1503t2170r1548b2222],
17	block	NN	O	block	nn	18	SENT_104	[p7l1587t2144r1817b2223],
18	size	NN	O	size	prep_with	7	SENT_104	[p7l1854t2145r2012b2223],
19	of	IN	O	of	_	0	SENT_104	[p7l2052t2143r2152b2223],
20	four	CD	NUMBER	four	prep_of	18	SENT_104	[p7l12t2272r192b2352],
21	and	CC	O	and	_	0	SENT_104	[p7l223t2273r380b2352],
22	stratification	NN	O	stratification	prep_of	18	SENT_104	[p7l416t2272r977b2352],
23	according	VBG	O	accord	_	0	SENT_104	[p7l1011t2273r1438b2374],
24	to	TO	O	to	prepc_according_to	27	SENT_104	[p7l1469t2290r1551b2352],
25	self	NN	O	self	nn	26	SENT_104	[p7l1588t2272r2134b2373],
26	—	NN	O	—	pobj	27	SENT_104	[p7l1588t2272r2134b2373],
27	reported	VBD	O	report	_	0	SENT_104	[p7l1588t2272r2134b2373],
28	race	NN	O	race	dobj	27	SENT_104	[p7l12t2426r178b2478],
29	(	RB	O	(	advmod	27	SENT_104	[p7l221t2400r472b2491],
30	white	JJ	O	white	amod	33	SENT_104	[p7l221t2400r472b2491],
31	VS.	NN	O	v.	nn	33	SENT_104	[p7l505t2426r610b2480],
32	nonwhite	JJ	O	nonwhite	amod	33	SENT_104	[p7l653t2400r1087b2496],
33	)	NN	O	)	nsubj	27	SENT_104	[p7l653t2400r1087b2496],
34	,	,	O	,	_	0	SENT_104	[p7l653t2400r1087b2496],
35	history	NN	O	history	appos	33	SENT_104	[p7l1131t2400r1422b2500],
36	of	IN	O	of	_	0	SENT_104	[p7l1457t2399r1554b2479],
37	receipt	NN	O	receipt	prep_of	35	SENT_104	[p7l1574t2401r1852b2500],
38	of	IN	O	of	_	0	SENT_104	[p7l1886t2399r1984b2479],
39	antiretroviral	JJ	O	antiretroviral	amod	42	SENT_104	[p7l2003t2426r2133b2478, p7l12t2529r455b2608],
40	therapy	NN	O	therapy	nn	42	SENT_104	[p7l496t2529r818b2628],
41	(	CD	NUMBER	(	num	42	SENT_104	[p7l862t2535r1097b2619],
42	none	NN	O	none	prep_of	37	SENT_104	[p7l862t2535r1097b2619],
43	vs.	IN	O	vs.	_	0	SENT_104	[p7l1137t2555r1245b2608],
44	any	DT	O	any	det	45	SENT_104	[p7l1294t2536r1491b2628],
45	)	NN	O	)	prep_vs.	35	SENT_104	[p7l1294t2536r1491b2628],
46	,	,	O	,	_	0	SENT_104	[p7l1294t2536r1491b2628],
47	and	CC	O	and	_	0	SENT_104	[p7l1540t2529r1698b2607],
48	intention	NN	O	intention	conj_and	35	SENT_104	[p7l1740t2530r2134b2607],
49	to	TO	O	to	aux	50	SENT_104	[p7l12t2647r94b2709],
50	commence	VB	O	commence	infmod	48	SENT_104	[p7l133t2656r598b2709],
51	a	DT	O	a	det	53	SENT_104	[p7l636t2656r680b2708],
52	new	JJ	O	new	amod	53	SENT_104	[p7l716t2656r894b2709],
53	I1OI1I1U	NN	O	i1oi1i1u	dobj	50	SENT_104	[p7l928t2630r1550b2709],
54	.	.	O	.	_	0	SENT_104	[p7l928t2630r1550b2709],

1	Cl	NN	O	cl	_	0	SENT_105	[p7l928t2630r1550b2709],
2	€	CD	NUMBER	€	num	3	SENT_105	[p7l928t2630r1550b2709],
3	OSlCl	NN	O	oslcl	dep	1	SENT_105	[p7l928t2630r1550b2709],
4	€	NN	O	€	nn	5	SENT_105	[p7l928t2630r1550b2709],
5	reversetranscriptase	NN	O	reversetranscriptase	dep	1	SENT_105	[p7l1588t2647r2133b2709, p7l13t2758r392b2857],

1	inhibitor	NN	O	inhibitor	nsubj	17	SENT_106	[p7l434t2757r816b2836],
2	between	IN	O	between	_	0	SENT_106	[p7l856t2757r1213b2837],
3	the	DT	O	the	det	4	SENT_106	[p7l1255t2757r1388b2835],
4	time	NN	O	time	prep_between	1	SENT_106	[p7l1431t2758r1623b2835],
5	of	IN	O	of	_	0	SENT_106	[p7l1666t2756r1765b2836],
6	the	DT	O	the	det	7	SENT_106	[p7l1789t2757r1922b2835],
7	visit	NN	O	visit	prep_of	4	SENT_106	[p7l1960t2758r2139b2837],
8	to	TO	O	to	aux	9	SENT_106	[p7l12t2903r94b2965],
9	assess	VB	O	assess	infmod	7	SENT_106	[p7l141t2912r404b2964],
10	eligibility	NN	O	eligibility	dobj	9	SENT_106	[p7l453t2886r864b2987],
11	and	CC	O	and	_	0	SENT_106	[p7l905t2886r1062b2965],
12	day	NN	DURATION	day	conj_and	10	SENT_106	[p7l1109t2886r1256b2986],
13	1	CD	NUMBER	1	num	12	SENT_106	[p7l1301t2892r1345b2964],
14	of	IN	O	of	_	0	SENT_106	[p7l1392t2885r1492b2965],
15	the	DT	O	the	det	16	SENT_106	[p7l1520t2886r1653b2965],
16	study	NN	O	study	prep_of	12	SENT_106	[p7l1700t2886r1930b2986],
17	(	VBD	O	(	_	0	SENT_106	[p7l1977t2886r2134b2977],
18	the	DT	DURATION	the	det	20	SENT_106	[p7l1977t2886r2134b2977],
19	first	JJ	DURATION	first	amod	20	SENT_106	[p7l12t3012r196b3091],
20	day	NN	DURATION	day	dobj	17	SENT_106	[p7l231t3013r378b3113],
21	of	IN	O	of	_	0	SENT_106	[p7l413t3012r513b3092],
22	abacavir	NN	O	abacavir	nn	24	SENT_106	[p7l534t3013r891b3093],
23	therapy	NN	O	therapy	nn	24	SENT_106	[p7l927t3013r1297b3113],
24	)	NN	O	)	prep_of	20	SENT_106	[p7l927t3013r1297b3113],
25	.	.	O	.	_	0	SENT_106	[p7l927t3013r1297b3113],

1	Blood	NN	O	blood	nn	2	SENT_107	[p7l140t3141r389b3220],
2	samples	NNS	O	sample	_	0	SENT_107	[p7l425t3141r769b3241],
3	for	IN	O	for	_	0	SENT_107	[p7l807t3140r930b3220],
4	use	NN	O	use	prep_for	2	SENT_107	[p7l962t3167r1102b3221],
5	in	IN	O	in	_	0	SENT_107	[p7l1137t3142r1221b3219],
6	HLA	NN	O	hlum	prep_in	2	SENT_107	[p7l1255t3141r1792b3220],
7	.	.	O	.	_	0	SENT_107	[p7l1255t3141r1792b3220],

1	—	NN	O	—	_	0	SENT_108	[p7l1255t3141r1792b3220],
2	.	.	O	.	_	0	SENT_108	[p7l1255t3141r1792b3220],

1	B	NN	O	b	nsubjpass	8	SENT_109	[p7l1255t3141r1792b3220],
2	*	CD	NUMBER	*	number	3	SENT_109	[p7l1255t3141r1792b3220],
3	5701	CD	DATE	5701	num	4	SENT_109	[p7l1255t3141r1792b3220],
4	screen	NN	O	screen	dep	1	SENT_109	[p7l1829t3167r2133b3219],
5	—	CD	NUMBER	—	num	6	SENT_109	[p7l1829t3167r2133b3219],
6	ing	NN	O	ing	dep	1	SENT_109	[p7l11t3271r151b3371],
7	were	VBD	O	be	auxpass	8	SENT_109	[p7l191t3296r393b3349],
8	collected	VBN	O	collect	_	0	SENT_109	[p7l441t3270r821b3349],
9	from	IN	O	from	_	0	SENT_109	[p7l868t3269r1079b3349],
10	all	DT	O	all	det	11	SENT_109	[p7l1125t3270r1230b3348],
11	patients	NNS	O	patient	prep_from	8	SENT_109	[p7l1275t3271r1617b3370],
12	during	IN	O	during	_	0	SENT_109	[p7l1667t3270r1956b3371],
13	the	DT	O	the	det	15	SENT_109	[p7l2001t3270r2134b3348],
14	evaluation	NN	O	evaluation	nn	15	SENT_109	[p7l12t3397r444b3477],
15	period	NN	O	period	prep_during	8	SENT_109	[p7l485t3397r781b3497],
16	.	.	O	.	_	0	SENT_109	[p7l485t3397r781b3497],

1	However	RB	O	however	advmod	19	SENT_110	[p7l828t3405r1215b3493],
2	,	,	O	,	_	0	SENT_110	[p7l828t3405r1215b3493],
3	only	RB	O	only	advmod	4	SENT_110	[p7l1264t3397r1445b3497],
4	those	DT	O	those	nsubjpass	19	SENT_110	[p7l1484t3397r1712b3476],
5	from	IN	O	from	_	0	SENT_110	[p7l1755t3396r1962b3476],
6	patients	NNS	O	patient	prep_from	4	SENT_110	[p7l2004t3423r2133b3497, p7l12t3527r249b3605],
7	who	WP	O	who	nsubjpass	11	SENT_110	[p7l296t3526r479b3605],
8	had	VBD	O	have	aux	11	SENT_110	[p7l529t3526r686b3605],
9	been	VBN	O	be	auxpass	11	SENT_110	[p7l736t3526r937b3605],
10	randomly	RB	O	randomly	advmod	11	SENT_110	[p7l986t3526r1400b3626],
11	assigned	VBN	O	assign	rcmod	6	SENT_110	[p7l1445t3526r1819b3627],
12	to	TO	O	to	_	0	SENT_110	[p7l1868t3543r1950b3605],
13	the	DT	O	the	det	17	SENT_110	[p7l2001t3526r2134b3604],
14	prospective	JJ	O	prospective	amod	17	SENT_110	[p7l11t3655r959b3755],
15	—	NN	O	—	nn	17	SENT_110	[p7l11t3655r959b3755],
16	screening	NN	O	screening	nn	17	SENT_110	[p7l11t3655r959b3755],
17	group	NN	O	group	prep_to	11	SENT_110	[p7l1017t3680r1269b3755],
18	were	VBD	O	be	auxpass	19	SENT_110	[p7l1326t3680r1528b3733],
19	subjected	VBN	O	subject	_	0	SENT_110	[p7l1591t3654r1990b3754],
20	to	TO	O	to	_	0	SENT_110	[p7l2051t3671r2133b3733],
21	real	JJ	O	real	amod	24	SENT_110	[p8l12t21r391b99],
22	—	JJ	O	—	amod	24	SENT_110	[p8l12t21r391b99],
23	time	NN	O	time	nn	24	SENT_110	[p8l12t21r391b99],
24	testing	NN	O	testing	prep_to	19	SENT_110	[p8l427t22r719b122],
25	for	IN	O	for	_	0	SENT_110	[p8l751t20r872b100],
26	carriage	NN	O	carriage	prep_for	24	SENT_110	[p8l905t22r1246b122],
27	of	IN	O	of	_	0	SENT_110	[p8l1282t20r1381b100],
28	HLA	NN	O	hlum	prep_of	26	SENT_110	[p8l1397t21r1925b100],
29	.	.	O	.	_	0	SENT_110	[p8l1397t21r1925b100],

1	—	NN	O	—	_	0	SENT_111	[p8l1397t21r1925b100],
2	.	.	O	.	_	0	SENT_111	[p8l1397t21r1925b100],

1	B	NN	O	b	_	0	SENT_112	[p8l1397t21r1925b100],
2	*	CD	NUMBER	*	number	3	SENT_112	[p8l1397t21r1925b100],
3	5701	CD	DATE	5701	dep	1	SENT_112	[p8l1397t21r1925b100],
4	during	IN	O	during	_	0	SENT_112	[p8l1961t21r2133b100, p8l11t150r149b250],
5	the	DT	O	the	det	7	SENT_112	[p8l177t149r310b227],
6	evaluation	NN	O	evaluation	nn	7	SENT_112	[p8l345t149r786b228],
7	period	NN	O	period	prep_during	3	SENT_112	[p8l818t149r1119b249],
8	.	.	O	.	_	0	SENT_112	[p8l818t149r1119b249],

1	Samples	NNS	O	sample	nsubjpass	15	SENT_113	[p8l1161t149r1512b249],
2	from	IN	O	from	_	0	SENT_113	[p8l1548t148r1759b228],
3	patients	NNS	O	patient	prep_from	1	SENT_113	[p8l1791t150r2132b249],
4	who	WP	O	who	nsubjpass	8	SENT_113	[p8l7t277r190b356],
5	had	VBD	O	have	aux	8	SENT_113	[p8l231t277r388b356],
6	been	VBN	O	be	auxpass	8	SENT_113	[p8l428t277r629b356],
7	randomly	RB	O	randomly	advmod	8	SENT_113	[p8l669t277r1084b377],
8	assigned	VBN	O	assign	rcmod	3	SENT_113	[p8l1118t277r1492b378],
9	to	TO	O	to	_	0	SENT_113	[p8l1532t294r1613b356],
10	the	DT	O	the	det	12	SENT_113	[p8l1655t277r1788b355],
11	control	NN	O	control	nn	12	SENT_113	[p8l1828t277r2134b356],
12	group	NN	O	group	prep_to	8	SENT_113	[p8l12t431r264b506],
13	were	VBD	O	be	auxpass	15	SENT_113	[p8l288t431r490b484],
14	retrospectively	RB	O	retrospectively	advmod	15	SENT_113	[p8l516t405r1146b505],
15	tested	VBN	O	test	_	0	SENT_113	[p8l1169t405r1422b484],
16	for	IN	O	for	_	0	SENT_113	[p8l1449t404r1573b484],
17	HLA	NN	O	hlum	prep_for	15	SENT_113	[p8l1596t405r2133b484],
18	.	.	O	.	_	0	SENT_113	[p8l1596t405r2133b484],

1	—	NN	O	—	_	0	SENT_114	[p8l1596t405r2133b484],
2	.	.	O	.	_	0	SENT_114	[p8l1596t405r2133b484],

1	B	NN	O	b	_	0	SENT_115	[p8l1596t405r2133b484],
2	*	CD	NUMBER	*	number	3	SENT_115	[p8l1596t405r2133b484],
3	5701	CD	DATE	5701	dep	1	SENT_115	[p8l1596t405r2133b484],
4	at	IN	O	at	_	0	SENT_115	[p8l11t549r90b610],
5	the	DT	O	the	det	6	SENT_115	[p8l148t532r281b610],
6	end	NN	O	end	prep_at	3	SENT_115	[p8l344t532r497b611],
7	of	IN	O	of	_	0	SENT_115	[p8l560t531r660b611],
8	the	DT	O	the	det	9	SENT_115	[p8l704t532r837b610],
9	study	NN	O	study	prep_of	6	SENT_115	[p8l901t532r1143b632],
10	.	.	O	.	_	0	SENT_115	[p8l901t532r1143b632],

1	HLA	NN	O	hlum	_	0	SENT_116	[p8l1211t532r2134b632],
2	.	.	O	.	_	0	SENT_116	[p8l1211t532r2134b632],

1	—	NN	O	—	_	0	SENT_117	[p8l1211t532r2134b632],
2	.	.	O	.	_	0	SENT_117	[p8l1211t532r2134b632],

1	B	NN	O	b	_	0	SENT_118	[p8l1211t532r2134b632],
2	*	CD	NUMBER	*	number	3	SENT_118	[p8l1211t532r2134b632],
3	5701	CD	NUMBER	5701	num	1	SENT_118	[p8l1211t532r2134b632],
4	.	.	O	.	_	0	SENT_118	[p8l1211t532r2134b632],

1	—	NN	O	—	_	0	SENT_119	[p8l1211t532r2134b632],
2	.	.	O	.	_	0	SENT_119	[p8l1211t532r2134b632],

1	positive	JJ	O	positive	amod	2	SENT_120	[p8l1211t532r2134b632],
2	patients	NNS	O	patient	nsubj	11	SENT_120	[p8l11t662r352b761],
3	in	IN	O	in	_	0	SENT_120	[p8l399t662r483b739],
4	the	DT	O	the	det	8	SENT_120	[p8l530t661r662b739],
5	prospective	JJ	O	prospective	amod	8	SENT_120	[p8l707t662r1656b762],
6	—	NN	O	—	nn	8	SENT_120	[p8l707t662r1656b762],
7	screening	NN	O	screening	nn	8	SENT_120	[p8l707t662r1656b762],
8	group	NN	O	group	prep_in	2	SENT_120	[p8l1699t687r1951b762],
9	did	VBD	O	do	aux	11	SENT_120	[p8l1999t661r2134b740],
10	not	RB	O	not	neg	11	SENT_120	[p8l12t806r154b868],
11	receive	VB	O	receive	_	0	SENT_120	[p8l188t790r477b868],
12	abacavir	NN	O	abacavir	dobj	11	SENT_120	[p8l515t789r871b868],
13	as	IN	O	as	_	0	SENT_120	[p8l906t815r991b867],
14	part	NN	O	part	prep_as	11	SENT_120	[p8l1031t806r1210b889],
15	of	IN	O	of	_	0	SENT_120	[p8l1244t788r1344b868],
16	the	DT	O	the	det	19	SENT_120	[p8l1364t789r1497b867],
17	study	NN	O	study	nn	19	SENT_120	[p8l1537t789r1767b889],
18	(	CD	NUMBER	(	num	19	SENT_120	[p8l1806t790r1986b890],
19	Fig	NN	O	fig	prep_of	14	SENT_120	[p8l1806t790r1986b890],
20	.	.	O	.	_	0	SENT_120	[p8l1806t790r1986b890],

1	1	CD	NUMBER	1	_	0	SENT_121	[p8l2033t795r2129b880],
2	)	NN	O	)	dep	1	SENT_121	[p8l2033t795r2129b880],
3	.	.	O	.	_	0	SENT_121	[p8l2033t795r2129b880],

1	HLA	NN	O	hlum	_	0	SENT_122	[p8l11t917r958b1018],
2	.	.	O	.	_	0	SENT_122	[p8l11t917r958b1018],

1	—	NN	O	—	_	0	SENT_123	[p8l11t917r958b1018],
2	.	.	O	.	_	0	SENT_123	[p8l11t917r958b1018],

1	B	NN	O	b	_	0	SENT_124	[p8l11t917r958b1018],
2	*	CD	NUMBER	*	number	3	SENT_124	[p8l11t917r958b1018],
3	5701	CD	NUMBER	5701	num	1	SENT_124	[p8l11t917r958b1018],
4	.	.	O	.	_	0	SENT_124	[p8l11t917r958b1018],

1	—	NN	O	—	_	0	SENT_125	[p8l11t917r958b1018],
2	.	.	O	.	_	0	SENT_125	[p8l11t917r958b1018],

1	negative	JJ	O	negative	amod	2	SENT_126	[p8l11t917r958b1018],
2	patients	NNS	O	patient	nsubj	16	SENT_126	[p8l1019t918r1360b1017],
3	in	IN	O	in	_	0	SENT_126	[p8l1424t918r1508b995],
4	the	DT	O	the	det	8	SENT_126	[p8l1570t917r1703b995],
5	prospective	JJ	O	prospective	amod	8	SENT_126	[p8l1765t943r2133b1017, p8l12t1046r604b1146],
6	—	NN	O	—	nn	8	SENT_126	[p8l1765t943r2133b1017, p8l12t1046r604b1146],
7	screening	NN	O	screening	nn	8	SENT_126	[p8l1765t943r2133b1017, p8l12t1046r604b1146],
8	group	NN	O	group	prep_in	2	SENT_126	[p8l643t1071r892b1146],
9	and	CC	O	and	_	0	SENT_126	[p8l935t1045r1091b1124],
10	all	DT	O	all	det	11	SENT_126	[p8l1132t1045r1235b1123],
11	patients	NNS	O	patient	prep_in	2	SENT_126	[p8l1275t1046r1609b1145],
12	in	IN	O	in	_	0	SENT_126	[p8l1653t1046r1736b1123],
13	the	DT	O	the	det	15	SENT_126	[p8l1779t1045r1909b1124],
14	control	NN	O	control	nn	15	SENT_126	[p8l1952t1071r2133b1124, p8l12t1173r159b1252],
15	group	NN	O	group	prep_in	11	SENT_126	[p8l195t1199r448b1274],
16	started	VBD	O	start	_	0	SENT_126	[p8l490t1173r789b1252],
17	the	DT	O	the	det	18	SENT_126	[p8l828t1173r960b1252],
18	study	NN	O	study	dobj	16	SENT_126	[p8l1002t1173r1232b1273],
19	after	IN	O	after	_	0	SENT_126	[p8l1266t1172r1468b1251],
20	receiving	VBG	O	receive	prepc_after	16	SENT_126	[p8l1504t1174r1896b1274],
21	notification	NN	O	notification	dobj	20	SENT_126	[p8l1931t1174r2133b1252, p8l12t1300r337b1380],
22	of	IN	O	of	_	0	SENT_126	[p8l367t1300r466b1380],
23	their	PRP$	O	they	poss	24	SENT_126	[p8l477t1301r677b1379],
24	eligibility	NN	O	eligibility	prep_of	21	SENT_126	[p8l704t1301r1104b1402],
25	to	TO	O	to	aux	26	SENT_126	[p8l1129t1318r1209b1380],
26	receive	VB	O	receive	infmod	24	SENT_126	[p8l1240t1302r1523b1380],
27	abacavir	NN	O	abacavir	dobj	26	SENT_126	[p8l1552t1301r1901b1380],
28	from	IN	O	from	_	0	SENT_126	[p8l1927t1300r2134b1380],
29	the	DT	O	the	det	31	SENT_126	[p8l12t1429r145b1507],
30	central	JJ	O	central	amod	31	SENT_126	[p8l189t1429r484b1507],
31	study	NN	O	study	prep_from	26	SENT_126	[p8l528t1429r1356b1530],
32	—	CD	NUMBER	—	num	34	SENT_126	[p8l528t1429r1356b1530],
33	management	NN	O	management	nn	34	SENT_126	[p8l528t1429r1356b1530],
34	group	NN	O	group	dep	31	SENT_126	[p8l1393t1455r1668b1530],
35	.	.	O	.	_	0	SENT_126	[p8l1393t1455r1668b1530],

1	Investigators	NNS	O	investigator	nsubj	12	SENT_127	[p8l1716t1430r2133b1530, p8l12t1575r199b1654],
2	,	,	O	,	_	0	SENT_127	[p8l1716t1430r2133b1530, p8l12t1575r199b1654],
3	patients	NNS	O	patient	conj_and	1	SENT_127	[p8l250t1559r616b1658],
4	,	,	O	,	_	0	SENT_127	[p8l250t1559r616b1658],
5	and	CC	O	and	_	0	SENT_127	[p8l667t1558r825b1637],
6	the	DT	O	the	det	10	SENT_127	[p8l871t1558r1004b1636],
7	study	NN	O	study	nn	10	SENT_127	[p8l1052t1558r1880b1659],
8	—	CD	NUMBER	—	num	10	SENT_127	[p8l1052t1558r1880b1659],
9	management	NN	O	management	nn	10	SENT_127	[p8l1052t1558r1880b1659],
10	team	NN	O	team	conj_and	1	SENT_127	[p8l1921t1575r2134b1636],
11	were	VBD	O	be	cop	12	SENT_127	[p8l7t1712r209b1765],
12	unaware	JJ	O	unaware	_	0	SENT_127	[p8l249t1712r615b1765],
13	of	IN	O	of	_	0	SENT_127	[p8l655t1685r755b1765],
14	the	DT	O	the	det	16	SENT_127	[p8l777t1686r909b1764],
15	group	NN	O	group	nn	16	SENT_127	[p8l949t1712r1201b1787],
16	assignments	NNS	O	assignment	prep_of	12	SENT_127	[p8l1241t1687r1805b1787],
17	.	.	O	.	_	0	SENT_127	[p8l1241t1687r1805b1787],

1	HLA	NN	O	hlum	_	0	SENT_128	[p8l140t1814r658b1893],
2	.	.	O	.	_	0	SENT_128	[p8l140t1814r658b1893],

1	—	NN	O	—	_	0	SENT_129	[p8l140t1814r658b1893],
2	.	.	O	.	_	0	SENT_129	[p8l140t1814r658b1893],

1	B	NN	O	b	nsubjpass	6	SENT_130	[p8l140t1814r658b1893],
2	*	CD	NUMBER	*	num	1	SENT_130	[p8l140t1814r658b1893],
3	5701	CD	NUMBER	5701	num	4	SENT_130	[p8l140t1814r658b1893],
4	screening	NN	O	screening	dep	1	SENT_130	[p8l694t1815r1095b1915],
5	was	VBD	O	be	auxpass	6	SENT_130	[p8l1121t1840r1279b1893],
6	performed	VBN	O	perform	_	0	SENT_130	[p8l1314t1813r1753b1914],
7	With	IN	O	with	_	0	SENT_130	[p8l1782t1814r1971b1893],
8	the	DT	O	the	det	9	SENT_130	[p8l2005t1814r2134b1892],
9	use	NN	O	use	prep_with	6	SENT_130	[p8l12t1968r150b2021],
10	of	IN	O	of	_	0	SENT_130	[p8l185t1941r284b2021],
11	DNA	NN	MISC	dna	nn	14	SENT_130	[p8l298t1942r1219b2042],
12	—	NN	O	—	nn	14	SENT_130	[p8l298t1942r1219b2042],
13	sequence	NN	O	sequence	nn	14	SENT_130	[p8l298t1942r1219b2042],
14	—	NN	O	—	prep_of	9	SENT_130	[p8l298t1942r1219b2042],
15	based	VBN	O	base	partmod	14	SENT_130	[p8l298t1942r1219b2042],
16	typing	NN	O	typing	nn	17	SENT_130	[p8l1254t1943r1526b2043],
17	(	NN	O	(	dobj	15	SENT_130	[p8l1562t1949r1663b2033],
18	at	IN	O	at	_	0	SENT_130	[p8l1562t1949r1663b2033],
19	the	DT	O	the	det	44	SENT_130	[p8l1693t1942r1823b2020],
20	Centre	NNP	O	Centre	dep	44	SENT_130	[p8l1858t1948r2134b2021],
21	for	IN	O	for	_	0	SENT_130	[p8l12t2069r131b2149],
22	Clinical	JJ	O	clinical	amod	23	SENT_130	[p8l156t2070r474b2149],
23	Immunology	NN	O	immunology	prep_for	20	SENT_130	[p8l501t2070r1044b2171],
24	and	CC	O	and	_	0	SENT_130	[p8l1067t2070r1221b2149],
25	Biomedical	NNP	ORGANIZATION	Biomedical	nn	26	SENT_130	[p8l1248t2070r1710b2149],
26	Statistics	NNPS	ORGANIZATION	Statistics	conj_and	23	SENT_130	[p8l1741t2071r2128b2166],
27	,	,	ORGANIZATION	,	_	0	SENT_130	[p8l1741t2071r2128b2166],
28	Royal	NNP	ORGANIZATION	Royal	nn	30	SENT_130	[p8l11t2198r250b2297],
29	Perth	NNP	ORGANIZATION	Perth	nn	30	SENT_130	[p8l295t2198r524b2276],
30	Hospital	NNP	ORGANIZATION	Hospital	conj_and	23	SENT_130	[p8l571t2198r960b2297],
31	,	,	O	,	_	0	SENT_130	[p8l571t2198r960b2297],
32	Perth	NNP	LOCATION	Perth	conj_and	23	SENT_130	[p8l1011t2198r1264b2293],
33	,	,	O	,	_	0	SENT_130	[p8l1011t2198r1264b2293],
34	Western	NNP	LOCATION	Western	nn	36	SENT_130	[p8l1312t2205r1666b2276],
35	Australia	NNP	LOCATION	Australia	nn	36	SENT_130	[p8l1710t2198r2129b2288],
36	)	NN	O	)	conj_and	23	SENT_130	[p8l1710t2198r2129b2288],
37	and	CC	O	and	_	0	SENT_130	[p8l11t2326r171b2405],
38	a	DT	O	a	det	40	SENT_130	[p8l225t2352r269b2404],
39	sequence	NN	O	sequence	nn	40	SENT_130	[p8l323t2325r1099b2426],
40	—	NN	O	—	conj_and	23	SENT_130	[p8l323t2325r1099b2426],
41	specific	JJ	O	specific	amod	44	SENT_130	[p8l323t2325r1099b2426],
42	oligonucleotide	NN	O	oligonucleotide	nn	44	SENT_130	[p8l1153t2326r1831b2427],
43	probe	NN	O	probe	nn	44	SENT_130	[p8l1884t2326r2134b2426],
44	method	NN	O	method	nn	47	SENT_130	[p8l12t2453r332b2532],
45	(	NN	O	(	nn	47	SENT_130	[p8l367t2453r848b2553],
46	Laboratory	NN	ORGANIZATION	laboratory	nn	47	SENT_130	[p8l367t2453r848b2553],
47	Corporation	NNP	ORGANIZATION	Corporation	prep_at	15	SENT_130	[p8l873t2454r1377b2553],
48	of	IN	ORGANIZATION	of	_	0	SENT_130	[p8l1408t2452r1506b2532],
49	America	NNP	ORGANIZATION	America	prep_of	47	SENT_130	[p8l1513t2454r1908b2549],
50	)	CD	NUMBER	)	num	49	SENT_130	[p8l1513t2454r1908b2549],
51	,	,	O	,	_	0	SENT_130	[p8l1513t2454r1908b2549],
52	with	IN	O	with	_	0	SENT_130	[p8l1939t2453r2134b2533],
53	additional	JJ	O	additional	amod	55	SENT_130	[p8l11t2582r438b2661],
54	DNA	NN	O	dna	nn	55	SENT_130	[p8l467t2589r673b2661],
55	sequencing	NN	O	sequencing	prep_with	15	SENT_130	[p8l702t2583r1178b2683],
56	for	IN	O	for	_	0	SENT_130	[p8l1205t2581r1327b2661],
57	patients	NNS	O	patient	prep_for	55	SENT_130	[p8l1352t2583r1687b2682],
58	for	IN	O	for	_	0	SENT_130	[p8l1719t2581r1840b2661],
59	Whom	WP	O	whom	dobj	64	SENT_130	[p8l1863t2582r2134b2661],
60	the	DT	O	the	det	62	SENT_130	[p8l12t2710r145b2788],
61	probe	NN	O	probe	nn	62	SENT_130	[p8l181t2710r426b2810],
62	results	NNS	O	result	nsubj	64	SENT_130	[p8l463t2710r746b2789],
63	were	VBD	O	be	cop	64	SENT_130	[p8l781t2736r982b2789],
64	positive	JJ	O	positive	prepc_for	57	SENT_130	[p8l1018t2711r1372b2810],
65	.	.	O	.	_	0	SENT_130	[p8l1018t2711r1372b2810],

1	Patients	NNS	O	patient	_	0	SENT_131	[p8l1413t2711r1752b2789],
2	wishing	VBG	O	wish	partmod	1	SENT_131	[p8l1787t2710r2137b2811],
3	to	TO	O	to	aux	4	SENT_131	[p8l12t2855r94b2917],
4	know	VB	O	know	xcomp	2	SENT_131	[p8l140t2838r381b2917],
5	their	PRP$	O	they	poss	6	SENT_131	[p8l422t2838r626b2917],
6	HLA	NN	O	hlum	dobj	4	SENT_131	[p8l667t2838r1204b2917],
7	.	.	O	.	_	0	SENT_131	[p8l667t2838r1204b2917],

1	—	NN	O	—	_	0	SENT_132	[p8l667t2838r1204b2917],
2	.	.	O	.	_	0	SENT_132	[p8l667t2838r1204b2917],

1	B	NN	O	b	nsubjpass	6	SENT_133	[p8l667t2838r1204b2917],
2	*	CD	NUMBER	*	num	1	SENT_133	[p8l667t2838r1204b2917],
3	5701	CD	NUMBER	5701	num	4	SENT_133	[p8l667t2838r1204b2917],
4	status	NN	O	status	dep	1	SENT_133	[p8l1251t2855r1502b2917],
5	were	VBD	O	be	auxpass	6	SENT_133	[p8l1544t2864r1746b2917],
6	notified	VBN	O	notify	_	0	SENT_133	[p8l1791t2837r2134b2917],
7	at	IN	O	at	_	0	SENT_133	[p8l11t2982r90b3043],
8	the	DT	O	the	det	9	SENT_133	[p8l125t2965r258b3043],
9	end	NN	O	end	prep_at	6	SENT_133	[p8l298t2965r451b3044],
10	of	IN	O	of	_	0	SENT_133	[p8l492t2964r591b3044],
11	the	DT	O	the	det	12	SENT_133	[p8l613t2965r746b3043],
12	study	NN	O	study	prep_of	9	SENT_133	[p8l787t2965r1030b3065],
13	.	.	O	.	_	0	SENT_133	[p8l787t2965r1030b3065],

1	Assessments	NNS	O	assessment	nsubjpass	3	SENT_134	[p8l137t3101r688b3171],
2	were	VBD	O	be	auxpass	3	SENT_134	[p8l737t3119r939b3173],
3	performed	VBN	O	perform	_	0	SENT_134	[p8l989t3092r1446b3193],
4	at	IN	O	at	_	0	SENT_134	[p8l1497t3110r1576b3171],
5	the	DT	O	the	det	6	SENT_134	[p8l1622t3093r1755b3171],
6	time	NN	O	time	prep_at	3	SENT_134	[p8l1807t3094r2000b3171],
7	of	IN	O	of	_	0	SENT_134	[p8l2053t3092r2152b3172],
8	study	NN	O	study	nn	9	SENT_134	[p8l13t3222r243b3321],
9	entry	NN	O	entry	prep_of	6	SENT_134	[p8l278t3239r514b3321],
10	,	,	O	,	_	0	SENT_134	[p8l278t3239r514b3321],
11	on	IN	O	on	_	0	SENT_134	[p8l559t3248r665b3300],
12	day	NN	DURATION	day	prep_on	3	SENT_134	[p8l704t3222r851b3321],
13	1	CD	NUMBER	1	number	14	SENT_134	[p8l888t3228r932b3299],
14	(	CD	NUMBER	(	num	16	SENT_134	[p8l977t3222r1408b3317],
15	baseline	NN	O	baseline	nn	16	SENT_134	[p8l977t3222r1408b3317],
16	)	NN	O	)	dep	12	SENT_134	[p8l977t3222r1408b3317],
17	,	,	O	,	_	0	SENT_134	[p8l977t3222r1408b3317],
18	and	CC	O	and	_	0	SENT_134	[p8l1452t3222r1610b3300],
19	at	IN	O	at	advmod	12	SENT_134	[p8l1648t3238r1727b3299],
20	Weeks	NNS	DURATION	week	conj_and	12	SENT_134	[p8l1756t3222r2017b3301],
21	1	CD	NUMBER	1	dep	20	SENT_134	[p8l2062t3228r2129b3317],
22	,	,	O	,	_	0	SENT_134	[p8l2062t3228r2129b3317],
23	2	CD	NUMBER	2	num	21	SENT_134	[p8l12t3356r83b3446],
24	,	,	O	,	_	0	SENT_134	[p8l12t3356r83b3446],
25	and	CC	NUMBER	and	_	0	SENT_134	[p8l136t3350r294b3429],
26	6	CD	NUMBER	6	dep	20	SENT_134	[p8l341t3356r412b3429],
27	.	.	O	.	_	0	SENT_134	[p8l341t3356r412b3429],

1	Investigators	NNS	O	investigator	nsubjpass	3	SENT_135	[p8l463t3351r1017b3451],
2	were	VBD	O	be	auxpass	3	SENT_135	[p8l1062t3376r1265b3429],
3	trained	VBN	O	train	conj_and	3	SENT_135	[p8l1312t3350r1621b3429],
4	in	IN	O	in	_	0	SENT_135	[p8l1667t3351r1751b3428],
5	relevant	JJ	O	relevant	amod	7	SENT_135	[p8l1798t3350r2139b3429],
6	study	NN	O	study	nn	7	SENT_135	[p8l13t3478r243b3578],
7	procedures	NNS	O	procedure	prep_in	3	SENT_135	[p8l288t3478r763b3578],
8	during	IN	O	during	_	0	SENT_135	[p8l816t3478r1105b3579],
9	teaching	NN	O	teaching	nn	10	SENT_135	[p8l1152t3478r1524b3579],
10	sessions	NNS	O	session	prep_during	3	SENT_135	[p8l1573t3479r1924b3557],
11	and	CC	O	and	_	0	SENT_135	[p8l1976t3478r2134b3557],
12	with	IN	O	with	_	0	SENT_135	[p8l7t3606r203b3685],
13	the	DT	O	the	det	14	SENT_135	[p8l247t3606r380b3684],
14	use	NN	O	use	prep_with	3	SENT_135	[p8l424t3632r564b3685],
15	of	IN	O	of	_	0	SENT_135	[p8l609t3605r709b3685],
16	illustrated	JJ	O	illustrated	amod	17	SENT_135	[p8l734t3606r1173b3685],
17	guides	NNS	O	guide	prep_of	14	SENT_135	[p8l1217t3606r1498b3707],
18	and	CC	O	and	_	0	SENT_135	[p8l1543t3606r1701b3685],
19	an	DT	O	a	det	20	SENT_135	[p8l1744t3632r1847b3684],
20	informational	JJ	O	informational	prep_of	14	SENT_135	[p8l1890t3605r2133b3685, p9l12t21r398b100],

1	video	NN	O	video	_	0	SENT_136	[p9l432t21r682b100],
2	.	.	O	.	_	0	SENT_136	[p9l432t21r682b100],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_137	[p9l140t150r825b248],
2	reactions	NNS	O	reaction	nsubjpass	6	SENT_137	[p9l859t150r1241b227],
3	to	TO	O	to	_	0	SENT_137	[p9l1284t166r1364b227],
4	abacavir	NN	O	abacavir	prep_to	2	SENT_137	[p9l1404t149r1752b228],
5	were	VBD	O	be	auxpass	6	SENT_137	[p9l1785t175r1983b228],
6	diagnosed	VBN	O	diagnose	_	0	SENT_137	[p9l2024t149r2133b227, p9l11t277r363b378],

1	by	IN	O	by	_	0	SENT_138	[p9l402t277r499b377],
2	the	DT	O	the	det	4	SENT_138	[p9l534t277r667b355],
3	principal	JJ	O	principal	amod	4	SENT_138	[p9l706t277r1092b377],
4	investigator	NN	O	investigator	pobj	1	SENT_138	[p9l1130t278r1639b378],
5	at	IN	O	at	_	0	SENT_138	[p9l1675t294r1754b355],
6	the	DT	O	the	det	7	SENT_138	[p9l1788t277r1921b355],
7	site	NN	O	site	prep_at	4	SENT_138	[p9l1962t278r2129b373],
8	,	,	O	,	_	0	SENT_138	[p9l1962t278r2129b373],

1	without	IN	O	without	_	0	SENT_139	[p9l7t404r346b484],
2	the	DT	O	the	det	3	SENT_139	[p9l395t404r528b482],
3	use	NN	O	use	pobj	1	SENT_139	[p9l582t430r723b484],
4	of	IN	O	of	_	0	SENT_139	[p9l777t403r878b483],
5	predefined	JJ	O	predefined	amod	7	SENT_139	[p9l911t403r1380b504],
6	clinical	JJ	O	clinical	amod	7	SENT_139	[p9l1434t404r1747b482],
7	criteria	NNS	O	criterion	prep_of	3	SENT_139	[p9l1801t405r2128b483],
8	.	.	O	.	_	0	SENT_139	[p9l1801t405r2128b483],

1	Patients	NNS	O	patient	_	0	SENT_140	[p9l11t534r350b611],
2	receiving	VBG	O	receive	csubj	5	SENT_140	[p9l393t534r783b634],
3	this	DT	O	this	det	4	SENT_140	[p9l821t533r980b611],
4	diagnosis	NN	O	diagnosis	dobj	2	SENT_140	[p9l1023t533r1434b634],
5	stopped	VBD	O	stop	rcmod	1	SENT_140	[p9l1477t533r1816b633],
6	taking	VBG	O	take	xcomp	5	SENT_140	[p9l1856t533r2137b634],
7	abacavir	NN	O	abacavir	dobj	6	SENT_140	[p9l11t661r368b740],
8	immediately	RB	O	immediately	advmod	6	SENT_140	[p9l399t661r938b760],
9	and	CC	O	and	_	0	SENT_140	[p9l968t661r1126b739],
10	permanently	RB	O	permanently	conj_and	8	SENT_140	[p9l1159t661r1722b760],
11	,	,	O	,	_	0	SENT_140	[p9l1159t661r1722b760],
12	and	CC	O	and	_	0	SENT_140	[p9l1762t661r1920b739],
13	they	PRP	O	they	conj_and	1	SENT_140	[p9l1956t661r2138b760],

1	570	CD	NUMBER	570	num	4	SENT_141	[p9l149t819r205b842],
2	N	NN	O	n	nn	4	SENT_141	[p9l908t829r921b844],
3	ENGLJ	NN	O	englj	nn	4	SENT_141	[p9l936t829r1014b851],
4	MED	NN	O	med	_	0	SENT_141	[p9l1029t829r1081b844],
5	358	CD	NUMBER	358	num	7	SENT_141	[p9l1091t823r1154b851],
6	;	:	O	;	_	0	SENT_141	[p9l1091t823r1154b851],
7	6	CD	NUMBER	6	dep	4	SENT_141	[p9l1091t823r1154b851],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_141	[p9l1188t829r1389b851],
9	FEBRUARY	NNP	DATE	FEBRUARY	dep	4	SENT_141	[p9l1426t829r1547b845],
10	7	CD	DATE	7	num	9	SENT_141	[p9l1557t829r1576b850],
11	,	,	DATE	,	_	0	SENT_141	[p9l1557t829r1576b850],
12	2008	CD	DATE	2008	num	9	SENT_141	[p9l1587t823r1650b845],

1	The	DT	O	the	det	4	SENT_142	[p9l935t862r986b886],
2	New	NNP	O	New	nn	4	SENT_142	[p9l995t863r1057b886],
3	England	NNP	O	England	nn	4	SENT_142	[p9l1066t862r1177b893],
4	Journal	NNP	O	Journal	_	0	SENT_142	[p9l1186t862r1283b886],
5	of	IN	O	of	_	0	SENT_142	[p9l1293t862r1322b886],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_142	[p9l1329t862r1454b886],

1	HLA-B	NN	O	hla-b	_	0	SENT_143	[p9l442t984r637b1007],
2	*	CD	NUMBER	*	num	4	SENT_143	[p9l442t984r637b1007],
3	S701	NN	O	s701	nn	4	SENT_143	[p9l442t984r637b1007],
4	SCREENING	NN	O	screening	dep	1	SENT_143	[p9l652t987r848b1006],
5	FOR	IN	O	for	_	0	SENT_143	[p9l862t987r926b1006],
6	ABACAVIR	NN	O	abacavir	nn	7	SENT_143	[p9l937t987r1102b1006],
7	HYPERSENSITIVITY	NN	O	hypersensitivity	prep_for	4	SENT_143	[p9l1115t987r1434b1006],

1	1956	CD	NUMBER	1956	num	2	SENT_144	[p9l950t1149r1005b1170],
2	Patients	NNS	O	patient	nsubjpass	7	SENT_144	[p9l1016t1149r1109b1169],
3	were	VBD	O	be	auxpass	4	SENT_144	[p9l1119t1155r1174b1170],
4	enrolled	VBN	O	enrol	_	0	SENT_144	[p9l1183t1147r1278b1169],
5	and	CC	O	and	_	0	SENT_144	[p9l1289t1147r1331b1169],
6	randomly	RB	O	randomly	advmod	7	SENT_144	[p9l1343t1147r1455b1176],
7	assigned	VBN	O	assign	conj_and	4	SENT_144	[p9l1014t1181r1118b1210],
8	(	CD	NUMBER	(	number	9	SENT_144	[p9l1131t1183r1182b1210],
9	1:1	CD	NUMBER	1:1	num	10	SENT_144	[p9l1131t1183r1182b1210],
10	)	NN	O	)	dobj	7	SENT_144	[p9l1131t1183r1182b1210],
11	to	TO	O	to	_	0	SENT_144	[p9l1193t1185r1216b1203],
12	a	DT	O	a	det	14	SENT_144	[p9l1225t1188r1237b1203],
13	study	NN	O	study	nn	14	SENT_144	[p9l1247t1181r1310b1210],
14	group	NN	O	group	prep_to	10	SENT_144	[p9l1319t1188r1389b1210],
15	l	NN	O	l	tmod	7	SENT_144	[p9l874t1290r886b1367],

1	980	CD	NUMBER	980	nsubjpass	3	SENT_145	[p9l668t1397r710b1417],
2	Were	VBD	O	be	auxpass	3	SENT_145	[p9l718t1397r779b1417],
3	assigned	VBN	O	assign	_	0	SENT_145	[p9l789t1395r893b1424],
4	to	TO	O	to	_	0	SENT_145	[p9l902t1399r926b1417],
5	the	DT	O	the	det	6	SENT_145	[p9l934t1395r971b1417],
6	prospec	NN	O	prospec	prep_to	3	SENT_145	[p9l982t1403r1083b1424],
7	-	:	O	-	_	0	SENT_145	[p9l982t1403r1083b1424],
8	976	CD	NUMBER	976	nsubjpass	10	SENT_145	[p9l1312t1399r1354b1419],
9	Were	VBD	O	be	auxpass	10	SENT_145	[p9l1362t1399r1424b1419],
10	assigned	VBN	O	assign	parataxis	3	SENT_145	[p9l1433t1397r1537b1426],
11	to	TO	O	to	_	0	SENT_145	[p9l1546t1401r1570b1419],
12	the	DT	O	the	det	16	SENT_145	[p9l1578t1397r1616b1419],
13	control	NN	O	control	nn	16	SENT_145	[p9l1625t1397r1707b1419],
14	tive-screening	JJ	O	tive-screening	amod	16	SENT_145	[p9l725t1431r893b1458],
15	group	NN	O	group	nn	16	SENT_145	[p9l902t1436r971b1458],
16	group	NN	O	group	prep_to	10	SENT_145	[p9l1370t1438r1440b1459],

1	980	CD	NUMBER	980	nsubj	6	SENT_146	[p9l668t1463r710b1484],
2	Underwent	JJ	O	underwent	amod	3	SENT_146	[p9l720t1462r851b1484],
3	prospective	JJ	O	prospective	dep	1	SENT_146	[p9l861t1464r998b1491],
4	genetic	JJ	O	genetic	amod	5	SENT_146	[p9l1007t1464r1093b1491],
5	913	CD	NUMBER	913	dep	3	SENT_146	[p9l1341t1465r1381b1486],
6	Received	VBN	O	receive	dep	22	SENT_146	[p9l1394t1464r1496b1486],
7	highly	RB	O	highly	advmod	8	SENT_146	[p9l1507t1464r1577b1493],
8	active	JJ	O	active	acomp	6	SENT_146	[p9l1586t1466r1654b1486],
9	antiscreening	VBG	O	antiscreen	xcomp	6	SENT_146	[p9l1663t1466r1715b1486, p9l727t1497r842b1524],
10	for	IN	O	for	_	0	SENT_146	[p9l850t1495r883b1517],
11	H	NN	O	h	nn	12	SENT_146	[p9l893t1497r910b1517],
12	LA-B	NN	O	la-b	prep_for	9	SENT_146	[p9l916t1497r1041b1517],
13	*	CD	NUMBER	*	num	12	SENT_146	[p9l916t1497r1041b1517],
14	570l	NN	O	570l	nn	16	SENT_146	[p9l916t1497r1041b1517],
15	retroviral	JJ	O	retroviral	amod	16	SENT_146	[p9l1396t1497r1501b1519],
16	therapy	NN	O	therapy	dobj	9	SENT_146	[p9l1511t1497r1600b1526],
17	involving	VBG	O	involve	_	0	SENT_146	[p9l1609t1497r1717b1526],
18	abacavir	NN	O	abacavir	prep_involving	16	SENT_146	[p9l1396t1530r1494b1552],
19	63	CD	NUMBER	63	num	18	SENT_146	[p9l1356t1565r1381b1586],
20	Did	VBD	O	do	aux	22	SENT_146	[p9l1394t1564r1433b1586],
21	not	RB	O	not	neg	22	SENT_146	[p9l1444t1568r1482b1586],
22	receive	VB	O	receive	_	0	SENT_146	[p9l1492t1566r1573b1586],
23	treatment	NN	O	treatment	dobj	22	SENT_146	[p9l1581t1568r1699b1586],
24	23	CD	NUMBER	23	num	26	SENT_146	[p9l1395t1599r1421b1619],
25	Withdrew	NNP	O	Withdrew	nn	26	SENT_146	[p9l1431t1597r1546b1619],
26	consent	NN	O	consent	nsubj	22	SENT_146	[p9l1555t1601r1649b1619],

1	55	CD	NUMBER	55	dep	100	SENT_147	[p9l169t1625r194b1645],
2	Were	VBD	O	be	dep	100	SENT_147	[p9l204t1625r266b1645],
3	positive	JJ	O	positive	dep	100	SENT_147	[p9l276t1625r367b1652],
4	for	IN	O	for	dep	100	SENT_147	[p9l376t1623r409b1645],
5	HLA-B	NN	O	hla-b	dep	100	SENT_147	[p9l419t1624r567b1645],
6	"	''	O	"	dep	100	SENT_147	[p9l419t1624r567b1645],
7	'	''	O	'	_	0	SENT_147	[p9l419t1624r567b1645],
8	570l	JJ	O	570l	dep	100	SENT_147	[p9l419t1624r567b1645],
9	9	CD	NUMBER	9	dep	100	SENT_147	[p9l1410t1632r1422b1652],
10	Had	VBD	O	have	dep	100	SENT_147	[p9l1434t1630r1481b1652],
11	a	DT	O	a	dep	100	SENT_147	[p9l1491t1638r1503b1652],
12	protocol	NN	O	protocol	dep	100	SENT_147	[p9l1514t1630r1610b1659],
13	Violation	NN	O	violation	dep	100	SENT_147	[p9l1620t1630r1722b1652],
14	54	CD	NUMBER	54	dep	100	SENT_147	[p9l198t1658r225b1678],
15	Did	VBD	O	do	dep	100	SENT_147	[p9l236t1656r275b1678],
16	not	RB	O	not	dep	100	SENT_147	[p9l286t1660r324b1678],
17	receive	VB	O	receive	dep	100	SENT_147	[p9l334t1658r415b1678],
18	highly	RB	O	highly	dep	100	SENT_147	[p9l425t1656r495b1685],
19	active	JJ	O	active	dep	100	SENT_147	[p9l504t1658r571b1678],
20	11	CD	NUMBER	11	dep	100	SENT_147	[p9l1397t1666r1421b1685],
21	were	VBD	O	be	dep	100	SENT_147	[p9l1431t1666r1492b1686],
22	bet	VBN	O	bet	dep	100	SENT_147	[p9l1502t1664r1544b1686],
23	to	TO	O	to	dep	100	SENT_147	[p9l1552t1668r1576b1686],
24	fo	VB	O	fo	dep	100	SENT_147	[p9l1585t1663r1695b1692],
25	|	CD	NUMBER	|	dep	100	SENT_147	[p9l1585t1663r1695b1692],
26	|	CD	NUMBER	|	dep	100	SENT_147	[p9l1585t1663r1695b1692],
27	ow_up	NN	O	ow_up	dep	100	SENT_147	[p9l1585t1663r1695b1692],
28	antiretroviral	JJ	O	antiretroviral	dep	100	SENT_147	[p9l236t1690r387b1712],
29	therapy	NN	O	therapy	dep	100	SENT_147	[p9l397t1690r486b1719],
30	4	CD	NUMBER	4	dep	100	SENT_147	[p9l1409t1699r1422b1719],
31	were	VBD	O	be	dep	100	SENT_147	[p9l1431t1699r1492b1719],
32	not	RB	O	not	dep	100	SENT_147	[p9l1503t1701r1540b1719],
33	Compiiant	JJ	O	compiiant	dep	100	SENT_147	[p9l1549t1697r1670b1726],
34	l	NN	O	l	dep	100	SENT_147	[p9l236t1723r343b1752],
35	"	''	O	"	dep	100	SENT_147	[p9l236t1723r343b1752],
36	'	''	O	'	_	0	SENT_147	[p9l236t1723r343b1752],
37	V	NN	O	v	dep	100	SENT_147	[p9l236t1723r343b1752],
38	°	NN	O	°	dep	100	SENT_147	[p9l236t1723r343b1752],
39	lVl	NN	O	lvl	dep	100	SENT_147	[p9l236t1723r343b1752],
40	"	''	O	"	dep	100	SENT_147	[p9l236t1723r343b1752],
41	g	NN	O	g	dep	100	SENT_147	[p9l236t1723r343b1752],
42	al33CaVl	NN	O	al33cavl	dep	100	SENT_147	[p9l352t1723r451b1745],
43	"	''	O	"	dep	100	SENT_147	[p9l352t1723r451b1745],
44	1	CD	NUMBER	1	dep	100	SENT_147	[p9l1412t1732r1421b1752],
45	Had	VBD	O	have	dep	100	SENT_147	[p9l1434t1730r1481b1752],
46	an	DT	O	a	dep	100	SENT_147	[p9l1491t1738r1518b1752],
47	adverse	JJ	O	adverse	dep	100	SENT_147	[p9l1528t1730r1619b1752],
48	event	NN	O	event	dep	100	SENT_147	[p9l1628t1734r1692b1752],
49	1	CD	NUMBER	1	dep	100	SENT_147	[p9l214t1758r224b1778],
50	Received	VBN	O	receive	dep	100	SENT_147	[p9l236t1756r338b1778],
51	highly	RB	O	highly	dep	100	SENT_147	[p9l349t1756r419b1785],
52	active	JJ	O	active	dep	100	SENT_147	[p9l428t1758r496b1778],
53	anti-	JJ	O	anti-	dep	100	SENT_147	[p9l505t1758r557b1778],
54	9	CD	NUMBER	9	dep	100	SENT_147	[p9l1410t1766r1422b1786],
55	were	VBD	O	be	dep	100	SENT_147	[p9l1431t1766r1492b1786],
56	not	RB	O	not	dep	100	SENT_147	[p9l1503t1768r1540b1786],
57	treated	VBN	O	treat	dep	100	SENT_147	[p9l1548t1764r1631b1786],
58	owing	VBG	O	owe	dep	100	SENT_147	[p9l1641t1766r1713b1793],
59	'	''	O	'	_	0	SENT_147	[p9l236t1790r341b1812],
60	et	FW	O	et	dep	100	SENT_147	[p9l236t1790r341b1812],
61	"	``	O	"	dep	100	SENT_147	[p9l236t1790r341b1812],
62	°	CD	NUMBER	°	dep	100	SENT_147	[p9l236t1790r341b1812],
63	Vl	JJ	O	vl	dep	100	SENT_147	[p9l236t1790r341b1812],
64	"	``	O	"	dep	100	SENT_147	[p9l236t1790r341b1812],
65	3l	NN	O	3l	dep	100	SENT_147	[p9l236t1790r341b1812],
66	l5he	NN	O	l5he	dep	100	SENT_147	[p9l351t1790r440b1819],
67	'	''	O	'	_	0	SENT_147	[p9l351t1790r440b1819],
68	3P	NN	O	3p	dep	100	SENT_147	[p9l351t1790r440b1819],
69	)	CD	NUMBER	)	dep	100	SENT_147	[p9l351t1790r440b1819],
70	’	NN	O	’	dep	100	SENT_147	[p9l351t1790r440b1819],
71	l	NN	O	l	dep	100	SENT_147	[p9l449t1790r557b1819],
72	”	CD	NUMBER	”	dep	100	SENT_147	[p9l449t1790r557b1819],
73	V	NN	O	v	dep	100	SENT_147	[p9l449t1790r557b1819],
74	°	NN	O	°	dep	100	SENT_147	[p9l449t1790r557b1819],
75	lVl	NN	O	lvl	dep	100	SENT_147	[p9l449t1790r557b1819],
76	“	CD	NUMBER	“	dep	100	SENT_147	[p9l449t1790r557b1819],
77	g	NN	O	g	dep	100	SENT_147	[p9l449t1790r557b1819],
78	to	TO	O	to	dep	100	SENT_147	[p9l1432t1801r1455b1819],
79	investigator	NN	O	investigator	dep	100	SENT_147	[p9l1466t1799r1625b1826],
80	's	POS	O	's	dep	100	SENT_147	[p9l1466t1799r1625b1826],
81	decision	NN	O	decision	dep	100	SENT_147	[p9l1634t1797r1732b1819],
82	abacavir	NN	O	abacavir	dep	100	SENT_147	[p9l236t1823r334b1845],
83	in	IN	O	in	dep	100	SENT_147	[p9l344t1825r362b1845],
84	error	NN	O	error	dep	100	SENT_147	[p9l373t1831r431b1845],
85	and	CC	O	and	dep	100	SENT_147	[p9l439t1823r481b1845],
86	was	VBD	O	be	dep	100	SENT_147	[p9l491t1831r536b1845],
87	5	CD	NUMBER	5	dep	100	SENT_147	[p9l1410t1832r1422b1852],
88	were	VBD	O	be	dep	100	SENT_147	[p9l1431t1832r1492b1852],
89	not	RB	O	not	dep	100	SENT_147	[p9l1503t1834r1540b1852],
90	treated	VBN	O	treat	dep	100	SENT_147	[p9l1548t1830r1631b1852],
91	for	IN	O	for	dep	100	SENT_147	[p9l1641t1830r1674b1852],
92	Pr	NN	O	pr	dep	100	SENT_147	[p9l236t1856r343b1885],
93	°	CD	NUMBER	°	dep	100	SENT_147	[p9l236t1856r343b1885],
94	mPtl	NN	O	mptl	dep	100	SENT_147	[p9l236t1856r343b1885],
95	)	CD	NUMBER	)	dep	100	SENT_147	[p9l236t1856r343b1885],
96	’	CD	NUMBER	’	dep	100	SENT_147	[p9l236t1856r343b1885],
97	Wltlldiaw	NNP	O	Wltlldiaw	dep	100	SENT_147	[p9l351t1856r475b1878],
98	”	CD	NUMBER	”	dep	100	SENT_147	[p9l351t1856r475b1878],
99	other	JJ	O	other	dep	100	SENT_147	[p9l1433t1864r1495b1886],
100	reasons	NNS	O	reason	_	0	SENT_147	[p9l1505t1871r1596b1886],

1	925	CD	NUMBER	925	nsubj	3	SENT_148	[p9l666t1967r706b1987],
2	Were	VBD	O	be	cop	3	SENT_148	[p9l716t1967r778b1987],
3	negative	JJ	O	negative	_	0	SENT_148	[p9l788t1967r886b1994],
4	for	IN	O	for	_	0	SENT_148	[p9l895t1965r928b1987],
5	HLA-B	NN	O	hla-b	prep_for	3	SENT_148	[p9l938t1966r1085b1987],
6	*	CD	NUMBER	*	num	5	SENT_148	[p9l938t1966r1085b1987],
7	5701	CD	NUMBER	5701	number	8	SENT_148	[p9l938t1966r1085b1987],
8	858	CD	NUMBER	858	dep	5	SENT_148	[p9l695t1999r737b2020],
9	Received	VBN	O	receive	partmod	5	SENT_148	[p9l748t1998r850b2020],
10	highly	RB	O	highly	advmod	11	SENT_148	[p9l862t1998r931b2027],
11	active	JJ	O	active	amod	13	SENT_148	[p9l940t2000r1008b2020],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_148	[p9l1017t2000r1069b2020, p9l755t2031r859b2053],
13	therapy	NN	O	therapy	dobj	9	SENT_148	[p9l869t2031r958b2060],
14	involving	VBG	O	involve	xcomp	9	SENT_148	[p9l968t2031r1075b2060],
15	abacavir	NN	O	abacavir	nsubj	19	SENT_148	[p9l754t2065r853b2087],
16	67	CD	NUMBER	67	num	15	SENT_148	[p9l710t2100r737b2120],
17	Did	VBD	O	do	aux	19	SENT_148	[p9l748t2098r787b2120],
18	not	RB	O	not	neg	19	SENT_148	[p9l798t2102r836b2120],
19	receive	VB	O	receive	ccomp	14	SENT_148	[p9l846t2100r927b2120],
20	treatment	NN	O	treatment	dobj	19	SENT_148	[p9l935t2102r1054b2120],
21	24	CD	NUMBER	24	num	20	SENT_148	[p9l724t2133r751b2153],
22	Withdrew	NNP	O	Withdrew	nn	23	SENT_148	[p9l760t2131r875b2154],
23	consent	NN	O	consent	nsubj	25	SENT_148	[p9l884t2136r978b2153],
24	18	CD	NUMBER	18	num	23	SENT_148	[p9l726t2166r751b2187],
25	Had	VBD	O	have	rcmod	20	SENT_148	[p9l763t2165r810b2187],
26	a	DT	O	a	det	27	SENT_148	[p9l821t2173r832b2187],
27	protocol	NN	O	protocol	dobj	25	SENT_148	[p9l843t2165r939b2194],
28	violation	NN	O	violation	nsubjpass	31	SENT_148	[p9l949t2165r1051b2187],
29	15	CD	NUMBER	15	num	28	SENT_148	[p9l726t2200r750b2220],
30	Were	VBD	O	be	auxpass	31	SENT_148	[p9l760t2200r821b2220],
31	lost	VBN	O	lose	rcmod	27	SENT_148	[p9l832t2198r874b2220],
32	to	TO	O	to	aux	33	SENT_148	[p9l881t2202r905b2220],
33	follow	VB	O	follow	xcomp	31	SENT_148	[p9l914t2198r1024b2227],
34	—	CD	NUMBER	—	number	36	SENT_148	[p9l914t2198r1024b2227],
35	up	IN	O	up	quantmod	36	SENT_148	[p9l914t2198r1024b2227],
36	3	CD	NUMBER	3	dobj	33	SENT_148	[p9l739t2233r750b2253],
37	Were	VBD	O	be	cop	39	SENT_148	[p9l760t2233r821b2254],
38	not	RB	O	not	neg	39	SENT_148	[p9l832t2236r870b2253],
39	compliant	JJ	O	compliant	rcmod	36	SENT_148	[p9l878t2231r999b2260],
40	3	CD	NUMBER	3	tmod	39	SENT_148	[p9l739t2267r750b2287],
41	Had	VBD	O	have	aux	48	SENT_148	[p9l763t2265r810b2287],
42	an	DT	O	a	det	44	SENT_148	[p9l821t2273r847b2287],
43	adverse	JJ	O	adverse	amod	44	SENT_148	[p9l858t2265r948b2287],
44	event	NN	O	event	nsubjpass	48	SENT_148	[p9l957t2269r1021b2287],
45	4	CD	NUMBER	4	num	44	SENT_148	[p9l738t2300r751b2320],
46	Were	VBD	O	be	auxpass	48	SENT_148	[p9l760t2300r821b2320],
47	not	RB	O	not	neg	48	SENT_148	[p9l832t2302r870b2320],
48	treated	VBN	O	treat	advcl	31	SENT_148	[p9l877t2298r960b2320],
49	for	IN	O	for	_	0	SENT_148	[p9l970t2298r1003b2320],
50	other	JJ	O	other	amod	51	SENT_148	[p9l1011t2298r1074b2320],
51	reasons	NNS	O	reason	prep_for	48	SENT_148	[p9l763t2339r854b2354],

1	803	CD	NUMBER	803	dep	132	SENT_149	[p9l679t2458r719b2478],
2	Could	MD	O	could	dep	132	SENT_149	[p9l730t2456r798b2478],
3	be	VB	O	be	dep	132	SENT_149	[p9l810t2456r836b2478],
4	evaluated	VBN	O	evaluate	dep	132	SENT_149	[p9l845t2456r957b2478],
5	for	IN	O	for	dep	132	SENT_149	[p9l967t2456r1000b2478],
6	clini	NNS	O	clinus	dep	132	SENT_149	[p9l1009t2456r1065b2478],
7	—	CD	NUMBER	—	dep	132	SENT_149	[p9l1009t2456r1065b2478],
8	847	CD	NUMBER	847	dep	132	SENT_149	[p9l1320t2458r1362b2478],
9	Could	MD	O	could	dep	132	SENT_149	[p9l1371t2456r1440b2478],
10	be	VB	O	be	dep	132	SENT_149	[p9l1451t2456r1477b2478],
11	evaluated	VBN	O	evaluate	dep	132	SENT_149	[p9l1487t2456r1599b2478],
12	for	IN	O	for	dep	132	SENT_149	[p9l1609t2456r1642b2478],
13	clinically	RB	O	clinically	dep	132	SENT_149	[p9l1650t2456r1707b2478, p9l728t2490r780b2519],
14	diagnosed	VBN	O	diagnose	dep	132	SENT_149	[p9l788t2490r911b2519],
15	hypersensi	NN	O	hypersensus	dep	132	SENT_149	[p9l922t2490r1057b2518],
16	-	:	O	-	_	0	SENT_149	[p9l922t2490r1057b2518],
17	cally	RB	O	cally	dep	132	SENT_149	[p9l1370t2490r1422b2518],
18	diagnosed	VBN	O	diagnose	dep	132	SENT_149	[p9l1430t2490r1552b2519],
19	hypersensitivity	NN	O	hypersensitivity	dep	132	SENT_149	[p9l1564t2490r1699b2518, p9l728t2525r784b2552],
20	reaction	NN	O	reaction	dep	132	SENT_149	[p9l794t2525r888b2545],
21	tivity	NN	O	tivity	dep	132	SENT_149	[p9l1369t2525r1426b2552],
22	reaction	NN	O	reaction	dep	132	SENT_149	[p9l1436t2525r1530b2545],
23	55	CD	NUMBER	55	dep	132	SENT_149	[p9l693t2558r719b2578],
24	Could	MD	O	could	dep	132	SENT_149	[p9l730t2556r798b2578],
25	not	RB	O	not	dep	132	SENT_149	[p9l810t2561r847b2578],
26	be	VB	O	be	dep	132	SENT_149	[p9l857t2556r883b2578],
27	evaluated	VBN	O	evaluate	dep	132	SENT_149	[p9l892t2556r1005b2578],
28	66	CD	NUMBER	66	dep	132	SENT_149	[p9l1335t2558r1362b2578],
29	Could	MD	O	could	dep	132	SENT_149	[p9l1371t2556r1440b2578],
30	not	RB	O	not	dep	132	SENT_149	[p9l1451t2561r1489b2578],
31	be	VB	O	be	dep	132	SENT_149	[p9l1499t2556r1525b2578],
32	evaluated	VBN	O	evaluate	dep	132	SENT_149	[p9l1534t2556r1647b2578],
33	6	CD	NUMBER	6	dep	132	SENT_149	[p9l737t2591r749b2612],
34	Withdrew	NN	O	withdrew	dep	132	SENT_149	[p9l758t2590r873b2612],
35	owing	VBG	O	owe	dep	132	SENT_149	[p9l882t2592r953b2619],
36	to	TO	O	to	dep	132	SENT_149	[p9l961t2594r984b2612],
37	an	DT	O	a	dep	132	SENT_149	[p9l994t2597r1020b2612],
38	15	CD	NUMBER	15	dep	132	SENT_149	[p9l1372t2592r1396b2612],
39	Withdrew	NN	O	withdrew	dep	132	SENT_149	[p9l1406t2590r1521b2612],
40	owing	VBG	O	owe	dep	132	SENT_149	[p9l1530t2592r1601b2619],
41	to	TO	O	to	dep	132	SENT_149	[p9l1609t2594r1632b2612],
42	an	DT	O	a	dep	132	SENT_149	[p9l1642t2597r1668b2612],
43	adverse	JJ	O	adverse	dep	132	SENT_149	[p9l759t2623r850b2645],
44	event	NN	O	event	dep	132	SENT_149	[p9l859t2627r923b2645],
45	other	JJ	O	other	dep	132	SENT_149	[p9l931t2623r994b2645],
46	than	IN	O	than	dep	132	SENT_149	[p9l1001t2623r1054b2645],
47	adverse	JJ	O	adverse	dep	132	SENT_149	[p9l1407t2623r1498b2645],
48	event	NN	O	event	dep	132	SENT_149	[p9l1507t2627r1571b2645],
49	other	JJ	O	other	dep	132	SENT_149	[p9l1579t2623r1642b2645],
50	than	IN	O	than	dep	132	SENT_149	[p9l1650t2623r1702b2645],
51	hypersensitivity	NN	O	hypersensitivity	dep	132	SENT_149	[p9l760t2656r944b2685],
52	reaction	NN	O	reaction	dep	132	SENT_149	[p9l954t2658r1048b2678],
53	hypersensitivity	NN	O	hypersensitivity	dep	132	SENT_149	[p9l1408t2656r1592b2685],
54	reaction	NN	O	reaction	dep	132	SENT_149	[p9l1602t2658r1696b2678],
55	5	CD	NUMBER	5	dep	132	SENT_149	[p9l737t2692r748b2712],
56	Were	VBD	O	be	dep	132	SENT_149	[p9l758t2692r819b2712],
57	lost	VBN	O	lose	dep	132	SENT_149	[p9l829t2690r871b2712],
58	to	TO	O	to	dep	132	SENT_149	[p9l879t2694r903b2712],
59	Follow-up	JJ	O	follow-up	dep	132	SENT_149	[p9l912t2689r1022b2718],
60	3	CD	NUMBER	3	dep	132	SENT_149	[p9l1385t2691r1396b2712],
61	Were	VBD	O	be	dep	132	SENT_149	[p9l1406t2692r1467b2712],
62	lost	VBN	O	lose	dep	132	SENT_149	[p9l1477t2690r1519b2712],
63	to	TO	O	to	dep	132	SENT_149	[p9l1527t2694r1551b2712],
64	Follow-up	JJ	O	follow-up	dep	132	SENT_149	[p9l1560t2689r1670b2718],
65	4	CD	NUMBER	4	dep	132	SENT_149	[p9l736t2725r749b2745],
66	Withdrew	VBD	O	withdraw	dep	132	SENT_149	[p9l758t2723r873b2745],
67	owing	VBG	O	owe	dep	132	SENT_149	[p9l882t2725r953b2752],
68	to	TO	O	to	dep	132	SENT_149	[p9l961t2727r984b2745],
69	a	DT	O	a	dep	132	SENT_149	[p9l994t2731r1005b2745],
70	5	CD	NUMBER	5	dep	132	SENT_149	[p9l1385t2725r1396b2745],
71	Withdrew	NN	O	withdrew	dep	132	SENT_149	[p9l1406t2723r1521b2745],
72	owing	VBG	O	owe	dep	132	SENT_149	[p9l1530t2725r1601b2752],
73	to	TO	O	to	dep	132	SENT_149	[p9l1609t2727r1632b2745],
74	a	DT	O	a	dep	132	SENT_149	[p9l1642t2731r1653b2745],
75	protocol	NN	O	protocol	dep	132	SENT_149	[p9l760t2756r857b2785],
76	violation	NN	O	violation	dep	132	SENT_149	[p9l867t2756r968b2778],
77	protocol	NN	O	protocol	dep	132	SENT_149	[p9l1408t2756r1505b2785],
78	violation	NN	O	violation	dep	132	SENT_149	[p9l1515t2756r1616b2778],
79	5	CD	NUMBER	5	dep	132	SENT_149	[p9l737t2792r748b2812],
80	Withdrew	NNP	O	Withdrew	dep	132	SENT_149	[p9l758t2790r873b2812],
81	for	IN	O	for	dep	132	SENT_149	[p9l881t2789r914b2812],
82	personal	JJ	O	personal	dep	132	SENT_149	[p9l924t2790r1024b2818],
83	5	CD	NUMBER	5	dep	132	SENT_149	[p9l1385t2792r1396b2812],
84	Withdrew	NN	O	withdrew	dep	132	SENT_149	[p9l1406t2790r1521b2812],
85	for	IN	O	for	dep	132	SENT_149	[p9l1529t2789r1562b2812],
86	personal	JJ	O	personal	dep	132	SENT_149	[p9l1572t2790r1672b2818],
87	reasons	NNS	O	reason	dep	132	SENT_149	[p9l760t2831r851b2845],
88	reasons	NNS	O	reason	dep	132	SENT_149	[p9l1408t2831r1499b2845],
89	3	CD	NUMBER	3	dep	132	SENT_149	[p9l737t2858r748b2878],
90	Withdrew	NN	O	withdrew	dep	132	SENT_149	[p9l758t2856r873b2879],
91	owing	VBG	O	owe	dep	132	SENT_149	[p9l882t2858r953b2885],
92	to	TO	O	to	dep	132	SENT_149	[p9l961t2861r984b2878],
93	2	CD	NUMBER	2	dep	132	SENT_149	[p9l1385t2858r1397b2878],
94	Withdrew	NN	O	withdrew	dep	132	SENT_149	[p9l1406t2856r1521b2879],
95	owing	VBG	O	owe	dep	132	SENT_149	[p9l1530t2858r1601b2885],
96	to	TO	O	to	dep	132	SENT_149	[p9l1609t2861r1632b2878],
97	noncompliance	JJ	O	noncompliance	dep	132	SENT_149	[p9l760t2890r944b2918],
98	noncompliance	NN	O	noncompliance	dep	132	SENT_149	[p9l1408t2890r1592b2918],
99	2	CD	NUMBER	2	dep	132	SENT_149	[p9l737t2925r749b2945],
100	Withdrew	NNP	O	Withdrew	dep	132	SENT_149	[p9l758t2923r873b2945],
101	for	IN	O	for	dep	132	SENT_149	[p9l881t2923r914b2945],
102	other	JJ	O	other	dep	132	SENT_149	[p9l923t2923r985b2945],
103	reasons	NNS	O	reason	dep	132	SENT_149	[p9l995t2931r1086b2945],
104	34	CD	NUMBER	34	dep	132	SENT_149	[p9l1371t2925r1397b2945],
105	Had	VBD	O	have	dep	132	SENT_149	[p9l1409t2923r1456b2945],
106	received	VBN	O	receive	dep	132	SENT_149	[p9l1467t2923r1563b2945],
107	abacavir	NN	O	abacavir	dep	132	SENT_149	[p9l1573t2923r1672b2945],
108	for	IN	O	for	dep	132	SENT_149	[p9l1680t2923r1713b2945],
109	27	CD	NUMBER	27	dep	132	SENT_149	[p9l722t2958r749b2978],
110	Had	VBD	O	have	dep	132	SENT_149	[p9l761t2956r807b2979],
111	received	VBN	O	receive	dep	132	SENT_149	[p9l819t2956r915b2979],
112	abacavir	NN	O	abacavir	dep	132	SENT_149	[p9l925t2956r1024b2979],
113	for	IN	O	for	dep	132	SENT_149	[p9l1032t2956r1065b2978],
114	<	JJR	O	<	dep	132	SENT_149	[p9l1399t2958r1441b2978],
115	41	CD	DURATION	41	dep	132	SENT_149	[p9l1399t2958r1441b2978],
116	days	NNS	NUMBER	day	dep	132	SENT_149	[p9l1452t2956r1504b2985],
117	<	JJR	O	<	dep	132	SENT_149	[p9l757t2992r800b3011],
118	41	CD	DURATION	41	dep	132	SENT_149	[p9l757t2992r800b3011],
119	days	NNS	NUMBER	day	dep	132	SENT_149	[p9l810t2990r862b3018],
120	2	CD	NUMBER	2	dep	132	SENT_149	[p9l1385t2992r1397b3011],
121	Missed	VBN	O	miss	dep	132	SENT_149	[p9l1409t2990r1492b3012],
122	the	DT	DATE	the	dep	132	SENT_149	[p9l1501t2990r1539b3012],
123	week	NN	DATE	week	dep	132	SENT_149	[p9l1547t2990r1606b3012],
124	6	CD	NUMBER	6	dep	132	SENT_149	[p9l1616t2992r1628b3012],
125	visit	NN	O	visit	dep	132	SENT_149	[p9l1637t2992r1685b3012],
126	3	CD	NUMBER	3	dep	132	SENT_149	[p9l737t3025r748b3045],
127	Missed	VBN	O	miss	dep	132	SENT_149	[p9l761t3023r844b3045],
128	the	DT	DATE	the	dep	132	SENT_149	[p9l853t3023r891b3045],
129	week	NN	DATE	week	dep	132	SENT_149	[p9l899t3023r958b3045],
130	6	CD	NUMBER	6	dep	132	SENT_149	[p9l968t3025r980b3045],
131	visit	NN	O	visit	dep	132	SENT_149	[p9l988t3025r1037b3045],
132	l	NN	O	l	_	0	SENT_149	[p9l874t3072r886b3122],

1	802	CD	NUMBER	802	nsubjpass	9	SENT_150	[p9l686t3154r727b3174],
2	Could	MD	O	could	aux	4	SENT_150	[p9l737t3152r805b3174],
3	be	VB	O	be	auxpass	4	SENT_150	[p9l817t3152r843b3174],
4	evaluated	VBN	O	evaluate	rcmod	1	SENT_150	[p9l852t3152r965b3174],
5	for	IN	O	for	_	0	SENT_150	[p9l974t3152r1008b3174],
6	842	CD	NUMBER	842	prep_for	4	SENT_150	[p9l1329t3152r1370b3173],
7	Could	MD	O	could	aux	9	SENT_150	[p9l1380t3150r1448b3173],
8	be	VB	O	be	auxpass	9	SENT_150	[p9l1460t3150r1486b3173],
9	evaluated	VBN	O	evaluate	_	0	SENT_150	[p9l1495t3150r1608b3173],
10	for	IN	O	for	mark	27	SENT_150	[p9l1617t3150r1651b3173],
11	immunologically	RB	O	immunologically	advmod	12	SENT_150	[p9l745t3186r944b3215],
12	confirmed	VBN	O	confirm	csubjpass	27	SENT_150	[p9l952t3185r1073b3208],
13	immunologically	RB	O	immunologically	advmod	12	SENT_150	[p9l1388t3184r1587b3213],
14	conﬁrmed	JJ	O	conﬁrmed	amod	17	SENT_150	[p9l1595t3184r1716b3206],
15	hypersensitivity	NN	O	hypersensitivity	nn	17	SENT_150	[p9l745t3219r930b3248],
16	reaction	NN	O	reaction	nn	17	SENT_150	[p9l940t3221r1033b3241],
17	hypersensitivity	NN	O	hypersensitivity	dobj	12	SENT_150	[p9l1388t3217r1573b3246],
18	reaction	NN	O	reaction	nsubj	20	SENT_150	[p9l1582t3219r1676b3239],
19	1	CD	NUMBER	1	num	18	SENT_150	[p9l717t3254r726b3274],
20	Refused	VBD	O	refuse	rcmod	17	SENT_150	[p9l739t3252r831b3274],
21	patch	NN	O	patch	nn	22	SENT_150	[p9l842t3252r905b3281],
22	testing	NN	O	testing	dobj	20	SENT_150	[p9l915t3254r997b3281],
23	5	CD	NUMBER	5	num	22	SENT_150	[p9l1358t3253r1369b3273],
24	Could	MD	O	could	aux	27	SENT_150	[p9l1380t3250r1448b3273],
25	not	RB	O	not	neg	27	SENT_150	[p9l1460t3255r1498b3273],
26	be	VB	O	be	auxpass	27	SENT_150	[p9l1507t3251r1534b3273],
27	evaluated	VBN	O	evaluate	advcl	9	SENT_150	[p9l1543t3251r1655b3273],
28	3	CD	NUMBER	3	dobj	27	SENT_150	[p9l1387t3286r1398b3306],
29	Refused	VBD	O	refuse	rcmod	28	SENT_150	[p9l1411t3284r1503b3306],
30	patch	NN	O	patch	nn	31	SENT_150	[p9l1515t3284r1577b3313],
31	testing	NN	O	testing	nsubj	40	SENT_150	[p9l1587t3286r1669b3313],
32	1	CD	NUMBER	1	nsubjpass	34	SENT_150	[p9l1389t3319r1398b3339],
33	Was	VBD	O	be	auxpass	34	SENT_150	[p9l1408t3319r1458b3339],
34	lost	VBN	O	lose	rcmod	31	SENT_150	[p9l1469t3317r1511b3339],
35	to	TO	O	to	_	0	SENT_150	[p9l1519t3321r1543b3339],
36	follow-up	NN	O	follow-up	prep_to	34	SENT_150	[p9l1551t3317r1662b3346],
37	1	CD	NUMBER	1	num	36	SENT_150	[p9l1389t3353r1398b3372],
38	Did	VBD	O	do	aux	40	SENT_150	[p9l1411t3351r1449b3373],
39	not	RB	O	not	neg	40	SENT_150	[p9l1461t3355r1499b3373],
40	attend	VB	O	attend	ccomp	29	SENT_150	[p9l1508t3351r1582b3373],
41	the	DT	O	the	det	43	SENT_150	[p9l1591t3351r1628b3373],
42	patchtest	JJS	O	patchtest	amod	43	SENT_150	[p9l1639t3351r1711b3379, p9l1407t3388r1451b3406],
43	visit	NN	O	visit	dobj	40	SENT_150	[p9l1459t3386r1508b3406],

1	Figure	NNP	O	Figure	_	0	SENT_151	[p9l123t3487r207b3519],
2	1	CD	NUMBER	1	dep	1	SENT_151	[p9l219t3488r241b3511],
3	.	.	O	.	_	0	SENT_151	[p9l219t3488r241b3511],

1	Enrollment	NN	O	enrollment	_	0	SENT_152	[p9l254t3486r414b3516],
2	,	,	O	,	_	0	SENT_152	[p9l254t3486r414b3516],
3	Randomization	NN	O	randomization	conj_and	1	SENT_152	[p9l427t3486r642b3516],
4	,	,	O	,	_	0	SENT_152	[p9l427t3486r642b3516],
5	and	CC	O	and	_	0	SENT_152	[p9l653t3486r702b3511],
6	Follow-up	JJ	MISC	follow-up	conj_and	1	SENT_152	[p9l716t3486r850b3519],
7	in	IN	O	in	_	0	SENT_152	[p9l862t3487r885b3511],
8	the	DT	O	the	det	9	SENT_152	[p9l896t3486r940b3511],
9	Study	NN	O	study	prep_in	6	SENT_152	[p9l950t3486r1035b3519],
10	.	.	O	.	_	0	SENT_152	[p9l950t3486r1035b3519],

1	All	DT	O	all	det	2	SENT_153	[p9l120t3536r154b3561],
2	patients	NNS	O	patient	nsubjpass	17	SENT_153	[p9l168t3539r278b3569],
3	who	WP	O	who	nsubj	4	SENT_153	[p9l289t3536r347b3561],
4	received	VBD	O	receive	rcmod	2	SENT_153	[p9l360t3536r471b3561],
5	abacavir	NN	O	abacavir	nsubjpass	7	SENT_153	[p9l484t3536r599b3561],
6	were	VBD	O	be	auxpass	7	SENT_153	[p9l608t3545r673b3561],
7	observed	VBN	O	observe	ccomp	4	SENT_153	[p9l684t3536r810b3561],
8	for	IN	O	for	_	0	SENT_153	[p9l822t3536r860b3561],
9	at	IN	DURATION	at	quantmod	11	SENT_153	[p9l871t3541r895b3561],
10	least	JJS	DURATION	least	mwe	9	SENT_153	[p9l908t3536r971b3561],
11	6	CD	DURATION	6	num	12	SENT_153	[p9l982t3538r996b3561],
12	weeks	NNS	NUMBER	week	prep_for	7	SENT_153	[p9l1007t3536r1091b3561],
13	after	IN	O	after	_	0	SENT_153	[p9l1103t3536r1167b3561],
14	the	DT	O	the	det	15	SENT_153	[p9l1176t3536r1219b3561],
15	therapy	NN	O	therapy	prep_after	7	SENT_153	[p9l1230t3536r1334b3569],
16	was	VBD	O	be	auxpass	17	SENT_153	[p9l1344t3545r1395b3561],
17	started	VBN	O	start	_	0	SENT_153	[p9l1408t3536r1513b3561],
18	.	.	O	.	_	0	SENT_153	[p9l1408t3536r1513b3561],

1	All	DT	O	all	det	2	SENT_154	[p9l1524t3536r1558b3561],
2	patients	NNS	O	patient	nsubjpass	10	SENT_154	[p9l1572t3539r1682b3569],
3	with	IN	O	with	_	0	SENT_154	[p9l120t3578r177b3603],
4	suspected	VBN	O	suspect	amod	6	SENT_154	[p9l191t3578r330b3611],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_154	[p9l344t3578r561b3611],
6	reaction	NN	O	reaction	prep_with	2	SENT_154	[p9l573t3580r683b3603],
7	to	TO	O	to	_	0	SENT_154	[p9l695t3583r722b3603],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_154	[p9l734t3578r848b3603],
9	were	VBD	O	be	auxpass	10	SENT_154	[p9l857t3587r922b3603],
10	scheduled	VBN	O	schedule	_	0	SENT_154	[p9l934t3578r1074b3603],
11	for	IN	O	for	_	0	SENT_154	[p9l1086t3577r1125b3603],
12	epicutaneous	JJ	O	epicutaneous	amod	14	SENT_154	[p9l1135t3580r1322b3611],
13	patch	NN	O	patch	nn	14	SENT_154	[p9l1335t3578r1408b3611],
14	testing	NN	O	testing	prep_for	10	SENT_154	[p9l1420t3580r1522b3611],
15	.	.	O	.	_	0	SENT_154	[p9l1420t3580r1522b3611],

1	N	NN	O	n	nn	3	SENT_155	[p10l567t54r581b69],
2	ENGLJ	NN	O	englj	nn	3	SENT_155	[p10l595t54r673b76],
3	MED	NN	O	med	_	0	SENT_155	[p10l688t54r740b69],
4	358	CD	NUMBER	358	num	6	SENT_155	[p10l750t48r813b76],
5	;	:	O	;	_	0	SENT_155	[p10l750t48r813b76],
6	6	CD	NUMBER	6	dep	3	SENT_155	[p10l750t48r813b76],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_155	[p10l847t54r1048b76],
8	FEBRUARY	NNP	DATE	FEBRUARY	dep	6	SENT_155	[p10l1085t54r1206b70],
9	7	CD	DATE	7	num	8	SENT_155	[p10l1216t54r1235b75],
10	,	,	DATE	,	_	0	SENT_155	[p10l1216t54r1235b75],
11	2008	CD	DATE	2008	num	8	SENT_155	[p10l1246t48r1309b70],
12	571	CD	NUMBER	571	dep	3	SENT_155	[p10l2011t44r2067b67],

1	The	DT	O	the	det	4	SENT_156	[p10l753t87r804b111],
2	New	NNP	O	New	nn	4	SENT_156	[p10l813t88r875b111],
3	England	NNP	O	England	nn	4	SENT_156	[p10l884t87r995b118],
4	Journal	NNP	O	Journal	_	0	SENT_156	[p10l1003t87r1101b111],
5	of	IN	O	of	_	0	SENT_156	[p10l1110t87r1139b111],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_156	[p10l1146t87r1271b111],

1	The	DT	O	the	det	4	SENT_157	[p10l672t275r717b296],
2	NEW	NNP	O	NEW	nn	4	SENT_157	[p10l736t277r821b296],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_157	[p10l840t277r1029b296],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_157	[p10l1048t277r1228b303],
5	of	IN	O	of	_	0	SENT_157	[p10l1247t275r1276b302],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_157	[p10l1288t277r1487b296],

1	returned	VBN	O	return	_	0	SENT_158	[p10l12t499r385b579],
2	to	TO	O	to	_	0	SENT_158	[p10l435t516r516b578],
3	the	DT	O	the	det	4	SENT_158	[p10l568t499r701b577],
4	site	NN	O	site	prep_to	1	SENT_158	[p10l752t500r895b577],
5	as	RB	O	as	advmod	6	SENT_158	[p10l944t525r1030b577],
6	soon	RB	O	soon	advmod	4	SENT_158	[p10l1083t525r1289b578],
7	as	IN	O	as	_	0	SENT_158	[p10l1336t525r1423b577],
8	possible	JJ	O	possible	prep_as	6	SENT_158	[p10l1472t499r1826b599],
9	for	IN	O	for	_	0	SENT_158	[p10l1875t498r1999b578],
10	an	DT	O	a	det	11	SENT_158	[p10l2044t525r2148b577],
11	assessment	NN	O	assessment	prep_for	1	SENT_158	[p10l11t644r506b705],
12	of	IN	O	of	_	0	SENT_158	[p10l541t626r641b706],
13	the	DT	O	the	det	15	SENT_158	[p10l663t627r797b705],
14	hypersensitivity	NN	O	hypersensitivity	nn	15	SENT_158	[p10l836t627r1522b727],
15	reaction	NN	O	reaction	prep_of	11	SENT_158	[p10l1557t628r1922b706],
16	.	.	O	.	_	0	SENT_158	[p10l1557t628r1922b706],

1	All	DT	O	all	det	2	SENT_159	[p10l138t756r262b834],
2	patients	NNS	O	patient	nsubj	60	SENT_159	[p10l296t757r632b857],
3	with	IN	O	with	_	0	SENT_159	[p10l666t756r859b836],
4	a	DT	O	a	det	6	SENT_159	[p10l895t782r939b835],
5	clinical	JJ	O	clinical	amod	6	SENT_159	[p10l974t756r1282b835],
6	diagnosis	NN	O	diagnosis	prep_with	2	SENT_159	[p10l1318t756r1723b858],
7	of	IN	O	of	_	0	SENT_159	[p10l1762t755r1862b836],
8	hypersensitivity	NN	O	hypersensitivity	prep_of	6	SENT_159	[p10l1879t756r2147b857, p10l13t886r439b985],
9	to	TO	O	to	_	0	SENT_159	[p10l494t902r576b964],
10	abacavir	NN	O	abacavir	prep_to	8	SENT_159	[p10l638t885r996b964],
11	underwent	VBD	O	undergo	_	0	SENT_159	[p10l1053t885r1521b965],
12	epicutaneous	JJ	O	epicutaneous	amod	14	SENT_159	[p10l1578t886r2145b985],
13	patch	NN	O	patch	nn	14	SENT_159	[p10l11t1014r248b1115],
14	testing	NN	O	testing	dobj	11	SENT_159	[p10l281t1015r581b1116],
15	6	CD	DURATION	6	number	17	SENT_159	[p10l612t1020r659b1094],
16	to	TO	DURATION	to	dep	17	SENT_159	[p10l693t1031r774b1094],
17	10	CD	DURATION	10	num	18	SENT_159	[p10l813t1020r907b1094],
18	weeks	NNS	NUMBER	week	tmod	14	SENT_159	[p10l936t1014r1199b1094],
19	after	IN	O	after	_	0	SENT_159	[p10l1233t1013r1437b1093],
20	the	DT	O	the	det	21	SENT_159	[p10l1467t1014r1601b1093],
21	onset	NN	O	onset	prep_after	11	SENT_159	[p10l1635t1031r1870b1094],
22	of	IN	O	of	_	0	SENT_159	[p10l1898t1013r1999b1094],
23	the	DT	O	the	det	24	SENT_159	[p10l2014t1014r2148b1093],
24	reaction	NN	O	reaction	prep_of	21	SENT_159	[p10l12t1144r368b1240],
25	,	,	O	,	_	0	SENT_159	[p10l12t1144r368b1240],
26	according	VBG	O	accord	_	0	SENT_159	[p10l408t1143r821b1245],
27	to	TO	O	to	prepc_according_to	11	SENT_159	[p10l852t1160r933b1223],
28	a	DT	O	a	det	29	SENT_159	[p10l968t1170r1012b1222],
29	modification	NN	O	modification	pobj	11	SENT_159	[p10l1045t1142r1587b1223],
30	of	IN	O	of	_	0	SENT_159	[p10l1622t1142r1721b1223],
31	the	DT	O	the	det	32	SENT_159	[p10l1737t1143r1866b1222],
32	method	NN	O	method	prep_of	29	SENT_159	[p10l1901t1143r2147b1222, p10l12t1271r116b1350],
33	of	IN	O	of	_	0	SENT_159	[p10l168t1270r269b1350],
34	Phillips	NNP	PERSON	Phillips	prep_of	32	SENT_159	[p10l304t1271r632b1371],
35	et	FW	O	et	nn	36	SENT_159	[p10l690t1288r768b1349],
36	al.	FW	O	al.	dep	34	SENT_159	[p10l818t1271r1087b1350],
37	11	CD	NUMBER	11	number	38	SENT_159	[p10l818t1271r1087b1350],
38	»	CD	NUMBER	»	num	39	SENT_159	[p10l818t1271r1087b1350],
39	16	CD	NUMBER	16	dep	36	SENT_159	[p10l818t1271r1087b1350],
40	The	DT	O	the	det	43	SENT_159	[p10l1140t1271r1303b1349],
41	first	JJ	ORDINAL	first	amod	43	SENT_159	[p10l1358t1270r1544b1349],
42	100	CD	NUMBER	100	num	43	SENT_159	[p10l1598t1277r1747b1350],
43	patients	NNS	O	patient	dep	36	SENT_159	[p10l1802t1272r2145b1371],
44	who	WP	O	who	nsubj	46	SENT_159	[p10l7t1400r192b1479],
45	could	MD	O	could	aux	46	SENT_159	[p10l235t1400r472b1479],
46	tolerate	VB	O	tolerate	dep	11	SENT_159	[p10l514t1400r837b1479],
47	abacavir	NN	O	abacavir	dobj	46	SENT_159	[p10l878t1400r1237b1479],
48	and	CC	O	and	_	0	SENT_159	[p10l1275t1400r1434b1479],
49	who	WP	O	who	nsubj	50	SENT_159	[p10l1472t1400r1656b1479],
50	completed	VBD	O	complete	conj_and	46	SENT_159	[p10l1700t1400r2148b1500],
51	the	DT	O	the	det	52	SENT_159	[p10l12t1529r146b1607],
52	study	NN	O	study	nsubj	53	SENT_159	[p10l185t1529r416b1629],
53	continued	VBD	O	continue	ccomp	50	SENT_159	[p10l450t1529r882b1608],
54	to	TO	O	to	aux	55	SENT_159	[p10l919t1546r1001b1608],
55	receive	VB	O	receive	xcomp	53	SENT_159	[p10l1040t1530r1330b1608],
56	abacavir	NN	O	abacavir	dobj	55	SENT_159	[p10l1367t1529r1726b1608],
57	and	CC	O	and	_	0	SENT_159	[p10l1759t1529r1918b1608],
58	then	RB	O	then	advmod	11	SENT_159	[p10l1956t1529r2148b1607],
59	also	RB	O	also	advmod	60	SENT_159	[p10l11t1658r174b1737],
60	underwent	VBD	O	undergo	conj_and	11	SENT_159	[p10l207t1658r649b1737],
61	epicutaneous	JJ	O	epicutaneous	amod	63	SENT_159	[p10l677t1659r1208b1758],
62	patch	NN	O	patch	nn	63	SENT_159	[p10l1241t1658r1465b1758],
63	testing	NN	O	testing	dobj	60	SENT_159	[p10l1497t1659r1778b1759],
64	between	IN	O	between	_	0	SENT_159	[p10l1807t1658r2148b1737],
65	weeks	NNS	DURATION	week	prep_between	63	SENT_159	[p10l7t1787r270b1866],
66	6	CD	NUMBER	6	num	65	SENT_159	[p10l312t1793r359b1866],
67	and	CC	O	and	_	0	SENT_159	[p10l400t1787r559b1866],
68	10	CD	NUMBER	10	prep_between	63	SENT_159	[p10l601t1793r717b1866],
69	.	.	O	.	_	0	SENT_159	[p10l601t1793r717b1866],

1	The	DT	O	the	det	2	SENT_160	[p10l138t1915r301b1994],
2	results	NNS	O	result	nsubjpass	7	SENT_160	[p10l334t1915r619b1995],
3	of	IN	O	of	_	0	SENT_160	[p10l656t1914r756b1995],
4	patch	NN	O	patch	nn	5	SENT_160	[p10l770t1915r1007b2016],
5	testing	NN	O	testing	prep_of	2	SENT_160	[p10l1041t1916r1341b2017],
6	were	VBD	O	be	auxpass	7	SENT_160	[p10l1366t1941r1570b1995],
7	scored	VBN	O	score	_	0	SENT_160	[p10l1605t1915r1884b1995],
8	by	IN	O	by	_	0	SENT_160	[p10l1918t1915r2016b2016],
9	an	DT	O	a	det	17	SENT_160	[p10l2044t1941r2148b1994],
10	expert	NN	O	expert	nn	17	SENT_160	[p10l12t2061r306b2144],
11	,	,	O	,	_	0	SENT_160	[p10l12t2061r306b2144],
12	independent	JJ	O	independent	amod	17	SENT_160	[p10l346t2044r908b2144],
13	,	,	O	,	_	0	SENT_160	[p10l346t2044r908b2144],
14	clinical	JJ	O	clinical	amod	17	SENT_160	[p10l951t2044r1748b2123],
15	—	NN	O	—	nn	17	SENT_160	[p10l951t2044r1748b2123],
16	evaluation	NN	O	evaluation	nn	17	SENT_160	[p10l951t2044r1748b2123],
17	committee	NN	O	committee	agent	7	SENT_160	[p10l1784t2045r2147b2123, p10l12t2190r134b2252],
18	on	IN	O	on	_	0	SENT_160	[p10l172t2199r279b2253],
19	the	DT	O	the	det	20	SENT_160	[p10l316t2173r450b2252],
20	basis	NN	O	basis	prep_on	17	SENT_160	[p10l487t2173r700b2253],
21	of	IN	O	of	_	0	SENT_160	[p10l740t2172r841b2253],
22	digital	JJ	O	digital	amod	23	SENT_160	[p10l860t2173r1139b2275],
23	photographs	NNS	O	photograph	prep_of	20	SENT_160	[p10l1174t2173r1725b2275],
24	taken	VBN	O	take	partmod	23	SENT_160	[p10l1765t2173r2004b2253],
25	on	IN	O	on	_	0	SENT_160	[p10l2041t2199r2148b2253],
26	site	NN	O	site	prep_on	24	SENT_160	[p10l13t2302r157b2379],
27	with	IN	O	with	_	0	SENT_160	[p10l194t2301r391b2381],
28	cameras	NNS	O	camera	prep_with	24	SENT_160	[p10l433t2327r789b2379],
29	provided	VBN	O	provide	partmod	28	SENT_160	[p10l831t2301r1208b2401],
30	for	IN	O	for	_	0	SENT_160	[p10l1249t2300r1374b2380],
31	use	NN	O	use	prep_for	29	SENT_160	[p10l1412t2327r1553b2380],
32	in	IN	O	in	_	0	SENT_160	[p10l1595t2302r1678b2379],
33	the	DT	O	the	det	34	SENT_160	[p10l1721t2301r1854b2379],
34	study	NN	O	study	prep_in	31	SENT_160	[p10l1897t2301r2142b2401],
35	,	,	O	,	_	0	SENT_160	[p10l1897t2301r2142b2401],
36	as	RB	O	as	_	0	SENT_160	[p10l11t2455r96b2507],
37	well	RB	O	well	_	0	SENT_160	[p10l129t2429r304b2509],
38	as	IN	O	as	_	0	SENT_160	[p10l338t2455r423b2507],
39	other	JJ	O	other	amod	40	SENT_160	[p10l460t2429r686b2508],
40	patch	NN	O	patch	prep_for	29	SENT_160	[p10l716t2429r1135b2529],
41	—	CD	NUMBER	—	num	43	SENT_160	[p10l716t2429r1135b2529],
42	test	NN	O	test	nn	43	SENT_160	[p10l716t2429r1135b2529],
43	information	NN	O	information	dep	40	SENT_160	[p10l1165t2428r1703b2508],
44	.	.	O	.	_	0	SENT_160	[p10l1165t2428r1703b2508],

1	The	DT	O	the	det	2	SENT_161	[p10l1740t2429r1900b2507],
2	committee	NN	O	committee	nsubj	4	SENT_161	[p10l1936t2455r2147b2508, p10l12t2558r281b2635],
3	was	VBD	O	be	cop	4	SENT_161	[p10l325t2583r489b2637],
4	unaware	JJ	O	unaware	_	0	SENT_161	[p10l540t2583r908b2637],
5	of	IN	O	of	_	0	SENT_161	[p10l958t2556r1059b2636],
6	the	DT	O	the	det	8	SENT_161	[p10l1091t2557r1224b2635],
7	clinical	JJ	O	clinical	amod	8	SENT_161	[p10l1274t2557r1590b2635],
8	history	NN	O	history	prep_of	4	SENT_161	[p10l1639t2557r1945b2657],
9	and	CC	O	and	_	0	SENT_161	[p10l1989t2557r2148b2636],
10	HLA	NN	O	hlum	prep_of	4	SENT_161	[p10l11t2685r542b2764],
11	.	.	O	.	_	0	SENT_161	[p10l11t2685r542b2764],

1	—	NN	O	—	_	0	SENT_162	[p10l11t2685r542b2764],
2	.	.	O	.	_	0	SENT_162	[p10l11t2685r542b2764],

1	B	NN	O	b	_	0	SENT_163	[p10l11t2685r542b2764],
2	*	CD	NUMBER	*	number	3	SENT_163	[p10l11t2685r542b2764],
3	5701	CD	NUMBER	5701	num	4	SENT_163	[p10l11t2685r542b2764],
4	status	NN	O	status	dep	1	SENT_163	[p10l582t2702r829b2765],
5	of	IN	O	of	_	0	SENT_163	[p10l869t2684r969b2764],
6	all	DT	O	all	det	7	SENT_163	[p10l987t2685r1090b2763],
7	patients	NNS	O	patient	prep_of	4	SENT_163	[p10l1125t2686r1485b2785],
8	.	.	O	.	_	0	SENT_163	[p10l1125t2686r1485b2785],

1	Both	CC	O	both	preconj	3	SENT_164	[p10l1526t2685r1729b2764],
2	the	DT	O	the	det	3	SENT_164	[p10l1766t2685r1898b2763],
3	committee	NN	O	committee	nsubj	24	SENT_164	[p10l1936t2711r2147b2764, p10l12t2815r281b2893],
4	and	CC	O	and	_	0	SENT_164	[p10l324t2814r481b2894],
5	the	DT	O	the	det	6	SENT_164	[p10l525t2814r656b2893],
6	investigators	NNS	O	investigator	conj_and	3	SENT_164	[p10l699t2815r1238b2916],
7	performing	VBG	O	perform	partmod	3	SENT_164	[p10l1282t2813r1777b2916],
8	the	DT	O	the	det	11	SENT_164	[p10l1817t2814r1949b2893],
9	epicutaneous	JJ	O	epicutaneous	amod	11	SENT_164	[p10l1993t2815r2147b2915, p10l12t2960r442b3023],
10	patch	NN	O	patch	nn	11	SENT_164	[p10l485t2943r717b3044],
11	testing	NN	O	testing	dobj	7	SENT_164	[p10l760t2944r1053b3045],
12	were	VBD	O	be	cop	24	SENT_164	[p10l1087t2969r1287b3023],
13	unaware	JJ	O	unaware	amod	24	SENT_164	[p10l1329t2969r1691b3023],
14	of	IN	O	of	_	0	SENT_164	[p10l1733t2942r1833b3023],
15	the	DT	O	the	det	16	SENT_164	[p10l1857t2943r1988b3022],
16	order	NN	O	order	prep_of	13	SENT_164	[p10l2031t2969r2147b3023, p10l12t3071r151b3150],
17	of	IN	O	of	_	0	SENT_164	[p10l205t3070r307b3150],
18	application	NN	O	application	prep_of	16	SENT_164	[p10l343t3071r837b3171],
19	of	IN	O	of	_	0	SENT_164	[p10l893t3070r994b3150],
20	the	DT	O	the	det	22	SENT_164	[p10l1032t3071r1168b3149],
21	test	NN	O	test	nn	22	SENT_164	[p10l1224t3088r1741b3150],
22	—	NN	O	—	prep_of	18	SENT_164	[p10l1224t3088r1741b3150],
23	contact	NN	O	contact	nn	24	SENT_164	[p10l1224t3088r1741b3150],
24	samples	NNS	O	sample	_	0	SENT_164	[p10l1793t3071r2146b3171],
25	within	IN	O	within	_	0	SENT_164	[p10l7t3200r300b3279],
26	the	DT	O	the	det	27	SENT_164	[p10l342t3200r476b3278],
27	patches	NNS	O	patch	prep_within	24	SENT_164	[p10l514t3200r865b3300],
28	.	.	O	.	_	0	SENT_164	[p10l514t3200r865b3300],

1	sruov	NN	O	sruov	nsubj	11	SENT_165	[p10l12t3476r270b3526],
2	oapacnve	NN	O	oapacnve	nn	5	SENT_165	[p10l303t3476r721b3547],
3	AND	CC	O	and	_	0	SENT_165	[p10l753t3477r924b3525],
4	END	NN	O	end	conj_and	2	SENT_165	[p10l963t3477r1123b3525],
5	pomrs	NNS	O	pomr	dep	1	SENT_165	[p10l1163t3476r1456b3526],
6	The	DT	O	the	det	7	SENT_165	[p10l8t3575r171b3653],
7	objective	NN	O	objective	dep	1	SENT_165	[p10l203t3575r579b3675],
8	of	IN	O	of	_	0	SENT_165	[p10l612t3574r712b3654],
9	the	DT	O	the	det	10	SENT_165	[p10l726t3575r860b3653],
10	study	NN	O	study	prep_of	7	SENT_165	[p10l894t3575r1125b3675],
11	was	VBD	O	be	_	0	SENT_165	[p10l1148t3601r1312b3655],
12	to	TO	O	to	aux	13	SENT_165	[p10l1346t3592r1428b3654],
13	test	VB	O	test	xcomp	11	SENT_165	[p10l1462t3592r1617b3653],
14	the	DT	O	the	det	15	SENT_165	[p10l1644t3575r1778b3653],
15	hypothesis	NN	O	hypothesis	dobj	13	SENT_165	[p10l1810t3575r2147b3675, p10l12t3705r168b3782],
16	that	IN	O	that	_	0	SENT_165	[p10l207t3704r381b3782],
17	prospective	JJ	O	prospective	amod	19	SENT_165	[p10l411t3705r903b3804],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	19	SENT_165	[p10l939t3704r1693b3805],
19	screening	NN	O	screening	prep_that	15	SENT_165	[p10l1731t3705r2151b3805],
20	for	IN	O	for	_	0	SENT_165	[p11l12t19r136b99],
21	HLA	NN	O	hlum	prep_for	19	SENT_165	[p11l180t20r721b99],
22	.	.	O	.	_	0	SENT_165	[p11l180t20r721b99],

1	—	NN	O	—	_	0	SENT_166	[p11l180t20r721b99],
2	.	.	O	.	_	0	SENT_166	[p11l180t20r721b99],

1	B	NN	O	b	nsubj	16	SENT_167	[p11l180t20r721b99],
2	*	CD	NUMBER	*	number	3	SENT_167	[p11l180t20r721b99],
3	5701	CD	DATE	5701	dep	1	SENT_167	[p11l180t20r721b99],
4	and	CC	O	and	_	0	SENT_167	[p11l768t20r927b99],
5	the	DT	O	the	det	6	SENT_167	[p11l974t20r1108b98],
6	exclusion	NN	O	exclusion	nsubj	16	SENT_167	[p11l1157t20r1557b100],
7	of	IN	O	of	_	0	SENT_167	[p11l1605t19r1706b99],
8	those	DT	O	those	det	9	SENT_167	[p11l1735t20r1969b99],
9	patients	NNS	O	patient	prep_of	6	SENT_167	[p11l2014t46r2147b120, p11l12t150r250b228],
10	carrying	VBG	O	carry	partmod	9	SENT_167	[p11l284t150r650b251],
11	the	DT	O	the	det	12	SENT_167	[p11l678t149r812b228],
12	allele	NN	O	allele	dobj	10	SENT_167	[p11l842t149r1067b228],
13	from	IN	O	from	_	0	SENT_167	[p11l1097t148r1309b229],
14	abacavir	NN	O	abacavir	nn	15	SENT_167	[p11l1340t149r1699b229],
15	treatment	NN	O	treatment	prep_from	10	SENT_167	[p11l1726t166r2153b228],
16	reduces	VBZ	O	reduce	_	0	SENT_167	[p11l12t277r337b356],
17	the	DT	O	the	det	18	SENT_167	[p11l370t277r503b355],
18	incidence	NN	O	incidence	dobj	16	SENT_167	[p11l534t277r942b356],
19	of	IN	O	of	_	0	SENT_167	[p11l973t276r1074b356],
20	hypersensitivity	NN	O	hypersensitivity	nn	21	SENT_167	[p11l1086t277r1771b377],
21	reaction	NN	O	reaction	prep_of	18	SENT_167	[p11l1797t278r2148b356],
22	to	TO	O	to	_	0	SENT_167	[p11l12t423r94b485],
23	abacavir	NN	O	abacavir	prep_to	21	SENT_167	[p11l156t406r515b485],
24	as	IN	O	as	_	0	SENT_167	[p11l573t432r659b484],
25	compared	VBN	O	compare	prepc_as	16	SENT_167	[p11l723t406r1151b506],
26	with	IN	O	with	pcomp	25	SENT_167	[p11l1208t406r1404b485],
27	that	DT	O	that	pobj	26	SENT_167	[p11l1466t406r1640b484],
28	in	IN	O	in	_	0	SENT_167	[p11l1696t407r1779b484],
29	an	DT	O	a	det	31	SENT_167	[p11l1840t432r1943b484],
30	unscreened	JJ	O	unscreened	amod	31	SENT_167	[p11l2005t432r2147b485, p11l13t535r381b614],
31	population	NN	O	population	prep_in	27	SENT_167	[p11l407t535r894b635],
32	.	.	O	.	_	0	SENT_167	[p11l407t535r894b635],

1	The	DT	O	the	det	4	SENT_168	[p11l923t535r1083b613],
2	primary	JJ	O	primary	amod	4	SENT_168	[p11l1110t536r1456b635],
3	end	NN	O	end	nn	4	SENT_168	[p11l1479t535r1631b614],
4	points	NNS	O	point	nsubj	7	SENT_168	[p11l1657t536r1923b635],
5	were	VBD	O	be	cop	7	SENT_168	[p11l1948t561r2148b615],
6	the	DT	O	the	det	7	SENT_168	[p11l12t664r146b743],
7	rate	NN	O	rate	_	0	SENT_168	[p11l194t681r355b743],
8	of	IN	O	of	_	0	SENT_168	[p11l404t663r504b744],
9	clinically	RB	O	clinically	amod	21	SENT_168	[p11l534t664r928b765],
10	diagnosed	VBN	O	diagnose	dep	9	SENT_168	[p11l972t664r1419b766],
11	hypersensitivity	NN	O	hypersensitivity	nn	12	SENT_168	[p11l1466t664r2152b765],
12	reaction	NN	O	reaction	dobj	10	SENT_168	[p11l12t794r363b872],
13	to	TO	O	to	_	0	SENT_168	[p11l406t810r488b872],
14	abacavir	NN	O	abacavir	prep_to	10	SENT_168	[p11l531t793r890b872],
15	during	IN	O	during	_	0	SENT_168	[p11l930t793r1221b894],
16	the	DT	O	the	det	20	SENT_168	[p11l1261t793r1395b872],
17	6-week	JJ	DURATION	6-week	amod	20	SENT_168	[p11l1439t793r1747b872],
18	observa	NN	O	observa	nn	20	SENT_168	[p11l1787t793r2147b872],
19	—	CD	NUMBER	—	num	20	SENT_168	[p11l1787t793r2147b872],
20	tion	NN	O	tion	prep_during	10	SENT_168	[p11l12t922r183b1001],
21	period	NN	O	period	prep_of	7	SENT_168	[p11l214t921r494b1022],
22	and	CC	O	and	_	0	SENT_168	[p11l525t921r684b1001],
23	the	DT	O	the	det	24	SENT_168	[p11l717t921r851b1000],
24	rate	NN	O	rate	conj_and	21	SENT_168	[p11l883t938r1044b1000],
25	of	IN	O	of	prep	24	SENT_168	[p11l1078t920r1178b1001],
26	immunologically	RB	O	immunologically	pcomp	25	SENT_168	[p11l1191t921r1934b1023],
27	confirmed	VBN	O	confirm	partmod	24	SENT_168	[p11l1963t947r2147b1001, p11l12t1048r298b1128],
28	hypersensitivity	NN	O	hypersensitivity	nn	29	SENT_168	[p11l328t1049r981b1149],
29	reaction	NN	O	reaction	dobj	27	SENT_168	[p11l1007t1050r1343b1128],
30	(	RB	O	(	advmod	31	SENT_168	[p11l1378t1048r1717b1140],
31	defined	VBN	O	define	partmod	29	SENT_168	[p11l1378t1048r1717b1140],
32	as	IN	O	as	_	0	SENT_168	[p11l1746t1075r1830b1127],
33	a	DT	O	a	det	36	SENT_168	[p11l1862t1075r1907b1127],
34	clinically	RB	O	clinically	advmod	35	SENT_168	[p11l1936t1049r2147b1127, p11l12t1178r203b1279],
35	diagnosed	VBN	O	diagnose	amod	36	SENT_168	[p11l229t1178r676b1280],
36	reaction	NN	O	reaction	prep_as	31	SENT_168	[p11l708t1179r1059b1258],
37	that	WDT	O	that	nsubjpass	39	SENT_168	[p11l1092t1178r1266b1257],
38	was	VBD	O	be	auxpass	39	SENT_168	[p11l1289t1204r1453b1258],
39	confirmed	VBN	O	confirm	rcmod	36	SENT_168	[p11l1489t1177r1945b1258],
40	by	IN	O	by	_	0	SENT_168	[p11l1979t1178r2077b1279],
41	a	DT	O	a	det	43	SENT_168	[p11l2105t1204r2149b1257],
42	positive	JJ	O	positive	amod	43	SENT_168	[p11l11t1308r343b1407],
43	result	NN	O	result	agent	39	SENT_168	[p11l375t1307r620b1386],
44	on	IN	O	on	_	0	SENT_168	[p11l647t1333r754b1386],
45	epicutaneous	JJ	O	epicutaneous	amod	47	SENT_168	[p11l786t1308r1355b1407],
46	patch	NN	O	patch	nn	47	SENT_168	[p11l1387t1307r1624b1407],
47	testing	NN	O	testing	prep_on	43	SENT_168	[p11l1656t1308r1956b1408],
48	6	CD	DURATION	6	number	50	SENT_168	[p11l1984t1313r2031b1386],
49	to	TO	DURATION	to	dep	50	SENT_168	[p11l2064t1324r2146b1386],
50	10	CD	DURATION	10	num	51	SENT_168	[p11l15t1441r109b1515],
51	weeks	NNS	NUMBER	week	npadvmod	39	SENT_168	[p11l140t1435r403b1515],
52	after	IN	O	after	_	0	SENT_168	[p11l439t1434r643b1514],
53	clinical	JJ	O	clinical	amod	55	SENT_168	[p11l675t1435r991b1514],
54	diagnosis	NN	O	diagnosis	nn	55	SENT_168	[p11l1026t1435r1491b1537],
55	)	NN	O	)	prep_after	39	SENT_168	[p11l1026t1435r1491b1537],
56	.	.	O	.	_	0	SENT_168	[p11l1026t1435r1491b1537],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_169	[p11l12t1712r504b1763],
2	ANALYSIS	NN	O	analysis	nsubjpass	14	SENT_169	[p11l535t1712r913b1763],
3	The	DT	O	the	det	5	SENT_169	[p11l8t1812r171b1891],
4	statistical	JJ	O	statistical	amod	5	SENT_169	[p11l207t1812r625b1891],
5	design	NN	O	design	dep	2	SENT_169	[p11l660t1812r943b1914],
6	and	CC	O	and	_	0	SENT_169	[p11l978t1812r1136b1892],
7	power	NN	O	power	nn	8	SENT_169	[p11l1169t1838r1438b1913],
8	calculations	NNS	O	calculation	nsubjpass	14	SENT_169	[p11l1470t1812r1990b1892],
9	for	IN	O	for	_	0	SENT_169	[p11l2027t1811r2151b1892],
10	the	DT	O	the	det	11	SENT_169	[p11l12t1940r146b2018],
11	study	NN	O	study	prep_for	8	SENT_169	[p11l179t1940r411b2040],
12	have	VBP	O	have	aux	14	SENT_169	[p11l437t1940r628b2020],
13	been	VBN	O	be	auxpass	14	SENT_169	[p11l660t1940r863b2019],
14	published	VBN	O	publish	_	0	SENT_169	[p11l892t1940r1317b2040],
15	previously	RB	DATE	previously	advmod	14	SENT_169	[p11l1347t1940r1883b2040],
16	.	.	O	.	_	0	SENT_169	[p11l1347t1940r1883b2040],

1	”	NN	O	”	ccomp	5	SENT_170	[p11l1347t1940r1883b2040],
2	Briefly	RB	O	briefly	advmod	1	SENT_170	[p11l1913t1939r2147b2018, p11l11t2069r94b2169],
3	,	,	O	,	_	0	SENT_170	[p11l1913t1939r2147b2018, p11l11t2069r94b2169],
4	we	PRP	O	we	nsubj	5	SENT_170	[p11l122t2095r239b2149],
5	calculated	VBD	O	calculate	_	0	SENT_170	[p11l267t2069r695b2148],
6	that	IN	O	that	complm	9	SENT_170	[p11l721t2069r891b2147],
7	we	PRP	O	we	nsubj	9	SENT_170	[p11l909t2095r1026b2149],
8	would	MD	O	would	aux	9	SENT_170	[p11l1048t2069r1311b2149],
9	need	VB	O	need	ccomp	5	SENT_170	[p11l1337t2069r1537b2148],
10	to	TO	O	to	aux	11	SENT_170	[p11l1563t2086r1644b2148],
11	enroll	VB	O	enroll	xcomp	9	SENT_170	[p11l1673t2069r1920b2148],
12	1578	CD	DATE	1578	num	13	SENT_170	[p11l1949t2075r2145b2148],
13	patients	NNS	O	patient	dobj	11	SENT_170	[p11l11t2199r354b2298],
14	who	WP	O	who	nsubjpass	17	SENT_170	[p11l390t2198r573b2277],
15	could	MD	O	could	aux	17	SENT_170	[p11l613t2198r848b2277],
16	be	VB	O	be	auxpass	17	SENT_170	[p11l887t2198r983b2277],
17	evaluated	VBN	O	evaluate	rcmod	13	SENT_170	[p11l1022t2198r1426b2277],
18	(	NN	O	(	dobj	17	SENT_170	[p11l1469t2204r1650b2289],
19	789	CD	NUMBER	789	num	18	SENT_170	[p11l1469t2204r1650b2289],
20	per	IN	O	per	_	0	SENT_170	[p11l1688t2224r1829b2298],
21	group	NN	O	group	prep_per	18	SENT_170	[p11l1862t2205r2142b2299],
22	)	CD	NUMBER	)	num	21	SENT_170	[p11l1862t2205r2142b2299],
23	for	IN	O	for	_	0	SENT_170	[p11l12t2324r136b2404],
24	the	DT	O	the	det	25	SENT_170	[p11l163t2325r297b2403],
25	study	NN	O	study	prep_for	17	SENT_170	[p11l327t2325r559b2425],
26	to	TO	O	to	aux	27	SENT_170	[p11l584t2342r666b2404],
27	have	VB	O	have	infmod	25	SENT_170	[p11l697t2325r888b2405],
28	a	DT	O	a	det	30	SENT_170	[p11l917t2351r961b2403],
29	statistical	JJ	O	statistical	amod	30	SENT_170	[p11l991t2325r1409b2403],
30	power	NN	O	power	nsubj	35	SENT_170	[p11l1436t2351r1706b2425],
31	of	IN	O	of	_	0	SENT_170	[p11l1733t2324r1834b2404],
32	90	CD	PERCENT	90	num	33	SENT_170	[p11l1845t2330r2035b2404],
33	%	NN	PERCENT	%	prep_of	30	SENT_170	[p11l1845t2330r2035b2404],
34	to	TO	O	to	aux	35	SENT_170	[p11l2064t2342r2146b2404],
35	detect	VB	O	detect	ccomp	27	SENT_170	[p11l12t2454r268b2533],
36	a	DT	O	a	det	38	SENT_170	[p11l293t2480r338b2532],
37	relative	JJ	O	relative	amod	38	SENT_170	[p11l368t2454r671b2533],
38	reduction	NN	O	reduction	dobj	35	SENT_170	[p11l703t2454r1107b2533],
39	in	IN	O	in	_	0	SENT_170	[p11l1138t2455r1220b2532],
40	the	DT	O	the	det	41	SENT_170	[p11l1252t2454r1383b2532],
41	incidence	NN	O	incidence	prep_in	35	SENT_170	[p11l1415t2454r1814b2533],
42	of	IN	O	of	_	0	SENT_170	[p11l1847t2453r1947b2533],
43	clinically	RB	O	clinically	advmod	44	SENT_170	[p11l1961t2454r2147b2532, p11l11t2582r234b2682],
44	diagnosed	VBN	O	diagnose	amod	45	SENT_170	[p11l257t2582r704b2683],
45	hypersensitivity	NN	O	hypersensitivity	prep_of	41	SENT_170	[p11l731t2582r1417b2682],
46	reaction	NN	O	reaction	amod	45	SENT_170	[p11l1440t2583r1791b2661],
47	to	TO	O	to	_	0	SENT_170	[p11l1818t2599r1900b2661],
48	abacavir	NN	O	abacavir	prep_to	46	SENT_170	[p11l1928t2582r2147b2661, p11l11t2711r167b2790],
49	of	IN	O	of	_	0	SENT_170	[p11l200t2709r299b2790],
50	50	CD	PERCENT	50	num	51	SENT_170	[p11l319t2715r502b2790],
51	%	NN	PERCENT	%	prep_of	48	SENT_170	[p11l319t2715r502b2790],
52	in	IN	O	in	_	0	SENT_170	[p11l536t2711r619b2788],
53	the	DT	O	the	det	57	SENT_170	[p11l656t2710r786b2789],
54	prospective	JJ	O	prospective	amod	57	SENT_170	[p11l821t2711r1743b2812],
55	—	NN	O	—	nn	57	SENT_170	[p11l821t2711r1743b2812],
56	screening	NN	O	screening	nn	57	SENT_170	[p11l821t2711r1743b2812],
57	group	NN	O	group	prep_in	51	SENT_170	[p11l1775t2736r2023b2812],
58	as	IN	O	as	prep	46	SENT_170	[p11l2062t2736r2145b2789],
59	compared	VBN	O	compare	_	0	SENT_170	[p11l12t2839r427b2939],
60	with	IN	O	with	prepc_compared_with	45	SENT_170	[p11l461t2839r651b2918],
61	the	DT	O	the	det	63	SENT_170	[p11l690t2839r820b2918],
62	control	NN	O	control	nn	63	SENT_170	[p11l860t2839r1155b2918],
63	group	NN	O	group	pobj	45	SENT_170	[p11l1193t2865r1438b2940],
64	(	CD	PERCENT	(	number	65	SENT_170	[p11l1483t2844r1709b2930],
65	7.3	CD	PERCENT	7.3	dep	66	SENT_170	[p11l1483t2844r1709b2930],
66	%	NN	PERCENT	%	dep	63	SENT_170	[p11l1483t2844r1709b2930],
67	vs.	CC	O	vs.	prep	45	SENT_170	[p11l1743t2865r1848b2918],
68	3.6	CD	PERCENT	3.6	num	69	SENT_170	[p11l1893t2844r2142b2935],
69	%	NN	PERCENT	%	dep	67	SENT_170	[p11l1893t2844r2142b2935],
70	)	CD	NUMBER	)	dep	69	SENT_170	[p11l1893t2844r2142b2935],
71	,	,	O	,	_	0	SENT_170	[p11l1893t2844r2142b2935],
72	with	IN	O	with	_	0	SENT_170	[p11l7t2967r204b3047],
73	a	DT	O	a	det	76	SENT_170	[p11l244t2994r289b3046],
74	two-sided	JJ	O	two-sided	amod	76	SENT_170	[p11l328t2967r751b3047],
75	significance	NN	O	significance	nn	76	SENT_170	[p11l793t2966r1321b3069],
76	level	NN	O	level	prep_with	45	SENT_170	[p11l1361t2967r1551b3047],
77	of	IN	O	of	_	0	SENT_170	[p11l1591t2966r1692b3047],
78	0.05	CD	NUMBER	0.05	prep_of	76	SENT_170	[p11l1714t2973r1914b3047],
79	.	.	O	.	_	0	SENT_170	[p11l1714t2973r1914b3047],

1	This	DT	O	this	det	2	SENT_171	[p11l1957t2967r2145b3046],
2	number	NN	O	number	nsubj	6	SENT_171	[p11l12t3095r346b3175],
3	of	IN	O	of	_	0	SENT_171	[p11l374t3094r473b3174],
4	patients	NNS	O	patient	prep_of	2	SENT_171	[p11l483t3096r820b3195],
5	also	RB	O	also	advmod	6	SENT_171	[p11l851t3095r1020b3174],
6	yielded	VBD	O	yield	_	0	SENT_171	[p11l1047t3095r1347b3195],
7	a	DT	O	a	det	9	SENT_171	[p11l1376t3121r1421b3173],
8	statistical	JJ	O	statistical	amod	9	SENT_171	[p11l1450t3095r1858b3173],
9	power	NN	O	power	dobj	6	SENT_171	[p11l1887t3121r2151b3195],
10	of	IN	O	of	_	0	SENT_171	[p11l11t3223r112b3303],
11	more	JJR	O	more	mwe	12	SENT_171	[p11l122t3250r341b3303],
12	than	IN	O	than	quantmod	13	SENT_171	[p11l370t3224r566b3302],
13	99	CD	PERCENT	99	num	14	SENT_171	[p11l595t3230r784b3303],
14	%	NN	PERCENT	%	prep_of	9	SENT_171	[p11l595t3230r784b3303],
15	to	TO	O	to	aux	16	SENT_171	[p11l812t3241r894b3303],
16	detect	VB	O	detect	xcomp	6	SENT_171	[p11l924t3224r1183b3303],
17	a	DT	O	a	det	19	SENT_171	[p11l1206t3250r1250b3302],
18	relative	JJ	O	relative	amod	19	SENT_171	[p11l1277t3224r1585b3303],
19	reduction	NN	O	reduction	dobj	16	SENT_171	[p11l1614t3224r2023b3303],
20	of	IN	O	of	_	0	SENT_171	[p11l2053t3223r2153b3303],
21	80	CD	PERCENT	80	num	22	SENT_171	[p11l11t3357r200b3431],
22	%	NN	PERCENT	%	prep_of	19	SENT_171	[p11l11t3357r200b3431],
23	in	IN	O	in	_	0	SENT_171	[p11l241t3353r324b3430],
24	the	DT	O	the	det	28	SENT_171	[p11l367t3352r500b3430],
25	prospective	JJ	O	prospective	amod	28	SENT_171	[p11l541t3353r1490b3453],
26	—	NN	O	—	nn	28	SENT_171	[p11l541t3353r1490b3453],
27	screening	NN	O	screening	nn	28	SENT_171	[p11l541t3353r1490b3453],
28	group	NN	O	group	prep_in	22	SENT_171	[p11l1530t3378r1782b3453],
29	for	IN	O	for	_	0	SENT_171	[p11l1826t3351r1949b3431],
30	immunologically	RB	O	immunologically	advmod	31	SENT_171	[p11l1988t3353r2133b3430, p11l11t3480r616b3581],
31	conﬁrmed	JJ	O	conﬁrmed	amod	33	SENT_171	[p11l637t3479r1082b3559],
32	hypersensitivity	NN	O	hypersensitivity	nn	33	SENT_171	[p11l1107t3480r1772b3580],
33	reaction	NN	O	reaction	prep_for	28	SENT_171	[p11l1793t3481r2134b3559],
34	to	TO	O	to	_	0	SENT_171	[p11l11t3624r93b3686],
35	abacavir	NN	O	abacavir	prep_to	33	SENT_171	[p11l128t3608r485b3687],
36	(	CD	PERCENT	(	num	35	SENT_171	[p11l521t3613r756b3698],
37	4.6	CD	PERCENT	4.6	number	38	SENT_171	[p11l521t3613r756b3698],
38	%	NN	PERCENT	%	amod	33	SENT_171	[p11l521t3613r756b3698],
39	vs.	CC	O	vs.	_	0	SENT_171	[p11l786t3634r895b3687],
40	0.9	CD	PERCENT	0.9	num	41	SENT_171	[p11l935t3613r1196b3698],
41	%	NN	PERCENT	%	conj_vs.	19	SENT_171	[p11l935t3613r1196b3698],
42	)	CD	NUMBER	)	dep	41	SENT_171	[p11l935t3613r1196b3698],
43	.	.	O	.	_	0	SENT_171	[p11l935t3613r1196b3698],

1	Hierarchical	JJ	O	hierarchical	amod	2	SENT_172	[p12l139t26r673b104],
2	testing	NN	O	testing	nsubjpass	4	SENT_172	[p12l704t27r1002b127],
3	was	VBD	O	be	auxpass	4	SENT_172	[p12l1026t52r1189b105],
4	used	VBN	O	use	_	0	SENT_172	[p12l1223t26r1419b105],
5	to	TO	O	to	aux	6	SENT_172	[p12l1451t43r1533b105],
6	adjust	VB	O	adjust	xcomp	4	SENT_172	[p12l1566t26r1822b126],
7	for	IN	O	for	_	0	SENT_172	[p12l1848t25r1971b105],
8	the	DT	O	the	det	9	SENT_172	[p12l2001t26r2134b104],
9	multiplicity	NN	O	multiplicity	prep_for	6	SENT_172	[p12l11t153r498b253],
10	of	IN	O	of	_	0	SENT_172	[p12l530t152r628b232],
11	primary	JJ	O	primary	amod	13	SENT_172	[p12l644t154r988b253],
12	end	NN	O	end	nn	13	SENT_172	[p12l1020t153r1171b232],
13	points	NNS	O	point	prep_of	9	SENT_172	[p12l1205t154r1493b253],
14	.	.	O	.	_	0	SENT_172	[p12l1205t154r1493b253],

1	Rates	NNS	O	rate	_	0	SENT_173	[p12l1533t160r1763b237],
2	of	IN	O	of	_	0	SENT_173	[p12l1802t152r1900b232],
3	clinically	RB	O	clinically	advmod	4	SENT_173	[p12l1918t153r2133b231, p12l11t282r206b382],
4	diagnosed	VBN	O	diagnose	amod	5	SENT_173	[p12l277t282r712b383],
5	hypersensitivity	NN	O	hypersensitivity	prep_of	1	SENT_173	[p12l788t282r1453b382],
6	reaction	NN	O	reaction	nsubjpass	8	SENT_173	[p12l1523t283r1864b361],
7	were	VBD	O	be	auxpass	8	SENT_173	[p12l1935t308r2134b361],
8	analyzed	VBN	O	analyze	rcmod	5	SENT_173	[p12l10t410r383b510],
9	only	RB	O	only	advmod	12	SENT_173	[p12l415t410r596b510],
10	if	IN	O	if	dep	12	SENT_173	[p12l623t409r699b488],
11	there	EX	O	there	expl	12	SENT_173	[p12l713t410r926b489],
12	was	VBD	O	be	ccomp	8	SENT_173	[p12l954t436r1114b489],
13	a	DT	O	a	det	15	SENT_173	[p12l1148t436r1192b488],
14	significant	JJ	O	significant	amod	15	SENT_173	[p12l1224t409r1682b511],
15	difference	NN	O	difference	nsubj	12	SENT_173	[p12l1710t409r2133b489],
16	in	IN	O	in	_	0	SENT_173	[p12l10t539r93b616],
17	the	DT	O	the	det	18	SENT_173	[p12l126t538r256b616],
18	rates	NNS	O	rate	prep_in	15	SENT_173	[p12l290t555r488b616],
19	of	IN	O	of	prep	1	SENT_173	[p12l524t537r623b617],
20	immunologically	RB	O	immunologically	pcomp	19	SENT_173	[p12l637t538r1360b639],
21	confirmed	VBN	O	confirm	partmod	1	SENT_173	[p12l1389t537r1833b617],
22	hypersensitivity	NN	O	hypersensitivity	nn	23	SENT_173	[p12l1866t538r2133b638, p12l12t667r424b766],
23	reaction	NN	O	reaction	dobj	21	SENT_173	[p12l455t667r788b745],
24	between	IN	O	between	_	0	SENT_173	[p12l825t666r1169b745],
25	the	DT	O	the	det	28	SENT_173	[p12l1205t666r1334b744],
26	two	CD	NUMBER	two	num	28	SENT_173	[p12l1370t683r1522b745],
27	study	NN	O	study	nn	28	SENT_173	[p12l1561t666r1782b766],
28	groups	NNS	O	group	prep_between	23	SENT_173	[p12l1812t692r2120b767],
29	.	.	O	.	_	0	SENT_173	[p12l1812t692r2120b767],

1	The	DT	O	the	det	3	SENT_174	[p12l136t793r298b871],
2	primary	JJ	O	primary	amod	3	SENT_174	[p12l333t794r684b893],
3	analysis	NN	O	analysis	nsubj	12	SENT_174	[p12l716t793r1055b893],
4	of	IN	O	of	_	0	SENT_174	[p12l1096t792r1196b872],
5	the	DT	O	the	det	6	SENT_174	[p12l1215t793r1348b871],
6	rates	NNS	O	rate	prep_of	3	SENT_174	[p12l1385t810r1588b871],
7	of	IN	O	of	_	0	SENT_174	[p12l1628t792r1727b872],
8	clinically	RB	O	clinically	advmod	9	SENT_174	[p12l1747t793r2138b893],
9	diagnosed	VBN	O	diagnose	amod	10	SENT_174	[p12l11t922r455b1023],
10	hypersensitivity	NN	O	hypersensitivity	prep_of	6	SENT_174	[p12l497t922r1179b1022],
11	reaction	NN	O	reaction	dep	3	SENT_174	[p12l1216t923r1565b1001],
12	involved	VBD	O	involve	_	0	SENT_174	[p12l1606t922r1958b1001],
13	the	DT	O	the	det	14	SENT_174	[p12l2001t922r2133b1000],
14	patients	NNS	O	patient	dobj	12	SENT_174	[p12l10t1051r336b1150],
15	who	WP	O	who	nsubjpass	18	SENT_174	[p12l362t1050r540b1129],
16	could	MD	O	could	aux	18	SENT_174	[p12l571t1050r797b1129],
17	be	VB	O	be	auxpass	18	SENT_174	[p12l826t1050r920b1129],
18	evaluated	VBN	O	evaluate	rcmod	14	SENT_174	[p12l949t1050r1334b1129],
19	among	IN	O	among	_	0	SENT_174	[p12l1362t1076r1654b1151],
20	all	DT	O	all	det	21	SENT_174	[p12l1678t1050r1778b1128],
21	patients	NNS	O	patient	prep_among	18	SENT_174	[p12l1805t1051r2131b1150],
22	who	WP	O	who	nsubj	23	SENT_174	[p12l6t1177r185b1256],
23	received	VBD	O	receive	rcmod	21	SENT_174	[p12l220t1177r551b1256],
24	at	IN	O	at	quantmod	26	SENT_174	[p12l583t1194r660b1255],
25	least	JJS	O	least	mwe	24	SENT_174	[p12l687t1177r878b1255],
26	one	CD	NUMBER	one	num	27	SENT_174	[p12l907t1203r1054b1256],
27	dose	NN	O	dose	dobj	23	SENT_174	[p12l1088t1177r1276b1256],
28	of	IN	O	of	_	0	SENT_174	[p12l1310t1176r1409b1256],
29	abacavir	NN	O	abacavir	prep_of	27	SENT_174	[p12l1423t1177r1780b1273],
30	,	,	O	,	_	0	SENT_174	[p12l1423t1177r1780b1273],
31	defined	VBN	O	define	partmod	27	SENT_174	[p12l1820t1176r2134b1256],
32	as	IN	O	as	_	0	SENT_174	[p12l10t1332r96b1384],
33	those	DT	O	those	prep_as	31	SENT_174	[p12l146t1306r378b1384],
34	who	WP	O	who	nsubj	36	SENT_174	[p12l421t1306r604b1385],
35	either	CC	O	either	advmod	36	SENT_174	[p12l654t1306r900b1384],
36	completed	VBD	O	complete	rcmod	33	SENT_174	[p12l946t1306r1391b1405],
37	the	DT	O	the	det	38	SENT_174	[p12l1438t1306r1571b1384],
38	weel	NN	O	weel	nsubj	39	SENT_174	[p12l1615t1306r1915b1385],
39	<	JJR	O	<	xcomp	36	SENT_174	[p12l1615t1306r1915b1385],
40	.	.	O	.	_	0	SENT_174	[p12l1615t1306r1915b1385],

1	—	NN	O	—	_	0	SENT_175	[p12l1615t1306r1915b1385],
2	.	.	O	.	_	0	SENT_175	[p12l1615t1306r1915b1385],

1	6	CD	NUMBER	6	num	2	SENT_176	[p12l1615t1306r1915b1385],
2	visit	NN	O	visit	_	0	SENT_176	[p12l1959t1307r2139b1385],
3	after	IN	O	after	_	0	SENT_176	[p12l10t1433r217b1512],
4	taking	VBG	O	take	prepc_after	2	SENT_176	[p12l260t1434r547b1535],
5	abacavir	NN	O	abacavir	dobj	4	SENT_176	[p12l588t1434r952b1513],
6	for	IN	O	for	_	0	SENT_176	[p12l995t1433r1120b1513],
7	at	IN	DURATION	at	quantmod	9	SENT_176	[p12l1162t1451r1242b1512],
8	least	JJS	DURATION	least	mwe	7	SENT_176	[p12l1282t1434r1486b1513],
9	41	CD	DURATION	41	num	10	SENT_176	[p12l1525t1440r1623b1513],
10	days	NNS	NUMBER	day	prep_for	5	SENT_176	[p12l1670t1434r1858b1534],
11	without	IN	O	without	_	0	SENT_176	[p12l1901t1434r2133b1513, p12l11t1578r153b1641],
12	evidence	NN	O	evidence	prep_without	4	SENT_176	[p12l184t1561r557b1641],
13	of	IN	O	of	_	0	SENT_176	[p12l593t1560r694b1640],
14	hypersensitivity	NN	O	hypersensitivity	nn	15	SENT_176	[p12l710t1561r1407b1661],
15	reaction	NN	O	reaction	prep_of	12	SENT_176	[p12l1438t1562r1793b1640],
16	or	CC	O	or	_	0	SENT_176	[p12l1829t1587r1919b1640],
17	who	WP	O	who	nsubj	18	SENT_176	[p12l1946t1561r2131b1641],
18	stopped	VBD	O	stop	conj_or	12	SENT_176	[p12l12t1690r351b1790],
19	taking	VBG	O	take	xcomp	18	SENT_176	[p12l395t1690r676b1791],
20	abacavir	NN	O	abacavir	dobj	19	SENT_176	[p12l715t1690r1090b1786],
21	,	,	O	,	_	0	SENT_176	[p12l715t1690r1090b1786],
22	owing	VBG	O	owe	xcomp	18	SENT_176	[p12l1140t1691r1409b1791],
23	to	TO	O	to	_	0	SENT_176	[p12l1450t1707r1531b1769],
24	a	DT	O	a	det	26	SENT_176	[p12l1576t1716r1620b1768],
25	clinical	JJ	O	clinical	amod	26	SENT_176	[p12l1664t1690r1977b1768],
26	diagnosis	NN	O	diagnosis	prep_to	22	SENT_176	[p12l2021t1690r2132b1769, p12l10t1819r335b1919],
27	of	IN	O	of	_	0	SENT_176	[p12l381t1817r481b1897],
28	a	DT	O	a	det	30	SENT_176	[p12l506t1844r551b1896],
29	hypersensitivity	NN	O	hypersensitivity	nn	30	SENT_176	[p12l593t1818r1274b1918],
30	reaction	NN	O	reaction	prep_of	26	SENT_176	[p12l1313t1819r1685b1914],
31	,	,	O	,	_	0	SENT_176	[p12l1313t1819r1685b1914],
32	before	IN	O	before	_	0	SENT_176	[p12l1735t1817r2003b1897],
33	or	CC	O	or	_	0	SENT_176	[p12l2048t1844r2137b1897],
34	during	IN	O	during	_	0	SENT_176	[p12l11t1946r301b2047],
35	the	DT	O	the	det	36	SENT_176	[p12l338t1946r471b2024],
36	weel	NN	O	weel	prep_before	22	SENT_176	[p12l506t1946r806b2025],
37	<	JJR	O	<	amod	36	SENT_176	[p12l506t1946r806b2025],
38	.	.	O	.	_	0	SENT_176	[p12l506t1946r806b2025],

1	—	NN	O	—	_	0	SENT_177	[p12l506t1946r806b2025],
2	.	.	O	.	_	0	SENT_177	[p12l506t1946r806b2025],

1	6	CD	NUMBER	6	_	0	SENT_178	[p12l506t1946r806b2025],
2	visit	NN	O	visit	dep	1	SENT_178	[p12l843t1947r1043b2025],
3	.	.	O	.	_	0	SENT_178	[p12l843t1947r1043b2025],

1	The	DT	O	the	det	3	SENT_179	[p12l1085t1946r1246b2024],
2	primary	JJ	O	primary	amod	3	SENT_179	[p12l1285t1947r1635b2046],
3	analysis	NN	O	analysis	nsubj	11	SENT_179	[p12l1669t1946r2010b2046],
4	of	IN	O	of	_	0	SENT_179	[p12l2052t1945r2152b2025],
5	rates	NNS	O	rate	prep_of	3	SENT_179	[p12l11t2091r214b2152],
6	of	IN	O	of	prep	5	SENT_179	[p12l255t2073r356b2153],
7	immunologically	RB	O	immunologically	pcomp	6	SENT_179	[p12l375t2074r1113b2175],
8	confirmed	VBN	O	confirm	partmod	3	SENT_179	[p12l1149t2073r1602b2153],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_179	[p12l1641t2074r2133b2174, p12l11t2203r223b2302],
10	reaction	NN	O	reaction	dobj	8	SENT_179	[p12l248t2203r589b2281],
11	involved	VBD	O	involve	_	0	SENT_179	[p12l619t2202r962b2281],
12	the	DT	O	the	det	14	SENT_179	[p12l993t2202r1124b2281],
13	same	JJ	O	same	amod	14	SENT_179	[p12l1155t2228r1372b2280],
14	group	NN	O	group	dobj	11	SENT_179	[p12l1402t2228r1651b2303],
15	of	IN	O	of	_	0	SENT_179	[p12l1683t2201r1782b2281],
16	patients	NNS	O	patient	prep_of	14	SENT_179	[p12l1792t2203r2131b2302],
17	except	IN	O	except	_	0	SENT_179	[p12l11t2347r273b2430],
18	six	CD	NUMBER	six	prep_except	16	SENT_179	[p12l299t2331r412b2408],
19	who	WP	O	who	nsubj	22	SENT_179	[p12l433t2330r611b2409],
20	did	VBD	O	do	aux	22	SENT_179	[p12l642t2330r772b2409],
21	not	RB	O	not	neg	22	SENT_179	[p12l801t2347r939b2409],
22	undergo	VB	O	undergo	rcmod	14	SENT_179	[p12l962t2330r1305b2431],
23	epicutaneous	JJ	O	epicutaneous	amod	25	SENT_179	[p12l1336t2331r1877b2430],
24	patch	NN	O	patch	nn	25	SENT_179	[p12l1906t2330r2134b2430],
25	testing	NN	O	testing	dobj	22	SENT_179	[p12l11t2459r309b2559],
26	because	IN	O	because	_	0	SENT_179	[p12l352t2458r688b2537],
27	of	IN	O	of	_	0	SENT_179	[p12l734t2457r833b2537],
28	refusal	NN	O	refusal	prep_because_of	22	SENT_179	[p12l860t2457r1178b2554],
29	,	,	O	,	_	0	SENT_179	[p12l860t2457r1178b2554],
30	failure	NN	O	failure	appos	28	SENT_179	[p12l1228t2457r1507b2537],
31	to	TO	O	to	aux	32	SENT_179	[p12l1552t2475r1633b2537],
32	appear	VB	O	appear	infmod	30	SENT_179	[p12l1679t2484r1971b2558],
33	for	IN	O	for	_	0	SENT_179	[p12l2013t2457r2136b2537],
34	testing	NN	O	testing	prep_for	32	SENT_179	[p12l11t2587r328b2687],
35	,	,	O	,	_	0	SENT_179	[p12l11t2587r328b2687],
36	or	CC	O	or	_	0	SENT_179	[p12l367t2612r456b2665],
37	loss	NN	O	loss	conj_or	14	SENT_179	[p12l485t2586r648b2665],
38	to	TO	O	to	aux	39	SENT_179	[p12l683t2603r765b2665],
39	follow	VB	O	follow	infmod	37	SENT_179	[p12l799t2585r1230b2686],
40	—	CD	NUMBER	—	dobj	39	SENT_179	[p12l799t2585r1230b2686],
41	up	RP	O	up	prt	39	SENT_179	[p12l799t2585r1230b2686],
42	.	.	O	.	_	0	SENT_179	[p12l799t2585r1230b2686],

1	Potential	JJ	O	potential	amod	2	SENT_180	[p12l1267t2586r1652b2665],
2	bias	NN	O	bias	nsubjpass	16	SENT_180	[p12l1686t2586r1854b2665],
3	introduced	VBN	O	introduce	partmod	2	SENT_180	[p12l1888t2587r2133b2665, p12l11t2713r263b2793],
4	by	IN	O	by	_	0	SENT_180	[p12l297t2713r395b2813],
5	the	DT	O	the	det	6	SENT_180	[p12l424t2713r557b2791],
6	exclusion	NN	O	exclusion	agent	3	SENT_180	[p12l593t2713r991b2792],
7	of	IN	O	of	_	0	SENT_180	[p12l1025t2712r1125b2792],
8	the	DT	O	the	det	9	SENT_180	[p12l1141t2713r1274b2791],
9	patients	NNS	O	patient	prep_of	6	SENT_180	[p12l1307t2714r1649b2813],
10	who	WP	O	who	nsubjpass	14	SENT_180	[p12l1680t2713r1863b2793],
11	could	MD	O	could	aux	14	SENT_180	[p12l1899t2713r2134b2793],
12	not	RB	O	not	neg	14	SENT_180	[p12l11t2859r154b2920],
13	be	VB	O	be	auxpass	14	SENT_180	[p12l187t2842r284b2920],
14	evaluated	VBN	O	evaluate	rcmod	9	SENT_180	[p12l322t2842r725b2921],
15	was	VBD	O	be	auxpass	16	SENT_180	[p12l757t2868r920b2921],
16	addressed	VBN	O	address	_	0	SENT_180	[p12l959t2842r1388b2920],
17	by	IN	O	by	_	0	SENT_180	[p12l1426t2842r1524b2941],
18	several	JJ	O	several	amod	20	SENT_180	[p12l1558t2842r1850b2921],
19	sensitivity	NN	O	sensitivity	nn	20	SENT_180	[p12l1888t2843r2132b2920, p12l11t2970r228b3069],
20	analyses	NNS	O	analysis	agent	16	SENT_180	[p12l258t2969r617b3069],
21	of	IN	O	of	_	0	SENT_180	[p12l655t2968r755b3048],
22	data	NNS	O	datum	prep_of	20	SENT_180	[p12l772t2969r955b3048],
23	from	IN	O	from	_	0	SENT_180	[p12l989t2968r1199b3048],
24	the	DT	O	the	det	26	SENT_180	[p12l1235t2969r1367b3047],
25	full	JJ	O	full	amod	26	SENT_180	[p12l1403t2968r1552b3048],
26	intention	NN	O	intention	prep_from	16	SENT_180	[p12l1585t2970r2132b3048],
27	—	CD	NUMBER	—	number	29	SENT_180	[p12l1585t2970r2132b3048],
28	to	TO	O	to	dep	29	SENT_180	[p12l1585t2970r2132b3048],
29	—	CD	NUMBER	—	num	31	SENT_180	[p12l1585t2970r2132b3048],
30	treat	NN	O	treat	nn	31	SENT_180	[p12l11t3114r210b3176],
31	population	NN	O	population	tmod	16	SENT_180	[p12l241t3098r712b3197],
32	that	WDT	O	that	nsubj	34	SENT_180	[p12l749t3098r921b3176],
33	had	VBD	O	have	aux	34	SENT_180	[p12l953t3098r1109b3176],
34	received	VBN	O	receive	rcmod	31	SENT_180	[p12l1145t3098r1491b3177],
35	abacavir	NN	O	abacavir	dobj	34	SENT_180	[p12l1526t3098r1900b3193],
36	,	,	O	,	_	0	SENT_180	[p12l1526t3098r1900b3193],
37	with	IN	O	with	_	0	SENT_180	[p12l1939t3098r2134b3177],
38	assumptions	NNS	O	assumption	prep_with	34	SENT_180	[p12l10t3227r535b3326],
39	about	IN	O	about	_	0	SENT_180	[p12l571t3226r806b3305],
40	the	DT	O	the	det	42	SENT_180	[p12l835t3226r964b3305],
41	missing	VBG	O	miss	amod	42	SENT_180	[p12l998t3227r1330b3327],
42	data	NNS	O	datum	prep_about	38	SENT_180	[p12l1361t3226r1538b3305],
43	ranging	VBG	O	range	partmod	42	SENT_180	[p12l1570t3227r1898b3327],
44	from	IN	O	from	_	0	SENT_180	[p12l1929t3225r2134b3305],
45	O	NN	O	o	prep_from	43	SENT_180	[p12l11t3360r58b3433],
46	to	TO	O	to	_	0	SENT_180	[p12l91t3371r171b3433],
47	100	CD	PERCENT	100	num	48	SENT_180	[p12l208t3359r441b3433],
48	%	NN	PERCENT	%	prep_to	43	SENT_180	[p12l208t3359r441b3433],
49	of	IN	O	of	_	0	SENT_180	[p12l473t3353r571b3433],
50	the	DT	O	the	det	51	SENT_180	[p12l585t3354r716b3433],
51	exclusions	NNS	O	exclusion	prep_of	48	SENT_180	[p12l749t3354r1179b3433],
52	being	VBG	O	be	auxpass	53	SENT_180	[p12l1214t3354r1450b3455],
53	associated	VBN	O	associate	partmod	51	SENT_180	[p12l1478t3354r1913b3433],
54	with	IN	O	with	_	0	SENT_180	[p12l1941t3354r2133b3433],
55	a	DT	O	a	det	57	SENT_180	[p12l10t3507r55b3559],
56	hypersensitivity	NN	O	hypersensitivity	nn	57	SENT_180	[p12l91t3481r756b3581],
57	reaction	NN	O	reaction	prep_with	53	SENT_180	[p12l790t3482r1153b3560],
58	.	.	O	.	_	0	SENT_180	[p12l790t3482r1153b3560],

1	The	DT	O	the	det	3	SENT_181	[p12l1193t3481r1352b3559],
2	safety	NN	O	safety	nn	3	SENT_181	[p12l1392t3480r1640b3581],
3	population	NN	O	population	nsubj	12	SENT_181	[p12l1672t3481r2134b3581],
4	for	IN	O	for	_	0	SENT_181	[p12l11t3608r132b3688],
5	analyses	NNS	O	analysis	prep_for	3	SENT_181	[p12l162t3609r514b3709],
6	of	IN	O	of	_	0	SENT_181	[p12l550t3608r649b3688],
7	adverse	JJ	O	adverse	amod	8	SENT_181	[p12l664t3609r973b3689],
8	events	NNS	O	event	prep_of	5	SENT_181	[p12l1007t3626r1265b3689],
9	and	CC	O	and	_	0	SENT_181	[p12l1300t3609r1456b3688],
10	laboratory	NN	O	laboratory	nn	11	SENT_181	[p12l1488t3609r1926b3709],
11	data	NNS	O	datum	prep_of	5	SENT_181	[p12l1956t3609r2135b3688],
12	included	VBD	O	include	_	0	SENT_181	[p13l10t21r366b100],
13	all	DT	O	all	det	14	SENT_181	[p13l394t21r495b99],
14	patients	NNS	O	patient	dobj	12	SENT_181	[p13l522t22r853b120],
15	who	WP	O	who	nsubj	16	SENT_181	[p13l878t21r1058b100],
16	received	VBD	O	receive	rcmod	14	SENT_181	[p13l1088t21r1423b100],
17	at	IN	O	at	quantmod	19	SENT_181	[p13l1450t37r1528b99],
18	least	JJS	O	least	mwe	17	SENT_181	[p13l1550t21r1743b99],
19	one	CD	NUMBER	one	num	20	SENT_181	[p13l1767t47r1915b99],
20	dose	NN	O	dose	dobj	16	SENT_181	[p13l1944t21r2134b99],
21	of	IN	O	of	_	0	SENT_181	[p13l11t148r112b228],
22	abacavir	NN	O	abacavir	prep_of	20	SENT_181	[p13l132t149r506b228],
23	.	.	O	.	_	0	SENT_181	[p13l132t149r506b228],

1	The	DT	O	the	det	2	SENT_182	[p13l136t277r298b355],
2	rates	NNS	O	rate	nsubjpass	9	SENT_182	[p13l343t294r545b355],
3	of	IN	O	of	_	0	SENT_182	[p13l593t276r693b356],
4	clinically	RB	O	clinically	advmod	5	SENT_182	[p13l720t277r1111b377],
5	diagnosed	VBN	O	diagnose	amod	6	SENT_182	[p13l1152t277r1596b378],
6	hypersensitivity	NN	O	hypersensitivity	prep_of	2	SENT_182	[p13l1641t277r2133b377, p13l11t406r228b504],
7	reaction	NN	O	reaction	dep	2	SENT_182	[p13l271t406r619b483],
8	were	VBD	O	be	auxpass	9	SENT_182	[p13l663t431r864b484],
9	compared	VBN	O	compare	_	0	SENT_182	[p13l913t405r1339b504],
10	between	IN	O	between	_	0	SENT_182	[p13l1388t405r1745b484],
11	the	DT	O	the	det	13	SENT_182	[p13l1793t405r1926b483],
12	two	CD	NUMBER	two	num	13	SENT_182	[p13l1975t422r2132b484],
13	groups	NNS	O	group	prep_between	9	SENT_182	[p13l11t559r307b634],
14	by	IN	O	by	_	0	SENT_182	[p13l350t533r447b633],
15	means	NNS	O	means	_	0	SENT_182	[p13l483t559r762b611],
16	of	IN	O	of	_	0	SENT_182	[p13l806t532r905b612],
17	logistic	JJ	O	logistic	amod	20	SENT_182	[p13l926t533r1724b634],
18	—	NN	O	—	nn	20	SENT_182	[p13l926t533r1724b634],
19	regression	NN	O	regression	nn	20	SENT_182	[p13l926t533r1724b634],
20	analysis	NN	O	analysis	prep_by_means_of	9	SENT_182	[p13l1763t533r2128b633],
21	,	,	O	,	_	0	SENT_182	[p13l1763t533r2128b633],
22	with	IN	O	with	_	0	SENT_182	[p13l6t661r202b740],
23	the	DT	O	the	det	25	SENT_182	[p13l248t661r382b739],
24	P	NN	O	p	nn	25	SENT_182	[p13l427t668r478b739],
25	value	NN	O	value	prep_with	9	SENT_182	[p13l519t661r738b740],
26	calculated	VBN	O	calculate	partmod	25	SENT_182	[p13l786t661r1221b740],
27	with	IN	O	with	_	0	SENT_182	[p13l1263t661r1458b740],
28	the	DT	O	the	det	29	SENT_182	[p13l1505t661r1638b739],
29	use	NN	O	use	prep_with	26	SENT_182	[p13l1684t687r1824b740],
30	of	IN	O	of	_	0	SENT_182	[p13l1872t660r1972b740],
31	the	DT	O	the	det	33	SENT_182	[p13l2001t661r2134b740],
32	lil	NN	O	lil	dep	33	SENT_182	[p13l10t789r682b868],
33	<	JJR	O	<	prep_of	29	SENT_182	[p13l10t789r682b868],
34	elihood	CD	NUMBER	elihood	num	37	SENT_182	[p13l10t789r682b868],
35	—	NN	O	—	nn	37	SENT_182	[p13l10t789r682b868],
36	ratio	NN	O	ratio	nn	37	SENT_182	[p13l10t789r682b868],
37	test	NN	O	test	dep	33	SENT_182	[p13l726t806r900b868],
38	.	.	O	.	_	0	SENT_182	[p13l726t806r900b868],

1	Because	IN	O	because	mark	10	SENT_183	[p13l946t796r1290b868],
2	of	IN	O	of	_	0	SENT_183	[p13l1332t788r1432b868],
3	the	DT	O	the	det	4	SENT_183	[p13l1456t789r1588b867],
4	numbers	NNS	O	number	prep_of	10	SENT_183	[p13l1630t789r2008b868],
5	of	IN	O	of	_	0	SENT_183	[p13l2052t788r2152b868],
6	immunologically	RB	O	immunologically	advmod	7	SENT_183	[p13l10t917r748b1018],
7	conﬁrmed	JJ	O	conﬁrmed	amod	9	SENT_183	[p13l793t916r1246b996],
8	hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_183	[p13l1295t917r1976b1017],
9	reactions	NNS	O	reaction	prep_of	4	SENT_183	[p13l2019t943r2133b996, p13l10t1046r302b1124],
10	reported	VBD	O	report	advcl	19	SENT_183	[p13l348t1045r721b1145],
11	,	,	O	,	_	0	SENT_183	[p13l348t1045r721b1145],
12	eXact	NNP	O	eXact	nsubjpass	19	SENT_183	[p13l771t1045r1764b1146],
13	—	CD	NUMBER	—	num	12	SENT_183	[p13l771t1045r1764b1146],
14	logistic	JJ	O	logistic	amod	17	SENT_183	[p13l771t1045r1764b1146],
15	—	NN	O	—	nn	17	SENT_183	[p13l771t1045r1764b1146],
16	regression	NN	O	regression	nn	17	SENT_183	[p13l771t1045r1764b1146],
17	analysis	NN	O	analysis	dep	12	SENT_183	[p13l1807t1045r2131b1145],
18	was	VBD	O	be	auxpass	19	SENT_183	[p13l6t1198r165b1252],
19	performed	VBN	O	perform	_	0	SENT_183	[p13l198t1171r638b1272],
20	for	IN	O	for	_	0	SENT_183	[p13l670t1171r789b1251],
21	that	DT	O	that	det	23	SENT_183	[p13l820t1172r986b1250],
22	end	NN	O	end	nn	23	SENT_183	[p13l1015t1172r1164b1251],
23	point	NN	O	point	prep_for	19	SENT_183	[p13l1195t1173r1435b1272],
24	,	,	O	,	_	0	SENT_183	[p13l1195t1173r1435b1272],
25	and	CC	O	and	_	0	SENT_183	[p13l1473t1172r1627b1251],
26	the	DT	O	the	det	29	SENT_183	[p13l1660t1172r1788b1250],
27	median	JJ	O	median	amod	29	SENT_183	[p13l1821t1172r2134b1251],
28	unbiased	JJ	O	unbiased	amod	29	SENT_183	[p13l11t1301r400b1380],
29	estimate	NN	O	estimate	nsubjpass	35	SENT_183	[p13l448t1302r813b1380],
30	of	IN	O	of	_	0	SENT_183	[p13l862t1300r962b1380],
31	the	DT	O	the	det	33	SENT_183	[p13l992t1301r1125b1380],
32	odds	NNS	O	odds	nn	33	SENT_183	[p13l1173t1301r1375b1380],
33	ratio	NN	O	ratio	prep_of	29	SENT_183	[p13l1425t1302r1623b1380],
34	was	VBD	O	be	auxpass	35	SENT_183	[p13l1667t1327r1830b1380],
35	calculated	VBN	O	calculate	conj_and	19	SENT_183	[p13l1881t1301r2132b1380, p13l10t1429r218b1508],
36	with	IN	O	with	_	0	SENT_183	[p13l259t1429r454b1508],
37	the	DT	O	the	det	38	SENT_183	[p13l499t1429r631b1508],
38	use	NN	O	use	prep_with	35	SENT_183	[p13l676t1455r816b1508],
39	of	IN	O	of	_	0	SENT_183	[p13l861t1428r961b1508],
40	the	DT	O	the	det	41	SENT_183	[p13l988t1429r1121b1507],
41	mid	JJ	O	mid	prep_of	38	SENT_183	[p13l1166t1429r1443b1508],
42	.	.	O	.	_	0	SENT_183	[p13l1166t1429r1443b1508],

1	—	NN	O	—	_	0	SENT_184	[p13l1166t1429r1443b1508],
2	.	.	O	.	_	0	SENT_184	[p13l1166t1429r1443b1508],

1	P	NN	O	p	nn	2	SENT_185	[p13l1166t1429r1443b1508],
2	value	NN	O	value	_	0	SENT_185	[p13l1481t1429r1701b1508],
3	from	IN	O	from	_	0	SENT_185	[p13l1745t1428r1956b1508],
4	the	DT	O	the	det	6	SENT_185	[p13l2001t1429r2134b1507],
5	score	NN	NUMBER	score	nn	6	SENT_185	[p13l12t1583r224b1636],
6	test	NN	O	test	prep_from	2	SENT_185	[p13l254t1574r420b1636],
7	.	.	O	.	_	0	SENT_185	[p13l254t1574r420b1636],

1	A	DT	O	a	det	3	SENT_186	[p13l450t1565r516b1635],
2	two	CD	NUMBER	two	number	3	SENT_186	[p13l541t1557r945b1636],
3	—	CD	NUMBER	—	nsubj	4	SENT_186	[p13l541t1557r945b1636],
4	sided	VBD	O	side	_	0	SENT_186	[p13l541t1557r945b1636],
5	significance	NN	O	significance	nn	6	SENT_186	[p13l975t1556r1476b1658],
6	level	NN	O	level	nsubjpass	11	SENT_186	[p13l1503t1557r1683b1636],
7	of	IN	O	of	_	0	SENT_186	[p13l1712t1556r1810b1636],
8	5	CD	PERCENT	5	num	9	SENT_186	[p13l1821t1562r1951b1636],
9	%	NN	PERCENT	%	prep_of	6	SENT_186	[p13l1821t1562r1951b1636],
10	was	VBD	O	be	auxpass	11	SENT_186	[p13l1973t1583r2131b1636],
11	used	VBN	O	use	ccomp	4	SENT_186	[p13l11t1685r201b1764],
12	in	IN	O	in	_	0	SENT_186	[p13l231t1686r312b1763],
13	all	DT	O	all	det	14	SENT_186	[p13l343t1685r442b1763],
14	comparisons	NNS	O	comparison	prep_in	11	SENT_186	[p13l473t1686r1004b1785],
15	between	IN	O	between	_	0	SENT_186	[p13l1037t1685r1382b1764],
16	the	DT	O	the	det	18	SENT_186	[p13l1413t1685r1541b1763],
17	study	NN	O	study	nn	18	SENT_186	[p13l1574t1685r1795b1785],
18	groups	NNS	O	group	prep_between	14	SENT_186	[p13l1821t1711r2129b1786],
19	.	.	O	.	_	0	SENT_186	[p13l1821t1711r2129b1786],

1	Sensitivity	NN	O	sensitivity	_	0	SENT_187	[p13l13t1814r467b1913],
2	,	,	O	,	_	0	SENT_187	[p13l13t1814r467b1913],
3	specificity	NN	O	specificity	conj_and	1	SENT_187	[p13l515t1812r969b1913],
4	,	,	O	,	_	0	SENT_187	[p13l515t1812r969b1913],
5	and	CC	O	and	_	0	SENT_187	[p13l1015t1813r1172b1892],
6	positive	JJ	O	positive	amod	10	SENT_187	[p13l1211t1814r1542b1913],
7	and	CC	O	and	_	0	SENT_187	[p13l1582t1813r1740b1892],
8	negative	JJ	O	negative	amod	10	SENT_187	[p13l1780t1814r2133b1914],
9	predictive	JJ	O	predictive	amod	10	SENT_187	[p13l10t1940r429b2040],
10	values	NNS	O	value	conj_and	1	SENT_187	[p13l474t1940r737b2020],
11	of	IN	O	of	_	0	SENT_187	[p13l789t1939r890b2019],
12	HLA	NN	O	hlum	prep_of	10	SENT_187	[p13l920t1940r1458b2019],
13	.	.	O	.	_	0	SENT_187	[p13l920t1940r1458b2019],

1	—	NN	O	—	_	0	SENT_188	[p13l920t1940r1458b2019],
2	.	.	O	.	_	0	SENT_188	[p13l920t1940r1458b2019],

1	B	NN	O	b	nsubjpass	11	SENT_189	[p13l920t1940r1458b2019],
2	*	CD	NUMBER	*	number	3	SENT_189	[p13l920t1940r1458b2019],
3	5701	CD	DATE	5701	npadvmod	1	SENT_189	[p13l920t1940r1458b2019],
4	for	IN	O	for	_	0	SENT_189	[p13l1508t1939r1631b2019],
5	the	DT	O	the	det	7	SENT_189	[p13l1678t1940r1811b2018],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_189	[p13l1861t1940r2133b2040, p13l12t2070r446b2168],
7	reaction	NN	O	reaction	prep_for	1	SENT_189	[p13l496t2070r845b2147],
8	to	TO	O	to	_	0	SENT_189	[p13l900t2086r982b2147],
9	abacavir	NN	O	abacavir	prep_to	7	SENT_189	[p13l1037t2069r1393b2148],
10	were	VBD	O	be	auxpass	11	SENT_189	[p13l1441t2095r1642b2148],
11	calculated	VBN	O	calculate	_	0	SENT_189	[p13l1699t2069r2134b2148],
12	with	IN	O	with	_	0	SENT_189	[p13l6t2197r196b2276],
13	the	DT	O	the	det	14	SENT_189	[p13l231t2197r360b2275],
14	use	NN	O	use	prep_with	11	SENT_189	[p13l395t2223r531b2276],
15	of	IN	O	of	_	0	SENT_189	[p13l567t2196r665b2276],
16	data	NNS	O	datum	prep_of	14	SENT_189	[p13l682t2197r859b2276],
17	from	IN	O	from	_	0	SENT_189	[p13l892t2196r1096b2276],
18	the	DT	O	the	det	20	SENT_189	[p13l1132t2197r1260b2275],
19	control	NN	O	control	nn	20	SENT_189	[p13l1297t2197r1590b2276],
20	group	NN	O	group	prep_from	16	SENT_189	[p13l1625t2223r1868b2298],
21	only	RB	O	only	advmod	11	SENT_189	[p13l1905t2197r2094b2297],
22	.	.	O	.	_	0	SENT_189	[p13l1905t2197r2094b2297],

1	572	CD	NUMBER	572	num	4	SENT_190	[p13l149t2373r205b2396],
2	N	NN	O	n	nn	4	SENT_190	[p13l908t2383r921b2398],
3	ENGLJ	NN	O	englj	nn	4	SENT_190	[p13l936t2383r1014b2405],
4	MED	NN	O	med	_	0	SENT_190	[p13l1029t2383r1081b2398],
5	358	CD	NUMBER	358	num	7	SENT_190	[p13l1091t2377r1154b2405],
6	;	:	O	;	_	0	SENT_190	[p13l1091t2377r1154b2405],
7	6	CD	NUMBER	6	dep	4	SENT_190	[p13l1091t2377r1154b2405],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_190	[p13l1188t2383r1389b2405],
9	FEBRUARY	NNP	DATE	FEBRUARY	dep	4	SENT_190	[p13l1426t2383r1547b2399],
10	7	CD	DATE	7	num	9	SENT_190	[p13l1557t2383r1576b2404],
11	,	,	DATE	,	_	0	SENT_190	[p13l1557t2383r1576b2404],
12	2008	CD	DATE	2008	num	9	SENT_190	[p13l1587t2377r1650b2399],

1	The	DT	O	the	det	4	SENT_191	[p13l935t2416r986b2440],
2	New	NNP	O	New	nn	4	SENT_191	[p13l995t2417r1057b2440],
3	England	NNP	O	England	nn	4	SENT_191	[p13l1066t2416r1177b2447],
4	Journal	NNP	O	Journal	_	0	SENT_191	[p13l1186t2416r1283b2440],
5	of	IN	O	of	_	0	SENT_191	[p13l1293t2416r1322b2440],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_191	[p13l1329t2416r1454b2440],

1	HLA-B	NN	O	hla-b	_	0	SENT_192	[p13l584t2604r779b2627],
2	*	CD	NUMBER	*	number	3	SENT_192	[p13l584t2604r779b2627],
3	5701	CD	NUMBER	5701	num	4	SENT_192	[p13l584t2604r779b2627],
4	SCREENING	NNP	O	SCREENING	dep	1	SENT_192	[p13l793t2607r989b2626],
5	FOR	IN	O	for	_	0	SENT_192	[p13l1004t2607r1068b2626],
6	ABACAVIR	NNP	O	ABACAVIR	nn	7	SENT_192	[p13l1079t2607r1244b2626],
7	HYPERSENSITIVITY	NN	O	hypersensitivity	prep_for	4	SENT_192	[p13l1257t2607r1576b2626],

1	RESULTS	NNS	O	result	_	0	SENT_193	[p13l841t2879r1321b2937],

1	A	DT	O	a	det	2	SENT_194	[p13l7t3115r74b3185],
2	total	NN	O	total	nsubjpass	7	SENT_194	[p13l116t3108r315b3186],
3	of	IN	O	of	_	0	SENT_194	[p13l360t3107r461b3186],
4	1956	CD	DATE	1956	num	5	SENT_194	[p13l491t3113r691b3186],
5	patients	NNS	O	patient	prep_of	2	SENT_194	[p13l736t3109r1080b3208],
6	were	VBD	O	be	auxpass	7	SENT_194	[p13l1123t3134r1326b3187],
7	enrolled	VBN	O	enrol	_	0	SENT_194	[p13l1372t3108r1727b3186],
8	and	CC	O	and	_	0	SENT_194	[p13l1771t3108r1930b3186],
9	randomly	RB	O	randomly	advmod	10	SENT_194	[p13l1975t3134r2148b3186, p13l12t3236r283b3337],
10	assigned	VBN	O	assign	conj_and	7	SENT_194	[p13l316t3236r693b3338],
11	to	TO	O	to	_	0	SENT_194	[p13l733t3252r814b3315],
12	a	DT	O	a	det	16	SENT_194	[p13l854t3262r899b3315],
13	study	NN	O	study	nn	16	SENT_194	[p13l938t3236r1169b3337],
14	group	NN	O	group	nn	16	SENT_194	[p13l1204t3262r1458b3338],
15	(	CD	NUMBER	(	num	16	SENT_194	[p13l1503t3237r1685b3338],
16	Fig	NN	O	fig	prep_to	10	SENT_194	[p13l1503t3237r1685b3338],
17	.	.	O	.	_	0	SENT_194	[p13l1503t3237r1685b3338],

1	1	CD	NUMBER	1	_	0	SENT_195	[p13l1733t3241r1828b3328],
2	)	NN	O	)	dep	1	SENT_195	[p13l1733t3241r1828b3328],
3	.	.	O	.	_	0	SENT_195	[p13l1733t3241r1828b3328],

1	Of	IN	O	of	_	0	SENT_196	[p13l1873t3235r1995b3315],
2	the	DT	O	the	det	4	SENT_196	[p13l2016t3236r2149b3315],
3	980	CD	NUMBER	980	num	4	SENT_196	[p13l11t3370r166b3443],
4	patients	NNS	O	patient	prep_of	18	SENT_196	[p13l202t3366r547b3465],
5	in	IN	O	in	_	0	SENT_196	[p13l585t3366r670b3442],
6	the	DT	O	the	det	10	SENT_196	[p13l707t3365r841b3443],
7	prospective	JJ	O	prospective	amod	10	SENT_196	[p13l877t3366r1833b3466],
8	—	NN	O	—	nn	10	SENT_196	[p13l877t3366r1833b3466],
9	screening	NN	O	screening	nn	10	SENT_196	[p13l877t3366r1833b3466],
10	group	NN	O	group	prep_in	4	SENT_196	[p13l1867t3390r2144b3466],
11	,	,	O	,	_	0	SENT_196	[p13l1867t3390r2144b3466],
12	55	CD	PERCENT	55	number	13	SENT_196	[p13l13t3500r106b3571],
13	(	CD	PERCENT	(	nsubjpass	18	SENT_196	[p13l147t3498r409b3584],
14	5.6	CD	PERCENT	5.6	num	15	SENT_196	[p13l147t3498r409b3584],
15	%	NN	PERCENT	%	dep	13	SENT_196	[p13l147t3498r409b3584],
16	)	CD	NUMBER	)	dep	13	SENT_196	[p13l147t3498r409b3584],
17	were	VBD	O	be	auxpass	18	SENT_196	[p13l443t3519r646b3572],
18	excluded	VBN	O	exclude	_	0	SENT_196	[p13l680t3493r1055b3572],
19	from	IN	O	from	_	0	SENT_196	[p13l1087t3492r1299b3571],
20	the	DT	O	the	det	22	SENT_196	[p13l1333t3493r1466b3571],
21	main	JJ	O	main	amod	22	SENT_196	[p13l1499t3494r1722b3571],
22	study	NN	O	study	prep_from	18	SENT_196	[p13l1756t3493r1988b3593],
23	because	IN	O	because	mark	26	SENT_196	[p13l2016t3493r2148b3571, p13l12t3647r246b3700],
24	they	PRP	O	they	nsubj	26	SENT_196	[p13l294t3621r479b3721],
25	were	VBD	O	be	cop	26	SENT_196	[p13l516t3647r719b3700],
26	carriers	NNS	O	carrier	advcl	18	SENT_196	[p13l767t3622r1095b3699],
27	of	IN	O	of	_	0	SENT_196	[p13l1144t3620r1245b3699],
28	the	DT	O	the	det	29	SENT_196	[p13l1274t3621r1407b3699],
29	HLA	NN	O	hlum	prep_of	26	SENT_196	[p13l1454t3621r1996b3699],
30	.	.	O	.	_	0	SENT_196	[p13l1454t3621r1996b3699],

1	—	NN	O	—	_	0	SENT_197	[p13l1454t3621r1996b3699],
2	.	.	O	.	_	0	SENT_197	[p13l1454t3621r1996b3699],

1	B	NN	O	b	_	0	SENT_198	[p13l1454t3621r1996b3699],
2	*	CD	NUMBER	*	number	3	SENT_198	[p13l1454t3621r1996b3699],
3	5701	CD	NUMBER	5701	dep	1	SENT_198	[p13l1454t3621r1996b3699],
4	allele	NN	O	allele	dep	3	SENT_198	[p13l2042t3621r2148b3699, p14l10t21r177b99],
5	.	.	O	.	_	0	SENT_198	[p13l2042t3621r2148b3699, p14l10t21r177b99],

1	The	DT	O	the	det	2	SENT_199	[p14l217t21r379b99],
2	populations	NNS	O	population	nsubj	12	SENT_199	[p14l415t21r932b121],
3	that	WDT	O	that	nsubjpass	6	SENT_199	[p14l972t21r1146b99],
4	could	MD	O	could	aux	6	SENT_199	[p14l1178t21r1414b100],
5	be	VB	O	be	auxpass	6	SENT_199	[p14l1451t21r1549b99],
6	evaluated	VBN	O	evaluate	rcmod	2	SENT_199	[p14l1587t21r1992b100],
7	for	IN	O	for	_	0	SENT_199	[p14l2028t20r2153b99],
8	clinically	RB	O	clinically	advmod	9	SENT_199	[p14l12t149r396b249],
9	diagnosed	VBN	O	diagnose	amod	10	SENT_199	[p14l424t149r863b250],
10	hypersensitivity	NN	O	hypersensitivity	prep_for	6	SENT_199	[p14l894t149r1564b249],
11	reaction	NN	O	reaction	dep	2	SENT_199	[p14l1591t150r1935b227],
12	consisted	VBD	O	consist	_	0	SENT_199	[p14l1967t174r2148b227, p14l12t277r253b355],
13	of	IN	O	of	_	0	SENT_199	[p14l296t276r396b355],
14	803	CD	NUMBER	803	num	15	SENT_199	[p14l422t282r570b356],
15	patients	NNS	O	patient	prep_of	12	SENT_199	[p14l615t278r960b377],
16	in	IN	O	in	_	0	SENT_199	[p14l1004t278r1089b354],
17	the	DT	O	the	det	23	SENT_199	[p14l1132t277r1266b355],
18	prospective	JJ	O	prospective	amod	23	SENT_199	[p14l1308t278r2148b377],
19	—	NN	O	—	nn	23	SENT_199	[p14l1308t278r2148b377],
20	screen	NN	O	screen	nn	23	SENT_199	[p14l1308t278r2148b377],
21	—	CD	NUMBER	—	num	23	SENT_199	[p14l1308t278r2148b377],
22	ing	NN	O	ing	nn	23	SENT_199	[p14l11t406r151b506],
23	group	NN	O	group	prep_in	15	SENT_199	[p14l183t430r437b506],
24	and	CC	O	and	_	0	SENT_199	[p14l473t405r632b483],
25	847	CD	NUMBER	847	num	26	SENT_199	[p14l668t410r818b483],
26	patients	NNS	O	patient	prep_in	15	SENT_199	[p14l853t406r1198b505],
27	in	IN	O	in	_	0	SENT_199	[p14l1234t406r1319b482],
28	the	DT	O	the	det	30	SENT_199	[p14l1355t405r1488b483],
29	control	NN	O	control	nn	30	SENT_199	[p14l1524t405r1832b483],
30	group	NN	O	group	prep_in	12	SENT_199	[p14l1867t430r2144b506],
31	.	.	O	.	_	0	SENT_199	[p14l1867t430r2144b506],

1	The	DT	O	the	det	2	SENT_200	[p14l7t533r170b611],
2	populations	NNS	O	population	nsubj	12	SENT_200	[p14l210t533r726b633],
3	that	WDT	O	that	nsubjpass	6	SENT_200	[p14l770t533r943b611],
4	could	MD	O	could	aux	6	SENT_200	[p14l980t533r1216b612],
5	be	VB	O	be	auxpass	6	SENT_200	[p14l1257t533r1354b611],
6	evaluated	VBN	O	evaluate	rcmod	2	SENT_200	[p14l1396t533r1801b612],
7	for	IN	O	for	_	0	SENT_200	[p14l1841t532r1966b611],
8	immunologically	RB	O	immunologically	advmod	9	SENT_200	[p14l2003t534r2148b610, p14l11t661r621b763],
9	confirmed	VBN	O	confirm	prepc_for	6	SENT_200	[p14l642t660r1090b740],
10	hypersensitivity	NN	O	hypersensitivity	nn	11	SENT_200	[p14l1115t661r1785b762],
11	reaction	NN	O	reaction	dobj	9	SENT_200	[p14l1806t662r2149b740],
12	consisted	VBD	O	consist	_	0	SENT_200	[p14l12t790r400b868],
13	of	IN	O	of	quantmod	14	SENT_200	[p14l431t789r529b868],
14	802	CD	NUMBER	802	num	15	SENT_200	[p14l541t795r687b868],
15	patients	NNS	O	patient	dobj	12	SENT_200	[p14l717t791r1046b890],
16	in	IN	O	in	_	0	SENT_200	[p14l1077t791r1159b867],
17	the	DT	O	the	det	23	SENT_200	[p14l1190t790r1319b868],
18	prospective	JJ	O	prospective	amod	23	SENT_200	[p14l1347t791r2148b890],
19	—	NN	O	—	nn	23	SENT_200	[p14l1347t791r2148b890],
20	screen	NN	O	screen	nn	23	SENT_200	[p14l1347t791r2148b890],
21	—	CD	NUMBER	—	num	23	SENT_200	[p14l1347t791r2148b890],
22	ing	NN	O	ing	nn	23	SENT_200	[p14l11t919r147b1019],
23	group	NN	O	group	prep_in	12	SENT_200	[p14l174t943r428b1019],
24	and	CC	O	and	_	0	SENT_200	[p14l464t918r623b996],
25	842	CD	NUMBER	842	num	26	SENT_200	[p14l658t923r809b996],
26	patients	NNS	O	patient	conj_and	23	SENT_200	[p14l844t919r1188b1018],
27	in	IN	O	in	_	0	SENT_200	[p14l1225t919r1309b995],
28	the	DT	O	the	det	30	SENT_200	[p14l1344t918r1478b996],
29	control	NN	O	control	nn	30	SENT_200	[p14l1514t918r1822b996],
30	group	NN	O	group	prep_in	12	SENT_200	[p14l1856t943r2134b1019],
31	.	.	O	.	_	0	SENT_200	[p14l1856t943r2134b1019],

1	Baseline	NN	O	baseline	nn	2	SENT_201	[p14l139t1047r502b1125],
2	characteristics	NNS	O	characteristic	nsubj	4	SENT_201	[p14l541t1047r1167b1125],
3	were	VBD	O	be	cop	4	SENT_201	[p14l1203t1073r1406b1126],
4	similar	JJ	O	similar	dep	10	SENT_201	[p14l1445t1047r1754b1125],
5	between	IN	O	between	_	0	SENT_201	[p14l1789t1047r2149b1126],
6	the	DT	O	the	det	9	SENT_201	[p14l12t1175r143b1254],
7	two	CD	NUMBER	two	num	9	SENT_201	[p14l180t1192r336b1255],
8	study	NN	O	study	nn	9	SENT_201	[p14l375t1175r601b1276],
9	groups	NNS	O	group	prep_between	4	SENT_201	[p14l632t1201r925b1277],
10	(	VBP	O	(	_	0	SENT_201	[p14l967t1175r1221b1267],
11	Table	NNP	O	Table	dobj	10	SENT_201	[p14l967t1175r1221b1267],
12	1	CD	NUMBER	1	num	11	SENT_201	[p14l1261t1180r1355b1267],
13	)	CD	NUMBER	)	nsubj	10	SENT_201	[p14l1261t1180r1355b1267],
14	.	.	O	.	_	0	SENT_201	[p14l1261t1180r1355b1267],

1	Self-reported	JJ	O	self-reported	amod	2	SENT_202	[p14l1399t1174r1944b1276],
2	race	NN	O	race	nsubj	4	SENT_202	[p14l1979t1201r2149b1254],
3	was	VBD	O	be	cop	4	SENT_202	[p14l7t1328r169b1382],
4	white	JJ	O	white	_	0	SENT_202	[p14l200t1302r437b1382],
5	in	IN	O	in	_	0	SENT_202	[p14l470t1303r553b1380],
6	1397	CD	DATE	1397	prep_in	4	SENT_202	[p14l589t1308r787b1381],
7	of	IN	O	of	_	0	SENT_202	[p14l822t1301r922b1381],
8	the	DT	O	the	det	10	SENT_202	[p14l937t1302r1069b1380],
9	1650	CD	DATE	1650	num	10	SENT_202	[p14l1106t1308r1299b1381],
10	patients	NNS	O	patient	prep_of	6	SENT_202	[p14l1332t1303r1669b1402],
11	who	WP	O	who	nsubjpass	14	SENT_202	[p14l1700t1302r1882b1382],
12	could	MD	O	could	aux	14	SENT_202	[p14l1918t1302r2149b1382],
13	be	VB	O	be	auxpass	14	SENT_202	[p14l12t1430r109b1509],
14	evaluated	VBN	O	evaluate	rcmod	6	SENT_202	[p14l155t1430r560b1510],
15	(	CD	PERCENT	(	number	16	SENT_202	[p14l610t1436r927b1525],
16	84.7	CD	PERCENT	84.7	num	17	SENT_202	[p14l610t1436r927b1525],
17	%	NN	PERCENT	%	dobj	14	SENT_202	[p14l610t1436r927b1525],
18	;	:	O	;	_	0	SENT_202	[p14l610t1436r927b1525],
19	679	CD	NUMBER	679	dep	17	SENT_202	[p14l977t1436r1126b1509],
20	of	IN	O	of	_	0	SENT_202	[p14l1173t1429r1274b1509],
21	the	DT	O	the	det	23	SENT_202	[p14l1301t1430r1434b1508],
22	803	CD	NUMBER	803	num	23	SENT_202	[p14l1481t1436r1628b1509],
23	patients	NNS	O	patient	prep_of	19	SENT_202	[p14l1676t1431r2019b1530],
24	in	IN	O	in	_	0	SENT_202	[p14l2066t1431r2150b1508],
25	the	DT	O	the	det	29	SENT_202	[p14l12t1559r145b1638],
26	prospective	JJ	O	prospective	amod	29	SENT_202	[p14l189t1560r1146b1661],
27	—	NN	O	—	nn	29	SENT_202	[p14l189t1560r1146b1661],
28	screening	NN	O	screening	nn	29	SENT_202	[p14l189t1560r1146b1661],
29	group	NN	O	group	prep_in	23	SENT_202	[p14l1187t1585r1441b1661],
30	and	CC	O	and	_	0	SENT_202	[p14l1487t1559r1646b1639],
31	718	CD	NUMBER	718	dobj	14	SENT_202	[p14l1692t1565r1840b1639],
32	of	IN	O	of	_	0	SENT_202	[p14l1888t1558r1989b1639],
33	the	DT	O	the	det	35	SENT_202	[p14l2016t1559r2149b1638],
34	847	CD	NUMBER	847	num	35	SENT_202	[p14l12t1694r163b1767],
35	patients	NNS	O	patient	prep_of	31	SENT_202	[p14l199t1689r544b1788],
36	in	IN	O	in	_	0	SENT_202	[p14l583t1689r667b1766],
37	the	DT	O	the	det	39	SENT_202	[p14l705t1688r839b1767],
38	control	NN	O	control	nn	39	SENT_202	[p14l878t1688r1186b1767],
39	group	NN	O	group	prep_in	14	SENT_202	[p14l1222t1695r1528b1789],
40	)	CD	NUMBER	)	dep	39	SENT_202	[p14l1222t1695r1528b1789],
41	.	.	O	.	_	0	SENT_202	[p14l1222t1695r1528b1789],

1	The	DT	O	the	det	2	SENT_203	[p14l1567t1688r1730b1766],
2	numbers	NNS	O	number	nsubj	14	SENT_203	[p14l1767t1688r2148b1767],
3	of	IN	O	of	_	0	SENT_203	[p14l12t1815r111b1896],
4	patients	NNS	O	patient	prep_of	2	SENT_203	[p14l125t1817r462b1917],
5	in	IN	O	in	_	0	SENT_203	[p14l497t1817r580b1894],
6	the	DT	O	the	dep	8	SENT_203	[p14l615t1816r747b1895],
7	other	JJ	O	other	amod	8	SENT_203	[p14l781t1816r1007b1896],
8	racial	JJ	O	racial	prep_in	4	SENT_203	[p14l1038t1816r1268b1895],
9	or	CC	O	or	_	0	SENT_203	[p14l1303t1842r1391b1896],
10	ethnic	JJ	O	ethnic	amod	11	SENT_203	[p14l1422t1816r1688b1895],
11	categories	NNS	O	category	prep_in	4	SENT_203	[p14l1721t1817r2148b1918],
12	were	VBD	O	be	cop	14	SENT_203	[p14l7t1970r210b2024],
13	too	RB	O	too	advmod	14	SENT_203	[p14l250t1961r388b2023],
14	small	JJ	O	small	_	0	SENT_203	[p14l431t1944r667b2022],
15	to	TO	O	to	aux	16	SENT_203	[p14l707t1961r788b2023],
16	perform	VB	O	perform	xcomp	14	SENT_203	[p14l828t1943r1186b2044],
17	subanalyses	NNS	O	subanalys	dobj	16	SENT_203	[p14l1227t1944r1767b2044],
18	.	.	O	.	_	0	SENT_203	[p14l1227t1944r1767b2044],

1	After	IN	O	after	_	0	SENT_204	[p14l137t2072r353b2152],
2	the	DT	O	the	det	3	SENT_204	[p14l380t2073r509b2152],
3	exclusion	NN	O	exclusion	prep_after	15	SENT_204	[p14l539t2073r922b2153],
4	of	IN	O	of	_	0	SENT_204	[p14l952t2072r1051b2153],
5	two	CD	NUMBER	two	num	6	SENT_204	[p14l1061t2090r1216b2153],
6	patients	NNS	O	patient	prep_of	3	SENT_204	[p14l1244t2074r1573b2174],
7	with	IN	O	with	_	0	SENT_204	[p14l1600t2073r1790b2153],
8	missing	VBG	O	miss	amod	9	SENT_204	[p14l1819t2074r2152b2175],
9	results	NNS	O	result	prep_with	6	SENT_204	[p14l11t2201r296b2281],
10	from	IN	O	from	_	0	SENT_204	[p14l339t2200r552b2280],
11	one	CD	NUMBER	one	num	12	SENT_204	[p14l593t2227r745b2280],
12	laboratory	NN	O	laboratory	prep_from	9	SENT_204	[p14l785t2201r1248b2301],
13	,	,	O	,	_	0	SENT_204	[p14l785t2201r1248b2301],
14	there	EX	O	there	expl	15	SENT_204	[p14l1295t2201r1514b2279],
15	was	VBD	O	be	_	0	SENT_204	[p14l1551t2227r1715b2281],
16	complete	JJ	O	complete	amod	17	SENT_204	[p14l1758t2201r2149b2301],
17	concordance	NN	O	concordance	nsubj	15	SENT_204	[p14l12t2331r560b2411],
18	between	IN	O	between	_	0	SENT_204	[p14l597t2331r958b2411],
19	the	DT	O	the	det	20	SENT_204	[p14l995t2331r1129b2411],
20	results	NNS	O	result	prep_between	17	SENT_204	[p14l1165t2331r1450b2411],
21	of	IN	O	of	_	0	SENT_204	[p14l1490t2330r1590b2411],
22	HLA	NN	O	hlum	prep_of	20	SENT_204	[p14l1607t2331r2149b2411],
23	.	.	O	.	_	0	SENT_204	[p14l1607t2331r2149b2411],

1	—	NN	O	—	_	0	SENT_205	[p14l1607t2331r2149b2411],
2	.	.	O	.	_	0	SENT_205	[p14l1607t2331r2149b2411],

1	B	NN	O	b	_	0	SENT_206	[p14l1607t2331r2149b2411],
2	*	CD	NUMBER	*	num	3	SENT_206	[p14l1607t2331r2149b2411],
3	5701	CD	NUMBER	5701	dep	1	SENT_206	[p14l1607t2331r2149b2411],

1	screening	NN	O	screening	_	0	SENT_207	[p14l13t2461r425b2562],
2	by	IN	O	by	_	0	SENT_207	[p14l465t2460r562b2561],
3	means	NNS	O	means	prep_by	1	SENT_207	[p14l600t2486r877b2539],
4	of	IN	O	of	_	0	SENT_207	[p14l922t2459r1022b2540],
5	the	DT	O	the	det	12	SENT_207	[p14l1047t2460r1178b2539],
6	sequence	NN	O	sequence	nn	12	SENT_207	[p14l1222t2459r1970b2561],
7	—	NN	O	—	nn	12	SENT_207	[p14l1222t2459r1970b2561],
8	speciﬁc	NN	O	speciﬁc	nn	12	SENT_207	[p14l1222t2459r1970b2561],
9	oli	NN	O	olus	nn	12	SENT_207	[p14l2013t2460r2148b2540],
10	—	NN	O	—	nn	12	SENT_207	[p14l2013t2460r2148b2540],
11	gonucleotide	NN	O	gonucleotide	nn	12	SENT_207	[p14l11t2589r556b2690],
12	probe	NN	O	probe	prep_of	1	SENT_207	[p14l588t2589r835b2689],
13	and	CC	O	and	_	0	SENT_207	[p14l870t2589r1029b2668],
14	DNA	NN	O	dna	nn	15	SENT_207	[p14l1063t2595r1273b2668],
15	sequencing	NN	O	sequencing	conj_and	12	SENT_207	[p14l1306t2590r1815b2690],
16	.	.	O	.	_	0	SENT_207	[p14l1306t2590r1815b2690],

1	A	DT	O	a	det	2	SENT_208	[p14l1853t2597r1919b2667],
2	total	NN	O	total	nsubj	13	SENT_208	[p14l1951t2589r2150b2668],
3	of	IN	O	of	_	0	SENT_208	[p14l12t2715r112b2795],
4	109	CD	NUMBER	109	prep_of	2	SENT_208	[p14l139t2722r286b2795],
5	of	IN	O	of	_	0	SENT_208	[p14l329t2715r430b2795],
6	the	DT	O	the	det	8	SENT_208	[p14l454t2716r587b2794],
7	1956	CD	DATE	1956	num	8	SENT_208	[p14l632t2722r833b2795],
8	patients	NNS	O	patient	prep_of	4	SENT_208	[p14l874t2717r1218b2816],
9	(	RB	O	(	advmod	13	SENT_208	[p14l1266t2721r1529b2807],
10	5.6	CD	PERCENT	5.6	num	11	SENT_208	[p14l1266t2721r1529b2807],
11	%	NN	PERCENT	%	nsubj	13	SENT_208	[p14l1266t2721r1529b2807],
12	)	CD	NUMBER	)	dep	11	SENT_208	[p14l1266t2721r1529b2807],
13	carried	VBD	O	carry	_	0	SENT_208	[p14l1577t2716r1880b2795],
14	HLA	NN	O	hlum	nn	16	SENT_208	[p14l1921t2724r2148b2794],
15	—	NN	O	—	nn	16	SENT_208	[p14l1921t2724r2148b2794],
16	B	NN	O	b	dobj	13	SENT_208	[p14l9t2846r345b2925],
17	*	CD	NUMBER	*	num	18	SENT_208	[p14l9t2846r345b2925],
18	5701	CD	NUMBER	5701	dep	16	SENT_208	[p14l9t2846r345b2925],
19	.	.	O	.	_	0	SENT_208	[p14l9t2846r345b2925],

1	The	DT	O	the	det	2	SENT_209	[p14l138t2974r300b3053],
2	incidences	NNS	O	incidence	nsubj	15	SENT_209	[p14l329t2974r780b3054],
3	of	IN	O	of	prep	2	SENT_209	[p14l813t2973r913b3054],
4	immunologically	RB	O	immunologically	advmod	5	SENT_209	[p14l923t2974r1667b3076],
5	confirmed	VBN	O	confirm	dep	3	SENT_209	[p14l1693t2973r2149b3054],
6	and	CC	O	and	_	0	SENT_209	[p14l11t3103r167b3182],
7	clinically	RB	O	clinically	dep	3	SENT_209	[p14l206t3103r591b3203],
8	diagnosed	VBD	O	diagnose	ccomp	7	SENT_209	[p14l625t3103r1064b3204],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_209	[p14l1102t3103r1772b3203],
10	reaction	NN	O	reaction	dobj	8	SENT_209	[p14l1806t3104r2149b3182],
11	to	TO	O	to	_	0	SENT_209	[p14l12t3248r93b3311],
12	abacavir	NN	O	abacavir	prep_to	8	SENT_209	[p14l141t3231r500b3311],
13	were	VBD	O	be	cop	15	SENT_209	[p14l538t3257r742b3311],
14	significantly	RB	O	significantly	advmod	15	SENT_209	[p14l789t3230r1338b3333],
15	lower	JJR	O	lower	_	0	SENT_209	[p14l1378t3231r1617b3311],
16	in	IN	O	in	_	0	SENT_209	[p14l1659t3232r1744b3309],
17	the	DT	O	the	det	21	SENT_209	[p14l1790t3231r1924b3310],
18	prospective	JJ	O	prospective	amod	21	SENT_209	[p14l1968t3257r2148b3332, p14l13t3361r779b3461],
19	—	NN	O	—	nn	21	SENT_209	[p14l1968t3257r2148b3332, p14l13t3361r779b3461],
20	screening	NN	O	screening	nn	21	SENT_209	[p14l1968t3257r2148b3332, p14l13t3361r779b3461],
21	group	NN	O	group	prep_in	15	SENT_209	[p14l806t3386r1051b3461],
22	than	IN	O	than	prep	15	SENT_209	[p14l1083t3360r1275b3438],
23	in	IN	O	in	pcomp	22	SENT_209	[p14l1304t3361r1386b3438],
24	the	DT	O	the	det	26	SENT_209	[p14l1417t3360r1546b3438],
25	control	NN	O	control	nn	26	SENT_209	[p14l1577t3360r1873b3439],
26	group	NN	O	group	pobj	23	SENT_209	[p14l1902t3386r2148b3461],

1	Table	NNP	O	Table	_	0	SENT_210	[p15l120t55r194b80],
2	1	CD	NUMBER	1	dep	1	SENT_210	[p15l204t57r226b80],
3	.	.	O	.	_	0	SENT_210	[p15l204t57r226b80],

1	Baseline	NN	O	baseline	nn	2	SENT_211	[p15l237t55r350b80],
2	Characteristics	NNS	O	characteristic	_	0	SENT_211	[p15l359t55r562b80],
3	of	IN	O	of	_	0	SENT_211	[p15l571t55r603b80],
4	the	DT	O	the	det	6	SENT_211	[p15l605t55r649b80],
5	Study	NNP	O	Study	nn	6	SENT_211	[p15l658t55r736b88],
6	Population	NNP	O	Population	prep_of	2	SENT_211	[p15l746t55r891b88],
7	That	IN	O	that	nsubjpass	10	SENT_211	[p15l901t55r963b80],
8	Could	MD	O	could	aux	10	SENT_211	[p15l971t55r1050b80],
9	Be	VB	O	be	auxpass	10	SENT_211	[p15l1062t57r1095b80],
10	Evaluated	VBN	O	evaluate	rcmod	6	SENT_211	[p15l1105t55r1236b80],
11	for	IN	O	for	_	0	SENT_211	[p15l1245t55r1284b80],
12	Clinically	RB	O	clinically	advmod	14	SENT_211	[p15l1292t55r1415b88],
13	Diagnosed	JJ	O	diagnosed	amod	14	SENT_211	[p15l1425t55r1569b88],
14	Hypersensitivity	NN	O	hypersensitivity	prep_for	10	SENT_211	[p15l123t97r351b130],
15	.	.	O	.	_	0	SENT_211	[p15l123t97r351b130],

1	Prospective	JJ	O	prospective	amod	4	SENT_212	[p15l945t172r1102b204],
2	Screening	NNP	O	Screening	nn	4	SENT_212	[p15l1112t172r1248b204],
3	Control	NNP	O	Control	nn	4	SENT_212	[p15l1359t171r1459b196],
4	Characteristic	NNP	O	Characteristic	dep	17	SENT_212	[p15l120t209r309b234],
5	(	CD	NUMBER	(	num	6	SENT_212	[p15l1036t211r1066b242],
6	N	NN	O	n	dep	4	SENT_212	[p15l1036t211r1066b242],
7	=	JJ	O	=	dep	11	SENT_212	[p15l1074t221r1091b230],
8	803	CD	NUMBER	803	number	9	SENT_212	[p15l1097t210r1154b242],
9	)	CD	NUMBER	)	num	11	SENT_212	[p15l1097t210r1154b242],
10	(	NN	O	(	nn	11	SENT_212	[p15l1351t211r1381b242],
11	N	NN	O	n	dep	6	SENT_212	[p15l1351t211r1381b242],
12	=	JJ	O	=	amod	6	SENT_212	[p15l1388t221r1405b230],
13	847	CD	NUMBER	847	tmod	12	SENT_212	[p15l1411t210r1468b242],
14	)	CD	NUMBER	)	num	15	SENT_212	[p15l1411t210r1468b242],
15	Sex	NN	O	sex	dep	17	SENT_212	[p15l121t268r166b292],
16	—	CD	NUMBER	—	num	17	SENT_212	[p15l174t282r208b284],
17	no.	NN	O	no.	dep	20	SENT_212	[p15l218t275r258b292],
18	(	CD	PERCENT	(	num	19	SENT_212	[p15l272t268r316b299],
19	%	NN	PERCENT	%	dep	17	SENT_212	[p15l272t268r316b299],
20	)	CD	NUMBER	)	_	0	SENT_212	[p15l272t268r316b299],

1	Male	JJ	O	male	dep	9	SENT_213	[p15l173t324r238b349],
2	595	CD	NUMBER	595	number	3	SENT_213	[p15l1028t326r1074b349],
3	(	CD	NUMBER	(	dep	1	SENT_213	[p15l1088t326r1163b357],
4	74.1	CD	NUMBER	74.1	num	5	SENT_213	[p15l1088t326r1163b357],
5	)	NN	O	)	dep	3	SENT_213	[p15l1088t326r1163b357],
6	602	CD	NUMBER	602	num	7	SENT_213	[p15l1342t326r1389b349],
7	(	NN	O	(	dep	9	SENT_213	[p15l1402t326r1477b357],
8	71.1	CD	NUMBER	71.1	num	9	SENT_213	[p15l1402t326r1477b357],
9	)	CD	NUMBER	)	dep	16	SENT_213	[p15l1402t326r1477b357],
10	Female	JJ	O	female	amod	11	SENT_213	[p15l173t382r270b407],
11	208	CD	NUMBER	208	dep	9	SENT_213	[p15l1028t383r1075b407],
12	(	CD	NUMBER	(	number	13	SENT_213	[p15l1088t384r1163b415],
13	25.9	CD	NUMBER	25.9	num	14	SENT_213	[p15l1088t384r1163b415],
14	)	NN	O	)	dep	11	SENT_213	[p15l1088t384r1163b415],
15	245	CD	NUMBER	245	num	16	SENT_213	[p15l1342t384r1388b407],
16	(	NN	O	(	dep	18	SENT_213	[p15l1402t383r1477b415],
17	28.9	CD	NUMBER	28.9	num	18	SENT_213	[p15l1402t383r1477b415],
18	)	NN	O	)	_	0	SENT_213	[p15l1402t383r1477b415],

1	Age	NNP	O	Age	_	0	SENT_214	[p15l120t441r171b472],
2	—	CD	NUMBER	—	num	3	SENT_214	[p15l180t448r246b472],
3	yr	NN	DURATION	yr	dep	1	SENT_214	[p15l180t448r246b472],

1	Mean	NN	O	mean	_	0	SENT_215	[p15l173t499r246b522],
2	42	CD	NUMBER	42	num	3	SENT_215	[p15l1079t499r1110b522],
3	42	CD	NUMBER	42	dep	1	SENT_215	[p15l1393t499r1424b522],

1	Range	NNP	O	Range	_	0	SENT_216	[p15l173t557r255b588],

1	Race	NN	O	race	nn	4	SENT_217	[p15l123t615r185b637],
2	or	CC	O	or	_	0	SENT_217	[p15l195t621r222b637],
3	ethnic	JJ	O	ethnic	nn	4	SENT_217	[p15l231t612r315b637],
4	group	NN	O	group	dep	9	SENT_217	[p15l324t621r404b645],
5	—	CD	NUMBER	—	num	6	SENT_217	[p15l412t628r446b630],
6	no.	NN	O	no.	dep	4	SENT_217	[p15l456t621r496b637],
7	(	CD	PERCENT	(	num	8	SENT_217	[p15l510t613r576b645],
8	%	NN	PERCENT	%	dep	9	SENT_217	[p15l510t613r576b645],
9	)	NN	O	)	_	0	SENT_217	[p15l510t613r576b645],
10	'	''	O	'	_	0	SENT_217	[p15l510t613r576b645],
11	i	FW	O	i	dep	9	SENT_217	[p15l510t613r576b645],
12	'	''	O	'	_	0	SENT_217	[p15l510t613r576b645],
13	White	NNP	O	White	dep	11	SENT_217	[p15l170t670r250b695],

1	Caucasian	JJ	MISC	caucasian	amod	4	SENT_218	[p15l221t730r359b753],
2	or	CC	O	or	_	0	SENT_218	[p15l371t736r398b753],
3	European	JJ	MISC	european	amod	4	SENT_218	[p15l410t730r536b760],
4	ancestry	NN	O	ancestry	dep	13	SENT_218	[p15l548t732r661b761],
5	665	CD	NUMBER	665	number	6	SENT_218	[p15l1028t730r1074b753],
6	(	CD	NUMBER	(	dep	4	SENT_218	[p15l1088t729r1163b761],
7	82.8	CD	NUMBER	82.8	num	8	SENT_218	[p15l1088t729r1163b761],
8	)	NN	O	)	dep	6	SENT_218	[p15l1088t729r1163b761],
9	702	CD	NUMBER	702	num	10	SENT_218	[p15l1343t729r1389b753],
10	(	NN	O	(	dep	13	SENT_218	[p15l1402t729r1477b761],
11	82.9	CD	NUMBER	82.9	number	12	SENT_218	[p15l1402t729r1477b761],
12	)	CD	NUMBER	)	num	13	SENT_218	[p15l1402t729r1477b761],
13	Arabic	JJ	MISC	arabic	dep	19	SENT_218	[p15l220t785r307b810],
14	or	CC	O	or	_	0	SENT_218	[p15l316t794r344b810],
15	North	JJ	MISC	north	amod	16	SENT_218	[p15l355t785r432b810],
16	African	JJ	MISC	african	amod	17	SENT_218	[p15l442t785r537b810],
17	ancestry	NN	O	ancestry	conj_or	13	SENT_218	[p15l549t790r661b818],
18	12	CD	NUMBER	12	num	19	SENT_218	[p15l1046t788r1075b810],
19	(	NN	O	(	dep	26	SENT_218	[p15l1088t787r1146b818],
20	1.5	CD	NUMBER	1.5	number	21	SENT_218	[p15l1088t787r1146b818],
21	)	CD	NUMBER	)	dep	19	SENT_218	[p15l1088t787r1146b818],
22	13	CD	NUMBER	13	num	23	SENT_218	[p15l1360t787r1387b810],
23	(	NN	O	(	dep	21	SENT_218	[p15l1402t787r1460b818],
24	1.5	CD	NUMBER	1.5	number	25	SENT_218	[p15l1402t787r1460b818],
25	)	CD	NUMBER	)	num	26	SENT_218	[p15l1402t787r1460b818],
26	Black	JJ	O	black	dep	45	SENT_218	[p15l173t843r243b868],
27	96	CD	NUMBER	96	number	28	SENT_218	[p15l1044t845r1075b868],
28	(	CD	NUMBER	(	num	26	SENT_218	[p15l1088t845r1163b876],
29	12.0	CD	NUMBER	12.0	num	30	SENT_218	[p15l1088t845r1163b876],
30	)	NN	O	)	dep	26	SENT_218	[p15l1088t845r1163b876],
31	96	CD	NUMBER	96	number	32	SENT_218	[p15l1358t845r1389b868],
32	(	CD	NUMBER	(	num	34	SENT_218	[p15l1402t845r1477b876],
33	11.3	CD	NUMBER	11.3	number	34	SENT_218	[p15l1402t845r1477b876],
34	)	CD	NUMBER	)	npadvmod	35	SENT_218	[p15l1402t845r1477b876],
35	American	JJ	MISC	american	dep	30	SENT_218	[p15l170t902r299b926],
36	Indian	JJ	MISC	indian	amod	35	SENT_218	[p15l313t901r395b926],
37	or	CC	O	or	_	0	SENT_218	[p15l407t909r435b926],
38	Alaskan	JJ	MISC	alaskan	amod	41	SENT_218	[p15l443t901r548b926],
39	native	JJ	O	native	amod	41	SENT_218	[p15l561t903r640b926],
40	8	CD	NUMBER	8	num	41	SENT_218	[p15l1061t902r1075b926],
41	(	NN	O	(	conj_or	26	SENT_218	[p15l1088t902r1146b934],
42	1.0	CD	NUMBER	1.0	number	43	SENT_218	[p15l1088t902r1146b934],
43	)	CD	NUMBER	)	dep	41	SENT_218	[p15l1088t902r1146b934],
44	10	CD	NUMBER	10	num	45	SENT_218	[p15l1360t902r1390b926],
45	(	NN	O	(	dep	52	SENT_218	[p15l1402t903r1460b934],
46	1.2	CD	NUMBER	1.2	number	47	SENT_218	[p15l1402t903r1460b934],
47	)	CD	NUMBER	)	dep	45	SENT_218	[p15l1402t903r1460b934],
48	Mixed	NNP	O	Mixed	dep	47	SENT_218	[p15l173t958r252b983],
49	7	CD	NUMBER	7	num	48	SENT_218	[p15l1062t960r1075b983],
50	(	CD	NUMBER	(	num	52	SENT_218	[p15l1088t960r1146b991],
51	0.9	CD	NUMBER	0.9	num	52	SENT_218	[p15l1088t960r1146b991],
52	)	NN	O	)	dep	58	SENT_218	[p15l1088t960r1146b991],
53	11	CD	NUMBER	11	num	54	SENT_218	[p15l1360t960r1388b983],
54	(	NN	O	(	dep	52	SENT_218	[p15l1402t960r1460b991],
55	1.3	CD	NUMBER	1.3	number	56	SENT_218	[p15l1402t960r1460b991],
56	)	CD	NUMBER	)	dep	54	SENT_218	[p15l1402t960r1460b991],
57	Other	JJ	O	other	amod	58	SENT_218	[p15l171t1016r250b1041],
58	14	CD	NUMBER	14	dep	63	SENT_218	[p15l1046t1018r1075b1041],
59	(	CD	NUMBER	(	number	60	SENT_218	[p15l1088t1018r1146b1049],
60	1.7	CD	NUMBER	1.7	dep	58	SENT_218	[p15l1088t1018r1146b1049],
61	)	CD	NUMBER	)	num	62	SENT_218	[p15l1088t1018r1146b1049],
62	15	CD	NUMBER	15	dep	60	SENT_218	[p15l1360t1018r1388b1041],
63	(	NN	O	(	dep	67	SENT_218	[p15l1402t1018r1460b1049],
64	1.8	CD	NUMBER	1.8	num	63	SENT_218	[p15l1402t1018r1460b1049],
65	)	CD	NUMBER	)	num	67	SENT_218	[p15l1402t1018r1460b1049],
66	Previous	JJ	O	previous	amod	67	SENT_218	[p15l123t1076r237b1099],
67	receipt	NN	O	receipt	_	0	SENT_218	[p15l249t1076r340b1106],
68	ofantiretroviral	JJ	O	ofantiretroviral	amod	69	SENT_218	[p15l350t1073r558b1099],
69	drugs	NNS	O	drug	nsubj	70	SENT_218	[p15l569t1074r645b1107],
70	—	VBP	O	—	rcmod	67	SENT_218	[p15l655t1089r688b1091],
71	no.	RB	O	no.	advmod	70	SENT_218	[p15l699t1082r738b1099],
72	(	CD	PERCENT	(	number	73	SENT_218	[p15l752t1075r797b1107],
73	%	NN	PERCENT	%	num	74	SENT_218	[p15l752t1075r797b1107],
74	)	CD	NUMBER	)	dobj	70	SENT_218	[p15l752t1075r797b1107],

1	No	DT	O	no	det	3	SENT_219	[p15l173t1133r212b1156],
2	147	CD	NUMBER	147	num	3	SENT_219	[p15l1029t1133r1075b1156],
3	(	NN	O	(	dep	8	SENT_219	[p15l1088t1133r1163b1164],
4	18.3	CD	NUMBER	18.3	num	5	SENT_219	[p15l1088t1133r1163b1164],
5	)	NN	O	)	dep	3	SENT_219	[p15l1088t1133r1163b1164],
6	149	CD	NUMBER	149	num	7	SENT_219	[p15l1343t1133r1389b1156],
7	(	NN	O	(	dep	8	SENT_219	[p15l1402t1133r1477b1164],
8	17.6	CD	NUMBER	17.6	dep	14	SENT_219	[p15l1402t1133r1477b1164],
9	)	CD	NUMBER	)	dep	8	SENT_219	[p15l1402t1133r1477b1164],
10	Yes	UH	O	yes	dep	12	SENT_219	[p15l170t1191r217b1214],
11	656	CD	NUMBER	656	num	12	SENT_219	[p15l1028t1191r1075b1214],
12	(	CD	NUMBER	(	rcmod	9	SENT_219	[p15l1088t1190r1163b1222],
13	81.7	CD	NUMBER	81.7	num	14	SENT_219	[p15l1088t1190r1163b1222],
14	)	NN	O	)	dep	16	SENT_219	[p15l1088t1190r1163b1222],
15	698	CD	NUMBER	698	num	16	SENT_219	[p15l1342t1191r1389b1214],
16	(	NN	O	(	dep	38	SENT_219	[p15l1402t1190r1477b1222],
17	82.4	CD	NUMBER	82.4	number	18	SENT_219	[p15l1402t1190r1477b1222],
18	)	CD	NUMBER	)	npadvmod	19	SENT_219	[p15l1402t1190r1477b1222],
19	Concurrent	JJ	O	concurrent	dep	38	SENT_219	[p15l121t1248r275b1272],
20	PI	NN	O	pi	nn	21	SENT_219	[p15l286t1249r308b1271],
21	use	NN	O	use	dep	32	SENT_219	[p15l322t1255r409b1272],
22	—	CD	NUMBER	—	num	23	SENT_219	[p15l322t1255r409b1272],
23	no.	NN	O	no.	dep	21	SENT_219	[p15l419t1255r459b1272],
24	(	CD	PERCENT	(	num	25	SENT_219	[p15l473t1248r517b1280],
25	%	NN	PERCENT	%	dep	23	SENT_219	[p15l473t1248r517b1280],
26	)	CD	NUMBER	)	number	27	SENT_219	[p15l473t1248r517b1280],
27	358	CD	NUMBER	358	num	25	SENT_219	[p15l1028t1248r1075b1272],
28	(	NN	O	(	dep	32	SENT_219	[p15l1088t1249r1163b1279],
29	44.6	CD	NUMBER	44.6	num	28	SENT_219	[p15l1088t1249r1163b1279],
30	)	NN	O	)	nn	32	SENT_219	[p15l1088t1249r1163b1279],
31	370	CD	NUMBER	370	num	32	SENT_219	[p15l1342t1248r1390b1272],
32	(	NN	O	(	dep	38	SENT_219	[p15l1402t1249r1477b1279],
33	43.7	CD	NUMBER	43.7	number	34	SENT_219	[p15l1402t1249r1477b1279],
34	)	CD	NUMBER	)	dep	32	SENT_219	[p15l1402t1249r1477b1279],
35	Introduction	NN	O	introduction	nn	37	SENT_219	[p15l123t1304r290b1329],
36	ofNNRT	NN	O	ofnnrt	nn	37	SENT_219	[p15l302t1304r430b1329],
37	|	NN	O	|	dep	34	SENT_219	[p15l302t1304r430b1329],
38	after	IN	O	after	_	0	SENT_219	[p15l443t1304r503b1329],
39	screening	VBG	O	screen	pcomp	38	SENT_219	[p15l513t1306r686b1337],
40	—	JJ	O	—	amod	41	SENT_219	[p15l513t1306r686b1337],
41	no.	NN	O	no.	nsubj	43	SENT_219	[p15l696t1313r736b1329],
42	(	CD	PERCENT	(	num	43	SENT_219	[p15l750t1305r794b1337],
43	%	NN	PERCENT	%	xcomp	39	SENT_219	[p15l750t1305r794b1337],
44	)	CD	NUMBER	)	num	46	SENT_219	[p15l750t1305r794b1337],
45	87	CD	NUMBER	87	num	46	SENT_219	[p15l1044t1306r1075b1330],
46	(	NN	O	(	dep	43	SENT_219	[p15l1088t1306r1163b1337],
47	10.8	CD	NUMBER	10.8	number	48	SENT_219	[p15l1088t1306r1163b1337],
48	)	CD	NUMBER	)	dep	43	SENT_219	[p15l1088t1306r1163b1337],
49	79	CD	NUMBER	79	num	50	SENT_219	[p15l1360t1306r1389b1329],
50	(	NN	O	(	dep	48	SENT_219	[p15l1402t1306r1460b1337],
51	9.3	CD	NUMBER	9.3	num	52	SENT_219	[p15l1402t1306r1460b1337],
52	)	NN	O	)	dep	39	SENT_219	[p15l1402t1306r1460b1337],

1	*	NN	O	*	nsubjpass	6	SENT_220	[p15l94t1391r109b1406],
2	All	DT	O	all	det	4	SENT_220	[p15l119t1389r152b1414],
3	P	NN	O	p	nn	4	SENT_220	[p15l167t1391r181b1414],
4	values	NNS	O	value	dep	1	SENT_220	[p15l191t1389r276b1414],
5	were	VBD	O	be	auxpass	6	SENT_220	[p15l288t1398r351b1414],
6	calculated	VBN	O	calculate	_	0	SENT_220	[p15l363t1389r498b1414],
7	post	NN	O	post	ccomp	6	SENT_220	[p15l512t1394r570b1422],
8	hoc	FW	O	hoc	dobj	7	SENT_220	[p15l582t1389r636b1414],
9	.	.	O	.	_	0	SENT_220	[p15l582t1389r636b1414],

1	The	DT	O	the	det	3	SENT_221	[p15l648t1389r698b1414],
2	P	NN	O	p	nn	3	SENT_221	[p15l712t1391r726b1414],
3	value	NN	O	value	nsubj	4	SENT_221	[p15l737t1389r808b1414],
4	reported	VBD	O	report	_	0	SENT_221	[p15l820t1389r933b1422],
5	for	IN	O	for	mark	11	SENT_221	[p15l945t1389r983b1414],
6	race	NN	O	race	nsubjpass	11	SENT_221	[p15l995t1398r1049b1414],
7	or	CC	O	or	_	0	SENT_221	[p15l1060t1398r1088b1414],
8	ethnic	JJ	O	ethnic	amod	9	SENT_221	[p15l1098t1389r1182b1414],
9	group	NN	O	group	conj_or	6	SENT_221	[p15l1193t1398r1272b1422],
10	was	VBD	O	be	auxpass	11	SENT_221	[p15l1283t1398r1334b1414],
11	calculated	VBN	O	calculate	advcl	4	SENT_221	[p15l1346t1389r1481b1414],
12	for	IN	O	for	_	0	SENT_221	[p15l1494t1389r1532b1414],
13	the	DT	O	the	det	14	SENT_221	[p15l1541t1389r1584b1414],
14	comparison	NN	O	comparison	prep_for	11	SENT_221	[p15l1595t1391r1756b1422],
15	between	IN	O	between	_	0	SENT_221	[p15l121t1426r231b1451],
16	both	DT	O	both	det	19	SENT_221	[p15l245t1426r304b1451],
17	subgroups	NNS	O	subgroup	nn	19	SENT_221	[p15l317t1426r461b1459],
18	ofwhite	JJ	O	ofwhite	amod	19	SENT_221	[p15l473t1426r582b1451],
19	patients	NNS	O	patient	prep_between	14	SENT_221	[p15l594t1428r701b1459],
20	and	CC	O	and	_	0	SENT_221	[p15l714t1426r762b1451],
21	all	DT	O	all	det	23	SENT_221	[p15l775t1426r803b1451],
22	other	JJ	O	other	amod	23	SENT_221	[p15l816t1426r887b1451],
23	patients	NNS	O	patient	conj_and	19	SENT_221	[p15l899t1428r1014b1459],
24	.	.	O	.	_	0	SENT_221	[p15l899t1428r1014b1459],

1	NNRTI	NNP	ORGANIZATION	NNRTI	nsubj	2	SENT_222	[p15l1029t1428r1120b1451],
2	denotes	VBZ	O	denote	_	0	SENT_222	[p15l1134t1426r1241b1451],
3	nonnucleoside	JJ	O	nonnucleoside	amod	5	SENT_222	[p15l1255t1426r1454b1451],
4	reverse-transcriptase	NN	O	reverse-transcriptase	nn	5	SENT_222	[p15l1467t1428r1752b1459],
5	inhibitor	NN	O	inhibitor	dobj	2	SENT_222	[p15l121t1463r242b1493],
6	,	,	O	,	_	0	SENT_222	[p15l121t1463r242b1493],
7	and	CC	O	and	_	0	SENT_222	[p15l255t1463r303b1489],
8	PI	NN	O	pi	nn	10	SENT_222	[p15l318t1465r340b1488],
9	protease	NN	O	protease	nn	10	SENT_222	[p15l355t1468r471b1496],
10	inhibitor	NN	O	inhibitor	conj_and	5	SENT_222	[p15l483t1463r605b1489],
11	.	.	O	.	_	0	SENT_222	[p15l483t1463r605b1489],

1	1	CD	NUMBER	1	number	2	SENT_223	[p15l95t1502r111b1533],
2	‘	CD	NUMBER	‘	num	3	SENT_223	[p15l95t1502r111b1533],
3	Race	NN	O	race	nsubj	8	SENT_223	[p15l122t1502r183b1525],
4	or	CC	O	or	_	0	SENT_223	[p15l194t1509r222b1525],
5	ethnic	JJ	O	ethnic	amod	6	SENT_223	[p15l233t1500r316b1525],
6	group	NN	O	group	conj_or	3	SENT_223	[p15l327t1509r406b1533],
7	was	VBD	O	be	cop	8	SENT_223	[p15l417t1509r468b1525],
8	self-reported	JJ	O	self-reported	_	0	SENT_223	[p15l481t1500r660b1533],
9	.	.	O	.	_	0	SENT_223	[p15l481t1500r660b1533],

1	One	CD	NUMBER	one	num	2	SENT_224	[p15l673t1502r730b1525],
2	patient	NN	O	patient	nsubj	9	SENT_224	[p15l742t1502r836b1533],
3	in	IN	O	in	_	0	SENT_224	[p15l848t1502r869b1525],
4	the	DT	O	the	det	6	SENT_224	[p15l881t1500r924b1525],
5	prospective-screening	JJ	O	prospective-screening	amod	6	SENT_224	[p15l937t1502r1236b1533],
6	group	NN	O	group	prep_in	2	SENT_224	[p15l1247t1509r1327b1533],
7	did	VBD	O	do	aux	9	SENT_224	[p15l1338t1500r1379b1525],
8	not	RB	O	not	neg	9	SENT_224	[p15l1393t1505r1436b1525],
9	provide	VB	O	provide	_	0	SENT_224	[p15l1448t1500r1549b1533],
10	this	DT	O	this	det	11	SENT_224	[p15l1559t1500r1608b1525],
11	information	NN	O	information	dobj	9	SENT_224	[p15l1622t1500r1736b1525, p15l119t1539r179b1562],
12	.	.	O	.	_	0	SENT_224	[p15l1622t1500r1736b1525, p15l119t1539r179b1562],

1	“	NN	O	“	nsubj	4	SENT_225	[p15l193t1537r298b1562],
2	Other	JJ	O	other	amod	1	SENT_225	[p15l193t1537r298b1562],
3	"	``	O	"	punct	4	SENT_225	[p15l193t1537r298b1562],
4	includes	VBZ	O	include	dep	28	SENT_225	[p15l311t1537r423b1562],
5	all	DT	O	all	det	7	SENT_225	[p15l435t1537r463b1562],
6	racial	JJ	O	racial	amod	7	SENT_225	[p15l478t1537r546b1562],
7	categories	NNS	O	category	dobj	4	SENT_225	[p15l559t1539r697b1570],
8	for	IN	O	for	_	0	SENT_225	[p15l709t1537r747b1562],
9	which	WDT	O	which	rel	11	SENT_225	[p15l756t1537r835b1562],
10	there	EX	O	there	expl	11	SENT_225	[p15l846t1537r916b1562],
11	were	VBD	O	be	rcmod	7	SENT_225	[p15l926t1546r990b1562],
12	less	JJR	O	less	mwe	13	SENT_225	[p15l1003t1537r1052b1562],
13	than	IN	O	than	quantmod	14	SENT_225	[p15l1063t1537r1122b1562],
14	1	CD	PERCENT	1	num	15	SENT_225	[p15l1137t1538r1178b1563],
15	%	NN	PERCENT	%	nsubj	11	SENT_225	[p15l1137t1538r1178b1563],
16	of	IN	O	of	_	0	SENT_225	[p15l1189t1537r1219b1562],
17	patients	NNS	O	patient	prep_of	15	SENT_225	[p15l1227t1539r1334b1570],
18	in	IN	O	in	_	0	SENT_225	[p15l1347t1539r1369b1562],
19	either	CC	O	either	advmod	21	SENT_225	[p15l1382t1537r1460b1562],
20	study	NN	O	study	nn	21	SENT_225	[p15l1471t1537r1543b1570],
21	group	NN	O	group	prep_in	17	SENT_225	[p15l1554t1546r1641b1570],
22	,	,	O	,	_	0	SENT_225	[p15l1554t1546r1641b1570],
23	including	VBG	O	include	_	0	SENT_225	[p15l1654t1537r1780b1570],
24	patients	NNS	O	patient	prep_including	11	SENT_225	[p15l121t1576r228b1607],
25	reporting	VBG	O	report	partmod	24	SENT_225	[p15l242t1576r366b1607],
26	both	CC	O	both	prep	25	SENT_225	[p15l378t1574r437b1599],
27	categories	NNS	O	category	dep	26	SENT_225	[p15l450t1576r588b1607],
28	ofwhite	VBP	O	ofwhite	_	0	SENT_225	[p15l600t1574r708b1599],
29	ancestry	NN	O	ancestry	dobj	28	SENT_225	[p15l720t1579r833b1607],
30	(	CD	NUMBER	(	number	31	SENT_225	[p15l846t1576r903b1607],
31	two	CD	NUMBER	two	nsubj	28	SENT_225	[p15l846t1576r903b1607],
32	in	IN	O	in	_	0	SENT_225	[p15l916t1576r938b1599],
33	the	DT	O	the	det	37	SENT_225	[p15l950t1574r992b1599],
34	prospective	JJ	O	prospective	amod	37	SENT_225	[p15l1005t1576r1304b1607],
35	—	NN	O	—	nn	37	SENT_225	[p15l1005t1576r1304b1607],
36	screening	NN	O	screening	nn	37	SENT_225	[p15l1005t1576r1304b1607],
37	group	NN	O	group	prep_in	31	SENT_225	[p15l1315t1583r1395b1607],
38	and	CC	O	and	_	0	SENT_225	[p15l1407t1574r1455b1599],
39	three	CD	NUMBER	three	nsubj	28	SENT_225	[p15l1467t1574r1536b1599],
40	in	IN	O	in	_	0	SENT_225	[p15l1548t1576r1570b1599],
41	the	DT	O	the	det	43	SENT_225	[p15l1582t1574r1624b1599],
42	control	NN	O	control	nn	43	SENT_225	[p15l1636t1574r1730b1599],
43	group	NN	O	group	prep_in	39	SENT_225	[p15l120t1613r219b1644],
44	)	CD	NUMBER	)	dep	39	SENT_225	[p15l120t1613r219b1644],
45	.	.	O	.	_	0	SENT_225	[p15l120t1613r219b1644],

1	NENGL	NN	O	nengl	nn	3	SENT_226	[p15l567t1758r673b1780],
2	)	CD	NUMBER	)	num	3	SENT_226	[p15l567t1758r673b1780],
3	MED358	NN	O	med358	_	0	SENT_226	[p15l688t1752r813b1780],
4	;	:	O	;	_	0	SENT_226	[p15l688t1752r813b1780],
5	6	CD	NUMBER	6	num	6	SENT_226	[p15l688t1752r813b1780],
6	WWW	NN	O	www	dep	3	SENT_226	[p15l847t1758r1048b1780],
7	.	.	O	.	_	0	SENT_226	[p15l847t1758r1048b1780],

1	NE	NNS	O	ne	nsubj	2	SENT_227	[p15l847t1758r1048b1780],
2	)	VBP	O	)	_	0	SENT_227	[p15l847t1758r1048b1780],
3	M.ORG	NN	O	m.org	nn	4	SENT_227	[p15l847t1758r1048b1780],
4	FEBRUARY7	NN	O	february7	dobj	2	SENT_227	[p15l1085t1758r1235b1779],
5	,	,	O	,	_	0	SENT_227	[p15l1085t1758r1235b1779],
6	2008	CD	DATE	2008	num	7	SENT_227	[p15l1246t1752r1309b1774],
7	573	CD	NUMBER	573	appos	4	SENT_227	[p15l2011t1748r2066b1771],

1	The	DT	O	the	det	4	SENT_228	[p15l753t1815r804b1839],
2	New	NNP	O	New	nn	4	SENT_228	[p15l813t1816r875b1839],
3	England	NNP	O	England	nn	4	SENT_228	[p15l884t1815r995b1846],
4	Journal	NNP	O	Journal	_	0	SENT_228	[p15l1003t1815r1101b1839],
5	of	IN	O	of	_	0	SENT_228	[p15l1110t1815r1139b1839],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_228	[p15l1146t1815r1271b1839],

1	Copyright	NN	O	copyright	_	0	SENT_229	[p15l545t1897r680b1928],
2	©	CD	NUMBER	©	num	6	SENT_229	[p15l689t1897r712b1921],
3	2008	CD	DATE	2008	num	6	SENT_229	[p15l722t1897r787b1921],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_229	[p15l797t1897r988b1921],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_229	[p15l998t1897r1106b1921],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_229	[p15l1116t1897r1221b1928],
7	.	.	O	.	_	0	SENT_229	[p15l1116t1897r1221b1928],

1	All	DT	O	all	det	2	SENT_230	[p15l1232t1897r1274b1921],
2	rights	NNS	O	rights	nsubj	3	SENT_230	[p15l1283t1897r1357b1928],
3	reserved	VBN	O	reserve	_	0	SENT_230	[p15l1367t1897r1486b1921],
4	.	.	O	.	_	0	SENT_230	[p15l1367t1897r1486b1921],

1	The	DT	O	the	det	4	SENT_231	[p15l670t1940r716b1961],
2	NEW	NNP	O	NEW	nn	4	SENT_231	[p15l734t1942r820b1961],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_231	[p15l839t1942r1027b1961],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_231	[p15l1046t1942r1226b1968],
5	of	IN	O	of	_	0	SENT_231	[p15l1246t1940r1274b1967],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_231	[p15l1286t1942r1485b1961],

1	Table	NNP	O	Table	_	0	SENT_232	[p15l261t2070r335b2095],
2	2	CD	NUMBER	2	dep	1	SENT_232	[p15l344t2073r366b2095],
3	.	.	O	.	_	0	SENT_232	[p15l344t2073r366b2095],

1	Incidence	NN	O	incidence	_	0	SENT_233	[p15l378t2070r508b2095],
2	of	IN	O	of	_	0	SENT_233	[p15l517t2070r548b2095],
3	Hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_233	[p15l554t2071r775b2103],
4	Reaction	NN	O	reaction	prep_of	1	SENT_233	[p15l785t2071r900b2095],
5	to	TO	O	to	_	0	SENT_233	[p15l910t2074r937b2095],
6	Abacavir	NNP	O	Abacavir	prep_to	1	SENT_233	[p15l945t2070r1088b2096],
7	.	.	O	.	_	0	SENT_233	[p15l945t2070r1088b2096],

1	*	NN	O	*	_	0	SENT_234	[p15l945t2070r1088b2096],

1	Prospective	JJ	O	prospective	amod	2	SENT_235	[p15l966t2146r1123b2178],
2	Odds	NNS	O	odds	_	0	SENT_235	[p15l1517t2146r1591b2171],
3	Ratio	NNP	O	Ratio	nn	8	SENT_235	[p15l1604t2146r1672b2171],
4	Hypersensitivity	NNP	O	Hypersensitivity	nn	8	SENT_235	[p15l263t2184r484b2216],
5	Reaction	NNP	O	Reaction	nn	8	SENT_235	[p15l496t2184r611b2208],
6	Screening	NNP	O	Screening	nn	8	SENT_235	[p15l975t2184r1111b2216],
7	Control	NNP	O	Control	nn	8	SENT_235	[p15l1268t2183r1368b2208],
8	(	NNP	O	(	dep	2	SENT_235	[p15l1528t2185r1596b2216],
9	95	CD	PERCENT	95	number	10	SENT_235	[p15l1528t2185r1596b2216],
10	%	NN	PERCENT	%	amod	11	SENT_235	[p15l1528t2185r1596b2216],
11	Cl	NN	O	cl	dep	8	SENT_235	[p15l1607t2185r1663b2216],
12	)	CD	NUMBER	)	num	13	SENT_235	[p15l1607t2185r1663b2216],
13	*	NN	O	*	dep	2	SENT_235	[p15l1607t2185r1663b2216],

1	no.	NN	O	no.	_	0	SENT_236	[p15l997t2250r1034b2266],
2	of	IN	O	of	_	0	SENT_236	[p15l1046t2241r1076b2274],
3	patients/total	JJ	O	patients/total	amod	4	SENT_236	[p15l1077t2241r1257b2274],
4	no.	NN	O	no.	prep_of	1	SENT_236	[p15l1266t2250r1302b2266],
5	(	CD	PERCENT	(	num	6	SENT_236	[p15l1317t2242r1362b2274],
6	%	NN	PERCENT	%	dep	1	SENT_236	[p15l1317t2242r1362b2274],
7	)	CD	NUMBER	)	dep	6	SENT_236	[p15l1317t2242r1362b2274],

1	Clinically	RB	O	clinically	advmod	2	SENT_237	[p15l262t2299r383b2332],
2	diagnosed	VBN	O	diagnose	_	0	SENT_237	[p15l393t2299r532b2332],
3	Total	JJ	O	total	amod	4	SENT_237	[p15l311t2356r378b2381],
4	population	NN	O	population	dobj	2	SENT_237	[p15l391t2356r536b2389],
5	that	WDT	O	that	nsubjpass	8	SENT_237	[p15l547t2356r600b2381],
6	could	MD	O	could	aux	8	SENT_237	[p15l610t2356r683b2382],
7	be	VB	O	be	auxpass	8	SENT_237	[p15l695t2356r725b2381],
8	evaluated	VBN	O	evaluate	rcmod	4	SENT_237	[p15l735t2356r863b2382],
9	27/803	CD	NUMBER	27/803	num	10	SENT_237	[p15l959t2358r1052b2389],
10	(	NN	O	(	dobj	8	SENT_237	[p15l1067t2358r1124b2389],
11	3.4	CD	NUMBER	3.4	number	12	SENT_237	[p15l1067t2358r1124b2389],
12	)	CD	NUMBER	)	dep	10	SENT_237	[p15l1067t2358r1124b2389],
13	66/847	CD	NUMBER	66/847	num	14	SENT_237	[p15l1235t2358r1329b2389],
14	(	NN	O	(	dep	21	SENT_237	[p15l1342t2358r1400b2389],
15	7.8	CD	NUMBER	7.8	number	16	SENT_237	[p15l1342t2358r1400b2389],
16	)	CD	NUMBER	)	dep	14	SENT_237	[p15l1342t2358r1400b2389],
17	0.40	CD	NUMBER	0.40	dep	16	SENT_237	[p15l1483t2358r1540b2382],
18	(	NN	O	(	dep	21	SENT_237	[p15l1553t2358r1702b2389],
19	0.25	CD	NUMBER	0.25	num	18	SENT_237	[p15l1553t2358r1702b2389],
20	—	CD	NUMBER	—	num	21	SENT_237	[p15l1553t2358r1702b2389],
21	0.62	CD	NUMBER	0.62	dep	26	SENT_237	[p15l1553t2358r1702b2389],
22	)	CD	NUMBER	)	num	24	SENT_237	[p15l1553t2358r1702b2389],
23	White	NNP	O	White	nn	24	SENT_237	[p15l311t2414r391b2439],
24	subgroup	NN	O	subgroup	dep	21	SENT_237	[p15l401t2414r531b2447],
25	24/679	CD	NUMBER	24/679	num	26	SENT_237	[p15l959t2416r1053b2447],
26	(	NN	O	(	dep	30	SENT_237	[p15l1067t2416r1124b2447],
27	3.5	CD	NUMBER	3.5	number	28	SENT_237	[p15l1067t2416r1124b2447],
28	)	CD	NUMBER	)	dep	26	SENT_237	[p15l1067t2416r1124b2447],
29	61/718	CD	NUMBER	61/718	dep	28	SENT_237	[p15l1235t2416r1329b2447],
30	(	NN	O	(	dep	33	SENT_237	[p15l1342t2416r1400b2447],
31	8.5	CD	NUMBER	8.5	num	30	SENT_237	[p15l1342t2416r1400b2447],
32	)	CD	NUMBER	)	num	33	SENT_237	[p15l1342t2416r1400b2447],
33	0.38	CD	NUMBER	0.38	dep	10	SENT_237	[p15l1483t2416r1539b2439],
34	(	CD	NUMBER	(	num	35	SENT_237	[p15l1553t2416r1702b2447],
35	O.	NNP	O	O.	dep	33	SENT_237	[p15l1553t2416r1702b2447],
36	23	CD	NUMBER	23	num	35	SENT_237	[p15l1553t2416r1702b2447],
37	—	CD	NUMBER	—	number	38	SENT_237	[p15l1553t2416r1702b2447],
38	0.62	CD	NUMBER	0.62	num	39	SENT_237	[p15l1553t2416r1702b2447],
39	)	NN	O	)	dep	35	SENT_237	[p15l1553t2416r1702b2447],
40	immunologically	RB	O	immunologically	advmod	41	SENT_237	[p15l264t2472r492b2505],
41	confirmed	VBD	O	confirm	dep	2	SENT_237	[p15l501t2471r639b2497],
42	Total	JJ	O	total	amod	43	SENT_237	[p15l311t2529r378b2555],
43	population	NN	O	population	dobj	41	SENT_237	[p15l391t2529r536b2562],
44	that	WDT	O	that	nsubjpass	47	SENT_237	[p15l547t2529r600b2555],
45	could	MD	O	could	aux	47	SENT_237	[p15l610t2529r683b2555],
46	be	VB	O	be	auxpass	47	SENT_237	[p15l695t2529r725b2555],
47	evaluated	VBN	O	evaluate	rcmod	43	SENT_237	[p15l735t2529r863b2555],
48	0/802	CD	NUMBER	0/802	number	49	SENT_237	[p15l972t2531r1049b2562],
49	23/842	CD	NUMBER	23/842	num	50	SENT_237	[p15l1235t2531r1329b2562],
50	(	NN	O	(	dobj	47	SENT_237	[p15l1342t2531r1400b2562],
51	2.7	CD	NUMBER	2.7	num	52	SENT_237	[p15l1342t2531r1400b2562],
52	)	NN	O	)	nsubj	2	SENT_237	[p15l1342t2531r1400b2562],
53	0.03	CD	NUMBER	0.03	dep	52	SENT_237	[p15l1483t2531r1538b2555],
54	(	CD	NUMBER	(	number	55	SENT_237	[p15l1553t2531r1702b2562],
55	0.00	CD	NUMBER	0.00	dep	53	SENT_237	[p15l1553t2531r1702b2562],
56	.	.	O	.	_	0	SENT_237	[p15l1553t2531r1702b2562],

1	—	NN	O	—	_	0	SENT_238	[p15l1553t2531r1702b2562],
2	.	.	O	.	_	0	SENT_238	[p15l1553t2531r1702b2562],

1	O.	NNP	O	O.	dep	10	SENT_239	[p15l1553t2531r1702b2562],
2	18	CD	NUMBER	18	num	1	SENT_239	[p15l1553t2531r1702b2562],
3	)	CD	NUMBER	)	num	6	SENT_239	[p15l1553t2531r1702b2562],
4	White	NNP	O	White	nn	6	SENT_239	[p15l311t2587r391b2612],
5	subgroup	NN	O	subgroup	nn	6	SENT_239	[p15l401t2587r531b2620],
6	O/679	NN	O	o/679	dep	1	SENT_239	[p15l972t2589r1050b2620],
7	22/713	CD	NUMBER	22/713	num	8	SENT_239	[p15l1235t2589r1327b2620],
8	(	NN	O	(	dep	10	SENT_239	[p15l1342t2589r1400b2620],
9	3.1	CD	NUMBER	3.1	num	10	SENT_239	[p15l1342t2589r1400b2620],
10	)	NN	O	)	dep	14	SENT_239	[p15l1342t2589r1400b2620],
11	0.03	CD	NUMBER	0.03	num	13	SENT_239	[p15l1483t2589r1538b2612],
12	(	CD	NUMBER	(	num	13	SENT_239	[p15l1553t2589r1702b2620],
13	o.	NN	O	o.	dep	10	SENT_239	[p15l1553t2589r1702b2620],
14	o0	NN	O	o0	dep	16	SENT_239	[p15l1553t2589r1702b2620],
15	—	CD	NUMBER	—	num	14	SENT_239	[p15l1553t2589r1702b2620],
16	o.	NN	O	o.	dep	18	SENT_239	[p15l1553t2589r1702b2620],
17	19	CD	NUMBER	19	num	16	SENT_239	[p15l1553t2589r1702b2620],
18	)	NN	O	)	_	0	SENT_239	[p15l1553t2589r1702b2620],

1	*	NN	O	*	nn	3	SENT_240	[p15l235t2674r250b2689],
2	P	NN	O	p	nn	3	SENT_240	[p15l262t2674r277b2697],
3	values	NNS	O	value	nsubj	13	SENT_240	[p15l287t2672r380b2702],
4	,	,	O	,	_	0	SENT_240	[p15l287t2672r380b2702],
5	odds	NNS	O	odds	nn	6	SENT_240	[p15l393t2672r459b2697],
6	ratios	NNS	O	ratio	appos	3	SENT_240	[p15l472t2674r554b2702],
7	,	,	O	,	_	0	SENT_240	[p15l472t2674r554b2702],
8	and	CC	O	and	_	0	SENT_240	[p15l567t2672r615b2697],
9	95	CD	PERCENT	95	number	10	SENT_240	[p15l628t2673r687b2698],
10	%	NN	PERCENT	%	amod	12	SENT_240	[p15l628t2673r687b2698],
11	confidence	NN	O	confidence	nn	12	SENT_240	[p15l699t2672r847b2697],
12	intervals	NNS	O	interval	nsubj	13	SENT_240	[p15l859t2672r973b2697],
13	(	VBP	O	(	_	0	SENT_240	[p15l988t2674r1049b2705],
14	Cls	NNS	O	cl	dobj	13	SENT_240	[p15l988t2674r1049b2705],
15	)	CD	NUMBER	)	nsubjpass	17	SENT_240	[p15l988t2674r1049b2705],
16	were	VBD	O	be	auxpass	17	SENT_240	[p15l1062t2681r1126b2697],
17	calculated	VBN	O	calculate	rcmod	14	SENT_240	[p15l1137t2672r1273b2697],
18	by	IN	O	by	_	0	SENT_240	[p15l1287t2672r1315b2705],
19	means	NNS	O	means	agent	17	SENT_240	[p15l1327t2681r1416b2697],
20	oflogistic-regression	JJ	O	oflogistic-regression	amod	21	SENT_240	[p15l1428t2672r1714b2705],
21	analysis	NN	O	analysis	dep	19	SENT_240	[p15l1727t2672r1833b2705],
22	and	CC	O	and	_	0	SENT_240	[p15l1845t2672r1893b2697],
23	adjusted	VBN	O	adjust	rcmod	14	SENT_240	[p15l261t2709r376b2742],
24	for	IN	O	for	_	0	SENT_240	[p15l388t2709r426b2734],
25	self-reported	JJ	O	self-reported	amod	27	SENT_240	[p15l437t2709r607b2742],
26	race	NN	O	race	nn	27	SENT_240	[p15l622t2718r675b2734],
27	(	NN	O	(	prep_for	23	SENT_240	[p15l690t2709r771b2742],
28	white	JJ	O	white	amod	27	SENT_240	[p15l690t2709r771b2742],
29	vs.	CC	O	vs.	prep	27	SENT_240	[p15l782t2718r817b2734],
30	nonwhite	JJ	O	nonwhite	amod	31	SENT_240	[p15l831t2709r975b2742],
31	)	NN	O	)	dep	29	SENT_240	[p15l831t2709r975b2742],
32	,	,	O	,	_	0	SENT_240	[p15l831t2709r975b2742],
33	history	NN	O	history	appos	31	SENT_240	[p15l989t2709r1080b2742],
34	of	IN	O	of	_	0	SENT_240	[p15l1091t2709r1121b2734],
35	receipt	NN	O	receipt	nn	37	SENT_240	[p15l1129t2711r1219b2742],
36	ofantiretroviral	NN	O	ofantiretroviral	nn	37	SENT_240	[p15l1230t2709r1440b2734],
37	therapy	NN	O	therapy	prep_of	33	SENT_240	[p15l1452t2709r1554b2742],
38	(	CD	NUMBER	(	num	39	SENT_240	[p15l1568t2711r1644b2742],
39	none	NN	O	none	dobj	17	SENT_240	[p15l1568t2711r1644b2742],
40	vs.	IN	O	vs.	_	0	SENT_240	[p15l1655t2718r1690b2734],
41	any	DT	O	any	det	42	SENT_240	[p15l1703t2711r1767b2742],
42	)	NN	O	)	prep_vs.	39	SENT_240	[p15l1703t2711r1767b2742],
43	,	,	O	,	_	0	SENT_240	[p15l1703t2711r1767b2742],
44	introduction	NN	O	introduction	conj_and	39	SENT_240	[p15l1781t2709r1904b2734, p15l259t2748r311b2771],
45	ofa	NN	O	ofa	nn	50	SENT_240	[p15l324t2746r373b2771],
46	new	JJ	O	new	amod	50	SENT_240	[p15l387t2755r440b2771],
47	nonnucleoside	JJ	O	nonnucleoside	amod	50	SENT_240	[p15l452t2746r652b2771],
48	reverse-transcriptase	NN	O	reverse-transcriptase	nn	50	SENT_240	[p15l664t2748r949b2779],
49	inhibitor	NN	O	inhibitor	nn	50	SENT_240	[p15l961t2746r1077b2771],
50	(	NN	O	(	dep	44	SENT_240	[p15l1090t2748r1140b2779],
51	yes	RB	O	yes	advmod	50	SENT_240	[p15l1090t2748r1140b2779],
52	or	CC	O	or	_	0	SENT_240	[p15l1152t2755r1180b2771],
53	no	DT	O	no	det	54	SENT_240	[p15l1192t2748r1243b2779],
54	)	NN	O	)	conj_or	50	SENT_240	[p15l1192t2748r1243b2779],
55	,	,	O	,	_	0	SENT_240	[p15l1192t2748r1243b2779],
56	and	CC	O	and	_	0	SENT_240	[p15l1257t2746r1304b2771],
57	concurrent	JJ	O	concurrent	amod	58	SENT_240	[p15l1317t2751r1466b2771],
58	use	NN	O	use	conj_and	39	SENT_240	[p15l1478t2755r1523b2771],
59	or	CC	O	or	_	0	SENT_240	[p15l1534t2755r1562b2771],
60	nonuse	JJ	O	nonuse	amod	63	SENT_240	[p15l1574t2755r1673b2771],
61	ofa	NN	O	ofa	nn	63	SENT_240	[p15l1684t2746r1734b2771],
62	protease	NN	O	protease	nn	63	SENT_240	[p15l1747t2751r1863b2779],
63	inhibitor	NN	O	inhibitor	conj_or	58	SENT_240	[p15l1876t2748r1908b2771, p15l261t2783r357b2808],
64	.	.	O	.	_	0	SENT_240	[p15l1876t2748r1908b2771, p15l261t2783r357b2808],

1	The	DT	O	the	det	3	SENT_241	[p15l368t2783r418b2808],
2	model	NN	O	model	nn	3	SENT_241	[p15l431t2783r605b2808],
3	—	NN	O	—	nsubj	31	SENT_241	[p15l431t2783r605b2808],
4	based	VBN	O	base	partmod	3	SENT_241	[p15l431t2783r605b2808],
5	incidences	NNS	O	incidence	nsubj	10	SENT_241	[p15l619t2783r761b2808],
6	of	IN	O	of	_	0	SENT_241	[p15l773t2783r803b2808],
7	clinically	RB	O	clinically	advmod	8	SENT_241	[p15l810t2783r926b2816],
8	diagnosed	VBN	O	diagnose	amod	9	SENT_241	[p15l936t2783r1076b2816],
9	hypersensitivity	NN	O	hypersensitivity	prep_of	5	SENT_241	[p15l1090t2783r1301b2816],
10	reaction	NN	O	reaction	conj_and	10	SENT_241	[p15l1313t2785r1420b2808],
11	to	TO	O	to	_	0	SENT_241	[p15l1432t2788r1459b2808],
12	abacavir	NN	O	abacavir	prep_to	10	SENT_241	[p15l1471t2783r1584b2808],
13	in	IN	O	in	_	0	SENT_241	[p15l1595t2785r1617b2808],
14	the	DT	O	the	det	16	SENT_241	[p15l1629t2783r1671b2808],
15	total	JJ	O	total	amod	16	SENT_241	[p15l1681t2783r1741b2808],
16	population	NN	O	population	prep_in	12	SENT_241	[p15l1755t2783r1900b2816],
17	that	WDT	O	that	nsubjpass	20	SENT_241	[p15l259t2820r313b2845],
18	could	MD	O	could	aux	20	SENT_241	[p15l324t2820r397b2845],
19	be	VB	O	be	auxpass	20	SENT_241	[p15l411t2820r441b2845],
20	evaluated	VBN	O	evaluate	rcmod	16	SENT_241	[p15l452t2820r580b2845],
21	and	CC	O	and	_	0	SENT_241	[p15l594t2820r642b2845],
22	in	IN	O	in	_	0	SENT_241	[p15l656t2822r677b2845],
23	the	DT	O	the	det	25	SENT_241	[p15l689t2820r732b2845],
24	white	JJ	O	white	amod	25	SENT_241	[p15l742t2820r815b2845],
25	subgroup	NN	O	subgroup	prep_in	10	SENT_241	[p15l827t2820r957b2853],
26	were	VBD	O	be	cop	31	SENT_241	[p15l967t2829r1031b2845],
27	3.3	CD	PERCENT	3.3	number	31	SENT_241	[p15l1043t2821r1110b2846],
28	%	NN	PERCENT	%	dep	31	SENT_241	[p15l1043t2821r1110b2846],
29	and	CC	O	and	_	0	SENT_241	[p15l1122t2820r1170b2845],
30	3.5	CD	PERCENT	3.5	conj_and	31	SENT_241	[p15l1183t2821r1258b2850],
31	%	NN	PERCENT	%	_	0	SENT_241	[p15l1183t2821r1258b2850],
32	,	,	O	,	_	0	SENT_241	[p15l1183t2821r1258b2850],
33	respectively	RB	O	respectively	advmod	31	SENT_241	[p15l1272t2820r1436b2853],
34	,	,	O	,	_	0	SENT_241	[p15l1272t2820r1436b2853],
35	for	IN	O	for	_	0	SENT_241	[p15l1448t2820r1486b2845],
36	the	DT	O	the	det	40	SENT_241	[p15l1495t2820r1538b2845],
37	prospective	JJ	O	prospective	amod	40	SENT_241	[p15l1551t2822r1850b2853],
38	—	NN	O	—	nn	40	SENT_241	[p15l1551t2822r1850b2853],
39	screening	NN	O	screening	nn	40	SENT_241	[p15l1551t2822r1850b2853],
40	group	NN	O	group	prep_for	31	SENT_241	[p15l261t2866r340b2890],
41	and	CC	O	and	_	0	SENT_241	[p15l352t2857r400b2882],
42	7.9	CD	PERCENT	7.9	num	43	SENT_241	[p15l414t2858r481b2883],
43	%	NN	PERCENT	%	conj_and	40	SENT_241	[p15l414t2858r481b2883],
44	and	CC	O	and	_	0	SENT_241	[p15l492t2857r540b2882],
45	8.6	CD	PERCENT	8.6	num	46	SENT_241	[p15l553t2858r628b2887],
46	%	NN	PERCENT	%	conj_and	43	SENT_241	[p15l553t2858r628b2887],
47	,	,	O	,	_	0	SENT_241	[p15l553t2858r628b2887],
48	respectively	RB	O	respectively	advmod	31	SENT_241	[p15l642t2857r807b2890],
49	,	,	O	,	_	0	SENT_241	[p15l642t2857r807b2890],
50	for	IN	O	for	_	0	SENT_241	[p15l818t2857r856b2882],
51	the	DT	O	the	det	53	SENT_241	[p15l866t2857r908b2882],
52	control	NN	O	control	nn	53	SENT_241	[p15l920t2857r1014b2882],
53	group	NN	O	group	prep_for	31	SENT_241	[p15l1027t2866r1114b2890],
54	.	.	O	.	_	0	SENT_241	[p15l1027t2866r1114b2890],

1	The	DT	O	the	det	3	SENT_242	[p15l1125t2857r1176b2882],
2	white	JJ	O	white	amod	3	SENT_242	[p15l1186t2857r1259b2882],
3	subgroup	NN	O	subgroup	nsubj	4	SENT_242	[p15l1271t2857r1401b2890],
4	included	VBD	O	include	_	0	SENT_242	[p15l1414t2857r1528b2882],
5	the	DT	O	the	det	9	SENT_242	[p15l1539t2857r1582b2882],
6	two	CD	NUMBER	two	nn	9	SENT_242	[p15l1592t2862r1641b2882],
7	and	CC	O	and	_	0	SENT_242	[p15l1653t2857r1701b2882],
8	three	CD	NUMBER	three	nn	9	SENT_242	[p15l1713t2857r1783b2882],
9	patients	NNS	O	patient	nsubj	13	SENT_242	[p15l1795t2859r1902b2890],
10	reporting	VBG	O	report	partmod	9	SENT_242	[p15l262t2896r386b2927],
11	both	CC	O	both	prep	10	SENT_242	[p15l398t2894r457b2919],
12	categories	NNS	O	category	dep	11	SENT_242	[p15l470t2896r608b2927],
13	ofwhite	VBP	O	ofwhite	ccomp	4	SENT_242	[p15l620t2894r729b2919],
14	ancestry	NN	O	ancestry	dobj	13	SENT_242	[p15l740t2899r853b2927],
15	in	IN	O	in	_	0	SENT_242	[p15l865t2896r886b2919],
16	the	DT	O	the	det	20	SENT_242	[p15l898t2894r941b2919],
17	prospective	JJ	O	prospective	amod	20	SENT_242	[p15l954t2896r1253b2927],
18	—	NN	O	—	nn	20	SENT_242	[p15l954t2896r1253b2927],
19	screening	NN	O	screening	nn	20	SENT_242	[p15l954t2896r1253b2927],
20	group	NN	O	group	prep_in	13	SENT_242	[p15l1264t2903r1344b2927],
21	and	CC	O	and	_	0	SENT_242	[p15l1356t2894r1404b2919],
22	the	DT	O	the	det	24	SENT_242	[p15l1415t2894r1458b2919],
23	control	NN	O	control	nn	24	SENT_242	[p15l1469t2894r1564b2919],
24	group	NN	O	group	prep_in	13	SENT_242	[p15l1577t2903r1664b2927],
25	,	,	O	,	_	0	SENT_242	[p15l1577t2903r1664b2927],
26	respectively	RB	O	respectively	advmod	13	SENT_242	[p15l1678t2894r1842b2927],
27	.	.	O	.	_	0	SENT_242	[p15l1678t2894r1842b2927],

1	The	DT	O	the	det	2	SENT_243	[p15l1853t2894r1904b2919],
2	odds	NNS	O	odds	nsubj	24	SENT_243	[p15l260t2931r326b2956],
3	ratios	NNS	O	ratio	nsubjpass	12	SENT_243	[p15l340t2933r413b2956],
4	for	IN	O	for	prep	3	SENT_243	[p15l425t2931r463b2956],
5	immunologically	RB	O	immunologically	pcomp	4	SENT_243	[p15l474t2931r701b2964],
6	confirmed	VBN	O	confirm	partmod	3	SENT_243	[p15l712t2931r850b2956],
7	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_243	[p15l864t2931r1075b2964],
8	reaction	NN	O	reaction	dobj	6	SENT_243	[p15l1087t2933r1194b2956],
9	to	TO	O	to	_	0	SENT_243	[p15l1206t2936r1232b2956],
10	abacavir	NN	O	abacavir	prep_to	6	SENT_243	[p15l1244t2931r1357b2956],
11	were	VBD	O	be	auxpass	12	SENT_243	[p15l1367t2940r1430b2956],
12	obtained	VBN	O	obtain	rcmod	2	SENT_243	[p15l1442t2931r1559b2956],
13	by	IN	O	by	_	0	SENT_243	[p15l1573t2931r1602b2964],
14	means	NNS	O	means	_	0	SENT_243	[p15l1614t2940r1702b2956],
15	of	IN	O	of	_	0	SENT_243	[p15l1714t2931r1744b2956],
16	exact	JJ	O	exact	amod	17	SENT_243	[p15l1751t2936r1819b2956],
17	methods	NNS	O	method	prep_by_means_of	12	SENT_243	[p15l1831t2931r1909b2956, p15l260t2968r316b2998],
18	,	,	O	,	_	0	SENT_243	[p15l1831t2931r1909b2956, p15l260t2968r316b2998],
19	owing	VBG	O	owe	xcomp	12	SENT_243	[p15l329t2970r410b3001],
20	to	TO	O	to	_	0	SENT_243	[p15l420t2973r447b2993],
21	the	DT	O	the	det	22	SENT_243	[p15l457t2968r500b2993],
22	absence	NN	O	absence	prep_to	19	SENT_243	[p15l512t2968r622b2993],
23	ofimmunologically	RB	O	ofimmunologically	advmod	24	SENT_243	[p15l633t2968r898b3001],
24	confirmed	VBD	O	confirm	_	0	SENT_243	[p15l908t2968r1046b2993],
25	hypersensitivity	NN	O	hypersensitivity	nn	26	SENT_243	[p15l1060t2968r1271b3001],
26	reaction	NN	O	reaction	dobj	24	SENT_243	[p15l1283t2970r1390b2993],
27	in	IN	O	in	_	0	SENT_243	[p15l1404t2970r1426b2993],
28	the	DT	O	the	det	32	SENT_243	[p15l1438t2968r1480b2993],
29	prospective	JJ	O	prospective	amod	32	SENT_243	[p15l1493t2970r1792b3001],
30	—	NN	O	—	nn	32	SENT_243	[p15l1493t2970r1792b3001],
31	screening	NN	O	screening	nn	32	SENT_243	[p15l1493t2970r1792b3001],
32	group	NN	O	group	prep_in	24	SENT_243	[p15l1804t2977r1890b3001],
33	.	.	O	.	_	0	SENT_243	[p15l1804t2977r1890b3001],

1	The	DT	O	the	det	3	SENT_244	[p15l259t3005r310b3030],
2	model	NN	O	model	nn	3	SENT_244	[p15l322t3005r405b3030],
3	(	NN	O	(	nsubj	14	SENT_244	[p15l421t3005r553b3038],
4	involving	VBG	O	involve	_	0	SENT_244	[p15l421t3005r553b3038],
5	a	DT	O	a	det	6	SENT_244	[p15l565t3014r577b3030],
6	median	NN	O	median	prep_involving	3	SENT_244	[p15l591t3005r698b3035],
7	,	,	O	,	_	0	SENT_244	[p15l591t3005r698b3035],
8	unbiased	JJ	O	unbiased	amod	11	SENT_244	[p15l712t3005r834b3030],
9	estimate	NN	O	estimate	nn	11	SENT_244	[p15l847t3007r964b3030],
10	ofthe	NN	O	ofthe	nn	11	SENT_244	[p15l975t3005r1053b3030],
11	odds	NNS	O	odds	appos	6	SENT_244	[p15l1064t3005r1130b3030],
12	ratio	NN	O	ratio	dep	11	SENT_244	[p15l1143t3007r1212b3038],
13	)	CD	NUMBER	)	num	12	SENT_244	[p15l1143t3007r1212b3038],
14	estimated	VBD	O	estimate	_	0	SENT_244	[p15l1227t3005r1360b3030],
15	the	DT	O	the	det	16	SENT_244	[p15l1372t3005r1415b3030],
16	odds	NNS	O	odds	dobj	14	SENT_244	[p15l1426t3005r1492b3030],
17	of	IN	O	of	_	0	SENT_244	[p15l1504t3005r1533b3030],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_244	[p15l1541t3005r1752b3038],
19	reaction	NN	O	reaction	prep_of	16	SENT_244	[p15l1764t3007r1871b3030],
20	in	IN	O	in	_	0	SENT_244	[p15l1885t3007r1907b3030],
21	the	DT	O	the	det	25	SENT_244	[p15l259t3042r302b3067],
22	prospective	JJ	O	prospective	amod	25	SENT_244	[p15l315t3044r614b3075],
23	—	NN	O	—	nn	25	SENT_244	[p15l315t3044r614b3075],
24	screening	NN	O	screening	nn	25	SENT_244	[p15l315t3044r614b3075],
25	group	NN	O	group	prep_in	14	SENT_244	[p15l625t3051r705b3075],
26	versus	CC	O	versus	prep	25	SENT_244	[p15l716t3051r803b3067],
27	the	DT	O	the	det	29	SENT_244	[p15l814t3042r857b3067],
28	control	NN	O	control	nn	29	SENT_244	[p15l868t3042r962b3067],
29	group	NN	O	group	dep	26	SENT_244	[p15l975t3051r1055b3075],
30	to	TO	O	to	aux	38	SENT_244	[p15l1065t3047r1092b3067],
31	be	VB	O	be	cop	38	SENT_244	[p15l1105t3042r1135b3067],
32	1:33	CD	TIME	1:33	number	33	SENT_244	[p15l1148t3044r1200b3067],
33	(	CD	NUMBER	(	nn	38	SENT_244	[p15l1217t3044r1404b3075],
34	1	CD	NUMBER	1	num	35	SENT_244	[p15l1217t3044r1404b3075],
35	+0.03	NN	NUMBER	+0.03	dep	33	SENT_244	[p15l1217t3044r1404b3075],
36	=	JJ	O	=	amod	38	SENT_244	[p15l1217t3044r1404b3075],
37	33	CD	NUMBER	33	tmod	36	SENT_244	[p15l1217t3044r1404b3075],
38	)	NN	O	)	xcomp	14	SENT_244	[p15l1217t3044r1404b3075],
39	.	.	O	.	_	0	SENT_244	[p15l1217t3044r1404b3075],

1	(	NN	O	(	_	0	SENT_245	[p15l1420t3042r1552b3075],
2	Although	IN	O	although	mark	9	SENT_245	[p15l1420t3042r1552b3075],
3	a	DT	O	a	det	5	SENT_245	[p15l1565t3051r1578b3067],
4	simple	JJ	O	simple	amod	5	SENT_245	[p15l1591t3042r1681b3075],
5	point	NN	O	point	nsubj	9	SENT_245	[p15l1694t3044r1763b3075],
6	estimate	NN	O	estimate	dep	9	SENT_245	[p15l1774t3044r1891b3067],
7	ofthe	NN	O	ofthe	nn	9	SENT_245	[p15l260t3079r338b3104],
8	odds	NNS	O	odds	nn	9	SENT_245	[p15l350t3079r415b3104],
9	ratio	NN	O	ratio	advcl	23	SENT_245	[p15l429t3081r488b3104],
10	from	IN	O	from	_	0	SENT_245	[p15l499t3079r563b3104],
11	the	DT	O	the	det	14	SENT_245	[p15l575t3079r617b3104],
12	raw	JJ	O	raw	amod	14	SENT_245	[p15l630t3088r677b3104],
13	data	NN	O	datum	nn	14	SENT_245	[p15l687t3079r745b3104],
14	yields	NNS	O	yield	prep_from	9	SENT_245	[p15l756t3079r832b3112],
15	a	DT	O	a	det	19	SENT_245	[p15l844t3088r857b3104],
16	more	RBR	O	more	advmod	17	SENT_245	[p15l870t3088r940b3104],
17	intuitive	JJ	O	intuitive	amod	19	SENT_245	[p15l952t3081r1061b3104],
18	value	NN	O	value	nn	19	SENT_245	[p15l1072t3079r1142b3104],
19	ofo	NN	O	ofo	dep	9	SENT_245	[p15l1154t3079r1212b3109],
20	,	,	O	,	_	0	SENT_245	[p15l1154t3079r1212b3109],
21	it	PRP	O	it	nsubj	23	SENT_245	[p15l1226t3081r1241b3104],
22	also	RB	O	also	advmod	23	SENT_245	[p15l1253t3079r1306b3104],
23	implies	VBZ	O	imply	rcmod	1	SENT_245	[p15l1319t3079r1416b3112],
24	an	DT	O	a	det	26	SENT_245	[p15l1429t3088r1459b3104],
25	inﬁnite	JJ	O	inﬁnite	amod	26	SENT_245	[p15l1473t3079r1566b3104],
26	reduction	NN	O	reduction	dobj	23	SENT_245	[p15l1579t3079r1706b3104],
27	in	IN	O	in	_	0	SENT_245	[p15l1720t3081r1741b3104],
28	the	DT	O	the	det	29	SENT_245	[p15l1753t3079r1796b3104],
29	odds	NNS	O	odds	prep_in	26	SENT_245	[p15l1807t3079r1881b3109],
30	,	,	O	,	_	0	SENT_245	[p15l1807t3079r1881b3109],
31	which	WDT	O	which	nsubj	33	SENT_245	[p15l259t3116r338b3141],
32	is	VBZ	O	be	cop	33	SENT_245	[p15l352t3118r371b3141],
33	problematic	JJ	O	problematic	rcmod	29	SENT_245	[p15l384t3116r547b3149],
34	for	IN	O	for	_	0	SENT_245	[p15l557t3116r595b3141],
35	linear	JJ	O	linear	amod	37	SENT_245	[p15l607t3116r681b3141],
36	regression	NN	O	regression	nn	37	SENT_245	[p15l693t3118r833b3149],
37	modeling	NN	O	modeling	prep_for	33	SENT_245	[p15l847t3116r975b3149],
38	in	IN	O	in	_	0	SENT_245	[p15l987t3118r1008b3141],
39	that	IN	O	that	complm	41	SENT_245	[p15l1020t3116r1074b3141],
40	it	PRP	O	it	nsubj	41	SENT_245	[p15l1086t3118r1101b3141],
41	introduces	VBZ	O	introduce	prepc_in	1	SENT_245	[p15l1113t3116r1256b3141],
42	error	NN	O	error	dobj	41	SENT_245	[p15l1269t3125r1335b3141],
43	from	IN	O	from	_	0	SENT_245	[p15l1344t3116r1408b3141],
44	division	NN	O	division	prep_from	42	SENT_245	[p15l1421t3116r1525b3141],
45	by	IN	O	by	_	0	SENT_245	[p15l1540t3116r1568b3149],
46	o.	NN	O	o.	prep_by	41	SENT_245	[p15l1578t3118r1611b3149],
47	)	CD	NUMBER	)	num	46	SENT_245	[p15l1578t3118r1611b3149],

1	(	NN	O	(	nsubj	3	SENT_246	[p15l12t3328r747b3429],
2	immunologically	RB	O	immunologically	advmod	3	SENT_246	[p15l12t3328r747b3429],
3	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_246	[p15l772t3328r1231b3407],
4	:	:	O	:	_	0	SENT_246	[p15l772t3328r1231b3407],
5	odds	NNS	O	odds	nn	6	SENT_246	[p15l1263t3328r1459b3407],
6	ratio	NN	O	ratio	dobj	3	SENT_246	[p15l1489t3329r1699b3424],
7	,	,	O	,	_	0	SENT_246	[p15l1489t3329r1699b3424],
8	0.03	CD	NUMBER	0.03	appos	6	SENT_246	[p15l1733t3334r1923b3424],
9	;	:	O	;	_	0	SENT_246	[p15l1733t3334r1923b3424],
10	95	CD	PERCENT	95	number	11	SENT_246	[p15l1955t3334r2135b3408],
11	%	NN	PERCENT	%	amod	12	SENT_246	[p15l1955t3334r2135b3408],
12	confidence	NN	O	confidence	dep	6	SENT_246	[p15l8t3456r481b3535],
13	interval	NN	O	interval	nn	16	SENT_246	[p15l531t3457r857b3536],
14	[	CD	NUMBER	[	num	16	SENT_246	[p15l916t3462r1093b3552],
15	CI	NN	O	ci	nn	16	SENT_246	[p15l916t3462r1093b3552],
16	]	NN	O	]	dep	12	SENT_246	[p15l916t3462r1093b3552],
17	,	,	O	,	_	0	SENT_246	[p15l916t3462r1093b3552],
18	o.	NN	O	o.	nn	19	SENT_246	[p15l1149t3462r1329b3535],
19	oo	NN	O	oo	appos	6	SENT_246	[p15l1149t3462r1329b3535],
20	to	TO	O	to	_	0	SENT_246	[p15l1381t3473r1463b3535],
21	0.18	CD	NUMBER	0.18	prep_to	19	SENT_246	[p15l1514t3462r1713b3552],
22	;	:	O	;	_	0	SENT_246	[p15l1514t3462r1713b3552],
23	P	NN	O	p	dep	24	SENT_246	[p15l1766t3462r2131b3552],
24	<	JJR	O	<	dep	21	SENT_246	[p15l1766t3462r2131b3552],
25	0.001	CD	NUMBER	0.001	dep	24	SENT_246	[p15l1766t3462r2131b3552],
26	;	:	O	;	_	0	SENT_246	[p15l1766t3462r2131b3552],
27	clinically	RB	O	clinically	advmod	28	SENT_246	[p15l8t3586r400b3686],
28	diagnosed	VBN	O	diagnose	amod	19	SENT_246	[p15l450t3585r919b3686],
29	:	:	O	:	_	0	SENT_246	[p15l450t3585r919b3686],
30	odds	NNS	O	odds	nn	31	SENT_246	[p15l977t3586r1179b3664],
31	ratio	NN	O	ratio	dep	19	SENT_246	[p15l1235t3586r1455b3681],
32	,	,	O	,	_	0	SENT_246	[p15l1235t3586r1455b3681],
33	0.40	CD	NUMBER	0.40	appos	31	SENT_246	[p15l1515t3591r1719b3681],
34	;	:	O	;	_	0	SENT_246	[p15l1515t3591r1719b3681],
35	95	CD	PERCENT	95	number	36	SENT_246	[p15l1776t3591r1961b3665],
36	%	NN	PERCENT	%	amod	37	SENT_246	[p15l1776t3591r1961b3665],
37	CI	NN	O	ci	dep	19	SENT_246	[p15l2014t3591r2130b3681],
38	,	,	O	,	_	0	SENT_246	[p15l2014t3591r2130b3681],

1	0.25	CD	NUMBER	0.25	num	3	SENT_247	[p16l7t26r185b99],
2	to	TO	O	to	dep	3	SENT_247	[p16l222t37r304b99],
3	0.62	CD	NUMBER	0.62	_	0	SENT_247	[p16l339t26r540b116],
4	;	:	O	;	_	0	SENT_247	[p16l339t26r540b116],
5	P	NN	O	p	dep	6	SENT_247	[p16l577t26r968b112],
6	<	JJR	O	<	dep	3	SENT_247	[p16l577t26r968b112],
7	0.001	CD	NUMBER	0.001	num	8	SENT_247	[p16l577t26r968b112],
8	)	NN	O	)	dep	6	SENT_247	[p16l577t26r968b112],
9	.	.	O	.	_	0	SENT_247	[p16l577t26r968b112],

1	No	DT	O	no	det	2	SENT_248	[p16l1006t28r1130b100],
2	case	NN	O	case	nsubjpass	16	SENT_248	[p16l1166t47r1346b99],
3	of	IN	O	of	_	0	SENT_248	[p16l1381t20r1482b99],
4	clinically	RB	O	clinically	advmod	5	SENT_248	[p16l1498t21r1890b121],
5	diagnosed	VBN	O	diagnose	amod	7	SENT_248	[p16l1920t21r2134b121, p16l7t149r257b227],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_248	[p16l286t148r953b249],
7	reaction	NN	O	reaction	prep_of	2	SENT_248	[p16l978t149r1319b227],
8	in	IN	O	in	_	0	SENT_248	[p16l1348t149r1430b226],
9	the	DT	O	the	det	13	SENT_248	[p16l1461t149r1592b227],
10	prospective	JJ	O	prospective	amod	13	SENT_248	[p16l1620t149r2133b249],
11	—	NN	O	—	nn	13	SENT_248	[p16l1620t149r2133b249],
12	screening	NN	O	screening	nn	13	SENT_248	[p16l8t277r419b377],
13	group	NN	O	group	prep_in	7	SENT_248	[p16l444t302r693b377],
14	was	VBD	O	be	auxpass	16	SENT_248	[p16l720t303r880b356],
15	immunologically	RB	O	immunologically	advmod	16	SENT_248	[p16l911t276r1636b377],
16	confirmed	VBN	O	confirm	_	0	SENT_248	[p16l1661t276r2130b355],
17	.	.	O	.	_	0	SENT_248	[p16l1661t276r2130b355],

1	Results	NNS	O	result	nsubj	3	SENT_249	[p16l6t404r319b488],
2	were	VBD	O	be	cop	3	SENT_249	[p16l364t431r566b484],
3	similar	JJ	O	similar	_	0	SENT_249	[p16l615t405r922b483],
4	for	IN	O	for	_	0	SENT_249	[p16l967t404r1090b483],
5	the	DT	O	the	det	6	SENT_249	[p16l1135t405r1267b483],
6	subgroup	NN	O	subgroup	prep_for	3	SENT_249	[p16l1317t405r1721b505],
7	of	IN	O	of	_	0	SENT_249	[p16l1770t404r1871b483],
8	white	JJ	O	white	amod	9	SENT_249	[p16l1895t405r2134b484],
9	patients	NNS	O	patient	prep_of	6	SENT_249	[p16l6t533r348b633],
10	(	RB	O	(	dep	11	SENT_249	[p16l399t533r658b624],
11	Table	NNP	O	Table	dep	9	SENT_249	[p16l399t533r658b624],
12	2	CD	NUMBER	2	number	13	SENT_249	[p16l702t538r802b624],
13	)	CD	NUMBER	)	num	11	SENT_249	[p16l702t538r802b624],
14	.	.	O	.	_	0	SENT_249	[p16l702t538r802b624],

1	Sensitivity	NN	O	sensitivity	nn	2	SENT_250	[p16l854t533r1296b633],
2	analyses	NNS	O	analysis	nsubj	16	SENT_250	[p16l1334t533r1694b633],
3	involving	VBG	O	involve	partmod	2	SENT_250	[p16l1740t533r2138b633],
4	the	DT	O	the	det	5	SENT_250	[p16l7t660r136b739],
5	intention	NN	O	intention	dobj	3	SENT_250	[p16l168t661r903b756],
6	—	CD	NUMBER	—	number	8	SENT_250	[p16l168t661r903b756],
7	to	TO	O	to	dep	8	SENT_250	[p16l168t661r903b756],
8	—	CD	NUMBER	—	num	9	SENT_250	[p16l168t661r903b756],
9	treat	NN	O	treat	dep	5	SENT_250	[p16l168t661r903b756],
10	,	,	O	,	_	0	SENT_250	[p16l168t661r903b756],
11	abacavir	NN	O	abacavir	nn	12	SENT_250	[p16l941t661r1651b761],
12	—	NN	O	—	appos	5	SENT_250	[p16l941t661r1651b761],
13	exposed	VBN	O	expose	partmod	12	SENT_250	[p16l941t661r1651b761],
14	population	NN	O	population	dobj	13	SENT_250	[p16l1682t661r2135b761],
15	also	RB	O	also	advmod	16	SENT_250	[p16l6t788r178b867],
16	had	VBD	O	have	_	0	SENT_250	[p16l219t789r376b867],
17	similar	JJ	O	similar	amod	18	SENT_250	[p16l416t788r723b867],
18	results	NNS	O	result	dobj	16	SENT_250	[p16l760t789r1068b868],
19	.	.	O	.	_	0	SENT_250	[p16l760t789r1068b868],

1	When	WRB	O	when	advmod	11	SENT_251	[p16l1109t789r1364b867],
2	o	NN	PERCENT	o	nn	3	SENT_251	[p16l1404t794r1539b868],
3	%	NN	PERCENT	%	nsubjpass	11	SENT_251	[p16l1404t794r1539b868],
4	and	CC	O	and	_	0	SENT_251	[p16l1577t789r1735b867],
5	100	CD	PERCENT	100	num	6	SENT_251	[p16l1778t794r2015b868],
6	%	NN	PERCENT	%	nsubjpass	11	SENT_251	[p16l1778t794r2015b868],
7	of	IN	O	of	_	0	SENT_251	[p16l2053t788r2153b867],
8	the	DT	O	the	det	9	SENT_251	[p16l7t917r141b995],
9	exclusions	NNS	O	exclusion	prep_of	6	SENT_251	[p16l196t917r636b996],
10	were	VBD	O	be	auxpass	11	SENT_251	[p16l689t943r891b996],
11	assumed	VBN	O	assume	_	0	SENT_251	[p16l945t916r1322b996],
12	to	TO	O	to	aux	15	SENT_251	[p16l1377t933r1458b995],
13	have	VB	O	have	aux	15	SENT_251	[p16l1513t917r1703b996],
14	been	VBN	O	be	auxpass	15	SENT_251	[p16l1758t917r1961b995],
15	associated	VBN	O	associate	xcomp	11	SENT_251	[p16l2013t943r2134b995, p16l8t1045r360b1123],

1	with	IN	O	with	_	0	SENT_252	[p16l393t1045r589b1124],
2	hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_252	[p16l627t1045r1310b1145],
3	reaction	NN	O	reaction	prep_with	33	SENT_252	[p16l1342t1045r1715b1140],
4	,	,	O	,	_	0	SENT_252	[p16l1342t1045r1715b1140],
5	the	DT	O	the	det	7	SENT_252	[p16l1758t1045r1892b1123],
6	odds	NNS	O	odds	nn	7	SENT_252	[p16l1930t1044r2132b1123],
7	ratios	NNS	O	ratio	appos	3	SENT_252	[p16l7t1173r248b1251],
8	for	IN	O	for	_	0	SENT_252	[p16l288t1172r412b1251],
9	immunologically	RB	O	immunologically	advmod	10	SENT_252	[p16l447t1172r1186b1273],
10	conﬁrmed	JJ	O	conﬁrmed	amod	12	SENT_252	[p16l1220t1172r1675b1251],
11	hypersensitivity	NN	O	hypersensitivity	nn	12	SENT_252	[p16l1712t1173r2134b1273, p16l8t1301r295b1401],
12	reaction	NN	O	reaction	prep_for	7	SENT_252	[p16l342t1301r692b1379],
13	to	TO	O	to	_	0	SENT_252	[p16l746t1317r827b1379],
14	abacavir	NN	O	abacavir	prep_to	12	SENT_252	[p16l880t1301r1238b1380],
15	in	IN	O	in	_	0	SENT_252	[p16l1287t1301r1371b1378],
16	the	DT	O	the	det	20	SENT_252	[p16l1423t1300r1557b1379],
17	prospective	JJ	O	prospective	amod	20	SENT_252	[p16l1608t1301r2134b1401],
18	—	NN	O	—	nn	20	SENT_252	[p16l1608t1301r2134b1401],
19	screening	NN	O	screening	nn	20	SENT_252	[p16l8t1429r428b1529],
20	group	NN	O	group	prep_in	14	SENT_252	[p16l471t1454r746b1529],
21	,	,	O	,	_	0	SENT_252	[p16l471t1454r746b1529],
22	as	IN	O	as	_	0	SENT_252	[p16l799t1455r884b1507],
23	compared	VBN	O	compare	prepc_as	33	SENT_252	[p16l934t1429r1362b1529],
24	with	IN	O	with	pcomp	23	SENT_252	[p16l1404t1428r1600b1508],
25	the	DT	O	the	det	27	SENT_252	[p16l1647t1429r1780b1507],
26	control	NN	O	control	nn	27	SENT_252	[p16l1828t1429r2135b1507],
27	group	NN	O	group	pobj	24	SENT_252	[p16l7t1582r282b1657],
28	,	,	O	,	_	0	SENT_252	[p16l7t1582r282b1657],
29	were	VBD	O	be	cop	33	SENT_252	[p16l327t1583r529b1636],
30	0.03	CD	NUMBER	0.03	number	31	SENT_252	[p16l574t1562r746b1635],
31	(	CD	NUMBER	(	num	32	SENT_252	[p16l799t1562r1194b1648],
32	P	NN	O	p	npadvmod	33	SENT_252	[p16l799t1562r1194b1648],
33	<	JJR	O	<	_	0	SENT_252	[p16l799t1562r1194b1648],
34	0.001	CD	NUMBER	0.001	num	35	SENT_252	[p16l799t1562r1194b1648],
35	)	NN	O	)	dep	59	SENT_252	[p16l799t1562r1194b1648],
36	and	CC	O	and	_	0	SENT_252	[p16l1242t1557r1401b1635],
37	0.62	CD	NUMBER	0.62	number	38	SENT_252	[p16l1445t1562r1622b1635],
38	(	CD	NUMBER	(	num	39	SENT_252	[p16l1672t1562r2130b1652],
39	P	NN	O	p	npadvmod	40	SENT_252	[p16l1672t1562r2130b1652],
40	=	JJ	O	=	conj_and	35	SENT_252	[p16l1672t1562r2130b1652],
41	0.006	CD	NUMBER	0.006	num	42	SENT_252	[p16l1672t1562r2130b1652],
42	)	NN	O	)	nsubj	59	SENT_252	[p16l1672t1562r2130b1652],
43	,	,	O	,	_	0	SENT_252	[p16l1672t1562r2130b1652],
44	respectively	RB	O	respectively	advmod	42	SENT_252	[p16l7t1685r522b1785],
45	,	,	O	,	_	0	SENT_252	[p16l7t1685r522b1785],
46	and	CC	O	and	_	0	SENT_252	[p16l588t1684r746b1763],
47	the	DT	O	the	det	49	SENT_252	[p16l805t1685r939b1763],
48	odds	NNS	O	odds	nn	49	SENT_252	[p16l999t1684r1201b1763],
49	ratios	NNS	O	ratio	nsubj	59	SENT_252	[p16l1263t1685r1504b1763],
50	for	IN	O	for	_	0	SENT_252	[p16l1566t1684r1690b1763],
51	clinically	RB	O	clinically	advmod	52	SENT_252	[p16l1747t1685r2139b1785],
52	diagnosed	VBN	O	diagnose	amod	53	SENT_252	[p16l8t1813r453b1913],
53	hypersensitivity	NN	O	hypersensitivity	prep_for	49	SENT_252	[p16l522t1813r1205b1913],
54	reaction	NN	O	reaction	dep	42	SENT_252	[p16l1269t1813r1619b1891],
55	were	VBD	O	be	cop	59	SENT_252	[p16l1683t1839r1886b1892],
56	0.40	CD	NUMBER	0.40	number	57	SENT_252	[p16l1955t1818r2134b1891],
57	(	CD	NUMBER	(	num	58	SENT_252	[p16l12t1946r407b2032],
58	P	NN	O	p	npadvmod	59	SENT_252	[p16l12t1946r407b2032],
59	<	JJR	O	<	ccomp	33	SENT_252	[p16l12t1946r407b2032],
60	0.001	CD	NUMBER	0.001	num	61	SENT_252	[p16l12t1946r407b2032],
61	)	NN	O	)	nsubj	33	SENT_252	[p16l12t1946r407b2032],
62	and	CC	O	and	_	0	SENT_252	[p16l452t1941r610b2019],
63	0.63	CD	NUMBER	0.63	number	64	SENT_252	[p16l650t1946r824b2019],
64	(	CD	NUMBER	(	num	65	SENT_252	[p16l872t1946r1324b2036],
65	P	NN	O	p	nsubj	33	SENT_252	[p16l872t1946r1324b2036],
66	=	JJ	O	=	amod	65	SENT_252	[p16l872t1946r1324b2036],
67	0.002	CD	NUMBER	0.002	num	68	SENT_252	[p16l872t1946r1324b2036],
68	)	NN	O	)	tmod	66	SENT_252	[p16l872t1946r1324b2036],
69	,	,	O	,	_	0	SENT_252	[p16l872t1946r1324b2036],
70	respectively	RB	O	respectively	amod	68	SENT_252	[p16l1369t1941r1884b2041],
71	.	.	O	.	_	0	SENT_252	[p16l1369t1941r1884b2041],

1	As	IN	O	as	mark	2	SENT_253	[p16l133t2076r239b2147],
2	shown	VBN	O	show	advcl	14	SENT_253	[p16l278t2069r561b2148],
3	in	IN	O	in	_	0	SENT_253	[p16l595t2069r679b2146],
4	Table	NNP	O	Table	prep_in	2	SENT_253	[p16l711t2069r941b2147],
5	3	CD	NUMBER	3	num	4	SENT_253	[p16l977t2074r1046b2164],
6	,	,	O	,	_	0	SENT_253	[p16l977t2074r1046b2164],
7	only	RB	O	only	advmod	9	SENT_253	[p16l1088t2069r1272b2169],
8	prospective	JJ	O	prospective	amod	9	SENT_253	[p16l1302t2069r1793b2169],
9	screening	NN	O	screening	nsubj	21	SENT_253	[p16l1830t2094r2134b2147, p16l6t2197r145b2297],
10	was	VBD	O	be	cop	14	SENT_253	[p16l173t2223r334b2276],
11	a	DT	O	a	det	14	SENT_253	[p16l372t2223r416b2275],
12	significantly	RB	O	significantly	advmod	13	SENT_253	[p16l453t2196r985b2297],
13	negative	JJ	O	negative	amod	14	SENT_253	[p16l1018t2197r1364b2297],
14	predictor	NN	O	predictor	_	0	SENT_253	[p16l1400t2197r1787b2297],
15	of	IN	O	of	_	0	SENT_253	[p16l1822t2196r1921b2275],
16	both	DT	O	both	prep_of	14	SENT_253	[p16l1940t2197r2135b2275],
17	clinically	RB	O	clinically	advmod	18	SENT_253	[p16l8t2325r400b2425],
18	diagnosed	VBN	O	diagnose	amod	16	SENT_253	[p16l451t2324r896b2425],
19	and	CC	O	and	_	0	SENT_253	[p16l949t2325r1107b2403],
20	immunologically	RB	O	immunologically	advmod	21	SENT_253	[p16l1160t2324r1900b2425],
21	confirmed	VBD	O	confirm	conj_and	14	SENT_253	[p16l1950t2350r2134b2403, p16l7t2452r297b2531],
22	hypersensitivity	NN	O	hypersensitivity	nn	23	SENT_253	[p16l334t2453r1001b2553],
23	reaction	NN	O	reaction	dobj	21	SENT_253	[p16l1034t2453r1398b2531],
24	.	.	O	.	_	0	SENT_253	[p16l1034t2453r1398b2531],

1	Only	RB	O	only	advmod	3	SENT_254	[p16l1441t2453r1643b2553],
2	concurrent	JJ	O	concurrent	amod	3	SENT_254	[p16l1677t2469r2140b2532],
3	use	NN	O	use	nsubj	21	SENT_254	[p16l7t2607r144b2660],
4	of	IN	O	of	_	0	SENT_254	[p16l180t2580r279b2659],
5	an	DT	O	a	det	8	SENT_254	[p16l294t2606r397b2659],
6	HIV	NN	MISC	hiv	nn	8	SENT_254	[p16l430t2588r602b2659],
7	protease	NN	O	protease	nn	8	SENT_254	[p16l632t2597r985b2681],
8	inhibitor	NN	O	inhibitor	prep_of	3	SENT_254	[p16l1020t2580r1390b2659],
9	and	CC	O	and	_	0	SENT_254	[p16l1422t2581r1577b2659],
10	introduction	NN	O	introduction	conj_and	3	SENT_254	[p16l1611t2581r2135b2660],
11	of	IN	O	of	_	0	SENT_254	[p16l8t2708r107b2787],
12	a	DT	O	a	det	18	SENT_254	[p16l134t2735r178b2787],
13	new	JJ	O	new	amod	18	SENT_254	[p16l222t2734r398b2788],
14	nonnucleoside	JJ	O	nonnucleoside	amod	18	SENT_254	[p16l439t2709r1050b2788],
15	reverse	JJ	O	reverse	amod	18	SENT_254	[p16l1096t2709r1976b2809],
16	—	NN	O	—	nn	18	SENT_254	[p16l1096t2709r1976b2809],
17	transcriptase	NN	O	transcriptase	nn	18	SENT_254	[p16l1096t2709r1976b2809],
18	inhibitor	NN	O	inhibitor	prep_of	10	SENT_254	[p16l2021t2709r2134b2786, p16l7t2837r287b2915],
19	were	VBD	O	be	cop	21	SENT_254	[p16l320t2863r516b2916],
20	significant	JJ	O	significant	amod	21	SENT_254	[p16l557t2836r1005b2937],
21	predictors	NNS	O	predictor	_	0	SENT_254	[p16l1038t2837r1455b2937],
22	of	IN	O	of	_	0	SENT_254	[p16l1497t2836r1596b2915],
23	clinically	RB	O	clinically	advmod	24	SENT_254	[p16l1617t2837r1990b2937],
24	diagnosed	VBN	O	diagnose	amod	25	SENT_254	[p16l2026t2836r2134b2915, p16l6t2965r372b3065],
25	hypersensitivity	NN	O	hypersensitivity	prep_of	21	SENT_254	[p16l419t2965r1118b3065],
26	reaction	NN	O	reaction	dep	21	SENT_254	[p16l1161t2965r1518b3043],
27	that	WDT	O	that	nsubjpass	31	SENT_254	[p16l1566t2965r1742b3043],
28	was	VBD	O	be	auxpass	31	SENT_254	[p16l1780t2991r1945b3044],
29	not	RB	O	not	neg	31	SENT_254	[p16l1995t2981r2140b3043],
30	immunologically	RB	O	immunologically	advmod	31	SENT_254	[p16l11t3092r764b3193],
31	confirmed	VBN	O	confirm	rcmod	26	SENT_254	[p16l843t3092r1329b3171],
32	.	.	O	.	_	0	SENT_254	[p16l843t3092r1329b3171],

1	However	RB	O	however	advmod	8	SENT_255	[p16l1417t3100r1818b3188],
2	,	,	O	,	_	0	SENT_255	[p16l1417t3100r1818b3188],
3	these	DT	O	these	det	4	SENT_255	[p16l1906t3093r2134b3171],
4	variables	NNS	O	variable	nsubjpass	8	SENT_255	[p16l7t3221r395b3300],
5	were	VBD	O	be	auxpass	8	SENT_255	[p16l432t3247r637b3300],
6	not	RB	O	not	neg	8	SENT_255	[p16l675t3237r821b3299],
7	significantly	RB	O	significantly	advmod	8	SENT_255	[p16l856t3220r1413b3321],
8	associated	VBN	O	associate	_	0	SENT_255	[p16l1446t3220r1901b3299],
9	with	IN	O	with	_	0	SENT_255	[p16l1935t3221r2134b3300],
10	immunologically	RB	O	immunologically	advmod	11	SENT_255	[p16l11t3348r764b3449],
11	confirmed	VBN	O	confirm	prepc_with	8	SENT_255	[p16l795t3348r1257b3427],
12	hypersensitivity	NN	O	hypersensitivity	nn	13	SENT_255	[p16l1291t3348r1988b3449],
13	reaction	NN	O	reaction	dobj	11	SENT_255	[p16l2018t3375r2133b3427, p16l11t3477r304b3554],
14	.	.	O	.	_	0	SENT_255	[p16l2018t3375r2133b3427, p16l11t3477r304b3554],

1	For	IN	O	for	_	0	SENT_256	[p16l140t3611r279b3682],
2	immunologically	RB	O	immunologically	advmod	3	SENT_256	[p16l312t3604r1035b3704],
3	confirmed	VBN	O	confirm	pcomp	1	SENT_256	[p16l1067t3603r1512b3682],
4	hypersensitiv	NN	O	hypersensitiv	nn	5	SENT_256	[p16l1548t3604r2133b3704],
5	—	NN	O	—	dobj	3	SENT_256	[p16l1548t3604r2133b3704],

1	ity	NN	O	ity	nn	2	SENT_257	[p17l11t21r117b121],
2	reaction	NN	O	reaction	_	0	SENT_257	[p17l160t21r532b116],
3	,	,	O	,	_	0	SENT_257	[p17l160t21r532b116],
4	the	DT	O	the	det	5	SENT_257	[p17l588t20r720b99],
5	HLA	NN	O	hlum	appos	2	SENT_257	[p17l770t21r1307b99],
6	.	.	O	.	_	0	SENT_257	[p17l770t21r1307b99],

1	—	NN	O	—	_	0	SENT_258	[p17l770t21r1307b99],
2	.	.	O	.	_	0	SENT_258	[p17l770t21r1307b99],

1	B	NN	O	b	nsubjpass	6	SENT_259	[p17l770t21r1307b99],
2	*	CD	NUMBER	*	num	1	SENT_259	[p17l770t21r1307b99],
3	5701	CD	DATE	5701	num	4	SENT_259	[p17l770t21r1307b99],
4	allele	NN	O	allele	dep	1	SENT_259	[p17l1358t20r1581b99],
5	was	VBD	O	be	auxpass	6	SENT_259	[p17l1627t47r1790b100],
6	associated	VBN	O	associate	_	0	SENT_259	[p17l1841t21r2133b99, p17l11t148r189b227],
7	with	IN	O	with	_	0	SENT_259	[p17l217t148r412b228],
8	a	DT	O	a	det	11	SENT_259	[p17l444t175r488b227],
9	positive	JJ	O	positive	amod	11	SENT_259	[p17l517t149r848b249],
10	predictive	JJ	O	predictive	amod	11	SENT_259	[p17l879t149r1298b249],
11	value	NN	O	value	prep_with	6	SENT_259	[p17l1326t148r1546b228],
12	of	IN	O	of	_	0	SENT_259	[p17l1579t148r1679b227],
13	47.9	CD	PERCENT	47.9	num	14	SENT_259	[p17l1691t154r1945b228],
14	%	NN	PERCENT	%	prep_of	11	SENT_259	[p17l1691t154r1945b228],
15	and	CC	O	and	_	0	SENT_259	[p17l1976t148r2134b227],
16	a	DT	O	a	det	19	SENT_259	[p17l11t303r56b355],
17	negative	JJ	O	negative	amod	19	SENT_259	[p17l91t277r436b377],
18	predictive	JJ	O	predictive	amod	19	SENT_259	[p17l471t276r881b377],
19	value	NN	O	value	prep_with	6	SENT_259	[p17l914t277r1128b356],
20	of	IN	O	of	_	0	SENT_259	[p17l1166t276r1265b355],
21	100	CD	PERCENT	100	num	22	SENT_259	[p17l1286t282r1542b355],
22	%	NN	PERCENT	%	prep_of	19	SENT_259	[p17l1286t282r1542b355],
23	.	.	O	.	_	0	SENT_259	[p17l1286t282r1542b355],

1	For	IN	O	for	_	0	SENT_260	[p17l1582t284r1722b355],
2	clinically	RB	O	clinically	advmod	3	SENT_260	[p17l1756t277r2138b377],
3	diagnosed	VBN	O	diagnose	amod	4	SENT_260	[p17l12t405r448b505],
4	hypersensitivity	NN	O	hypersensitivity	prep_for	12	SENT_260	[p17l488t405r1153b505],
5	reaction	NN	O	reaction	nsubj	12	SENT_260	[p17l1188t405r1551b500],
6	,	,	O	,	_	0	SENT_260	[p17l1188t405r1551b500],
7	the	DT	O	the	det	8	SENT_260	[p17l1596t404r1727b483],
8	presence	NN	O	presence	appos	5	SENT_260	[p17l1766t430r2134b505],
9	of	IN	O	of	_	0	SENT_260	[p17l12t532r110b611],
10	the	DT	O	the	det	11	SENT_260	[p17l120t533r248b611],
11	allele	NN	O	allele	prep_of	8	SENT_260	[p17l276t532r489b611],
12	had	VBD	O	have	_	0	SENT_260	[p17l517t532r669b611],
13	a	DT	O	a	det	16	SENT_260	[p17l697t559r741b611],
14	positive	JJ	O	positive	amod	16	SENT_260	[p17l766t533r1082b633],
15	predictive	JJ	O	predictive	amod	16	SENT_260	[p17l1108t533r1509b633],
16	value	NN	O	value	dobj	12	SENT_260	[p17l1533t533r1743b612],
17	of	IN	O	of	_	0	SENT_260	[p17l1773t532r1871b611],
18	61.2	CD	PERCENT	61.2	num	19	SENT_260	[p17l1881t538r2135b611],
19	%	NN	PERCENT	%	prep_of	16	SENT_260	[p17l1881t538r2135b611],
20	and	CC	O	and	_	0	SENT_260	[p17l11t660r165b739],
21	a	DT	O	a	det	24	SENT_260	[p17l199t687r243b739],
22	negative	JJ	O	negative	amod	24	SENT_260	[p17l277t661r615b761],
23	predictive	JJ	O	predictive	amod	24	SENT_260	[p17l649t661r1049b761],
24	value	NN	O	value	conj_and	16	SENT_260	[p17l1080t661r1292b740],
25	of	IN	O	of	_	0	SENT_260	[p17l1328t660r1425b739],
26	95.5	CD	PERCENT	95.5	num	27	SENT_260	[p17l1442t666r1695b740],
27	%	NN	PERCENT	%	prep_of	24	SENT_260	[p17l1442t666r1695b740],
28	(	CD	NUMBER	(	num	29	SENT_260	[p17l1734t661r1982b752],
29	Table	NNP	O	Table	dep	27	SENT_260	[p17l1734t661r1982b752],
30	4	CD	NUMBER	4	number	31	SENT_260	[p17l2016t666r2113b752],
31	)	CD	NUMBER	)	dep	29	SENT_260	[p17l2016t666r2113b752],
32	.	.	O	.	_	0	SENT_260	[p17l2016t666r2113b752],

1	The	DT	O	the	det	3	SENT_261	[p17l137t788r296b867],
2	100	CD	NUMBER	100	num	3	SENT_261	[p17l336t794r481b867],
3	patients	NNS	O	patient	nsubj	16	SENT_261	[p17l516t789r850b889],
4	who	WP	O	who	nsubj	12	SENT_261	[p17l884t789r1064b868],
5	had	VBD	O	have	rcmod	3	SENT_261	[p17l1101t789r1255b867],
6	clinical	JJ	O	clinical	amod	7	SENT_261	[p17l1292t789r1597b867],
7	tolerance	NN	O	tolerance	dobj	5	SENT_261	[p17l1633t789r2017b867],
8	of	IN	O	of	_	0	SENT_261	[p17l2054t788r2152b867],
9	abacavir	NN	O	abacavir	prep_of	7	SENT_261	[p17l11t916r367b996],
10	and	CC	O	and	_	0	SENT_261	[p17l396t916r554b995],
11	then	RB	O	then	advmod	12	SENT_261	[p17l586t917r777b995],
12	underwent	VBD	O	undergo	rcmod	3	SENT_261	[p17l809t917r1273b996],
13	epicutaneous	JJ	O	epicutaneous	amod	15	SENT_261	[p17l1301t917r1866b1017],
14	patch	NN	O	patch	nn	15	SENT_261	[p17l1898t917r2134b1017],
15	testing	NN	O	testing	dobj	12	SENT_261	[p17l12t1045r310b1145],
16	had	VBD	O	have	_	0	SENT_261	[p17l355t1045r512b1123],
17	negative	JJ	O	negative	amod	18	SENT_261	[p17l559t1045r912b1145],
18	tests	NNS	O	test	dobj	16	SENT_261	[p17l961t1061r1180b1140],
19	,	,	O	,	_	0	SENT_261	[p17l961t1061r1180b1140],
20	resulting	VBG	O	result	partmod	16	SENT_261	[p17l1233t1045r1621b1145],
21	in	IN	O	in	_	0	SENT_261	[p17l1664t1045r1748b1122],
22	a	DT	O	a	det	23	SENT_261	[p17l1796t1071r1840b1123],
23	specificity	NN	O	specificity	prep_in	20	SENT_261	[p17l1888t1045r2133b1145, p17l12t1172r233b1273],
24	of	IN	O	of	_	0	SENT_261	[p17l270t1172r370b1251],
25	patch	NN	O	patch	nn	26	SENT_261	[p17l392t1172r628b1273],
26	testing	NN	O	testing	prep_of	23	SENT_261	[p17l670t1173r968b1273],
27	of	IN	O	of	_	0	SENT_261	[p17l1006t1172r1106b1251],
28	100	CD	NUMBER	100	number	29	SENT_261	[p17l1133t1178r1369b1251],
29	°	CD	NUMBER	°	prep_of	26	SENT_261	[p17l1133t1178r1369b1251],
30	/	:	O	/	punct	31	SENT_261	[p17l1133t1178r1369b1251],
31	o	NN	O	o	dep	29	SENT_261	[p17l1133t1178r1369b1251],
32	(	CD	PERCENT	(	num	31	SENT_261	[p17l1414t1178r1626b1264],
33	95	CD	PERCENT	95	number	34	SENT_261	[p17l1414t1178r1626b1264],
34	%	NN	PERCENT	%	amod	35	SENT_261	[p17l1414t1178r1626b1264],
35	CI	NN	O	ci	dobj	20	SENT_261	[p17l1667t1178r1782b1268],
36	,	,	O	,	_	0	SENT_261	[p17l1667t1178r1782b1268],
37	96.4	CD	NUMBER	96.4	number	40	SENT_261	[p17l1829t1178r2009b1251],
38	to	TO	O	to	dep	40	SENT_261	[p17l2051t1189r2133b1251],
39	100	CD	NUMBER	100	number	40	SENT_261	[p17l15t1306r186b1392],
40	)	CD	NUMBER	)	appos	35	SENT_261	[p17l15t1306r186b1392],
41	for	IN	O	for	prep	40	SENT_261	[p17l239t1300r361b1379],
42	clinically	RB	O	clinically	pobj	41	SENT_261	[p17l406t1301r788b1401],
43	diagnosed	VBN	O	diagnose	partmod	40	SENT_261	[p17l831t1300r1266b1401],
44	hypersensitivity	NN	O	hypersensitivity	nn	45	SENT_261	[p17l1314t1301r1978b1401],
45	reaction	NN	O	reaction	dobj	43	SENT_261	[p17l2022t1327r2133b1379, p17l11t1429r291b1507],
46	.	.	O	.	_	0	SENT_261	[p17l2022t1327r2133b1379, p17l11t1429r291b1507],

1	None	NN	O	none	nsubj	7	SENT_262	[p17l329t1436r557b1507],
2	of	IN	O	of	_	0	SENT_262	[p17l595t1428r695b1507],
3	the	DT	O	the	det	5	SENT_262	[p17l714t1429r847b1507],
4	100	CD	NUMBER	100	num	5	SENT_262	[p17l888t1434r1035b1507],
5	patients	NNS	O	patient	prep_of	1	SENT_262	[p17l1072t1429r1413b1529],
6	were	VBD	O	be	cop	7	SENT_262	[p17l1448t1455r1649b1508],
7	carriers	NNS	O	carrier	_	0	SENT_262	[p17l1688t1429r2013b1507],
8	of	IN	O	of	_	0	SENT_262	[p17l2053t1428r2152b1507],
9	HLA	NN	O	hlum	prep_of	7	SENT_262	[p17l11t1557r572b1635],
10	.	.	O	.	_	0	SENT_262	[p17l11t1557r572b1635],

1	—	NN	O	—	_	0	SENT_263	[p17l11t1557r572b1635],
2	.	.	O	.	_	0	SENT_263	[p17l11t1557r572b1635],

1	B	NN	O	b	_	0	SENT_264	[p17l11t1557r572b1635],
2	*	CD	NUMBER	*	number	3	SENT_264	[p17l11t1557r572b1635],
3	5701	CD	NUMBER	5701	num	1	SENT_264	[p17l11t1557r572b1635],
4	.	.	O	.	_	0	SENT_264	[p17l11t1557r572b1635],

1	In	IN	O	in	_	0	SENT_265	[p17l618t1564r707b1634],
2	all	DT	O	all	prep_in	20	SENT_265	[p17l748t1557r875b1652],
3	,	,	O	,	_	0	SENT_265	[p17l748t1557r875b1652],
4	61	CD	NUMBER	61	nsubj	20	SENT_265	[p17l924t1562r1019b1635],
5	of	IN	O	of	_	0	SENT_265	[p17l1063t1556r1163b1635],
6	the	DT	O	the	det	8	SENT_265	[p17l1187t1557r1319b1635],
7	66	CD	NUMBER	66	num	8	SENT_265	[p17l1362t1562r1462b1635],
8	patients	NNS	O	patient	prep_of	4	SENT_265	[p17l1503t1557r1840b1657],
9	in	IN	O	in	_	0	SENT_265	[p17l1881t1557r1964b1634],
10	the	DT	O	the	det	12	SENT_265	[p17l2004t1557r2134b1635],
11	control	NN	O	control	nn	12	SENT_265	[p17l12t1685r325b1763],
12	group	NN	O	group	prep_in	8	SENT_265	[p17l396t1710r653b1785],
13	who	WP	O	who	nsubj	14	SENT_265	[p17l723t1684r907b1764],
14	had	VBD	O	have	rcmod	12	SENT_265	[p17l981t1685r1140b1763],
15	clinically	RB	O	clinically	advmod	16	SENT_265	[p17l1212t1685r1613b1785],
16	diagnosed	VBN	O	diagnose	amod	18	SENT_265	[p17l1681t1685r2134b1785],
17	hypersensitivity	NN	O	hypersensitivity	nn	18	SENT_265	[p17l12t1813r709b1913],
18	reaction	NN	O	reaction	dobj	14	SENT_265	[p17l745t1813r1101b1891],
19	also	RB	O	also	advmod	20	SENT_265	[p17l1140t1813r1315b1891],
20	had	VBD	O	have	_	0	SENT_265	[p17l1356t1813r1515b1891],
21	epicutaneous	JJ	O	epicutaneous	amod	24	SENT_265	[p17l1556t1813r2132b1913],
22	patch	NN	O	patch	nn	24	SENT_265	[p17l11t1941r587b2041],
23	—	NN	O	—	nn	24	SENT_265	[p17l11t1941r587b2041],
24	testing	NN	O	testing	dobj	20	SENT_265	[p17l11t1941r587b2041],
25	results	VBZ	O	result	rcmod	24	SENT_265	[p17l622t1941r905b2020],
26	that	DT	O	that	nsubjpass	29	SENT_265	[p17l946t1941r1119b2019],
27	could	MD	O	could	aux	29	SENT_265	[p17l1153t1940r1387b2020],
28	be	VB	O	be	auxpass	29	SENT_265	[p17l1426t1940r1523b2019],
29	evaluated	VBN	O	evaluate	ccomp	25	SENT_265	[p17l1562t1940r1987b2020],
30	.	.	O	.	_	0	SENT_265	[p17l1562t1940r1987b2020],

1	Of	IN	O	of	_	0	SENT_266	[p17l2032t1940r2152b2019],
2	these	DT	O	these	det	4	SENT_266	[p17l12t2069r236b2147],
3	61	CD	NUMBER	61	num	4	SENT_266	[p17l276t2074r372b2147],
4	patients	NNS	O	patient	prep_of	16	SENT_266	[p17l412t2069r778b2169],
5	,	,	O	,	_	0	SENT_266	[p17l412t2069r778b2169],
6	all	DT	O	all	det	8	SENT_266	[p17l823t2068r928b2147],
7	23	CD	NUMBER	23	num	8	SENT_266	[p17l967t2074r1065b2147],
8	patients	NNS	O	patient	nsubj	16	SENT_266	[p17l1107t2069r1449b2169],
9	with	IN	O	with	_	0	SENT_266	[p17l1486t2068r1681b2148],
10	a	DT	O	a	det	14	SENT_266	[p17l1721t2095r1765b2147],
11	positive	JJ	O	positive	amod	14	SENT_266	[p17l1802t2069r2133b2169],
12	epicutaneous	JJ	O	epicutaneous	amod	14	SENT_266	[p17l12t2197r577b2297],
13	patch	NN	O	patch	nn	14	SENT_266	[p17l620t2197r856b2297],
14	test	NN	O	test	prep_with	8	SENT_266	[p17l899t2213r1053b2275],
15	were	VBD	O	be	cop	16	SENT_266	[p17l1086t2223r1287b2276],
16	HLA	NN	O	hlum	_	0	SENT_266	[p17l1329t2197r2133b2297],
17	.	.	O	.	_	0	SENT_266	[p17l1329t2197r2133b2297],

1	—	NN	O	—	_	0	SENT_267	[p17l1329t2197r2133b2297],
2	.	.	O	.	_	0	SENT_267	[p17l1329t2197r2133b2297],

1	B	NN	O	b	_	0	SENT_268	[p17l1329t2197r2133b2297],
2	*	CD	NUMBER	*	number	3	SENT_268	[p17l1329t2197r2133b2297],
3	5701	CD	NUMBER	5701	num	1	SENT_268	[p17l1329t2197r2133b2297],
4	.	.	O	.	_	0	SENT_268	[p17l1329t2197r2133b2297],

1	—	NN	O	—	_	0	SENT_269	[p17l1329t2197r2133b2297],
2	.	.	O	.	_	0	SENT_269	[p17l1329t2197r2133b2297],

1	posi	NN	O	posus	nn	2	SENT_270	[p17l1329t2197r2133b2297],
2	tive	NN	O	tive	_	0	SENT_270	[p17l12t2325r183b2420],
3	,	,	O	,	_	0	SENT_270	[p17l12t2325r183b2420],
4	whereas	IN	O	whereas	mark	15	SENT_270	[p17l219t2325r571b2404],
5	32	CD	NUMBER	32	nsubj	15	SENT_270	[p17l609t2330r705b2403],
6	of	IN	O	of	_	0	SENT_270	[p17l742t2324r842b2403],
7	38	CD	NUMBER	38	prep_of	5	SENT_270	[p17l859t2330r957b2403],
8	with	IN	O	with	_	0	SENT_270	[p17l990t2325r1185b2404],
9	a	DT	O	a	det	13	SENT_270	[p17l1219t2351r1264b2403],
10	negative	JJ	O	negative	amod	13	SENT_270	[p17l1297t2325r1650b2425],
11	epicutaneous	JJ	O	epicutaneous	amod	13	SENT_270	[p17l1686t2325r2133b2425, p17l12t2477r158b2531],
12	patch	NN	O	patch	nn	13	SENT_270	[p17l203t2453r439b2552],
13	test	NN	O	test	prep_with	7	SENT_270	[p17l484t2468r639b2530],
14	were	VBD	O	be	cop	15	SENT_270	[p17l674t2478r875b2531],
15	HLA	NN	O	hlum	dep	2	SENT_270	[p17l920t2453r1866b2552],
16	.	.	O	.	_	0	SENT_270	[p17l920t2453r1866b2552],

1	—	NN	O	—	_	0	SENT_271	[p17l920t2453r1866b2552],
2	.	.	O	.	_	0	SENT_271	[p17l920t2453r1866b2552],

1	B	NN	O	b	_	0	SENT_272	[p17l920t2453r1866b2552],
2	*	CD	NUMBER	*	number	3	SENT_272	[p17l920t2453r1866b2552],
3	5701	CD	NUMBER	5701	num	1	SENT_272	[p17l920t2453r1866b2552],
4	.	.	O	.	_	0	SENT_272	[p17l920t2453r1866b2552],

1	—	NN	O	—	_	0	SENT_273	[p17l920t2453r1866b2552],
2	.	.	O	.	_	0	SENT_273	[p17l920t2453r1866b2552],

1	negative	JJ	O	negative	amod	2	SENT_274	[p17l920t2453r1866b2552],
2	(	NN	O	(	_	0	SENT_274	[p17l1916t2453r2134b2543],
3	with	IN	O	with	_	0	SENT_274	[p17l1916t2453r2134b2543],
4	the	DT	O	the	prep_with	2	SENT_274	[p17l12t2581r145b2658],
5	remaining	VBG	O	remain	amod	4	SENT_274	[p17l185t2581r637b2680],
6	6	CD	NUMBER	6	dep	2	SENT_274	[p17l674t2586r720b2658],
7	being	VBG	O	be	cop	8	SENT_274	[p17l761t2581r1003b2680],
8	HLA	NN	O	hlum	rcmod	6	SENT_274	[p17l1038t2581r2012b2680],
9	.	.	O	.	_	0	SENT_274	[p17l1038t2581r2012b2680],

1	—	NN	O	—	_	0	SENT_275	[p17l1038t2581r2012b2680],
2	.	.	O	.	_	0	SENT_275	[p17l1038t2581r2012b2680],

1	B	NN	O	b	_	0	SENT_276	[p17l1038t2581r2012b2680],
2	*	CD	NUMBER	*	number	3	SENT_276	[p17l1038t2581r2012b2680],
3	5701	CD	NUMBER	5701	num	1	SENT_276	[p17l1038t2581r2012b2680],
4	.	.	O	.	_	0	SENT_276	[p17l1038t2581r2012b2680],

1	—	NN	O	—	_	0	SENT_277	[p17l1038t2581r2012b2680],
2	.	.	O	.	_	0	SENT_277	[p17l1038t2581r2012b2680],

1	positive	JJ	O	positive	amod	2	SENT_278	[p17l1038t2581r2012b2680],
2	)	NN	O	)	_	0	SENT_278	[p17l1038t2581r2012b2680],
3	.	.	O	.	_	0	SENT_278	[p17l1038t2581r2012b2680],

1	A	DT	O	a	det	2	SENT_279	[p17l137t2716r203b2786],
2	total	NN	O	total	_	0	SENT_279	[p17l256t2709r453b2787],
3	of	IN	O	of	_	0	SENT_279	[p17l509t2708r608b2787],
4	665	CD	NUMBER	665	prep_of	2	SENT_279	[p17l646t2714r794b2787],
5	of	IN	O	of	_	0	SENT_279	[p17l853t2708r953b2787],
6	1772	CD	NUMBER	1772	num	7	SENT_279	[p17l994t2714r1192b2787],
7	patients	NNS	O	patient	prep_of	4	SENT_279	[p17l1247t2709r1589b2809],
8	exposed	VBN	O	expose	partmod	7	SENT_279	[p17l1647t2708r1996b2809],
9	to	TO	O	to	xcomp	8	SENT_279	[p17l2051t2725r2133b2787],

1	574	CD	NUMBER	574	num	4	SENT_280	[p17l149t2884r205b2907],
2	N	NN	O	n	nn	4	SENT_280	[p17l908t2894r921b2909],
3	ENGLJ	NN	O	englj	nn	4	SENT_280	[p17l936t2894r1014b2916],
4	MED	NN	O	med	_	0	SENT_280	[p17l1029t2894r1081b2909],
5	358	CD	NUMBER	358	dep	4	SENT_280	[p17l1091t2888r1154b2916],
6	;	:	O	;	_	0	SENT_280	[p17l1091t2888r1154b2916],
7	6	CD	NUMBER	6	num	8	SENT_280	[p17l1091t2888r1154b2916],
8	WWW	NN	O	www	dep	4	SENT_280	[p17l1188t2894r1295b2910],
9	.	.	O	.	_	0	SENT_280	[p17l1188t2894r1295b2910],

1	NE	NN	O	ne	nn	3	SENT_281	[p17l1188t2894r1295b2910],
2	M.ORG	NN	O	m.org	nn	3	SENT_281	[p17l1309t2894r1389b2910],
3	FEBRUARY	NN	DATE	february	_	0	SENT_281	[p17l1426t2894r1547b2910],
4	7	CD	DATE	7	dep	3	SENT_281	[p17l1557t2894r1576b2915],
5	,	,	DATE	,	_	0	SENT_281	[p17l1557t2894r1576b2915],
6	2008	CD	DATE	2008	appos	4	SENT_281	[p17l1587t2888r1650b2910],

1	The	DT	O	the	det	5	SENT_282	[p17l935t2927r986b2951],
2	New	NNP	O	New	nn	5	SENT_282	[p17l995t2928r1057b2951],
3	England	NNP	O	England	nn	5	SENT_282	[p17l1066t2927r1177b2958],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_282	[p17l1186t2928r1275b2951],
5	o	NN	O	o	_	0	SENT_282	[p17l1293t2935r1308b2951],
6	Medicine	NN	O	medicine	dep	5	SENT_282	[p17l1329t2927r1454b2951],

1	H	NN	O	h	nn	2	SENT_283	[p17l585t3052r606b3071],
2	LA-B	NN	O	la-b	_	0	SENT_283	[p17l612t3049r720b3072],
3	*	CD	NUMBER	*	number	4	SENT_283	[p17l612t3049r720b3072],
4	5	CD	NUMBER	5	dep	2	SENT_283	[p17l612t3049r720b3072],
5	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	NNP	O	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	nn	6	SENT_283	[p17l726t3052r1534b3071],
6	TY	NN	O	ty	dep	4	SENT_283	[p17l1539t3052r1577b3071],

1	Table	NNP	O	Table	_	0	SENT_284	[p18l262t71r336b96],
2	3	CD	NUMBER	3	dep	1	SENT_284	[p18l345t73r368b96],
3	.	.	O	.	_	0	SENT_284	[p18l345t73r368b96],

1	Results	NNS	O	result	nsubj	8	SENT_285	[p18l380t71r477b96],
2	of	IN	O	of	_	0	SENT_285	[p18l486t71r518b96],
3	Multivariate	NNP	O	Multivariate	nn	4	SENT_285	[p18l523t71r687b96],
4	Analysis	NN	O	analysis	prep_of	1	SENT_285	[p18l695t71r808b104],
5	for	IN	O	for	_	0	SENT_285	[p18l817t71r855b96],
6	Covariates	NNP	O	Covariates	prep_for	4	SENT_285	[p18l863t72r1006b96],
7	Potentially	RB	O	potentially	advmod	8	SENT_285	[p18l1018t71r1160b104],
8	Associated	VBD	O	associate	_	0	SENT_285	[p18l1167t71r1315b96],
9	with	IN	O	with	_	0	SENT_285	[p18l1325t71r1383b96],
10	Hypersensitivity	NN	O	hypersensitivity	prep_with	8	SENT_285	[p18l1395t72r1616b104],
11	to	TO	O	to	_	0	SENT_285	[p18l1624t75r1651b96],
12	Abacavir	NNP	O	Abacavir	prep_to	8	SENT_285	[p18l1659t71r1802b96],
13	.	.	O	.	_	0	SENT_285	[p18l1659t71r1802b96],

1	*	NN	O	*	_	0	SENT_286	[p18l1659t71r1802b96],

1	Clinically	RB	O	clinically	_	0	SENT_287	[p18l1693t146r1816b179],

1	Diagnosed	VBN	O	diagnose	_	0	SENT_288	[p18l1624t184r1768b217],
2	but	CC	O	but	cc	3	SENT_288	[p18l1781t184r1825b209],
3	Not	RB	O	not	prep	1	SENT_288	[p18l1837t186r1887b209],
4	immunologically	RB	O	immunologically	dep	3	SENT_288	[p18l1340t221r1568b254],
5	immunologically	RB	O	immunologically	advmod	7	SENT_288	[p18l1641t221r1869b254],
6	Clinically	RB	O	clinically	advmod	7	SENT_288	[p18l999t259r1122b292],
7	Diagnosed	JJ	O	diagnosed	amod	12	SENT_288	[p18l1134t259r1278b292],
8	Conﬁrmed	NNP	O	Conﬁrmed	nn	12	SENT_288	[p18l1380t259r1524b284],
9	Conﬁrmed	NNP	O	Conﬁrmed	nn	12	SENT_288	[p18l1682t259r1825b284],
10	Hypersensitivity	NN	O	hypersensitivity	nn	12	SENT_288	[p18l1030t297r1250b329],
11	Hypersensitivity	NN	O	hypersensitivity	nn	12	SENT_288	[p18l1343t297r1564b329],
12	Hypersensitivity	NN	O	hypersensitivity	dobj	1	SENT_288	[p18l1645t297r1865b330],

1	Covariate	NNP	O	Covariate	nn	6	SENT_289	[p18l262t335r392b359],
2	Reaction	NNP	O	Reaction	nn	6	SENT_289	[p18l1082t335r1197b359],
3	Reaction	NNP	O	Reaction	nn	6	SENT_289	[p18l1396t335r1510b359],
4	Reaction	NNP	O	Reaction	nn	6	SENT_289	[p18l1697t335r1812b359],
5	Prospective	JJ	O	prospective	amod	6	SENT_289	[p18l265t394r421b424],
6	screening	NN	O	screening	dep	14	SENT_289	[p18l431t394r569b425],
7	,	,	O	,	_	0	SENT_289	[p18l431t394r569b425],
8	vs.	CC	O	vs.	prep	6	SENT_289	[p18l580t401r616b417],
9	control	NN	O	control	nn	10	SENT_289	[p18l627t392r721b417],
10	Odds	NNS	O	odds	dep	8	SENT_289	[p18l313t449r386b475],
11	ratio	NN	O	ratio	dep	14	SENT_289	[p18l398t452r458b475],
12	(	CD	PERCENT	(	num	11	SENT_289	[p18l471t451r540b482],
13	95	CD	PERCENT	95	num	14	SENT_289	[p18l471t451r540b482],
14	%	NN	PERCENT	%	dep	18	SENT_289	[p18l471t451r540b482],
15	CI	NN	O	ci	dep	14	SENT_289	[p18l550t451r587b482],
16	)	CD	NUMBER	)	number	17	SENT_289	[p18l550t451r587b482],
17	0.40	CD	NUMBER	0.40	dep	15	SENT_289	[p18l1028t451r1085b475],
18	(	NN	O	(	dep	21	SENT_289	[p18l1097t451r1247b482],
19	0.25	CD	NUMBER	0.25	num	18	SENT_289	[p18l1097t451r1247b482],
20	—	CD	NUMBER	—	num	21	SENT_289	[p18l1097t451r1247b482],
21	0.62	CD	NUMBER	0.62	dep	26	SENT_289	[p18l1097t451r1247b482],
22	)	NN	O	)	dep	21	SENT_289	[p18l1097t451r1247b482],
23	0.03	CD	NUMBER	0.03	num	22	SENT_289	[p18l1342t451r1396b475],
24	(	CD	NUMBER	(	number	25	SENT_289	[p18l1411t451r1561b482],
25	0.00	CD	NUMBER	0.00	dep	22	SENT_289	[p18l1411t451r1561b482],
26	—	NN	O	—	dep	30	SENT_289	[p18l1411t451r1561b482],
27	0.18	CD	NUMBER	0.18	num	26	SENT_289	[p18l1411t451r1561b482],
28	)	CD	NUMBER	)	num	30	SENT_289	[p18l1411t451r1561b482],
29	0.69	CD	NUMBER	0.69	num	30	SENT_289	[p18l1643t451r1699b475],
30	(	NN	O	(	dep	37	SENT_289	[p18l1712t451r1862b482],
31	0.41	CD	NUMBER	0.41	number	32	SENT_289	[p18l1712t451r1862b482],
32	—	CD	NUMBER	—	dep	30	SENT_289	[p18l1712t451r1862b482],
33	1.14	CD	NUMBER	1.14	num	34	SENT_289	[p18l1712t451r1862b482],
34	)	NN	O	)	dep	32	SENT_289	[p18l1712t451r1862b482],
35	P	NN	O	p	nn	37	SENT_289	[p18l315t509r330b532],
36	value	NN	O	value	nn	37	SENT_289	[p18l339t507r410b532],
37	P	NN	O	p	_	0	SENT_289	[p18l1086t509r1192b532],
38	<	VBG	O	<	rcmod	37	SENT_289	[p18l1086t509r1192b532],
39	0.001	CD	NUMBER	0.001	num	40	SENT_289	[p18l1086t509r1192b532],
40	P	NN	O	p	npadvmod	41	SENT_289	[p18l1400t509r1506b532],
41	<	JJR	O	<	acomp	38	SENT_289	[p18l1400t509r1506b532],
42	0.001	CD	NUMBER	0.001	num	43	SENT_289	[p18l1400t509r1506b532],
43	P	NN	O	p	dep	41	SENT_289	[p18l1706t509r1803b532],
44	=	JJ	O	=	amod	43	SENT_289	[p18l1706t509r1803b532],
45	0.15	CD	NUMBER	0.15	tmod	44	SENT_289	[p18l1706t509r1803b532],

1	White	NNP	O	White	_	0	SENT_290	[p18l262t565r342b590],
2	race	NN	O	race	dep	1	SENT_290	[p18l353t574r414b594],
3	,	,	O	,	_	0	SENT_290	[p18l353t574r414b594],
4	vs.	CC	O	vs.	prep	2	SENT_290	[p18l425t573r460b590],
5	nonwhite	JJ	O	nonwhite	dep	4	SENT_290	[p18l473t565r597b590],

1	Odds	NNS	O	odds	nn	2	SENT_291	[p18l313t622r386b648],
2	ratio	NN	O	ratio	dep	9	SENT_291	[p18l398t625r458b648],
3	(	CD	PERCENT	(	num	5	SENT_291	[p18l471t624r540b655],
4	95	CD	PERCENT	95	num	5	SENT_291	[p18l471t624r540b655],
5	%	NN	PERCENT	%	dep	2	SENT_291	[p18l471t624r540b655],
6	CI	NN	O	ci	dep	9	SENT_291	[p18l550t624r587b655],
7	)	CD	NUMBER	)	num	6	SENT_291	[p18l550t624r587b655],
8	2.19	CD	NUMBER	2.19	num	9	SENT_291	[p18l1028t625r1084b648],
9	(	NN	O	(	dep	13	SENT_291	[p18l1097t624r1247b655],
10	1.10	CD	NUMBER	1.10	dep	9	SENT_291	[p18l1097t624r1247b655],
11	—	CD	NUMBER	—	number	12	SENT_291	[p18l1097t624r1247b655],
12	5.01	CD	NUMBER	5.01	dep	10	SENT_291	[p18l1097t624r1247b655],
13	)	NN	O	)	dep	17	SENT_291	[p18l1097t624r1247b655],
14	4.21	CD	NUMBER	4.21	num	13	SENT_291	[p18l1333t625r1388b647],
15	(	CD	NUMBER	(	num	17	SENT_291	[p18l1403t624r1569b655],
16	0.67	CD	NUMBER	0.67	num	17	SENT_291	[p18l1403t624r1569b655],
17	—	NN	O	—	dep	22	SENT_291	[p18l1403t624r1569b655],
18	175.5	CD	NUMBER	175.5	number	19	SENT_291	[p18l1403t624r1569b655],
19	)	CD	NUMBER	)	dep	17	SENT_291	[p18l1403t624r1569b655],
20	2.00	CD	NUMBER	2.00	num	21	SENT_291	[p18l1643t624r1700b648],
21	(	NN	O	(	dep	19	SENT_291	[p18l1712t624r1862b655],
22	0.91	CD	NUMBER	0.91	_	0	SENT_291	[p18l1712t624r1862b655],
23	—	CD	NUMBER	—	number	24	SENT_291	[p18l1712t624r1862b655],
24	5.27	CD	NUMBER	5.27	num	33	SENT_291	[p18l1712t624r1862b655],
25	)	NN	O	)	nn	33	SENT_291	[p18l1712t624r1862b655],
26	Pvalue	NN	O	pvalue	nn	33	SENT_291	[p18l315t680r410b705],
27	P	NN	O	p	dep	33	SENT_291	[p18l1090t682r1189b705],
28	=	JJ	O	=	dep	27	SENT_291	[p18l1090t682r1189b705],
29	0.02	CD	NUMBER	0.02	num	30	SENT_291	[p18l1090t682r1189b705],
30	P	NN	O	p	dep	28	SENT_291	[p18l1404t682r1502b705],
31	=	JJ	O	=	amod	33	SENT_291	[p18l1404t682r1502b705],
32	0.11	CD	NUMBER	0.11	num	33	SENT_291	[p18l1404t682r1502b705],
33	P	NN	O	p	dep	22	SENT_291	[p18l1706t682r1804b705],
34	=	JJ	O	=	amod	33	SENT_291	[p18l1706t682r1804b705],
35	0.09	CD	NUMBER	0.09	tmod	34	SENT_291	[p18l1706t682r1804b705],

1	No	DT	O	no	det	3	SENT_292	[p18l265t740r304b763],
2	previous	JJ	O	previous	amod	3	SENT_292	[p18l315t740r430b770],
3	receipt	NN	O	receipt	_	0	SENT_292	[p18l442t740r533b770],
4	ofantiretroviral	JJ	O	ofantiretroviral	amod	5	SENT_292	[p18l542t737r750b763],
5	drugs	NNS	O	drug	dep	3	SENT_292	[p18l762t738r846b771],
6	,	,	O	,	_	0	SENT_292	[p18l762t738r846b771],
7	vs.	FW	O	vs.	prep	5	SENT_292	[p18l856t747r892b763],
8	any	DT	O	any	det	10	SENT_292	[p18l903t746r949b771],
9	Odds	NNS	O	odds	nn	10	SENT_292	[p18l313t795r386b821],
10	ratio	NN	O	ratio	pobj	7	SENT_292	[p18l398t798r458b821],
11	(	CD	PERCENT	(	number	12	SENT_292	[p18l471t797r540b828],
12	95	CD	PERCENT	95	num	13	SENT_292	[p18l471t797r540b828],
13	%	NN	PERCENT	%	dep	3	SENT_292	[p18l471t797r540b828],
14	CI	NN	O	ci	dep	13	SENT_292	[p18l550t797r587b828],
15	)	CD	NUMBER	)	number	16	SENT_292	[p18l550t797r587b828],
16	1.37	CD	NUMBER	1.37	dep	3	SENT_292	[p18l1030t797r1084b821],
17	(	CD	NUMBER	(	num	18	SENT_292	[p18l1097t797r1247b828],
18	o.	NN	O	o.	dep	16	SENT_292	[p18l1097t797r1247b828],
19	79	CD	NUMBER	79	number	20	SENT_292	[p18l1097t797r1247b828],
20	—	CD	NUMBER	—	dep	3	SENT_292	[p18l1097t797r1247b828],
21	2.32	CD	NUMBER	2.32	num	22	SENT_292	[p18l1097t797r1247b828],
22	)	NN	O	)	dep	20	SENT_292	[p18l1097t797r1247b828],
23	1.20	CD	NUMBER	1.20	number	24	SENT_292	[p18l1344t797r1399b821],
24	(	CD	NUMBER	(	dep	3	SENT_292	[p18l1411t797r1561b828],
25	o.	NN	O	o.	dep	24	SENT_292	[p18l1411t797r1561b828],
26	31	CD	NUMBER	31	num	27	SENT_292	[p18l1411t797r1561b828],
27	—	NN	O	—	dep	3	SENT_292	[p18l1411t797r1561b828],
28	3	CD	NUMBER	3	dep	27	SENT_292	[p18l1411t797r1561b828],
29	.	.	O	.	_	0	SENT_292	[p18l1411t797r1561b828],

1	z2	NN	O	z2	_	0	SENT_293	[p18l1411t797r1561b828],
2	)	CD	NUMBER	)	num	1	SENT_293	[p18l1411t797r1561b828],
3	1.49	CD	NUMBER	1.49	number	4	SENT_293	[p18l1645t798r1699b821],
4	(	CD	NUMBER	(	dep	1	SENT_293	[p18l1712t797r1862b828],
5	o.	NN	O	o.	dep	4	SENT_293	[p18l1712t797r1862b828],
6	7z	CD	NUMBER	7z	num	5	SENT_293	[p18l1712t797r1862b828],
7	—	CD	NUMBER	—	number	8	SENT_293	[p18l1712t797r1862b828],
8	2.73	CD	NUMBER	2.73	num	17	SENT_293	[p18l1712t797r1862b828],
9	)	NN	O	)	nn	17	SENT_293	[p18l1712t797r1862b828],
10	Pvalue	NN	O	pvalue	nn	17	SENT_293	[p18l315t853r410b878],
11	P	NN	O	p	dep	17	SENT_293	[p18l1090t855r1189b878],
12	=	JJ	O	=	dep	11	SENT_293	[p18l1090t855r1189b878],
13	0.26	CD	NUMBER	0.26	num	14	SENT_293	[p18l1090t855r1189b878],
14	P	NN	O	p	dep	12	SENT_293	[p18l1404t855r1503b878],
15	=	JJ	O	=	amod	17	SENT_293	[p18l1404t855r1503b878],
16	0.66	CD	NUMBER	0.66	num	17	SENT_293	[p18l1404t855r1503b878],
17	P	NN	O	p	dep	1	SENT_293	[p18l1706t855r1804b878],
18	=	JJ	O	=	amod	17	SENT_293	[p18l1706t855r1804b878],
19	0.22	CD	NUMBER	0.22	tmod	18	SENT_293	[p18l1706t855r1804b878],

1	Introduction	NN	O	introduction	dep	22	SENT_294	[p18l265t911r432b936],
2	of	IN	O	of	_	0	SENT_294	[p18l444t910r473b936],
3	N	NN	O	n	nn	5	SENT_294	[p18l481t913r499b936],
4	N	NN	O	n	nn	5	SENT_294	[p18l506t913r524b936],
5	RTI	NNP	ORGANIZATION	RTI	prep_of	1	SENT_294	[p18l531t913r581b940],
6	,	,	O	,	_	0	SENT_294	[p18l531t913r581b940],
7	vs.	FW	O	vs.	prep	5	SENT_294	[p18l592t919r628b936],
8	no	DT	O	no	det	11	SENT_294	[p18l640t919r672b936],
9	introduction	NN	O	introduction	nn	11	SENT_294	[p18l683t911r850b936],
10	Odds	NNS	O	odds	nn	11	SENT_294	[p18l313t968r386b994],
11	ratio	NN	O	ratio	pobj	7	SENT_294	[p18l398t971r458b994],
12	(	CD	PERCENT	(	number	13	SENT_294	[p18l471t970r540b1001],
13	95	CD	PERCENT	95	dep	14	SENT_294	[p18l471t970r540b1001],
14	%	NN	PERCENT	%	dep	11	SENT_294	[p18l471t970r540b1001],
15	CI	NN	O	ci	dep	5	SENT_294	[p18l550t970r587b1001],
16	)	CD	NUMBER	)	number	17	SENT_294	[p18l550t970r587b1001],
17	3.19	CD	NUMBER	3.19	dep	15	SENT_294	[p18l1029t970r1084b994],
18	(	NN	O	(	dep	22	SENT_294	[p18l1097t970r1247b1001],
19	1.61	CD	NUMBER	1.61	num	18	SENT_294	[p18l1097t970r1247b1001],
20	—	CD	NUMBER	—	num	22	SENT_294	[p18l1097t970r1247b1001],
21	6.18	CD	NUMBER	6.18	num	22	SENT_294	[p18l1097t970r1247b1001],
22	)	NN	O	)	dep	26	SENT_294	[p18l1097t970r1247b1001],
23	1.45	CD	NUMBER	1.45	number	24	SENT_294	[p18l1344t971r1396b994],
24	(	CD	NUMBER	(	dep	22	SENT_294	[p18l1411t970r1561b1001],
25	0.22	CD	NUMBER	0.22	dep	24	SENT_294	[p18l1411t970r1561b1001],
26	—	NN	O	—	dep	29	SENT_294	[p18l1411t970r1561b1001],
27	6.49	CD	NUMBER	6.49	num	26	SENT_294	[p18l1411t970r1561b1001],
28	)	CD	NUMBER	)	num	29	SENT_294	[p18l1411t970r1561b1001],
29	4.04	CD	NUMBER	4.04	dep	45	SENT_294	[p18l1643t970r1699b994],
30	(	NN	O	(	dep	29	SENT_294	[p18l1712t970r1862b1001],
31	1.82	CD	NUMBER	1.82	num	30	SENT_294	[p18l1712t970r1862b1001],
32	—	CD	NUMBER	—	number	33	SENT_294	[p18l1712t970r1862b1001],
33	8.83	CD	NUMBER	8.83	num	37	SENT_294	[p18l1712t970r1862b1001],
34	)	NN	O	)	nn	37	SENT_294	[p18l1712t970r1862b1001],
35	P	NN	O	p	nn	37	SENT_294	[p18l315t1028r330b1051],
36	value	NN	O	value	nn	37	SENT_294	[p18l339t1026r410b1051],
37	P	NN	O	p	dep	30	SENT_294	[p18l1082t1028r1197b1051],
38	=	JJ	O	=	amod	45	SENT_294	[p18l1082t1028r1197b1051],
39	o.	NN	O	o.	nn	45	SENT_294	[p18l1082t1028r1197b1051],
40	ool	NN	O	ool	nn	45	SENT_294	[p18l1082t1028r1197b1051],
41	P	NN	O	p	nn	45	SENT_294	[p18l1404t1028r1503b1051],
42	=	JJ	O	=	amod	45	SENT_294	[p18l1404t1028r1503b1051],
43	O.	NNP	O	O.	nn	45	SENT_294	[p18l1404t1028r1503b1051],
44	57	CD	NUMBER	57	num	45	SENT_294	[p18l1404t1028r1503b1051],
45	P	NN	O	p	dep	47	SENT_294	[p18l1701t1028r1807b1051],
46	<	JJR	O	<	dep	45	SENT_294	[p18l1701t1028r1807b1051],
47	0.001	CD	NUMBER	0.001	_	0	SENT_294	[p18l1701t1028r1807b1051],

1	Concurrent	JJ	O	concurrent	amod	3	SENT_295	[p18l263t1086r417b1109],
2	PI	NN	O	pi	nn	3	SENT_295	[p18l429t1086r450b1108],
3	use	NN	O	use	_	0	SENT_295	[p18l464t1092r516b1113],
4	,	,	O	,	_	0	SENT_295	[p18l464t1092r516b1113],
5	vs.	IN	O	vs.	amod	8	SENT_295	[p18l527t1092r562b1109],
6	no	DT	O	no	det	8	SENT_295	[p18l575t1092r607b1109],
7	concurrent	JJ	O	concurrent	amod	8	SENT_295	[p18l617t1088r765b1109],
8	use	NN	O	use	appos	3	SENT_295	[p18l776t1092r821b1109],

1	Odds	NNS	O	odds	nn	2	SENT_296	[p18l313t1141r386b1166],
2	ratio	NN	O	ratio	dep	9	SENT_296	[p18l398t1144r458b1166],
3	(	CD	PERCENT	(	num	5	SENT_296	[p18l471t1143r540b1174],
4	95	CD	PERCENT	95	num	5	SENT_296	[p18l471t1143r540b1174],
5	%	NN	PERCENT	%	dep	2	SENT_296	[p18l471t1143r540b1174],
6	CI	NN	O	ci	dep	9	SENT_296	[p18l550t1143r587b1174],
7	)	CD	NUMBER	)	num	6	SENT_296	[p18l550t1143r587b1174],
8	1.86	CD	NUMBER	1.86	num	9	SENT_296	[p18l1030t1143r1084b1167],
9	(	NN	O	(	dep	13	SENT_296	[p18l1097t1143r1247b1174],
10	1.16	CD	NUMBER	1.16	number	11	SENT_296	[p18l1097t1143r1247b1174],
11	—	CD	NUMBER	—	dep	9	SENT_296	[p18l1097t1143r1247b1174],
12	3.01	CD	NUMBER	3.01	dep	11	SENT_296	[p18l1097t1143r1247b1174],
13	)	NN	O	)	dep	17	SENT_296	[p18l1097t1143r1247b1174],
14	1.05	CD	NUMBER	1.05	num	13	SENT_296	[p18l1344t1143r1396b1167],
15	(	CD	NUMBER	(	num	17	SENT_296	[p18l1411t1143r1561b1174],
16	0.39	CD	NUMBER	0.39	num	17	SENT_296	[p18l1411t1143r1561b1174],
17	—	NN	O	—	dep	22	SENT_296	[p18l1411t1143r1561b1174],
18	2.79	CD	NUMBER	2.79	number	19	SENT_296	[p18l1411t1143r1561b1174],
19	)	CD	NUMBER	)	dep	17	SENT_296	[p18l1411t1143r1561b1174],
20	2.38	CD	NUMBER	2.38	num	21	SENT_296	[p18l1643t1143r1699b1167],
21	(	NN	O	(	dep	19	SENT_296	[p18l1712t1143r1862b1174],
22	1.33	CD	NUMBER	1.33	_	0	SENT_296	[p18l1712t1143r1862b1174],
23	—	CD	NUMBER	—	number	24	SENT_296	[p18l1712t1143r1862b1174],
24	4.39	CD	NUMBER	4.39	num	35	SENT_296	[p18l1712t1143r1862b1174],
25	)	NN	O	)	nn	35	SENT_296	[p18l1712t1143r1862b1174],
26	P	NN	O	p	nn	35	SENT_296	[p18l315t1201r330b1224],
27	value	NN	O	value	nn	28	SENT_296	[p18l339t1199r410b1224],
28	P	NN	O	p	dep	35	SENT_296	[p18l1082t1201r1198b1224],
29	=	JJ	O	=	dep	28	SENT_296	[p18l1082t1201r1198b1224],
30	0.009	CD	NUMBER	0.009	num	31	SENT_296	[p18l1082t1201r1198b1224],
31	P	NN	O	p	dep	29	SENT_296	[p18l1404t1201r1502b1224],
32	=	JJ	O	=	amod	35	SENT_296	[p18l1404t1201r1502b1224],
33	O.	NNP	O	O.	nn	35	SENT_296	[p18l1404t1201r1502b1224],
34	91	CD	NUMBER	91	num	35	SENT_296	[p18l1404t1201r1502b1224],
35	P	NN	O	p	dep	22	SENT_296	[p18l1697t1201r1811b1224],
36	=	JJ	O	=	amod	35	SENT_296	[p18l1697t1201r1811b1224],
37	0.003	CD	NUMBER	0.003	tmod	36	SENT_296	[p18l1697t1201r1811b1224],

1	*	NN	O	*	npadvmod	10	SENT_297	[p18l236t1286r251b1301],
2	Before	IN	O	before	_	0	SENT_297	[p18l264t1284r349b1309],
3	analysis	NN	O	analysis	nn	7	SENT_297	[p18l360t1284r466b1317],
4	ofthe	NN	O	ofthe	nn	7	SENT_297	[p18l479t1284r557b1309],
5	primary	JJ	O	primary	amod	7	SENT_297	[p18l569t1286r673b1317],
6	end	NN	O	end	nn	7	SENT_297	[p18l684t1284r732b1309],
7	points	NNS	O	point	prep_before	10	SENT_297	[p18l746t1286r837b1317],
8	,	,	O	,	_	0	SENT_297	[p18l746t1286r837b1317],
9	we	PRP	O	we	nsubj	10	SENT_297	[p18l849t1293r885b1309],
10	performed	VBD	O	perform	_	0	SENT_297	[p18l898t1284r1038b1317],
11	stepwise	JJ	O	stepwise	amod	13	SENT_297	[p18l1052t1286r1169b1317],
12	regression	NN	O	regression	nn	13	SENT_297	[p18l1182t1286r1321b1317],
13	analysis	NN	O	analysis	dobj	10	SENT_297	[p18l1334t1284r1440b1317],
14	of	IN	O	of	_	0	SENT_297	[p18l1453t1284r1482b1309],
15	ntially	RB	O	ntially	advmod	16	SENT_297	[p18l1552t1284r1631b1317],
16	important	JJ	O	important	amod	17	SENT_297	[p18l1643t1286r1779b1317],
17	covariates	NNS	O	covariate	prep_of	13	SENT_297	[p18l1790t1286r1879b1309, p18l262t1326r315b1347],
18	for	IN	O	for	_	0	SENT_297	[p18l327t1321r365b1347],
19	the	DT	O	the	det	20	SENT_297	[p18l374t1321r417b1347],
20	prediction	NN	O	prediction	prep_for	10	SENT_297	[p18l429t1321r565b1355],
21	of	IN	O	of	_	0	SENT_297	[p18l578t1321r607b1347],
22	clinically	RB	O	clinically	amod	68	SENT_297	[p18l614t1321r730b1355],
23	suspected	VBN	O	suspect	dep	22	SENT_297	[p18l741t1321r877b1355],
24	ersensitivity	NN	O	ersensitivity	nn	25	SENT_297	[p18l940t1324r1102b1355],
25	rea	NN	O	rea	dobj	23	SENT_297	[p18l1114t1330r1153b1347],
26	'	''	O	'	_	0	SENT_297	[p18l1182t1324r1186b1327],
27	n.	IN	O	n.	_	0	SENT_297	[p18l1208t1330r1230b1347],
28	The	DT	O	the	det	32	SENT_297	[p18l1241t1321r1292b1347],
29	three	CD	NUMBER	three	num	32	SENT_297	[p18l1302t1321r1372b1347],
30	random	JJ	O	random	amod	32	SENT_297	[p18l1384t1321r1497b1347],
31	‘	NN	O	‘	nn	32	SENT_297	[p18l1384t1321r1497b1347],
32	‘	NN	O	‘	prep_n.	25	SENT_297	[p18l1543t1324r1583b1347],
33	on	IN	O	on	_	0	SENT_297	[p18l1543t1324r1583b1347],
34	a	DT	O	a	det	35	SENT_297	[p18l1658t1330r1671b1347],
35	(	NN	O	(	prep_on	23	SENT_297	[p18l1686t1321r1773b1355],
36	which	WDT	O	which	nsubj	38	SENT_297	[p18l1686t1321r1773b1355],
37	w	RB	O	w	advmod	38	SENT_297	[p18l1784t1331r1806b1347],
38	forced	VBD	O	force	rcmod	35	SENT_297	[p18l261t1358r345b1384],
39	to	TO	O	to	aux	40	SENT_297	[p18l356t1363r383b1384],
40	remai	VB	O	remai	xcomp	38	SENT_297	[p18l396t1361r470b1384],
41	‘	CD	NUMBER	‘	tmod	40	SENT_297	[p18l502t1361r506b1364],
42	the	DT	O	the	det	44	SENT_297	[p18l536t1358r578b1384],
43	model	NN	O	model	nn	44	SENT_297	[p18l591t1358r684b1392],
44	)	NN	O	)	dobj	40	SENT_297	[p18l591t1358r684b1392],
45	and	CC	O	and	_	0	SENT_297	[p18l699t1358r747b1384],
46	other	JJ	O	other	amod	47	SENT_297	[p18l760t1358r832b1384],
47	ad	NN	O	ad	dobj	40	SENT_297	[p18l842t1358r872b1384],
48	'	''	O	'	_	0	SENT_297	[p18l895t1361r898b1364],
49	‘	CD	NUMBER	‘	num	51	SENT_297	[p18l913t1361r917b1364],
50	nal	JJ	O	nal	amod	51	SENT_297	[p18l940t1358r977b1384],
51	factors	NNS	O	factor	nsubj	52	SENT_297	[p18l989t1358r1081b1384],
52	retai	VBP	O	retai	rcmod	44	SENT_297	[p18l1094t1361r1151b1384],
53	(	NN	O	(	nsubj	60	SENT_297	[p18l1218t1358r1299b1392],
54	listed	VBN	O	list	partmod	53	SENT_297	[p18l1218t1358r1299b1392],
55	above	IN	O	above	_	0	SENT_297	[p18l1312t1358r1400b1392],
56	)	NN	O	)	prep_above	54	SENT_297	[p18l1312t1358r1400b1392],
57	were	VBD	O	be	cop	60	SENT_297	[p18l1413t1367r1477b1384],
58	then	RB	O	then	advmod	60	SENT_297	[p18l1487t1358r1547b1384],
59	inc	NN	O	inc	nn	60	SENT_297	[p18l1561t1361r1599b1384],
60	d	NN	O	d	ccomp	52	SENT_297	[p18l1660t1358r1675b1384],
61	in	IN	O	in	_	0	SENT_297	[p18l1689t1361r1710b1384],
62	h	NN	O	h	prep_in	60	SENT_297	[p18l1735t1358r1748b1384],
63	an	DT	O	a	det	65	SENT_297	[p18l1776t1367r1806b1384],
64	es	NN	O	e	nn	65	SENT_297	[p18l1862t1367r1890b1384],
65	ofthe	NN	O	ofthe	dep	60	SENT_297	[p18l262t1395r339b1421],
66	primary	JJ	O	primary	amod	65	SENT_297	[p18l352t1398r456b1429],
67	e	SYM	O	e	dep	60	SENT_297	[p18l466t1404r480b1421],
68	points	NNS	O	point	prep_of	20	SENT_297	[p18l529t1398r620b1429],
69	.	.	O	.	_	0	SENT_297	[p18l529t1398r620b1429],

1	The	DT	O	the	det	3	SENT_298	[p18l631t1395r682b1421],
2	additional	JJ	O	additional	amod	3	SENT_298	[p18l693t1395r828b1421],
3	factors	NNS	O	factor	nsubj	4	SENT_298	[p18l840t1395r932b1421],
4	w	VBP	O	w	_	0	SENT_298	[p18l943t1405r965b1421],
5	sex	NN	O	sex	dobj	4	SENT_298	[p18l1019t1404r1067b1425],
6	,	,	O	,	_	0	SENT_298	[p18l1019t1404r1067b1425],
7	Centers	NNPS	ORGANIZATION	Centers	conj_or	5	SENT_298	[p18l1080t1397r1183b1421],
8	for	IN	ORGANIZATION	for	_	0	SENT_298	[p18l1194t1395r1232b1421],
9	Disease	NNP	ORGANIZATION	Disease	nn	10	SENT_298	[p18l1244t1398r1349b1421],
10	Control	NNP	ORGANIZATION	Control	prep_for	7	SENT_298	[p18l1361t1395r1460b1421],
11	and	CC	ORGANIZATION	and	_	0	SENT_298	[p18l1473t1395r1521b1421],
12	Prevention	NNP	ORGANIZATION	Prevention	nn	13	SENT_298	[p18l1536t1398r1679b1421],
13	c	NN	O	c	conj_and	10	SENT_298	[p18l1692t1404r1705b1421],
14	,	,	O	,	_	0	SENT_298	[p18l1761t1417r1765b1425],
15	HIV	NN	O	hiv	nn	16	SENT_298	[p18l1780t1398r1832b1421],
16	RNA	NN	O	rna	appos	10	SENT_298	[p18l1844t1397r1905b1421],
17	at	IN	O	at	_	0	SENT_298	[p18l333t1438r357b1458],
18	baseline	NN	O	baseline	prep_at	16	SENT_298	[p18l369t1433r487b1462],
19	,	,	O	,	_	0	SENT_298	[p18l369t1433r487b1462],
20	+	CC	O	+	_	0	SENT_298	[p18l560t1441r576b1458],
21	cell	NN	O	cell	nn	22	SENT_298	[p18l588t1433r630b1458],
22	count	NN	O	count	appos	10	SENT_298	[p18l643t1438r721b1458],
23	at	IN	O	at	_	0	SENT_298	[p18l732t1438r756b1458],
24	baseline	NN	O	baseline	prep_at	22	SENT_298	[p18l768t1433r886b1462],
25	,	,	O	,	_	0	SENT_298	[p18l768t1433r886b1462],
26	onc	NN	O	onc	appos	24	SENT_298	[p18l899t1442r948b1458],
27	-	:	O	-	_	0	SENT_298	[p18l965t1448r972b1451],
28	'	''	O	'	_	0	SENT_298	[p18l1009t1433r1036b1466],
29	ly	RB	O	ly	advmod	7	SENT_298	[p18l1009t1433r1036b1466],
30	or	CC	O	or	_	0	SENT_298	[p18l1047t1442r1075b1458],
31	twice-daily	JJ	O	twice-daily	amod	33	SENT_298	[p18l1084t1433r1228b1466],
32	abacavir	NN	O	abacavir	nn	33	SENT_298	[p18l1239t1433r1351b1458],
33	dosing	NN	O	dosing	dobj	4	SENT_298	[p18l1362t1433r1461b1466],
34	,	,	O	,	_	0	SENT_298	[p18l1362t1433r1461b1466],
35	and	CC	O	and	_	0	SENT_298	[p18l1474t1433r1522b1458],
36	concurrent	JJ	O	concurrent	amod	37	SENT_298	[p18l1534t1438r1683b1458],
37	use	NN	O	use	dobj	4	SENT_298	[p18l1695t1442r1740b1458],
38	or	CC	O	or	_	0	SENT_298	[p18l1751t1442r1779b1458],
39	nonuse	JJ	O	nonuse	amod	40	SENT_298	[p18l1791t1442r1890b1458],
40	protease	NN	O	protease	conj_or	37	SENT_298	[p18l324t1474r440b1503],
41	inh	NN	O	inh	dep	37	SENT_298	[p18l453t1469r501b1495],
42	'	''	O	'	_	0	SENT_298	[p18l453t1469r501b1495],
43	'	''	O	'	_	0	SENT_298	[p18l523t1472r526b1475],
44	r	NN	O	r	prep	41	SENT_298	[p18l559t1478r568b1495],
45	(	CD	NUMBER	(	num	47	SENT_298	[p18l581t1471r636b1503],
46	Pl	NN	O	pl	nn	47	SENT_298	[p18l581t1471r636b1503],
47	)	NN	O	)	dep	44	SENT_298	[p18l581t1471r636b1503],
48	.	.	O	.	_	0	SENT_298	[p18l581t1471r636b1503],

1	For	IN	O	for	_	0	SENT_299	[p18l651t1472r694b1495],
2	the	DT	O	the	det	3	SENT_299	[p18l703t1469r746b1495],
3	analysis	NN	O	analysis	prep_for	5	SENT_299	[p18l758t1469r864b1503],
4	ofimmunologically	RB	O	ofimmunologically	advmod	5	SENT_299	[p18l876t1469r1140b1503],
5	conﬁrmed	VBD	O	conﬁrmed	_	0	SENT_299	[p18l1151t1469r1289b1495],
6	hypersensitivity	NN	O	hypersensitivity	dobj	5	SENT_299	[p18l1303t1469r1514b1503],
7	reaction	NN	O	reaction	nsubj	5	SENT_299	[p18l1526t1472r1641b1499],
8	,	,	O	,	_	0	SENT_299	[p18l1526t1472r1641b1499],
9	the	DT	O	the	det	11	SENT_299	[p18l1653t1469r1696b1495],
10	same	JJ	O	same	amod	11	SENT_299	[p18l1708t1478r1780b1495],
11	covariates	NNS	O	covariate	appos	7	SENT_299	[p18l1791t1472r1880b1495, p18l262t1511r315b1532],
12	we	PRP	O	we	nsubj	13	SENT_299	[p18l326t1515r363b1532],
13	used	VBD	O	use	rcmod	11	SENT_299	[p18l403t1506r464b1532],
14	as	IN	O	as	_	0	SENT_299	[p18l477t1515r505b1532],
15	those	DT	O	those	det	24	SENT_299	[p18l516t1506r591b1532],
16	found	VBN	O	find	amod	24	SENT_299	[p18l602t1506r680b1532],
17	to	TO	O	to	aux	19	SENT_299	[p18l692t1511r719b1532],
18	be	VB	O	be	cop	19	SENT_299	[p18l732t1506r761b1532],
19	important	JJ	O	important	xcomp	16	SENT_299	[p18l774t1509r909b1540],
20	for	IN	O	for	_	0	SENT_299	[p18l920t1506r957b1532],
21	clinically	RB	O	clinically	advmod	22	SENT_299	[p18l968t1506r1084b1540],
22	diagnosed	VBN	O	diagnose	amod	23	SENT_299	[p18l1095t1506r1234b1540],
23	hypersensitivity	NN	O	hypersensitivity	prep_for	19	SENT_299	[p18l1248t1506r1459b1540],
24	reaction	NN	O	reaction	prep_as	13	SENT_299	[p18l1471t1509r1587b1532],
25	.	.	O	.	_	0	SENT_299	[p18l1471t1509r1587b1532],

1	NNRTI	NNP	ORGANIZATION	NNRTI	nsubj	2	SENT_300	[p18l1602t1509r1693b1532],
2	denotes	VBZ	O	denote	_	0	SENT_300	[p18l1707t1506r1814b1532],
3	nonnucle	NN	O	nonnucle	dobj	2	SENT_300	[p18l1828t1515r1887b1532, p18l263t1544r334b1569],
4	'	''	O	'	_	0	SENT_300	[p18l370t1546r373b1550],
5	e	SYM	O	e	dep	7	SENT_300	[p18l395t1553r408b1569],
6	reverse-transcriptase	JJ	O	reverse-transcriptase	amod	7	SENT_300	[p18l421t1546r706b1577],
7	inhibitor	NN	O	inhibitor	dep	2	SENT_300	[p18l718t1544r840b1569],
8	.	.	O	.	_	0	SENT_300	[p18l718t1544r840b1569],

1	abacavir	NN	O	abacavir	nsubj	12	SENT_301	[p18l10t1705r370b1785],
2	(	CD	PERCENT	(	num	4	SENT_301	[p18l419t1710r726b1797],
3	37.5	CD	PERCENT	37.5	num	4	SENT_301	[p18l419t1710r726b1797],
4	%	NN	PERCENT	%	dobj	11	SENT_301	[p18l419t1710r726b1797],
5	)	CD	NUMBER	)	dep	4	SENT_301	[p18l419t1710r726b1797],
6	for	IN	O	for	_	0	SENT_301	[p18l779t1704r903b1785],
7	whom	WP	O	whom	prep_for	4	SENT_301	[p18l943t1705r1217b1785],
8	the	DT	O	the	det	9	SENT_301	[p18l1265t1705r1399b1784],
9	data	NNS	O	datum	nsubj	11	SENT_301	[p18l1448t1705r1633b1785],
10	were	VBD	O	be	cop	11	SENT_301	[p18l1674t1731r1878b1785],
11	available	JJ	O	available	rcmod	1	SENT_301	[p18l1926t1705r2153b1785, p18l10t1835r182b1914],
12	reported	VBD	O	report	_	0	SENT_301	[p18l225t1835r596b1935],
13	an	DT	O	a	det	15	SENT_301	[p18l638t1861r742b1913],
14	adverse	JJ	O	adverse	amod	15	SENT_301	[p18l785t1835r1103b1914],
15	event	NN	O	event	dobj	12	SENT_301	[p18l1147t1852r1394b1914],
16	.	.	O	.	_	0	SENT_301	[p18l1147t1852r1394b1914],

1	Grade	NNP	O	Grade	nsubjpass	7	SENT_302	[p18l1443t1835r1701b1914],
2	1	CD	NUMBER	1	num	4	SENT_302	[p18l1748t1840r1792b1912],
3	adverse	JJ	O	adverse	amod	4	SENT_302	[p18l1836t1835r2154b1914],
4	events	NNS	O	event	npadvmod	5	SENT_302	[p18l11t1981r277b2044],
5	only	RB	O	only	advmod	7	SENT_302	[p18l323t1964r509b2065],
6	were	VBD	O	be	auxpass	7	SENT_302	[p18l543t1990r747b2044],
7	reported	VBN	O	report	dep	30	SENT_302	[p18l790t1964r1161b2065],
8	in	IN	O	in	_	0	SENT_302	[p18l1203t1965r1287b2042],
9	355	CD	NUMBER	355	prep_in	7	SENT_302	[p18l1331t1970r1475b2044],
10	of	IN	O	of	_	0	SENT_302	[p18l1522t1963r1623b2044],
11	the	DT	O	the	det	13	SENT_302	[p18l1648t1964r1782b2043],
12	665	CD	NUMBER	665	num	13	SENT_302	[p18l1826t1970r1975b2044],
13	patients	NNS	O	patient	prep_of	9	SENT_302	[p18l2021t1990r2153b2065, p18l11t2095r244b2173],
14	(	IN	O	(	_	0	SENT_302	[p18l281t2099r612b2191],
15	53.4	CD	PERCENT	53.4	num	16	SENT_302	[p18l281t2099r612b2191],
16	%	NN	PERCENT	%	prep_(	7	SENT_302	[p18l281t2099r612b2191],
17	)	CD	NUMBER	)	dep	16	SENT_302	[p18l281t2099r612b2191],
18	,	,	O	,	_	0	SENT_302	[p18l281t2099r612b2191],
19	and	CC	O	and	_	0	SENT_302	[p18l648t2094r805b2174],
20	246	CD	NUMBER	246	prep_(	7	SENT_302	[p18l835t2100r985b2174],
21	of	IN	O	of	_	0	SENT_302	[p18l1017t2093r1118b2174],
22	the	DT	O	the	det	24	SENT_302	[p18l1130t2094r1261b2173],
23	665	CD	NUMBER	665	num	24	SENT_302	[p18l1292t2100r1440b2174],
24	patients	NNS	O	patient	prep_of	20	SENT_302	[p18l1472t2095r1810b2195],
25	(	IN	O	(	_	0	SENT_302	[p18l1847t2099r2149b2186],
26	37.0	CD	PERCENT	37.0	num	27	SENT_302	[p18l1847t2099r2149b2186],
27	%	NN	PERCENT	%	prep_(	7	SENT_302	[p18l1847t2099r2149b2186],
28	)	CD	NUMBER	)	nsubjpass	30	SENT_302	[p18l1847t2099r2149b2186],
29	were	VBD	O	be	auxpass	30	SENT_302	[p18l6t2250r209b2304],
30	considered	VBN	O	consider	_	0	SENT_302	[p18l252t2224r722b2304],
31	to	TO	O	to	aux	33	SENT_302	[p18l764t2241r846b2304],
32	have	VB	O	have	aux	33	SENT_302	[p18l889t2224r1081b2304],
33	had	VBD	O	have	xcomp	30	SENT_302	[p18l1123t2224r1281b2304],
34	an	DT	O	a	det	35	SENT_302	[p18l1322t2250r1427b2303],
35	event	NN	O	event	dobj	33	SENT_302	[p18l1469t2241r1695b2304],
36	related	JJ	O	related	amod	35	SENT_302	[p18l1733t2224r2028b2304],
37	to	TO	O	to	_	0	SENT_302	[p18l2070t2241r2153b2304],
38	the	DT	O	the	det	39	SENT_302	[p18l11t2353r143b2432],
39	use	NN	O	use	prep_to	36	SENT_302	[p18l177t2379r317b2433],
40	of	IN	O	of	_	0	SENT_302	[p18l353t2352r452b2432],
41	abacavir	NN	O	abacavir	prep_of	39	SENT_302	[p18l467t2353r837b2433],
42	.	.	O	.	_	0	SENT_302	[p18l467t2353r837b2433],

1	The	DT	O	the	det	3	SENT_303	[p18l874t2353r1034b2432],
2	only	JJ	O	only	amod	3	SENT_303	[p18l1069t2353r1252b2454],
3	events	NNS	O	event	nsubj	27	SENT_303	[p18l1283t2370r1543b2433],
4	of	IN	O	of	_	0	SENT_303	[p18l1581t2352r1681b2432],
5	grade	NN	O	grade	prep_of	3	SENT_303	[p18l1696t2353r1934b2455],
6	2	CD	NUMBER	2	dep	3	SENT_303	[p18l1968t2359r2039b2450],
7	,	,	O	,	_	0	SENT_303	[p18l1968t2359r2039b2450],
8	3	CD	NUMBER	3	num	6	SENT_303	[p18l2080t2359r2149b2450],
9	,	,	O	,	_	0	SENT_303	[p18l2080t2359r2149b2450],
10	or	CC	O	or	_	0	SENT_303	[p18l11t2509r98b2563],
11	4	CD	NUMBER	4	dep	3	SENT_303	[p18l127t2490r198b2580],
12	,	,	O	,	_	0	SENT_303	[p18l127t2490r198b2580],
13	reported	VBN	O	report	partmod	3	SENT_303	[p18l238t2483r593b2584],
14	in	IN	O	in	_	0	SENT_303	[p18l626t2484r708b2561],
15	more	JJR	O	more	mwe	16	SENT_303	[p18l742t2509r957b2563],
16	than	IN	O	than	quantmod	17	SENT_303	[p18l992t2483r1183b2562],
17	1	CD	PERCENT	1	num	18	SENT_303	[p18l1221t2488r1345b2563],
18	%	NN	PERCENT	%	prep_in	13	SENT_303	[p18l1221t2488r1345b2563],
19	of	IN	O	of	_	0	SENT_303	[p18l1379t2482r1478b2563],
20	the	DT	O	the	det	22	SENT_303	[p18l1493t2483r1623b2562],
21	study	NN	O	study	nn	22	SENT_303	[p18l1659t2483r1883b2584],
22	population	NN	O	population	prep_of	18	SENT_303	[p18l1910t2509r2153b2584, p18l9t2612r269b2709],
23	,	,	O	,	_	0	SENT_303	[p18l1910t2509r2153b2584, p18l9t2612r269b2709],
24	were	VBD	O	be	cop	27	SENT_303	[p18l308t2638r512b2692],
25	drug	NN	O	drug	nn	27	SENT_303	[p18l555t2612r761b2714],
26	hypersensitivity	NN	O	hypersensitivity	nn	27	SENT_303	[p18l798t2612r1487b2713],
27	(	NN	O	(	_	0	SENT_303	[p18l1529t2613r1641b2704],
28	in	IN	O	in	_	0	SENT_303	[p18l1529t2613r1641b2704],
29	79	CD	NUMBER	79	prep_in	27	SENT_303	[p18l1684t2618r1782b2691],
30	of	IN	O	of	_	0	SENT_303	[p18l1826t2611r1926b2691],
31	1772	CD	DATE	1772	num	32	SENT_303	[p18l1953t2618r2153b2691],
32	patients	NNS	O	patient	prep_of	27	SENT_303	[p18l8t2743r354b2843],
33	[	IN	O	[	_	0	SENT_303	[p18l406t2747r702b2834],
34	4.5	CD	PERCENT	4.5	num	35	SENT_303	[p18l406t2747r702b2834],
35	%	NN	PERCENT	%	prep_[	27	SENT_303	[p18l406t2747r702b2834],
36	]	CD	NUMBER	]	num	37	SENT_303	[p18l406t2747r702b2834],
37	)	NN	O	)	dep	35	SENT_303	[p18l406t2747r702b2834],
38	and	CC	O	and	_	0	SENT_303	[p18l747t2742r907b2822],
39	diarrhea	NN	O	diarrhea	nn	40	SENT_303	[p18l948t2742r1314b2822],
40	(	NN	O	(	prep_[	27	SENT_303	[p18l1359t2743r1471b2834],
41	in	IN	O	in	_	0	SENT_303	[p18l1359t2743r1471b2834],
42	32	CD	NUMBER	32	prep_in	40	SENT_303	[p18l1513t2748r1610b2822],
43	of	IN	O	of	_	0	SENT_303	[p18l1653t2741r1754b2822],
44	1772	CD	DATE	1772	num	45	SENT_303	[p18l1780t2748r1980b2821],
45	patients	NNS	O	patient	prep_of	40	SENT_303	[p18l2021t2768r2153b2843, p18l11t2873r250b2951],
46	[	IN	O	[	_	0	SENT_303	[p18l315t2877r642b2964],
47	1.8	CD	PERCENT	1.8	num	48	SENT_303	[p18l315t2877r642b2964],
48	%	NN	PERCENT	%	prep_[	45	SENT_303	[p18l315t2877r642b2964],
49	]	CD	NUMBER	]	num	50	SENT_303	[p18l315t2877r642b2964],
50	)	NN	O	)	dep	40	SENT_303	[p18l315t2877r642b2964],
51	.	.	O	.	_	0	SENT_303	[p18l315t2877r642b2964],

1	A	DT	O	a	det	2	SENT_304	[p18l698t2880r765b2950],
2	total	NN	O	total	nsubj	8	SENT_304	[p18l817t2872r1015b2952],
3	of	IN	O	of	_	0	SENT_304	[p18l1069t2871r1170b2952],
4	119	CD	NUMBER	119	number	6	SENT_304	[p18l1209t2878r1358b2952],
5	of	IN	O	of	quantmod	6	SENT_304	[p18l1414t2871r1514b2952],
6	1772	CD	NUMBER	1772	num	7	SENT_304	[p18l1553t2878r1754b2951],
7	patients	NNS	O	patient	prep_of	2	SENT_304	[p18l1807t2873r2152b2973],
8	(	VBP	O	(	_	0	SENT_304	[p18l15t3007r279b3093],
9	6.7	CD	PERCENT	6.7	num	10	SENT_304	[p18l15t3007r279b3093],
10	%	NN	PERCENT	%	dobj	8	SENT_304	[p18l15t3007r279b3093],
11	)	CD	NUMBER	)	nsubjpass	13	SENT_304	[p18l15t3007r279b3093],
12	were	VBD	O	be	auxpass	13	SENT_304	[p18l346t3028r550b3081],
13	reported	VBN	O	report	rcmod	10	SENT_304	[p18l616t3002r987b3102],
14	to	TO	O	to	aux	15	SENT_304	[p18l1054t3019r1136b3081],
15	have	VB	O	have	xcomp	13	SENT_304	[p18l1203t3002r1395b3081],
16	serious	JJ	O	serious	amod	18	SENT_304	[p18l1463t3003r1768b3081],
17	adverse	JJ	O	adverse	amod	18	SENT_304	[p18l1836t3002r2154b3081],
18	events	NNS	O	event	dobj	15	SENT_304	[p18l11t3148r302b3228],
19	,	,	O	,	_	0	SENT_304	[p18l11t3148r302b3228],
20	of	IN	O	of	_	0	SENT_304	[p18l355t3130r456b3211],
21	which	WDT	O	which	rel	36	SENT_304	[p18l480t3131r745b3211],
22	the	DT	O	the	det	24	SENT_304	[p18l792t3131r926b3210],
23	majority	NN	O	majority	nn	24	SENT_304	[p18l973t3132r1338b3232],
24	(	NN	O	(	nsubjpass	36	SENT_304	[p18l1386t3132r1498b3223],
25	in	IN	O	in	_	0	SENT_304	[p18l1386t3132r1498b3223],
26	97	CD	NUMBER	97	number	28	SENT_304	[p18l1545t3137r1644b3211],
27	of	IN	O	of	quantmod	28	SENT_304	[p18l1693t3130r1793b3211],
28	119	CD	NUMBER	119	num	29	SENT_304	[p18l1825t3137r1974b3211],
29	patients	NNS	O	patient	prep_in	24	SENT_304	[p18l2021t3157r2153b3232, p18l11t3262r250b3339],
30	[	IN	O	[	_	0	SENT_304	[p18l304t3266r655b3352],
31	81.5	CD	PERCENT	81.5	num	32	SENT_304	[p18l304t3266r655b3352],
32	%	NN	PERCENT	%	prep_[	29	SENT_304	[p18l304t3266r655b3352],
33	]	CD	NUMBER	]	number	34	SENT_304	[p18l304t3266r655b3352],
34	)	CD	NUMBER	)	num	32	SENT_304	[p18l304t3266r655b3352],
35	Were	VBD	O	be	auxpass	36	SENT_304	[p18l700t3287r904b3340],
36	considered	VBN	O	consider	rcmod	18	SENT_304	[p18l949t3261r1418b3340],
37	to	TO	O	to	aux	39	SENT_304	[p18l1462t3278r1544b3340],
38	be	VB	O	be	auxpass	39	SENT_304	[p18l1590t3261r1688b3340],
39	related	VBN	O	relate	xcomp	36	SENT_304	[p18l1731t3261r2026b3340],
40	to	TO	O	to	_	0	SENT_304	[p18l2071t3278r2153b3339],
41	abacavir	NN	O	abacavir	nn	42	SENT_304	[p18l10t3390r370b3469],
42	therapy	NN	O	therapy	prep_to	39	SENT_304	[p18l399t3390r738b3490],
43	.	.	O	.	_	0	SENT_304	[p18l399t3390r738b3490],

1	Almost	RB	O	almost	advmod	6	SENT_305	[p18l772t3390r1093b3469],
2	all	PDT	O	all	predet	6	SENT_305	[p18l1120t3390r1225b3468],
3	the	DT	O	the	det	6	SENT_305	[p18l1258t3390r1392b3468],
4	serious	JJ	O	serious	amod	6	SENT_305	[p18l1426t3391r1731b3469],
5	abacavirrelated	JJ	O	abacavirrelated	amod	6	SENT_305	[p18l1764t3390r2153b3469, p18l10t3519r305b3599],
6	events	NNS	O	event	nsubj	7	SENT_305	[p18l340t3536r606b3599],
7	(	VBP	O	(	_	0	SENT_305	[p18l646t3520r759b3611],
8	in	IN	O	in	_	0	SENT_305	[p18l646t3520r759b3611],
9	93	CD	NUMBER	93	prep_in	7	SENT_305	[p18l793t3525r888b3599],
10	of	IN	O	of	_	0	SENT_305	[p18l926t3518r1027b3599],
11	97	CD	NUMBER	97	num	12	SENT_305	[p18l1042t3525r1141b3599],
12	patients	NNS	O	patient	prep_of	9	SENT_305	[p18l1174t3520r1519b3620],
13	[	IN	O	[	quantmod	14	SENT_305	[p18l1565t3524r1916b3611],
14	95.9	CD	PERCENT	95.9	num	15	SENT_305	[p18l1565t3524r1916b3611],
15	%	NN	PERCENT	%	dobj	7	SENT_305	[p18l1565t3524r1916b3611],
16	]	CD	NUMBER	]	num	17	SENT_305	[p18l1565t3524r1916b3611],
17	)	NN	O	)	nsubj	20	SENT_305	[p18l1565t3524r1916b3611],
18	were	VBD	O	be	cop	20	SENT_305	[p18l1951t3545r2154b3599],
19	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_305	[p18l10t3649r698b3749],
20	reactions	NNS	O	reaction	rcmod	15	SENT_305	[p18l745t3650r1165b3745],
21	,	,	O	,	_	0	SENT_305	[p18l745t3650r1165b3745],
22	which	WDT	O	which	nsubjpass	24	SENT_305	[p18l1217t3649r1482b3728],
23	were	VBD	O	be	auxpass	24	SENT_305	[p18l1528t3675r1732b3728],
24	reported	VBN	O	report	rcmod	20	SENT_305	[p18l1784t3649r2154b3749],
25	as	IN	O	as	_	0	SENT_305	[p19l10t47r96b100],
26	serious	JJ	O	serious	amod	28	SENT_305	[p19l143t22r448b101],
27	adverse	JJ	O	adverse	amod	28	SENT_305	[p19l494t21r812b101],
28	events	NNS	O	event	prep_as	24	SENT_305	[p19l857t38r1123b101],
29	regardless	RB	O	regardless	_	0	SENT_305	[p19l1169t21r1612b123],
30	of	IN	O	of	_	0	SENT_305	[p19l1660t20r1760b100],
31	their	PRP$	O	they	poss	32	SENT_305	[p19l1786t21r1992b100],
32	severity	NN	O	severity	prep_regardless_of	24	SENT_305	[p19l2035t47r2153b100, p19l6t152r260b251],
33	.	.	O	.	_	0	SENT_305	[p19l2035t47r2153b100, p19l6t152r260b251],

1	The	DT	O	the	det	3	SENT_306	[p19l137t280r295b359],
2	reported	VBN	O	report	amod	3	SENT_306	[p19l341t280r696b381],
3	symptoms	NNS	O	symptom	nsubj	12	SENT_306	[p19l742t297r1174b381],
4	of	IN	O	of	_	0	SENT_306	[p19l1222t279r1321b360],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_306	[p19l1347t280r2003b381],
6	reaction	NN	O	reaction	prep_of	3	SENT_306	[p19l2043t306r2153b359, p19l10t410r262b488],
7	to	TO	O	to	_	0	SENT_306	[p19l293t426r372b487],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_306	[p19l403t409r745b488],
9	in	IN	O	in	_	0	SENT_306	[p19l772t410r853b486],
10	our	PRP$	O	we	poss	11	SENT_306	[p19l884t435r1025b488],
11	study	NN	O	study	prep_in	8	SENT_306	[p19l1054t409r1276b509],
12	included	VBD	O	include	dep	23	SENT_306	[p19l1300t409r1653b488],
13	fever	NN	O	fever	dobj	12	SENT_306	[p19l1683t408r1897b505],
14	,	,	O	,	_	0	SENT_306	[p19l1683t408r1897b505],
15	rash	NN	O	rash	dobj	12	SENT_306	[p19l1932t409r2130b505],
16	,	,	O	,	_	0	SENT_306	[p19l1932t409r2130b505],
17	gastrointestinal	JJ	O	gastrointestinal	amod	18	SENT_306	[p19l10t537r693b638],
18	disturbances	NNS	O	disturbance	dobj	12	SENT_306	[p19l727t537r1303b633],
19	,	,	O	,	_	0	SENT_306	[p19l727t537r1303b633],
20	and	CC	O	and	_	0	SENT_306	[p19l1340t537r1498b616],
21	constitutional	JJ	O	constitutional	amod	22	SENT_306	[p19l1533t537r2136b616],
22	symptoms	NNS	O	symptom	dobj	12	SENT_306	[p19l11t682r454b765],
23	(	VBP	O	(	_	0	SENT_306	[p19l501t671r696b766],
24	e.g.	FW	O	e.g.	dobj	23	SENT_306	[p19l501t671r696b766],
25	,	,	O	,	_	0	SENT_306	[p19l501t671r696b766],
26	tachycardia	NN	O	tachycardia	appos	24	SENT_306	[p19l741t665r1257b765],
27	,	,	O	,	_	0	SENT_306	[p19l741t665r1257b765],
28	hypotension	NN	O	hypotension	appos	24	SENT_306	[p19l1301t665r1855b765],
29	,	,	O	,	_	0	SENT_306	[p19l1301t665r1855b765],
30	myal	JJ	O	myal	amod	32	SENT_306	[p19l1899t665r2134b765],
31	—	CD	NUMBER	—	tmod	30	SENT_306	[p19l1899t665r2134b765],
32	gia	NN	O	gium	appos	24	SENT_306	[p19l10t794r163b894],
33	,	,	O	,	_	0	SENT_306	[p19l10t794r163b894],
34	fatigue	NN	O	fatigue	appos	24	SENT_306	[p19l208t792r529b894],
35	,	,	O	,	_	0	SENT_306	[p19l208t792r529b894],
36	pain	NN	O	pain	appos	24	SENT_306	[p19l573t794r787b893],
37	,	,	O	,	_	0	SENT_306	[p19l573t794r787b893],
38	malaise	NN	O	malaise	appos	24	SENT_306	[p19l833t793r1188b889],
39	,	,	O	,	_	0	SENT_306	[p19l833t793r1188b889],
40	dizziness	NN	O	dizziness	appos	24	SENT_306	[p19l1235t793r1658b889],
41	,	,	O	,	_	0	SENT_306	[p19l1235t793r1658b889],
42	and	CC	O	and	_	0	SENT_306	[p19l1702t793r1861b872],
43	headache	NN	O	headache	appos	24	SENT_306	[p19l1900t793r2134b872, p19l10t921r239b1017],
44	)	NN	O	)	nsubj	23	SENT_306	[p19l1900t793r2134b872, p19l10t921r239b1017],
45	,	,	O	,	_	0	SENT_306	[p19l1900t793r2134b872, p19l10t921r239b1017],
46	findings	NNS	O	finding	appos	44	SENT_306	[p19l281t920r631b1022],
47	that	WDT	O	that	nsubj	49	SENT_306	[p19l671t921r837b999],
48	are	VBP	O	be	cop	49	SENT_306	[p19l868t947r993b999],
49	consistent	JJ	O	consistent	rcmod	46	SENT_306	[p19l1030t922r1451b1000],
50	with	IN	O	with	_	0	SENT_306	[p19l1478t921r1667b1000],
51	those	DT	O	those	prep_with	49	SENT_306	[p19l1705t921r1928b1000],
52	previously	RB	DATE	previously	advmod	53	SENT_306	[p19l1964t947r2134b1021, p19l6t1049r307b1148],
53	reported	VBN	O	report	amod	51	SENT_306	[p19l347t1049r737b1148],
54	.	.	O	.	_	0	SENT_306	[p19l347t1049r737b1148],

1	The	DT	O	the	det	3	SENT_307	[p19l785t1049r947b1126],
2	median	JJ	O	median	amod	3	SENT_307	[p19l991t1049r1315b1127],
3	time	NN	O	time	nsubj	13	SENT_307	[p19l1361t1050r1554b1126],
4	to	TO	O	to	_	0	SENT_307	[p19l1600t1065r1681b1127],
5	the	DT	O	the	det	6	SENT_307	[p19l1728t1049r1861b1126],
6	onset	NN	O	onset	prep_to	3	SENT_307	[p19l1907t1065r2140b1127],
7	of	IN	O	of	_	0	SENT_307	[p19l11t1176r111b1256],
8	symptoms	NNS	O	symptom	prep_of	6	SENT_307	[p19l145t1194r588b1277],
9	was	VBD	O	be	cop	13	SENT_307	[p19l637t1203r799b1256],
10	10	CD	DURATION	10	num	11	SENT_307	[p19l856t1183r949b1256],
11	days	NNS	NUMBER	day	tmod	13	SENT_307	[p19l1002t1177r1187b1277],
12	(	RB	O	(	advmod	13	SENT_307	[p19l1245t1177r1814b1277],
13	interquartile	JJ	O	interquartile	_	0	SENT_307	[p19l1245t1177r1814b1277],
14	range	NN	O	range	tmod	13	SENT_307	[p19l1865t1203r2130b1278],
15	,	,	O	,	_	0	SENT_307	[p19l1865t1203r2130b1278],
16	3	CD	NUMBER	3	number	19	SENT_307	[p19l11t1310r55b1384],
17	to	TO	O	to	dep	19	SENT_307	[p19l100t1321r182b1384],
18	14	CD	NUMBER	14	number	19	SENT_307	[p19l229t1310r348b1396],
19	)	CD	NUMBER	)	appos	14	SENT_307	[p19l229t1310r348b1396],
20	in	IN	O	in	_	0	SENT_307	[p19l395t1306r478b1382],
21	the	DT	O	the	det	23	SENT_307	[p19l520t1305r653b1383],
22	prospective-screening	JJ	O	prospective-screening	amod	23	SENT_307	[p19l694t1306r1644b1406],
23	group	NN	O	group	prep_in	19	SENT_307	[p19l1682t1331r1935b1406],
24	and	CC	O	and	_	0	SENT_307	[p19l1977t1305r2135b1384],
25	9	CD	DURATION	9	num	26	SENT_307	[p19l10t1438r57b1512],
26	days	NNS	NUMBER	day	conj_and	23	SENT_307	[p19l91t1433r272b1533],
27	(	RB	O	(	advmod	29	SENT_307	[p19l312t1433r867b1533],
28	interquartile	JJ	O	interquartile	dep	29	SENT_307	[p19l312t1433r867b1533],
29	range	NN	O	range	amod	19	SENT_307	[p19l899t1459r1158b1534],
30	,	,	O	,	_	0	SENT_307	[p19l899t1459r1158b1534],
31	5	CD	NUMBER	5	number	34	SENT_307	[p19l1198t1440r1240b1512],
32	to	TO	O	to	dep	34	SENT_307	[p19l1277t1450r1357b1512],
33	12	CD	NUMBER	12	number	34	SENT_307	[p19l1394t1438r1517b1524],
34	)	CD	NUMBER	)	npadvmod	19	SENT_307	[p19l1394t1438r1517b1524],
35	in	IN	O	in	_	0	SENT_307	[p19l1554t1434r1636b1510],
36	the	DT	O	the	det	38	SENT_307	[p19l1669t1433r1799b1511],
37	control	NN	O	control	nn	38	SENT_307	[p19l1833t1433r2136b1512],
38	group	NN	O	group	prep_in	19	SENT_307	[p19l10t1587r275b1662],
39	.	.	O	.	_	0	SENT_307	[p19l10t1587r275b1662],

1	For	IN	O	for	_	0	SENT_308	[p19l315t1569r453b1640],
2	the	DT	O	the	det	6	SENT_308	[p19l488t1561r616b1639],
3	immunologically	RB	O	immunologically	advmod	4	SENT_308	[p19l653t1561r1361b1662],
4	confirmed	VBN	O	confirm	amod	6	SENT_308	[p19l1394t1560r1831b1640],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_308	[p19l1867t1561r2134b1661, p19l11t1690r435b1789],
6	reaction	NN	O	reaction	prep_for	22	SENT_308	[p19l471t1690r812b1768],
7	in	IN	O	in	_	0	SENT_308	[p19l851t1690r934b1766],
8	the	DT	O	the	det	10	SENT_308	[p19l975t1689r1105b1767],
9	control	NN	O	control	nn	10	SENT_308	[p19l1146t1689r1446b1768],
10	group	NN	O	group	prep_in	6	SENT_308	[p19l1485t1715r1755b1790],
11	,	,	O	,	_	0	SENT_308	[p19l1485t1715r1755b1790],
12	the	DT	O	the	det	14	SENT_308	[p19l1801t1689r1932b1767],
13	median	JJ	O	median	amod	14	SENT_308	[p19l1972t1715r2134b1767, p19l11t1817r200b1895],
14	time	NN	O	time	nsubj	22	SENT_308	[p19l241t1818r435b1895],
15	to	TO	O	to	_	0	SENT_308	[p19l477t1834r558b1895],
16	the	DT	O	the	det	17	SENT_308	[p19l601t1817r734b1895],
17	onset	NN	O	onset	prep_to	14	SENT_308	[p19l776t1834r1010b1896],
18	of	IN	O	of	_	0	SENT_308	[p19l1047t1816r1147b1896],
19	symptoms	NNS	O	symptom	prep_of	17	SENT_308	[p19l1171t1834r1614b1917],
20	was	VBD	O	be	cop	22	SENT_308	[p19l1653t1843r1816b1896],
21	8	CD	DURATION	8	num	22	SENT_308	[p19l1860t1823r1905b1896],
22	days	NNS	NUMBER	day	_	0	SENT_308	[p19l1949t1817r2134b1917],
23	(	RB	O	(	advmod	24	SENT_308	[p19l15t1945r598b2045],
24	interquartile	JJ	O	interquartile	amod	25	SENT_308	[p19l15t1945r598b2045],
25	range	NN	O	range	attr	22	SENT_308	[p19l643t1971r913b2046],
26	,	,	O	,	_	0	SENT_308	[p19l643t1971r913b2046],
27	5	CD	NUMBER	5	number	29	SENT_308	[p19l964t1953r1007b2024],
28	to	TO	O	to	dep	29	SENT_308	[p19l1055t1962r1138b2024],
29	10	CD	NUMBER	10	appos	25	SENT_308	[p19l1187t1951r1335b2036],
30	)	CD	NUMBER	)	dep	29	SENT_308	[p19l1187t1951r1335b2036],
31	.	.	O	.	_	0	SENT_308	[p19l1187t1951r1335b2036],

1	All	DT	O	all	det	2	SENT_309	[p19l1382t1945r1510b2022],
2	symptoms	NNS	O	symptom	nsubj	6	SENT_309	[p19l1555t1962r2006b2045],
3	of	IN	O	of	_	0	SENT_309	[p19l2053t1944r2153b2024],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_309	[p19l10t2073r708b2173],
5	reaction	NN	O	reaction	prep_of	2	SENT_309	[p19l740t2074r1096b2152],
6	improved	VBD	O	improve	_	0	SENT_309	[p19l1132t2073r1545b2173],
7	quickly	RB	O	quickly	advmod	6	SENT_309	[p19l1582t2073r1900b2173],
8	after	IN	O	after	_	0	SENT_309	[p19l1931t2072r2138b2151],
9	the	DT	O	the	det	10	SENT_309	[p19l11t2201r143b2279],
10	Withdrawal	NN	O	withdrawal	prep_after	6	SENT_309	[p19l177t2201r668b2280],
11	of	IN	O	of	_	0	SENT_309	[p19l706t2200r806b2280],
12	abacavir	NN	O	abacavir	prep_of	10	SENT_309	[p19l825t2201r1200b2297],
13	,	,	O	,	_	0	SENT_309	[p19l825t2201r1200b2297],
14	with	IN	O	with	_	0	SENT_309	[p19l1238t2201r1434b2280],
15	no	DT	O	no	det	16	SENT_309	[p19l1472t2227r1577b2280],
16	sequelae	NN	O	sequela	prep_with	6	SENT_309	[p19l1618t2201r2004b2301],
17	.	.	O	.	_	0	SENT_309	[p19l1618t2201r2004b2301],

1	In	IN	O	in	_	0	SENT_310	[p19l2046t2209r2135b2278],
2	addition	NN	O	addition	prep_in	16	SENT_310	[p19l10t2329r398b2425],
3	,	,	O	,	_	0	SENT_310	[p19l10t2329r398b2425],
4	all	DT	O	all	det	6	SENT_310	[p19l454t2329r561b2407],
5	five	CD	NUMBER	five	num	6	SENT_310	[p19l611t2328r767b2408],
6	patients	NNS	O	patient	nsubj	16	SENT_310	[p19l817t2330r1166b2429],
7	with	IN	O	with	_	0	SENT_310	[p19l1215t2329r1414b2408],
8	clinically	RB	O	clinically	advmod	9	SENT_310	[p19l1465t2329r1867b2429],
9	diagnosed	VBN	O	diagnose	amod	11	SENT_310	[p19l1914t2329r2134b2430, p19l10t2457r268b2536],
10	hypersensitivity	NN	O	hypersensitivity	nn	11	SENT_310	[p19l303t2457r1001b2557],
11	reactions	NNS	O	reaction	prep_with	6	SENT_310	[p19l1031t2458r1431b2536],
12	occurring	VBG	O	occur	partmod	11	SENT_310	[p19l1469t2458r1900b2558],
13	after	IN	O	after	_	0	SENT_310	[p19l1931t2456r2138b2535],
14	day	NN	DURATION	day	prep_after	12	SENT_310	[p19l11t2585r155b2685],
15	21	CD	NUMBER	21	num	14	SENT_310	[p19l180t2590r279b2662],
16	had	VBD	O	have	_	0	SENT_310	[p19l309t2585r464b2664],
17	negative	JJ	O	negative	amod	18	SENT_310	[p19l493t2586r839b2686],
18	results	NNS	O	result	dobj	16	SENT_310	[p19l870t2585r1147b2664],
19	on	IN	O	on	_	0	SENT_310	[p19l1179t2611r1284b2664],
20	epicutaneous	JJ	O	epicutaneous	amod	22	SENT_310	[p19l1315t2586r1868b2685],
21	patch	NN	O	patch	nn	22	SENT_310	[p19l1899t2585r2135b2685],
22	testing	NN	O	testing	prep_on	18	SENT_310	[p19l11t2715r328b2814],
23	.	.	O	.	_	0	SENT_310	[p19l11t2715r328b2814],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_311	[p19l544t2899r622b2921],
2	MED	NNP	O	MED	_	0	SENT_311	[p19l637t2899r689b2914],
3	;	:	O	;	_	0	SENT_311	[p19l742t2900r746b2919],
4	WWW	NNP	O	WWW	nn	7	SENT_311	[p19l796t2899r997b2921],
5	,	,	O	,	_	0	SENT_311	[p19l796t2899r997b2921],
6	NEJM.ORG	NNP	O	NEJM.ORG	appos	7	SENT_311	[p19l796t2899r997b2921],
7	FEBRUARY	NNP	DATE	FEBRUARY	dep	2	SENT_311	[p19l1034t2899r1155b2915],
8	7,2008	CD	NUMBER	7,2008	number	9	SENT_311	[p19l1165t2893r1259b2920],
9	575	CD	NUMBER	575	dep	7	SENT_311	[p19l1960t2889r2015b2912],

1	e	LS	O	e	dep	4	SENT_312	[p19l739t2940r753b2956],
2	New	NNP	O	New	nn	4	SENT_312	[p19l762t2933r824b2956],
3	England	NNP	O	England	nn	4	SENT_312	[p19l833t2932r944b2963],
4	Journal	NNP	O	Journal	_	0	SENT_312	[p19l953t2932r1050b2956],
5	of	IN	O	of	prep	4	SENT_312	[p19l1060t2932r1089b2956],
6	Medicine	NNP	O	Medicine	dep	4	SENT_312	[p19l1095t2932r1220b2956],

1	The	DT	O	the	det	4	SENT_313	[p19l816t3057r861b3078],
2	NEW	NNP	O	NEW	nn	4	SENT_313	[p19l880t3059r965b3078],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_313	[p19l984t3059r1173b3078],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_313	[p19l1192t3059r1372b3085],
5	of	IN	O	of	_	0	SENT_313	[p19l1391t3057r1420b3084],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_313	[p19l1431t3059r1631b3078],

1	Table	NNP	O	Table	_	0	SENT_314	[p20l119t71r193b96],
2	4	CD	NUMBER	4	dep	1	SENT_314	[p20l201t74r224b96],
3	.	.	O	.	_	0	SENT_314	[p20l201t74r224b96],

1	Performance	NNP	O	Performance	nn	2	SENT_315	[p20l236t71r409b96],
2	Characteristics	NNS	O	characteristic	_	0	SENT_315	[p20l418t71r621b96],
3	of	IN	O	of	_	0	SENT_315	[p20l630t71r661b96],
4	HLA-B	NN	O	hla-b	prep_of	2	SENT_315	[p20l667t73r836b97],
5	‘	SYM	O	‘	dep	2	SENT_315	[p20l667t73r836b97],
6	-	:	O	-	_	0	SENT_315	[p20l667t73r836b97],
7	"	``	O	"	punct	10	SENT_315	[p20l667t73r836b97],
8	‘	CD	NUMBER	‘	number	9	SENT_315	[p20l667t73r836b97],
9	5701	CD	NUMBER	5701	num	10	SENT_315	[p20l667t73r836b97],
10	Screening	NN	O	screening	dep	2	SENT_315	[p20l847t72r982b104],
11	for	IN	O	for	_	0	SENT_315	[p20l990t71r1029b96],
12	Hypersensitivity	NN	O	hypersensitivity	nn	13	SENT_315	[p20l1039t72r1260b104],
13	Reaction	NN	O	reaction	prep_for	10	SENT_315	[p20l1270t72r1385b96],
14	to	TO	O	to	_	0	SENT_315	[p20l1395t75r1422b96],
15	Abacavir	NNP	O	Abacavir	prep_to	10	SENT_315	[p20l1430t71r1549b96],
16	in	IN	O	in	_	0	SENT_315	[p20l1558t72r1581b96],
17	the	DT	O	the	det	19	SENT_315	[p20l1590t71r1634b96],
18	Control	NNP	ORGANIZATION	Control	nn	19	SENT_315	[p20l1643t71r1743b96],
19	Group	NNP	ORGANIZATION	Group	prep_in	10	SENT_315	[p20l1753t73r1865b104],
20	.	.	O	.	_	0	SENT_315	[p20l1753t73r1865b104],

1	*	NN	O	*	_	0	SENT_316	[p20l1753t73r1865b104],

1	Positive	JJ	O	positive	dep	13	SENT_317	[p20l905t147r1011b172],
2	for	IN	O	for	_	0	SENT_317	[p20l1020t146r1059b172],
3	Negative	JJ	O	negative	prep_for	1	SENT_317	[p20l1151t147r1271b179],
4	for	IN	O	for	_	0	SENT_317	[p20l1281t146r1319b172],
5	Performance	NNP	O	Performance	nn	8	SENT_317	[p20l1630t146r1803b172],
6	Characteristic	NNP	O	Characteristic	nn	8	SENT_317	[p20l1813t146r2001b172],
7	Subgroup	NN	O	subgroup	nn	8	SENT_317	[p20l119t184r252b217],
8	H	NN	O	h	prep_for	3	SENT_317	[p20l896t186r916b209],
9	LA-B	NN	O	la-b	dep	13	SENT_317	[p20l922t185r1066b209],
10	*	CD	NUMBER	*	num	9	SENT_317	[p20l922t185r1066b209],
11	5701	CD	NUMBER	5701	num	13	SENT_317	[p20l922t185r1066b209],
12	H	NN	O	h	nn	13	SENT_317	[p20l1149t186r1169b209],
13	LA-B	NN	O	la-b	dep	23	SENT_317	[p20l1175t185r1318b209],
14	*	CD	NUMBER	*	number	15	SENT_317	[p20l1175t185r1318b209],
15	5701	CD	NUMBER	5701	num	16	SENT_317	[p20l1175t185r1318b209],
16	Total	JJ	O	total	dep	13	SENT_317	[p20l1428t184r1495b209],
17	for	IN	O	for	_	0	SENT_317	[p20l1615t184r1653b209],
18	Hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_317	[p20l1665t185r1885b217],
19	Reaction	NN	O	reaction	nn	20	SENT_317	[p20l1897t185r2012b209],
20	number	NN	O	number	prep_for	16	SENT_317	[p20l1088t243r1191b268],
21	of	IN	O	of	_	0	SENT_317	[p20l1198t242r1228b276],
22	patients	NNS	O	patient	prep_of	20	SENT_317	[p20l1229t244r1333b276],
23	percent	NN	O	percent	dep	26	SENT_317	[p20l1701t248r1796b276],
24	(	CD	PERCENT	(	num	23	SENT_317	[p20l1808t244r1877b276],
25	95	CD	PERCENT	95	num	26	SENT_317	[p20l1808t244r1877b276],
26	%	NN	PERCENT	%	dep	27	SENT_317	[p20l1808t244r1877b276],
27	Cl	NN	O	cl	_	0	SENT_317	[p20l1888t245r1925b276],
28	)	CD	NUMBER	)	num	27	SENT_317	[p20l1888t245r1925b276],

1	Clinically	RB	O	clinically	advmod	2	SENT_318	[p20l119t303r242b335],
2	diagnosed	VBN	O	diagnose	_	0	SENT_318	[p20l251t303r391b335],
3	hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_318	[p20l402t303r616b335],
4	reaction	NN	O	reaction	dobj	2	SENT_318	[p20l626t303r734b328],
5	Total	JJ	O	total	amod	6	SENT_318	[p20l119t362r186b387],
6	population	NN	O	population	dep	2	SENT_318	[p20l199t362r344b395],
7	that	WDT	O	that	nsubjpass	10	SENT_318	[p20l355t362r408b387],
8	could	MD	O	could	aux	10	SENT_318	[p20l418t362r490b387],
9	be	VB	O	be	auxpass	10	SENT_318	[p20l503t362r533b387],
10	evaluated	VBN	O	evaluate	rcmod	6	SENT_318	[p20l543t362r671b387],

1	Hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_319	[p20l172t424r390b455],
2	reaction	NN	O	reaction	nn	3	SENT_319	[p20l401t424r507b447],
3	Sensitivity	NN	O	sensitivity	_	0	SENT_319	[p20l1625t424r1770b455],
4	:	:	O	:	_	0	SENT_319	[p20l1625t424r1770b455],
5	45.5	CD	NUMBER	45.5	dep	3	SENT_319	[p20l1780t424r1836b447],
6	(	CD	NUMBER	(	number	7	SENT_319	[p20l1850t424r2000b455],
7	33.1	CD	NUMBER	33.1	num	8	SENT_319	[p20l1850t424r2000b455],
8	—	NN	O	—	dep	5	SENT_319	[p20l1850t424r2000b455],
9	58.2	CD	NUMBER	58.2	number	10	SENT_319	[p20l1850t424r2000b455],
10	)	CD	NUMBER	)	dep	5	SENT_319	[p20l1850t424r2000b455],
11	No	DT	O	no	det	14	SENT_319	[p20l172t484r211b507],
12	hypersensitivity	NN	O	hypersensitivity	nn	14	SENT_319	[p20l222t482r433b515],
13	reaction	NN	O	reaction	nn	14	SENT_319	[p20l443t484r550b507],
14	Speciﬁcity	NN	O	speciﬁcity	dep	10	SENT_319	[p20l1625t481r1769b515],
15	:	:	O	:	_	0	SENT_319	[p20l1625t481r1769b515],
16	97.6	CD	NUMBER	97.6	number	17	SENT_319	[p20l1780t484r1836b507],
17	(	CD	NUMBER	(	dep	10	SENT_319	[p20l1849t483r1999b515],
18	96.2	CD	NUMBER	96.2	num	19	SENT_319	[p20l1849t483r1999b515],
19	—	NN	O	—	dep	17	SENT_319	[p20l1849t483r1999b515],
20	98.5	CD	NUMBER	98.5	num	21	SENT_319	[p20l1849t483r1999b515],
21	)	NN	O	)	dep	17	SENT_319	[p20l1849t483r1999b515],

1	PPV	NN	O	ppv	_	0	SENT_320	[p20l1627t522r1686b545],
2	:	:	O	:	_	0	SENT_320	[p20l1627t522r1686b545],
3	61.2	CD	NUMBER	61.2	number	4	SENT_320	[p20l1698t521r1753b544],
4	(	CD	NUMBER	(	dep	1	SENT_320	[p20l1766t521r1916b552],
5	46.2	CD	NUMBER	46.2	num	6	SENT_320	[p20l1766t521r1916b552],
6	—	NN	O	—	dep	4	SENT_320	[p20l1766t521r1916b552],
7	74.8	CD	NUMBER	74.8	number	8	SENT_320	[p20l1766t521r1916b552],
8	)	CD	NUMBER	)	num	9	SENT_320	[p20l1766t521r1916b552],
9	NPV	NN	O	npv	dep	4	SENT_320	[p20l1627t559r1693b582],
10	:	:	O	:	_	0	SENT_320	[p20l1627t559r1693b582],
11	95.5	CD	NUMBER	95.5	dep	4	SENT_320	[p20l1704t559r1759b582],
12	(	CD	NUMBER	(	number	13	SENT_320	[p20l1773t558r1923b590],
13	93.8	CD	NUMBER	93.8	num	14	SENT_320	[p20l1773t558r1923b590],
14	—	NN	O	—	dep	11	SENT_320	[p20l1773t558r1923b590],
15	96.8	CD	NUMBER	96.8	num	16	SENT_320	[p20l1773t558r1923b590],
16	)	NN	O	)	dep	11	SENT_320	[p20l1773t558r1923b590],

1	White	NNP	O	White	_	0	SENT_321	[p20l119t616r199b642],
2	subgroup	NN	O	subgroup	dep	1	SENT_321	[p20l209t616r339b650],

1	Hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_322	[p20l172t678r390b709],
2	reaction	NN	O	reaction	nn	3	SENT_322	[p20l401t679r507b701],
3	Sensitivity	NN	O	sensitivity	_	0	SENT_322	[p20l1625t678r1770b709],
4	:	:	O	:	_	0	SENT_322	[p20l1625t678r1770b709],
5	47.5	CD	NUMBER	47.5	number	6	SENT_322	[p20l1780t678r1836b701],
6	(	CD	NUMBER	(	dep	3	SENT_322	[p20l1850t678r2000b709],
7	34.6	CD	NUMBER	34.6	num	8	SENT_322	[p20l1850t678r2000b709],
8	—	NN	O	—	dep	6	SENT_322	[p20l1850t678r2000b709],
9	60.7	CD	NUMBER	60.7	number	10	SENT_322	[p20l1850t678r2000b709],
10	)	CD	NUMBER	)	dep	6	SENT_322	[p20l1850t678r2000b709],
11	No	DT	O	no	det	14	SENT_322	[p20l172t738r211b761],
12	hypersensitivity	NN	O	hypersensitivity	nn	14	SENT_322	[p20l222t736r433b769],
13	reaction	NN	O	reaction	nn	14	SENT_322	[p20l443t738r550b761],
14	Speciﬁcity	NN	O	speciﬁcity	dep	10	SENT_322	[p20l1625t736r1769b769],
15	:	:	O	:	_	0	SENT_322	[p20l1625t736r1769b769],
16	97.1	CD	NUMBER	97.1	number	17	SENT_322	[p20l1780t738r1835b761],
17	(	CD	NUMBER	(	dep	10	SENT_322	[p20l1849t737r1999b769],
18	95.5	CD	NUMBER	95.5	num	19	SENT_322	[p20l1849t737r1999b769],
19	—	NN	O	—	dep	17	SENT_322	[p20l1849t737r1999b769],
20	98.3	CD	NUMBER	98.3	num	21	SENT_322	[p20l1849t737r1999b769],
21	)	NN	O	)	dep	17	SENT_322	[p20l1849t737r1999b769],

1	PPV	NN	O	ppv	_	0	SENT_323	[p20l1627t776r1686b799],
2	:	:	O	:	_	0	SENT_323	[p20l1627t776r1686b799],
3	60.4	CD	NUMBER	60.4	dep	1	SENT_323	[p20l1698t775r1753b799],
4	(	CD	NUMBER	(	number	5	SENT_323	[p20l1766t775r1916b806],
5	45.3	CD	NUMBER	45.3	dep	3	SENT_323	[p20l1766t775r1916b806],
6	—	NN	O	—	dep	14	SENT_323	[p20l1766t775r1916b806],
7	74.2	CD	NUMBER	74.2	number	8	SENT_323	[p20l1766t775r1916b806],
8	)	CD	NUMBER	)	num	9	SENT_323	[p20l1766t775r1916b806],
9	NPV	NN	O	npv	dep	6	SENT_323	[p20l1627t813r1693b836],
10	:	:	O	:	_	0	SENT_323	[p20l1627t813r1693b836],
11	95.2	CD	NUMBER	95.2	number	12	SENT_323	[p20l1704t813r1760b836],
12	(	CD	NUMBER	(	dep	9	SENT_323	[p20l1773t813r1923b844],
13	93.3	CD	NUMBER	93.3	dep	14	SENT_323	[p20l1773t813r1923b844],
14	—	NN	O	—	dep	1	SENT_323	[p20l1773t813r1923b844],
15	96.7	CD	NUMBER	96.7	num	16	SENT_323	[p20l1773t813r1923b844],
16	)	NN	O	)	dep	14	SENT_323	[p20l1773t813r1923b844],

1	immunologically	RB	O	immunologically	advmod	2	SENT_324	[p20l121t871r349b903],
2	confirmed	VBN	O	confirm	_	0	SENT_324	[p20l357t870r495b896],
3	hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_324	[p20l507t871r721b903],
4	reaction	NN	O	reaction	dobj	2	SENT_324	[p20l730t871r838b896],
5	Total	JJ	O	total	amod	6	SENT_324	[p20l119t930r186b956],
6	population	NN	O	population	dep	2	SENT_324	[p20l199t930r344b963],
7	that	WDT	O	that	nsubjpass	10	SENT_324	[p20l355t930r408b956],
8	could	MD	O	could	aux	10	SENT_324	[p20l418t930r491b956],
9	be	VB	O	be	auxpass	10	SENT_324	[p20l503t930r533b956],
10	evaluated	VBN	O	evaluate	rcmod	6	SENT_324	[p20l543t930r671b956],

1	Hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_325	[p20l172t992r390b1023],
2	reaction	NN	O	reaction	nn	3	SENT_325	[p20l401t992r507b1015],
3	Sensitivity	NN	O	sensitivity	_	0	SENT_325	[p20l1625t992r1770b1023],
4	:	:	O	:	_	0	SENT_325	[p20l1625t992r1770b1023],
5	100	CD	NUMBER	100	number	6	SENT_325	[p20l1783t992r1829b1015],
6	(	CD	NUMBER	(	dep	3	SENT_325	[p20l1842t992r1983b1023],
7	85.2	CD	NUMBER	85.2	num	8	SENT_325	[p20l1842t992r1983b1023],
8	—	NN	O	—	dep	6	SENT_325	[p20l1842t992r1983b1023],
9	100	CD	NUMBER	100	num	10	SENT_325	[p20l1842t992r1983b1023],
10	)	CD	NUMBER	)	dep	19	SENT_325	[p20l1842t992r1983b1023],
11	No	DT	O	no	det	14	SENT_325	[p20l172t1052r211b1075],
12	hypersensitivity	NN	O	hypersensitivity	nn	14	SENT_325	[p20l222t1050r433b1083],
13	reaction	NN	O	reaction	nn	14	SENT_325	[p20l443t1052r550b1075],
14	iﬁcity	NN	O	iﬁcity	dep	10	SENT_325	[p20l1692t1049r1769b1083],
15	:	:	O	:	_	0	SENT_325	[p20l1692t1049r1769b1083],
16	96.9	CD	NUMBER	96.9	number	17	SENT_325	[p20l1780t1052r1836b1075],
17	(	CD	NUMBER	(	dep	14	SENT_325	[p20l1849t1051r1999b1083],
18	95.5	CD	NUMBER	95.5	dep	19	SENT_325	[p20l1849t1051r1999b1083],
19	—	NN	O	—	dep	3	SENT_325	[p20l1849t1051r1999b1083],
20	98.0	CD	NUMBER	98.0	num	21	SENT_325	[p20l1849t1051r1999b1083],
21	)	NN	O	)	dep	19	SENT_325	[p20l1849t1051r1999b1083],

1	;	:	O	;	_	0	SENT_326	[p20l1682t1096r1686b1112],
2	.	.	O	.	_	0	SENT_326	[p20l1732t1108r1736b1112],

1	(	NN	O	(	_	0	SENT_327	[p20l1766t1089r1916b1120],
2	33.3	CD	NUMBER	33.3	num	1	SENT_327	[p20l1766t1089r1916b1120],
3	—	CD	NUMBER	—	number	4	SENT_327	[p20l1766t1089r1916b1120],
4	62.8	CD	NUMBER	62.8	dep	1	SENT_327	[p20l1766t1089r1916b1120],
5	)	NN	O	)	nn	7	SENT_327	[p20l1766t1089r1916b1120],
6	N	NN	O	n	nn	7	SENT_327	[p20l1627t1127r1645b1150],
7	PV	NN	O	pv	dep	4	SENT_327	[p20l1652t1127r1693b1150],
8	:	:	O	:	_	0	SENT_327	[p20l1652t1127r1693b1150],
9	(	CD	NUMBER	(	number	10	SENT_327	[p20l1765t1126r1906b1158],
10	99.5	CD	NUMBER	99.5	num	11	SENT_327	[p20l1765t1126r1906b1158],
11	—	NN	O	—	dep	4	SENT_327	[p20l1765t1126r1906b1158],
12	1oo	CD	NUMBER	1oo	num	13	SENT_327	[p20l1765t1126r1906b1158],
13	)	NN	O	)	dep	11	SENT_327	[p20l1765t1126r1906b1158],

1	White	NNP	O	White	_	0	SENT_328	[p20l119t1184r199b1210],
2	subgroup	NN	O	subgroup	dep	1	SENT_328	[p20l209t1184r339b1218],

1	Hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_329	[p20l172t1246r390b1277],
2	reaction	NN	O	reaction	nn	3	SENT_329	[p20l401t1247r507b1269],
3	Sensitivity	NN	O	sensitivity	_	0	SENT_329	[p20l1625t1246r1770b1277],
4	:	:	O	:	_	0	SENT_329	[p20l1625t1246r1770b1277],
5	100	CD	NUMBER	100	number	6	SENT_329	[p20l1783t1246r1829b1269],
6	(	CD	NUMBER	(	dep	3	SENT_329	[p20l1842t1246r1983b1277],
7	84.6	CD	NUMBER	84.6	num	8	SENT_329	[p20l1842t1246r1983b1277],
8	—	NN	O	—	dep	6	SENT_329	[p20l1842t1246r1983b1277],
9	100	CD	NUMBER	100	num	10	SENT_329	[p20l1842t1246r1983b1277],
10	)	CD	NUMBER	)	dep	19	SENT_329	[p20l1842t1246r1983b1277],
11	No	DT	O	no	det	14	SENT_329	[p20l172t1306r211b1329],
12	hypersensitivity	NN	O	hypersensitivity	nn	14	SENT_329	[p20l222t1304r433b1337],
13	reaction	NN	O	reaction	nn	14	SENT_329	[p20l443t1306r550b1329],
14	Speciﬁcity	NN	O	speciﬁcity	dep	10	SENT_329	[p20l1625t1304r1769b1337],
15	:	:	O	:	_	0	SENT_329	[p20l1625t1304r1769b1337],
16	96.4	CD	NUMBER	96.4	number	17	SENT_329	[p20l1780t1306r1836b1329],
17	(	CD	NUMBER	(	dep	14	SENT_329	[p20l1849t1306r1999b1337],
18	94.7	CD	NUMBER	94.7	dep	19	SENT_329	[p20l1849t1306r1999b1337],
19	—	NN	O	—	dep	3	SENT_329	[p20l1849t1306r1999b1337],
20	97.6	CD	NUMBER	97.6	num	21	SENT_329	[p20l1849t1306r1999b1337],
21	)	NN	O	)	dep	19	SENT_329	[p20l1849t1306r1999b1337],

1	PPV	NN	O	ppv	_	0	SENT_330	[p20l1627t1344r1686b1367],
2	:	:	O	:	_	0	SENT_330	[p20l1627t1344r1686b1367],
3	46.8	CD	NUMBER	46.8	number	4	SENT_330	[p20l1697t1343r1753b1367],
4	(	CD	NUMBER	(	dep	1	SENT_330	[p20l1766t1343r1916b1374],
5	32.1	CD	NUMBER	32.1	num	6	SENT_330	[p20l1766t1343r1916b1374],
6	—	NN	O	—	dep	4	SENT_330	[p20l1766t1343r1916b1374],
7	61.9	CD	NUMBER	61.9	number	8	SENT_330	[p20l1766t1343r1916b1374],
8	)	CD	NUMBER	)	num	9	SENT_330	[p20l1766t1343r1916b1374],
9	NPV	NN	O	npv	dep	4	SENT_330	[p20l1627t1381r1693b1404],
10	:	:	O	:	_	0	SENT_330	[p20l1627t1381r1693b1404],
11	100	CD	NUMBER	100	number	12	SENT_330	[p20l1706t1381r1752b1404],
12	(	CD	NUMBER	(	dep	9	SENT_330	[p20l1765t1380r1906b1412],
13	99.4	CD	NUMBER	99.4	number	14	SENT_330	[p20l1765t1380r1906b1412],
14	—	CD	NUMBER	—	num	16	SENT_330	[p20l1765t1380r1906b1412],
15	lO0	NN	O	lo0	nn	16	SENT_330	[p20l1765t1380r1906b1412],
16	)	NN	O	)	dep	9	SENT_330	[p20l1765t1380r1906b1412],

1	*	NN	O	*	nn	3	SENT_331	[p20l93t1466r108b1480],
2	whit	NN	O	whit	nn	3	SENT_331	[p20l178t1464r236b1489],
3	ubgroup	NN	O	ubgroup	nsubj	4	SENT_331	[p20l279t1464r393b1497],
4	included	VBD	O	include	_	0	SENT_331	[p20l405t1464r519b1489],
5	the	DT	O	the	det	9	SENT_331	[p20l531t1464r574b1489],
6	two	CD	NUMBER	two	nn	9	SENT_331	[p20l584t1469r633b1489],
7	and	CC	O	and	_	0	SENT_331	[p20l645t1464r693b1489],
8	three	CD	NUMBER	three	nn	9	SENT_331	[p20l705t1464r774b1489],
9	patients	NNS	O	patient	nsubj	13	SENT_331	[p20l787t1466r894b1496],
10	reporting	VBG	O	report	partmod	9	SENT_331	[p20l908t1466r1032b1497],
11	both	CC	O	both	prep	10	SENT_331	[p20l1044t1464r1103b1489],
12	categories	NNS	O	category	dep	11	SENT_331	[p20l1116t1466r1254b1497],
13	ofwhite	VBP	O	ofwhite	ccomp	4	SENT_331	[p20l1266t1463r1375b1489],
14	ancestry	NN	O	ancestry	dobj	13	SENT_331	[p20l1387t1469r1499b1497],
15	in	IN	O	in	_	0	SENT_331	[p20l1511t1466r1532b1489],
16	the	DT	O	the	det	18	SENT_331	[p20l1544t1464r1587b1489],
17	prospective-screening	JJ	O	prospective-screening	amod	18	SENT_331	[p20l1600t1466r1899b1497],
18	group	NN	O	group	prep_in	13	SENT_331	[p20l1910t1473r1990b1497],
19	and	CC	O	and	_	0	SENT_331	[p20l2002t1464r2050b1489],
20	contr	NN	O	contr	nn	21	SENT_331	[p20l171t1506r242b1526],
21	roup	NN	O	roup	prep_in	13	SENT_331	[p20l297t1510r365b1534],
22	,	,	O	,	_	0	SENT_331	[p20l297t1510r365b1534],
23	respectively	RB	O	respectively	advmod	13	SENT_331	[p20l379t1501r544b1534],
24	.	.	O	.	_	0	SENT_331	[p20l379t1501r544b1534],

1	NPV	NN	O	npv	nsubj	2	SENT_332	[p20l559t1503r618b1526],
2	denotes	VBZ	O	denote	_	0	SENT_332	[p20l629t1501r736b1526],
3	negative	JJ	O	negative	amod	5	SENT_332	[p20l750t1503r862b1534],
4	predictive	JJ	O	predictive	amod	5	SENT_332	[p20l875t1501r1006b1533],
5	value	NN	O	value	dobj	2	SENT_332	[p20l1017t1501r1095b1530],
6	,	,	O	,	_	0	SENT_332	[p20l1017t1501r1095b1530],
7	and	CC	O	and	_	0	SENT_332	[p20l1108t1501r1156b1526],
8	PPV	NN	O	ppv	nn	11	SENT_332	[p20l1171t1503r1224b1526],
9	positive	JJ	O	positive	amod	11	SENT_332	[p20l1236t1503r1340b1533],
10	predictive	JJ	O	predictive	amod	11	SENT_332	[p20l1353t1501r1485b1533],
11	value	NN	O	value	conj_and	5	SENT_332	[p20l1495t1501r1573b1526],
12	.	.	O	.	_	0	SENT_332	[p20l1495t1501r1573b1526],

1	DISCUSSION	NN	O	discussion	_	0	SENT_333	[p20l736t1813r1422b1873],

1	The	DT	O	the	det	2	SENT_334	[p20l6t2047r166b2125],
2	results	NNS	O	result	nsubj	9	SENT_334	[p20l196t2047r474b2127],
3	of	IN	O	of	_	0	SENT_334	[p20l507t2046r607b2126],
4	the	DT	O	the	det	8	SENT_334	[p20l618t2047r750b2125],
5	PREDICT	NNP	O	PREDICT	nn	8	SENT_334	[p20l778t2053r1243b2131],
6	—	NN	O	—	nn	8	SENT_334	[p20l778t2053r1243b2131],
7	1	CD	NUMBER	1	num	8	SENT_334	[p20l778t2053r1243b2131],
8	study	NN	O	study	prep_of	2	SENT_334	[p20l1275t2047r1502b2147],
9	show	VBP	O	show	_	0	SENT_334	[p20l1528t2047r1752b2127],
10	that	IN	O	that	_	0	SENT_334	[p20l1778t2047r1949b2125],
11	prospective	JJ	O	prospective	amod	12	SENT_334	[p20l1972t2073r2148b2147, p20l11t2177r360b2276],
12	HLA	NN	O	hlum	prep_that	9	SENT_334	[p20l405t2176r957b2255],
13	.	.	O	.	_	0	SENT_334	[p20l405t2176r957b2255],

1	—	NN	O	—	_	0	SENT_335	[p20l405t2176r957b2255],
2	.	.	O	.	_	0	SENT_335	[p20l405t2176r957b2255],

1	B	NN	O	b	nsubj	6	SENT_336	[p20l405t2176r957b2255],
2	*	CD	NUMBER	*	num	1	SENT_336	[p20l405t2176r957b2255],
3	5701	CD	NUMBER	5701	num	4	SENT_336	[p20l405t2176r957b2255],
4	screening	NN	O	screening	dep	1	SENT_336	[p20l1006t2177r1435b2277],
5	can	MD	O	can	aux	6	SENT_336	[p20l1479t2202r1631b2254],
6	reduce	VB	O	reduce	_	0	SENT_336	[p20l1677t2176r1965b2255],
7	the	DT	O	the	det	8	SENT_336	[p20l2012t2176r2148b2255],
8	incidence	NN	O	incidence	dobj	6	SENT_336	[p20l9t2303r418b2382],
9	of	IN	O	of	_	0	SENT_336	[p20l454t2302r555b2382],
10	hypersensitivity	NN	O	hypersensitivity	nn	11	SENT_336	[p20l571t2303r1258b2403],
11	reaction	NN	O	reaction	prep_of	8	SENT_336	[p20l1288t2304r1639b2382],
12	to	TO	O	to	_	0	SENT_336	[p20l1674t2320r1756b2382],
13	abacavir	NN	O	abacavir	nn	15	SENT_336	[p20l1792t2303r2152b2383],
14	(	CD	NUMBER	(	num	15	SENT_336	[p20l15t2432r274b2523],
15	Table	NNP	O	Table	prep_to	6	SENT_336	[p20l15t2432r274b2523],
16	2	CD	NUMBER	2	number	17	SENT_336	[p20l325t2438r426b2523],
17	)	CD	NUMBER	)	num	15	SENT_336	[p20l325t2438r426b2523],
18	.	.	O	.	_	0	SENT_336	[p20l325t2438r426b2523],

1	In	IN	O	in	_	0	SENT_337	[p20l480t2440r569b2510],
2	our	PRP$	O	we	poss	3	SENT_337	[p20l621t2458r768b2511],
3	study	NN	O	study	prep_in	16	SENT_337	[p20l816t2432r1061b2532],
4	,	,	O	,	_	0	SENT_337	[p20l816t2432r1061b2532],
5	prospectively	RB	O	prospectively	advmod	3	SENT_337	[p20l1115t2432r1686b2532],
6	excluding	VBG	O	exclude	_	0	SENT_337	[p20l1733t2432r2153b2533],
7	HLA-B	NN	O	hla-b	prep_excluding	3	SENT_337	[p20l9t2560r920b2661],
8	*	CD	NUMBER	*	number	9	SENT_337	[p20l9t2560r920b2661],
9	5701	CD	NUMBER	5701	num	10	SENT_337	[p20l9t2560r920b2661],
10	—	NN	O	—	npadvmod	11	SENT_337	[p20l9t2560r920b2661],
11	positive	JJ	O	positive	amod	12	SENT_337	[p20l9t2560r920b2661],
12	patients	NNS	O	patient	nsubj	23	SENT_337	[p20l950t2561r1287b2661],
13	from	IN	O	from	_	0	SENT_337	[p20l1320t2559r1529b2640],
14	receiving	VBG	O	receive	prepc_from	12	SENT_337	[p20l1560t2561r1945b2662],
15	abacavir	NN	O	abacavir	dobj	14	SENT_337	[p20l1972t2560r2148b2640, p20l10t2690r213b2769],
16	eliminated	VBD	O	eliminate	_	0	SENT_337	[p20l245t2689r712b2769],
17	immunologically	RB	O	immunologically	advmod	18	SENT_337	[p20l748t2689r1492b2791],
18	confirmed	VBN	O	confirm	dep	16	SENT_337	[p20l1525t2688r1982b2769],
19	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_337	[p20l2019t2689r2148b2790, p20l8t2819r591b2919],
20	reaction	NN	O	reaction	dobj	18	SENT_337	[p20l629t2819r980b2898],
21	and	CC	O	and	_	0	SENT_337	[p20l1021t2818r1180b2898],
22	significantly	RB	O	significantly	advmod	23	SENT_337	[p20l1224t2817r1772b2920],
23	reduced	VBD	O	reduce	conj_and	16	SENT_337	[p20l1809t2818r2149b2898],
24	the	DT	O	the	det	25	SENT_337	[p20l10t2947r144b3026],
25	rate	NN	O	rate	dobj	23	SENT_337	[p20l188t2964r349b3026],
26	of	IN	O	of	_	0	SENT_337	[p20l394t2946r495b3027],
27	diagnosis	NN	O	diagnosis	prep_of	25	SENT_337	[p20l521t2947r935b3049],
28	of	IN	O	of	_	0	SENT_337	[p20l981t2946r1082b3027],
29	clinical	JJ	O	clinical	amod	31	SENT_337	[p20l1108t2947r1423b3026],
30	hypersensitivity	NN	O	hypersensitivity	nn	31	SENT_337	[p20l1467t2947r2154b3048],
31	reaction	NN	O	reaction	prep_of	27	SENT_337	[p20l10t3077r366b3155],
32	.	.	O	.	_	0	SENT_337	[p20l10t3077r366b3155],

1	HLA	NN	O	hlum	_	0	SENT_338	[p20l396t3076r918b3155],
2	.	.	O	.	_	0	SENT_338	[p20l396t3076r918b3155],

1	—	NN	O	—	_	0	SENT_339	[p20l396t3076r918b3155],
2	.	.	O	.	_	0	SENT_339	[p20l396t3076r918b3155],

1	B	NN	O	b	nsubj	6	SENT_340	[p20l396t3076r918b3155],
2	*	CD	NUMBER	*	number	3	SENT_340	[p20l396t3076r918b3155],
3	5701	CD	NUMBER	5701	num	4	SENT_340	[p20l396t3076r918b3155],
4	carriage	NN	O	carriage	npadvmod	5	SENT_340	[p20l944t3077r1279b3177],
5	clearly	RB	O	clearly	advmod	6	SENT_340	[p20l1305t3076r1573b3176],
6	demarcated	VBD	O	demarcate	_	0	SENT_340	[p20l1593t3076r2080b3155],
7	a	DT	O	a	det	11	SENT_340	[p20l2105t3102r2150b3154],
8	high	JJ	O	high	amod	11	SENT_340	[p20l10t3204r390b3306],
9	—	NN	O	—	nn	11	SENT_340	[p20l10t3204r390b3306],
10	risk	NN	O	risk	nn	11	SENT_340	[p20l10t3204r390b3306],
11	group	NN	O	group	dobj	6	SENT_340	[p20l415t3230r661b3306],
12	of	IN	O	of	_	0	SENT_340	[p20l694t3203r793b3284],
13	patients	NNS	O	patient	prep_of	11	SENT_340	[p20l803t3205r1155b3305],
14	,	,	O	,	_	0	SENT_340	[p20l803t3205r1155b3305],
15	accounting	VBG	O	account	appos	13	SENT_340	[p20l1190t3205r1656b3306],
16	for	IN	O	for	_	0	SENT_340	[p20l1683t3203r1803b3284],
17	approximately	RB	O	approximately	quantmod	19	SENT_340	[p20l1830t3230r2148b3305, p20l9t3332r329b3432],
18	6	CD	NUMBER	6	number	19	SENT_340	[p20l366t3337r498b3412],
19	°	CD	NUMBER	°	prep_for	15	SENT_340	[p20l366t3337r498b3412],
20	/	:	O	/	punct	21	SENT_340	[p20l366t3337r498b3412],
21	o	NN	O	o	dep	15	SENT_340	[p20l366t3337r498b3412],
22	of	IN	O	of	_	0	SENT_340	[p20l539t3331r639b3411],
23	the	DT	O	the	det	24	SENT_340	[p20l662t3332r796b3410],
24	population	NN	O	population	prep_of	21	SENT_340	[p20l835t3332r1334b3432],
25	,	,	O	,	_	0	SENT_340	[p20l835t3332r1334b3432],
26	from	IN	O	from	_	0	SENT_340	[p20l1380t3331r1592b3411],
27	the	DT	O	the	prep_from	24	SENT_340	[p20l1634t3332r1767b3410],
28	remaining	VBG	O	remain	amod	27	SENT_340	[p20l1808t3333r2148b3410, p20l9t3462r150b3563],
29	94	CD	NUMBER	94	num	30	SENT_340	[p20l178t3466r365b3541],
30	°	CD	NUMBER	°	dep	27	SENT_340	[p20l178t3466r365b3541],
31	/	:	O	/	punct	21	SENT_340	[p20l178t3466r365b3541],
32	o	NN	O	o	dep	15	SENT_340	[p20l178t3466r365b3541],
33	who	WP	O	who	nsubj	34	SENT_340	[p20l391t3461r575b3541],
34	Were	VBD	O	be	rcmod	32	SENT_340	[p20l604t3487r807b3541],
35	at	IN	O	at	_	0	SENT_340	[p20l838t3478r917b3540],
36	low	JJ	O	low	amod	37	SENT_340	[p20l942t3461r1099b3541],
37	risk	NN	O	risk	prep_at	34	SENT_340	[p20l1126t3461r1292b3541],
38	for	IN	O	for	_	0	SENT_340	[p20l1318t3460r1443b3541],
39	a	DT	O	a	det	41	SENT_340	[p20l1470t3488r1515b3540],
40	hypersensitivity	NN	O	hypersensitivity	nn	41	SENT_340	[p20l1544t3461r2148b3562, p20l9t3591r118b3690],
41	reaction	NN	O	reaction	prep_for	37	SENT_340	[p20l148t3591r499b3669],
42	to	TO	O	to	_	0	SENT_340	[p20l534t3607r616b3669],
43	abacavir	NN	O	abacavir	prep_to	34	SENT_340	[p20l652t3590r1029b3669],
44	.	.	O	.	_	0	SENT_340	[p20l652t3590r1029b3669],

1	The	DT	O	the	det	5	SENT_341	[p21l136t22r294b101],
2	double	JJ	O	double	amod	5	SENT_341	[p21l323t22r850b102],
3	—	NN	O	—	nn	5	SENT_341	[p21l323t22r850b102],
4	blind	JJ	O	blind	amod	5	SENT_341	[p21l323t22r850b102],
5	design	NN	O	design	nsubj	12	SENT_341	[p21l879t22r1152b124],
6	of	IN	O	of	_	0	SENT_341	[p21l1180t21r1278b102],
7	the	DT	O	the	det	11	SENT_341	[p21l1288t22r1417b101],
8	PREDICT	NNP	O	PREDICT	nn	11	SENT_341	[p21l1444t28r1901b106],
9	—	NN	O	—	nn	11	SENT_341	[p21l1444t28r1901b106],
10	1	CD	NUMBER	1	num	11	SENT_341	[p21l1444t28r1901b106],
11	study	NN	O	study	prep_of	5	SENT_341	[p21l1931t22r2154b123],
12	meant	VBD	O	mean	_	0	SENT_341	[p21l10t169r284b231],
13	that	IN	O	that	_	0	SENT_341	[p21l314t152r487b230],
14	HLA	NN	O	hlum	prep_that	12	SENT_341	[p21l517t152r1058b231],
15	.	.	O	.	_	0	SENT_341	[p21l517t152r1058b231],

1	—	NN	O	—	_	0	SENT_342	[p21l517t152r1058b231],
2	.	.	O	.	_	0	SENT_342	[p21l517t152r1058b231],

1	B	NN	O	b	nsubjpass	8	SENT_343	[p21l517t152r1058b231],
2	*	CD	NUMBER	*	num	1	SENT_343	[p21l517t152r1058b231],
3	5701	CD	NUMBER	5701	num	4	SENT_343	[p21l517t152r1058b231],
4	status	NN	O	status	dep	1	SENT_343	[p21l1095t169r1348b231],
5	could	MD	O	could	aux	8	SENT_343	[p21l1386t152r1622b231],
6	not	RB	O	not	neg	8	SENT_343	[p21l1656t169r1800b231],
7	be	VB	O	be	auxpass	8	SENT_343	[p21l1830t152r1928b231],
8	considered	VBN	O	consider	_	0	SENT_343	[p21l1963t178r2148b231, p21l11t280r318b359],
9	in	IN	O	in	_	0	SENT_343	[p21l352t281r435b358],
10	evaluating	VBG	O	evaluate	prepc_in	8	SENT_343	[p21l470t280r919b381],
11	the	DT	O	the	det	12	SENT_343	[p21l950t280r1084b358],
12	symptoms	NNS	O	symptom	dobj	10	SENT_343	[p21l1119t297r1565b380],
13	that	WDT	O	that	nsubj	14	SENT_343	[p21l1601t280r1775b358],
14	resulted	VBD	O	result	rcmod	12	SENT_343	[p21l1803t280r2149b359],
15	in	IN	O	in	_	0	SENT_343	[p21l9t409r93b486],
16	a	DT	O	a	det	17	SENT_343	[p21l136t435r181b487],
17	diagnosis	NN	O	diagnosis	prep_in	14	SENT_343	[p21l224t408r638b510],
18	of	IN	O	of	_	0	SENT_343	[p21l685t407r785b488],
19	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_343	[p21l811t408r1497b509],
20	reaction	NN	O	reaction	prep_of	17	SENT_343	[p21l1536t409r1911b488],
21	.	.	O	.	_	0	SENT_343	[p21l1536t409r1911b488],

1	This	DT	O	this	nsubj	2	SENT_344	[p21l1957t408r2146b487],
2	strengthens	VBZ	O	strengthen	_	0	SENT_344	[p21l9t539r510b640],
3	our	PRP$	O	we	poss	4	SENT_344	[p21l549t564r694b619],
4	findings	NNS	O	finding	dobj	2	SENT_344	[p21l726t538r1110b640],
5	,	,	O	,	_	0	SENT_344	[p21l726t538r1110b640],
6	by	IN	O	by	_	0	SENT_344	[p21l1153t539r1249b640],
7	ensuring	VBG	O	ensure	prepc_by	2	SENT_344	[p21l1281t539r1660b640],
8	that	IN	O	that	complm	16	SENT_344	[p21l1692t539r1863b618],
9	equivalent	JJ	O	equivalent	amod	11	SENT_344	[p21l1894t539r2148b640, p21l6t669r212b748],
10	clinical	JJ	O	clinical	amod	11	SENT_344	[p21l240t669r541b748],
11	vigilance	NN	O	vigilance	nsubjpass	16	SENT_344	[p21l570t669r943b770],
12	and	CC	O	and	_	0	SENT_344	[p21l976t669r1131b748],
13	diagnostic	JJ	O	diagnostic	amod	14	SENT_344	[p21l1164t669r1599b770],
14	criteria	NNS	O	criterion	conj_and	11	SENT_344	[p21l1632t669r1924b748],
15	were	VBD	O	be	auxpass	16	SENT_344	[p21l1951t695r2148b749],
16	used	VBN	O	use	ccomp	7	SENT_344	[p21l7t799r205b879],
17	in	IN	O	in	_	0	SENT_344	[p21l252t799r336b877],
18	the	DT	O	the	det	19	SENT_344	[p21l383t799r518b878],
19	assessment	NN	O	assessment	prep_in	16	SENT_344	[p21l564t815r1059b878],
20	of	IN	O	of	_	0	SENT_344	[p21l1102t798r1203b878],
21	the	DT	O	the	det	22	SENT_344	[p21l1232t799r1365b878],
22	patients	NNS	O	patient	prep_of	19	SENT_344	[p21l1412t799r1756b900],
23	who	WP	O	who	nsubj	24	SENT_344	[p21l1801t799r1986b879],
24	received	VBD	O	receive	rcmod	22	SENT_344	[p21l2034t825r2148b878, p21l8t929r270b1009],
25	abacavir	NN	O	abacavir	dobj	24	SENT_344	[p21l331t929r691b1009],
26	in	IN	O	in	_	0	SENT_344	[p21l749t929r834b1007],
27	both	DT	O	both	det	28	SENT_344	[p21l896t928r1096b1008],
28	groups	NNS	O	group	prep_in	24	SENT_344	[p21l1158t954r1481b1030],
29	.	.	O	.	_	0	SENT_344	[p21l1158t954r1481b1030],

1	However	RB	O	however	advmod	9	SENT_345	[p21l1548t936r1946b1025],
2	,	,	O	,	_	0	SENT_345	[p21l1548t936r1946b1025],
3	the	DT	O	the	det	7	SENT_345	[p21l2015t929r2148b1008],
4	double	JJ	O	double	amod	7	SENT_345	[p21l8t1058r548b1139],
5	—	NN	O	—	nn	7	SENT_345	[p21l8t1058r548b1139],
6	blind	JJ	O	blind	amod	7	SENT_345	[p21l8t1058r548b1139],
7	design	NN	O	design	nsubj	9	SENT_345	[p21l580t1058r859b1160],
8	also	RB	O	also	advmod	9	SENT_345	[p21l890t1059r1059b1138],
9	means	VBZ	O	mean	_	0	SENT_345	[p21l1093t1084r1370b1138],
10	that	IN	O	that	complm	14	SENT_345	[p21l1404t1059r1575b1138],
11	we	PRP	O	we	nsubj	14	SENT_345	[p21l1598t1085r1715b1139],
12	could	MD	O	could	aux	14	SENT_345	[p21l1748t1058r1980b1139],
13	not	RB	O	not	neg	14	SENT_345	[p21l2012t1075r2154b1138],
14	address	VB	O	address	ccomp	9	SENT_345	[p21l6t1188r333b1268],
15	the	DT	O	the	det	17	SENT_345	[p21l399t1189r532b1268],
16	potential	JJ	O	potential	amod	17	SENT_345	[p21l594t1189r985b1290],
17	benefits	NNS	O	benefit	dobj	14	SENT_345	[p21l1049t1188r1396b1268],
18	of	IN	O	of	_	0	SENT_345	[p21l1461t1188r1562b1268],
19	HLA	NN	O	hlum	prep_of	17	SENT_345	[p21l1606t1189r2148b1268],
20	.	.	O	.	_	0	SENT_345	[p21l1606t1189r2148b1268],

1	—	NN	O	—	_	0	SENT_346	[p21l1606t1189r2148b1268],
2	.	.	O	.	_	0	SENT_346	[p21l1606t1189r2148b1268],

1	B	NN	O	b	_	0	SENT_347	[p21l1606t1189r2148b1268],
2	*	CD	NUMBER	*	number	3	SENT_347	[p21l1606t1189r2148b1268],
3	5701	CD	NUMBER	5701	num	4	SENT_347	[p21l1606t1189r2148b1268],
4	screening	NN	O	screening	dep	1	SENT_347	[p21l9t1319r431b1420],
5	observed	VBN	O	observe	partmod	1	SENT_347	[p21l467t1319r851b1399],
6	in	IN	O	in	_	0	SENT_347	[p21l889t1319r973b1397],
7	open	JJ	O	open	amod	10	SENT_347	[p21l1013t1319r1684b1420],
8	—	NN	O	—	nn	10	SENT_347	[p21l1013t1319r1684b1420],
9	screening	NN	O	screening	nn	10	SENT_347	[p21l1013t1319r1684b1420],
10	studies	NNS	O	study	prep_in	5	SENT_347	[p21l1722t1319r2024b1399],
11	in	IN	O	in	_	0	SENT_347	[p21l2064t1319r2149b1397],
12	the	DT	O	the	det	13	SENT_347	[p21l7t1448r142b1526],
13	clinic	NN	O	clinic	prep_in	10	SENT_347	[p21l180t1448r438b1543],
14	,	,	O	,	_	0	SENT_347	[p21l180t1448r438b1543],
15	such	JJ	O	such	_	0	SENT_347	[p21l484t1448r679b1527],
16	as	IN	O	as	_	0	SENT_347	[p21l717t1474r803b1526],
17	a	DT	O	a	det	18	SENT_347	[p21l843t1474r888b1526],
18	decrease	NN	O	decrease	prep_such_as	10	SENT_347	[p21l925t1447r1294b1526],
19	in	IN	O	in	_	0	SENT_347	[p21l1332t1448r1416b1525],
20	the	DT	O	the	det	21	SENT_347	[p21l1455t1448r1589b1526],
21	rate	NN	O	rate	prep_in	18	SENT_347	[p21l1628t1464r1788b1526],
22	of	IN	O	of	_	0	SENT_347	[p21l1828t1447r1929b1526],
23	false	JJ	O	false	amod	26	SENT_347	[p21l1948t1447r2149b1526],
24	positive	JJ	O	positive	amod	26	SENT_347	[p21l6t1578r332b1679],
25	clinical	JJ	O	clinical	amod	26	SENT_347	[p21l377t1578r686b1657],
26	diagnoses	NNS	O	diagnosis	prep_of	21	SENT_347	[p21l729t1578r1154b1679],
27	of	IN	O	of	_	0	SENT_347	[p21l1201t1577r1300b1657],
28	hypersensitivity	NN	O	hypersensitivity	nn	29	SENT_347	[p21l1326t1578r1997b1679],
29	reaction	NN	O	reaction	prep_of	26	SENT_347	[p21l2035t1604r2148b1657, p21l6t1708r267b1787],
30	in	IN	O	in	_	0	SENT_347	[p21l328t1708r412b1786],
31	patients	NNS	O	patient	prep_in	5	SENT_347	[p21l474t1708r819b1809],
32	known	VBN	O	know	partmod	31	SENT_347	[p21l884t1708r1184b1788],
33	to	TO	O	to	aux	35	SENT_347	[p21l1248t1724r1330b1787],
34	be	VB	O	be	cop	35	SENT_347	[p21l1396t1708r1493b1787],
35	HLA	NN	O	hlum	xcomp	32	SENT_347	[p21l1556t1708r2152b1787],
36	.	.	O	.	_	0	SENT_347	[p21l1556t1708r2152b1787],

1	—	NN	O	—	_	0	SENT_348	[p21l1556t1708r2152b1787],
2	.	.	O	.	_	0	SENT_348	[p21l1556t1708r2152b1787],

1	B	NN	O	b	_	0	SENT_349	[p21l1556t1708r2152b1787],
2	*	CD	NUMBER	*	number	3	SENT_349	[p21l1556t1708r2152b1787],
3	5701	CD	NUMBER	5701	dep	1	SENT_349	[p21l1556t1708r2152b1787],
4	negative	JJ	O	negative	quantmod	3	SENT_349	[p21l7t1838r562b1938],
5	.13	CD	NUMBER	.13	num	6	SENT_349	[p21l7t1838r562b1938],
6	'15	CD	NUMBER	'15	dep	3	SENT_349	[p21l7t1838r562b1938],

1	The	DT	O	the	det	4	SENT_350	[p21l134t1967r296b2046],
2	3.4	CD	PERCENT	3.4	num	4	SENT_350	[p21l344t1972r555b2046],
3	%	NN	PERCENT	%	nn	4	SENT_350	[p21l344t1972r555b2046],
4	rate	NN	O	rate	nsubj	22	SENT_350	[p21l601t1983r763b2046],
5	of	IN	O	of	_	0	SENT_350	[p21l810t1966r911b2046],
6	clinically	RB	O	clinically	amod	20	SENT_350	[p21l941t1966r1335b2068],
7	diagnosed	VBN	O	diagnose	dep	6	SENT_350	[p21l1379t1967r1827b2068],
8	hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_350	[p21l1874t1967r2148b2068, p21l8t2097r436b2198],
9	reaction	NN	O	reaction	dobj	7	SENT_350	[p21l468t2097r812b2176],
10	that	WDT	O	that	nsubjpass	14	SENT_350	[p21l850t2096r1020b2176],
11	was	VBD	O	be	auxpass	14	SENT_350	[p21l1049t2123r1210b2177],
12	not	RB	O	not	neg	14	SENT_350	[p21l1250t2113r1392b2176],
13	immunologically	RB	O	immunologically	advmod	14	SENT_350	[p21l1424t2096r2154b2198],
14	confirmed	VBN	O	confirm	rcmod	9	SENT_350	[p21l8t2226r466b2306],
15	in	IN	O	in	_	0	SENT_350	[p21l502t2227r587b2305],
16	the	DT	O	the	det	19	SENT_350	[p21l625t2226r759b2306],
17	prospective	JJ	O	prospective	amod	19	SENT_350	[p21l796t2227r1753b2328],
18	—	NN	O	—	nn	19	SENT_350	[p21l796t2227r1753b2328],
19	screening	NN	O	screening	prep_in	14	SENT_350	[p21l796t2227r1753b2328],
20	group	NN	O	group	prep_of	4	SENT_350	[p21l1787t2252r2042b2328],
21	is	VBZ	O	be	cop	22	SENT_350	[p21l2081t2227r2146b2306],
22	similar	JJ	O	similar	_	0	SENT_350	[p21l8t2357r317b2436],
23	to	TO	O	to	_	0	SENT_350	[p21l357t2373r440b2436],
24	the	DT	O	the	det	27	SENT_350	[p21l484t2357r617b2436],
25	false	JJ	O	false	amod	27	SENT_350	[p21l660t2356r860b2436],
26	positive	JJ	O	positive	amod	27	SENT_350	[p21l901t2357r1235b2458],
27	rates	NNS	O	rate	prep_to	22	SENT_350	[p21l1278t2373r1482b2436],
28	of	IN	O	of	_	0	SENT_350	[p21l1528t2356r1628b2436],
29	hypersensitivity	NN	O	hypersensitivity	nn	31	SENT_350	[p21l1651t2357r2148b2458, p21l7t2487r215b2587],
30	reaction	NN	O	reaction	nn	31	SENT_350	[p21l243t2487r579b2565],
31	(	NN	O	(	prep_of	27	SENT_350	[p21l616t2492r691b2578],
32	2	CD	NUMBER	2	number	35	SENT_350	[p21l616t2492r691b2578],
33	to	TO	O	to	dep	35	SENT_350	[p21l724t2503r804b2565],
34	7	CD	NUMBER	7	number	35	SENT_350	[p21l839t2492r993b2578],
35	°	CD	NUMBER	°	attr	22	SENT_350	[p21l839t2492r993b2578],
36	/	:	O	/	punct	38	SENT_350	[p21l839t2492r993b2578],
37	o	NN	O	o	nn	38	SENT_350	[p21l839t2492r993b2578],
38	)	NN	O	)	dep	35	SENT_350	[p21l839t2492r993b2578],
39	among	IN	O	among	_	0	SENT_350	[p21l1029t2512r1324b2587],
40	patients	NNS	O	patient	prep_among	35	SENT_350	[p21l1351t2487r1681b2587],
41	not	RB	O	not	neg	42	SENT_350	[p21l1715t2503r1855b2565],
42	receiving	VBG	O	receive	dep	40	SENT_350	[p21l1882t2487r2148b2566, p21l6t2616r143b2717],
43	abacavir	NN	O	abacavir	nsubj	57	SENT_350	[p21l180t2615r547b2696],
44	in	IN	O	in	_	0	SENT_350	[p21l590t2616r675b2694],
45	double	JJ	O	double	amod	50	SENT_350	[p21l723t2615r1287b2696],
46	—	JJ	O	—	amod	50	SENT_350	[p21l723t2615r1287b2696],
47	blind	JJ	O	blind	amod	50	SENT_350	[p21l723t2615r1287b2696],
48	comparative	JJ	O	comparative	amod	50	SENT_350	[p21l1335t2616r2148b2717],
49	—	NN	O	—	nn	50	SENT_350	[p21l1335t2616r2148b2717],
50	treat	NN	O	treat	prep_in	43	SENT_350	[p21l1335t2616r2148b2717],
51	—	CD	NUMBER	—	num	53	SENT_350	[p21l1335t2616r2148b2717],
52	ment	NN	O	ment	nn	53	SENT_350	[p21l7t2762r233b2824],
53	studies	NNS	O	study	dep	43	SENT_350	[p21l289t2746r837b2825],
54	.4	CD	NUMBER	.4	dep	53	SENT_350	[p21l289t2746r837b2825],
55	'	''	O	'	_	0	SENT_350	[p21l289t2746r837b2825],
56	6	CD	NUMBER	6	npadvmod	57	SENT_350	[p21l289t2746r837b2825],
57	>	JJR	O	>	xcomp	42	SENT_350	[p21l289t2746r837b2825],
58	21	CD	NUMBER	21	tmod	42	SENT_350	[p21l289t2746r837b2825],
59	Moreover	RB	O	moreover	advmod	58	SENT_350	[p21l893t2752r1330b2841],
60	,	,	O	,	_	0	SENT_350	[p21l893t2752r1330b2841],
61	the	DT	O	the	det	63	SENT_350	[p21l1395t2746r1532b2824],
62	concomitant	JJ	O	concomitant	amod	63	SENT_350	[p21l1592t2746r2154b2824],
63	use	NN	O	use	attr	22	SENT_350	[p21l7t2901r151b2955],
64	of	IN	O	of	_	0	SENT_350	[p21l202t2874r304b2954],
65	a	DT	O	a	det	67	SENT_350	[p21l336t2901r381b2954],
66	protease	NN	O	protease	nn	67	SENT_350	[p21l429t2891r803b2976],
67	inhibitor	NN	O	inhibitor	prep_of	63	SENT_350	[p21l853t2875r1248b2954],
68	and	CC	O	and	_	0	SENT_350	[p21l1296t2875r1457b2954],
69	initiation	NN	O	initiation	attr	22	SENT_350	[p21l1507t2875r1920b2954],
70	of	IN	O	of	_	0	SENT_350	[p21l1972t2874r2074b2954],
71	a	DT	O	a	prep_of	69	SENT_350	[p21l2106t2901r2150b2954],

1	576	CD	NUMBER	576	num	4	SENT_351	[p21l149t3051r205b3075],
2	N	NN	O	n	nn	4	SENT_351	[p21l908t3062r921b3077],
3	ENGLJ	NN	O	englj	nn	4	SENT_351	[p21l936t3062r1014b3084],
4	MED	NN	O	med	_	0	SENT_351	[p21l1029t3062r1081b3077],
5	358	CD	NUMBER	358	dep	4	SENT_351	[p21l1091t3056r1154b3084],
6	;	:	O	;	_	0	SENT_351	[p21l1091t3056r1154b3084],
7	6	CD	NUMBER	6	num	8	SENT_351	[p21l1091t3056r1154b3084],
8	WWW	NN	O	www	dep	4	SENT_351	[p21l1188t3062r1295b3078],
9	.	.	O	.	_	0	SENT_351	[p21l1188t3062r1295b3078],

1	NE	NN	O	ne	nn	3	SENT_352	[p21l1188t3062r1295b3078],
2	M.ORG	NN	O	m.org	nn	3	SENT_352	[p21l1309t3062r1389b3078],
3	FEBRUARY	NN	DATE	february	_	0	SENT_352	[p21l1426t3062r1547b3078],
4	7	CD	DATE	7	dep	3	SENT_352	[p21l1557t3062r1576b3083],
5	,	,	DATE	,	_	0	SENT_352	[p21l1557t3062r1576b3083],
6	2008	CD	DATE	2008	appos	4	SENT_352	[p21l1587t3056r1650b3078],

1	The	DT	O	the	det	5	SENT_353	[p21l935t3095r986b3119],
2	New	NNP	O	New	nn	5	SENT_353	[p21l995t3096r1057b3119],
3	England	NNP	O	England	nn	5	SENT_353	[p21l1066t3095r1177b3126],
4	Jouma	NNP	PERSON	Jouma	nn	5	SENT_353	[p21l1186t3096r1275b3119],
5	o	NN	O	o	_	0	SENT_353	[p21l1293t3103r1308b3119],
6	Medicine	NN	O	medicine	dep	5	SENT_353	[p21l1329t3095r1454b3119],

1	HLA-B	NN	O	hla-b	_	0	SENT_354	[p21l584t3283r779b3306],
2	*	CD	NUMBER	*	number	3	SENT_354	[p21l584t3283r779b3306],
3	5701	CD	NUMBER	5701	num	4	SENT_354	[p21l584t3283r779b3306],
4	SCREENING	NNP	O	SCREENING	dep	1	SENT_354	[p21l793t3286r989b3305],
5	FOR	IN	O	for	_	0	SENT_354	[p21l1004t3286r1068b3305],
6	ABACAVIR	NNP	O	ABACAVIR	nn	7	SENT_354	[p21l1079t3286r1244b3305],
7	HYPERSENSITIVITY	NN	O	hypersensitivity	prep_for	4	SENT_354	[p21l1257t3286r1576b3305],

1	new	JJ	O	new	amod	4	SENT_355	[p21l10t3526r190b3579],
2	nonnucleoside	JJ	O	nonnucleoside	amod	4	SENT_355	[p21l222t3500r858b3579],
3	reverse-transcriptase	NN	O	reverse-transcriptase	nn	4	SENT_355	[p21l893t3501r1814b3599],
4	inhibitor	NN	O	inhibitor	nsubj	9	SENT_355	[p21l1847t3500r2134b3578, p21l11t3645r133b3707],
5	were	VBD	O	be	cop	9	SENT_355	[p21l167t3654r369b3707],
6	the	DT	O	the	det	9	SENT_355	[p21l410t3628r544b3706],
7	only	JJ	O	only	amod	9	SENT_355	[p21l586t3628r770b3728],
8	significant	JJ	O	significant	amod	9	SENT_355	[p21l808t3627r1277b3729],
9	predictors	NNS	O	predictor	_	0	SENT_355	[p21l1312t3628r1747b3728],
10	of	IN	O	of	prep	9	SENT_355	[p21l1791t3627r1891b3707],
11	clinically	RB	O	clinically	pobj	10	SENT_355	[p21l1914t3628r2134b3706, p22l11t20r209b120],

1	diagnosed	VBN	O	diagnose	dep	7	SENT_356	[p22l264t20r709b121],
2	but	CC	O	but	_	0	SENT_356	[p22l768t20r908b99],
3	not	RB	O	not	conj_but	1	SENT_356	[p22l961t37r1104b99],
4	immunologically	RB	O	immunologically	advmod	5	SENT_356	[p22l1157t20r1896b121],
5	con	JJ	O	con	conj_but	1	SENT_356	[p22l1950t46r2134b99],
6	—	CD	NUMBER	—	nsubj	7	SENT_356	[p22l1950t46r2134b99],
7	firmed	VBD	O	firm	_	0	SENT_356	[p22l10t146r306b226],
8	hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_356	[p22l375t147r1058b247],
9	reaction	NN	O	reaction	nsubj	16	SENT_356	[p22l1122t148r1471b226],
10	in	IN	O	in	_	0	SENT_356	[p22l1541t148r1625b225],
11	our	PRP$	O	we	poss	12	SENT_356	[p22l1695t173r1841b227],
12	study	NN	O	study	prep_in	9	SENT_356	[p22l1910t147r2140b247],
13	(	CD	NUMBER	(	num	16	SENT_356	[p22l15t276r263b366],
14	Table	NNP	O	Table	nn	16	SENT_356	[p22l15t276r263b366],
15	3	CD	NUMBER	3	num	16	SENT_356	[p22l294t282r387b366],
16	)	NN	O	)	xcomp	7	SENT_356	[p22l294t282r387b366],
17	.	.	O	.	_	0	SENT_356	[p22l294t282r387b366],

1	This	DT	O	this	det	2	SENT_357	[p22l420t276r602b353],
2	result	NN	O	result	nsubj	3	SENT_357	[p22l635t276r868b355],
3	indicates	VBZ	O	indicate	_	0	SENT_357	[p22l892t276r1259b354],
4	that	IN	O	that	complm	53	SENT_357	[p22l1292t276r1458b354],
5	symptoms	NNS	O	symptom	nsubj	53	SENT_357	[p22l1485t293r1914b375],
6	such	JJ	O	such	_	0	SENT_357	[p22l1947t276r2135b355],
7	as	IN	O	as	_	0	SENT_357	[p22l10t429r95b481],
8	rash	NN	O	rash	prep_such_as	5	SENT_357	[p22l143t403r325b481],
9	associated	VBN	O	associate	partmod	8	SENT_357	[p22l371t403r816b482],
10	with	IN	O	with	_	0	SENT_357	[p22l858t403r1054b483],
11	efavirenz	NN	O	efavirenz	prep_with	9	SENT_357	[p22l1100t402r1596b499],
12	,	,	O	,	_	0	SENT_357	[p22l1100t402r1596b499],
13	”	NN	O	”	nn	15	SENT_357	[p22l1100t402r1596b499],
14	hypersensitivity	NN	O	hypersensitivity	nn	15	SENT_357	[p22l1642t403r2134b503, p22l11t532r222b631],
15	reaction	NN	O	reaction	prep_such_as	5	SENT_357	[p22l251t532r592b610],
16	(	CD	NUMBER	(	num	17	SENT_357	[p22l631t530r874b627],
17	fever	NN	O	fever	dep	15	SENT_357	[p22l631t530r874b627],
18	,	,	O	,	_	0	SENT_357	[p22l631t530r874b627],
19	rash	NN	O	rash	prep_such_as	5	SENT_357	[p22l914t531r1116b627],
20	,	,	O	,	_	0	SENT_357	[p22l914t531r1116b627],
21	or	CC	O	or	_	0	SENT_357	[p22l1155t557r1243b610],
22	hepatitis	NN	O	hepatitis	nn	23	SENT_357	[p22l1273t531r1661b631],
23	)	NN	O	)	conj_or	8	SENT_357	[p22l1273t531r1661b631],
24	associated	VBN	O	associate	partmod	23	SENT_357	[p22l1699t531r2135b610],
25	with	IN	O	with	_	0	SENT_357	[p22l6t660r201b739],
26	nevirapine	NN	O	nevirapine	prep_with	24	SENT_357	[p22l242t661r794b760],
27	,23	CD	NUMBER	,23	num	26	SENT_357	[p22l242t661r794b760],
28	or	CC	O	or	_	0	SENT_357	[p22l838t686r927b739],
29	gastrointestinal	JJ	O	gastrointestinal	amod	30	SENT_357	[p22l964t660r1648b761],
30	symptoms	NNS	O	symptom	conj_or	26	SENT_357	[p22l1690t677r2134b760],
31	associated	VBN	O	associate	partmod	30	SENT_357	[p22l10t788r455b866],
32	with	IN	O	with	_	0	SENT_357	[p22l498t788r694b867],
33	an	DT	O	a	det	36	SENT_357	[p22l741t814r845b866],
34	HIV	NN	MISC	hiv	nn	36	SENT_357	[p22l892t795r1067b866],
35	protease	NN	O	protease	nn	36	SENT_357	[p22l1110t804r1474b887],
36	inhibitor	NN	O	inhibitor	prep_with	31	SENT_357	[p22l1521t788r1905b866],
37	con	NN	O	con	dep	30	SENT_357	[p22l1951t814r2134b866],
38	—	CD	NUMBER	—	num	37	SENT_357	[p22l1951t814r2134b866],
39	tributed	VBN	O	tribute	partmod	37	SENT_357	[p22l11t916r346b995],
40	to	TO	O	to	_	0	SENT_357	[p22l386t933r466b995],
41	diagnoses	NNS	O	diagnosis	prep_to	39	SENT_357	[p22l508t916r930b1017],
42	of	IN	O	of	_	0	SENT_357	[p22l973t915r1072b995],
43	hypersensitivity	NN	O	hypersensitivity	nn	44	SENT_357	[p22l1093t916r1759b1016],
44	reaction	NN	O	reaction	prep_of	41	SENT_357	[p22l1794t917r2135b995],
45	to	TO	O	to	_	0	SENT_357	[p22l11t1061r92b1123],
46	abacavir	NN	O	abacavir	prep_to	39	SENT_357	[p22l137t1044r494b1123],
47	that	WDT	O	that	nsubj	52	SENT_357	[p22l536t1044r709b1122],
48	were	VBD	O	be	cop	52	SENT_357	[p22l743t1070r945b1123],
49	not	RB	O	not	neg	52	SENT_357	[p22l989t1061r1133b1123],
50	immunologically	RB	O	immunologically	advmod	52	SENT_357	[p22l1171t1044r1910b1145],
51	con	JJ	O	con	amod	52	SENT_357	[p22l1950t1070r2134b1123],
52	—	CD	NUMBER	—	rcmod	46	SENT_357	[p22l1950t1070r2134b1123],
53	firmed	VBD	O	firm	ccomp	3	SENT_357	[p22l10t1171r329b1251],
54	.	.	O	.	_	0	SENT_357	[p22l10t1171r329b1251],

1	Although	IN	O	although	mark	12	SENT_358	[p22l135t1300r544b1401],
2	a	DT	O	a	det	4	SENT_358	[p22l609t1326r653b1378],
3	positive	JJ	O	positive	amod	4	SENT_358	[p22l716t1301r1048b1400],
4	result	NN	O	result	nsubj	12	SENT_358	[p22l1114t1300r1358b1379],
5	of	IN	O	of	_	0	SENT_358	[p22l1419t1299r1519b1379],
6	epicutaneous	JJ	O	epicutaneous	amod	8	SENT_358	[p22l1568t1301r2133b1400],
7	patch	NN	O	patch	nn	8	SENT_358	[p22l9t1428r245b1528],
8	testing	NN	O	testing	prep_of	4	SENT_358	[p22l291t1429r590b1529],
9	in	IN	O	in	_	0	SENT_358	[p22l631t1429r715b1506],
10	our	PRP$	O	we	poss	11	SENT_358	[p22l762t1454r908b1507],
11	study	NN	O	study	prep_in	8	SENT_358	[p22l953t1428r1183b1528],
12	indicates	VBZ	O	indicate	advcl	26	SENT_358	[p22l1223t1428r1608b1507],
13	a	DT	O	a	det	19	SENT_358	[p22l1655t1454r1700b1506],
14	true	JJ	O	true	amod	19	SENT_358	[p22l1745t1445r1939b1524],
15	,	,	O	,	_	0	SENT_358	[p22l1745t1445r1939b1524],
16	immunologically	RB	O	immunologically	advmod	17	SENT_358	[p22l1990t1429r2134b1506, p22l10t1556r616b1657],
17	mediated	VBN	O	mediate	dep	19	SENT_358	[p22l654t1556r1046b1635],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_358	[p22l1089t1556r1755b1656],
19	reaction	NN	O	reaction	dobj	12	SENT_358	[p22l1794t1557r2135b1635],
20	to	TO	O	to	_	0	SENT_358	[p22l11t1701r92b1763],
21	abacavir	NN	O	abacavir	prep_to	12	SENT_358	[p22l127t1684r502b1780],
22	,	,	O	,	_	0	SENT_358	[p22l127t1684r502b1780],
23	a	DT	O	a	det	25	SENT_358	[p22l541t1710r585b1762],
24	negative	JJ	O	negative	amod	25	SENT_358	[p22l618t1685r971b1785],
25	result	NN	O	result	nsubj	26	SENT_358	[p22l1006t1684r1250b1763],
26	can	MD	O	can	_	0	SENT_358	[p22l1280t1710r1429b1762],
27	neither	CC	O	neither	dep	26	SENT_358	[p22l1463t1684r1768b1762],
28	rule	VB	O	rule	conj	26	SENT_358	[p22l1800t1684r1966b1763],
29	out	RP	O	out	prt	28	SENT_358	[p22l2002t1701r2140b1763],
30	this	DT	O	this	det	31	SENT_358	[p22l11t1812r170b1890],
31	diagnosis	NN	O	diagnosis	dobj	28	SENT_358	[p22l211t1812r622b1913],
32	nor	CC	O	nor	_	0	SENT_358	[p22l662t1838r809b1891],
33	be	VB	O	be	auxpass	34	SENT_358	[p22l844t1812r941b1891],
34	used	VBN	O	use	conj_nor	31	SENT_358	[p22l979t1812r1176b1891],
35	to	TO	O	to	aux	36	SENT_358	[p22l1214t1829r1296b1891],
36	justify	VB	O	justify	xcomp	34	SENT_358	[p22l1321t1811r1605b1912],
37	rechallenge	NN	O	rechallenge	dobj	36	SENT_358	[p22l1639t1812r2135b1913],
38	with	IN	O	with	_	0	SENT_358	[p22l6t1939r198b2019],
39	abacavir	NN	O	abacavir	prep_with	36	SENT_358	[p22l233t1939r599b2019],
40	.	.	O	.	_	0	SENT_358	[p22l233t1939r599b2019],

1	The	DT	O	the	det	2	SENT_359	[p22l636t1939r796b2017],
2	fact	NN	O	fact	_	0	SENT_359	[p22l832t1938r988b2017],
3	that	IN	O	that	_	0	SENT_359	[p22l1019t1939r1188b2017],
4	six	CD	NUMBER	six	num	5	SENT_359	[p22l1220t1940r1336b2017],
5	HLA	NN	O	hlum	prep_that	2	SENT_359	[p22l1368t1939r2134b2039],
6	.	.	O	.	_	0	SENT_359	[p22l1368t1939r2134b2039],

1	—	NN	O	—	_	0	SENT_360	[p22l1368t1939r2134b2039],
2	.	.	O	.	_	0	SENT_360	[p22l1368t1939r2134b2039],

1	B	NN	O	b	_	0	SENT_361	[p22l1368t1939r2134b2039],
2	*	CD	NUMBER	*	number	3	SENT_361	[p22l1368t1939r2134b2039],
3	5701	CD	NUMBER	5701	num	1	SENT_361	[p22l1368t1939r2134b2039],
4	.	.	O	.	_	0	SENT_361	[p22l1368t1939r2134b2039],

1	—	NN	O	—	_	0	SENT_362	[p22l1368t1939r2134b2039],
2	.	.	O	.	_	0	SENT_362	[p22l1368t1939r2134b2039],

1	pos	NN	O	po	nn	3	SENT_363	[p22l1368t1939r2134b2039],
2	itive	JJ	O	itive	amod	3	SENT_363	[p22l10t2069r185b2147],
3	patients	NNS	O	patient	nsubj	6	SENT_363	[p22l223t2069r564b2168],
4	had	VBD	O	have	aux	6	SENT_363	[p22l606t2068r763b2147],
5	clinically	RB	O	clinically	advmod	6	SENT_363	[p22l803t2068r1195b2168],
6	diagnosed	VBN	O	diagnose	_	0	SENT_363	[p22l1230t2068r1674b2169],
7	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_363	[p22l1714t2068r2134b2168, p22l11t2197r290b2296],
8	reaction	NN	O	reaction	dobj	6	SENT_363	[p22l320t2197r661b2275],
9	to	TO	O	to	_	0	SENT_363	[p22l696t2213r776b2275],
10	abacavir	NN	O	abacavir	prep_to	6	SENT_363	[p22l811t2196r1160b2275],
11	but	CC	O	but	_	0	SENT_363	[p22l1192t2196r1330b2275],
12	negative	JJ	O	negative	amod	13	SENT_363	[p22l1359t2197r1705b2297],
13	results	NNS	O	result	nsubj	21	SENT_363	[p22l1739t2196r2016b2275],
14	of	IN	O	of	_	0	SENT_363	[p22l2053t2195r2153b2275],
15	epicutaneous	JJ	O	epicutaneous	amod	17	SENT_363	[p22l11t2325r576b2423],
16	patch	NN	O	patch	nn	17	SENT_363	[p22l612t2324r848b2423],
17	tests	NNS	O	test	prep_of	13	SENT_363	[p22l884t2340r1078b2402],
18	may	MD	O	may	aux	21	SENT_363	[p22l1116t2350r1295b2423],
19	have	VB	O	have	aux	21	SENT_363	[p22l1326t2324r1516b2403],
20	been	VBN	O	be	cop	21	SENT_363	[p22l1552t2324r1754b2402],
21	due	JJ	O	due	conj_but	6	SENT_363	[p22l1790t2324r1939b2403],
22	to	TO	O	to	_	0	SENT_363	[p22l1975t2341r2056b2402],
23	a	DT	O	a	det	27	SENT_363	[p22l2092t2350r2137b2402],
24	false	JJ	O	false	amod	27	SENT_363	[p22l10t2451r209b2531],
25	positive	JJ	O	positive	amod	27	SENT_363	[p22l245t2453r576b2552],
26	clinical	JJ	O	clinical	amod	27	SENT_363	[p22l614t2452r927b2530],
27	diagnosis	NN	O	diagnosis	prep_to	21	SENT_363	[p22l965t2452r1377b2553],
28	of	IN	O	of	_	0	SENT_363	[p22l1416t2451r1516b2531],
29	hypersensitivity	NN	O	hypersensitivity	nn	30	SENT_363	[p22l1534t2452r2134b2552, p22l10t2581r113b2680],
30	reaction	NN	O	reaction	prep_of	27	SENT_363	[p22l144t2581r478b2659],
31	or	CC	O	or	_	0	SENT_363	[p22l515t2606r602b2659],
32	a	DT	O	a	det	35	SENT_363	[p22l634t2606r678b2658],
33	false	JJ	O	false	amod	35	SENT_363	[p22l712t2579r902b2659],
34	negative	JJ	O	negative	amod	35	SENT_363	[p22l939t2581r1277b2681],
35	result	NN	O	result	conj_or	27	SENT_363	[p22l1313t2580r1546b2659],
36	of	IN	O	of	_	0	SENT_363	[p22l1578t2579r1675b2659],
37	patch	NN	O	patch	nn	38	SENT_363	[p22l1692t2580r1919b2680],
38	testing	NN	O	testing	prep_of	35	SENT_363	[p22l1955t2597r2134b2658, p22l10t2709r150b2809],
39	from	IN	O	from	_	0	SENT_363	[p22l186t2707r396b2787],
40	either	CC	O	either	preconj	42	SENT_363	[p22l437t2708r684b2786],
41	operator	NN	O	operator	nn	42	SENT_363	[p22l722t2725r1087b2808],
42	error	NN	O	error	prep_from	21	SENT_363	[p22l1125t2734r1337b2787],
43	or	CC	O	or	_	0	SENT_363	[p22l1374t2734r1463b2787],
44	host	NN	O	host	nn	45	SENT_363	[p22l1500t2708r1687b2787],
45	factors	NNS	O	factor	prep_from	21	SENT_363	[p22l1721t2707r2037b2787],
46	.	.	O	.	_	0	SENT_363	[p22l1721t2707r2037b2787],

1	As	IN	O	as	prep	14	SENT_364	[p22l135t2843r243b2913],
2	in	IN	O	in	pcomp	1	SENT_364	[p22l285t2837r369b2913],
3	other	JJ	O	other	amod	4	SENT_364	[p22l411t2836r644b2914],
4	studies	NNS	O	study	pobj	2	SENT_364	[p22l684t2836r1016b2931],
5	,	,	O	,	_	0	SENT_364	[p22l684t2836r1016b2931],
6	all	DT	O	all	det	7	SENT_364	[p22l1063t2836r1169b2913],
7	patients	NNS	O	patient	nsubj	14	SENT_364	[p22l1208t2837r1558b2935],
8	with	IN	O	with	_	0	SENT_364	[p22l1597t2836r1796b2915],
9	a	DT	O	a	det	13	SENT_364	[p22l1836t2862r1881b2913],
10	positive	JJ	O	positive	amod	13	SENT_364	[p22l1919t2837r2134b2935, p22l11t2965r158b3043],
11	epicutaneous	JJ	O	epicutaneous	amod	13	SENT_364	[p22l190t2965r755b3063],
12	patch	NN	O	patch	nn	13	SENT_364	[p22l787t2964r1023b3063],
13	test	NN	O	test	prep_with	7	SENT_364	[p22l1055t2981r1210b3042],
14	carried	VBD	O	carry	_	0	SENT_364	[p22l1236t2964r1537b3042],
15	HLA	NN	O	hlum	dobj	14	SENT_364	[p22l1568t2964r2129b3059],
16	.	.	O	.	_	0	SENT_364	[p22l1568t2964r2129b3059],

1	—	NN	O	—	_	0	SENT_365	[p22l1568t2964r2129b3059],
2	.	.	O	.	_	0	SENT_365	[p22l1568t2964r2129b3059],

1	B	NN	O	b	nsubj	5	SENT_366	[p22l1568t2964r2129b3059],
2	*	CD	NUMBER	*	num	3	SENT_366	[p22l1568t2964r2129b3059],
3	5701	CD	NUMBER	5701	dep	1	SENT_366	[p22l1568t2964r2129b3059],
4	,	,	O	,	_	0	SENT_366	[p22l1568t2964r2129b3059],
5	providing	VBG	O	provide	_	0	SENT_366	[p22l9t3092r429b3193],
6	further	JJ	O	further	amod	7	SENT_366	[p22l464t3091r774b3171],
7	evidence	NN	O	evidence	dobj	5	SENT_366	[p22l811t3092r1177b3171],
8	that	IN	O	that	_	0	SENT_366	[p22l1217t3092r1390b3170],
9	the	DT	O	the	det	10	SENT_366	[p22l1424t3092r1557b3170],
10	HLA	NN	O	hlum	prep_that	5	SENT_366	[p22l1596t3092r2135b3171],
11	.	.	O	.	_	0	SENT_366	[p22l1596t3092r2135b3171],

1	—	NN	O	—	_	0	SENT_367	[p22l1596t3092r2135b3171],
2	.	.	O	.	_	0	SENT_367	[p22l1596t3092r2135b3171],

1	B	NN	O	b	dep	35	SENT_368	[p22l1596t3092r2135b3171],
2	*	CD	NUMBER	*	num	1	SENT_368	[p22l1596t3092r2135b3171],
3	5701	CD	NUMBER	5701	num	4	SENT_368	[p22l1596t3092r2135b3171],
4	test	NN	O	test	nsubj	5	SENT_368	[p22l11t3237r169b3298],
5	has	VBZ	O	have	rcmod	1	SENT_368	[p22l215t3220r361b3298],
6	a	DT	O	a	det	9	SENT_368	[p22l415t3246r459b3298],
7	high	JJ	O	high	amod	9	SENT_368	[p22l510t3220r709b3321],
8	sensitivity	NN	O	sensitivity	nn	9	SENT_368	[p22l762t3221r1207b3320],
9	(	NN	O	(	dobj	5	SENT_368	[p22l1259t3220r1634b3320],
10	perhaps	RB	O	perhaps	advmod	16	SENT_368	[p22l1259t3220r1634b3320],
11	100	CD	PERCENT	100	num	12	SENT_368	[p22l1692t3226r1956b3311],
12	%	NN	PERCENT	%	dep	10	SENT_368	[p22l1692t3226r1956b3311],
13	)	CD	NUMBER	)	dep	10	SENT_368	[p22l1692t3226r1956b3311],
14	for	IN	O	for	prep	10	SENT_368	[p22l2013t3219r2139b3299],
15	immunologically	RB	O	immunologically	pcomp	14	SENT_368	[p22l10t3348r733b3449],
16	confirmed	VBN	O	confirm	partmod	9	SENT_368	[p22l761t3347r1206b3427],
17	hypersensitivity	NN	O	hypersensitivity	nn	18	SENT_368	[p22l1238t3348r1904b3448],
18	reaction	NN	O	reaction	dep	16	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
19	.9	CD	NUMBER	.9	num	20	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
20	v11	NN	O	v11	dep	18	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
21	»	CD	NUMBER	»	number	22	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
22	17	CD	NUMBER	17	num	23	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
23	»	NN	O	»	dep	18	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
24	18	CD	NUMBER	18	num	26	SENT_368	[p22l1931t3374r2134b3426, p22l11t3477r493b3555],
25	Clinical	JJ	O	clinical	amod	26	SENT_368	[p22l528t3476r846b3555],
26	diagnosis	NN	O	diagnosis	dep	23	SENT_368	[p22l880t3476r1297b3577],
27	,	,	O	,	_	0	SENT_368	[p22l880t3476r1297b3577],
28	on	IN	O	on	_	0	SENT_368	[p22l1338t3502r1441b3555],
29	the	DT	O	the	det	31	SENT_368	[p22l1476t3476r1604b3554],
30	other	JJ	O	other	amod	31	SENT_368	[p22l1640t3476r1859b3555],
31	hand	NN	O	hand	prep_on	35	SENT_368	[p22l1890t3476r2130b3572],
32	,	,	O	,	_	0	SENT_368	[p22l1890t3476r2130b3572],
33	is	VBZ	O	be	cop	35	SENT_368	[p22l10t3605r75b3682],
34	most	RBS	O	most	advmod	35	SENT_368	[p22l109t3621r326b3683],
35	reliable	JJ	O	reliable	_	0	SENT_368	[p22l353t3604r669b3683],
36	for	IN	O	for	_	0	SENT_368	[p22l701t3603r825b3683],
37	identifying	VBG	O	identify	prepc_for	35	SENT_368	[p22l853t3603r1329b3705],
38	patients	NNS	O	patient	dobj	37	SENT_368	[p22l1357t3605r1699b3704],
39	who	WP	O	who	nsubj	40	SENT_368	[p22l1729t3604r1912b3683],
40	have	VBP	O	have	rcmod	38	SENT_368	[p22l1945t3604r2135b3683],
41	tolerance	NN	O	tolerance	dobj	40	SENT_368	[p23l11t21r387b100],
42	of	IN	O	of	_	0	SENT_368	[p23l425t20r523b100],
43	abacavir	NN	O	abacavir	prep_of	41	SENT_368	[p23l541t21r899b100],
44	.	.	O	.	_	0	SENT_368	[p23l541t21r899b100],

1	Thus	RB	O	thus	advmod	7	SENT_369	[p23l938t21r1166b117],
2	,	,	O	,	_	0	SENT_369	[p23l938t21r1166b117],
3	immunologically	RB	O	immunologically	advmod	7	SENT_369	[p23l1208t21r1917b122],
4	conﬁrmed	JJ	O	conﬁrmed	amod	6	SENT_369	[p23l1950t47r2134b100, p23l10t147r300b227],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_369	[p23l334t148r1001b248],
6	reaction	NN	O	reaction	nsubj	7	SENT_369	[p23l1031t149r1372b227],
7	provides	VBZ	O	provide	_	0	SENT_369	[p23l1405t148r1759b248],
8	the	DT	O	the	det	10	SENT_369	[p23l1797t148r1927b226],
9	best	JJS	O	best	amod	10	SENT_369	[p23l1963t148r2140b227],
10	estimate	NN	O	estimate	dobj	7	SENT_369	[p23l11t277r369b354],
11	of	IN	O	of	_	0	SENT_369	[p23l400t275r498b355],
12	sensitivity	NN	O	sensitivity	nn	14	SENT_369	[p23l511t277r934b376],
13	(	CD	NUMBER	(	num	14	SENT_369	[p23l964t281r1226b367],
14	1000/o	NN	O	1000/o	prep_of	10	SENT_369	[p23l964t281r1226b367],
15	in	IN	O	in	_	0	SENT_369	[p23l1254t277r1337b354],
16	our	PRP$	O	we	poss	18	SENT_369	[p23l1367t302r1511b356],
17	study	NN	O	study	nn	18	SENT_369	[p23l1538t276r1809b376],
18	)	NN	O	)	prep_in	14	SENT_369	[p23l1538t276r1809b376],
19	,	,	O	,	_	0	SENT_369	[p23l1538t276r1809b376],
20	Whereas	IN	O	whereas	mark	23	SENT_369	[p23l1840t276r2134b356, p23l10t431r94b483],
21	clinical	JJ	O	clinical	amod	22	SENT_369	[p23l130t405r436b483],
22	diagnosis	NN	O	diagnosis	nsubj	23	SENT_369	[p23l469t405r872b506],
23	provides	VBZ	O	provide	dep	7	SENT_369	[p23l905t405r1259b505],
24	the	DT	O	the	det	26	SENT_369	[p23l1295t405r1426b484],
25	best	JJS	O	best	amod	26	SENT_369	[p23l1459t405r1633b484],
26	estimate	NN	O	estimate	dobj	23	SENT_369	[p23l1662t406r2020b483],
27	of	IN	O	of	_	0	SENT_369	[p23l2054t404r2153b484],
28	speciﬁcity	NN	O	speciﬁcity	prep_of	26	SENT_369	[p23l11t531r443b632],
29	(	CD	PERCENT	(	number	30	SENT_369	[p23l479t537r799b623],
30	97.6	CD	PERCENT	97.6	num	31	SENT_369	[p23l479t537r799b623],
31	%	NN	PERCENT	%	dep	28	SENT_369	[p23l479t537r799b623],
32	)	CD	NUMBER	)	dep	31	SENT_369	[p23l479t537r799b623],
33	.	.	O	.	_	0	SENT_369	[p23l479t537r799b623],

1	Given	VBN	O	give	_	0	SENT_370	[p23l840t533r1081b612],
2	these	DT	O	these	det	3	SENT_370	[p23l1117t532r1337b610],
3	estimates	NNS	O	estimate	dep	1	SENT_370	[p23l1373t533r1772b610],
4	and	CC	O	and	_	0	SENT_370	[p23l1810t532r1966b611],
5	the	DT	O	the	det	9	SENT_370	[p23l2002t532r2135b610],
6	5.6	CD	PERCENT	5.6	number	7	SENT_370	[p23l12t666r223b740],
7	%	NN	PERCENT	%	amod	9	SENT_370	[p23l12t666r223b740],
8	carriage	NN	O	carriage	nn	9	SENT_370	[p23l268t662r624b762],
9	frequency	NN	O	frequency	conj_and	3	SENT_370	[p23l669t660r1102b761],
10	of	IN	O	of	_	0	SENT_370	[p23l1142t660r1243b740],
11	HLA	NN	O	hlum	prep_of	9	SENT_370	[p23l1268t661r1816b740],
12	.	.	O	.	_	0	SENT_370	[p23l1268t661r1816b740],

1	—	NN	O	—	_	0	SENT_371	[p23l1268t661r1816b740],
2	.	.	O	.	_	0	SENT_371	[p23l1268t661r1816b740],

1	B	NN	O	b	nsubj	10	SENT_372	[p23l1268t661r1816b740],
2	*	CD	NUMBER	*	number	3	SENT_372	[p23l1268t661r1816b740],
3	5701	CD	NUMBER	5701	npadvmod	1	SENT_372	[p23l1268t661r1816b740],
4	in	IN	O	in	_	0	SENT_372	[p23l1861t662r1945b739],
5	our	PRP$	O	we	poss	6	SENT_372	[p23l1990t687r2138b740],
6	study	NN	O	study	prep_in	1	SENT_372	[p23l11t789r254b889],
7	,	,	O	,	_	0	SENT_372	[p23l11t789r254b889],
8	the	DT	O	the	det	9	SENT_372	[p23l293t789r426b868],
9	overall	JJ	O	overall	appos	6	SENT_372	[p23l458t789r744b868],
10	estimated	VBN	O	estimate	_	0	SENT_372	[p23l776t789r1199b868],
11	positive	JJ	O	positive	amod	15	SENT_372	[p23l1229t790r1560b889],
12	and	CC	O	and	_	0	SENT_372	[p23l1592t789r1750b868],
13	negative	JJ	O	negative	conj_and	11	SENT_372	[p23l1781t790r2135b890],
14	predictive	JJ	O	predictive	amod	15	SENT_372	[p23l9t917r409b1017],
15	values	NNS	O	value	dobj	10	SENT_372	[p23l440t917r692b996],
16	of	IN	O	of	_	0	SENT_372	[p23l730t916r828b996],
17	HLA	NN	O	hlum	prep_of	15	SENT_372	[p23l844t917r1363b996],
18	.	.	O	.	_	0	SENT_372	[p23l844t917r1363b996],

1	—	NN	O	—	_	0	SENT_373	[p23l844t917r1363b996],
2	.	.	O	.	_	0	SENT_373	[p23l844t917r1363b996],

1	B	NN	O	b	nsubj	18	SENT_374	[p23l844t917r1363b996],
2	*	CD	NUMBER	*	number	3	SENT_374	[p23l844t917r1363b996],
3	5701	CD	NUMBER	5701	num	4	SENT_374	[p23l844t917r1363b996],
4	testing	NN	O	testing	npadvmod	1	SENT_374	[p23l1398t918r1684b1018],
5	for	IN	O	for	_	0	SENT_374	[p23l1716t916r1835b996],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_374	[p23l1867t917r2134b1017, p23l11t1046r445b1144],
7	reaction	NN	O	reaction	prep_for	1	SENT_374	[p23l473t1046r822b1123],
8	to	TO	O	to	_	0	SENT_374	[p23l855t1062r936b1123],
9	abacavir	NN	O	abacavir	prep_to	7	SENT_374	[p23l969t1045r1326b1124],
10	in	IN	O	in	_	0	SENT_374	[p23l1354t1046r1438b1122],
11	this	DT	O	this	det	12	SENT_374	[p23l1470t1045r1630b1123],
12	population	NN	O	population	prep_in	9	SENT_374	[p23l1662t1045r2135b1144],
13	are	VBP	O	be	cop	18	SENT_374	[p23l10t1199r139b1251],
14	58	CD	PERCENT	58	number	18	SENT_374	[p23l180t1178r365b1252],
15	%	NN	PERCENT	%	dep	18	SENT_374	[p23l180t1178r365b1252],
16	and	CC	O	and	_	0	SENT_374	[p23l403t1173r561b1251],
17	100	CD	PERCENT	100	conj_and	18	SENT_374	[p23l604t1178r864b1268],
18	%	NN	PERCENT	%	_	0	SENT_374	[p23l604t1178r864b1268],
19	,	,	O	,	_	0	SENT_374	[p23l604t1178r864b1268],
20	respectively	RB	O	respectively	advmod	18	SENT_374	[p23l909t1173r1424b1272],
21	.	.	O	.	_	0	SENT_374	[p23l909t1173r1424b1272],

1	The	DT	O	the	det	2	SENT_375	[p23l136t1301r297b1380],
2	fact	NN	O	fact	_	0	SENT_375	[p23l350t1300r509b1379],
3	that	IN	O	that	_	0	SENT_375	[p23l556t1301r729b1379],
4	19	CD	NUMBER	19	prep_that	2	SENT_375	[p23l780t1307r876b1380],
5	of	IN	O	of	_	0	SENT_375	[p23l931t1300r1030b1380],
6	49	CD	NUMBER	49	num	7	SENT_375	[p23l1063t1307r1162b1380],
7	HLA	NN	O	hlum	prep_of	2	SENT_375	[p23l1216t1301r1754b1380],
8	.	.	O	.	_	0	SENT_375	[p23l1216t1301r1754b1380],

1	—	NN	O	—	_	0	SENT_376	[p23l1216t1301r1754b1380],
2	.	.	O	.	_	0	SENT_376	[p23l1216t1301r1754b1380],

1	B	NN	O	b	_	0	SENT_377	[p23l1216t1301r1754b1380],
2	*	CD	NUMBER	*	number	3	SENT_377	[p23l1216t1301r1754b1380],
3	5701	CD	NUMBER	5701	dep	1	SENT_377	[p23l1216t1301r1754b1380],
4	carriers	NNS	O	carrier	dep	3	SENT_377	[p23l1808t1302r2133b1379],

1	(	NN	O	(	nsubj	32	SENT_378	[p23l15t1434r336b1520],
2	38.8	CD	PERCENT	38.8	num	3	SENT_378	[p23l15t1434r336b1520],
3	%	NN	PERCENT	%	nsubj	22	SENT_378	[p23l15t1434r336b1520],
4	)	CD	NUMBER	)	nsubj	9	SENT_378	[p23l15t1434r336b1520],
5	in	IN	O	in	_	0	SENT_378	[p23l388t1430r471b1507],
6	the	DT	O	the	det	8	SENT_378	[p23l520t1429r652b1507],
7	control	NN	O	control	nn	8	SENT_378	[p23l701t1429r1008b1508],
8	group	NN	O	group	prep_in	4	SENT_378	[p23l1055t1455r1307b1530],
9	tolerated	VBD	O	tolerate	rcmod	3	SENT_378	[p23l1357t1429r1735b1508],
10	abacavir	NN	O	abacavir	dobj	9	SENT_378	[p23l1782t1429r2139b1508],
11	during	IN	O	during	_	0	SENT_378	[p23l11t1557r301b1658],
12	the	DT	O	the	det	15	SENT_378	[p23l356t1557r489b1635],
13	6-week	JJ	DURATION	6-week	amod	15	SENT_378	[p23l548t1557r855b1636],
14	observation	NN	O	observation	nn	15	SENT_378	[p23l910t1557r1412b1636],
15	period	NN	O	period	prep_during	9	SENT_378	[p23l1468t1557r1746b1657],
16	Without	IN	O	without	_	0	SENT_378	[p23l1801t1557r2140b1636],
17	evidence	NN	O	evidence	prep_without	9	SENT_378	[p23l11t1684r369b1764],
18	of	IN	O	of	_	0	SENT_378	[p23l408t1683r507b1763],
19	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_378	[p23l526t1684r1192b1784],
20	reaction	NN	O	reaction	prep_of	17	SENT_378	[p23l1225t1685r1567b1763],
21	is	VBZ	O	be	cop	22	SENT_378	[p23l1604t1685r1669b1762],
22	consistent	JJ	O	consistent	rcmod	1	SENT_378	[p23l1710t1685r2140b1763],
23	with	IN	O	with	_	0	SENT_378	[p23l6t1812r201b1892],
24	previous	JJ	O	previous	amod	25	SENT_378	[p23l237t1813r600b1912],
25	evidence	NN	O	evidence	prep_with	22	SENT_378	[p23l641t1812r1007b1891],
26	from	IN	O	from	_	0	SENT_378	[p23l1046t1811r1256b1891],
27	ex	FW	O	ex	nn	29	SENT_378	[p23l1295t1838r1387b1890],
28	vivo	FW	O	vivo	nn	29	SENT_378	[p23l1417t1813r1586b1892],
29	studies	NNS	O	study	prep_from	22	SENT_378	[p23l1627t1812r1927b1892],
30	that	WDT	O	that	nsubj	31	SENT_378	[p23l1968t1812r2140b1890],
31	abacavir	VBP	O	abacavir	rcmod	29	SENT_378	[p23l10t1941r374b2020],
32	stimulates	VBZ	O	stimulate	_	0	SENT_378	[p23l439t1941r893b2020],
33	an	DT	O	a	det	35	SENT_378	[p23l962t1967r1065b2019],
34	antigen	NN	O	antigen	nn	35	SENT_378	[p23l1131t1940r1840b2042],
35	—	NN	O	—	dobj	32	SENT_378	[p23l1131t1940r1840b2042],
36	specific	JJ	O	specific	amod	39	SENT_378	[p23l1131t1940r1840b2042],
37	HLA	NN	O	hlum	nn	39	SENT_378	[p23l1905t1949r2134b2019],
38	—	NN	O	—	nn	39	SENT_378	[p23l1905t1949r2134b2019],
39	B	NN	O	b	dep	35	SENT_378	[p23l8t2069r790b2147],
40	*	CD	NUMBER	*	number	41	SENT_378	[p23l8t2069r790b2147],
41	5701	CD	NUMBER	5701	num	42	SENT_378	[p23l8t2069r790b2147],
42	—	NN	O	—	npadvmod	43	SENT_378	[p23l8t2069r790b2147],
43	restricted	JJ	O	restricted	amod	44	SENT_378	[p23l8t2069r790b2147],
44	CD8	NN	O	cd8	dep	39	SENT_378	[p23l822t2075r1066b2147],
45	+	CC	O	+	_	0	SENT_378	[p23l822t2075r1066b2147],
46	T-cell	NN	O	t-cell	nn	47	SENT_378	[p23l1095t2069r1331b2147],
47	response	NN	O	response	nn	50	SENT_378	[p23l1363t2095r1745b2168],
48	and	CC	O	and	_	0	SENT_378	[p23l1777t2069r1935b2147],
49	that	IN	O	that	nn	50	SENT_378	[p23l1968t2069r2140b2147],
50	HLA	NN	O	hlum	dobj	32	SENT_378	[p23l10t2196r548b2275],
51	.	.	O	.	_	0	SENT_378	[p23l10t2196r548b2275],

1	—	NN	O	—	_	0	SENT_379	[p23l10t2196r548b2275],
2	.	.	O	.	_	0	SENT_379	[p23l10t2196r548b2275],

1	B	NN	O	b	nsubj	9	SENT_380	[p23l10t2196r548b2275],
2	*	CD	NUMBER	*	num	3	SENT_380	[p23l10t2196r548b2275],
3	5701	CD	NUMBER	5701	dep	1	SENT_380	[p23l10t2196r548b2275],
4	is	VBZ	O	be	cop	5	SENT_380	[p23l599t2197r664b2274],
5	necessary	JJ	O	necessary	_	0	SENT_380	[p23l718t2222r1151b2296],
6	,	,	O	,	_	0	SENT_380	[p23l718t2222r1151b2296],
7	but	CC	O	but	_	0	SENT_380	[p23l1208t2196r1348b2276],
8	not	RB	O	not	neg	9	SENT_380	[p23l1393t2213r1537b2275],
9	sufficient	JJ	O	sufficient	conj_but	5	SENT_380	[p23l1584t2195r1996b2276],
10	by	IN	O	by	_	0	SENT_380	[p23l2043t2196r2140b2296],
11	itself	PRP	O	itself	prep_by	5	SENT_380	[p23l10t2323r244b2420],
12	,	,	O	,	_	0	SENT_380	[p23l10t2323r244b2420],
13	for	IN	O	for	_	0	SENT_380	[p23l293t2323r416b2403],
14	a	DT	O	a	det	16	SENT_380	[p23l456t2350r500b2402],
15	hypersensitivity	NN	O	hypersensitivity	nn	16	SENT_380	[p23l542t2324r1224b2424],
16	reaction	NN	O	reaction	prep_for	5	SENT_380	[p23l1263t2325r1769b2403],
17	.9	CD	NUMBER	.9	number	18	SENT_380	[p23l1263t2325r1769b2403],
18	’11	CD	NUMBER	’11	dep	16	SENT_380	[p23l1263t2325r1769b2403],
19	However	RB	O	however	advmod	5	SENT_380	[p23l1812t2332r2134b2404, p23l11t2478r110b2548],
20	,	,	O	,	_	0	SENT_380	[p23l1812t2332r2134b2404, p23l11t2478r110b2548],
21	the	DT	O	the	det	23	SENT_380	[p23l157t2452r290b2530],
22	clinical	JJ	O	clinical	amod	23	SENT_380	[p23l332t2452r646b2530],
23	value	NN	O	value	attr	5	SENT_380	[p23l682t2452r902b2532],
24	of	IN	O	of	_	0	SENT_380	[p23l944t2451r1044b2531],
25	prospective	JJ	O	prospective	amod	26	SENT_380	[p23l1065t2453r1555b2552],
26	HLA	NN	O	hlum	prep_of	23	SENT_380	[p23l1596t2452r2134b2531],
27	.	.	O	.	_	0	SENT_380	[p23l1596t2452r2134b2531],

1	—	NN	O	—	_	0	SENT_381	[p23l1596t2452r2134b2531],
2	.	.	O	.	_	0	SENT_381	[p23l1596t2452r2134b2531],

1	B	NN	O	b	nsubj	5	SENT_382	[p23l1596t2452r2134b2531],
2	*	CD	NUMBER	*	num	1	SENT_382	[p23l1596t2452r2134b2531],
3	5701	CD	NUMBER	5701	num	4	SENT_382	[p23l1596t2452r2134b2531],
4	screening	NN	O	screening	dep	1	SENT_382	[p23l11t2582r430b2682],
5	is	VBZ	O	be	_	0	SENT_382	[p23l471t2582r537b2659],
6	to	TO	O	to	aux	7	SENT_382	[p23l584t2598r665b2660],
7	identify	VB	O	identify	ccomp	5	SENT_382	[p23l711t2580r1045b2681],
8	patients	NNS	O	patient	dobj	7	SENT_382	[p23l1083t2582r1426b2681],
9	at	IN	O	at	_	0	SENT_382	[p23l1472t2598r1551b2659],
10	greatest	JJS	O	greatest	amod	11	SENT_382	[p23l1591t2598r1936b2682],
11	risk	NN	O	risk	prep_at	7	SENT_382	[p23l1976t2581r2140b2660],
12	rather	RB	O	rather	_	0	SENT_382	[p23l10t2708r270b2786],
13	than	IN	O	than	_	0	SENT_382	[p23l315t2708r511b2786],
14	to	TO	O	to	aux	15	SENT_382	[p23l559t2725r640b2787],
15	predict	VB	O	predict	conj_negcc	7	SENT_382	[p23l688t2708r992b2808],
16	which	WDT	O	which	dobj	20	SENT_382	[p23l1030t2708r1293b2788],
17	patients	NNS	O	patient	nsubj	20	SENT_382	[p23l1338t2709r1680b2808],
18	will	MD	O	will	aux	20	SENT_382	[p23l1725t2708r1890b2788],
19	deﬁnitely	RB	O	deﬁnitely	advmod	20	SENT_382	[p23l1938t2707r2134b2787, p23l10t2837r248b2936],
20	have	VB	O	have	ccomp	15	SENT_382	[p23l283t2837r474b2916],
21	a	DT	O	a	det	23	SENT_382	[p23l512t2863r557b2914],
22	hypersensitivity	NN	O	hypersensitivity	nn	23	SENT_382	[p23l595t2837r1276b2936],
23	reaction	NN	O	reaction	dobj	20	SENT_382	[p23l1312t2838r1684b2915],
24	.	.	O	.	_	0	SENT_382	[p23l1312t2838r1684b2915],

1	In	IN	O	in	_	0	SENT_383	[p23l1728t2844r1816b2914],
2	a	DT	O	a	det	3	SENT_383	[p23l1855t2863r1900b2914],
3	population	NN	O	population	pobj	1	SENT_383	[p23l1936t2863r2134b2936, p23l10t2965r315b3044],
4	similar	JJ	O	similar	amod	3	SENT_383	[p23l363t2965r670b3043],
5	to	TO	O	to	_	0	SENT_383	[p23l714t2982r795b3043],
6	that	DT	O	that	prep_to	4	SENT_383	[p23l844t2965r1016b3043],
7	in	IN	O	in	_	0	SENT_383	[p23l1057t2966r1141b3042],
8	the	DT	O	the	det	12	SENT_383	[p23l1188t2965r1321b3043],
9	PREDICT	NNP	O	PREDICT	nn	12	SENT_383	[p23l1366t2971r1838b3048],
10	—	NN	O	—	nn	12	SENT_383	[p23l1366t2971r1838b3048],
11	1	CD	NUMBER	1	num	12	SENT_383	[p23l1366t2971r1838b3048],
12	study	NN	O	study	prep_in	6	SENT_383	[p23l1887t2965r2130b3064],
13	,	,	O	,	_	0	SENT_383	[p23l1887t2965r2130b3064],
14	with	IN	O	with	_	0	SENT_383	[p23l6t3093r201b3172],
15	an	DT	O	a	det	17	SENT_383	[p23l251t3119r354b3171],
16	approximate	JJ	O	approximate	amod	17	SENT_383	[p23l404t3094r944b3193],
17	HLA	NN	O	hlum	prep_with	3	SENT_383	[p23l995t3093r1533b3172],
18	.	.	O	.	_	0	SENT_383	[p23l995t3093r1533b3172],

1	—	NN	O	—	_	0	SENT_384	[p23l995t3093r1533b3172],
2	.	.	O	.	_	0	SENT_384	[p23l995t3093r1533b3172],

1	B	NN	O	b	nsubj	16	SENT_385	[p23l995t3093r1533b3172],
2	*	CD	NUMBER	*	number	3	SENT_385	[p23l995t3093r1533b3172],
3	5701	CD	NUMBER	5701	num	5	SENT_385	[p23l995t3093r1533b3172],
4	carriage	NN	O	carriage	nn	5	SENT_385	[p23l1585t3094r1934b3194],
5	frequency	NN	O	frequency	npadvmod	1	SENT_385	[p23l1985t3092r2134b3171, p23l11t3247r302b3321],
6	of	IN	O	of	_	0	SENT_385	[p23l331t3220r429b3300],
7	6	CD	PERCENT	6	num	8	SENT_385	[p23l444t3226r595b3317],
8	%	NN	PERCENT	%	prep_of	1	SENT_385	[p23l444t3226r595b3317],
9	,	,	O	,	_	0	SENT_385	[p23l444t3226r595b3317],
10	the	DT	O	the	det	11	SENT_385	[p23l634t3221r763b3299],
11	screening	NN	O	screening	appos	8	SENT_385	[p23l798t3222r1199b3322],
12	of	IN	O	of	_	0	SENT_385	[p23l1229t3220r1326b3300],
13	100	CD	NUMBER	100	num	14	SENT_385	[p23l1344t3227r1488b3300],
14	patients	NNS	O	patient	prep_of	11	SENT_385	[p23l1520t3222r1847b3321],
15	would	MD	O	would	aux	16	SENT_385	[p23l1878t3221r2135b3300],
16	prevent	VB	O	prevent	_	0	SENT_385	[p23l9t3366r329b3449],
17	approximately	RB	O	approximately	quantmod	18	SENT_385	[p23l370t3349r987b3449],
18	four	CD	NUMBER	four	num	19	SENT_385	[p23l1029t3348r1210b3428],
19	diagnoses	NNS	O	diagnosis	dobj	16	SENT_385	[p23l1254t3349r1685b3450],
20	of	IN	O	of	_	0	SENT_385	[p23l1735t3348r1835b3428],
21	hypersensitivity	NN	O	hypersensitivity	prep_of	19	SENT_385	[p23l1863t3349r2134b3449, p23l11t3478r446b3577],
22	While	IN	O	while	mark	23	SENT_385	[p23l471t3477r706b3556],
23	ruling	VBG	O	rule	dep	16	SENT_385	[p23l741t3477r1009b3578],
24	out	RP	O	out	prt	23	SENT_385	[p23l1040t3494r1179b3556],
25	the	DT	O	the	det	26	SENT_385	[p23l1208t3477r1341b3556],
26	use	NN	O	use	dobj	23	SENT_385	[p23l1375t3503r1515b3556],
27	of	IN	O	of	_	0	SENT_385	[p23l1550t3476r1651b3556],
28	abacavir	NN	O	abacavir	prep_of	26	SENT_385	[p23l1665t3477r2022b3556],
29	in	IN	O	in	_	0	SENT_385	[p23l2052t3478r2135b3555],
30	two	CD	NUMBER	two	num	31	SENT_385	[p23l11t3622r164b3684],
31	HLA	NN	O	hlum	prep_in	28	SENT_385	[p23l193t3605r1080b3704],
32	.	.	O	.	_	0	SENT_385	[p23l193t3605r1080b3704],

1	—	NN	O	—	_	0	SENT_386	[p23l193t3605r1080b3704],
2	.	.	O	.	_	0	SENT_386	[p23l193t3605r1080b3704],

1	B	NN	O	b	_	0	SENT_387	[p23l193t3605r1080b3704],
2	*	CD	NUMBER	*	number	3	SENT_387	[p23l193t3605r1080b3704],
3	5701	CD	NUMBER	5701	num	1	SENT_387	[p23l193t3605r1080b3704],
4	.	.	O	.	_	0	SENT_387	[p23l193t3605r1080b3704],

1	—	NN	O	—	_	0	SENT_388	[p23l193t3605r1080b3704],
2	.	.	O	.	_	0	SENT_388	[p23l193t3605r1080b3704],

1	positive	JJ	O	positive	amod	2	SENT_389	[p23l193t3605r1080b3704],
2	patients	NNS	O	patient	_	0	SENT_389	[p23l1107t3606r1434b3704],
3	who	WP	O	who	nsubj	6	SENT_389	[p23l1460t3605r1639b3684],
4	would	MD	O	would	aux	6	SENT_389	[p23l1665t3605r1923b3684],
5	have	VB	O	have	aux	6	SENT_389	[p23l1951t3605r2135b3684],
6	tolerated	VBN	O	tolerate	rcmod	2	SENT_389	[p24l11t21r377b100],
7	the	DT	O	the	det	8	SENT_389	[p24l417t21r550b99],
8	drug	NN	O	drug	dobj	6	SENT_389	[p24l591t21r814b122],
9	.	.	O	.	_	0	SENT_389	[p24l591t21r814b122],

1	Although	IN	O	although	mark	12	SENT_390	[p24l135t149r544b250],
2	the	DT	O	the	det	3	SENT_390	[p24l604t149r737b227],
3	population	NN	O	population	nsubj	12	SENT_390	[p24l796t149r1268b249],
4	in	IN	O	in	_	0	SENT_390	[p24l1328t150r1412b227],
5	the	DT	O	the	det	9	SENT_390	[p24l1472t149r1605b227],
6	PREDICT	NNP	O	PREDICT	nn	9	SENT_390	[p24l1664t155r2135b232],
7	—	NN	O	—	nn	9	SENT_390	[p24l1664t155r2135b232],
8	1	CD	NUMBER	1	num	9	SENT_390	[p24l1664t155r2135b232],
9	study	NN	O	study	prep_in	3	SENT_390	[p24l11t277r242b376],
10	was	VBD	O	be	cop	12	SENT_390	[p24l277t303r439b356],
11	predominantly	RB	O	predominantly	advmod	12	SENT_390	[p24l484t277r1127b376],
12	White	JJ	O	white	_	0	SENT_390	[p24l1162t277r1425b372],
13	,	,	O	,	_	0	SENT_390	[p24l1162t277r1425b372],
14	the	DT	O	the	det	15	SENT_390	[p24l1475t277r1608b355],
15	association	NN	O	association	dobj	12	SENT_390	[p24l1651t278r2135b355],
16	between	IN	O	between	_	0	SENT_390	[p24l11t405r369b484],
17	HLA	NN	O	hlum	prep_between	15	SENT_390	[p24l415t405r953b483],
18	.	.	O	.	_	0	SENT_390	[p24l415t405r953b483],

1	—	NN	O	—	_	0	SENT_391	[p24l415t405r953b483],
2	.	.	O	.	_	0	SENT_391	[p24l415t405r953b483],

1	B	NN	O	b	nsubj	9	SENT_392	[p24l415t405r953b483],
2	*	CD	NUMBER	*	number	3	SENT_392	[p24l415t405r953b483],
3	5701	CD	DATE	5701	dep	1	SENT_392	[p24l415t405r953b483],
4	and	CC	O	and	_	0	SENT_392	[p24l999t405r1157b483],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_392	[p24l1204t405r1886b504],
6	reaction	NN	O	reaction	conj_and	1	SENT_392	[p24l1928t431r2134b483, p24l11t534r174b612],
7	to	TO	O	to	_	0	SENT_392	[p24l208t550r288b612],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_392	[p24l322t533r664b612],
9	appears	VBZ	O	appear	_	0	SENT_392	[p24l694t559r1014b633],
10	to	TO	O	to	aux	12	SENT_392	[p24l1051t550r1130b612],
11	be	VB	O	be	cop	12	SENT_392	[p24l1166t533r1261b612],
12	generalizable	JJ	O	generalizable	xcomp	9	SENT_392	[p24l1295t533r1844b634],
13	across	IN	O	across	_	0	SENT_392	[p24l1878t559r2134b612],
14	racial	JJ	O	racial	amod	15	SENT_392	[p24l10t661r240b739],
15	groups	NNS	O	group	prep_across	12	SENT_392	[p24l269t687r584b762],
16	.	.	O	.	_	0	SENT_392	[p24l269t687r584b762],

1	A	DT	O	a	det	3	SENT_393	[p24l617t669r683b739],
2	recent	JJ	O	recent	amod	3	SENT_393	[p24l710t678r970b740],
3	retrospective	NN	O	retrospective	nsubj	13	SENT_393	[p24l996t662r1559b761],
4	,	,	O	,	_	0	SENT_393	[p24l996t662r1559b761],
5	case	NN	O	case	nn	8	SENT_393	[p24l1596t661r2136b740],
6	—	CD	NUMBER	—	num	8	SENT_393	[p24l1596t661r2136b740],
7	control	NN	O	control	nn	8	SENT_393	[p24l1596t661r2136b740],
8	study	NN	O	study	appos	3	SENT_393	[p24l11t789r237b888],
9	in	IN	O	in	_	0	SENT_393	[p24l269t790r351b866],
10	the	DT	O	the	det	12	SENT_393	[p24l388t789r519b867],
11	United	NNP	LOCATION	United	nn	12	SENT_393	[p24l555t789r838b867],
12	States	NNPS	LOCATION	States	prep_in	8	SENT_393	[p24l877t795r1120b867],
13	showed	VBD	O	show	_	0	SENT_393	[p24l1161t789r1478b868],
14	100	CD	NUMBER	100	number	15	SENT_393	[p24l1518t794r1751b868],
15	°	CD	NUMBER	°	dobj	13	SENT_393	[p24l1518t794r1751b868],
16	/	:	O	/	punct	18	SENT_393	[p24l1518t794r1751b868],
17	o	NN	O	o	nn	18	SENT_393	[p24l1518t794r1751b868],
18	sensitivity	NN	O	sensitivity	dep	15	SENT_393	[p24l1789t790r2134b868, p24l10t918r117b1017],
19	of	IN	O	of	_	0	SENT_393	[p24l153t916r253b996],
20	HLA	NN	O	hlum	prep_of	15	SENT_393	[p24l273t917r812b996],
21	.	.	O	.	_	0	SENT_393	[p24l273t917r812b996],

1	—	NN	O	—	_	0	SENT_394	[p24l273t917r812b996],
2	.	.	O	.	_	0	SENT_394	[p24l273t917r812b996],

1	B	NN	O	b	nsubj	7	SENT_395	[p24l273t917r812b996],
2	*	CD	NUMBER	*	number	3	SENT_395	[p24l273t917r812b996],
3	5701	CD	NUMBER	5701	dep	4	SENT_395	[p24l273t917r812b996],
4	carriage	NN	O	carriage	amod	1	SENT_395	[p24l853t918r1201b1018],
5	for	IN	O	for	prep	4	SENT_395	[p24l1241t916r1365b996],
6	immunologically	RB	O	immunologically	pcomp	5	SENT_395	[p24l1401t917r2140b1018],
7	confirmed	VBN	O	confirm	_	0	SENT_395	[p24l11t1043r456b1123],
8	hypersensitivity	NN	O	hypersensitivity	dobj	7	SENT_395	[p24l490t1044r1156b1144],
9	in	IN	O	in	_	0	SENT_395	[p24l1184t1045r1267b1122],
10	both	CC	O	both	preconj	12	SENT_395	[p24l1301t1044r1496b1123],
11	White	JJ	O	white	amod	12	SENT_395	[p24l1525t1044r1760b1124],
12	patients	NNS	O	patient	prep_in	8	SENT_395	[p24l1793t1045r2133b1144],
13	and	CC	O	and	_	0	SENT_395	[p24l10t1173r168b1251],
14	black	JJ	O	black	amod	15	SENT_395	[p24l211t1173r440b1252],
15	patients	NNS	O	patient	conj_and	12	SENT_395	[p24l477t1174r921b1272],
16	.	.	O	.	_	0	SENT_395	[p24l477t1174r921b1272],

1	“	NN	O	“	_	0	SENT_396	[p24l477t1174r921b1272],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_396	[p24l962t1173r1536b1268],
3	,	,	O	,	_	0	SENT_396	[p24l962t1173r1536b1268],
4	the	DT	O	the	det	5	SENT_396	[p24l1584t1173r1718b1251],
5	presence	NN	O	presence	appos	1	SENT_396	[p24l1759t1199r2135b1272],
6	of	IN	O	of	_	0	SENT_396	[p24l11t1300r111b1380],
7	HLA	NN	O	hlum	prep_of	5	SENT_396	[p24l124t1301r662b1380],
8	.	.	O	.	_	0	SENT_396	[p24l124t1301r662b1380],

1	—	NN	O	—	_	0	SENT_397	[p24l124t1301r662b1380],
2	.	.	O	.	_	0	SENT_397	[p24l124t1301r662b1380],

1	B	NN	O	b	nsubjpass	5	SENT_398	[p24l124t1301r662b1380],
2	*	CD	NUMBER	*	num	3	SENT_398	[p24l124t1301r662b1380],
3	5701	CD	NUMBER	5701	dep	1	SENT_398	[p24l124t1301r662b1380],
4	is	VBZ	O	be	auxpass	5	SENT_398	[p24l695t1302r761b1379],
5	associated	VBN	O	associate	_	0	SENT_398	[p24l795t1301r1240b1380],
6	with	IN	O	with	_	0	SENT_398	[p24l1268t1301r1464b1380],
7	clinically	RB	O	clinically	amod	24	SENT_398	[p24l1497t1301r1890b1401],
8	diagnosed	VBN	O	diagnose	dep	7	SENT_398	[p24l1918t1301r2134b1402, p24l10t1429r263b1507],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_398	[p24l308t1429r989b1528],
10	reaction	NN	O	reaction	dobj	8	SENT_398	[p24l1029t1430r1378b1507],
11	in	IN	O	in	_	0	SENT_398	[p24l1422t1430r1506b1506],
12	Hispanic	JJ	O	hispanic	prep_in	10	SENT_398	[p24l1549t1430r1934b1528],
13	and	CC	O	and	_	0	SENT_398	[p24l1977t1429r2135b1507],
14	Thai	NNP	LOCATION	Thai	nn	15	SENT_398	[p24l6t1556r203b1634],
15	patients	NNS	O	patient	conj_and	10	SENT_398	[p24l242t1557r584b1656],
16	infected	VBN	O	infect	partmod	15	SENT_398	[p24l626t1555r975b1635],
17	with	IN	O	with	_	0	SENT_398	[p24l1011t1556r1206b1636],
18	HIV	NN	MISC	hiv	prep_with	16	SENT_398	[p24l1247t1561r1607b1635],
19	.1	CD	NUMBER	.1	num	18	SENT_398	[p24l1247t1561r1607b1635],
20	"	``	O	"	punct	18	SENT_398	[p24l1247t1561r1607b1635],
21	»	NN	O	»	dep	18	SENT_398	[p24l1247t1561r1607b1635],
22	24	CD	NUMBER	24	num	21	SENT_398	[p24l1247t1561r1607b1635],
23	Prospective	JJ	O	prospective	amod	24	SENT_398	[p24l1645t1557r2135b1656],
24	HLA	NN	O	hlum	prep_with	5	SENT_398	[p24l10t1685r524b1764],
25	.	.	O	.	_	0	SENT_398	[p24l10t1685r524b1764],

1	—	NN	O	—	_	0	SENT_399	[p24l10t1685r524b1764],
2	.	.	O	.	_	0	SENT_399	[p24l10t1685r524b1764],

1	B	NN	O	b	nsubj	19	SENT_400	[p24l10t1685r524b1764],
2	*	CD	NUMBER	*	number	3	SENT_400	[p24l10t1685r524b1764],
3	5701	CD	NUMBER	5701	num	4	SENT_400	[p24l10t1685r524b1764],
4	screening	NN	O	screening	dep	1	SENT_400	[p24l555t1686r970b1786],
5	,	,	O	,	_	0	SENT_400	[p24l555t1686r970b1786],
6	as	IN	O	as	mark	7	SENT_400	[p24l1003t1711r1086b1763],
7	shown	VBN	O	show	dep	1	SENT_400	[p24l1118t1685r1390b1764],
8	in	IN	O	in	_	0	SENT_400	[p24l1419t1686r1500b1763],
9	the	DT	O	the	det	13	SENT_400	[p24l1529t1685r1656b1764],
10	PREDICT	NNP	O	PREDICT	nn	13	SENT_400	[p24l1684t1691r2135b1768],
11	—	NN	O	—	nn	13	SENT_400	[p24l1684t1691r2135b1768],
12	1	CD	NUMBER	1	num	13	SENT_400	[p24l1684t1691r2135b1768],
13	study	NN	O	study	prep_in	7	SENT_400	[p24l11t1813r254b1913],
14	,	,	O	,	_	0	SENT_400	[p24l11t1813r254b1913],
15	may	MD	O	may	aux	19	SENT_400	[p24l296t1839r475b1913],
16	therefore	RB	O	therefore	advmod	19	SENT_400	[p24l507t1812r897b1892],
17	be	VB	O	be	cop	19	SENT_400	[p24l933t1813r1030b1892],
18	broadly	RB	O	broadly	advmod	19	SENT_400	[p24l1066t1813r1389b1913],
19	useful	JJ	O	useful	_	0	SENT_400	[p24l1420t1812r1707b1909],
20	,	,	O	,	_	0	SENT_400	[p24l1420t1812r1707b1909],
21	although	IN	O	although	mark	30	SENT_400	[p24l1748t1813r2135b1914],
22	the	DT	O	the	det	25	SENT_400	[p24l11t1940r143b2018],
23	cost	NN	O	cost	nn	25	SENT_400	[p24l185t1939r940b2020],
24	—	NN	O	—	nn	25	SENT_400	[p24l185t1939r940b2020],
25	effectiveness	NN	O	effectiveness	nsubj	30	SENT_400	[p24l185t1939r940b2020],
26	of	IN	O	of	_	0	SENT_400	[p24l985t1939r1085b2019],
27	the	DT	O	the	det	28	SENT_400	[p24l1108t1940r1241b2018],
28	test	NN	O	test	prep_of	25	SENT_400	[p24l1283t1957r1437b2018],
29	Will	MD	O	will	aux	30	SENT_400	[p24l1469t1940r1634b2020],
30	depend	VB	O	depend	advcl	19	SENT_400	[p24l1675t1940r1988b2040],
31	on	IN	O	on	_	0	SENT_400	[p24l2029t1966r2135b2019],
32	several	JJ	O	several	amod	33	SENT_400	[p24l11t2069r290b2148],
33	estimates	NNS	O	estimate	prep_on	30	SENT_400	[p24l321t2070r713b2148],
34	that	WDT	O	that	nsubj	35	SENT_400	[p24l746t2069r912b2147],
35	vary	VBP	O	vary	rcmod	33	SENT_400	[p24l933t2095r1109b2169],
36	among	IN	O	among	_	0	SENT_400	[p24l1135t2095r1427b2170],
37	populations	NNS	O	population	prep_among	35	SENT_400	[p24l1453t2069r1945b2169],
38	and	CC	O	and	_	0	SENT_400	[p24l1978t2069r2136b2148],
39	health	NN	O	health	nn	41	SENT_400	[p24l10t2197r281b2275],
40	care	NN	O	care	nn	41	SENT_400	[p24l320t2223r495b2276],
41	settings	NNS	O	setting	prep_among	35	SENT_400	[p24l535t2198r874b2298],
42	as	IN	O	as	_	0	SENT_400	[p24l914t2223r999b2275],
43	Well	NNP	O	Well	prep_as	37	SENT_400	[p24l1035t2197r1213b2276],
44	as	IN	O	as	_	0	SENT_400	[p24l1250t2223r1335b2275],
45	the	DT	O	the	det	46	SENT_400	[p24l1376t2197r1509b2276],
46	availability	NN	O	availability	prep_as	35	SENT_400	[p24l1547t2197r2019b2297],
47	of	IN	O	of	_	0	SENT_400	[p24l2053t2196r2153b2276],
48	appropriate	JJ	O	appropriate	amod	50	SENT_400	[p24l10t2326r505b2424],
49	laboratory	NN	O	laboratory	nn	50	SENT_400	[p24l544t2325r992b2424],
50	assays	NNS	O	assay	prep_of	46	SENT_400	[p24l1026t2330r1492b2424],
51	.25	CD	NUMBER	.25	number	52	SENT_400	[p24l1026t2330r1492b2424],
52	'27	CD	NUMBER	'27	num	50	SENT_400	[p24l1026t2330r1492b2424],

1	Supported	VBN	O	support	_	0	SENT_401	[p24l97t2537r434b2612],
2	by	IN	O	by	_	0	SENT_401	[p24l460t2537r534b2612],
3	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_by	1	SENT_401	[p24l556t2537r1147b2598],
4	.	.	O	.	_	0	SENT_401	[p24l556t2537r1147b2598],

1	Drs.	NNP	O	Drs.	nn	2	SENT_402	[p24l94t2638r227b2692],
2	Mallal	NNP	PERSON	Mallal	nsubj	8	SENT_402	[p24l264t2633r492b2704],
3	,	,	O	,	_	0	SENT_402	[p24l264t2633r492b2704],
4	Carosi	NNP	PERSON	Carosi	conj_and	2	SENT_402	[p24l531t2633r759b2704],
5	,	,	O	,	_	0	SENT_402	[p24l531t2633r759b2704],
6	and	CC	O	and	_	0	SENT_402	[p24l797t2633r917b2692],
7	Molina	NNP	PERSON	Molina	conj_and	2	SENT_402	[p24l949t2633r1184b2692],
8	report	NN	O	report	_	0	SENT_402	[p24l1217t2645r1422b2708],
9	receiving	VBG	O	receive	xcomp	8	SENT_402	[p24l1453t2633r1754b2708],
10	consulting	NN	O	consulting	nn	11	SENT_402	[p24l1786t2633r2139b2708],
11	fees	NNS	O	fee	nsubj	28	SENT_402	[p24l9t2728r155b2800],
12	,	,	O	,	_	0	SENT_402	[p24l9t2728r155b2800],
13	lecture	NN	O	lecture	nn	14	SENT_402	[p24l183t2729r408b2789],
14	fees	NNS	O	fee	appos	11	SENT_402	[p24l433t2728r578b2800],
15	,	,	O	,	_	0	SENT_402	[p24l433t2728r578b2800],
16	and	CC	O	and	_	0	SENT_402	[p24l608t2729r728b2788],
17	grant	NN	O	grant	nn	18	SENT_402	[p24l752t2741r931b2804],
18	support	NN	O	support	conj_and	14	SENT_402	[p24l954t2742r1209b2804],
19	from	IN	O	from	_	0	SENT_402	[p24l1230t2728r1391b2788],
20	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	18	SENT_402	[p24l1415t2729r2008b2800],
21	;	:	O	;	_	0	SENT_402	[p24l1415t2729r2008b2800],
22	Dr.	NNP	O	Dr.	nn	23	SENT_402	[p24l2034t2734r2132b2788],
23	Mallal	NNP	PERSON	Mallal	dep	14	SENT_402	[p24l7t2825r235b2896],
24	,	,	O	,	_	0	SENT_402	[p24l7t2825r235b2896],
25	being	VBG	O	be	cop	28	SENT_402	[p24l272t2825r457b2900],
26	the	DT	O	the	det	28	SENT_402	[p24l488t2825r589b2883],
27	sole	JJ	O	sole	amod	28	SENT_402	[p24l622t2825r749b2884],
28	shareholder	NN	O	shareholder	dep	9	SENT_402	[p24l782t2825r1173b2884],
29	of	IN	O	of	_	0	SENT_402	[p24l1203t2824r1280b2884],
30	a	DT	O	a	det	31	SENT_402	[p24l1298t2845r1331b2883],
31	company	NN	O	company	prep_of	28	SENT_402	[p24l1362t2844r1662b2900],
32	with	IN	O	with	_	0	SENT_402	[p24l1687t2825r1837b2885],
33	a	DT	O	a	det	34	SENT_402	[p24l1868t2844r1901b2883],
34	patent	NN	O	patent	prep_with	31	SENT_402	[p24l1932t2837r2140b2900],
35	pending	VBG	O	pend	prep	9	SENT_402	[p24l8t2921r283b2996],
36	for	IN	O	for	pcomp	35	SENT_402	[p24l310t2920r404b2980],
37	HLA	NN	O	hlum	pobj	36	SENT_402	[p24l432t2921r844b2980],
38	.	.	O	.	_	0	SENT_402	[p24l432t2921r844b2980],

1	—	NN	O	—	_	0	SENT_403	[p24l432t2921r844b2980],
2	.	.	O	.	_	0	SENT_403	[p24l432t2921r844b2980],

1	B	NN	O	b	nsubj	4	SENT_404	[p24l432t2921r844b2980],
2	*	CD	NUMBER	*	number	3	SENT_404	[p24l432t2921r844b2980],
3	5701	CD	NUMBER	5701	num	4	SENT_404	[p24l432t2921r844b2980],
4	testing	NN	O	testing	_	0	SENT_404	[p24l875t2922r1120b2996],
5	;	:	O	;	_	0	SENT_404	[p24l875t2922r1120b2996],
6	Drs.	NNP	O	Drs.	nn	7	SENT_404	[p24l1152t2926r1285b2980],
7	Phillips	NNP	PERSON	Phillips	dep	4	SENT_404	[p24l1318t2921r1568b2996],
8	and	CC	O	and	_	0	SENT_404	[p24l1599t2921r1719b2980],
9	Hay	NNP	O	Hay	conj_and	7	SENT_404	[p24l1749t2926r1888b2996],
10	,	,	O	,	_	0	SENT_404	[p24l1749t2926r1888b2996],
11	receiving	VBG	O	receive	partmod	4	SENT_404	[p24l1923t2922r2135b2981, p24l8t3018r116b3092],
12	consulting	NN	O	consulting	nn	13	SENT_404	[p24l161t3017r514b3092],
13	fees	NNS	O	fee	dobj	11	SENT_404	[p24l559t3016r705b3088],
14	,	,	O	,	_	0	SENT_404	[p24l559t3016r705b3088],
15	lecture	NN	O	lecture	nn	16	SENT_404	[p24l755t3017r980b3077],
16	fees	NNS	O	fee	appos	13	SENT_404	[p24l1028t3016r1173b3088],
17	,	,	O	,	_	0	SENT_404	[p24l1028t3016r1173b3088],
18	and	CC	O	and	_	0	SENT_404	[p24l1224t3017r1344b3076],
19	other	JJ	O	other	amod	20	SENT_404	[p24l1392t3017r1567b3076],
20	payments	NNS	O	payment	conj_and	13	SENT_404	[p24l1611t3029r1927b3092],
21	from	IN	O	from	_	0	SENT_404	[p24l1976t3016r2136b3076],
22	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	20	SENT_404	[p24l9t3113r601b3184],
23	;	:	O	;	_	0	SENT_404	[p24l9t3113r601b3184],
24	Drs.	NNP	O	Drs.	nn	25	SENT_404	[p24l631t3118r764b3172],
25	Workman	NNP	PERSON	Workman	dobj	11	SENT_404	[p24l794t3113r1123b3173],
26	and	CC	O	and	_	0	SENT_404	[p24l1150t3113r1270b3172],
27	Nolan	NNP	PERSON	Nolan	conj_and	25	SENT_404	[p24l1296t3113r1515b3184],
28	,	,	O	,	_	0	SENT_404	[p24l1296t3113r1515b3184],
29	receiving	VBG	O	receive	partmod	13	SENT_404	[p24l1547t3113r1848b3188],
30	consulting	NN	O	consulting	nn	31	SENT_404	[p24l1874t3113r2135b3173, p24l8t3210r116b3284],
31	fees	NNS	O	fee	dobj	29	SENT_404	[p24l154t3208r280b3267],
32	from	IN	O	from	_	0	SENT_404	[p24l323t3208r484b3268],
33	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	29	SENT_404	[p24l525t3209r1117b3280],
34	;	:	O	;	_	0	SENT_404	[p24l525t3209r1117b3280],
35	Dr.	NNP	O	Dr.	nn	36	SENT_404	[p24l1160t3214r1258b3268],
36	Kozyrev	NNP	PERSON	Kozyrev	dobj	11	SENT_404	[p24l1302t3214r1579b3284],
37	,	,	O	,	_	0	SENT_404	[p24l1302t3214r1579b3284],
38	receiving	VBG	O	receive	partmod	36	SENT_404	[p24l1624t3210r1925b3284],
39	other	JJ	O	other	amod	40	SENT_404	[p24l1964t3209r2139b3268],
40	payments	NNS	O	payment	dobj	38	SENT_404	[p24l8t3318r324b3380],
41	from	IN	O	from	_	0	SENT_404	[p24l353t3304r514b3364],
42	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	38	SENT_404	[p24l542t3305r1134b3376],
43	;	:	O	;	_	0	SENT_404	[p24l542t3305r1134b3376],
44	Dr.	NNP	O	Dr.	nn	45	SENT_404	[p24l1165t3310r1262b3364],
45	Hay	NNP	O	Hay	dobj	11	SENT_404	[p24l1294t3310r1434b3380],
46	,	,	O	,	_	0	SENT_404	[p24l1294t3310r1434b3380],
47	receiving	VBG	O	receive	partmod	45	SENT_404	[p24l1466t3306r1767b3380],
48	grant	NN	O	grant	nn	49	SENT_404	[p24l1792t3317r1971b3380],
49	support	NN	O	support	dobj	47	SENT_404	[p24l1997t3324r2135b3380, p24l8t3413r149b3476],
50	from	IN	O	from	_	0	SENT_404	[p24l170t3400r331b3460],
51	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	47	SENT_404	[p24l356t3401r948b3472],
52	;	:	O	;	_	0	SENT_404	[p24l356t3401r948b3472],
53	Ms.	NNP	O	Ms.	nn	55	SENT_404	[p24l973t3406r1089b3460],
54	S.	NNP	PERSON	S.	nn	55	SENT_404	[p24l1120t3405r1172b3460],
55	Hughes	NNP	PERSON	Hughes	dep	45	SENT_404	[p24l1201t3401r1470b3476],
56	,	,	O	,	_	0	SENT_404	[p24l1201t3401r1470b3476],
57	Dr.	NNP	O	Dr.	nn	59	SENT_404	[p24l1498t3406r1595b3460],
58	A.	NNP	PERSON	A.	nn	59	SENT_404	[p24l1622t3406r1689b3460],
59	Hughes	NNP	PERSON	Hughes	appos	55	SENT_404	[p24l1718t3401r1987b3476],
60	,	,	O	,	_	0	SENT_404	[p24l1718t3401r1987b3476],
61	and	CC	O	and	_	0	SENT_404	[p24l2016t3401r2136b3460],
62	Drs.	NNP	O	Drs.	nn	63	SENT_404	[p24l8t3502r141b3556],
63	Fitch	NNP	PERSON	Fitch	conj_and	13	SENT_404	[p24l177t3497r357b3568],
64	,	,	O	,	_	0	SENT_404	[p24l177t3497r357b3568],
65	Thorborn	NNP	O	Thorborn	conj_and	63	SENT_404	[p24l392t3497r727b3568],
66	,	,	O	,	_	0	SENT_404	[p24l392t3497r727b3568],
67	and	CC	O	and	_	0	SENT_404	[p24l764t3497r884b3556],
68	Benbow	NNP	PERSON	Benbow	conj_and	63	SENT_404	[p24l916t3497r1194b3568],
69	,	,	O	,	_	0	SENT_404	[p24l916t3497r1194b3568],
70	being	VBG	O	be	cop	71	SENT_404	[p24l1232t3497r1417b3572],
71	employees	NNS	O	employee	partmod	11	SENT_404	[p24l1447t3497r1786b3572],
72	of	IN	O	of	_	0	SENT_404	[p24l1821t3496r1897b3556],
73	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_of	71	SENT_404	[p24l1916t3497r2135b3556, p24l11t3593r404b3664],
74	;	:	O	;	_	0	SENT_404	[p24l1916t3497r2135b3556, p24l11t3593r404b3664],
75	Ms.	NNP	O	Ms.	nn	77	SENT_404	[p24l443t3598r558b3652],
76	S.	NNP	PERSON	S.	nn	77	SENT_404	[p24l601t3597r653b3652],
77	Hughes	NNP	PERSON	Hughes	dep	71	SENT_404	[p24l694t3593r963b3668],
78	,	,	O	,	_	0	SENT_404	[p24l694t3593r963b3668],
79	Dr.	NNP	O	Dr.	nn	81	SENT_404	[p24l1004t3598r1102b3652],
80	A.	NNP	PERSON	A.	nn	81	SENT_404	[p24l1140t3598r1208b3652],
81	Hughes	NNP	PERSON	Hughes	dobj	4	SENT_404	[p24l1249t3593r1518b3668],
82	,	,	O	,	_	0	SENT_404	[p24l1249t3593r1518b3668],
83	and	CC	O	and	_	0	SENT_404	[p24l1559t3593r1679b3652],
84	Dr.	NNP	O	Dr.	nn	85	SENT_404	[p24l1715t3598r1813b3652],
85	Benbow	NNP	PERSON	Benbow	conj_and	81	SENT_404	[p24l1853t3593r2131b3664],
86	,	,	O	,	_	0	SENT_404	[p24l1853t3593r2131b3664],

1	owning	VBG	O	own	_	0	SENT_405	[p25l10t17r262b92],
2	stock	NN	O	stock	dobj	1	SENT_405	[p25l309t17r484b77],
3	in	IN	O	in	_	0	SENT_405	[p25l530t18r594b75],
4	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_in	1	SENT_405	[p25l643t17r1235b88],
5	;	:	O	;	_	0	SENT_405	[p25l643t17r1235b88],
6	and	CC	O	and	_	0	SENT_405	[p25l1286t17r1406b76],
7	Dr.	NNP	O	Dr.	nn	8	SENT_405	[p25l1454t22r1551b76],
8	Ryan	NNP	PERSON	Ryan	conj_and	1	SENT_405	[p25l1604t22r1785b92],
9	,	,	O	,	_	0	SENT_405	[p25l1604t22r1785b92],
10	receiving	VBG	O	receive	partmod	8	SENT_405	[p25l1838t17r2139b92],
11	medical	JJ	O	medical	amod	12	SENT_405	[p25l9t113r542b188],
12	—	NN	O	—	dobj	10	SENT_405	[p25l9t113r542b188],
13	writing	VBG	O	write	xcomp	10	SENT_405	[p25l9t113r542b188],
14	fees	NNS	O	fee	dobj	13	SENT_405	[p25l564t112r690b171],
15	from	IN	O	from	_	0	SENT_405	[p25l716t112r877b172],
16	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_from	13	SENT_405	[p25l902t113r1493b174],
17	.	.	O	.	_	0	SENT_405	[p25l902t113r1493b174],

1	No	DT	O	no	det	4	SENT_406	[p25l1521t118r1616b172],
2	other	JJ	O	other	amod	4	SENT_406	[p25l1642t113r1816b172],
3	potential	JJ	O	potential	amod	4	SENT_406	[p25l1838t113r2136b188],
4	conflict	NN	O	conflict	nsubjpass	12	SENT_406	[p25l10t208r268b268],
5	of	IN	O	of	_	0	SENT_406	[p25l290t208r367b268],
6	interest	NN	O	interest	prep_of	4	SENT_406	[p25l378t210r629b268],
7	relevant	JJ	O	relevant	amod	6	SENT_406	[p25l650t209r912b269],
8	to	TO	O	to	_	0	SENT_406	[p25l934t221r996b268],
9	this	DT	O	this	det	10	SENT_406	[p25l1023t209r1146b267],
10	article	NN	O	article	prep_to	7	SENT_406	[p25l1172t209r1378b267],
11	was	VBD	O	be	auxpass	12	SENT_406	[p25l1400t228r1524b269],
12	reported	VBN	O	report	_	0	SENT_406	[p25l1551t209r1851b284],
13	.	.	O	.	_	0	SENT_406	[p25l1551t209r1851b284],

1	We	PRP	O	we	nsubj	2	SENT_407	[p25l92t310r193b363],
2	thank	VBP	O	thank	_	0	SENT_407	[p25l228t305r423b364],
3	P.	NNP	PERSON	P.	nn	4	SENT_407	[p25l453t310r503b363],
4	Parada	NNP	PERSON	Parada	dobj	2	SENT_407	[p25l540t305r781b376],
5	,	,	O	,	_	0	SENT_407	[p25l540t305r781b376],
6	D.	NNP	O	D.	nn	7	SENT_407	[p25l818t310r886b363],
7	Waterhouse	NNP	O	Waterhouse	appos	4	SENT_407	[p25l922t305r1329b376],
8	,	,	O	,	_	0	SENT_407	[p25l922t305r1329b376],
9	T.	NNP	PERSON	T.	nn	10	SENT_407	[p25l1364t309r1422b363],
10	Stark	NNP	PERSON	Stark	appos	4	SENT_407	[p25l1462t305r1649b376],
11	,	,	O	,	_	0	SENT_407	[p25l1462t305r1649b376],
12	N.	NNP	PERSON	N.	nn	13	SENT_407	[p25l1685t310r1757b364],
13	Givens	NNP	PERSON	Givens	appos	4	SENT_407	[p25l1795t305r2033b376],
14	,	,	O	,	_	0	SENT_407	[p25l1795t305r2033b376],
15	B.	NNP	PERSON	B.	nn	16	SENT_407	[p25l2070t310r2131b363],
16	Delafont	NNP	PERSON	Delafont	appos	4	SENT_407	[p25l8t400r314b472],
17	,	,	O	,	_	0	SENT_407	[p25l8t400r314b472],
18	H.	NNP	PERSON	H.	nn	19	SENT_407	[p25l366t406r439b460],
19	Pearce	NNP	PERSON	Pearce	appos	4	SENT_407	[p25l490t406r722b472],
20	,	,	O	,	_	0	SENT_407	[p25l490t406r722b472],
21	I.	NNP	PERSON	I.	nn	22	SENT_407	[p25l773t406r814b460],
22	Buxton	NNP	PERSON	Buxton	appos	4	SENT_407	[p25l866t406r1120b472],
23	,	,	O	,	_	0	SENT_407	[p25l866t406r1120b472],
24	W.	NNP	PERSON	W.	nn	25	SENT_407	[p25l1170t406r1252b460],
25	Spreen	NNP	PERSON	Spreen	appos	4	SENT_407	[p25l1307t405r1546b476],
26	,	,	O	,	_	0	SENT_407	[p25l1307t405r1546b476],
27	C.	NNP	PERSON	C.	nn	28	SENT_407	[p25l1599t405r1662b460],
28	Brothers	NNPS	PERSON	Brothers	appos	4	SENT_407	[p25l1714t401r2015b472],
29	,	,	O	,	_	0	SENT_407	[p25l1714t401r2015b472],
30	A.	NN	PERSON	a.	nn	31	SENT_407	[p25l2065t406r2132b460],
31	Nelsen	NNP	PERSON	Nelsen	appos	4	SENT_407	[p25l7t497r251b568],
32	,	,	O	,	_	0	SENT_407	[p25l7t497r251b568],
33	E.	NNP	PERSON	E.	nn	34	SENT_407	[p25l282t502r342b556],
34	Lai	NNP	PERSON	Lai	appos	4	SENT_407	[p25l373t498r491b568],
35	,	,	O	,	_	0	SENT_407	[p25l373t498r491b568],
36	A.	NNP	PERSON	A.	nn	37	SENT_407	[p25l520t502r587b556],
37	Roses	NNPS	PERSON	Roses	appos	4	SENT_407	[p25l618t502r829b568],
38	,	,	O	,	_	0	SENT_407	[p25l618t502r829b568],
39	C.	NNP	PERSON	C.	nn	40	SENT_407	[p25l861t501r925b556],
40	Stainsby	NNP	PERSON	Stainsby	appos	4	SENT_407	[p25l958t497r1248b572],
41	,	,	O	,	_	0	SENT_407	[p25l958t497r1248b572],
42	J.	NNP	PERSON	J.	nn	43	SENT_407	[p25l1272t502r1316b565],
43	Hernandez	NNP	PERSON	Hernandez	appos	4	SENT_407	[p25l1348t497r1729b568],
44	,	,	O	,	_	0	SENT_407	[p25l1348t497r1729b568],
45	T.	NNP	PERSON	T.	nn	46	SENT_407	[p25l1759t501r1817b556],
46	Scott	NNP	PERSON	Scott	appos	4	SENT_407	[p25l1852t501r2033b568],
47	,	,	O	,	_	0	SENT_407	[p25l1852t501r2033b568],
48	K.	NNP	PERSON	K.	nn	49	SENT_407	[p25l2065t502r2131b558],
49	Man	NNP	PERSON	Man	appos	4	SENT_407	[p25l7t598r172b664],
50	,	,	O	,	_	0	SENT_407	[p25l7t598r172b664],
51	K.	NNP	PERSON	K.	nn	52	SENT_407	[p25l197t598r263b654],
52	Parry	NNP	PERSON	Parry	appos	4	SENT_407	[p25l288t593r763b668],
53	.	.	O	.	_	0	SENT_407	[p25l288t593r763b668],

1	—	NN	O	—	_	0	SENT_408	[p25l288t593r763b668],
2	.	.	O	.	_	0	SENT_408	[p25l288t593r763b668],

1	Billings	NNS	O	billing	_	0	SENT_409	[p25l288t593r763b668],
2	,	,	O	,	_	0	SENT_409	[p25l288t593r763b668],
3	L.	FW	PERSON	l.	appos	1	SENT_409	[p25l787t598r845b652],
4	Curtis	NNP	PERSON	Curtis	dep	3	SENT_409	[p25l870t594r1091b664],
5	,	,	O	,	_	0	SENT_409	[p25l870t594r1091b664],
6	C.	NNP	PERSON	C.	nn	7	SENT_409	[p25l1117t597r1180b652],
7	Cox	NNP	PERSON	Cox	appos	1	SENT_409	[p25l1206t597r1347b664],
8	,	,	O	,	_	0	SENT_409	[p25l1206t597r1347b664],
9	M.	NNP	PERSON	M.	nn	10	SENT_409	[p25l1371t598r1453b652],
10	Mosteller	NNP	PERSON	Mosteller	appos	1	SENT_409	[p25l1477t593r1804b664],
11	,	,	O	,	_	0	SENT_409	[p25l1477t593r1804b664],
12	D.	NNP	PERSON	D.	nn	13	SENT_409	[p25l1829t598r1896b652],
13	Zamoryakhin	NNP	PERSON	Zamoryakhin	appos	1	SENT_409	[p25l1920t598r2135b652, p25l9t689r283b764],
14	,	,	O	,	_	0	SENT_409	[p25l1920t598r2135b652, p25l9t689r283b764],
15	R.	NNP	PERSON	R.	nn	16	SENT_409	[p25l318t694r385b751],
16	Le	NNP	PERSON	Le	appos	1	SENT_409	[p25l419t689r683b760],
17	.	.	O	.	_	0	SENT_409	[p25l419t689r683b760],

1	—	NN	O	—	_	0	SENT_410	[p25l419t689r683b760],
2	.	.	O	.	_	0	SENT_410	[p25l419t689r683b760],

1	Gall	NN	PERSON	gall	_	0	SENT_411	[p25l419t689r683b760],
2	,	,	O	,	_	0	SENT_411	[p25l419t689r683b760],
3	and	CC	O	and	_	0	SENT_411	[p25l718t689r838b748],
4	E.	NNP	PERSON	E.	nn	5	SENT_411	[p25l869t694r929b748],
5	Loeschel	NNP	PERSON	Loeschel	conj_and	1	SENT_411	[p25l963t689r1251b748],
6	for	IN	O	for	_	0	SENT_411	[p25l1282t688r1377b748],
7	their	PRP$	O	they	poss	8	SENT_411	[p25l1407t689r1564b747],
8	contributions	NNS	O	contribution	prep_for	5	SENT_411	[p25l1594t689r2039b749],
9	to	TO	O	to	_	0	SENT_411	[p25l2073t702r2135b748],
10	the	DT	O	the	det	11	SENT_411	[p25l10t785r111b843],
11	design	NN	O	design	prep_to	8	SENT_411	[p25l136t785r352b860],
12	and	CC	O	and	_	0	SENT_411	[p25l377t785r497b844],
13	conduct	NN	O	conduct	conj_and	11	SENT_411	[p25l523t785r785b845],
14	of	IN	O	of	_	0	SENT_411	[p25l807t784r882b844],
15	the	DT	O	the	det	19	SENT_411	[p25l894t785r996b843],
16	PREDICT	NNP	O	PREDICT	nn	19	SENT_411	[p25l1020t789r1381b847],
17	—	NN	O	—	nn	19	SENT_411	[p25l1020t789r1381b847],
18	1	CD	NUMBER	1	num	19	SENT_411	[p25l1020t789r1381b847],
19	study	NN	O	study	prep_of	11	SENT_411	[p25l1407t785r1598b860],
20	;	:	O	;	_	0	SENT_411	[p25l1407t785r1598b860],
21	S.	NNP	PERSON	S.	nn	22	SENT_411	[p25l1628t789r1679b844],
22	Knowles	NNP	PERSON	Knowles	dep	1	SENT_411	[p25l1708t785r1989b846],
23	and	CC	O	and	_	0	SENT_411	[p25l2016t785r2136b844],
24	S.	NNP	PERSON	S.	nn	25	SENT_411	[p25l11t885r63b940],
25	Walker	NNP	PERSON	Walker	dep	1	SENT_411	[p25l88t881r323b941],
26	of	IN	O	of	_	0	SENT_411	[p25l345t880r421b940],
27	Quality	NNP	ORGANIZATION	Quality	nn	28	SENT_411	[p25l431t881r675b956],
28	Control	NNP	ORGANIZATION	Control	prep_of	25	SENT_411	[p25l695t881r945b940],
29	and	CC	ORGANIZATION	and	_	0	SENT_411	[p25l968t881r1088b940],
30	Research	NNP	ORGANIZATION	Research	nn	32	SENT_411	[p25l1110t881r1428b952],
31	,	,	O	,	_	0	SENT_411	[p25l1110t881r1428b952],
32	Department	NNP	ORGANIZATION	Department	conj_and	28	SENT_411	[p25l1455t886r1856b956],
33	of	IN	ORGANIZATION	of	_	0	SENT_411	[p25l1876t880r1953b940],
34	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	32	SENT_411	[p25l1961t881r2135b939, p25l9t996r192b1052],
35	,	,	O	,	_	0	SENT_411	[p25l1961t881r2135b939, p25l9t996r192b1052],
36	Sunnybrook	NNP	ORGANIZATION	Sunnybrook	nn	39	SENT_411	[p25l224t977r624b1052],
37	Health	NNP	ORGANIZATION	Health	nn	39	SENT_411	[p25l645t977r868b1035],
38	Sciences	NNPS	ORGANIZATION	Sciences	nn	39	SENT_411	[p25l896t978r1168b1036],
39	Centre	NNP	ORGANIZATION	Centre	appos	34	SENT_411	[p25l1196t981r1431b1048],
40	,	,	O	,	_	0	SENT_411	[p25l1196t981r1431b1048],
41	for	IN	O	for	_	0	SENT_411	[p25l1461t976r1555b1036],
42	their	PRP$	O	they	poss	43	SENT_411	[p25l1579t977r1736b1035],
43	help	NN	O	help	prep_for	25	SENT_411	[p25l1760t977r1898b1052],
44	in	IN	O	in	_	0	SENT_411	[p25l1924t978r1988b1035],
45	distributing	VBG	O	distribute	prepc_in	43	SENT_411	[p25l2015t977r2135b1036, p25l10t1073r307b1148],
46	the	DT	O	the	det	50	SENT_411	[p25l343t1073r444b1131],
47	patch	NN	O	patch	nn	50	SENT_411	[p25l482t1073r921b1148],
48	—	NN	O	—	nn	50	SENT_411	[p25l482t1073r921b1148],
49	testing	NN	O	testing	nn	50	SENT_411	[p25l482t1073r921b1148],
50	kits	NNS	O	kit	dobj	45	SENT_411	[p25l957t1073r1095b1144],
51	;	:	O	;	_	0	SENT_411	[p25l957t1073r1095b1144],
52	N.	NNP	PERSON	N.	nn	53	SENT_411	[p25l1135t1078r1207b1133],
53	Shear	NNP	PERSON	Shear	conj_and	22	SENT_411	[p25l1252t1073r1449b1144],
54	,	,	O	,	_	0	SENT_411	[p25l1252t1073r1449b1144],
55	B.	NNP	PERSON	B.	nn	56	SENT_411	[p25l1490t1078r1552b1132],
56	Milpied	NNP	PERSON	Milpied	conj_and	22	SENT_411	[p25l1592t1073r1864b1148],
57	,	,	O	,	_	0	SENT_411	[p25l1592t1073r1864b1148],
58	and	CC	O	and	_	0	SENT_411	[p25l1906t1073r2026b1132],
59	D.	NNP	PERSON	D.	nn	60	SENT_411	[p25l2064t1078r2131b1132],
60	Bruynzeel	NNP	PERSON	Bruynzeel	conj_and	22	SENT_411	[p25l8t1169r356b1244],
61	,	,	O	,	_	0	SENT_411	[p25l8t1169r356b1244],
62	members	NNS	O	member	conj_and	22	SENT_411	[p25l391t1169r695b1228],
63	of	IN	O	of	_	0	SENT_411	[p25l729t1168r806b1228],
64	the	DT	O	the	det	66	SENT_411	[p25l823t1169r925b1227],
65	independent	JJ	O	independent	amod	66	SENT_411	[p25l956t1169r1370b1244],
66	committee	NN	O	committee	prep_of	62	SENT_411	[p25l1398t1170r1751b1228],
67	that	WDT	O	that	nsubj	68	SENT_411	[p25l1783t1169r1915b1227],
68	evaluated	VBD	O	evaluate	rcmod	62	SENT_411	[p25l1944t1169r2135b1229, p25l9t1265r145b1324],
69	digital	JJ	O	digital	amod	70	SENT_411	[p25l182t1265r395b1340],
70	photographs	NNS	O	photograph	dobj	68	SENT_411	[p25l431t1265r851b1340],
71	of	IN	O	of	_	0	SENT_411	[p25l889t1264r965b1324],
72	the	DT	O	the	det	74	SENT_411	[p25l988t1265r1089b1324],
73	patch-test	JJ	O	patch-test	amod	74	SENT_411	[p25l1125t1265r1453b1340],
74	results	NNS	O	result	prep_of	70	SENT_411	[p25l1485t1265r1723b1336],
75	;	:	O	;	_	0	SENT_411	[p25l1485t1265r1723b1336],
76	and	CC	O	and	_	0	SENT_411	[p25l1762t1265r1882b1324],
77	all	PDT	O	all	predet	79	SENT_411	[p25l1918t1265r1998b1323],
78	the	DT	O	the	det	79	SENT_411	[p25l2034t1265r2136b1323],
79	patients	NNS	O	patient	conj_and	22	SENT_411	[p25l8t1362r271b1436],
80	and	CC	O	and	_	0	SENT_411	[p25l298t1361r418b1420],
81	medical	JJ	O	medical	amod	82	SENT_411	[p25l444t1361r704b1420],
82	staff	NN	O	staff	conj_and	22	SENT_411	[p25l731t1360r893b1419],
83	at	IN	O	at	_	0	SENT_411	[p25l904t1374r965b1419],
84	the	DT	O	the	det	85	SENT_411	[p25l987t1361r1089b1419],
85	study	NN	O	study	poss	88	SENT_411	[p25l1116t1361r1339b1436],
86	’s	POS	O	’s	_	0	SENT_411	[p25l1116t1361r1339b1436],
87	recruitment	NN	O	recruitment	nn	88	SENT_411	[p25l1366t1362r1759b1421],
88	sites	NNS	O	site	prep_at	82	SENT_411	[p25l1783t1362r1945b1420],
89	.	.	O	.	_	0	SENT_411	[p25l1783t1362r1945b1420],

1	N	NN	O	n	nn	3	SENT_412	[p25l516t1521r530b1536],
2	ENGLJ	NN	O	englj	nn	3	SENT_412	[p25l544t1521r622b1543],
3	MED	NN	O	med	_	0	SENT_412	[p25l637t1521r689b1536],
4	358	CD	NUMBER	358	num	6	SENT_412	[p25l699t1515r762b1543],
5	;	:	O	;	_	0	SENT_412	[p25l699t1515r762b1543],
6	6	CD	NUMBER	6	dep	3	SENT_412	[p25l699t1515r762b1543],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_412	[p25l796t1521r997b1543],
8	FEBRUARY	NNP	DATE	FEBRUARY	dep	6	SENT_412	[p25l1034t1521r1155b1537],
9	7	CD	DATE	7	num	8	SENT_412	[p25l1165t1521r1184b1542],
10	,	,	DATE	,	_	0	SENT_412	[p25l1165t1521r1184b1542],
11	2008	CD	DATE	2008	num	8	SENT_412	[p25l1195t1515r1258b1537],
12	577	CD	NUMBER	577	dep	3	SENT_412	[p25l1960t1511r2016b1534],

1	The	DT	O	the	det	4	SENT_413	[p25l702t1554r753b1578],
2	New	NNP	O	New	nn	4	SENT_413	[p25l762t1555r824b1578],
3	England	NNP	O	England	nn	4	SENT_413	[p25l833t1554r944b1585],
4	Journal	NNP	O	Journal	_	0	SENT_413	[p25l952t1554r1050b1578],
5	of	IN	O	of	_	0	SENT_413	[p25l1059t1554r1088b1578],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_413	[p25l1095t1554r1220b1578],

1	The	DT	O	the	det	4	SENT_414	[p25l672t1679r718b1700],
2	NEW	NNP	O	NEW	nn	4	SENT_414	[p25l736t1681r822b1700],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_414	[p25l841t1681r1029b1700],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_414	[p25l1048t1681r1228b1707],
5	of	IN	O	of	_	0	SENT_414	[p25l1248t1679r1276b1706],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_414	[p25l1288t1681r1487b1700],

1	AP	NN	O	ap	nn	4	SENT_415	[p25l1016t1782r1046b1798],
2	PE	NN	O	pe	nn	4	SENT_415	[p25l1051t1782r1077b1798],
3	N	NN	O	n	nn	4	SENT_415	[p25l1082t1782r1096b1798],
4	DIX	NN	O	dix	_	0	SENT_415	[p25l1102t1782r1144b1798],

1	Members	NNS	O	member	_	0	SENT_416	[p25l236t1814r352b1838],
2	of	IN	O	of	_	0	SENT_416	[p25l362t1814r392b1838],
3	the	DT	O	the	det	5	SENT_416	[p25l396t1814r433b1838],
4	PREDICT	NNP	O	PREDICT	nn	5	SENT_416	[p25l442t1816r585b1839],
5	—	NN	O	—	prep_of	1	SENT_416	[p25l442t1816r585b1839],
6	1	CD	NUMBER	1	num	8	SENT_416	[p25l442t1816r585b1839],
7	study	NN	O	study	nn	8	SENT_416	[p25l595t1814r660b1844],
8	team	NN	O	team	nsubj	9	SENT_416	[p25l669t1819r729b1838],
9	were	VBD	O	be	rcmod	1	SENT_416	[p25l737t1822r796b1838],
10	as	IN	O	as	mark	11	SENT_416	[p25l805t1822r829b1838],
11	follows	VBZ	O	follow	advcl	9	SENT_416	[p25l839t1814r937b1838],
12	:	:	O	:	_	0	SENT_416	[p25l839t1814r937b1838],
13	N.	NNP	PERSON	N.	nn	14	SENT_416	[p25l947t1816r975b1838],
14	Abrescia	NNP	PERSON	Abrescia	dep	1	SENT_416	[p25l985t1814r1098b1843],
15	,	,	O	,	_	0	SENT_416	[p25l985t1814r1098b1843],
16	F.	NNP	PERSON	F.	nn	17	SENT_416	[p25l1108t1816r1130b1838],
17	Ackermann	NNP	PERSON	Ackermann	appos	14	SENT_416	[p25l1140t1814r1290b1843],
18	,	,	O	,	_	0	SENT_416	[p25l1140t1814r1290b1843],
19	K.	NNP	PERSON	K.	nn	20	SENT_416	[p25l1301t1816r1326b1838],
20	Aguirrebengoa	NNP	PERSON	Aguirrebengoa	appos	14	SENT_416	[p25l1336t1814r1528b1844],
21	,	,	O	,	_	0	SENT_416	[p25l1336t1814r1528b1844],
22	I.	NNP	PERSON	I.	nn	23	SENT_416	[p25l1538t1816r1554b1838],
23	Ahmed	NNP	PERSON	Ahmed	appos	14	SENT_416	[p25l1564t1814r1750b1843],
24	—	CD	NUMBER	—	number	25	SENT_416	[p25l1564t1814r1750b1843],
25	]	CD	NUMBER	]	num	26	SENT_416	[p25l1564t1814r1750b1843],
26	ushuf	NN	O	ushuf	dep	23	SENT_416	[p25l1564t1814r1750b1843],
27	,	,	O	,	_	0	SENT_416	[p25l1564t1814r1750b1843],
28	J.	NNP	PERSON	J.	nn	29	SENT_416	[p25l1758t1816r1775b1841],
29	Ainsworth	NNP	PERSON	Ainsworth	appos	14	SENT_416	[p25l1785t1814r1922b1843],
30	,	,	O	,	_	0	SENT_416	[p25l1785t1814r1922b1843],
31	F.	NNP	PERSON	F.	nn	32	SENT_416	[p25l237t1854r258b1875],
32	Alberici	NNP	PERSON	Alberici	appos	29	SENT_416	[p25l269t1852r372b1880],
33	,	,	O	,	_	0	SENT_416	[p25l269t1852r372b1880],
34	T.	NNP	PERSON	T.	nn	35	SENT_416	[p25l383t1854r407b1875],
35	Allegre	NNP	PERSON	Allegre	appos	29	SENT_416	[p25l418t1852r513b1881],
36	,	,	O	,	_	0	SENT_416	[p25l418t1852r513b1881],
37	M.A.	NNP	PERSON	M.A.	nn	38	SENT_416	[p25l524t1854r583b1875],
38	Alleman	NNP	PERSON	Alleman	appos	29	SENT_416	[p25l594t1852r705b1880],
39	,	,	O	,	_	0	SENT_416	[p25l594t1852r705b1880],
40	C.	NNP	PERSON	C.	nn	42	SENT_416	[p25l717t1854r742b1875],
41	Alonso	NNP	PERSON	Alonso	nn	42	SENT_416	[p25l753t1852r840b1875],
42	Villaverde	NNP	PERSON	Villaverde	appos	29	SENT_416	[p25l850t1852r978b1880],
43	,	,	O	,	_	0	SENT_416	[p25l850t1852r978b1880],
44	G.	NNP	PERSON	G.	nn	45	SENT_416	[p25l990t1854r1018b1875],
45	Angioni	NNP	PERSON	Angioni	appos	29	SENT_416	[p25l1029t1852r1136b1881],
46	,	,	O	,	_	0	SENT_416	[p25l1029t1852r1136b1881],
47	A.	NNP	PERSON	A.	nn	48	SENT_416	[p25l1147t1854r1172b1875],
48	Antinori	NNP	PERSON	Antinori	appos	29	SENT_416	[p25l1183t1852r1294b1880],
49	,	,	O	,	_	0	SENT_416	[p25l1183t1852r1294b1880],
50	C.	NNP	PERSON	C.	nn	51	SENT_416	[p25l1306t1854r1330b1875],
51	Aquilina	NNP	PERSON	Aquilina	appos	29	SENT_416	[p25l1342t1852r1454b1881],
52	,	,	O	,	_	0	SENT_416	[p25l1342t1852r1454b1881],
53	K.	NNP	PERSON	K.	nn	54	SENT_416	[p25l1466t1854r1491b1875],
54	Arastéh	NNP	PERSON	Arastéh	appos	29	SENT_416	[p25l1502t1851r1604b1880],
55	,	,	O	,	_	0	SENT_416	[p25l1502t1851r1604b1880],
56	LR	NNP	ORGANIZATION	LR	appos	29	SENT_416	[p25l1613t1854r1658b1878],
57	.	.	O	.	_	0	SENT_416	[p25l1613t1854r1658b1878],

1	Arribas	NNP	PERSON	Arribas	_	0	SENT_417	[p25l1669t1852r1766b1880],
2	,	,	O	,	_	0	SENT_417	[p25l1669t1852r1766b1880],
3	J.	NNP	PERSON	J.	nn	6	SENT_417	[p25l1776t1854r1793b1878],
4	Arumain	NNP	PERSON	Arumain	nn	6	SENT_417	[p25l1804t1852r1923b1875],
5	—	NN	O	—	nn	6	SENT_417	[p25l1804t1852r1923b1875],
6	ayagam	NN	O	ayagam	appos	1	SENT_417	[p25l237t1896r337b1918],
7	,	,	O	,	_	0	SENT_417	[p25l237t1896r337b1918],
8	H.	NNP	PERSON	H.	nn	9	SENT_417	[p25l347t1891r375b1912],
9	Aumaitre	NNP	PERSON	Aumaitre	appos	6	SENT_417	[p25l385t1889r506b1917],
10	,	,	O	,	_	0	SENT_417	[p25l385t1889r506b1917],
11	M.	NNP	PERSON	M.	nn	12	SENT_417	[p25l516t1891r547b1912],
12	Beniowski	NNP	PERSON	Beniowski	appos	6	SENT_417	[p25l557t1889r693b1917],
13	,	,	O	,	_	0	SENT_417	[p25l557t1889r693b1917],
14	M.	NNP	PERSON	M.	nn	15	SENT_417	[p25l702t1891r734b1912],
15	Bentata	NNP	PERSON	Bentata	appos	6	SENT_417	[p25l744t1891r843b1917],
16	,	,	O	,	_	0	SENT_417	[p25l744t1891r843b1917],
17	J.	NNP	PERSON	J.	nn	18	SENT_417	[p25l850t1891r867b1915],
18	Berenguer	NNP	PERSON	Berenguer	appos	6	SENT_417	[p25l877t1891r1011b1918],
19	,	,	O	,	_	0	SENT_417	[p25l877t1891r1011b1918],
20	C.	NNP	PERSON	C.	nn	21	SENT_417	[p25l1022t1891r1046b1912],
21	Bergin	NNP	PERSON	Bergin	appos	6	SENT_417	[p25l1056t1889r1144b1918],
22	,	,	O	,	_	0	SENT_417	[p25l1056t1889r1144b1918],
23	J.	NNP	O	J.	appos	6	SENT_417	[p25l1152t1891r1203b1915],
24	.	.	O	.	_	0	SENT_417	[p25l1152t1891r1203b1915],

1	—	NN	O	—	_	0	SENT_418	[p25l1152t1891r1203b1915],
2	.	.	O	.	_	0	SENT_418	[p25l1152t1891r1203b1915],

1	F.	NNP	PERSON	F.	nn	2	SENT_419	[p25l1152t1891r1203b1915],
2	Bergmann	NNP	PERSON	Bergmann	_	0	SENT_419	[p25l1213t1891r1349b1918],
3	,	,	O	,	_	0	SENT_419	[p25l1213t1891r1349b1918],
4	B.	NNP	PERSON	B.	nn	5	SENT_419	[p25l1359t1891r1382b1912],
5	Bernasconi	NNP	PERSON	Bernasconi	appos	2	SENT_419	[p25l1392t1889r1537b1917],
6	,	,	O	,	_	0	SENT_419	[p25l1392t1889r1537b1917],
7	J.	NNP	O	J.	appos	5	SENT_419	[p25l1544t1891r1605b1915],
8	.	.	O	.	_	0	SENT_419	[p25l1544t1891r1605b1915],

1	—	NN	O	—	_	0	SENT_420	[p25l1544t1891r1605b1915],
2	.	.	O	.	_	0	SENT_420	[p25l1544t1891r1605b1915],

1	M.	NNP	PERSON	M.	nn	2	SENT_421	[p25l1544t1891r1605b1915],
2	Besnier	NNP	PERSON	Besnier	_	0	SENT_421	[p25l1615t1889r1714b1917],
3	,	,	O	,	_	0	SENT_421	[p25l1615t1889r1714b1917],
4	A.	NNP	PERSON	A.	nn	5	SENT_421	[p25l1723t1891r1748b1912],
5	Biglino	NNP	PERSON	Biglino	appos	2	SENT_421	[p25l1758t1889r1855b1918],
6	,	,	O	,	_	0	SENT_421	[p25l1758t1889r1855b1918],
7	W.L.	NNP	PERSON	W.L.	nn	8	SENT_421	[p25l1864t1891r1922b1912],
8	Blok	NNP	PERSON	Blok	appos	2	SENT_421	[p25l237t1926r300b1954],
9	,	,	O	,	_	0	SENT_421	[p25l237t1926r300b1954],
10	A.	NNP	PERSON	A.	nn	11	SENT_421	[p25l312t1928r337b1949],
11	Boron	NNP	PERSON	Boron	appos	2	SENT_421	[p25l350t1926r595b1954],
12	.	.	O	.	_	0	SENT_421	[p25l350t1926r595b1954],

1	—	NN	O	—	_	0	SENT_422	[p25l350t1926r595b1954],
2	.	.	O	.	_	0	SENT_422	[p25l350t1926r595b1954],

1	Kaczmarska	NNP	PERSON	Kaczmarska	_	0	SENT_423	[p25l350t1926r595b1954],
2	,	,	O	,	_	0	SENT_423	[p25l350t1926r595b1954],
3	M.	NNP	PERSON	M.	nn	4	SENT_423	[p25l607t1928r639b1949],
4	Branco	NNP	PERSON	Branco	appos	1	SENT_423	[p25l652t1928r746b1954],
5	,	,	O	,	_	0	SENT_423	[p25l652t1928r746b1954],
6	N	NNP	O	N	appos	4	SENT_423	[p25l758t1928r780b1949],
7	.	.	O	.	_	0	SENT_423	[p25l782t1928r818b1949],

1	H.	NNP	PERSON	H.	nn	2	SENT_424	[p25l782t1928r818b1949],
2	Brockmeyer	NNP	PERSON	Brockmeyer	_	0	SENT_424	[p25l830t1926r985b1955],
3	,	,	O	,	_	0	SENT_424	[p25l830t1926r985b1955],
4	W.	NNP	PERSON	W.	nn	5	SENT_424	[p25l997t1928r1031b1949],
5	Bronsveld	NNP	PERSON	Bronsveld	appos	2	SENT_424	[p25l1044t1926r1173b1953],
6	,	,	O	,	_	0	SENT_424	[p25l1044t1926r1173b1953],
7	E.	NNP	PERSON	E.	nn	8	SENT_424	[p25l1186t1928r1209b1949],
8	Brottier	NNP	PERSON	Brottier	appos	5	SENT_424	[p25l1222t1926r1434b1954],
9	.	.	O	.	_	0	SENT_424	[p25l1222t1926r1434b1954],

1	—	NN	O	—	_	0	SENT_425	[p25l1222t1926r1434b1954],
2	.	.	O	.	_	0	SENT_425	[p25l1222t1926r1434b1954],

1	Mancini	NNP	PERSON	Mancini	_	0	SENT_426	[p25l1222t1926r1434b1954],
2	,	,	O	,	_	0	SENT_426	[p25l1222t1926r1434b1954],
3	A.	NNP	PERSON	A.	nn	4	SENT_426	[p25l1446t1928r1472b1949],
4	Bykov	NNP	PERSON	Bykov	appos	1	SENT_426	[p25l1484t1926r1564b1955],
5	,	,	O	,	_	0	SENT_426	[p25l1484t1926r1564b1955],
6	U.	NNP	PERSON	U.	nn	7	SENT_426	[p25l1577t1928r1604b1949],
7	Caixas	NNP	PERSON	Caixas	appos	4	SENT_426	[p25l1617t1926r1703b1954],
8	,	,	O	,	_	0	SENT_426	[p25l1617t1926r1703b1954],
9	P.	NNP	PERSON	P.	nn	10	SENT_426	[p25l1716t1928r1738b1949],
10	Caramello	NNP	PERSON	Caramello	appos	4	SENT_426	[p25l1751t1926r1884b1954],
11	,	,	O	,	_	0	SENT_426	[p25l1751t1926r1884b1954],
12	A.	NNP	PERSON	A.	nn	13	SENT_426	[p25l1896t1928r1922b1949],
13	Cargnel	NNP	PERSON	Cargnel	appos	4	SENT_426	[p25l237t1963r340b1992],
14	,	,	O	,	_	0	SENT_426	[p25l237t1963r340b1992],
15	M.	NNP	PERSON	M.	nn	16	SENT_426	[p25l351t1965r382b1986],
16	Castaﬁo	NNP	PERSON	Castaﬁo	appos	4	SENT_426	[p25l394t1964r500b1991],
17	,	,	O	,	_	0	SENT_426	[p25l394t1964r500b1991],
18	A.M.	NNP	PERSON	A.M.	nn	19	SENT_426	[p25l510t1965r569b1986],
19	Cattelan	NNP	PERSON	Cattelan	appos	4	SENT_426	[p25l581t1963r689b1991],
20	,	,	O	,	_	0	SENT_426	[p25l581t1963r689b1991],
21	M.	NNP	PERSON	M.	nn	22	SENT_426	[p25l700t1965r731b1986],
22	Cavassini	NNP	PERSON	Cavassini	appos	4	SENT_426	[p25l743t1963r865b1991],
23	,	,	O	,	_	0	SENT_426	[p25l743t1963r865b1991],
24	D.	NNP	PERSON	D.	nn	25	SENT_426	[p25l876t1965r903b1986],
25	Chadwick	NNP	PERSON	Chadwick	appos	4	SENT_426	[p25l915t1963r1044b1991],
26	,	,	O	,	_	0	SENT_426	[p25l915t1963r1044b1991],
27	J.	NNP	O	J.	appos	4	SENT_426	[p25l1052t1965r1104b1989],
28	.	.	O	.	_	0	SENT_426	[p25l1052t1965r1104b1989],

1	—	NN	O	—	_	0	SENT_427	[p25l1052t1965r1104b1989],
2	.	.	O	.	_	0	SENT_427	[p25l1052t1965r1104b1989],

1	P.	NNP	PERSON	P.	nn	2	SENT_428	[p25l1052t1965r1104b1989],
2	Chave	NNP	PERSON	Chave	_	0	SENT_428	[p25l1115t1963r1196b1991],
3	,	,	O	,	_	0	SENT_428	[p25l1115t1963r1196b1991],
4	J.	NNP	O	J.	appos	2	SENT_428	[p25l1204t1965r1265b1989],
5	.	.	O	.	_	0	SENT_428	[p25l1204t1965r1265b1989],

1	—	NN	O	—	_	0	SENT_429	[p25l1204t1965r1265b1989],
2	.	.	O	.	_	0	SENT_429	[p25l1204t1965r1265b1989],

1	M.	NNP	PERSON	M.	nn	2	SENT_430	[p25l1204t1965r1265b1989],
2	Chennebault	NNP	PERSON	Chennebault	dep	43	SENT_430	[p25l1277t1963r1441b1991],
3	,	,	O	,	_	0	SENT_430	[p25l1277t1963r1441b1991],
4	F.	NNP	PERSON	F.	nn	5	SENT_430	[p25l1452t1965r1474b1986],
5	Chiodo	NNP	PERSON	Chiodo	appos	2	SENT_430	[p25l1485t1963r1582b1991],
6	,	,	O	,	_	0	SENT_430	[p25l1485t1963r1582b1991],
7	A.	NNP	PERSON	A.	nn	8	SENT_430	[p25l1592t1965r1618b1986],
8	Chirianni	NNP	PERSON	Chirianni	appos	2	SENT_430	[p25l1629t1963r1753b1991],
9	,	,	O	,	_	0	SENT_430	[p25l1629t1963r1753b1991],
10	M.	NNP	PERSON	M.	nn	11	SENT_430	[p25l1763t1965r1795b1986],
11	Chowers	NNP	PERSON	Chowers	appos	2	SENT_430	[p25l1806t1963r1922b1991],
12	,	,	O	,	_	0	SENT_430	[p25l1806t1963r1922b1991],
13	S.	NNP	PERSON	S.	nn	14	SENT_430	[p25l238t2002r258b2023],
14	Christensen	NNP	PERSON	Christensen	appos	2	SENT_430	[p25l270t2000r424b2028],
15	,	,	O	,	_	0	SENT_430	[p25l270t2000r424b2028],
16	J.	NNP	PERSON	J.	nn	17	SENT_430	[p25l433t2002r450b2026],
17	Chuah	NNP	PERSON	Chuah	appos	2	SENT_430	[p25l462t2000r550b2028],
18	,	,	O	,	_	0	SENT_430	[p25l462t2000r550b2028],
19	B.	NNP	PERSON	B.	nn	20	SENT_430	[p25l561t2002r585b2023],
20	Clotet	NNP	PERSON	Clotet	appos	2	SENT_430	[p25l597t2000r676b2027],
21	,	,	O	,	_	0	SENT_430	[p25l597t2000r676b2027],
22	N.	NNP	PERSON	N.	nn	23	SENT_430	[p25l688t2002r716b2023],
23	Clumeck	NNP	PERSON	Clumeck	appos	2	SENT_430	[p25l728t2000r844b2028],
24	,	,	O	,	_	0	SENT_430	[p25l728t2000r844b2028],
25	L.L.	NNP	PERSON	L.L.	nn	26	SENT_430	[p25l855t2002r900b2023],
26	Cortés	NNP	PERSON	Cortés	appos	2	SENT_430	[p25l912t1999r998b2028],
27	,	,	O	,	_	0	SENT_430	[p25l912t1999r998b2028],
28	L.	NNP	PERSON	L.	nn	29	SENT_430	[p25l1010t2002r1031b2023],
29	Cosco	NNP	PERSON	Cosco	appos	2	SENT_430	[p25l1043t2002r1124b2028],
30	,	,	O	,	_	0	SENT_430	[p25l1043t2002r1124b2028],
31	E.	NNP	PERSON	E.	nn	32	SENT_430	[p25l1136t2002r1159b2023],
32	Counillon	NNP	PERSON	Counillon	appos	2	SENT_430	[p25l1170t2000r1300b2028],
33	,	,	O	,	_	0	SENT_430	[p25l1170t2000r1300b2028],
34	A.	NNP	PERSON	A.	nn	36	SENT_430	[p25l1311t2002r1336b2023],
35	D’Arminio	NNP	PERSON	D’Arminio	nn	36	SENT_430	[p25l1348t2000r1479b2023],
36	Monforte	NNP	PERSON	Monforte	appos	2	SENT_430	[p25l1489t2000r1612b2028],
37	,	,	O	,	_	0	SENT_430	[p25l1489t2000r1612b2028],
38	C.	NNP	PERSON	C.	nn	39	SENT_430	[p25l1624t2002r1648b2023],
39	Daniel	NNP	PERSON	Daniel	appos	2	SENT_430	[p25l1660t2000r1747b2028],
40	,	,	O	,	_	0	SENT_430	[p25l1660t2000r1747b2028],
41	A.	NN	PERSON	a.	appos	2	SENT_430	[p25l1757t2002r1783b2023],
42	De	NNP	PERSON	De	nn	43	SENT_430	[p25l1794t2002r1827b2023],
43	BurghThomas	NNP	PERSON	BurghThomas	_	0	SENT_430	[p25l1837t2000r1923b2029, p25l236t2037r344b2065],
44	,	,	O	,	_	0	SENT_430	[p25l1837t2000r1923b2029, p25l236t2037r344b2065],
45	M.	NNP	PERSON	M.	nn	46	SENT_430	[p25l354t2039r386b2060],
46	Gérgolas	NNP	PERSON	Gérgolas	appos	43	SENT_430	[p25l397t2036r517b2066],
47	,	,	O	,	_	0	SENT_430	[p25l397t2036r517b2066],
48	I.	NNP	O	I.	appos	43	SENT_430	[p25l525t2039r576b2063],
49	.	.	O	.	_	0	SENT_430	[p25l525t2039r576b2063],

1	—	NN	O	—	_	0	SENT_431	[p25l525t2039r576b2063],
2	.	.	O	.	_	0	SENT_431	[p25l525t2039r576b2063],

1	F.	NNP	PERSON	F.	nn	2	SENT_432	[p25l525t2039r576b2063],
2	Delfraissy	NNP	PERSON	Delfraissy	_	0	SENT_432	[p25l587t2037r715b2066],
3	,	,	O	,	_	0	SENT_432	[p25l587t2037r715b2066],
4	P.	NNP	PERSON	P.	nn	5	SENT_432	[p25l726t2039r747b2060],
5	Dellamonica	NNP	PERSON	Dellamonica	appos	2	SENT_432	[p25l758t2037r921b2065],
6	,	,	O	,	_	0	SENT_432	[p25l758t2037r921b2065],
7	I.G.	NNP	O	I.G.	nn	9	SENT_432	[p25l929t2039r977b2063],
8	den	NN	O	den	nn	9	SENT_432	[p25l988t2037r1032b2060],
9	Hollander	NNP	PERSON	Hollander	appos	2	SENT_432	[p25l1041t2037r1172b2064],
10	,	,	O	,	_	0	SENT_432	[p25l1041t2037r1172b2064],
11	J.	NNP	O	J.	appos	2	SENT_432	[p25l1181t2039r1241b2063],
12	.	.	O	.	_	0	SENT_432	[p25l1181t2039r1241b2063],

1	—	NN	O	—	_	0	SENT_433	[p25l1181t2039r1241b2063],
2	.	.	O	.	_	0	SENT_433	[p25l1181t2039r1241b2063],

1	M.	NNP	PERSON	M.	nn	2	SENT_434	[p25l1181t2039r1241b2063],
2	Descamps	NNP	PERSON	Descamps	_	0	SENT_434	[p25l1252t2039r1386b2066],
3	,	,	O	,	_	0	SENT_434	[p25l1252t2039r1386b2066],
4	A.	NNP	PERSON	A.	nn	5	SENT_434	[p25l1396t2039r1421b2060],
5	Devidas	NNP	PERSON	Devidas	appos	2	SENT_434	[p25l1432t2037r1535b2065],
6	,	,	O	,	_	0	SENT_434	[p25l1432t2037r1535b2065],
7	P.	NNP	PERSON	P.	nn	9	SENT_434	[p25l1545t2039r1567b2060],
8	Di	NNP	PERSON	Di	nn	9	SENT_434	[p25l1578t2037r1606b2060],
9	Gregorio	NNP	PERSON	Gregorio	appos	2	SENT_434	[p25l1615t2037r1733b2066],
10	,	,	O	,	_	0	SENT_434	[p25l1615t2037r1733b2066],
11	G.	NNP	PERSON	G.	nn	13	SENT_434	[p25l1744t2039r1772b2060],
12	Di	NNP	PERSON	Di	nn	13	SENT_434	[p25l1782t2037r1811b2060],
13	Perri	NNP	PERSON	Perri	appos	2	SENT_434	[p25l1819t2037r1884b2065],
14	,	,	O	,	_	0	SENT_434	[p25l1819t2037r1884b2065],
15	D.	NNP	PERSON	D.	nn	16	SENT_434	[p25l1895t2039r1922b2060],
16	Dockrell	NNP	PERSON	Dockrell	appos	2	SENT_434	[p25l237t2074r348b2102],
17	,	,	O	,	_	0	SENT_434	[p25l237t2074r348b2102],
18	P.	NNP	PERSON	P.	nn	19	SENT_434	[p25l361t2076r382b2097],
19	Domingo	NNP	PERSON	Domingo	appos	2	SENT_434	[p25l394t2074r519b2103],
20	,	,	O	,	_	0	SENT_434	[p25l394t2074r519b2103],
21	S.	NNP	PERSON	S.	nn	22	SENT_434	[p25l532t2076r552b2097],
22	Echevarria	NNP	PERSON	Echevarria	appos	2	SENT_434	[p25l564t2073r699b2102],
23	,	,	O	,	_	0	SENT_434	[p25l564t2073r699b2102],
24	B.	NNP	PERSON	B.	nn	25	SENT_434	[p25l711t2076r735b2097],
25	Elharrar	NNP	PERSON	Elharrar	appos	2	SENT_434	[p25l747t2074r854b2102],
26	,	,	O	,	_	0	SENT_434	[p25l747t2074r854b2102],
27	S.	NNP	PERSON	S.	nn	28	SENT_434	[p25l868t2076r888b2097],
28	Esser	NNP	PERSON	Esser	appos	2	SENT_434	[p25l900t2076r972b2102],
29	,	,	O	,	_	0	SENT_434	[p25l900t2076r972b2102],
30	V.	NNP	PERSON	V.	nn	31	SENT_434	[p25l983t2076r1007b2097],
31	Estrada	NNP	PERSON	Estrada	appos	2	SENT_434	[p25l1019t2074r1118b2102],
32	,	,	O	,	_	0	SENT_434	[p25l1019t2074r1118b2102],
33	A.	NNP	PERSON	A.	nn	34	SENT_434	[p25l1129t2076r1155b2097],
34	Fakoya	NNP	PERSON	Fakoya	appos	2	SENT_434	[p25l1167t2074r1259b2103],
35	,	,	O	,	_	0	SENT_434	[p25l1167t2074r1259b2103],
36	G.	NNP	PERSON	G.	nn	37	SENT_434	[p25l1272t2076r1299b2097],
37	Féitkenheuer	NNP	PERSON	Féitkenheuer	appos	2	SENT_434	[p25l1311t2074r1471b2101],
38	,	,	O	,	_	0	SENT_434	[p25l1311t2074r1471b2101],
39	V.	NNP	PERSON	V.	nn	40	SENT_434	[p25l1483t2076r1507b2097],
40	Faucherre	NNP	PERSON	Faucherre	appos	2	SENT_434	[p25l1519t2074r1648b2102],
41	,	,	O	,	_	0	SENT_434	[p25l1519t2074r1648b2102],
42	I.	NNP	PERSON	I.	nn	43	SENT_434	[p25l1658t2076r1675b2100],
43	Fehr	NNP	PERSON	Fehr	appos	2	SENT_434	[p25l1687t2074r1749b2102],
44	,	,	O	,	_	0	SENT_434	[p25l1687t2074r1749b2102],
45	G.	NNP	PERSON	G.	nn	46	SENT_434	[p25l1762t2076r1789b2097],
46	Ferrea	NNP	PERSON	Ferrea	appos	2	SENT_434	[p25l1801t2076r1885b2102],
47	,	,	O	,	_	0	SENT_434	[p25l1801t2076r1885b2102],
48	C.	NNP	PERSON	C.	nn	50	SENT_434	[p25l1897t2076r1922b2097],
49	Fontier	NNP	PERSON	Fontier	nn	50	SENT_434	[p25l237t2111r326b2134],
50	Roussel	NNP	PERSON	Roussel	appos	2	SENT_434	[p25l336t2111r439b2139],
51	,	,	O	,	_	0	SENT_434	[p25l336t2111r439b2139],
52	L.	NNP	PERSON	L.	nn	53	SENT_434	[p25l451t2113r473b2134],
53	Force	NNP	PERSON	Force	appos	2	SENT_434	[p25l485t2113r559b2139],
54	,	,	O	,	_	0	SENT_434	[p25l485t2113r559b2139],
55	G.	NNP	PERSON	G.	nn	56	SENT_434	[p25l572t2113r599b2134],
56	Force	NNP	PERSON	Force	appos	2	SENT_434	[p25l612t2113r686b2139],
57	,	,	O	,	_	0	SENT_434	[p25l612t2113r686b2139],
58	R.	NNP	PERSON	R.	nn	59	SENT_434	[p25l698t2113r723b2136],
59	Fox	NNP	PERSON	Fox	appos	2	SENT_434	[p25l735t2113r786b2139],
60	,	,	O	,	_	0	SENT_434	[p25l735t2113r786b2139],
61	H.	NNP	PERSON	H.	nn	62	SENT_434	[p25l799t2113r827b2134],
62	Furrer	NNP	PERSON	Furrer	appos	2	SENT_434	[p25l839t2113r922b2139],
63	,	,	O	,	_	0	SENT_434	[p25l839t2113r922b2139],
64	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_434	[p25l934t2113r983b2138],
65	.	.	O	.	_	0	SENT_434	[p25l934t2113r983b2138],

1	Galindo	NNP	PERSON	Galindo	nn	2	SENT_435	[p25l995t2111r1094b2134],
2	Puerto	NNP	PERSON	Puerto	_	0	SENT_435	[p25l1105t2113r1192b2139],
3	,	,	O	,	_	0	SENT_435	[p25l1105t2113r1192b2139],
4	H.	NNP	PERSON	H.	nn	5	SENT_435	[p25l1204t2113r1232b2134],
5	Gallais	NNP	PERSON	Gallais	appos	2	SENT_435	[p25l1245t2111r1337b2139],
6	,	,	O	,	_	0	SENT_435	[p25l1245t2111r1337b2139],
7	J.-A	NNP	O	J.-A	appos	5	SENT_435	[p25l1346t2113r1401b2138],
8	.	.	O	.	_	0	SENT_435	[p25l1346t2113r1401b2138],

1	Gastaut	NNP	O	Gastaut	_	0	SENT_436	[p25l1413t2113r1515b2139],
2	,	,	O	,	_	0	SENT_436	[p25l1413t2113r1515b2139],
3	J.	NNP	PERSON	J.	nn	4	SENT_436	[p25l1525t2113r1542b2138],
4	Gatell	NNP	PERSON	Gatell	appos	1	SENT_436	[p25l1554t2111r1634b2139],
5	,	,	O	,	_	0	SENT_436	[p25l1554t2111r1634b2139],
6	M.	NNP	PERSON	M.	nn	7	SENT_436	[p25l1646t2113r1678b2134],
7	Geit	NNP	PERSON	Geit	appos	4	SENT_436	[p25l1690t2111r1749b2139],
8	,	,	O	,	_	0	SENT_436	[p25l1690t2111r1749b2139],
9	D.	NNP	PERSON	D.	nn	10	SENT_436	[p25l1761t2113r1788b2134],
10	Genné	NNP	PERSON	Genné	appos	4	SENT_436	[p25l1800t2110r1888b2139],
11	,	,	O	,	_	0	SENT_436	[p25l1800t2110r1888b2139],
12	F.	NNP	PERSON	F.	nn	13	SENT_436	[p25l1900t2113r1921b2134],
13	Ghinelli	NNP	PERSON	Ghinelli	appos	4	SENT_436	[p25l237t2148r344b2176],
14	,	,	O	,	_	0	SENT_436	[p25l237t2148r344b2176],
15	J.-C	NNP	O	J.-C	appos	4	SENT_436	[p25l352t2150r406b2175],
16	.	.	O	.	_	0	SENT_436	[p25l352t2150r406b2175],

1	Goffard	NNP	PERSON	Goffard	_	0	SENT_437	[p25l417t2148r521b2176],
2	,	,	O	,	_	0	SENT_437	[p25l417t2148r521b2176],
3	D.	NNP	PERSON	D.	nn	4	SENT_437	[p25l531t2150r558b2171],
4	Gorriahn	NNP	PERSON	Gorriahn	appos	1	SENT_437	[p25l569t2148r689b2176],
5	,	,	O	,	_	0	SENT_437	[p25l569t2148r689b2176],
6	R.	NNP	PERSON	R.	nn	7	SENT_437	[p25l700t2150r725b2173],
7	Greil	NNP	PERSON	Greil	appos	4	SENT_437	[p25l736t2148r804b2176],
8	,	,	O	,	_	0	SENT_437	[p25l736t2148r804b2176],
9	F.	NNP	PERSON	F.	nn	11	SENT_437	[p25l814t2150r836b2171],
10	Gutiérrez	NNP	PERSON	Gutiérrez	nn	11	SENT_437	[p25l847t2147r963b2171],
11	Rodero	NNP	PERSON	Rodero	appos	4	SENT_437	[p25l972t2148r1069b2176],
12	,	,	O	,	_	0	SENT_437	[p25l972t2148r1069b2176],
13	B.	NNP	PERSON	B.	nn	14	SENT_437	[p25l1079t2150r1103b2171],
14	Haas	NNP	PERSON	Haas	appos	4	SENT_437	[p25l1114t2150r1182b2176],
15	,	,	O	,	_	0	SENT_437	[p25l1114t2150r1182b2176],
16	W.	NNP	PERSON	W.	nn	17	SENT_437	[p25l1192t2150r1226b2171],
17	Halota	NNP	PERSON	Halota	appos	4	SENT_437	[p25l1237t2148r1325b2176],
18	,	,	O	,	_	0	SENT_437	[p25l1237t2148r1325b2176],
19	T.	NNP	PERSON	T.	nn	20	SENT_437	[p25l1335t2150r1359b2171],
20	Harrer	NNP	PERSON	Harrer	appos	4	SENT_437	[p25l1370t2150r1458b2176],
21	,	,	O	,	_	0	SENT_437	[p25l1370t2150r1458b2176],
22	J.	NNP	PERSON	J.	nn	24	SENT_437	[p25l1466t2150r1483b2175],
23	Hernandez	NNP	PERSON	Hernandez	nn	24	SENT_437	[p25l1494t2147r1630b2171],
24	Quero	NNP	PERSON	Quero	appos	4	SENT_437	[p25l1639t2150r1722b2177],
25	,	,	O	,	_	0	SENT_437	[p25l1639t2150r1722b2177],
26	M.	NNP	PERSON	M.	nn	27	SENT_437	[p25l1732t2150r1764b2171],
27	Hildebrand	NNP	PERSON	Hildebrand	appos	4	SENT_437	[p25l1775t2148r1922b2176],
28	,	,	O	,	_	0	SENT_437	[p25l1775t2148r1922b2176],
29	B.	NNP	PERSON	B.	nn	30	SENT_437	[p25l237t2187r260b2208],
30	Hoen	NNP	PERSON	Hoen	appos	4	SENT_437	[p25l272t2187r346b2213],
31	,	,	O	,	_	0	SENT_437	[p25l272t2187r346b2213],
32	A.	NNP	PERSON	A.	nn	33	SENT_437	[p25l357t2187r382b2208],
33	Horban	NNP	PERSON	Horban	appos	4	SENT_437	[p25l394t2185r495b2213],
34	,	,	O	,	_	0	SENT_437	[p25l394t2185r495b2213],
35	H.	NNP	O	H.	appos	4	SENT_437	[p25l507t2187r572b2208],
36	.	.	O	.	_	0	SENT_437	[p25l507t2187r572b2208],

1	—	NN	O	—	_	0	SENT_438	[p25l507t2187r572b2208],
2	.	.	O	.	_	0	SENT_438	[p25l507t2187r572b2208],

1	A.	NN	PERSON	a.	nn	2	SENT_439	[p25l507t2187r572b2208],
2	Horst	NNP	PERSON	Horst	_	0	SENT_439	[p25l583t2187r660b2213],
3	,	,	O	,	_	0	SENT_439	[p25l583t2187r660b2213],
4	M.	NNP	PERSON	M.	nn	5	SENT_439	[p25l671t2187r703b2208],
5	Hower	NNP	PERSON	Hower	appos	2	SENT_439	[p25l714t2187r804b2213],
6	,	,	O	,	_	0	SENT_439	[p25l714t2187r804b2213],
7	C.	NNP	PERSON	C.	nn	8	SENT_439	[p25l815t2187r840b2208],
8	Jacomet	NNP	PERSON	Jacomet	appos	2	SENT_439	[p25l849t2187r956b2213],
9	,	,	O	,	_	0	SENT_439	[p25l849t2187r956b2213],
10	Vjeantils	NNP	O	Vjeantils	appos	2	SENT_439	[p25l967t2185r1090b2213],
11	,	,	O	,	_	0	SENT_439	[p25l967t2185r1090b2213],
12	M.	NNP	PERSON	M.	nn	14	SENT_439	[p25l1101t2187r1133b2208],
13	Joao	NNP	PERSON	Joao	nn	14	SENT_439	[p25l1142t2186r1197b2211],
14	Aguas	NNP	PERSON	Aguas	appos	2	SENT_439	[p25l1207t2182r1290b2214],
15	,	,	O	,	_	0	SENT_439	[p25l1207t2182r1290b2214],
16	M.	NNP	PERSON	M.	nn	17	SENT_439	[p25l1301t2187r1332b2208],
17	Johnson	NNP	PERSON	Johnson	appos	2	SENT_439	[p25l1341t2185r1453b2213],
18	,	,	O	,	_	0	SENT_439	[p25l1341t2185r1453b2213],
19	I.	NNP	O	I.	nsubj	20	SENT_439	[p25l1462t2187r1479b2211],
20	lost	VBD	O	lose	dep	2	SENT_439	[p25l1488t2187r1543b2213],
21	,	,	O	,	_	0	SENT_439	[p25l1488t2187r1543b2213],
22	J.R.	NNP	PERSON	J.R.	nn	23	SENT_439	[p25l1551t2187r1596b2211],
23	Iuttmann	NNP	PERSON	Iuttmann	appos	2	SENT_439	[p25l1605t2187r1729b2213],
24	,	,	O	,	_	0	SENT_439	[p25l1605t2187r1729b2213],
25	C.	NNP	PERSON	C.	nn	26	SENT_439	[p25l1740t2187r1765b2208],
26	Katlama	NNP	PERSON	Katlama	appos	2	SENT_439	[p25l1776t2185r1885b2213],
27	,	,	O	,	_	0	SENT_439	[p25l1776t2185r1885b2213],
28	R.	NNP	PERSON	R.	nn	30	SENT_439	[p25l1897t2187r1922b2209],
29	H.	NNP	PERSON	H.	nn	30	SENT_439	[p25l237t2223r265b2245],
30	Kauffmann	NNP	PERSON	Kauffmann	appos	2	SENT_439	[p25l277t2221r423b2250],
31	,	,	O	,	_	0	SENT_439	[p25l277t2221r423b2250],
32	S.	NNP	PERSON	S.	nn	33	SENT_439	[p25l435t2223r456b2245],
33	Kegg	NNP	PERSON	Kegg	appos	2	SENT_439	[p25l467t2223r537b2251],
34	,	,	O	,	_	0	SENT_439	[p25l467t2223r537b2251],
35	M.	NNP	O	M.	appos	2	SENT_439	[p25l548t2223r617b2245],
36	.	.	O	.	_	0	SENT_439	[p25l548t2223r617b2245],

1	—	NN	O	—	_	0	SENT_440	[p25l548t2223r617b2245],
2	.	.	O	.	_	0	SENT_440	[p25l548t2223r617b2245],

1	A.	NN	PERSON	a.	dep	5	SENT_441	[p25l548t2223r617b2245],
2	Khuong	NNP	PERSON	Khuong	dep	1	SENT_441	[p25l628t2221r821b2251],
3	—	CD	NUMBER	—	num	2	SENT_441	[p25l628t2221r821b2251],
4	]	CD	NUMBER	]	num	5	SENT_441	[p25l628t2221r821b2251],
5	osses	NNS	O	oss	_	0	SENT_441	[p25l628t2221r821b2251],
6	,	,	O	,	_	0	SENT_441	[p25l628t2221r821b2251],
7	H.	NNP	PERSON	H.	nn	8	SENT_441	[p25l832t2223r860b2245],
8	Klinker	NNP	PERSON	Klinker	appos	5	SENT_441	[p25l872t2221r970b2250],
9	,	,	O	,	_	0	SENT_441	[p25l872t2221r970b2250],
10	H.	NNP	PERSON	H.	nn	11	SENT_441	[p25l981t2223r1009b2245],
11	Knobel	NNP	PERSON	Knobel	appos	5	SENT_441	[p25l1021t2221r1116b2250],
12	,	,	O	,	_	0	SENT_441	[p25l1021t2221r1116b2250],
13	P.P.	NNP	PERSON	P.P.	nn	14	SENT_441	[p25l1127t2223r1173b2245],
14	Koopmans	NNP	PERSON	Koopmans	appos	5	SENT_441	[p25l1184t2223r1326b2251],
15	,	,	O	,	_	0	SENT_441	[p25l1184t2223r1326b2251],
16	GJ	NNP	O	GJ	appos	5	SENT_441	[p25l1338t2223r1383b2248],
17	.	.	O	.	_	0	SENT_441	[p25l1338t2223r1383b2248],

1	Kootstra	NNP	PERSON	Kootstra	_	0	SENT_442	[p25l1394t2223r1506b2249],
2	,	,	O	,	_	0	SENT_442	[p25l1394t2223r1506b2249],
3	B.	NNP	PERSON	B.	nn	4	SENT_442	[p25l1518t2223r1541b2245],
4	Kuhlmann	NNP	PERSON	Kuhlmann	appos	1	SENT_442	[p25l1553t2221r1691b2250],
5	,	,	O	,	_	0	SENT_442	[p25l1553t2221r1691b2250],
6	V.	NNP	PERSON	V.	nn	7	SENT_442	[p25l1702t2223r1726b2245],
7	Kulagin	NNP	PERSON	Kulagin	appos	4	SENT_442	[p25l1737t2221r1841b2251],
8	,	,	O	,	_	0	SENT_442	[p25l1737t2221r1841b2251],
9	P.	NNP	PERSON	P.	nn	10	SENT_442	[p25l1852t2223r1874b2245],
10	Lacor	NNP	PERSON	Lacor	appos	4	SENT_442	[p25l1885t2223r1923b2245, p25l237t2266r282b2287],
11	,	,	O	,	_	0	SENT_442	[p25l1885t2223r1923b2245, p25l237t2266r282b2287],
12	A.	NNP	PERSON	A.	nn	13	SENT_442	[p25l292t2261r317b2282],
13	Lazzarin	NNP	PERSON	Lazzarin	appos	4	SENT_442	[p25l328t2259r440b2287],
14	,	,	O	,	_	0	SENT_442	[p25l328t2259r440b2287],
15	G.	NNP	PERSON	G.	nn	17	SENT_442	[p25l451t2261r479b2282],
16	Le	NNP	PERSON	Le	nn	17	SENT_442	[p25l489t2261r517b2282],
17	Moal	NNP	PERSON	Moal	appos	4	SENT_442	[p25l526t2259r595b2287],
18	,	,	O	,	_	0	SENT_442	[p25l526t2259r595b2287],
19	P.	NNP	PERSON	P.	nn	20	SENT_442	[p25l606t2261r627b2282],
20	Leclercq	NNP	PERSON	Leclercq	appos	4	SENT_442	[p25l638t2259r747b2288],
21	,	,	O	,	_	0	SENT_442	[p25l638t2259r747b2288],
22	Y.	NNP	PERSON	Y.	nn	23	SENT_442	[p25l757t2261r779b2282],
23	Levy	NNP	PERSON	Levy	appos	4	SENT_442	[p25l790t2261r849b2288],
24	,	,	O	,	_	0	SENT_442	[p25l790t2261r849b2288],
25	1	CD	NUMBER	1	appos	4	SENT_442	[p25l860t2261r876b2282],
26	.	.	O	.	_	0	SENT_442	[p25l860t2261r876b2282],

1	Levy	NNP	PERSON	Levy	_	0	SENT_443	[p25l886t2261r946b2288],
2	,	,	O	,	_	0	SENT_443	[p25l886t2261r946b2288],
3	J.	NNP	O	J.	appos	1	SENT_443	[p25l954t2261r1015b2285],
4	.	.	O	.	_	0	SENT_443	[p25l954t2261r1015b2285],

1	—	NN	O	—	_	0	SENT_444	[p25l954t2261r1015b2285],
2	.	.	O	.	_	0	SENT_444	[p25l954t2261r1015b2285],

1	M.	NNP	PERSON	M.	nn	2	SENT_445	[p25l954t2261r1015b2285],
2	Livrozet	NNP	PERSON	Livrozet	_	0	SENT_445	[p25l1025t2259r1130b2287],
3	,	,	O	,	_	0	SENT_445	[p25l1025t2259r1130b2287],
4	]	CD	NUMBER	]	appos	2	SENT_445	[p25l1138t2261r1189b2285],
5	.	.	O	.	_	0	SENT_445	[p25l1138t2261r1189b2285],

1	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l1138t2261r1189b2285],
2	Llibre	NNP	PERSON	Llibre	dep	113	SENT_446	[p25l1200t2259r1278b2287],
3	,	,	O	,	_	0	SENT_446	[p25l1200t2259r1278b2287],
4	F.	NNP	PERSON	F.	dep	113	SENT_446	[p25l1288t2261r1310b2282],
5	Lozano	NNP	PERSON	Lozano	dep	113	SENT_446	[p25l1320t2261r1417b2287],
6	,	,	O	,	_	0	SENT_446	[p25l1320t2261r1417b2287],
7	F.	NNP	PERSON	F.	dep	113	SENT_446	[p25l1428t2261r1449b2282],
8	Lucht	NNP	PERSON	Lucht	dep	113	SENT_446	[p25l1460t2259r1536b2287],
9	,	,	O	,	_	0	SENT_446	[p25l1460t2259r1536b2287],
10	P.	NNP	PERSON	P.	dep	113	SENT_446	[p25l1547t2261r1568b2282],
11	Malfertheiner	NNP	PERSON	Malfertheiner	dep	113	SENT_446	[p25l1578t2259r1754b2287],
12	,	,	O	,	_	0	SENT_446	[p25l1578t2259r1754b2287],
13	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l1764t2261r1796b2282],
14	Marquez	NNP	PERSON	Marquez	dep	113	SENT_446	[p25l1806t2258r1922b2288],
15	,	,	O	,	_	0	SENT_446	[p25l1806t2258r1922b2288],
16	C.	NNP	PERSON	C.	dep	113	SENT_446	[p25l237t2298r261b2319],
17	Mazhude	NNP	PERSON	Mazhude	dep	113	SENT_446	[p25l273t2296r394b2324],
18	,	,	O	,	_	0	SENT_446	[p25l273t2296r394b2324],
19	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l405t2298r437b2319],
20	Mazzeo	NNP	PERSON	Mazzeo	dep	113	SENT_446	[p25l448t2298r550b2324],
21	,	,	O	,	_	0	SENT_446	[p25l448t2298r550b2324],
22	F.	NNP	PERSON	F.	dep	113	SENT_446	[p25l562t2298r583b2319],
23	Melo	NNP	PERSON	Melo	dep	113	SENT_446	[p25l594t2296r656b2319],
24	Mota	NNP	PERSON	Mota	dep	113	SENT_446	[p25l666t2298r736b2324],
25	,	,	O	,	_	0	SENT_446	[p25l666t2298r736b2324],
26	I.	NNP	PERSON	I.	dep	113	SENT_446	[p25l748t2298r763b2319],
27	Mezzaroma	NNP	PERSON	Mezzaroma	dep	113	SENT_446	[p25l775t2298r927b2324],
28	,	,	O	,	_	0	SENT_446	[p25l775t2298r927b2324],
29	P.	NNP	PERSON	P.	dep	113	SENT_446	[p25l939t2298r960b2319],
30	Mian	NNP	PERSON	Mian	dep	113	SENT_446	[p25l971t2296r1041b2324],
31	,	,	O	,	_	0	SENT_446	[p25l971t2296r1041b2324],
32	C.	NNP	PERSON	C.	dep	113	SENT_446	[p25l1053t2298r1078b2319],
33	Michel	NNP	PERSON	Michel	dep	113	SENT_446	[p25l1089t2296r1180b2324],
34	,	,	O	,	_	0	SENT_446	[p25l1089t2296r1180b2324],
35	C.	NNP	PERSON	C.	dep	113	SENT_446	[p25l1192t2298r1216b2319],
36	Michelet	NNP	PERSON	Michelet	dep	113	SENT_446	[p25l1227t2296r1341b2324],
37	,	,	O	,	_	0	SENT_446	[p25l1227t2296r1341b2324],
38	C.	NNP	PERSON	C.	dep	113	SENT_446	[p25l1353t2298r1377b2319],
39	Michon	NNP	PERSON	Michon	dep	113	SENT_446	[p25l1388t2296r1491b2324],
40	,	,	O	,	_	0	SENT_446	[p25l1388t2296r1491b2324],
41	J.M.	NNP	PERSON	J.M.	dep	113	SENT_446	[p25l1500t2298r1550b2323],
42	Santamaria	NNP	PERSON	Santamaria	dep	113	SENT_446	[p25l1563t2296r1708b2324],
43	,	,	O	,	_	0	SENT_446	[p25l1563t2296r1708b2324],
44	V.	NNP	PERSON	V.	dep	113	SENT_446	[p25l1719t2298r1743b2319],
45	Molotilov	NNP	PERSON	Molotilov	dep	113	SENT_446	[p25l1754t2296r1879b2324],
46	,	,	O	,	_	0	SENT_446	[p25l1754t2296r1879b2324],
47	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l1890t2298r1922b2319],
48	Montroni	NNP	PERSON	Montroni	dep	113	SENT_446	[p25l236t2333r361b2361],
49	,	,	O	,	_	0	SENT_446	[p25l236t2333r361b2361],
50	I.	NNP	PERSON	I.	dep	113	SENT_446	[p25l370t2335r387b2359],
51	Moreau	NNP	PERSON	Moreau	dep	113	SENT_446	[p25l398t2335r499b2361],
52	,	,	O	,	_	0	SENT_446	[p25l398t2335r499b2361],
53	E.	NNP	PERSON	E.	dep	113	SENT_446	[p25l510t2335r533b2356],
54	Morgan	NNP	PERSON	Morgan	dep	113	SENT_446	[p25l544t2335r648b2362],
55	,	,	O	,	_	0	SENT_446	[p25l544t2335r648b2362],
56	P.	NNP	PERSON	P.	dep	113	SENT_446	[p25l659t2335r681b2356],
57	Morlat	NNP	PERSON	Morlat	dep	113	SENT_446	[p25l692t2333r781b2361],
58	,	,	O	,	_	0	SENT_446	[p25l692t2333r781b2361],
59	G.	NNP	PERSON	G.	dep	113	SENT_446	[p25l793t2335r820b2356],
60	Moshkovich	NNP	PERSON	Moshkovich	dep	113	SENT_446	[p25l831t2333r989b2360],
61	,	,	O	,	_	0	SENT_446	[p25l831t2333r989b2360],
62	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l1000t2335r1032b2356],
63	Moutschen	NNP	PERSON	Moutschen	dep	113	SENT_446	[p25l1043t2333r1188b2361],
64	,	,	O	,	_	0	SENT_446	[p25l1043t2333r1188b2361],
65	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l1199t2335r1230b2356],
66	Mﬁller	NNP	PERSON	Mﬁller	dep	113	SENT_446	[p25l1241t2333r1329b2361],
67	,	,	O	,	_	0	SENT_446	[p25l1241t2333r1329b2361],
68	A.	NNP	PERSON	A.	dep	113	SENT_446	[p25l1340t2335r1365b2356],
69	Mutz	NNP	PERSON	Mutz	dep	113	SENT_446	[p25l1376t2335r1446b2361],
70	,	,	O	,	_	0	SENT_446	[p25l1376t2335r1446b2361],
71	L.	NNP	PERSON	L.	dep	113	SENT_446	[p25l1457t2335r1479b2356],
72	Naumova	NNP	PERSON	Naumova	dep	113	SENT_446	[p25l1490t2335r1615b2361],
73	,	,	O	,	_	0	SENT_446	[p25l1490t2335r1615b2361],
74	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l1626t2335r1657b2356],
75	Nelson	NNP	PERSON	Nelson	dep	113	SENT_446	[p25l1668t2333r1763b2361],
76	,	,	O	,	_	0	SENT_446	[p25l1668t2333r1763b2361],
77	A.	NNP	PERSON	A.	dep	113	SENT_446	[p25l1774t2335r1799b2356],
78	Ocampo	NNP	PERSON	Ocampo	dep	113	SENT_446	[p25l1811t2335r1922b2362],
79	,	,	O	,	_	0	SENT_446	[p25l1811t2335r1922b2362],
80	O.	NNP	O	O.	dep	113	SENT_446	[p25l237t2371r264b2393],
81	(	NNP	O	(	dep	113	SENT_446	[p25l276t2369r409b2398],
82	Dktedalen	NNP	O	Dktedalen	dep	113	SENT_446	[p25l276t2369r409b2398],
83	,	,	O	,	_	0	SENT_446	[p25l276t2369r409b2398],
84	C.	NNP	PERSON	C.	dep	113	SENT_446	[p25l421t2371r446b2393],
85	Oliveira	NNP	PERSON	Oliveira	dep	113	SENT_446	[p25l458t2369r560b2398],
86	,	,	O	,	_	0	SENT_446	[p25l458t2369r560b2398],
87	P.	NNP	PERSON	P.	dep	113	SENT_446	[p25l572t2371r593b2393],
88	Ortolani	NNP	PERSON	Ortolani	dep	113	SENT_446	[p25l605t2369r715b2398],
89	,	,	O	,	_	0	SENT_446	[p25l605t2369r715b2398],
90	G.	NNP	PERSON	G.	dep	113	SENT_446	[p25l727t2371r755b2393],
91	Pagano	NNP	PERSON	Pagano	dep	113	SENT_446	[p25l767t2371r864b2399],
92	,	,	O	,	_	0	SENT_446	[p25l767t2371r864b2399],
93	M.	NNP	PERSON	M.	dep	113	SENT_446	[p25l875t2371r907b2393],
94	Partisani	NNP	PERSON	Partisani	dep	113	SENT_446	[p25l919t2370r1033b2398],
95	,	,	O	,	_	0	SENT_446	[p25l919t2370r1033b2398],
96	G.	NNP	PERSON	G.	dep	113	SENT_446	[p25l1045t2371r1073b2393],
97	Pastore	NNP	PERSON	Pastore	dep	113	SENT_446	[p25l1085t2371r1182b2398],
98	,	,	O	,	_	0	SENT_446	[p25l1085t2371r1182b2398],
99	A.	NNP	PERSON	A.	dep	113	SENT_446	[p25l1193t2371r1218b2393],
100	Paula	NNP	PERSON	Paula	dep	113	SENT_446	[p25l1230t2369r1297b2393],
101	Reis	NNP	PERSON	Reis	dep	113	SENT_446	[p25l1307t2370r1366b2398],
102	,	,	O	,	_	0	SENT_446	[p25l1307t2370r1366b2398],
103	I.	NNP	PERSON	I.	dep	113	SENT_446	[p25l1375t2371r1392b2396],
104	Pedreira	NNP	PERSON	Pedreira	dep	113	SENT_446	[p25l1404t2369r1506b2393],
105	Andrade	NNP	PERSON	Andrade	dep	113	SENT_446	[p25l1515t2369r1627b2398],
106	,	,	O	,	_	0	SENT_446	[p25l1515t2369r1627b2398],
107	E.	NNP	PERSON	E.	dep	113	SENT_446	[p25l1639t2371r1661b2393],
108	Pedrol	NNP	PERSON	Pedrol	dep	113	SENT_446	[p25l1673t2369r1759b2398],
109	,	,	O	,	_	0	SENT_446	[p25l1673t2369r1759b2398],
110	G.	NNP	PERSON	G.	dep	113	SENT_446	[p25l1771t2371r1799b2393],
111	Pellizzer	NNP	PERSON	Pellizzer	dep	113	SENT_446	[p25l1811t2369r1922b2398],
112	,	,	O	,	_	0	SENT_446	[p25l1811t2369r1922b2398],
113	MJ	NNP	ORGANIZATION	MJ	_	0	SENT_446	[p25l236t2409r285b2433],
114	.	.	O	.	_	0	SENT_446	[p25l236t2409r285b2433],

1	Pérez	NNP	PERSON	Pérez	nn	2	SENT_447	[p25l297t2406r363b2430],
2	Elias	NNP	PERSON	Elias	_	0	SENT_447	[p25l373t2406r438b2435],
3	,	,	O	,	_	0	SENT_447	[p25l373t2406r438b2435],
4	P.	NNP	PERSON	P.	nn	5	SENT_447	[p25l450t2409r472b2430],
5	Perfezou	NNP	PERSON	Perfezou	appos	2	SENT_447	[p25l483t2407r598b2435],
6	,	,	O	,	_	0	SENT_447	[p25l483t2407r598b2435],
7	P.	NNP	PERSON	P.	nn	8	SENT_447	[p25l610t2409r631b2430],
8	Perre	NNP	PERSON	Perre	appos	5	SENT_447	[p25l643t2409r713b2435],
9	,	,	O	,	_	0	SENT_447	[p25l643t2409r713b2435],
10	S.	NNP	PERSON	S.	nn	12	SENT_447	[p25l726t2409r746b2430],
11	Pheng	NNP	PERSON	Pheng	nn	12	SENT_447	[p25l758t2407r836b2436],
12	Quah	NNP	PERSON	Quah	appos	5	SENT_447	[p25l845t2407r919b2435],
13	,	,	O	,	_	0	SENT_447	[p25l845t2407r919b2435],
14	P.	NNP	PERSON	P.	nn	15	SENT_447	[p25l931t2409r952b2430],
15	Philibert	NNP	PERSON	Philibert	appos	5	SENT_447	[p25l964t2407r1076b2435],
16	,	,	O	,	_	0	SENT_447	[p25l964t2407r1076b2435],
17	G.	NNP	PERSON	G.	nn	18	SENT_447	[p25l1088t2409r1115b2430],
18	Pialoux	NNP	PERSON	Pialoux	appos	5	SENT_447	[p25l1127t2407r1224b2435],
19	,	,	O	,	_	0	SENT_447	[p25l1127t2407r1224b2435],
20	L.	NNP	PERSON	L.	nn	21	SENT_447	[p25l1236t2409r1257b2430],
21	Piroth	NNP	PERSON	Piroth	appos	5	SENT_447	[p25l1269t2407r1351b2435],
22	,	,	O	,	_	0	SENT_447	[p25l1269t2407r1351b2435],
23	A.	NNP	PERSON	A.	nn	24	SENT_447	[p25l1362t2409r1387b2430],
24	Plettenberg	NNP	PERSON	Plettenberg	appos	5	SENT_447	[p25l1399t2407r1547b2436],
25	,	,	O	,	_	0	SENT_447	[p25l1399t2407r1547b2436],
26	D.	NNP	PERSON	D.	nn	27	SENT_447	[p25l1558t2409r1585b2430],
27	Podzamczer	NNP	PERSON	Podzamczer	appos	5	SENT_447	[p25l1597t2407r1755b2435],
28	,	,	O	,	_	0	SENT_447	[p25l1597t2407r1755b2435],
29	A.	NNP	PERSON	A.	nn	30	SENT_447	[p25l1766t2409r1791b2430],
30	Poggio	NNP	PERSON	Poggio	appos	5	SENT_447	[p25l1803t2407r1895b2436],
31	,	,	O	,	_	0	SENT_447	[p25l1803t2407r1895b2436],
32	J.	NNP	PERSON	J.	nn	33	SENT_447	[p25l1905t2409r1922b2433],
33	Portilla	NNP	PERSON	Portilla	appos	5	SENT_447	[p25l237t2443r332b2472],
34	,	,	O	,	_	0	SENT_447	[p25l237t2443r332b2472],
35	S.	NNP	LOCATION	S.	nn	36	SENT_447	[p25l346t2445r366b2467],
36	Portsmouth	NNP	LOCATION	Portsmouth	appos	5	SENT_447	[p25l379t2443r532b2472],
37	,	,	O	,	_	0	SENT_447	[p25l379t2443r532b2472],
38	I.	NNP	PERSON	I.	nn	40	SENT_447	[p25l542t2445r559b2470],
39	Portu	NNP	PERSON	Portu	nn	40	SENT_447	[p25l572t2445r638b2467],
40	Zapirain	NNP	PERSON	Zapirain	appos	5	SENT_447	[p25l649t2444r759b2473],
41	,	,	O	,	_	0	SENT_447	[p25l649t2444r759b2473],
42	L.	NNP	PERSON	L.	nn	43	SENT_447	[p25l772t2445r793b2467],
43	Potemina	NNP	PERSON	Potemina	appos	5	SENT_447	[p25l806t2444r930b2472],
44	,	,	O	,	_	0	SENT_447	[p25l806t2444r930b2472],
45	T.	NNP	PERSON	T.	nn	46	SENT_447	[p25l942t2445r966b2467],
46	Prazuck	NNP	PERSON	Prazuck	appos	5	SENT_447	[p25l979t2443r1083b2472],
47	,	,	O	,	_	0	SENT_447	[p25l979t2443r1083b2472],
48	L.	NNP	O	L.	appos	5	SENT_447	[p25l1096t2445r1145b2470],
49	.	.	O	.	_	0	SENT_447	[p25l1096t2445r1145b2470],

1	—	NN	O	—	_	0	SENT_448	[p25l1096t2445r1145b2470],
2	.	.	O	.	_	0	SENT_448	[p25l1096t2445r1145b2470],

1	J.	NNP	PERSON	J.	nn	2	SENT_449	[p25l1096t2445r1145b2470],
2	Prisecariu	NNP	PERSON	Prisecariu	_	0	SENT_449	[p25l1158t2444r1286b2472],
3	,	,	O	,	_	0	SENT_449	[p25l1158t2444r1286b2472],
4	F.	NNP	PERSON	F.	nn	5	SENT_449	[p25l1299t2445r1320b2467],
5	Pulido	NNP	PERSON	Pulido	appos	2	SENT_449	[p25l1333t2443r1418b2472],
6	,	,	O	,	_	0	SENT_449	[p25l1333t2443r1418b2472],
7	T.	NNP	PERSON	T.	nn	8	SENT_449	[p25l1430t2445r1454b2467],
8	Quirino	NNP	PERSON	Quirino	appos	2	SENT_449	[p25l1468t2444r1570b2472],
9	,	,	O	,	_	0	SENT_449	[p25l1468t2444r1570b2472],
10	F.	NNP	PERSON	F.	nn	11	SENT_449	[p25l1583t2445r1604b2467],
11	Rafﬁ	NNP	PERSON	Rafﬁ	appos	2	SENT_449	[p25l1617t2443r1683b2472],
12	,	,	O	,	_	0	SENT_449	[p25l1617t2443r1683b2472],
13	J.	NNP	O	J.	appos	2	SENT_449	[p25l1693t2445r1754b2470],
14	.	.	O	.	_	0	SENT_449	[p25l1693t2445r1754b2470],

1	—	NN	O	—	_	0	SENT_450	[p25l1693t2445r1754b2470],
2	.	.	O	.	_	0	SENT_450	[p25l1693t2445r1754b2470],

1	M.	NNP	PERSON	M.	nn	2	SENT_451	[p25l1693t2445r1754b2470],
2	Ragnaud	NNP	PERSON	Ragnaud	_	0	SENT_451	[p25l1767t2443r1884b2473],
3	,	,	O	,	_	0	SENT_451	[p25l1767t2443r1884b2473],
4	R.	NNP	PERSON	R.	nn	5	SENT_451	[p25l1897t2445r1922b2468],
5	Rajakumar	NNP	PERSON	Rajakumar	appos	2	SENT_451	[p25l237t2481r377b2510],
6	,	,	O	,	_	0	SENT_451	[p25l237t2481r377b2510],
7	D.	NNP	PERSON	D.	nn	8	SENT_451	[p25l387t2483r414b2504],
8	Reichelt	NNP	PERSON	Reichelt	appos	2	SENT_451	[p25l424t2481r531b2509],
9	,	,	O	,	_	0	SENT_451	[p25l424t2481r531b2509],
10	D.	NNP	PERSON	D.	nn	11	SENT_451	[p25l540t2483r567b2504],
11	Reschke	NNP	PERSON	Reschke	appos	2	SENT_451	[p25l577t2481r687b2509],
12	,	,	O	,	_	0	SENT_451	[p25l577t2481r687b2509],
13	L.	NNP	PERSON	L.	nn	14	SENT_451	[p25l696t2483r718b2504],
14	Rezzouk	NNP	PERSON	Rezzouk	appos	2	SENT_451	[p25l727t2481r841b2509],
15	,	,	O	,	_	0	SENT_451	[p25l727t2481r841b2509],
16	E.	NNP	PERSON	E.	nn	17	SENT_451	[p25l851t2483r873b2504],
17	Ribera	NNP	PERSON	Ribera	appos	2	SENT_451	[p25l883t2481r970b2509],
18	,	,	O	,	_	0	SENT_451	[p25l883t2481r970b2509],
19	C.	NNP	PERSON	C.	nn	20	SENT_451	[p25l980t2483r1005b2504],
20	Richter	NNP	PERSON	Richter	appos	2	SENT_451	[p25l1014t2481r1110b2509],
21	,	,	O	,	_	0	SENT_451	[p25l1014t2481r1110b2509],
22	J.	NNP	PERSON	J.	nn	23	SENT_451	[p25l1118t2483r1135b2507],
23	Ringstad	NNP	PERSON	Ringstad	appos	2	SENT_451	[p25l1145t2481r1262b2510],
24	,	,	O	,	_	0	SENT_451	[p25l1145t2481r1262b2510],
25	J.	NNP	PERSON	J.	nn	26	SENT_451	[p25l1269t2483r1286b2507],
26	Rios	NNP	PERSON	Rios	appos	2	SENT_451	[p25l1296t2480r1357b2509],
27	,	,	O	,	_	0	SENT_451	[p25l1296t2480r1357b2509],
28	R.	NNP	PERSON	R.	nn	29	SENT_451	[p25l1367t2483r1392b2505],
29	Riou	NNP	PERSON	Riou	appos	2	SENT_451	[p25l1402t2481r1467b2509],
30	,	,	O	,	_	0	SENT_451	[p25l1402t2481r1467b2509],
31	G.	NNP	PERSON	G.	nn	32	SENT_451	[p25l1477t2483r1504b2504],
32	Rizzardini	NNP	PERSON	Rizzardini	appos	2	SENT_451	[p25l1514t2481r1648b2509],
33	,	,	O	,	_	0	SENT_451	[p25l1514t2481r1648b2509],
34	E.	NNP	PERSON	E.	nn	35	SENT_451	[p25l1658t2483r1681b2504],
35	Rosenthal	NNP	PERSON	Rosenthal	appos	2	SENT_451	[p25l1690t2481r1822b2509],
36	,	,	O	,	_	0	SENT_451	[p25l1690t2481r1822b2509],
37	J.	NNP	PERSON	J.	nn	38	SENT_451	[p25l1829t2483r1846b2507],
38	Ross	NNP	PERSON	Ross	appos	2	SENT_451	[p25l1856t2483r1922b2509],
39	,	,	O	,	_	0	SENT_451	[p25l1856t2483r1922b2509],
40	M.	NNP	PERSON	M.	nn	41	SENT_451	[p25l236t2520r268b2541],
41	Rothen	NNP	PERSON	Rothen	appos	2	SENT_451	[p25l279t2518r376b2546],
42	,	,	O	,	_	0	SENT_451	[p25l279t2518r376b2546],
43	C.	NNP	PERSON	C.	nn	44	SENT_451	[p25l388t2520r412b2541],
44	Rouger	NNP	PERSON	Rouger	appos	2	SENT_451	[p25l423t2520r520b2547],
45	,	,	O	,	_	0	SENT_451	[p25l423t2520r520b2547],
46	S.	NNP	PERSON	S.	nn	47	SENT_451	[p25l532t2520r553b2541],
47	Ruban	NNP	PERSON	Ruban	appos	2	SENT_451	[p25l564t2518r651b2546],
48	,	,	O	,	_	0	SENT_451	[p25l564t2518r651b2546],
49	R.	NNP	PERSON	R.	nn	50	SENT_451	[p25l663t2520r688b2542],
50	Rubio	NNP	PERSON	Rubio	appos	2	SENT_451	[p25l699t2518r780b2546],
51	,	,	O	,	_	0	SENT_451	[p25l699t2518r780b2546],
52	J.	NNP	O	J.	appos	2	SENT_451	[p25l789t2520r843b2544],
53	.	.	O	.	_	0	SENT_451	[p25l789t2520r843b2544],

1	—	NN	O	—	_	0	SENT_452	[p25l789t2520r843b2544],
2	.	.	O	.	_	0	SENT_452	[p25l789t2520r843b2544],

1	A.	NN	O	a.	nn	2	SENT_453	[p25l789t2520r843b2544],
2	Rump	NNP	O	Rump	_	0	SENT_453	[p25l854t2520r937b2547],
3	,	,	O	,	_	0	SENT_453	[p25l854t2520r937b2547],
4	S.	NNP	PERSON	S.	nn	5	SENT_453	[p25l949t2520r969b2541],
5	Rusconi	NNP	PERSON	Rusconi	appos	2	SENT_453	[p25l981t2518r1088b2546],
6	,	,	O	,	_	0	SENT_453	[p25l981t2518r1088b2546],
7	D.	NNP	PERSON	D.	nn	8	SENT_453	[p25l1099t2520r1126b2541],
8	Salmon	NNP	PERSON	Salmon	appos	5	SENT_453	[p25l1138t2518r1324b2546],
9	.	.	O	.	_	0	SENT_453	[p25l1138t2518r1324b2546],

1	—	NN	O	—	_	0	SENT_454	[p25l1138t2518r1324b2546],
2	.	.	O	.	_	0	SENT_454	[p25l1138t2518r1324b2546],

1	Ceron	NNP	PERSON	Ceron	_	0	SENT_455	[p25l1138t2518r1324b2546],
2	,	,	O	,	_	0	SENT_455	[p25l1138t2518r1324b2546],
3	I.	NNP	PERSON	I.	nn	5	SENT_455	[p25l1333t2520r1350b2544],
4	Sanz	NNP	PERSON	Sanz	nn	5	SENT_455	[p25l1362t2520r1420b2541],
5	Moreno	NNP	PERSON	Moreno	appos	1	SENT_455	[p25l1429t2520r1534b2546],
6	,	,	O	,	_	0	SENT_455	[p25l1429t2520r1534b2546],
7	J.	NNP	PERSON	J.	nn	14	SENT_455	[p25l1542t2520r1560b2544],
8	Sanz	NNP	PERSON	Sanz	nn	14	SENT_455	[p25l1572t2520r1636b2546],
9	,	,	O	,	_	0	SENT_455	[p25l1572t2520r1636b2546],
10	R	NNP	O	R	appos	14	SENT_455	[p25l1648t2520r1673b2542],
11	,	,	O	,	_	0	SENT_455	[p25l1648t2520r1673b2542],
12	Sarmento	NNP	PERSON	Sarmento	appos	14	SENT_455	[p25l1685t2520r1803b2541],
13	e	LS	O	e	dep	14	SENT_455	[p25l1813t2525r1825b2541],
14	Castro	NNP	PERSON	Castro	appos	1	SENT_455	[p25l1835t2520r1922b2546],
15	,	,	O	,	_	0	SENT_455	[p25l1835t2520r1922b2546],
16	H.	NNP	O	H.	appos	1	SENT_455	[p25l237t2557r309b2578],
17	.	.	O	.	_	0	SENT_455	[p25l237t2557r309b2578],

1	—	NN	O	—	_	0	SENT_456	[p25l237t2557r309b2578],
2	.	.	O	.	_	0	SENT_456	[p25l237t2557r309b2578],

1	M.	NNP	PERSON	M.	nn	2	SENT_457	[p25l237t2557r309b2578],
2	Schalk	NNP	PERSON	Schalk	_	0	SENT_457	[p25l320t2555r407b2583],
3	,	,	O	,	_	0	SENT_457	[p25l320t2555r407b2583],
4	B.	NNP	PERSON	B.	nn	5	SENT_457	[p25l418t2557r441b2578],
5	Schappert	NNP	PERSON	Schappert	appos	2	SENT_457	[p25l453t2555r582b2584],
6	,	,	O	,	_	0	SENT_457	[p25l453t2555r582b2584],
7	K.	NNP	PERSON	K.	nn	8	SENT_457	[p25l593t2557r618b2578],
8	Schewe	NNP	PERSON	Schewe	appos	2	SENT_457	[p25l629t2555r727b2583],
9	,	,	O	,	_	0	SENT_457	[p25l629t2555r727b2583],
10	R.E.	NNP	PERSON	R.E.	nn	11	SENT_457	[p25l737t2557r787b2579],
11	Schmidt	NNP	PERSON	Schmidt	appos	2	SENT_457	[p25l799t2555r907b2583],
12	,	,	O	,	_	0	SENT_457	[p25l799t2555r907b2583],
13	I.	NNP	O	I.	appos	2	SENT_457	[p25l915t2557r966b2581],
14	.	.	O	.	_	0	SENT_457	[p25l915t2557r966b2581],

1	—	NN	O	—	_	0	SENT_458	[p25l915t2557r966b2581],
2	.	.	O	.	_	0	SENT_458	[p25l915t2557r966b2581],

1	L.	NNP	PERSON	L.	nn	2	SENT_459	[p25l915t2557r966b2581],
2	Schmit	NNP	PERSON	Schmit	_	0	SENT_459	[p25l977t2555r1070b2583],
3	,	,	O	,	_	0	SENT_459	[p25l977t2555r1070b2583],
4	E.	NNP	PERSON	E.	nn	5	SENT_459	[p25l1080t2557r1102b2578],
5	Schnaitmann	NNP	PERSON	Schnaitmann	appos	2	SENT_459	[p25l1114t2555r1284b2583],
6	,	,	O	,	_	0	SENT_459	[p25l1114t2555r1284b2583],
7	L.	NNP	PERSON	L.	nn	8	SENT_459	[p25l1294t2557r1315b2578],
8	Schneider	NNP	PERSON	Schneider	appos	5	SENT_459	[p25l1327t2555r1455b2583],
9	,	,	O	,	_	0	SENT_459	[p25l1327t2555r1455b2583],
10	D.	NNP	PERSON	D.	nn	11	SENT_459	[p25l1465t2557r1492b2578],
11	Schuermann	NNP	PERSON	Schuermann	appos	5	SENT_459	[p25l1503t2555r1666b2583],
12	,	,	O	,	_	0	SENT_459	[p25l1503t2555r1666b2583],
13	D.	NNP	PERSON	D.	nn	14	SENT_459	[p25l1676t2557r1703b2578],
14	Sereni	NNP	PERSON	Sereni	appos	5	SENT_459	[p25l1714t2555r1797b2583],
15	,	,	O	,	_	0	SENT_459	[p25l1714t2555r1797b2583],
16	M.	NNP	PERSON	M.	nn	17	SENT_459	[p25l1807t2557r1839b2578],
17	Sezin	NNP	PERSON	Sezin	appos	5	SENT_459	[p25l1850t2555r1922b2583],
18	,	,	O	,	_	0	SENT_459	[p25l1850t2555r1922b2583],
19	Z.	NNP	PERSON	Z.	nn	20	SENT_459	[p25l236t2594r259b2615],
20	Shtoeger	NNP	PERSON	Shtoeger	appos	5	SENT_459	[p25l269t2592r385b2621],
21	,	,	O	,	_	0	SENT_459	[p25l269t2592r385b2621],
22	G.	NNP	PERSON	G.	nn	23	SENT_459	[p25l395t2594r422b2615],
23	Singh	NNP	PERSON	Singh	appos	5	SENT_459	[p25l433t2592r510b2621],
24	,	,	O	,	_	0	SENT_459	[p25l433t2592r510b2621],
25	P.	NNP	PERSON	P.	nn	26	SENT_459	[p25l520t2594r541b2615],
26	Sood	NNP	PERSON	Sood	appos	5	SENT_459	[p25l552t2592r620b2620],
27	,	,	O	,	_	0	SENT_459	[p25l552t2592r620b2620],
28	V.	NNP	PERSON	V.	nn	29	SENT_459	[p25l628t2594r652b2615],
29	Soriano	NNP	PERSON	Soriano	appos	5	SENT_459	[p25l663t2592r764b2620],
30	,	,	O	,	_	0	SENT_459	[p25l663t2592r764b2620],
31	F.	NNP	PERSON	F.	nn	32	SENT_459	[p25l774t2594r795b2615],
32	Soscia	NNP	PERSON	Soscia	appos	5	SENT_459	[p25l805t2592r889b2620],
33	,	,	O	,	_	0	SENT_459	[p25l805t2592r889b2620],
34	A.	NNP	PERSON	A.	nn	35	SENT_459	[p25l898t2594r923b2615],
35	Sotto	NNP	PERSON	Sotto	appos	5	SENT_459	[p25l933t2594r1003b2619],
36	,	,	O	,	_	0	SENT_459	[p25l933t2594r1003b2619],
37	H.G.	NNP	PERSON	H.G.	nn	38	SENT_459	[p25l1013t2594r1072b2615],
38	Sprenger	NNP	PERSON	Sprenger	appos	5	SENT_459	[p25l1082t2594r1200b2621],
39	,	,	O	,	_	0	SENT_459	[p25l1082t2594r1200b2621],
40	S.	NNP	PERSON	S.	nn	41	SENT_459	[p25l1210t2594r1230b2615],
41	Staszewski	NNP	PERSON	Staszewski	appos	5	SENT_459	[p25l1241t2592r1381b2620],
42	,	,	O	,	_	0	SENT_459	[p25l1241t2592r1381b2620],
43	M.	NNP	PERSON	M.	nn	45	SENT_459	[p25l1390t2594r1422b2615],
44	Stella	NNP	PERSON	Stella	nn	45	SENT_459	[p25l1432t2592r1499b2615],
45	Mura	NNP	PERSON	Mura	appos	5	SENT_459	[p25l1506t2594r1578b2620],
46	,	,	O	,	_	0	SENT_459	[p25l1506t2594r1578b2620],
47	A.	NNP	PERSON	A.	nn	48	SENT_459	[p25l1587t2594r1612b2615],
48	Streinu	NNP	PERSON	Streinu	appos	5	SENT_459	[p25l1622t2592r1804b2620],
49	.	.	O	.	_	0	SENT_459	[p25l1622t2592r1804b2620],

1	—	NN	O	—	_	0	SENT_460	[p25l1622t2592r1804b2620],
2	.	.	O	.	_	0	SENT_460	[p25l1622t2592r1804b2620],

1	Cercel	NNP	PERSON	Cercel	dep	119	SENT_461	[p25l1622t2592r1804b2620],
2	,	,	O	,	_	0	SENT_461	[p25l1622t2592r1804b2620],
3	G.	NNP	PERSON	G.	dep	119	SENT_461	[p25l1814t2594r1842b2615],
4	Sture	NNP	PERSON	Sture	dep	119	SENT_461	[p25l1852t2594r1922b2620],
5	,	,	O	,	_	0	SENT_461	[p25l1852t2594r1922b2620],
6	L.	NNP	PERSON	L.	dep	119	SENT_461	[p25l237t2631r258b2652],
7	Sultanov	NNP	PERSON	Sultanov	dep	119	SENT_461	[p25l271t2629r382b2657],
8	,	,	O	,	_	0	SENT_461	[p25l271t2629r382b2657],
9	F.	NNP	PERSON	F.	dep	119	SENT_461	[p25l394t2631r415b2652],
10	Suter	NNP	PERSON	Suter	dep	119	SENT_461	[p25l428t2631r497b2657],
11	,	,	O	,	_	0	SENT_461	[p25l428t2631r497b2657],
12	M.	NNP	PERSON	M.	dep	119	SENT_461	[p25l508t2631r540b2652],
13	Tarasova	NNP	PERSON	Tarasova	dep	119	SENT_461	[p25l551t2631r668b2657],
14	,	,	O	,	_	0	SENT_461	[p25l551t2631r668b2657],
15	M.	NNP	PERSON	M.	dep	119	SENT_461	[p25l679t2631r711b2652],
16	Telenti	NNP	PERSON	Telenti	dep	119	SENT_461	[p25l722t2629r814b2657],
17	,	,	O	,	_	0	SENT_461	[p25l722t2629r814b2657],
18	H.	NNP	PERSON	H.	dep	119	SENT_461	[p25l826t2631r854b2652],
19	Thaker	NNP	PERSON	Thaker	dep	119	SENT_461	[p25l865t2629r959b2657],
20	,	,	O	,	_	0	SENT_461	[p25l865t2629r959b2657],
21	F.	NNP	PERSON	F.	dep	119	SENT_461	[p25l971t2631r992b2652],
22	Tollinchi	NNP	PERSON	Tollinchi	dep	119	SENT_461	[p25l1003t2629r1122b2657],
23	,	,	O	,	_	0	SENT_461	[p25l1003t2629r1122b2657],
24	O.	NNP	PERSON	O.	dep	119	SENT_461	[p25l1134t2631r1161b2652],
25	Tonkikh	NNP	PERSON	Tonkikh	dep	119	SENT_461	[p25l1171t2629r1284b2657],
26	,	,	O	,	_	0	SENT_461	[p25l1171t2629r1284b2657],
27	M.	NNP	PERSON	M.	dep	119	SENT_461	[p25l1295t2631r1327b2652],
28	Trezzi	NNP	PERSON	Trezzi	dep	119	SENT_461	[p25l1338t2629r1422b2657],
29	,	,	O	,	_	0	SENT_461	[p25l1338t2629r1422b2657],
30	O.	NNP	PERSON	O.	dep	119	SENT_461	[p25l1434t2631r1461b2652],
31	Tsybakova	NNP	PERSON	Tsybakova	dep	119	SENT_461	[p25l1472t2629r1608b2658],
32	,	,	O	,	_	0	SENT_461	[p25l1472t2629r1608b2658],
33	D.	NNP	PERSON	D.	dep	119	SENT_461	[p25l1619t2631r1646b2652],
34	Turner	NNP	PERSON	Turner	dep	119	SENT_461	[p25l1657t2631r1749b2657],
35	,	,	O	,	_	0	SENT_461	[p25l1657t2631r1749b2657],
36	A.	NNP	PERSON	A.	dep	119	SENT_461	[p25l1760t2631r1785b2652],
37	Vaglia	NNP	PERSON	Vaglia	dep	119	SENT_461	[p25l1796t2629r1879b2658],
38	,	,	O	,	_	0	SENT_461	[p25l1796t2629r1879b2658],
39	M.	NNP	PERSON	M.	dep	119	SENT_461	[p25l1890t2631r1922b2652],
40	M.	NNP	PERSON	M.	dep	119	SENT_461	[p25l236t2668r268b2689],
41	van	NNP	PERSON	van	dep	119	SENT_461	[p25l278t2673r321b2689],
42	den	NN	PERSON	den	dep	119	SENT_461	[p25l331t2666r376b2689],
43	Berge	NNP	PERSON	Berge	dep	119	SENT_461	[p25l385t2668r462b2695],
44	,	,	O	,	_	0	SENT_461	[p25l385t2668r462b2695],
45	M.E.	NNP	PERSON	M.E.	dep	119	SENT_461	[p25l473t2668r530b2689],
46	van	NNP	PERSON	van	dep	119	SENT_461	[p25l540t2673r583b2689],
47	der	VBD	PERSON	der	dep	119	SENT_461	[p25l593t2666r633b2689],
48	Ende	NNP	PERSON	Ende	dep	119	SENT_461	[p25l642t2666r710b2693],
49	,	,	O	,	_	0	SENT_461	[p25l642t2666r710b2693],
50	I.	NNP	PERSON	I.	dep	119	SENT_461	[p25l719t2668r736b2692],
51	van	NNP	PERSON	van	dep	119	SENT_461	[p25l747t2673r789b2689],
52	Lunzen	NNP	PERSON	Lunzen	dep	119	SENT_461	[p25l799t2668r897b2694],
53	,	,	O	,	_	0	SENT_461	[p25l799t2668r897b2694],
54	E.	NNP	PERSON	E.	dep	119	SENT_461	[p25l908t2668r931b2689],
55	Van	NNP	PERSON	Van	dep	119	SENT_461	[p25l941t2668r989b2689],
56	Wijngaerden	NNP	PERSON	Wijngaerden	dep	119	SENT_461	[p25l998t2666r1164b2695],
57	,	,	O	,	_	0	SENT_461	[p25l998t2666r1164b2695],
58	S.	NNP	PERSON	S.	dep	119	SENT_461	[p25l1176t2668r1196b2689],
59	Vandecasteele	NNP	PERSON	Vandecasteele	dep	119	SENT_461	[p25l1206t2666r1387b2694],
60	,	,	O	,	_	0	SENT_461	[p25l1206t2666r1387b2694],
61	J.	NNP	O	J.	dep	119	SENT_461	[p25l1396t2668r1413b2692],
62	Vera	NNP	O	Vera	dep	119	SENT_461	[p25l1423t2668r1485b2693],
63	,	,	O	,	_	0	SENT_461	[p25l1423t2668r1485b2693],
64	R	NNP	O	R	dep	119	SENT_461	[p25l1497t2668r1522b2690],
65	,	,	O	,	_	0	SENT_461	[p25l1497t2668r1522b2690],
66	Verdon	NNP	PERSON	Verdon	dep	119	SENT_461	[p25l1532t2666r1629b2694],
67	,	,	O	,	_	0	SENT_461	[p25l1532t2666r1629b2694],
68	P.	NNP	PERSON	P.	dep	119	SENT_461	[p25l1640t2668r1662b2689],
69	Vemazza	NNP	PERSON	Vemazza	dep	119	SENT_461	[p25l1672t2668r1792b2693],
70	,	,	O	,	_	0	SENT_461	[p25l1672t2668r1792b2693],
71	N.	NNP	PERSON	N.	dep	119	SENT_461	[p25l1803t2668r1832b2689],
72	Vetter	NNP	PERSON	Vetter	dep	119	SENT_461	[p25l1842t2668r1922b2694],
73	,	,	O	,	_	0	SENT_461	[p25l1842t2668r1922b2694],
74	F.	NNP	PERSON	F.	dep	119	SENT_461	[p25l237t2705r258b2726],
75	Vidal	NNP	PERSON	Vidal	dep	119	SENT_461	[p25l268t2703r338b2731],
76	,	,	O	,	_	0	SENT_461	[p25l268t2703r338b2731],
77	P.	NNP	PERSON	P.	dep	119	SENT_461	[p25l349t2705r371b2726],
78	Vigano	NNP	PERSON	Vigano	dep	119	SENT_461	[p25l381t2702r475b2732],
79	,	,	O	,	_	0	SENT_461	[p25l381t2702r475b2732],
80	E.	NNP	PERSON	E.	dep	119	SENT_461	[p25l486t2705r509b2726],
81	Vinogradova	NNP	PERSON	Vinogradova	dep	119	SENT_461	[p25l519t2703r682b2732],
82	,	,	O	,	_	0	SENT_461	[p25l519t2703r682b2732],
83	C.	NNP	PERSON	C.	dep	119	SENT_461	[p25l693t2705r718b2726],
84	Viscoli	NNP	PERSON	Viscoli	dep	119	SENT_461	[p25l728t2703r818b2731],
85	,	,	O	,	_	0	SENT_461	[p25l728t2703r818b2731],
86	D.	NNP	PERSON	D.	dep	119	SENT_461	[p25l829t2705r856b2726],
87	Vittecoq	NNP	PERSON	Vittecoq	dep	119	SENT_461	[p25l866t2703r975b2732],
88	,	,	O	,	_	0	SENT_461	[p25l866t2703r975b2732],
89	D.	NNP	PERSON	D.	dep	119	SENT_461	[p25l986t2705r1013b2726],
90	Vogelaers	NNP	PERSON	Vogelaers	dep	119	SENT_461	[p25l1023t2703r1150b2732],
91	,	,	O	,	_	0	SENT_461	[p25l1023t2703r1150b2732],
92	R.	NNP	PERSON	R.	dep	119	SENT_461	[p25l1161t2705r1186b2727],
93	Volkert	NNP	PERSON	Volkert	dep	119	SENT_461	[p25l1197t2703r1294b2731],
94	,	,	O	,	_	0	SENT_461	[p25l1197t2703r1294b2731],
95	E.	NNP	PERSON	E.	dep	119	SENT_461	[p25l1304t2705r1327b2726],
96	Voronin	NNP	PERSON	Voronin	dep	119	SENT_461	[p25l1337t2703r1445b2731],
97	,	,	O	,	_	0	SENT_461	[p25l1337t2703r1445b2731],
98	R.	NNP	PERSON	R.	dep	119	SENT_461	[p25l1457t2705r1481b2727],
99	Vriesendorp	NNP	PERSON	Vriesendorp	dep	119	SENT_461	[p25l1492t2703r1650b2732],
100	,	,	O	,	_	0	SENT_461	[p25l1492t2703r1650b2732],
101	V.	NNP	PERSON	V.	dep	119	SENT_461	[p25l1660t2705r1684b2726],
102	Vullo	NNP	PERSON	Vullo	dep	119	SENT_461	[p25l1694t2703r1766b2731],
103	,	,	O	,	_	0	SENT_461	[p25l1694t2703r1766b2731],
104	A.	NN	PERSON	a.	dep	119	SENT_461	[p25l1777t2705r1802b2726],
105	Wade	NNP	PERSON	Wade	dep	119	SENT_461	[p25l1812t2703r1889b2730],
106	,	,	O	,	_	0	SENT_461	[p25l1812t2703r1889b2730],
107	Y.	NNP	PERSON	Y.	dep	119	SENT_461	[p25l1900t2705r1922b2726],
108	Welker	NNP	PERSON	Welker	dep	119	SENT_461	[p25l236t2740r331b2768],
109	,	,	O	,	_	0	SENT_461	[p25l236t2740r331b2768],
110	E.	NNP	PERSON	E.	dep	119	SENT_461	[p25l342t2742r365b2763],
111	Wilkins	NNP	PERSON	Wilkins	dep	119	SENT_461	[p25l375t2740r479b2768],
112	,	,	O	,	_	0	SENT_461	[p25l375t2740r479b2768],
113	M.	NNP	PERSON	M.	dep	119	SENT_461	[p25l489t2742r521b2763],
114	Wiselka	NNP	PERSON	Wiselka	dep	119	SENT_461	[p25l532t2740r637b2768],
115	,	,	O	,	_	0	SENT_461	[p25l532t2740r637b2768],
116	Y.	NNP	PERSON	Y.	dep	119	SENT_461	[p25l647t2742r670b2763],
117	Yazdanpanah	NNP	PERSON	Yazdanpanah	dep	119	SENT_461	[p25l680t2740r854b2769],
118	,	,	O	,	_	0	SENT_461	[p25l680t2740r854b2769],
119	G.	NNP	O	G.	_	0	SENT_461	[p25l865t2742r927b2763],
120	.	.	O	.	_	0	SENT_461	[p25l865t2742r927b2763],

1	—	NN	O	—	_	0	SENT_462	[p25l865t2742r927b2763],
2	.	.	O	.	_	0	SENT_462	[p25l865t2742r927b2763],

1	P.	NNP	PERSON	P.	nn	2	SENT_463	[p25l865t2742r927b2763],
2	Yeni	NNP	PERSON	Yeni	_	0	SENT_463	[p25l937t2740r998b2768],
3	,	,	O	,	_	0	SENT_463	[p25l937t2740r998b2768],
4	O.	NNP	PERSON	O.	nn	5	SENT_463	[p25l1009t2742r1037b2763],
5	Yurin	NNP	PERSON	Yurin	appos	2	SENT_463	[p25l1047t2740r1121b2768],
6	,	,	O	,	_	0	SENT_463	[p25l1047t2740r1121b2768],
7	R.	NNP	PERSON	R.	nn	8	SENT_463	[p25l1132t2742r1157b2764],
8	Zangerle	NNP	PERSON	Zangerle	appos	5	SENT_463	[p25l1168t2740r1283b2769],
9	.	.	O	.	_	0	SENT_463	[p25l1168t2740r1283b2769],

1	REFERENCES	NNS	O	reference	_	0	SENT_464	[p25l17t2933r684b2996],

1	1	LS	NUMBER	1	_	0	SENT_465	[p25l15t3166r90b3243],
2	.	.	O	.	_	0	SENT_465	[p25l15t3166r90b3243],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_466	[p25l207t3154r589b3269],
2	E	NNP	O	E	_	0	SENT_466	[p25l640t3162r763b3259],
3	]	NN	O	]	dep	2	SENT_466	[p25l640t3162r763b3259],
4	.	.	O	.	_	0	SENT_466	[p25l640t3162r763b3259],

1	The	DT	O	the	det	2	SENT_467	[p25l816t3154r1004b3243],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_467	[p25l1053t3154r1983b3269],
3	of	IN	O	of	_	0	SENT_467	[p25l2036t3152r2151b3244],
4	antiretroviral	JJ	O	antiretroviral	amod	5	SENT_467	[p25l11t3303r686b3394],
5	therapy	NN	O	therapy	prep_of	2	SENT_467	[p25l778t3303r1174b3418],
6	.	.	O	.	_	0	SENT_467	[p25l778t3303r1174b3418],

1	Curr	NNP	PERSON	Curr	nn	2	SENT_468	[p25l1273t3309r1502b3394],
2	Opin	NNP	PERSON	Opin	_	0	SENT_468	[p25l1591t3305r1840b3418],
3	HIV	NN	O	hiv	dep	2	SENT_468	[p25l1931t3311r2135b3392],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_469	[p25l7t3458r266b3543],
2	2006	CD	DATE	2006	num	1	SENT_469	[p25l309t3458r1048b3561],
3	;	:	O	;	_	0	SENT_469	[p25l309t3458r1048b3561],
4	1:249	CD	NUMBER	1:249	number	5	SENT_469	[p25l309t3458r1048b3561],
5	-56	CD	NUMBER	-56	dep	1	SENT_469	[p25l309t3458r1048b3561],
6	.	.	O	.	_	0	SENT_469	[p25l309t3458r1048b3561],

1	2	LS	NUMBER	2	_	0	SENT_470	[p25l9t3613r90b3690],
2	.	.	O	.	_	0	SENT_470	[p25l9t3613r90b3690],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_471	[p25l208t3601r897b3716],
2	S	NNP	O	S	_	0	SENT_471	[p25l933t3607r1012b3710],
3	,	,	O	,	_	0	SENT_471	[p25l933t3607r1012b3710],
4	McGuirk	NNP	PERSON	McGuirk	nn	5	SENT_471	[p25l1049t3601r1502b3692],
5	S	NNP	O	S	dep	2	SENT_471	[p25l1534t3607r1613b3710],
6	,	,	O	,	_	0	SENT_471	[p25l1534t3607r1613b3710],
7	Powell	NNP	PERSON	Powell	nn	8	SENT_471	[p25l1651t3601r1983b3692],
8	G	NNP	PERSON	G	appos	5	SENT_471	[p25l2016t3607r2124b3710],
9	,	,	O	,	_	0	SENT_471	[p25l2016t3607r2124b3710],

1	et	FW	O	et	_	0	SENT_472	[p26l13t42r102b113],
2	al.	FW	O	al.	dep	1	SENT_472	[p26l171t24r284b114],
3	.	.	O	.	_	0	SENT_472	[p26l171t24r284b114],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_473	[p26l365t26r1190b139],
2	reactions	NNS	O	reaction	_	0	SENT_473	[p26l1259t26r1718b114],
3	during	IN	O	during	_	0	SENT_473	[p26l1795t24r2135b139],
4	therapy	NN	O	therapy	prep_during	2	SENT_473	[p26l11t173r391b288],
5	with	IN	O	with	_	0	SENT_473	[p26l428t173r656b264],
6	the	DT	O	the	det	11	SENT_473	[p26l703t173r859b262],
7	nucleoside	JJ	O	nucleoside	amod	11	SENT_473	[p26l907t173r1439b264],
8	reverse	JJ	O	reverse	amod	11	SENT_473	[p26l1486t203r1837b264],
9	transcriptase	NN	O	transcriptase	nn	11	SENT_473	[p26l1886t191r2129b262, p26l13t324r458b437],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_473	[p26l545t322r994b412],
11	abacavir	NN	O	abacavir	prep_with	2	SENT_473	[p26l1075t322r1516b413],
12	.	.	O	.	_	0	SENT_473	[p26l1075t322r1516b413],

1	Clin	NNP	O	Clin	nn	2	SENT_474	[p26l1609t322r1817b412],
2	Ther	NNP	O	Ther	_	0	SENT_474	[p26l1898t322r2135b411],
3	2001	CD	DATE	2001	num	2	SENT_474	[p26l11t477r856b580],
4	;	:	O	;	_	0	SENT_474	[p26l11t477r856b580],
5	23:1603	CD	NUMBER	23:1603	number	6	SENT_474	[p26l11t477r856b580],
6	-14	CD	NUMBER	-14	dep	2	SENT_474	[p26l11t477r856b580],
7	.	.	O	.	_	0	SENT_474	[p26l11t477r856b580],

1	3	LS	NUMBER	3	_	0	SENT_475	[p26l11t630r90b709],
2	.	.	O	.	_	0	SENT_475	[p26l11t630r90b709],

1	Hernandez	NNP	PERSON	Hernandez	nn	2	SENT_476	[p26l208t620r763b711],
2	JE	NNP	O	JE	_	0	SENT_476	[p26l796t628r935b729],
3	,	,	O	,	_	0	SENT_476	[p26l796t628r935b729],
4	Cutrell	NNP	O	Cutrell	nn	5	SENT_476	[p26l986t620r1330b711],
5	A	NNP	O	A	appos	2	SENT_476	[p26l1371t628r1473b729],
6	,	,	O	,	_	0	SENT_476	[p26l1371t628r1473b729],
7	Edwards	NNP	PERSON	Edwards	nn	8	SENT_476	[p26l1524t620r1953b711],
8	M	NNP	O	M	appos	2	SENT_476	[p26l1999t628r2124b729],
9	,	,	O	,	_	0	SENT_476	[p26l1999t628r2124b729],
10	et	FW	O	et	nn	11	SENT_476	[p26l13t787r102b858],
11	al.	FW	O	al.	appos	2	SENT_476	[p26l141t769r255b859],
12	.	.	O	.	_	0	SENT_476	[p26l141t769r255b859],

1	Clinical	JJ	O	clinical	amod	3	SENT_477	[p26l307t769r699b859],
2	risk	NN	O	risk	nn	3	SENT_477	[p26l743t769r935b860],
3	factors	NNS	O	factor	_	0	SENT_477	[p26l976t767r1317b859],
4	for	IN	O	for	_	0	SENT_477	[p26l1364t767r1510b859],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_477	[p26l1551t769r2129b884, p26l11t920r266b1033],
6	reactions	NNS	O	reaction	prep_for	3	SENT_477	[p26l314t920r773b1008],
7	to	TO	O	to	_	0	SENT_477	[p26l830t936r925b1008],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_477	[p26l978t918r1423b1009],
9	:	:	O	:	_	0	SENT_477	[p26l978t918r1423b1009],
10	retrospective	JJ	O	retrospective	amod	11	SENT_477	[p26l1479t920r2131b1033],
11	analysis	NN	O	analysis	dep	3	SENT_477	[p26l11t1067r411b1182],
12	of	IN	O	of	_	0	SENT_477	[p26l470t1065r585b1157],
13	over	IN	O	over	quantmod	14	SENT_477	[p26l620t1096r830b1158],
14	8,000	CD	NUMBER	8,000	num	15	SENT_477	[p26l883t1073r1158b1176],
15	subjects	NNS	O	subject	prep_of	11	SENT_477	[p26l1217t1067r1615b1182],
16	receiving	VBG	O	receive	partmod	15	SENT_477	[p26l1674t1069r2135b1182],
17	abacavir	NN	O	abacavir	dobj	16	SENT_477	[p26l11t1216r430b1307],
18	in	IN	O	in	_	0	SENT_477	[p26l468t1216r565b1305],
19	34	CD	NUMBER	34	num	21	SENT_477	[p26l606t1222r725b1307],
20	clinical	JJ	O	clinical	amod	21	SENT_477	[p26l766t1216r1136b1305],
21	trials	NNS	O	trial	prep_in	17	SENT_477	[p26l1178t1216r1467b1306],
22	.	.	O	.	_	0	SENT_477	[p26l1178t1216r1467b1306],

1	In	IN	O	in	dep	3	SENT_478	[p26l1512t1224r1645b1306],
2	:	:	O	:	_	0	SENT_478	[p26l1512t1224r1645b1306],
3	Program	NN	O	program	_	0	SENT_478	[p26l1690t1224r2131b1331],
4	and	CC	O	and	_	0	SENT_478	[p26l11t1364r195b1453],
5	abstracts	NNS	O	abstract	conj_and	3	SENT_478	[p26l274t1364r725b1453],
6	of	IN	O	of	_	0	SENT_478	[p26l810t1362r925b1453],
7	the	DT	O	the	det	10	SENT_478	[p26l984t1364r1140b1453],
8	43rd	JJ	ORDINAL	43rd	amod	10	SENT_478	[p26l1217t1364r1441b1455],
9	Interscience	NNP	O	Interscience	nn	10	SENT_478	[p26l1520t1366r2130b1453],
10	Conference	NN	O	conference	prep_of	3	SENT_478	[p26l11t1511r571b1603],
11	on	IN	O	on	_	0	SENT_478	[p26l630t1542r751b1603],
12	Antimicrobial	NNP	O	Antimicrobial	nn	13	SENT_478	[p26l802t1513r1499b1603],
13	Agents	NNPS	O	Agents	prep_on	10	SENT_478	[p26l1550t1521r1892b1628],
14	and	CC	O	and	_	0	SENT_478	[p26l1949t1513r2131b1603],
15	Chemotherapy	NNP	O	Chemotherapy	conj_and	3	SENT_478	[p26l11t1662r753b1777],
16	,	,	O	,	_	0	SENT_478	[p26l11t1662r753b1777],
17	Chicago	NNP	LOCATION	Chicago	nn	19	SENT_478	[p26l794t1662r1220b1777],
18	,	,	O	,	_	0	SENT_478	[p26l794t1662r1220b1777],
19	September	NNP	DATE	September	appos	15	SENT_478	[p26l1263t1662r1789b1777],
20	14-17	CD	DATE	14-17	num	19	SENT_478	[p26l1823t1668r2124b1771],
21	,	,	DATE	,	_	0	SENT_478	[p26l1823t1668r2124b1771],
22	2003	CD	DATE	2003	num	19	SENT_478	[p26l11t1817r272b1902],
23	.	.	O	.	_	0	SENT_478	[p26l11t1817r272b1902],

1	Washington	NNP	LOCATION	Washington	nn	3	SENT_479	[p26l326t1811r960b1926],
2	,	,	O	,	_	0	SENT_479	[p26l326t1811r960b1926],
3	DC	NNP	LOCATION	DC	_	0	SENT_479	[p26l1016t1817r1196b1901],
4	:	:	O	:	_	0	SENT_479	[p26l1016t1817r1196b1901],
5	American	NNP	ORGANIZATION	American	nn	6	SENT_479	[p26l1247t1811r1732b1900],
6	Society	NNP	ORGANIZATION	Society	dep	3	SENT_479	[p26l1785t1813r2136b1926],
7	for	IN	ORGANIZATION	for	_	0	SENT_479	[p26l11t1958r153b2050],
8	Microbiology	NNP	ORGANIZATION	Microbiology	prep_for	6	SENT_479	[p26l183t1960r862b2075],
9	,	,	O	,	_	0	SENT_479	[p26l183t1960r862b2075],
10	2003:339	CD	NUMBER	2003:339	appos	8	SENT_479	[p26l905t1966r1370b2051],
11	.	.	O	.	_	0	SENT_479	[p26l905t1966r1370b2051],

1	abstract	JJ	O	abstract	_	0	SENT_480	[p26l1413t1960r1835b2050],
2	.	.	O	.	_	0	SENT_480	[p26l1413t1960r1835b2050],

1	4	LS	NUMBER	4	_	0	SENT_481	[p26l9t2121r90b2198],
2	.	.	O	.	_	0	SENT_481	[p26l9t2121r90b2198],

1	DeJesus	NNP	PERSON	DeJesus	nn	2	SENT_482	[p26l207t2117r595b2214],
2	E	NNP	O	E	_	0	SENT_482	[p26l636t2117r727b2218],
3	,	,	O	,	_	0	SENT_482	[p26l636t2117r727b2218],
4	Herrera	NNP	PERSON	Herrera	nn	5	SENT_482	[p26l774t2117r1160b2198],
5	G	NNP	PERSON	G	appos	2	SENT_482	[p26l1199t2115r1307b2218],
6	,	,	O	,	_	0	SENT_482	[p26l1199t2115r1307b2218],
7	Teofilo	NNP	PERSON	Teofilo	nn	8	SENT_482	[p26l1350t2107r1708b2199],
8	E	NNP	PERSON	E	appos	2	SENT_482	[p26l1748t2117r1839b2218],
9	,	,	O	,	_	0	SENT_482	[p26l1748t2117r1839b2218],
10	et	FW	O	et	nn	11	SENT_482	[p26l1886t2128r1977b2198],
11	al.	FW	O	al.	appos	2	SENT_482	[p26l2010t2109r2125b2199],
12	.	.	O	.	_	0	SENT_482	[p26l2010t2109r2125b2199],

1	Abacavir	NNP	O	Abacavir	nsubj	4	SENT_483	[p26l7t2257r440b2348],
2	versus	CC	O	versus	prep	1	SENT_483	[p26l466t2286r773b2348],
3	zidovudine	NN	O	zidovudine	dep	2	SENT_483	[p26l808t2257r1350b2348],
4	combined	VBN	O	combine	_	0	SENT_483	[p26l1385t2257r1874b2346],
5	with	IN	O	with	_	0	SENT_483	[p26l1902t2257r2131b2348],
6	lamivudine	NN	O	lamivudine	prep_with	4	SENT_483	[p26l9t2406r579b2497],
7	and	CC	O	and	_	0	SENT_483	[p26l642t2406r826b2496],
8	efavirenz	NN	O	efavirenz	prep_with	4	SENT_483	[p26l887t2404r1376b2515],
9	,	,	O	,	_	0	SENT_483	[p26l887t2404r1376b2515],
10	for	IN	O	for	_	0	SENT_483	[p26l1445t2404r1589b2496],
11	the	DT	O	the	det	12	SENT_483	[p26l1648t2406r1803b2495],
12	treatment	NN	O	treatment	prep_for	4	SENT_483	[p26l1866t2424r2129b2495, p26l11t2572r270b2643],
13	of	IN	O	of	_	0	SENT_483	[p26l314t2552r430b2643],
14	antiretroviral	JJ	O	antiretroviral	amod	20	SENT_483	[p26l458t2554r1435b2645],
15	—	NN	O	—	nn	20	SENT_483	[p26l458t2554r1435b2645],
16	naive	JJ	O	naive	amod	20	SENT_483	[p26l458t2554r1435b2645],
17	HIV	NN	MISC	hiv	nn	20	SENT_483	[p26l1484t2552r2131b2643],
18	—	NN	O	—	nn	20	SENT_483	[p26l1484t2552r2131b2643],
19	infected	JJ	O	infected	amod	20	SENT_483	[p26l1484t2552r2131b2643],
20	adults	NNS	O	adult	prep_of	12	SENT_483	[p26l11t2703r342b2794],
21	.	.	O	.	_	0	SENT_483	[p26l11t2703r342b2794],

1	Clin	NNP	O	Clin	nn	3	SENT_484	[p26l389t2703r596b2793],
2	Infect	NNP	O	Infect	nn	3	SENT_484	[p26l634t2701r933b2792],
3	Dis	NNP	O	Dis	_	0	SENT_484	[p26l964t2705r1127b2792],
4	2004	CD	DATE	2004	num	3	SENT_484	[p26l1170t2709r2033b2812],
5	;	:	O	;	_	0	SENT_484	[p26l1170t2709r2033b2812],
6	39:1038	CD	NUMBER	39:1038	number	7	SENT_484	[p26l1170t2709r2033b2812],
7	-46	CD	NUMBER	-46	dep	3	SENT_484	[p26l1170t2709r2033b2812],
8	.	.	O	.	_	0	SENT_484	[p26l1170t2709r2033b2812],

1	5	CD	NUMBER	5	_	0	SENT_485	[p26l13t2864r90b2941],
2	.	.	O	.	_	0	SENT_485	[p26l13t2864r90b2941],

1	Gulick	NNP	PERSON	Gulick	nn	2	SENT_486	[p26l209t2852r547b2943],
2	RM	NN	O	rm	_	0	SENT_486	[p26l628t2860r836b2961],
3	,	,	O	,	_	0	SENT_486	[p26l628t2860r836b2961],
4	Ribaudo	NNP	PERSON	Ribaudo	nn	6	SENT_486	[p26l929t2852r1348b2947],
5	H	NNP	O	H	nn	6	SENT_486	[p26l1437t2860r1585b2961],
6	]	NNP	O	]	appos	2	SENT_486	[p26l1437t2860r1585b2961],
7	,	,	O	,	_	0	SENT_486	[p26l1437t2860r1585b2961],
8	Shikuma	NNP	ORGANIZATION	Shikuma	nn	9	SENT_486	[p26l1682t2852r2132b2943],
9	CM	NN	ORGANIZATION	cm	appos	2	SENT_486	[p26l11t3007r209b3110],
10	,	,	O	,	_	0	SENT_486	[p26l11t3007r209b3110],
11	et	FW	O	et	nn	12	SENT_486	[p26l254t3019r345b3090],
12	al.	FW	O	al.	appos	2	SENT_486	[p26l375t3001r490b3091],
13	.	.	O	.	_	0	SENT_486	[p26l375t3001r490b3091],

1	Three	CD	NUMBER	three	num	2	SENT_487	[p26l529t3001r860b3090],
2	—	CD	NUMBER	—	_	0	SENT_487	[p26l529t3001r860b3090],
3	vs	CC	O	vs	_	0	SENT_487	[p26l895t3031r992b3092],
4	four-drug	JJ	O	four-drug	amod	6	SENT_487	[p26l1031t2999r1526b3116],
5	antiretroviral	JJ	O	antiretroviral	amod	6	SENT_487	[p26l1558t3001r2129b3092, p26l11t3150r144b3239],
6	regimens	NNS	O	regimen	conj_vs	2	SENT_487	[p26l197t3152r666b3265],
7	for	IN	O	for	_	0	SENT_487	[p26l723t3148r867b3240],
8	the	DT	O	the	det	10	SENT_487	[p26l919t3150r1075b3239],
9	initial	JJ	O	initial	amod	10	SENT_487	[p26l1130t3150r1433b3239],
10	treatment	NN	O	treatment	prep_for	6	SENT_487	[p26l1488t3168r1985b3239],
11	of	IN	O	of	_	0	SENT_487	[p26l2036t3148r2153b3240],
12	HIV-1	NN	O	hiv-1	nn	13	SENT_487	[p26l11t3304r298b3387],
13	infection	NN	O	infection	prep_of	10	SENT_487	[p26l339t3296r824b3387],
14	:	:	O	:	_	0	SENT_487	[p26l339t3296r824b3387],
15	a	DT	O	a	dep	2	SENT_487	[p26l869t3328r921b3387],
16	randomized	VBN	O	randomize	partmod	15	SENT_487	[p26l962t3298r1572b3387],
17	controlled	JJ	O	controlled	amod	18	SENT_487	[p26l1615t3298r2131b3387],
18	trial	NN	O	trial	dobj	16	SENT_487	[p26l11t3447r249b3537],
19	.	.	O	.	_	0	SENT_487	[p26l11t3447r249b3537],

1	JAMA	NNP	O	JAMA	_	0	SENT_488	[p26l284t3455r585b3552],
2	2006	CD	DATE	2006	num	1	SENT_488	[p26l620t3453r1482b3556],
3	;	:	O	;	_	0	SENT_488	[p26l620t3453r1482b3556],
4	296:769	CD	NUMBER	296:769	number	5	SENT_488	[p26l620t3453r1482b3556],
5	—	CD	NUMBER	—	dep	1	SENT_488	[p26l620t3453r1482b3556],
6	81	CD	NUMBER	81	dep	5	SENT_488	[p26l620t3453r1482b3556],
7	.	.	O	.	_	0	SENT_488	[p26l620t3453r1482b3556],

1	6	CD	NUMBER	6	_	0	SENT_489	[p26l11t3606r90b3686],
2	.	.	O	.	_	0	SENT_489	[p26l11t3606r90b3686],

1	Staszewski	NNP	PERSON	Staszewski	nn	2	SENT_490	[p26l211t3596r765b3687],
2	S	NNP	O	S	_	0	SENT_490	[p26l808t3602r887b3705],
3	,	,	O	,	_	0	SENT_490	[p26l808t3602r887b3705],
4	Keiser	NNP	PERSON	Keiser	nn	5	SENT_490	[p26l934t3598r1249b3689],
5	P	NN	PERSON	p	appos	2	SENT_490	[p26l1285t3604r1362b3705],
6	,	,	O	,	_	0	SENT_490	[p26l1285t3604r1362b3705],
7	Montaner	NNP	PERSON	Montaner	nn	8	SENT_490	[p26l1407t3604r1904b3686],
8	J	NNP	PERSON	J	appos	2	SENT_490	[p26l1929t3604r1997b3705],
9	,	,	O	,	_	0	SENT_490	[p26l1929t3604r1997b3705],
10	et	FW	O	et	nn	11	SENT_490	[p26l2046t3614r2136b3685],
11	al.	FW	O	al.	appos	2	SENT_490	[p27l11t26r124b115],
12	.	.	O	.	_	0	SENT_490	[p27l11t26r124b115],

1	Abacavir	NNP	O	Abacavir	nn	3	SENT_491	[p27l167t26r1821b117],
2	—	CD	NUMBER	—	num	3	SENT_491	[p27l167t26r1821b117],
3	lamivudine	NN	O	lamivudine	_	0	SENT_491	[p27l167t26r1821b117],
4	—	CD	NUMBER	—	num	5	SENT_491	[p27l167t26r1821b117],
5	zidovudine	NN	O	zidovudine	dep	3	SENT_491	[p27l167t26r1821b117],
6	vs	CC	O	vs	_	0	SENT_491	[p27l1856t56r1953b117],
7	indinavir-lamivudine-zidovudine	NN	O	indinavir-lamivudine-zidovudine	conj_vs	5	SENT_491	[p27l1995t28r2129b115, p27l13t174r1582b265],

1	in	IN	O	in	_	0	SENT_492	[p27l1623t176r1720b263],
2	antiretroviral-naive	JJ	O	antiretroviral-naive	pobj	1	SENT_492	[p27l1761t176r2129b263, p27l11t322r644b413],

1	HIV-infected	JJ	O	hiv-infected	amod	2	SENT_493	[p27l705t320r1352b411],
2	adults	NNS	O	adult	_	0	SENT_493	[p27l1415t322r1747b413],
3	:	:	O	:	_	0	SENT_493	[p27l1415t322r1747b413],
4	a	DT	O	a	dep	2	SENT_493	[p27l1814t352r1865b411],
5	randomized	VBN	O	randomize	partmod	4	SENT_493	[p27l1926t351r2129b411, p27l13t471r450b561],

1	equivalence	JJ	O	equivalence	amod	2	SENT_494	[p27l525t471r1109b586],
2	trial	NN	O	trial	_	0	SENT_494	[p27l1182t471r1419b561],
3	.	.	O	.	_	0	SENT_494	[p27l1182t471r1419b561],

1	JAMA	NNP	O	JAMA	_	0	SENT_495	[p27l1487t479r1789b576],
2	2001	CD	DATE	2001	num	1	SENT_495	[p27l1858t477r2126b580],
3	;	:	O	;	_	0	SENT_495	[p27l1858t477r2126b580],

1	285:1155	CD	NUMBER	285:1155	num	2	SENT_496	[p27l11t626r652b711],
2	-63	CD	NUMBER	-63	_	0	SENT_496	[p27l11t626r652b711],
3	.	.	O	.	_	0	SENT_496	[p27l11t626r652b711],

1	[	NN	O	[	nn	2	SENT_497	[p27l735t628r1218b729],
2	Erratum	NN	O	erratum	_	0	SENT_497	[p27l735t628r1218b729],
3	,	,	O	,	_	0	SENT_497	[p27l735t628r1218b729],
4	JAMA	NNP	O	JAMA	appos	2	SENT_497	[p27l1279t628r1580b725],
5	2001	CD	DATE	2001	num	4	SENT_497	[p27l1643t626r2126b729],
6	;	:	O	;	_	0	SENT_497	[p27l1643t626r2126b729],
7	285	CD	NUMBER	285	dep	4	SENT_497	[p27l1643t626r2126b729],
8	:	:	O	:	_	0	SENT_497	[p27l1643t626r2126b729],

1	7	CD	NUMBER	7	_	0	SENT_498	[p27l13t929r90b1006],
2	.	.	O	.	_	0	SENT_498	[p27l13t929r90b1006],

1	Mallal	JJ	O	mallal	amod	2	SENT_499	[p27l205t917r535b1006],
2	S	NN	O	s	_	0	SENT_499	[p27l586t923r666b1026],
3	,	,	O	,	_	0	SENT_499	[p27l586t923r666b1026],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_499	[p27l719t917r1032b1008],
5	D	NNP	PERSON	D	appos	2	SENT_499	[p27l1079t925r1184b1026],
6	,	,	O	,	_	0	SENT_499	[p27l1079t925r1184b1026],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_499	[p27l1235t919r1463b1006],
8	C	NNP	O	C	appos	2	SENT_499	[p27l1506t923r1605b1026],
9	,	,	O	,	_	0	SENT_499	[p27l1506t923r1605b1026],
10	et	FW	O	et	nn	11	SENT_499	[p27l1660t935r1752b1006],
11	al.	FW	O	al.	appos	2	SENT_499	[p27l1795t917r1912b1007],
12	.	.	O	.	_	0	SENT_499	[p27l1795t917r1912b1007],

1	Association	NNP	O	Association	_	0	SENT_500	[p27l1963t925r2129b1006, p27l13t1068r452b1156],

1	between	IN	O	between	_	0	SENT_501	[p27l483t1066r887b1157],
2	presence	NN	O	presence	pobj	1	SENT_501	[p27l915t1095r1338b1181],
3	of	IN	O	of	_	0	SENT_501	[p27l1370t1064r1483b1156],
4	HLA-B	NN	O	hla-b	prep_of	2	SENT_501	[p27l1490t1066r2124b1175],
5	*	CD	NUMBER	*	number	6	SENT_501	[p27l1490t1066r2124b1175],
6	5701	CD	NUMBER	5701	num	4	SENT_501	[p27l1490t1066r2124b1175],
7	,	,	O	,	_	0	SENT_501	[p27l1490t1066r2124b1175],

1	HLA-DR7	NN	O	hla-dr7	_	0	SENT_502	[p27l11t1223r519b1324],
2	,	,	O	,	_	0	SENT_502	[p27l11t1223r519b1324],
3	and	CC	O	and	_	0	SENT_502	[p27l561t1215r747b1305],
4	HLA-DQ3	NN	O	hla-dq3	conj_and	1	SENT_502	[p27l782t1221r1277b1328],
5	and	CC	O	and	_	0	SENT_502	[p27l1316t1215r1503b1305],
6	hypersensitivity	NN	O	hypersensitivity	conj_and	1	SENT_502	[p27l1538t1215r2129b1330, p27l11t1366r274b1479],

1	to	TO	O	to	_	0	SENT_503	[p27l331t1382r427b1454],
2	HIV-1	NN	O	hiv-1	nn	4	SENT_503	[p27l491t1370r782b1454],
3	reverse-transcriptase	NN	O	reverse-transcriptase	nn	4	SENT_503	[p27l845t1366r1930b1479],
4	inhibitor	NN	O	inhibitor	pobj	1	SENT_503	[p27l1993t1366r2129b1453, p27l10t1623r181b1667],

1	abacavir	NN	O	abacavir	_	0	SENT_504	[p27l223t1623r443b1667],
2	.	.	O	.	_	0	SENT_504	[p27l223t1623r443b1667],

1	Lancet	NNP	O	Lancet	_	0	SENT_505	[p27l489t1627r656b1667],
2	2002	CD	DATE	2002	num	1	SENT_505	[p27l697t1626r1042b1676, p27l11t1697r81b1738],
3	;	:	O	;	_	0	SENT_505	[p27l697t1626r1042b1676, p27l11t1697r81b1738],
4	359:72732	CD	NUMBER	359:72732	dep	1	SENT_505	[p27l697t1626r1042b1676, p27l11t1697r81b1738],
5	.	.	O	.	_	0	SENT_505	[p27l697t1626r1042b1676, p27l11t1697r81b1738],

1	8	CD	NUMBER	8	_	0	SENT_506	[p27l9t1769r48b1809],
2	.	.	O	.	_	0	SENT_506	[p27l9t1769r48b1809],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_507	[p27l106t1765r441b1821],
2	S	NNP	O	S	_	0	SENT_507	[p27l462t1768r501b1818],
3	,	,	O	,	_	0	SENT_507	[p27l462t1768r501b1818],
4	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_507	[p27l524t1765r710b1821],
5	AR	NNS	ORGANIZATION	ar	appos	2	SENT_507	[p27l729t1769r818b1818],
6	,	,	O	,	_	0	SENT_507	[p27l729t1769r818b1818],
7	Mosteller	NNP	PERSON	Mosteller	nn	8	SENT_507	[p27l840t1765r1042b1809, p27l10t1850r56b1880],
8	M	NNP	O	M	appos	2	SENT_507	[p27l80t1840r141b1889],
9	,	,	O	,	_	0	SENT_507	[p27l80t1840r141b1889],
10	et	FW	O	et	nn	11	SENT_507	[p27l171t1845r215b1880],
11	al.	FW	O	al.	appos	2	SENT_507	[p27l238t1836r294b1880],
12	.	.	O	.	_	0	SENT_507	[p27l238t1836r294b1880],

1	Genetic	JJ	O	genetic	amod	2	SENT_508	[p27l323t1837r512b1880],
2	variations	NNS	O	variation	_	0	SENT_508	[p27l536t1836r779b1880],
3	in	IN	O	in	_	0	SENT_508	[p27l806t1836r854b1879],
4	HLA	NN	O	hlum	prep_in	2	SENT_508	[p27l880t1840r1041b1880],
5	.	.	O	.	_	0	SENT_508	[p27l880t1840r1041b1880],

1	—	NN	O	—	_	0	SENT_509	[p27l880t1840r1041b1880],
2	.	.	O	.	_	0	SENT_509	[p27l880t1840r1041b1880],

1	B	NN	O	b	nn	2	SENT_510	[p27l880t1840r1041b1880],
2	region	NN	O	region	_	0	SENT_510	[p27l10t1907r167b1963],
3	and	CC	O	and	_	0	SENT_510	[p27l198t1907r288b1951],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_510	[p27l319t1907r710b1963],
5	reactions	NNS	O	reaction	conj_and	2	SENT_510	[p27l739t1907r963b1951],
6	to	TO	O	to	_	0	SENT_510	[p27l995t1916r1042b1951],
7	abacavir	NN	O	abacavir	prep_to	2	SENT_510	[p27l10t1978r225b2022],
8	.	.	O	.	_	0	SENT_510	[p27l10t1978r225b2022],

1	Lancet	NNP	O	Lancet	_	0	SENT_511	[p27l246t1982r410b2022],
2	2002	CD	DATE	2002	num	1	SENT_511	[p27l427t1981r837b2031],
3	;	:	O	;	_	0	SENT_511	[p27l427t1981r837b2031],
4	359:1121	CD	NUMBER	359:1121	number	5	SENT_511	[p27l427t1981r837b2031],
5	-2	CD	NUMBER	-2	dep	1	SENT_511	[p27l427t1981r837b2031],
6	.	.	O	.	_	0	SENT_511	[p27l427t1981r837b2031],

1	9	CD	NUMBER	9	_	0	SENT_512	[p27l10t2054r48b2093],
2	.	.	O	.	_	0	SENT_512	[p27l10t2054r48b2093],

1	Martin	NNP	PERSON	Martin	nn	2	SENT_513	[p27l105t2050r275b2093],
2	AM	NNP	O	AM	_	0	SENT_513	[p27l301t2053r402b2102],
3	,	,	O	,	_	0	SENT_513	[p27l301t2053r402b2102],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_513	[p27l432t2049r581b2093],
5	D	NNP	PERSON	D	appos	2	SENT_513	[p27l608t2053r659b2102],
6	,	,	O	,	_	0	SENT_513	[p27l608t2053r659b2102],
7	Gaudieri	NNP	PERSON	Gaudieri	nn	8	SENT_513	[p27l690t2049r902b2093],
8	S	NNP	O	S	appos	2	SENT_513	[p27l931t2052r970b2102],
9	,	,	O	,	_	0	SENT_513	[p27l931t2052r970b2102],
10	et	FW	O	et	nn	11	SENT_513	[p27l1001t2058r1045b2093],
11	al.	FW	O	al.	appos	2	SENT_513	[p27l10t2120r65b2164],
12	.	.	O	.	_	0	SENT_513	[p27l10t2120r65b2164],

1	Predisposition	NN	O	predisposition	nsubj	5	SENT_514	[p27l89t2120r446b2176],
2	to	TO	O	to	_	0	SENT_514	[p27l468t2129r514b2164],
3	abacavir	NN	O	abacavir	nn	4	SENT_514	[p27l536t2120r740b2165],
4	hypersensitivity	NN	O	hypersensitivity	prep_to	1	SENT_514	[p27l760t2120r1042b2176, p27l10t2191r134b2247],
5	conferred	VBD	O	confer	_	0	SENT_514	[p27l172t2190r409b2235],
6	by	IN	O	by	_	0	SENT_514	[p27l450t2191r505b2247],
7	HLA-B	NN	O	hla-b	prep_by	5	SENT_514	[p27l542t2191r849b2235],
8	*	CD	NUMBER	*	number	9	SENT_514	[p27l542t2191r849b2235],
9	5701	CD	DATE	5701	dep	7	SENT_514	[p27l542t2191r849b2235],
10	and	CC	O	and	_	0	SENT_514	[p27l889t2191r979b2235],
11	a	DT	O	a	det	13	SENT_514	[p27l1018t2205r1043b2235],
12	haplotypic	JJ	O	haplotypic	amod	13	SENT_514	[p27l10t2262r268b2318],
13	Hsp70	NN	O	hsp70	conj_and	7	SENT_514	[p27l287t2265r583b2318],
14	.	.	O	.	_	0	SENT_514	[p27l287t2265r583b2318],

1	—	NN	O	—	_	0	SENT_515	[p27l287t2265r583b2318],
2	.	.	O	.	_	0	SENT_515	[p27l287t2265r583b2318],

1	Hom	NNP	PERSON	Hom	_	0	SENT_516	[p27l287t2265r583b2318],
2	Variant	JJ	O	variant	dep	1	SENT_516	[p27l602t2263r788b2306],
3	.	.	O	.	_	0	SENT_516	[p27l602t2263r788b2306],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_517	[p27l810t2266r919b2306],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_517	[p27l938t2262r1042b2306],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_517	[p27l8t2333r129b2377],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_517	[p27l149t2333r217b2377],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_517	[p27l236t2337r274b2377],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_517	[p27l294t2336r318b2377],
7	A	NNP	O	A	_	0	SENT_517	[p27l337t2337r374b2376],
8	2004	CD	DATE	2004	num	7	SENT_517	[p27l391t2336r808b2386],
9	;	:	O	;	_	0	SENT_517	[p27l391t2336r808b2386],
10	101:4180	CD	NUMBER	101:4180	number	11	SENT_517	[p27l391t2336r808b2386],
11	-5	CD	NUMBER	-5	dep	7	SENT_517	[p27l391t2336r808b2386],
12	.	.	O	.	_	0	SENT_517	[p27l391t2336r808b2386],

1	10	CD	NUMBER	10	_	0	SENT_518	[p27l12t2408r76b2448],
2	.	.	O	.	_	0	SENT_518	[p27l12t2408r76b2448],

1	Hughes	NNP	ORGANIZATION	Hughes	nn	2	SENT_519	[p27l106t2404r292b2460],
2	AR	NNS	ORGANIZATION	ar	_	0	SENT_519	[p27l316t2408r404b2457],
3	,	,	O	,	_	0	SENT_519	[p27l316t2408r404b2457],
4	Mosteller	NNP	PERSON	Mosteller	nn	5	SENT_519	[p27l430t2404r663b2448],
5	M	NNP	O	M	appos	2	SENT_519	[p27l685t2408r746b2457],
6	,	,	O	,	_	0	SENT_519	[p27l685t2408r746b2457],
7	Bansal	NNP	PERSON	Bansal	nn	8	SENT_519	[p27l773t2404r938b2448],
8	AT	NNP	O	AT	appos	2	SENT_519	[p27l960t2407r1039b2457],
9	,	,	O	,	_	0	SENT_519	[p27l960t2407r1039b2457],
10	et	FW	O	et	nn	11	SENT_519	[p27l10t2484r54b2519],
11	al.	FW	O	al.	appos	2	SENT_519	[p27l73t2475r129b2519],
12	.	.	O	.	_	0	SENT_519	[p27l73t2475r129b2519],

1	Association	NNP	O	Association	_	0	SENT_520	[p27l152t2475r441b2519],
2	of	IN	O	of	_	0	SENT_520	[p27l464t2474r521b2519],
3	genetic	JJ	O	genetic	amod	4	SENT_520	[p27l532t2475r709b2531],
4	variations	NNS	O	variation	prep_of	1	SENT_520	[p27l728t2475r972b2520],
5	in	IN	O	in	_	0	SENT_520	[p27l995t2475r1042b2518],
6	HLA	NN	O	hlum	prep_in	1	SENT_520	[p27l10t2550r171b2590],
7	.	.	O	.	_	0	SENT_520	[p27l10t2550r171b2590],

1	—	NN	O	—	_	0	SENT_521	[p27l10t2550r171b2590],
2	.	.	O	.	_	0	SENT_521	[p27l10t2550r171b2590],

1	B	NN	O	b	nn	2	SENT_522	[p27l10t2550r171b2590],
2	region	NN	O	region	_	0	SENT_522	[p27l214t2547r372b2602],
3	with	IN	O	with	_	0	SENT_522	[p27l411t2546r522b2590],
4	hypersensitivity	NN	O	hypersensitivity	prep_with	2	SENT_522	[p27l565t2546r955b2602],
5	to	TO	O	to	_	0	SENT_522	[p27l995t2555r1041b2590],
6	abacavir	NN	O	abacavir	prep_to	2	SENT_522	[p27l10t2617r214b2661],
7	in	IN	O	in	_	0	SENT_522	[p27l228t2618r275b2660],
8	some	DT	O	some	prep_in	6	SENT_522	[p27l292t2631r433b2670],
9	,	,	O	,	_	0	SENT_522	[p27l292t2631r433b2670],
10	but	CC	O	but	_	0	SENT_522	[p27l452t2617r532b2661],
11	not	RB	O	not	_	0	SENT_522	[p27l545t2626r626b2661],
12	all	DT	O	all	conj_negcc	6	SENT_522	[p27l639t2617r712b2670],
13	,	,	O	,	_	0	SENT_522	[p27l639t2617r712b2670],
14	populations	NNS	O	population	appos	12	SENT_522	[p27l730t2617r1039b2673],
15	.	.	O	.	_	0	SENT_522	[p27l730t2617r1039b2673],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_523	[p27l9t2688r495b2744],
2	2004	CD	DATE	2004	num	1	SENT_523	[p27l515t2691r872b2741],
3	;	:	O	;	_	0	SENT_523	[p27l515t2691r872b2741],
4	5:203	CD	NUMBER	5:203	number	5	SENT_523	[p27l515t2691r872b2741],
5	—	CD	NUMBER	—	dep	1	SENT_523	[p27l515t2691r872b2741],
6	11	CD	NUMBER	11	dep	5	SENT_523	[p27l515t2691r872b2741],
7	.	.	O	.	_	0	SENT_523	[p27l515t2691r872b2741],

1	11	CD	NUMBER	11	_	0	SENT_524	[p27l12t2764r76b2803],
2	.	.	O	.	_	0	SENT_524	[p27l12t2764r76b2803],

1	Phillips	NNP	PERSON	Phillips	nn	3	SENT_525	[p27l105t2759r292b2815],
2	E	NNP	O	E	nn	3	SENT_525	[p27l319t2763r379b2812],
3	]	NN	O	]	_	0	SENT_525	[p27l319t2763r379b2812],
4	,	,	O	,	_	0	SENT_525	[p27l319t2763r379b2812],
5	Wong	NNP	PERSON	Wong	nn	6	SENT_525	[p27l407t2763r552b2815],
6	GA	NNP	O	GA	appos	3	SENT_525	[p27l577t2762r668b2812],
7	,	,	O	,	_	0	SENT_525	[p27l577t2762r668b2812],
8	Kaul	NNP	PERSON	Kaul	nn	9	SENT_525	[p27l698t2759r810b2804],
9	R	NNP	O	R	appos	3	SENT_525	[p27l836t2763r885b2812],
10	,	,	O	,	_	0	SENT_525	[p27l836t2763r885b2812],
11	et	FW	O	et	nn	12	SENT_525	[p27l915t2768r960b2803],
12	al.	FW	O	al.	appos	3	SENT_525	[p27l984t2759r1039b2803],
13	.	.	O	.	_	0	SENT_525	[p27l984t2759r1039b2803],

1	Clinical	JJ	O	clinical	amod	4	SENT_526	[p27l10t2830r201b2874],
2	and	CC	O	and	_	0	SENT_526	[p27l219t2830r309b2874],
3	immunogenetic	JJ	O	immunogenetic	conj_and	1	SENT_526	[p27l327t2830r717b2886],
4	correlates	NNS	O	correlate	_	0	SENT_526	[p27l736t2830r975b2874],
5	of	IN	O	of	_	0	SENT_526	[p27l996t2829r1052b2874],
6	abacavir	NN	O	abacavir	nn	7	SENT_526	[p27l10t2901r214b2945],
7	hypersensitivity	NN	O	hypersensitivity	prep_of	4	SENT_526	[p27l244t2901r642b2957],
8	.	.	O	.	_	0	SENT_526	[p27l244t2901r642b2957],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_527	[p27l675t2904r802b2945],
2	2005	CD	DATE	2005	num	1	SENT_527	[p27l834t2904r1040b2954],
3	;	:	O	;	_	0	SENT_527	[p27l834t2904r1040b2954],
4	19	CD	NUMBER	19	num	6	SENT_527	[p27l834t2904r1040b2954],
5	:	:	O	:	_	0	SENT_527	[p27l834t2904r1040b2954],
6	979-81	CD	NUMBER	979-81	dep	1	SENT_527	[p27l10t2975r188b3016],
7	.	.	O	.	_	0	SENT_527	[p27l10t2975r188b3016],

1	12	CD	NUMBER	12	_	0	SENT_528	[p27l12t3048r76b3087],
2	.	.	O	.	_	0	SENT_528	[p27l12t3048r76b3087],

1	Tesch	NNP	PERSON	Tesch	nn	2	SENT_529	[p27l104t3043r244b3087],
2	N	NNP	O	N	_	0	SENT_529	[p27l264t3047r317b3096],
3	,	,	O	,	_	0	SENT_529	[p27l264t3047r317b3096],
4	Vogel	NNP	PERSON	Vogel	nn	5	SENT_529	[p27l339t3043r475b3099],
5	M	NNP	O	M	appos	2	SENT_529	[p27l494t3047r556b3096],
6	,	,	O	,	_	0	SENT_529	[p27l494t3047r556b3096],
7	Wasmuth	NNP	PERSON	Wasmuth	nn	8	SENT_529	[p27l578t3043r812b3087],
8	JC	NNP	O	JC	appos	2	SENT_529	[p27l827t3046r897b3096],
9	,	,	O	,	_	0	SENT_529	[p27l827t3046r897b3096],
10	et	FW	O	et	nn	11	SENT_529	[p27l922t3052r966b3087],
11	al.	FW	O	al.	appos	2	SENT_529	[p27l983t3043r1039b3087],
12	.	.	O	.	_	0	SENT_529	[p27l983t3043r1039b3087],

1	Abacavir-associated	JJ	O	abacavir-associated	amod	3	SENT_530	[p27l8t3114r498b3158],
2	drug	NN	O	drug	nn	3	SENT_530	[p27l519t3114r635b3170],
3	hypersensitivity	NN	O	hypersensitivity	nsubjpass	6	SENT_530	[p27l654t3114r1045b3170],
4	is	VBZ	O	be	auxpass	6	SENT_530	[p27l10t3186r47b3229],
5	strongly	RB	O	strongly	advmod	6	SENT_530	[p27l86t3185r287b3241],
6	associated	VBN	O	associate	_	0	SENT_530	[p27l321t3185r576b3229],
7	with	IN	O	with	_	0	SENT_530	[p27l609t3185r721b3230],
8	the	DT	O	the	det	11	SENT_530	[p27l757t3185r833b3229],
9	human	JJ	O	human	amod	11	SENT_530	[p27l869t3185r1042b3229],
10	leukocyte	NN	O	leukocyte	nn	11	SENT_530	[p27l9t3256r243b3312],
11	antigen	NN	O	antigen	prep_with	6	SENT_530	[p27l281t3257r467b3312],
12	B-57	JJ	MISC	b-57	amod	13	SENT_530	[p27l504t3260r614b3300],
13	allele	NN	O	allele	dep	11	SENT_530	[p27l652t3256r794b3300],
14	.	.	O	.	_	0	SENT_530	[p27l652t3256r794b3300],

1	In	IN	O	in	dep	3	SENT_531	[p27l835t3260r900b3300],
2	:	:	O	:	_	0	SENT_531	[p27l835t3260r900b3300],
3	Programs	NNS	O	program	_	0	SENT_531	[p27l940t3260r1042b3300, p27l10t3341r163b3383],
4	and	CC	O	and	_	0	SENT_531	[p27l192t3327r282b3371],
5	abstracts	NNS	O	abstract	conj_and	3	SENT_531	[p27l309t3327r529b3371],
6	of	IN	O	of	_	0	SENT_531	[p27l559t3326r616b3371],
7	the	DT	O	the	det	10	SENT_531	[p27l633t3327r709b3371],
8	8th	JJ	ORGANIZATION	8th	amod	10	SENT_531	[p27l737t3327r817b3371],
9	International	NNP	ORGANIZATION	International	nn	10	SENT_531	[p27l844t3331r1042b3371, p27l10t3398r153b3442],
10	Congress	NNP	ORGANIZATION	Congress	prep_of	3	SENT_531	[p27l176t3401r403b3454],
11	on	IN	O	on	_	0	SENT_531	[p27l428t3412r488b3442],
12	Drug	NNP	MISC	Drug	nn	13	SENT_531	[p27l510t3402r636b3454],
13	Therapy	NN	MISC	therapy	prep_on	10	SENT_531	[p27l655t3398r855b3454],
14	in	IN	MISC	in	_	0	SENT_531	[p27l875t3398r922b3441],
15	HIV	NN	MISC	hiv	nn	16	SENT_531	[p27l945t3402r1044b3442],
16	Infection	NN	MISC	infection	prep_in	3	SENT_531	[p27l9t3468r248b3522],
17	,	,	O	,	_	0	SENT_531	[p27l9t3468r248b3522],
18	Glasgow	NNP	LOCATION	Glasgow	appos	16	SENT_531	[p27l279t3469r501b3525],
19	,	,	O	,	_	0	SENT_531	[p27l279t3469r501b3525],
20	Scotland	NNP	LOCATION	Scotland	nn	22	SENT_531	[p27l534t3469r760b3522],
21	,	,	O	,	_	0	SENT_531	[p27l534t3469r760b3522],
22	November	NNP	DATE	November	appos	18	SENT_531	[p27l790t3469r1044b3513],
23	12-16	CD	DATE	12-16	num	22	SENT_531	[p27l12t3543r167b3593],
24	,	,	O	,	_	0	SENT_531	[p27l12t3543r167b3593],
25	2006:44	CD	NUMBER	2006:44	num	22	SENT_531	[p27l190t3543r399b3584],
26	.	.	O	.	_	0	SENT_531	[p27l190t3543r399b3584],

1	abstract	JJ	O	abstract	_	0	SENT_532	[p27l422t3540r631b3584],
2	.	.	O	.	_	0	SENT_532	[p27l422t3540r631b3584],

1	13	CD	NUMBER	13	_	0	SENT_533	[p27l12t3616r76b3655],
2	.	.	O	.	_	0	SENT_533	[p27l12t3616r76b3655],

1	Rauch	NNP	PERSON	Rauch	nn	2	SENT_534	[p27l105t3611r259b3658],
2	A	NNP	O	A	nsubj	21	SENT_534	[p27l279t3615r329b3664],
3	,	,	O	,	_	0	SENT_534	[p27l279t3615r329b3664],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_534	[p27l352t3611r501b3655],
5	D	NNP	PERSON	D	appos	2	SENT_534	[p27l522t3615r573b3664],
6	,	,	O	,	_	0	SENT_534	[p27l522t3615r573b3664],
7	Martin	NNP	PERSON	Martin	nn	8	SENT_534	[p27l596t3612r767b3655],
8	A	NNP	O	A	appos	2	SENT_534	[p27l786t3615r836b3664],
9	,	,	O	,	_	0	SENT_534	[p27l786t3615r836b3664],
10	McKinnon	NNP	PERSON	McKinnon	nn	11	SENT_534	[p27l860t3612r1042b3656, p27l10t3696r103b3726],
11	E	NNP	O	E	appos	2	SENT_534	[p27l129t3686r173b3735],
12	,	,	O	,	_	0	SENT_534	[p27l129t3686r173b3735],
13	Almeida	NNP	ORGANIZATION	Almeida	nn	14	SENT_534	[p27l201t3682r408b3726],
14	C	NNP	ORGANIZATION	C	appos	2	SENT_534	[p27l434t3685r481b3735],
15	,	,	O	,	_	0	SENT_534	[p27l434t3685r481b3735],
16	Mallal	NNP	O	Mallal	nn	17	SENT_534	[p27l509t3682r666b3726],
17	S.	NNP	O	S.	appos	2	SENT_534	[p27l694t3685r732b3726],
18	Prospective	JJ	O	prospective	amod	20	SENT_534	[p27l761t3683r1042b3738],
19	genetic	JJ	O	genetic	amod	20	SENT_534	[p27l10t3753r186b3809],
20	screening	NN	O	screening	dep	17	SENT_534	[p27l205t3753r445b3809],
21	decreases	VBZ	O	decrease	_	0	SENT_534	[p27l462t3753r696b3797],
22	the	DT	O	the	det	23	SENT_534	[p27l716t3753r791b3797],
23	incidence	NN	O	incidence	dobj	21	SENT_534	[p27l810t3753r1042b3797],
24	Stegman	NNP	PERSON	Stegman	nn	25	SENT_534	[p27l1119t1626r1334b1679],
25	S	NNP	O	S	nsubj	37	SENT_534	[p27l1353t1626r1392b1676],
26	,	,	O	,	_	0	SENT_534	[p27l1353t1626r1392b1676],
27	Caillat-Zucman	NNP	O	Caillat-Zucman	nn	30	SENT_534	[p27l1413t1623r1790b1667],
28	S.	NNP	O	S.	nn	30	SENT_534	[p27l1810t1626r1848b1667],
29	Prospective	JJ	O	prospective	amod	30	SENT_534	[p27l1869t1623r2150b1679],
30	screening	NN	O	screening	appos	25	SENT_534	[p27l1118t1694r1358b1750],
31	for	IN	O	for	_	0	SENT_534	[p27l1385t1693r1455b1738],
32	human	JJ	O	human	amod	34	SENT_534	[p27l1482t1694r1655b1738],
33	leukocyte	NN	O	leukocyte	nn	34	SENT_534	[p27l1683t1694r1917b1750],
34	antigenB	NN	O	antigenb	prep_for	30	SENT_534	[p27l1946t1694r2149b1750, p27l1117t1765r1294b1809],
35	*	CD	NUMBER	*	number	36	SENT_534	[p27l1946t1694r2149b1750, p27l1117t1765r1294b1809],
36	5701	CD	NUMBER	5701	num	34	SENT_534	[p27l1946t1694r2149b1750, p27l1117t1765r1294b1809],
37	avoids	VBZ	O	avoid	rcmod	23	SENT_534	[p27l1331t1765r1483b1809],
38	abacavir	NN	O	abacavir	nn	40	SENT_534	[p27l1521t1765r1725b1809],
39	hypersensitivity	NN	O	hypersensitivity	nn	40	SENT_534	[p27l1762t1765r2152b1821],
40	reaction	NN	O	reaction	dobj	37	SENT_534	[p27l1118t1837r1317b1880],
41	in	IN	O	in	_	0	SENT_534	[p27l1347t1837r1394b1879],
42	the	DT	O	the	det	47	SENT_534	[p27l1425t1836r1500b1880],
43	ethnically	RB	O	ethnically	advmod	44	SENT_534	[p27l1531t1836r1775b1892],
44	mixed	JJ	O	mixed	amod	47	SENT_534	[p27l1803t1836r1954b1880],
45	French	JJ	MISC	french	amod	47	SENT_534	[p27l1983t1836r2150b1880],
46	HIV	NN	MISC	hiv	nn	47	SENT_534	[p27l1117t1911r1216b1951],
47	population	NN	O	population	prep_in	40	SENT_534	[p27l1241t1907r1524b1963],
48	.	.	O	.	_	0	SENT_534	[p27l1241t1907r1524b1963],

1	J	NNP	O	J	nn	5	SENT_535	[p27l1549t1911r1570b1958],
2	Acquir	NNP	MISC	Acquir	nn	5	SENT_535	[p27l1593t1908r1759b1963],
3	Immune	NNP	MISC	Immune	nn	5	SENT_535	[p27l1784t1911r1992b1951],
4	Defic	NNP	MISC	Defic	nn	5	SENT_535	[p27l2019t1906r2150b1951],
5	Syndr	NNP	MISC	Syndr	_	0	SENT_535	[p27l1119t1978r1259b2034],
6	2007	CD	DATE	2007	num	5	SENT_535	[p27l1277t1981r1567b2031],
7	;	:	O	;	_	0	SENT_535	[p27l1277t1981r1567b2031],
8	45:1	CD	NUMBER	45:1	number	9	SENT_535	[p27l1277t1981r1567b2031],
9	-3	CD	NUMBER	-3	dep	5	SENT_535	[p27l1277t1981r1567b2031],
10	.	.	O	.	_	0	SENT_535	[p27l1277t1981r1567b2031],

1	16	CD	NUMBER	16	_	0	SENT_536	[p27l1119t2054r1184b2093],
2	.	.	O	.	_	0	SENT_536	[p27l1119t2054r1184b2093],

1	Phillips	NNP	PERSON	Phillips	nn	3	SENT_537	[p27l1213t2049r1399b2105],
2	E	NNP	O	E	nn	3	SENT_537	[p27l1426t2053r1486b2102],
3	]	NN	O	]	_	0	SENT_537	[p27l1426t2053r1486b2102],
4	,	,	O	,	_	0	SENT_537	[p27l1426t2053r1486b2102],
5	Sullivan	NNP	PERSON	Sullivan	nn	6	SENT_537	[p27l1516t2049r1711b2093],
6	JR	NNP	O	JR	appos	3	SENT_537	[p27l1731t2053r1804b2102],
7	,	,	O	,	_	0	SENT_537	[p27l1731t2053r1804b2102],
8	Knowles	NNP	PERSON	Knowles	nn	9	SENT_537	[p27l1833t2049r2042b2094],
9	SR	NN	O	sr	appos	3	SENT_537	[p27l2071t2052r2146b2102],
10	,	,	O	,	_	0	SENT_537	[p27l2071t2052r2146b2102],
11	Shear	NNP	ORGANIZATION	Shear	nn	12	SENT_537	[p27l1119t2120r1255b2164],
12	NH	NNP	ORGANIZATION	NH	appos	3	SENT_537	[p27l1276t2124r1376b2164],
13	.	.	O	.	_	0	SENT_537	[p27l1276t2124r1376b2164],

1	Utility	NN	O	utility	nsubj	10	SENT_538	[p27l1403t2120r1560b2176],
2	of	IN	O	of	_	0	SENT_538	[p27l1582t2119r1638b2164],
3	patch	NN	O	patch	nn	4	SENT_538	[p27l1651t2120r1786b2176],
4	testing	NN	O	testing	prep_of	1	SENT_538	[p27l1811t2120r1982b2176],
5	in	IN	O	in	_	0	SENT_538	[p27l2003t2120r2051b2163],
6	patients	NNS	O	patient	prep_in	4	SENT_538	[p27l2074t2134r2149b2176, p27l1118t2192r1254b2235],
7	with	IN	O	with	_	0	SENT_538	[p27l1296t2191r1407b2235],
8	hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_538	[p27l1450t2191r1841b2247],
9	syndromes	NNS	O	syndrome	prep_with	6	SENT_538	[p27l1883t2191r2148b2247],
10	associated	VBN	O	associate	_	0	SENT_538	[p27l1117t2262r1372b2306],
11	with	IN	O	with	_	0	SENT_538	[p27l1400t2262r1511b2306],
12	abacavir	NN	O	abacavir	prep_with	10	SENT_538	[p27l1540t2262r1755b2306],
13	.	.	O	.	_	0	SENT_538	[p27l1540t2262r1755b2306],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_539	[p27l1786t2265r1912b2306],
2	2002	CD	DATE	2002	num	1	SENT_539	[p27l1944t2265r2148b2315],
3	;	:	O	;	_	0	SENT_539	[p27l1944t2265r2148b2315],
4	16	CD	NUMBER	16	num	6	SENT_539	[p27l1944t2265r2148b2315],
5	:	:	O	:	_	0	SENT_539	[p27l1944t2265r2148b2315],
6	2223-5	CD	NUMBER	2223-5	dep	1	SENT_539	[p27l1118t2336r1297b2377],
7	.	.	O	.	_	0	SENT_539	[p27l1118t2336r1297b2377],

1	17	CD	NUMBER	17	_	0	SENT_540	[p27l1119t2409r1184b2448],
2	.	.	O	.	_	0	SENT_540	[p27l1119t2409r1184b2448],

1	Saag	NNP	PERSON	Saag	nn	2	SENT_541	[p27l1215t2407r1329b2460],
2	M	NNP	O	M	_	0	SENT_541	[p27l1344t2408r1405b2457],
3	,	,	O	,	_	0	SENT_541	[p27l1344t2408r1405b2457],
4	Balu	NNP	PERSON	Balu	nn	5	SENT_541	[p27l1426t2404r1534b2448],
5	R	NNP	O	R	appos	2	SENT_541	[p27l1551t2408r1600b2457],
6	,	,	O	,	_	0	SENT_541	[p27l1551t2408r1600b2457],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_541	[p27l1621t2404r1807b2460],
8	E	NNP	O	E	appos	2	SENT_541	[p27l1826t2408r1870b2457],
9	,	,	O	,	_	0	SENT_541	[p27l1826t2408r1870b2457],
10	et	FW	O	et	nn	11	SENT_541	[p27l1892t2413r1936b2448],
11	al.	FW	O	al.	appos	2	SENT_541	[p27l1951t2404r2006b2448],
12	.	.	O	.	_	0	SENT_541	[p27l1951t2404r2006b2448],

1	High	JJ	O	high	amod	2	SENT_542	[p27l2027t2404r2150b2460],
2	sensitivity	NN	O	sensitivity	_	0	SENT_542	[p27l1118t2475r1367b2531],
3	of	IN	O	of	_	0	SENT_542	[p27l1404t2474r1461b2519],
4	HLA-B	NN	O	hla-b	prep_of	2	SENT_542	[p27l1488t2475r1795b2519],
5	*	CD	NUMBER	*	number	6	SENT_542	[p27l1488t2475r1795b2519],
6	5701	CD	NUMBER	5701	dep	2	SENT_542	[p27l1488t2475r1795b2519],
7	in	IN	O	in	_	0	SENT_542	[p27l1834t2475r1881b2518],
8	immunologically-confirmed	JJ	O	immunologically-confirmed	amod	9	SENT_542	[p27l1919t2475r2149b2519, p27l1117t2545r1607b2602],
9	cases	NNS	O	case	prep_in	6	SENT_542	[p27l1630t2560r1757b2590],
10	of	IN	O	of	_	0	SENT_542	[p27l1782t2545r1838b2590],
11	abacavir	NN	O	abacavir	nn	12	SENT_542	[p27l1851t2546r2055b2590],
12	hypersensitivity	NN	O	hypersensitivity	prep_of	9	SENT_542	[p27l2077t2546r2149b2602, p27l1117t2617r1449b2673],
13	in	IN	O	in	_	0	SENT_542	[p27l1461t2617r1509b2660],
14	White	NNP	O	White	prep_in	12	SENT_542	[p27l1522t2617r1670b2661],
15	and	CC	O	and	_	0	SENT_542	[p27l1685t2617r1775b2661],
16	Black	JJ	O	black	amod	17	SENT_542	[p27l1789t2617r1924b2662],
17	patients	NNS	O	patient	conj_and	14	SENT_542	[p27l1936t2617r2146b2673],
18	.	.	O	.	_	0	SENT_542	[p27l1936t2617r2146b2673],

1	Clin	NNP	O	Clin	nn	3	SENT_543	[p27l1118t2688r1219b2732],
2	Infect	NNP	O	Infect	nn	3	SENT_543	[p27l1237t2687r1383b2732],
3	Dis	NNP	O	Dis	_	0	SENT_543	[p27l1399t2688r1477b2732],
4	(	NN	O	(	dep	3	SENT_543	[p27l1501t2688r1564b2739],
5	in	IN	O	in	_	0	SENT_543	[p27l1501t2688r1564b2739],
6	press	NN	O	press	nn	7	SENT_543	[p27l1583t2692r1740b2744],
7	)	NN	O	)	prep_in	4	SENT_543	[p27l1583t2692r1740b2744],
8	.	.	O	.	_	0	SENT_543	[p27l1583t2692r1740b2744],

1	18	CD	NUMBER	18	_	0	SENT_544	[p27l1119t2763r1184b2803],
2	.	.	O	.	_	0	SENT_544	[p27l1119t2763r1184b2803],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_545	[p27l1213t2759r1399b2815],
2	E	NNP	O	E	_	0	SENT_545	[p27l1428t2763r1472b2812],
3	,	,	O	,	_	0	SENT_545	[p27l1428t2763r1472b2812],
4	Rauch	NNP	PERSON	Rauch	nn	5	SENT_545	[p27l1503t2759r1656b2806],
5	A	NNP	O	A	appos	2	SENT_545	[p27l1682t2763r1732b2812],
6	,	,	O	,	_	0	SENT_545	[p27l1682t2763r1732b2812],
7	Nolan	NNP	PERSON	Nolan	nn	8	SENT_545	[p27l1763t2759r1912b2803],
8	D	NNP	PERSON	D	appos	2	SENT_545	[p27l1939t2763r1990b2812],
9	,	,	O	,	_	0	SENT_545	[p27l1939t2763r1990b2812],
10	et	FW	O	et	nn	11	SENT_545	[p27l2022t2768r2066b2803],
11	al.	FW	O	al.	appos	2	SENT_545	[p27l2091t2759r2146b2803],
12	.	.	O	.	_	0	SENT_545	[p27l2091t2759r2146b2803],

1	Genetic	JJ	O	genetic	amod	2	SENT_546	[p27l1117t2830r1306b2874],
2	characterization	NN	O	characterization	nsubj	9	SENT_546	[p27l1329t2830r1731b2874],
3	of	IN	O	of	_	0	SENT_546	[p27l1754t2829r1810b2874],
4	patients	NNS	O	patient	prep_of	2	SENT_546	[p27l1822t2830r2017b2886],
5	with	IN	O	with	_	0	SENT_546	[p27l2039t2830r2150b2874],
6	MHC	NN	O	mhc	nn	7	SENT_546	[p27l1116t2904r1243b2945],
7	class	NN	O	class	prep_with	4	SENT_546	[p27l1265t2901r1382b2945],
8	I	CD	NUMBER	i	num	7	SENT_546	[p27l1402t2905r1419b2944],
9	mediated	VBD	O	mediate	_	0	SENT_546	[p27l1439t2901r1667b2945],
10	abacavir	NN	O	abacavir	nn	12	SENT_546	[p27l1686t2901r1890b2945],
11	hypersensitivity	NN	O	hypersensitivity	nn	12	SENT_546	[p27l1909t2901r2149b2957, p27l1118t2972r1282b3028],
12	reaction	NN	O	reaction	dobj	9	SENT_546	[p27l1317t2972r1530b3016],
13	.	.	O	.	_	0	SENT_546	[p27l1317t2972r1530b3016],

1	In	IN	O	in	dep	3	SENT_547	[p27l1569t2976r1633b3016],
2	:	:	O	:	_	0	SENT_547	[p27l1569t2976r1633b3016],
3	Programs	NNS	O	program	_	0	SENT_547	[p27l1671t2976r1910b3028],
4	and	CC	O	and	_	0	SENT_547	[p27l1948t2972r2037b3016],
5	abstracts	NNS	O	abstract	conj_and	3	SENT_547	[p27l2073t2972r2149b3016, p27l1118t3052r1279b3087],
6	of	IN	O	of	_	0	SENT_547	[p27l1301t3042r1358b3087],
7	the	DT	O	the	det	10	SENT_547	[p27l1369t3043r1444b3087],
8	4th	JJ	ORDINAL	4th	amod	10	SENT_547	[p27l1465t3043r1546b3087],
9	IAS	NNP	O	IAS	nn	10	SENT_547	[p27l1566t3046r1650b3087],
10	Conference	NN	O	conference	prep_of	3	SENT_547	[p27l1672t3042r1951b3087],
11	on	IN	O	on	_	0	SENT_547	[p27l1972t3057r2032b3087],
12	HIV	NN	O	hiv	nn	13	SENT_547	[p27l2053t3047r2152b3087],
13	Pathogenesis	NN	ORGANIZATION	pathogenesis	prep_on	10	SENT_547	[p27l1117t3114r1454b3170],
14	,	,	O	,	_	0	SENT_547	[p27l1117t3114r1454b3170],
15	Treatment	NN	ORGANIZATION	treatment	prep_on	10	SENT_547	[p27l1479t3117r1736b3158],
16	and	CC	ORGANIZATION	and	_	0	SENT_547	[p27l1758t3114r1847b3158],
17	Prevention	NNP	ORGANIZATION	Prevention	prep_on	10	SENT_547	[p27l1871t3115r2147b3167],
18	,	,	O	,	_	0	SENT_547	[p27l1871t3115r2147b3167],
19	Sydney	NNP	LOCATION	Sydney	nn	21	SENT_547	[p27l1119t3185r1297b3241],
20	,	,	O	,	_	0	SENT_547	[p27l1119t3185r1297b3241],
21	July	NNP	DATE	July	appos	17	SENT_547	[p27l1314t3185r1409b3241],
22	22-25	CD	DATE	22-25	num	21	SENT_547	[p27l1426t3188r1584b3238],
23	,	,	O	,	_	0	SENT_547	[p27l1426t3188r1584b3238],
24	2007:49	CD	NUMBER	2007:49	num	21	SENT_547	[p27l1606t3188r1806b3229],
25	.	.	O	.	_	0	SENT_547	[p27l1606t3188r1806b3229],

1	abstract	JJ	O	abstract	_	0	SENT_548	[p27l1828t3185r2038b3229],
2	.	.	O	.	_	0	SENT_548	[p27l1828t3185r2038b3229],

1	19	CD	NUMBER	19	_	0	SENT_549	[p27l1119t3261r1184b3300],
2	.	.	O	.	_	0	SENT_549	[p27l1119t3261r1184b3300],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_550	[p27l1213t3256r1399b3312],
2	E	NNP	O	E	_	0	SENT_550	[p27l1428t3260r1472b3309],
3	,	,	O	,	_	0	SENT_550	[p27l1428t3260r1472b3309],
4	Rauch	NNP	PERSON	Rauch	nn	5	SENT_550	[p27l1503t3256r1656b3303],
5	A	NNP	O	A	appos	2	SENT_550	[p27l1682t3260r1732b3309],
6	,	,	O	,	_	0	SENT_550	[p27l1682t3260r1732b3309],
7	Nolan	NNP	PERSON	Nolan	nn	8	SENT_550	[p27l1763t3256r1912b3300],
8	D	NNP	PERSON	D	appos	2	SENT_550	[p27l1939t3260r1990b3309],
9	,	,	O	,	_	0	SENT_550	[p27l1939t3260r1990b3309],
10	et	FW	O	et	nn	11	SENT_550	[p27l2022t3265r2066b3300],
11	al.	FW	O	al.	appos	2	SENT_550	[p27l2091t3256r2146b3300],
12	.	.	O	.	_	0	SENT_550	[p27l2091t3256r2146b3300],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	8	SENT_551	[p27l1117t3327r1568b3383],
2	and	CC	O	and	_	0	SENT_551	[p27l1590t3327r1680b3371],
3	clinical	JJ	O	clinical	amod	4	SENT_551	[p27l1702t3327r1882b3371],
4	characteristics	NNS	O	characteristic	conj_and	1	SENT_551	[p27l1903t3327r2149b3371, p27l1117t3398r1243b3442],
5	of	IN	O	of	_	0	SENT_551	[p27l1281t3397r1338b3442],
6	patch	NN	O	patch	nn	7	SENT_551	[p27l1363t3398r1498b3454],
7	test	NN	O	test	prep_of	4	SENT_551	[p27l1535t3407r1623b3442],
8	confirmed	VBD	O	confirm	_	0	SENT_551	[p27l1658t3397r1917b3442],
9	patients	NNS	O	patient	dobj	8	SENT_551	[p27l1953t3399r2148b3454],
10	with	IN	O	with	_	0	SENT_551	[p27l1115t3469r1226b3513],
11	abacavir	NN	O	abacavir	nn	12	SENT_551	[p27l1242t3469r1446b3513],
12	hypersensitivity	NN	O	hypersensitivity	prep_with	8	SENT_551	[p27l1460t3469r1859b3525],
13	.	.	O	.	_	0	SENT_551	[p27l1460t3469r1859b3525],

1	Rev	NN	MISC	rev	nn	3	SENT_552	[p27l1877t3473r1966b3516],
2	Antivir	NNP	MISC	Antivir	nn	3	SENT_552	[p27l1978t3469r2151b3513],
3	Ther	NNP	O	Ther	_	0	SENT_552	[p27l1116t3540r1231b3584],
4	2006	CD	DATE	2006	num	3	SENT_552	[p27l1248t3543r1496b3593],
5	;	:	O	;	_	0	SENT_552	[p27l1248t3543r1496b3593],
6	3:57	CD	TIME	3:57	dep	3	SENT_552	[p27l1248t3543r1496b3593],
7	.	.	O	.	_	0	SENT_552	[p27l1248t3543r1496b3593],

1	abstract	JJ	O	abstract	_	0	SENT_553	[p27l1518t3540r1728b3584],
2	.	.	O	.	_	0	SENT_553	[p27l1518t3540r1728b3584],

1	20	CD	NUMBER	20	_	0	SENT_554	[p27l1117t3615r1184b3655],
2	.	.	O	.	_	0	SENT_554	[p27l1117t3615r1184b3655],

1	Hughes	NNP	PERSON	Hughes	nn	2	SENT_555	[p27l1214t3611r1397b3667],
2	S	NNP	O	S	_	0	SENT_555	[p27l1416t3614r1455b3664],
3	,	,	O	,	_	0	SENT_555	[p27l1416t3614r1455b3664],
4	Hughes	NNP	O	Hughes	nn	5	SENT_555	[p27l1474t3611r1657b3667],
5	A	NNP	O	A	appos	2	SENT_555	[p27l1673t3615r1723b3664],
6	,	,	O	,	_	0	SENT_555	[p27l1673t3615r1723b3664],
7	Brothers	NNP	ORGANIZATION	Brothers	nn	8	SENT_555	[p27l1742t3611r1948b3655],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_555	[p27l1966t3614r2013b3664],
9	,	,	O	,	_	0	SENT_555	[p27l1966t3614r2013b3664],
10	et	FW	O	et	nn	11	SENT_555	[p27l2034t3620r2077b3655],
11	al.	FW	O	al.	appos	2	SENT_555	[p27l2091t3611r2146b3655],
12	.	.	O	.	_	0	SENT_555	[p27l2091t3611r2146b3655],

1	PREDICT-1	NN	O	predict-1	nsubj	3	SENT_556	[p27l1117t3685r1386b3729],
2	(	CD	NUMBER	(	num	1	SENT_556	[p27l1419t3685r1756b3733],
3	CNA106030	NN	O	cna106030	_	0	SENT_556	[p27l1419t3685r1756b3733],
4	)	CD	NUMBER	)	num	3	SENT_556	[p27l1419t3685r1756b3733],
5	:	:	O	:	_	0	SENT_556	[p27l1419t3685r1756b3733],
6	the	DT	O	the	det	7	SENT_556	[p27l1789t3682r1865b3726],
7	first	JJ	ORDINAL	first	dep	3	SENT_556	[p27l1895t3681r2001b3726],
8	powered	VBN	O	power	partmod	7	SENT_556	[p27l2028t3696r2149b3738, p27l1118t3753r1235b3806],
9	,	,	O	,	_	0	SENT_556	[p27l2028t3696r2149b3738, p27l1118t3753r1235b3806],
10	prospective	JJ	O	prospective	amod	11	SENT_556	[p27l1258t3753r1539b3809],
11	trial	NN	O	trial	dobj	3	SENT_556	[p27l1559t3753r1661b3797],
12	of	IN	O	of	_	0	SENT_556	[p27l1682t3752r1739b3797],
13	pharmacogenet	NN	O	pharmacogenet	nn	14	SENT_556	[p27l1748t3753r2149b3809],
14	—	NN	O	—	prep_of	11	SENT_556	[p27l1748t3753r2149b3809],

1	of	IN	O	of	_	0	SENT_557	[p28l10t14r67b59],
2	abacavir	NN	O	abacavir	nn	4	SENT_557	[p28l87t15r291b59],
3	hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_557	[p28l320t15r711b71],
4	reactions	NNS	O	reaction	pobj	1	SENT_557	[p28l740t15r963b59],
5	in	IN	O	in	_	0	SENT_557	[p28l995t15r1042b58],
6	the	DT	O	the	det	11	SENT_557	[p28l10t86r86b130],
7	Western	JJ	MISC	western	amod	11	SENT_557	[p28l104t90r306b130],
8	Australian	JJ	MISC	australian	amod	11	SENT_557	[p28l324t86r583b130],
9	HIV	NN	O	hiv	nn	11	SENT_557	[p28l603t90r702b130],
10	cohort	NN	O	cohort	nn	11	SENT_557	[p28l721t86r882b130],
11	study	NN	O	study	prep_in	4	SENT_557	[p28l900t86r1039b142],
12	.	.	O	.	_	0	SENT_557	[p28l900t86r1039b142],

1	Clin	NNP	O	Clin	nn	3	SENT_558	[p28l10t157r111b201],
2	Infect	NNP	O	Infect	nn	3	SENT_558	[p28l130t156r275b201],
3	Dis	NNP	O	Dis	_	0	SENT_558	[p28l291t157r370b201],
4	2006	CD	DATE	2006	num	3	SENT_558	[p28l390t160r776b210],
5	;	:	O	;	_	0	SENT_558	[p28l390t160r776b210],
6	43:99	CD	NUMBER	43:99	num	7	SENT_558	[p28l390t160r776b210],
7	—	NN	O	—	dep	3	SENT_558	[p28l390t160r776b210],
8	102	CD	NUMBER	102	dep	7	SENT_558	[p28l390t160r776b210],
9	.	.	O	.	_	0	SENT_558	[p28l390t160r776b210],

1	14	CD	NUMBER	14	_	0	SENT_559	[p28l12t233r76b272],
2	.	.	O	.	_	0	SENT_559	[p28l12t233r76b272],

1	Reeves	NNS	O	reeve	tmod	16	SENT_560	[p28l105t232r270b275],
2	I	PRP	O	I	dep	1	SENT_560	[p28l319t232r349b281],
3	,	,	O	,	_	0	SENT_560	[p28l319t232r349b281],
4	Churchill	NNP	PERSON	Churchill	nn	5	SENT_560	[p28l401t228r633b272],
5	D	NNP	PERSON	D	nsubj	16	SENT_560	[p28l680t232r731b281],
6	,	,	O	,	_	0	SENT_560	[p28l680t232r731b281],
7	Fisher	NNP	PERSON	Fisher	nn	9	SENT_560	[p28l782t228r932b272],
8	M.	NNP	O	M.	nn	9	SENT_560	[p28l978t232r1039b272],
9	Screening	NNP	O	Screening	appos	5	SENT_560	[p28l11t299r255b355],
10	for	IN	O	for	_	0	SENT_560	[p28l272t298r342b343],
11	HLA-B	NN	O	hla-b	prep_for	9	SENT_560	[p28l358t301r636b343],
12	‘	CD	NUMBER	‘	number	13	SENT_560	[p28l358t301r636b343],
13	*	CD	NUMBER	*	dep	9	SENT_560	[p28l358t301r636b343],
14	’S	NN	O	’s	dep	13	SENT_560	[p28l358t301r636b343],
15	701	CD	NUMBER	701	num	14	SENT_560	[p28l358t301r636b343],
16	reduces	VBZ	O	reduce	_	0	SENT_560	[p28l657t299r841b343],
17	the	DT	O	the	det	18	SENT_560	[p28l861t299r937b343],
18	frequency	NN	O	frequency	dobj	16	SENT_560	[p28l956t298r1042b343, p28l10t384r183b426],
19	of	IN	O	of	_	0	SENT_560	[p28l202t369r260b414],
20	abacavir	NN	O	abacavir	nn	21	SENT_560	[p28l271t370r475b414],
21	hypersensitivity	NN	O	hypersensitivity	prep_of	18	SENT_560	[p28l495t370r894b426],
22	.	.	O	.	_	0	SENT_560	[p28l495t370r894b426],

1	Antivir	NNP	O	Antivir	nn	2	SENT_561	[p28l917t370r1042b414, p28l8t442r73b485],
2	Ther	NNP	O	Ther	_	0	SENT_561	[p28l89t441r204b485],
3	2006	CD	DATE	2006	num	5	SENT_561	[p28l222t441r690b497],
4	;	:	O	;	_	0	SENT_561	[p28l222t441r690b497],
5	11	CD	NUMBER	11	dep	2	SENT_561	[p28l222t441r690b497],
6	:	:	O	:	_	0	SENT_561	[p28l222t441r690b497],
7	Suppl	NNP	O	Suppl	dep	2	SENT_561	[p28l222t441r690b497],
8	:	:	O	:	_	0	SENT_561	[p28l222t441r690b497],
9	L11	NN	O	l11	dep	7	SENT_561	[p28l222t441r690b497],
10	.	.	O	.	_	0	SENT_561	[p28l222t441r690b497],

1	abstract	JJ	O	abstract	_	0	SENT_562	[p28l712t441r921b485],
2	.	.	O	.	_	0	SENT_562	[p28l712t441r921b485],

1	15	CD	NUMBER	15	_	0	SENT_563	[p28l12t517r76b556],
2	.	.	O	.	_	0	SENT_563	[p28l12t517r76b556],

1	Zucman	NN	MISC	zucman	_	0	SENT_564	[p28l105t516r304b556],
2	D	NN	O	d	nn	1	SENT_564	[p28l337t516r388b565],
3	,	,	O	,	_	0	SENT_564	[p28l337t516r388b565],
4	Truchis	FW	O	truchis	dep	1	SENT_564	[p28l422t512r608b556],
5	P	NN	O	p	dep	1	SENT_564	[p28l643t516r680b565],
6	,	,	O	,	_	0	SENT_564	[p28l643t516r680b565],
7	Majerholc	NN	O	majerholc	nn	8	SENT_564	[p28l716t512r959b568],
8	C	NN	O	c	appos	5	SENT_564	[p28l992t515r1039b565],
9	,	,	O	,	_	0	SENT_564	[p28l992t515r1039b565],
10	ic	JJ	O	ic	amod	11	SENT_564	[p28l1117t15r1156b59],
11	screening	NN	O	screening	appos	5	SENT_564	[p28l1171t15r1410b71],
12	to	TO	O	to	aux	13	SENT_564	[p28l1423t24r1469b59],
13	reduce	VB	O	reduce	infmod	11	SENT_564	[p28l1484t15r1644b59],
14	drug	NN	O	drug	nn	16	SENT_564	[p28l1659t15r1775b71],
15	adverse	JJ	O	adverse	amod	16	SENT_564	[p28l1787t15r1967b59],
16	events	NNS	O	event	dobj	13	SENT_564	[p28l1981t24r2147b59],
17	.	.	O	.	_	0	SENT_564	[p28l1981t24r2147b59],

1	Pharm	NNP	O	Pharm	nn	2	SENT_565	[p28l1117t86r1279b130],
2	Stat	NN	O	stat	_	0	SENT_565	[p28l1299t89r1392b130],
3	(	CD	NUMBER	(	num	2	SENT_565	[p28l1412t87r1476b137],
4	in	IN	O	in	_	0	SENT_565	[p28l1412t87r1476b137],
5	press	NN	O	press	nn	6	SENT_565	[p28l1494t90r1651b142],
6	)	NN	O	)	prep_in	2	SENT_565	[p28l1494t90r1651b142],
7	.	.	O	.	_	0	SENT_565	[p28l1494t90r1651b142],

1	21	CD	NUMBER	21	_	0	SENT_566	[p28l1117t162r1184b201],
2	.	.	O	.	_	0	SENT_566	[p28l1117t162r1184b201],

1	Hernandez	NNP	PERSON	Hernandez	nn	2	SENT_567	[p28l1214t157r1484b201],
2	J	NNP	PERSON	J	_	0	SENT_567	[p28l1495t161r1528b210],
3	,	,	O	,	_	0	SENT_567	[p28l1495t161r1528b210],
4	Cutrell	NNP	O	Cutrell	nn	5	SENT_567	[p28l1548t157r1716b201],
5	A	NNP	O	A	appos	2	SENT_567	[p28l1730t161r1780b210],
6	,	,	O	,	_	0	SENT_567	[p28l1730t161r1780b210],
7	Bonny	NNP	ORGANIZATION	Bonny	nn	8	SENT_567	[p28l1799t161r1956b213],
8	T	NN	ORGANIZATION	t	appos	2	SENT_567	[p28l1969t160r2013b210],
9	,	,	O	,	_	0	SENT_567	[p28l1969t160r2013b210],
10	et	FW	O	et	nn	11	SENT_567	[p28l2033t166r2077b201],
11	al.	FW	O	al.	appos	2	SENT_567	[p28l2091t157r2146b201],
12	.	.	O	.	_	0	SENT_567	[p28l2091t157r2146b201],

1	Diagnosis	NN	O	diagnosis	nsubj	8	SENT_568	[p28l1117t228r1361b284],
2	of	IN	O	of	_	0	SENT_568	[p28l1384t227r1441b272],
3	abacavir	NN	O	abacavir	nn	5	SENT_568	[p28l1452t228r1655b272],
4	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_568	[p28l1675t228r2066b284],
5	reactions	NNS	O	reaction	prep_of	1	SENT_568	[p28l2085t242r2149b272, p28l1117t299r1292b343],
6	among	IN	O	among	_	0	SENT_568	[p28l1305t313r1476b355],
7	patients	NNS	O	patient	prep_among	5	SENT_568	[p28l1486t299r1682b355],
8	not	RB	O	not	_	0	SENT_568	[p28l1696t308r1778b343],
9	receiving	VBG	O	receive	xcomp	8	SENT_568	[p28l1787t299r2012b355],
10	abacavir	NN	O	abacavir	dobj	9	SENT_568	[p28l2022t299r2149b343, p28l1117t370r1208b414],
11	in	IN	O	in	_	0	SENT_568	[p28l1231t370r1279b413],
12	two	CD	NUMBER	two	num	14	SENT_568	[p28l1303t379r1393b414],
13	blinded	JJ	O	blinded	amod	14	SENT_568	[p28l1419t370r1604b414],
14	studies	NNS	O	study	prep_in	9	SENT_568	[p28l1630t370r1816b414],
15	.	.	O	.	_	0	SENT_568	[p28l1630t370r1816b414],

1	Antivir	NNP	O	Antivir	nn	2	SENT_569	[p28l1842t370r2015b414],
2	Ther	NNP	O	Ther	_	0	SENT_569	[p28l2036t370r2151b414],

1	2003	CD	DATE	2003	num	3	SENT_570	[p28l1118t441r1556b497],
2	;	:	O	;	_	0	SENT_570	[p28l1118t441r1556b497],
3	8	CD	NUMBER	8	_	0	SENT_570	[p28l1118t441r1556b497],
4	:	:	O	:	_	0	SENT_570	[p28l1118t441r1556b497],
5	Suppl	NNP	O	Suppl	dep	3	SENT_570	[p28l1118t441r1556b497],
6	:	:	O	:	_	0	SENT_570	[p28l1118t441r1556b497],
7	L88	NN	O	l88	dep	5	SENT_570	[p28l1118t441r1556b497],
8	.	.	O	.	_	0	SENT_570	[p28l1118t441r1556b497],

1	abstract	JJ	O	abstract	_	0	SENT_571	[p28l1578t441r1788b485],
2	.	.	O	.	_	0	SENT_571	[p28l1578t441r1788b485],

1	22	CD	NUMBER	22	_	0	SENT_572	[p28l1117t517r1184b556],
2	.	.	O	.	_	0	SENT_572	[p28l1117t517r1184b556],

1	Sustiva	NNP	O	Sustiva	nn	2	SENT_573	[p28l1215t512r1386b556],
2	EMEA	NNP	O	EMEA	_	0	SENT_573	[p28l1416t516r1581b556],
3	.	.	O	.	_	0	SENT_573	[p28l1416t516r1581b556],

1	Summary	NN	O	summary	_	0	SENT_574	[p28l1617t515r1855b568],
2	of	IN	O	of	_	0	SENT_574	[p28l1883t511r1940b556],
3	product	NN	O	product	nn	4	SENT_574	[p28l1960t512r2152b568],
4	characteristics	NNS	O	characteristic	prep_of	1	SENT_574	[p28l93t907r286b929],
5	.	.	O	.	_	0	SENT_574	[p28l93t907r286b929],

1	2007	CD	DATE	2007	_	0	SENT_575	[p28l306t908r371b929],
2	.	.	O	.	_	0	SENT_575	[p28l306t908r371b929],

1	(	NN	O	(	nsubj	2	SENT_576	[p28l392t906r515b933],
2	Accessed	VBD	O	access	_	0	SENT_576	[p28l392t906r515b933],
3	January	NNP	DATE	January	tmod	2	SENT_576	[p28l530t909r630b936],
4	11	CD	DATE	11	num	3	SENT_576	[p28l94t945r130b971],
5	,	,	DATE	,	_	0	SENT_576	[p28l94t945r130b971],
6	2008	CD	DATE	2008	num	3	SENT_576	[p28l145t945r214b971],
7	,	,	O	,	_	0	SENT_576	[p28l145t945r214b971],
8	at	IN	O	at	_	0	SENT_576	[p28l229t948r252b966],
9	http	NN	O	http	prep_at	2	SENT_576	[p28l265t943r628b972],
10	:	:	O	:	_	0	SENT_576	[p28l265t943r628b972],
11	I/www	NN	O	i/www	dep	9	SENT_576	[p28l265t943r628b972],
12	.	.	O	.	_	0	SENT_576	[p28l265t943r628b972],

1	emea	NN	O	emea	_	0	SENT_577	[p28l265t943r628b972],
2	.	.	O	.	_	0	SENT_577	[p28l265t943r628b972],

1	europa	NN	O	europa	_	0	SENT_578	[p28l265t943r628b972],
2	.	.	O	.	_	0	SENT_578	[p28l265t943r628b972],

1	eu	NN	O	eu	_	0	SENT_579	[p28l265t943r628b972],
2	/	:	O	/	punct	3	SENT_579	[p28l265t943r628b972],
3	humandocs/PDFs/EPAR	NN	O	humandocs/pdfs/epar	dep	1	SENT_579	[p28l93t979r504b1006],
4	/	:	O	/	punct	3	SENT_579	[p28l93t979r504b1006],
5	Sustiva	NNP	O	Sustiva	dep	3	SENT_579	[p28l93t979r504b1006],
6	]	CD	NUMBER	]	num	7	SENT_579	[p28l93t979r504b1006],
7	H-249-PI-en	NN	O	h-249-pi-en	dep	5	SENT_579	[p28l93t1016r311b1046],
8	.	.	O	.	_	0	SENT_579	[p28l93t1016r311b1046],

1	pdf	NN	O	pdf	_	0	SENT_580	[p28l93t1016r311b1046],
2	.	.	O	.	_	0	SENT_580	[p28l93t1016r311b1046],
3	)	SYM	O	)	dep	1	SENT_580	[p28l93t1016r311b1046],

1	23	CD	NUMBER	23	_	0	SENT_581	[p28l93t1056r128b1076],
2	.	.	O	.	_	0	SENT_581	[p28l93t1056r128b1076],

1	Viramune	NNP	O	Viramune	nn	2	SENT_582	[p28l142t1053r268b1077],
2	EMEA	NNP	O	EMEA	_	0	SENT_582	[p28l282t1055r367b1076],
3	.	.	O	.	_	0	SENT_582	[p28l282t1055r367b1076],

1	Summary	NN	O	summary	_	0	SENT_583	[p28l384t1055r508b1083],
2	of	IN	O	of	_	0	SENT_583	[p28l521t1053r551b1076],
3	product	NN	O	product	nn	4	SENT_583	[p28l560t1053r629b1083, p28l93t1095r132b1113],
4	characteristics	NNS	O	characteristic	prep_of	1	SENT_583	[p28l143t1090r336b1113],
5	.	.	O	.	_	0	SENT_583	[p28l143t1090r336b1113],

1	2007	CD	DATE	2007	_	0	SENT_584	[p28l349t1092r414b1113],
2	.	.	O	.	_	0	SENT_584	[p28l349t1092r414b1113],

1	(	NN	O	(	nsubj	2	SENT_585	[p28l429t1090r553b1117],
2	Accessed	VBD	O	access	_	0	SENT_585	[p28l429t1090r553b1117],
3	January	NNP	DATE	January	tmod	2	SENT_585	[p28l562t1092r629b1116, p28l93t1135r133b1157],
4	11	CD	DATE	11	num	3	SENT_585	[p28l143t1129r179b1155],
5	,	,	DATE	,	_	0	SENT_585	[p28l143t1129r179b1155],
6	2008	CD	DATE	2008	num	3	SENT_585	[p28l191t1129r259b1155],
7	,	,	O	,	_	0	SENT_585	[p28l191t1129r259b1155],
8	at	IN	O	at	_	0	SENT_585	[p28l271t1132r295b1150],
9	httpzl/www	NN	O	httpzl/www	prep_at	2	SENT_585	[p28l304t1127r627b1157],
10	.	.	O	.	_	0	SENT_585	[p28l304t1127r627b1157],

1	emea	NN	O	emea	_	0	SENT_586	[p28l304t1127r627b1157],
2	.	.	O	.	_	0	SENT_586	[p28l304t1127r627b1157],

1	europa	NN	O	europa	_	0	SENT_587	[p28l304t1127r627b1157],
2	.	.	O	.	_	0	SENT_587	[p28l304t1127r627b1157],

1	eulhumandocs/PDFS/EPAR	NN	O	eulhumandocs/pdfs/epar	_	0	SENT_588	[p28l93t1164r579b1191],
2	/	:	O	/	punct	1	SENT_588	[p28l93t1164r579b1191],
3	Viramunel	NNP	O	Viramunel	dep	1	SENT_588	[p28l93t1164r579b1191],
4	H-183-PI-en	NN	O	h-183-pi-en	dep	3	SENT_588	[p28l93t1201r311b1231],
5	.	.	O	.	_	0	SENT_588	[p28l93t1201r311b1231],

1	pdf	NN	O	pdf	_	0	SENT_589	[p28l93t1201r311b1231],
2	.	.	O	.	_	0	SENT_589	[p28l93t1201r311b1231],
3	)	SYM	O	)	dep	1	SENT_589	[p28l93t1201r311b1231],

1	24	CD	NUMBER	24	_	0	SENT_590	[p28l93t1241r128b1261],
2	.	.	O	.	_	0	SENT_590	[p28l93t1241r128b1261],

1	Mosteller	NNP	PERSON	Mosteller	nn	2	SENT_591	[p28l142t1238r263b1261],
2	M	NNP	O	M	_	0	SENT_591	[p28l274t1240r306b1266],
3	,	,	O	,	_	0	SENT_591	[p28l274t1240r306b1266],
4	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_591	[p28l319t1238r416b1268],
5	A	NNP	ORGANIZATION	A	appos	2	SENT_591	[p28l427t1240r453b1266],
6	,	,	O	,	_	0	SENT_591	[p28l427t1240r453b1266],
7	Warren	NNP	PERSON	Warren	nn	8	SENT_591	[p28l465t1240r560b1261],
8	L	NNP	PERSON	L	appos	2	SENT_591	[p28l571t1240r594b1266],
9	,	,	O	,	_	0	SENT_591	[p28l571t1240r594b1266],
10	et	FW	O	et	nn	11	SENT_591	[p28l607t1243r630b1261],
11	al.	FW	O	al.	appos	2	SENT_591	[p28l93t1275r122b1298],
12	.	.	O	.	_	0	SENT_591	[p28l93t1275r122b1298],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	3	SENT_592	[p28l133t1276r354b1305],
2	(	NN	O	(	nn	3	SENT_592	[p28l365t1277r419b1302],
3	PG	NN	O	pg	_	0	SENT_592	[p28l365t1277r419b1302],
4	)	CD	NUMBER	)	num	5	SENT_592	[p28l365t1277r419b1302],
5	investigation	NN	O	investigation	dep	3	SENT_592	[p28l430t1276r595b1305],
6	of	IN	O	of	prep	5	SENT_592	[p28l605t1275r634b1298],

1	N	NN	O	n	nn	3	SENT_593	[p28l908t653r921b668],
2	ENGLJ	NN	O	englj	nn	3	SENT_593	[p28l936t653r1014b675],
3	MED	NN	O	med	_	0	SENT_593	[p28l1029t653r1081b668],
4	358	CD	NUMBER	358	dep	3	SENT_593	[p28l1091t647r1154b675],
5	;	:	O	;	_	0	SENT_593	[p28l1091t647r1154b675],
6	6	CD	NUMBER	6	dep	3	SENT_593	[p28l1091t647r1154b675],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_593	[p28l1188t653r1389b675],
8	FEBRUARY	NNP	DATE	FEBRUARY	dep	6	SENT_593	[p28l1426t653r1547b669],
9	7	CD	DATE	7	num	8	SENT_593	[p28l1557t653r1576b674],
10	,	,	DATE	,	_	0	SENT_593	[p28l1557t653r1576b674],
11	2008	CD	DATE	2008	num	8	SENT_593	[p28l1587t647r1650b669],
12	The	DT	O	the	det	15	SENT_593	[p28l935t686r986b710],
13	New	NNP	O	New	nn	15	SENT_593	[p28l995t687r1057b710],
14	England	NNP	O	England	nn	15	SENT_593	[p28l1066t686r1177b717],
15	Journal	NNP	O	Journal	dep	3	SENT_593	[p28l1186t686r1283b710],
16	of	IN	O	of	_	0	SENT_593	[p28l1293t686r1322b710],
17	Medicine	NNP	O	Medicine	prep_of	15	SENT_593	[p28l1329t686r1454b710],

1	HLA-B	NN	O	hla-b	_	0	SENT_594	[p28l441t808r636b831],
2	*	CD	NUMBER	*	num	4	SENT_594	[p28l441t808r636b831],
3	S701	NN	O	s701	nn	4	SENT_594	[p28l441t808r636b831],
4	SCREENING	NN	O	screening	dep	1	SENT_594	[p28l651t811r847b830],
5	FOR	IN	O	for	_	0	SENT_594	[p28l861t811r925b830],
6	ABACAVIR	NN	O	abacavir	nn	7	SENT_594	[p28l936t811r1101b830],
7	HYPERSENSITIVITY	NN	O	hypersensitivity	prep_for	4	SENT_594	[p28l1114t811r1433b830],

1	hypersensitivity	NN	O	hypersensitivity	_	0	SENT_595	[p28l668t906r871b936],
2	to	TO	O	to	_	0	SENT_595	[p28l879t911r904b929],
3	abacavir	NN	O	abacavir	prep_to	1	SENT_595	[p28l913t906r1025b929],
4	.	.	O	.	_	0	SENT_595	[p28l913t906r1025b929],

1	In	IN	O	in	dep	6	SENT_596	[p28l1036t909r1069b929],
2	:	:	O	:	_	0	SENT_596	[p28l1036t909r1069b929],
3	Programs	NNS	O	program	nsubj	6	SENT_596	[p28l1079t908r1203b936],
4	and	CC	O	and	_	0	SENT_596	[p28l668t943r715b966],
5	abstracts	NNS	O	abstract	conj_and	3	SENT_596	[p28l726t943r841b966],
6	(	VBP	O	(	_	0	SENT_596	[p28l855t943r906b970],
7	vol	NN	O	vol	dobj	6	SENT_596	[p28l855t943r906b970],
8	.	.	O	.	_	0	SENT_596	[p28l855t943r906b970],

1	2	CD	NUMBER	2	num	2	SENT_597	[p28l919t945r942b969],
2	)	NN	O	)	_	0	SENT_597	[p28l919t945r942b969],
3	of	IN	O	of	_	0	SENT_597	[p28l955t943r985b966],
4	the	DT	O	the	det	8	SENT_597	[p28l992t943r1031b966],
5	XVI	NNP	MISC	XVI	nn	8	SENT_597	[p28l1042t945r1089b966],
6	International	NNP	MISC	International	nn	8	SENT_597	[p28l1101t945r1204b966, p28l668t980r743b1002],
7	AIDS	NNP	MISC	AIDS	nn	8	SENT_597	[p28l753t981r818b1002],
8	Conference	NNP	MISC	Conference	prep_of	2	SENT_597	[p28l830t979r982b1007],
9	,	,	O	,	_	0	SENT_597	[p28l830t979r982b1007],
10	Toronto	NNP	LOCATION	Toronto	appos	2	SENT_597	[p28l994t981r1102b1007],
11	,	,	O	,	_	0	SENT_597	[p28l994t981r1102b1007],
12	August	NNP	DATE	August	appos	2	SENT_597	[p28l1114t982r1206b1009],
13	13	CD	DATE	13	num	12	SENT_597	[p28l669t1018r751b1044],
14	—	CD	NUMBER	—	number	15	SENT_597	[p28l669t1018r751b1044],
15	18	CD	NUMBER	18	dep	12	SENT_597	[p28l669t1018r751b1044],
16	,	,	O	,	_	0	SENT_597	[p28l669t1018r751b1044],
17	2006:76	CD	NUMBER	2006:76	appos	2	SENT_597	[p28l763t1018r869b1039],
18	.	.	O	.	_	0	SENT_597	[p28l763t1018r869b1039],

1	poster	NN	O	poster	_	0	SENT_598	[p28l880t1021r967b1046],
2	.	.	O	.	_	0	SENT_598	[p28l880t1021r967b1046],

1	25	CD	NUMBER	25	_	0	SENT_599	[p28l668t1056r703b1076],
2	.	.	O	.	_	0	SENT_599	[p28l668t1056r703b1076],

1	Martin	NNP	PERSON	Martin	nn	2	SENT_600	[p28l717t1053r806b1076],
2	AM	NNP	O	AM	dep	22	SENT_600	[p28l818t1055r870b1081],
3	,	,	O	,	_	0	SENT_600	[p28l818t1055r870b1081],
4	Krueger	NNP	PERSON	Krueger	nn	5	SENT_600	[p28l884t1055r988b1083],
5	R	NNP	PERSON	R	appos	2	SENT_600	[p28l999t1055r1025b1081],
6	,	,	O	,	_	0	SENT_600	[p28l999t1055r1025b1081],
7	Almeida	NNP	LOCATION	Almeida	nn	8	SENT_600	[p28l1038t1053r1146b1076],
8	CA	NNP	LOCATION	CA	appos	2	SENT_600	[p28l1158t1055r1203b1081],
9	,	,	O	,	_	0	SENT_600	[p28l1158t1055r1203b1081],
10	Nolan	NNP	PERSON	Nolan	nn	11	SENT_600	[p28l668t1090r745b1113],
11	D	NNP	PERSON	D	appos	2	SENT_600	[p28l756t1092r783b1118],
12	,	,	O	,	_	0	SENT_600	[p28l756t1092r783b1118],
13	Phillips	NNP	PERSON	Phillips	nn	14	SENT_600	[p28l796t1090r892b1119],
14	E	NNP	O	E	appos	2	SENT_600	[p28l904t1092r927b1118],
15	,	,	O	,	_	0	SENT_600	[p28l904t1092r927b1118],
16	Mallal	NNP	O	Mallal	nn	18	SENT_600	[p28l939t1090r1021b1113],
17	S.	NNP	O	S.	nn	18	SENT_600	[p28l1033t1092r1053b1113],
18	A	NNP	O	A	appos	2	SENT_600	[p28l1065t1092r1084b1113],
19	sensitive	JJ	O	sensitive	amod	22	SENT_600	[p28l1095t1090r1204b1113],
20	and	CC	O	and	_	0	SENT_600	[p28l668t1127r715b1150],
21	rapid	JJ	O	rapid	amod	22	SENT_600	[p28l727t1127r792b1157],
22	alternative	NN	O	alternative	_	0	SENT_600	[p28l805t1127r939b1150],
23	to	TO	O	to	_	0	SENT_600	[p28l952t1132r976b1150],
24	HLA	NN	O	hlum	nn	25	SENT_600	[p28l989t1129r1047b1150],
25	typing	NN	O	typing	prep_to	22	SENT_600	[p28l1059t1127r1142b1157],
26	as	IN	O	as	_	0	SENT_600	[p28l1153t1135r1178b1150],
27	a	DT	O	a	det	30	SENT_600	[p28l1191t1135r1204b1150],
28	genetic	JJ	O	genetic	amod	30	SENT_600	[p28l668t1164r760b1194],
29	screening	NN	O	screening	nn	30	SENT_600	[p28l771t1164r895b1194],
30	test	NN	O	test	prep_as	25	SENT_600	[p28l905t1169r951b1187],
31	for	IN	O	for	_	0	SENT_600	[p28l961t1164r997b1187],
32	abacavir	NN	O	abacavir	nn	34	SENT_600	[p28l1007t1164r1113b1187],
33	hypersensitivity	NN	O	hypersensitivity	nn	34	SENT_600	[p28l1123t1164r1204b1194, p28l669t1202r798b1231],
34	syndrome	NN	O	syndrome	prep_for	30	SENT_600	[p28l807t1201r939b1231],
35	.	.	O	.	_	0	SENT_600	[p28l807t1201r939b1231],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_601	[p28l950t1201r1151b1231],
2	Genomics	NNP	O	Genomics	_	0	SENT_601	[p28l1159t1203r1204b1224, p28l668t1238r760b1261],
3	2006	CD	DATE	2006	num	2	SENT_601	[p28l771t1240r952b1266],
4	;	:	O	;	_	0	SENT_601	[p28l771t1240r952b1266],
5	16:353	CD	NUMBER	16:353	number	6	SENT_601	[p28l771t1240r952b1266],
6	-7	CD	NUMBER	-7	dep	2	SENT_601	[p28l771t1240r952b1266],
7	.	.	O	.	_	0	SENT_601	[p28l771t1240r952b1266],

1	26	CD	NUMBER	26	_	0	SENT_602	[p28l668t1278r703b1298],
2	.	.	O	.	_	0	SENT_602	[p28l668t1278r703b1298],

1	Martin	NNP	PERSON	Martin	nn	2	SENT_603	[p28l717t1276r806b1298],
2	AM	NNP	O	AM	_	0	SENT_603	[p28l817t1278r869b1303],
3	,	,	O	,	_	0	SENT_603	[p28l817t1278r869b1303],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_603	[p28l882t1275r959b1298],
5	D	NNP	PERSON	D	appos	2	SENT_603	[p28l971t1277r997b1303],
6	,	,	O	,	_	0	SENT_603	[p28l971t1277r997b1303],
7	Mallal	NNP	O	Mallal	nn	9	SENT_603	[p28l1010t1275r1091b1298],
8	S.	NNP	O	S.	nn	9	SENT_603	[p28l1104t1277r1124b1298],
9	HLAB	NNP	O	HLAB	appos	2	SENT_603	[p28l1137t1278r1204b1298, p28l1243t906r1335b929],
10	*	VBD	O	*	partmod	9	SENT_603	[p28l1137t1278r1204b1298, p28l1243t906r1335b929],
11	5701	CD	NUMBER	5701	num	12	SENT_603	[p28l1137t1278r1204b1298, p28l1243t906r1335b929],
12	typing	NN	O	typing	dobj	10	SENT_603	[p28l1350t907r1433b936],
13	by	IN	O	by	_	0	SENT_603	[p28l1447t906r1475b936],
14	sequence-speciﬁc	NN	O	sequence-speciﬁc	nn	15	SENT_603	[p28l1489t906r1716b936],
15	amplification	NN	O	amplification	agent	10	SENT_603	[p28l1730t914r1779b929, p28l1243t943r1384b972],
16	:	:	O	:	_	0	SENT_603	[p28l1730t914r1779b929, p28l1243t943r1384b972],
17	validation	NN	O	validation	dep	2	SENT_603	[p28l1407t943r1535b966],
18	and	CC	O	and	_	0	SENT_603	[p28l1558t943r1604b966],
19	comparison	NN	O	comparison	dep	2	SENT_603	[p28l1628t943r1779b972],
20	with	IN	O	with	_	0	SENT_603	[p28l1242t979r1300b1003],
21	sequence-based	JJ	O	sequence-based	amod	22	SENT_603	[p28l1311t979r1511b1009],
22	typing	NN	O	typing	prep_with	17	SENT_603	[p28l1522t980r1611b1009],
23	.	.	O	.	_	0	SENT_603	[p28l1522t980r1611b1009],

1	Tissue	NN	O	tissue	nn	2	SENT_604	[p28l1623t980r1704b1003],
2	Antigens	NNS	O	antigen	_	0	SENT_604	[p28l1714t980r1779b1002, p28l1243t1023r1301b1046],
3	2005	CD	DATE	2005	dep	2	SENT_604	[p28l1312t1018r1497b1044],
4	;	:	O	;	_	0	SENT_604	[p28l1312t1018r1497b1044],
5	65:571	CD	NUMBER	65:571	num	6	SENT_604	[p28l1312t1018r1497b1044],
6	-4	CD	NUMBER	-4	dep	2	SENT_604	[p28l1312t1018r1497b1044],
7	.	.	O	.	_	0	SENT_604	[p28l1312t1018r1497b1044],

1	27	CD	NUMBER	27	_	0	SENT_605	[p28l1243t1056r1278b1076],
2	.	.	O	.	_	0	SENT_605	[p28l1243t1056r1278b1076],

1	Hammond	NNP	PERSON	Hammond	nn	2	SENT_606	[p28l1293t1053r1431b1076],
2	E	NNP	O	E	_	0	SENT_606	[p28l1442t1055r1465b1081],
3	,	,	O	,	_	0	SENT_606	[p28l1442t1055r1465b1081],
4	Almeida	NNP	PERSON	Almeida	nn	5	SENT_606	[p28l1478t1053r1585b1076],
5	C-A	NNP	O	C-A	appos	2	SENT_606	[p28l1597t1055r1650b1081],
6	,	,	O	,	_	0	SENT_606	[p28l1597t1055r1650b1081],
7	Mamotte	NNP	O	Mamotte	nn	8	SENT_606	[p28l1663t1055r1779b1076],
8	C	NNP	O	C	appos	2	SENT_606	[p28l1243t1092r1268b1118],
9	,	,	O	,	_	0	SENT_606	[p28l1243t1092r1268b1118],
10	et	FW	O	et	nn	11	SENT_606	[p28l1285t1095r1308b1113],
11	al.	FW	O	al.	appos	2	SENT_606	[p28l1322t1090r1351b1113],
12	.	.	O	.	_	0	SENT_606	[p28l1322t1090r1351b1113],

1	External	JJ	MISC	external	amod	3	SENT_607	[p28l1369t1090r1476b1113],
2	quality	NN	O	quality	nn	3	SENT_607	[p28l1491t1090r1580b1119],
3	assessment	NN	O	assessment	_	0	SENT_607	[p28l1594t1095r1740b1113],
4	of	IN	O	of	_	0	SENT_607	[p28l1755t1090r1784b1113],
5	HLA-B	NN	O	hla-b	prep_of	3	SENT_607	[p28l1243t1127r1402b1150],
6	*	CD	NUMBER	*	number	7	SENT_607	[p28l1243t1127r1402b1150],
7	5701	CD	NUMBER	5701	num	8	SENT_607	[p28l1243t1127r1402b1150],
8	reporting	NN	O	reporting	dep	3	SENT_607	[p28l1419t1127r1547b1157],
9	:	:	O	:	_	0	SENT_607	[p28l1419t1127r1547b1157],
10	an	DT	O	a	det	13	SENT_607	[p28l1565t1135r1595b1150],
11	international	JJ	O	international	amod	13	SENT_607	[p28l1611t1127r1779b1150],
12	multicentre	JJ	O	multicentre	amod	13	SENT_607	[p28l1243t1164r1391b1188],
13	survey	NN	O	survey	dep	3	SENT_607	[p28l1403t1172r1489b1194],
14	.	.	O	.	_	0	SENT_607	[p28l1403t1172r1489b1194],

1	Antivir	NNP	O	Antivir	nn	2	SENT_608	[p28l1501t1164r1591b1187],
2	Ther	NNP	O	Ther	_	0	SENT_608	[p28l1601t1164r1661b1187],
3	2007	CD	DATE	2007	num	2	SENT_608	[p28l1673t1166r1778b1192],
4	;	:	O	;	_	0	SENT_608	[p28l1673t1166r1778b1192],
5	12	CD	NUMBER	12	num	7	SENT_608	[p28l1673t1166r1778b1192],
6	:	:	O	:	_	0	SENT_608	[p28l1673t1166r1778b1192],
7	1027-32	CD	NUMBER	1027-32	dep	2	SENT_608	[p28l1244t1203r1347b1225],
8	.	.	O	.	_	0	SENT_608	[p28l1244t1203r1347b1225],

1	Copyright	NN	O	copyright	_	0	SENT_609	[p28l1244t1242r1337b1267],
2	©	CD	NUMBER	©	num	6	SENT_609	[p28l1346t1244r1367b1265],
3	2008	CD	DATE	2008	num	6	SENT_609	[p28l1377t1243r1427b1261],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_609	[p28l1435t1242r1575b1261],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_609	[p28l1585t1242r1661b1261],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_609	[p28l1669t1243r1741b1267],
7	.	.	O	.	_	0	SENT_609	[p28l1669t1243r1741b1267],

1	POSTING	VBG	O	post	_	0	SENT_610	[p28l541t1414r639b1430],
2	PRESENTATIONS	NNS	O	presentation	dobj	1	SENT_610	[p28l653t1414r834b1430],
3	AT	IN	O	at	_	0	SENT_610	[p28l845t1414r872b1430],
4	MEDICAL	NNP	O	MEDICAL	nn	5	SENT_610	[p28l885t1414r983b1430],
5	MEETINGS	NNP	O	MEETINGS	prep_at	1	SENT_610	[p28l995t1414r1109b1430],
6	ON	IN	O	on	_	0	SENT_610	[p28l1121t1414r1155b1430],
7	THE	DT	O	the	det	8	SENT_610	[p28l1167t1414r1211b1430],
8	INTERNET	NNP	O	INTERNET	prep_on	5	SENT_610	[p28l1224t1414r1333b1430],

1	Posting	VBG	O	post	csubjpass	27	SENT_611	[p28l439t1450r535b1479],
2	an	DT	O	a	det	4	SENT_611	[p28l543t1457r572b1472],
3	audio	JJ	O	audio	amod	4	SENT_611	[p28l581t1449r650b1472],
4	recording	NN	O	recording	dobj	1	SENT_611	[p28l659t1449r782b1479],
5	of	IN	O	of	_	0	SENT_611	[p28l790t1449r819b1472],
6	an	DT	O	a	det	8	SENT_611	[p28l822t1457r852b1472],
7	oral	JJ	O	oral	amod	8	SENT_611	[p28l861t1449r909b1472],
8	presentation	NN	O	presentation	prep_of	4	SENT_611	[p28l917t1450r1075b1479],
9	at	IN	O	at	_	0	SENT_611	[p28l1084t1454r1107b1472],
10	a	DT	O	a	det	12	SENT_611	[p28l1114t1457r1127b1472],
11	medical	JJ	O	medical	amod	12	SENT_611	[p28l1136t1449r1234b1472],
12	meeting	NN	O	meeting	prep_at	1	SENT_611	[p28l1243t1450r1346b1479],
13	on	IN	O	on	_	0	SENT_611	[p28l1354t1457r1385b1472],
14	the	DT	O	the	det	15	SENT_611	[p28l1394t1449r1432b1472],
15	Internet	NN	MISC	internet	prep_on	12	SENT_611	[p28l431t1489r538b1515],
16	,	,	O	,	_	0	SENT_611	[p28l431t1489r538b1515],
17	with	IN	O	with	_	0	SENT_611	[p28l547t1487r603b1510],
18	selected	VBN	O	select	amod	19	SENT_611	[p28l612t1487r712b1510],
19	slides	NNS	O	slide	prep_with	15	SENT_611	[p28l721t1487r791b1510],
20	from	IN	O	from	_	0	SENT_611	[p28l800t1486r861b1510],
21	the	DT	O	the	det	22	SENT_611	[p28l870t1487r908b1510],
22	presentation	NN	O	presentation	prep_from	19	SENT_611	[p28l917t1487r1082b1516],
23	,	,	O	,	_	0	SENT_611	[p28l917t1487r1082b1516],
24	will	MD	O	will	aux	27	SENT_611	[p28l1091t1487r1138b1510],
25	not	RB	O	not	neg	27	SENT_611	[p28l1146t1492r1189b1510],
26	be	VB	O	be	auxpass	27	SENT_611	[p28l1196t1487r1224b1510],
27	considered	VBN	O	consider	_	0	SENT_611	[p28l1233t1487r1371b1510],
28	prior	RB	O	prior	prep	27	SENT_611	[p28l1379t1487r1442b1516],
29	publication	NN	O	publication	pobj	28	SENT_611	[p28l425t1524r575b1554],
30	.	.	O	.	_	0	SENT_611	[p28l425t1524r575b1554],

1	This	DT	O	this	nsubj	3	SENT_612	[p28l585t1524r639b1547],
2	will	MD	O	will	aux	3	SENT_612	[p28l647t1524r694b1547],
3	allow	VB	O	allow	_	0	SENT_612	[p28l702t1524r771b1547],
4	students	NNS	O	student	dobj	3	SENT_612	[p28l779t1524r884b1547],
5	and	CC	O	and	_	0	SENT_612	[p28l893t1524r939b1547],
6	physicians	NNS	O	physician	dobj	3	SENT_612	[p28l947t1524r1079b1554],
7	who	WP	O	who	nsubj	9	SENT_612	[p28l1087t1524r1141b1547],
8	are	VBP	O	be	cop	9	SENT_612	[p28l1150t1532r1187b1547],
9	unable	JJ	O	unable	rcmod	4	SENT_612	[p28l1196t1524r1280b1547],
10	to	TO	O	to	aux	11	SENT_612	[p28l1289t1529r1312b1547],
11	attend	VB	O	attend	xcomp	9	SENT_612	[p28l1321t1524r1400b1547],
12	the	DT	O	the	det	13	SENT_612	[p28l1408t1524r1447b1547],
13	meeting	NN	O	meeting	dobj	11	SENT_612	[p28l441t1562r544b1591],
14	to	TO	O	to	aux	15	SENT_612	[p28l552t1567r575b1585],
15	hear	VB	O	hear	infmod	13	SENT_612	[p28l584t1562r639b1585],
16	the	DT	O	the	det	17	SENT_612	[p28l647t1562r686b1585],
17	presentation	NN	O	presentation	dobj	15	SENT_612	[p28l694t1562r852b1591],
18	and	CC	O	and	_	0	SENT_612	[p28l860t1562r907b1585],
19	view	VB	O	view	infmod	13	SENT_612	[p28l914t1562r971b1585],
20	the	DT	O	the	det	21	SENT_612	[p28l979t1562r1017b1585],
21	slides	NNS	O	slide	dobj	19	SENT_612	[p28l1026t1562r1104b1585],
22	.	.	O	.	_	0	SENT_612	[p28l1026t1562r1104b1585],

1	If	IN	O	if	mark	3	SENT_613	[p28l1114t1561r1138b1584],
2	there	EX	O	there	expl	3	SENT_613	[p28l1141t1562r1205b1585],
3	are	VBP	O	be	advcl	12	SENT_613	[p28l1213t1569r1250b1585],
4	any	DT	O	any	det	5	SENT_613	[p28l1259t1569r1303b1591],
5	questions	NNS	O	question	nsubj	3	SENT_613	[p28l1310t1562r1431b1591],
6	about	IN	O	about	_	0	SENT_613	[p28l442t1599r514b1622],
7	this	DT	O	this	det	8	SENT_613	[p28l522t1599r567b1622],
8	policy	NN	O	policy	prep_about	5	SENT_613	[p28l576t1599r658b1629],
9	,	,	O	,	_	0	SENT_613	[p28l576t1599r658b1629],
10	authors	NNS	O	author	nsubj	12	SENT_613	[p28l668t1599r763b1622],
11	should	MD	O	should	aux	12	SENT_613	[p28l772t1599r858b1622],
12	feel	VB	O	feel	_	0	SENT_613	[p28l866t1599r910b1622],
13	free	JJ	O	free	acomp	12	SENT_613	[p28l919t1599r966b1622],
14	to	TO	O	to	aux	15	SENT_613	[p28l975t1604r998b1622],
15	call	VB	O	call	xcomp	13	SENT_613	[p28l1007t1599r1050b1622],
16	the	DT	O	the	det	18	SENT_613	[p28l1058t1599r1207b1629],
17	]	NN	O	]	nn	18	SENT_613	[p28l1058t1599r1207b1629],
18	oumaI	NN	O	oumaus	poss	21	SENT_613	[p28l1058t1599r1207b1629],
19	’s	POS	O	’s	_	0	SENT_613	[p28l1058t1599r1207b1629],
20	Editorial	NN	MISC	editorial	nn	21	SENT_613	[p28l1216t1599r1324b1622],
21	Ofﬂces	NNS	MISC	ofﬂces	dobj	15	SENT_613	[p28l1333t1599r1428b1622],
22	.	.	O	.	_	0	SENT_613	[p28l1333t1599r1428b1622],

1	N	NN	O	n	nn	2	SENT_614	[p28l566t1754r580b1769],
2	ENGLJ	NN	O	englj	_	0	SENT_614	[p28l594t1754r672b1776],
3	MED	NN	O	med	dep	2	SENT_614	[p28l687t1754r739b1769],
4	358	CD	NUMBER	358	num	3	SENT_614	[p28l749t1748r812b1776],
5	;	:	O	;	_	0	SENT_614	[p28l749t1748r812b1776],
6	6	CD	NUMBER	6	num	7	SENT_614	[p28l749t1748r812b1776],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	dep	3	SENT_614	[p28l846t1754r1047b1776],

1	FEBRUARY	NN	DATE	february	_	0	SENT_615	[p28l1084t1754r1205b1770],
2	7	CD	DATE	7	num	1	SENT_615	[p28l1215t1754r1234b1775],
3	,	,	DATE	,	_	0	SENT_615	[p28l1215t1754r1234b1775],
4	2008	CD	DATE	2008	appos	1	SENT_615	[p28l1245t1748r1308b1770],

1	The	DT	O	the	det	4	SENT_616	[p28l752t1811r803b1835],
2	New	NNP	O	New	nn	4	SENT_616	[p28l812t1812r874b1835],
3	England	NNP	O	England	nn	4	SENT_616	[p28l883t1811r994b1842],
4	Journal	NNP	O	Journal	_	0	SENT_616	[p28l1002t1811r1100b1835],
5	of	IN	O	of	_	0	SENT_616	[p28l1109t1811r1138b1835],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_616	[p28l1145t1811r1270b1835],

